data_5vkg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5vkg _Structure_validation_residue.Date_analyzed 2018-01-09 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.4 t . . . . . 0 N--CA 1.449 -0.476 0 CA-C-O 120.892 0.377 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -94.58 158.43 15.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 95.4 mt-10 -64.14 -41.15 97.3 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.196 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.3 m -58.58 -47.43 84.33 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.165 0.984 . . . . 0.0 108.985 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -63.32 -33.64 75.96 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.874 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.7 tp -56.3 -38.49 71.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.6 mptp? -60.73 -42.8 98.04 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.367 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.1 -37.73 88.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.617 0.722 . . . . 0.0 110.884 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.3 mmm -67.54 -36.68 81.46 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.114 -177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.87 19.69 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.651 0.263 . . . . 0.0 111.116 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.7 p -64.56 -21.78 66.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.806 0.336 . . . . 0.0 110.532 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -72.06 -23.01 61.29 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.984 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.409 ' CZ ' HD21 ' A' ' 52' ' ' LEU . 30.2 m-85 -77.44 160.18 28.89 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.849 0.357 . . . . 0.0 110.365 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.6 -21.19 24.15 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.305 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.16 47.53 1.12 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 122.324 -0.235 . . . . 0.0 110.766 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -58.27 -24.65 60.12 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -73.61 -53.79 9.65 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.6 tp -65.13 -39.7 93.43 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.722 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.1 m -63.08 -48.68 77.55 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.338 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.3 t -61.5 -46.42 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 120.635 0.255 . . . . 0.0 110.47 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -62.63 -44.91 95.08 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.647 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -64.21 -36.88 85.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.948 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.3 p -64.81 -34.3 78.04 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.736 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.69 -44.91 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -61.37 -38.02 85.49 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.408 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.72 -44.73 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.95 -21.57 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.354 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.5 m -73.47 -45.88 51.52 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.535 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.0 tp -88.47 -39.27 14.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.032 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -111.07 66.97 0.63 Allowed 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -56.99 -17.64 10.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.288 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -66.85 -14.87 63.18 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.87 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 tp -99.98 114.27 27.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.1 ttpp -108.89 131.86 21.53 Favored Pre-proline 0 C--N 1.356 0.874 0 CA-C-N 119.521 1.055 . . . . 0.0 112.007 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.1 133.42 11.0 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.49 1.46 . . . . 0.0 112.535 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.4 t -133.96 139.36 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 110.71 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.1 tp -81.93 136.27 35.32 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -140.6 154.48 46.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.144 0.497 . . . . 0.0 111.27 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.6 m -91.56 131.46 36.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.9 t80 . . . . . 0 C--O 1.236 0.381 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.818 179.821 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 121.121 0.486 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -82.12 119.3 23.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.848 0.832 . . . . 0.0 109.733 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.409 HD21 ' CZ ' ' A' ' 15' ' ' TYR . 61.3 mt -121.44 146.71 46.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.791 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 53.5 ttp -97.54 142.79 28.94 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.682 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -135.81 152.85 51.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.452 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.5 mt -95.45 123.58 39.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -135.89 136.61 40.67 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.16 -146.69 11.47 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.522 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.1 p -132.84 159.4 39.93 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.77 116.48 18.18 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.895 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -70.56 124.81 11.1 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 CA-C-N 120.017 1.042 . . . . 0.0 109.942 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.1 t -125.56 118.43 24.62 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 119.671 -0.812 . . . . 0.0 113.015 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.7 142.22 52.19 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.944 1.763 . . . . 0.0 109.813 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -163.08 117.54 1.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.48 26.39 10.83 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.299 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.93 -5.62 78.44 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -112.97 142.78 45.27 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -121.65 132.26 54.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.775 0.321 . . . . 0.0 111.818 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -115.9 151.74 34.76 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.523 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -95.69 106.29 18.38 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 mp -90.83 118.56 68.71 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.79 122.1 2.24 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.601 2.201 . . . . 0.0 110.534 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.424 HG21 HD12 ' A' ' 72' ' ' ILE . 31.9 pt -134.44 149.51 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.796 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.1 m -123.5 127.9 49.01 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.947 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.71 115.49 30.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.868 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -103.69 125.81 50.42 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.6 mt -90.84 138.64 31.43 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.0 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.51 146.44 36.38 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -56.79 -14.99 3.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.476 0.58 . . . . 0.0 111.679 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.4 p -106.03 13.11 29.65 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.259 0.552 . . . . 0.0 111.536 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.406 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 60.1 t80 -61.4 144.39 92.07 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.406 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 24.4 Cg_endo -92.23 8.09 61.35 Favored 'Cis proline' 0 N--CA 1.514 2.721 0 CA-C-N 121.216 1.47 . . . . 0.0 115.623 1.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -71.51 -15.28 62.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.853 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.82 137.76 19.85 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.24 143.82 66.07 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 121.579 1.6 . . . . 0.0 110.751 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.82 138.9 13.57 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.444 1.43 . . . . 0.0 111.893 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 mt -95.2 131.73 41.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 40.3 t -110.06 150.75 28.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.066 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -133.28 127.05 32.81 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.535 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.3 t -96.1 121.56 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -68.95 109.69 4.74 Favored Pre-proline 0 N--CA 1.476 0.846 0 CA-C-O 119.167 -0.444 . . . . 0.0 111.15 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.21 164.71 11.26 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.577 1.518 . . . . 0.0 112.238 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.7 p -139.31 172.85 12.22 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.7 m -57.95 -41.19 82.33 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.86 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.9 m -90.29 -11.89 39.44 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.897 0.771 . . . . 0.0 111.733 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.0 tpp -108.91 124.45 50.69 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.15 165.33 14.32 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.353 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.2 mt -96.16 110.59 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -90.98 102.14 14.9 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.4 p -59.83 142.71 52.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.314 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -158.33 -144.15 3.86 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.705 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -65.95 -27.48 68.19 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -128.96 -7.79 4.93 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 119.047 -1.061 . . . . 0.0 113.407 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.21 126.56 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.167 0.894 . . . . 0.0 111.736 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -88.65 -161.41 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.76 -20.83 25.62 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.863 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -90.23 -1.79 57.97 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.728 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.9 11.73 56.26 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.855 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -63.01 140.56 58.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.527 0.664 . . . . 0.0 109.667 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 98.7 mt -116.6 117.99 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.107 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -102.38 137.29 40.83 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.8 mt -136.64 116.61 10.85 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.317 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.14 -38.25 24.66 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 121.844 1.696 . . . . 0.0 114.519 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.402 ' CD2' ' N ' ' A' ' 114' ' ' LEU . 1.3 p90 -61.53 -29.73 70.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.512 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 1.7 tt -69.56 -42.53 74.44 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.717 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -65.03 -29.29 70.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.309 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -107.44 13.56 26.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.071 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.424 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 6.5 t90 -76.43 121.96 23.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.75 0.786 . . . . 0.0 110.36 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -92.42 128.08 38.14 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.277 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -84.34 125.47 71.91 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.424 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -108.8 91.93 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.705 0 CA-C-N 120.866 1.345 . . . . 0.0 112.628 -2.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -113.77 -58.83 2.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.778 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.1 p -67.19 -39.02 86.3 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.52 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 58.95 161.69 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.474 0.654 . . . . 0.0 111.829 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 tt -58.39 -41.17 84.24 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.194 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.9 tp -56.75 -38.13 72.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.68 -39.69 98.24 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 tp -59.07 -38.98 80.73 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.02 -47.53 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.579 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -66.08 -36.83 84.26 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.89 -37.82 80.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.9 tpp -59.0 -43.03 91.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.82 -26.07 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.621 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.2 t -94.63 -52.05 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.5 p -64.77 -13.72 15.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 122.547 0.339 . . . . 0.0 111.402 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -101.98 -17.64 16.01 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.255 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.55 -28.07 60.14 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -64.81 -35.48 81.23 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.332 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -163.49 84.6 1.35 Allowed Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -44.06 112.6 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.497 1.465 . . . . 0.0 110.665 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.35 -20.44 61.71 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.358 1.372 . . . . 0.0 110.427 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.9 m -127.72 150.11 33.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 16.7 p90 . . . . . 0 N--CA 1.471 0.608 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.03 -179.513 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.4 t . . . . . 0 CA--C 1.515 -0.398 0 CA-C-O 121.298 0.571 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.48 154.57 18.13 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.467 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 39.9 mt-10 -62.18 -40.61 96.62 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.954 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.8 t -58.83 -47.7 83.9 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 122.148 0.975 . . . . 0.0 109.269 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -64.51 -30.4 71.43 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.855 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.2 tp -60.0 -37.05 78.56 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -62.8 -43.27 99.24 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.432 178.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.31 -37.44 83.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.94 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -37.51 87.71 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.017 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.39 24.82 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.883 0.373 . . . . 0.0 111.856 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.5 t -64.59 -37.17 86.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.07 0.462 . . . . 0.0 111.147 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.22 -12.38 60.87 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.89 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -77.99 159.55 28.72 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -81.86 -26.87 33.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.651 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -116.19 55.24 0.81 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 119.67 -0.205 . . . . 0.0 110.809 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 ptt-85 -63.76 -24.7 67.87 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -53.88 8.56 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.038 -0.414 . . . . 0.0 111.709 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -42.88 96.6 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.117 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.0 m -60.61 -48.07 83.4 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.419 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.6 t -61.05 -44.74 98.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -41.4 98.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.566 -0.853 . . . . 0.0 109.784 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -39.2 89.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.071 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 p -65.72 -37.86 87.58 Favored 'General case' 0 CA--C 1.507 -0.673 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.461 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.85 -43.99 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.486 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -61.86 -37.91 86.29 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.025 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.1 t -71.23 -43.11 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.82 -20.27 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.114 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -78.31 -47.54 17.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -84.23 -39.74 18.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.794 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -110.56 66.98 0.63 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -58.08 -16.58 13.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.82 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -65.34 -22.0 66.77 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.826 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 tp -91.84 114.29 26.78 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -108.26 123.21 38.17 Favored Pre-proline 0 C--N 1.357 0.926 0 CA-C-N 119.551 1.069 . . . . 0.0 111.663 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.89 134.09 9.37 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.383 1.388 . . . . 0.0 112.976 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.9 155.3 41.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 110.711 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.97 122.43 30.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.992 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -125.07 133.06 53.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.584 0.23 . . . . 0.0 111.21 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.3 p -69.48 146.09 52.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.237 0.443 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.425 -179.107 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 . . . . . 0 N--CA 1.468 0.435 0 CA-C-O 120.966 0.412 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.7 121.59 17.48 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.92 126.43 39.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.962 0.411 . . . . 0.0 109.914 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.9 ttp -84.55 150.48 25.19 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.922 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -138.73 157.28 46.38 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.318 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mt -108.36 125.05 51.28 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.4 m -140.33 139.2 35.36 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.977 0.418 . . . . 0.0 112.12 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.19 -149.51 15.05 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.628 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.0 p -131.75 159.21 39.12 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -130.25 116.53 17.68 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.9 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -70.79 125.97 12.15 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 CA-C-N 119.892 0.997 . . . . 0.0 109.878 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.0 t -130.02 127.32 22.68 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.573 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.09 149.64 52.71 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.092 1.861 . . . . 0.0 110.452 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -161.63 106.42 1.28 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.338 0.589 . . . . 0.0 111.889 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 51.15 39.58 23.84 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.914 -0.491 . . . . 0.0 111.951 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.22 -0.55 83.73 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -121.13 132.16 54.69 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -110.09 131.04 55.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.659 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -113.89 151.43 32.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.621 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -97.96 104.07 16.07 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.98 117.09 67.92 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.11 124.88 3.91 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.525 2.15 . . . . 0.0 110.919 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.4 pt -132.67 147.96 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.613 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.5 m -123.01 126.13 46.55 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-O 121.385 0.612 . . . . 0.0 110.0 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.09 109.97 22.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.506 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.496 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 91.0 m95 -98.38 121.62 40.55 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.657 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.7 144.28 26.12 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.874 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mt -88.76 154.48 20.25 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -60.13 -17.68 42.07 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.524 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -100.47 1.32 41.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.732 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -53.81 145.77 30.13 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -92.37 12.07 53.97 Favored 'Cis proline' 0 N--CA 1.519 2.994 0 N-CA-C 116.061 1.524 . . . . 0.0 116.061 1.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -80.78 -2.38 46.86 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.296 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.82 122.83 26.32 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 118.555 -0.736 . . . . 0.0 109.08 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.76 132.66 21.58 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 CA-C-N 121.313 1.505 . . . . 0.0 112.505 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.32 144.27 14.41 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 122.382 2.054 . . . . 0.0 111.474 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.55 132.9 42.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.881 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 41.8 t -110.33 151.21 27.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.642 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -131.69 127.39 36.79 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.325 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.7 t -90.76 123.77 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -71.12 110.21 6.84 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 119.338 -0.363 . . . . 0.0 111.334 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -85.73 157.87 10.46 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.901 1.734 . . . . 0.0 113.218 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.2 p -135.78 165.59 25.25 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.93 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.2 p -60.32 -24.57 65.11 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -104.19 13.53 32.13 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.93 0.786 . . . . 0.0 110.728 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.24 148.15 50.8 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.59 165.98 23.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 120.156 -0.617 . . . . 0.0 110.438 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 90.3 mt -103.27 105.76 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -94.77 108.64 20.65 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.238 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 82.3 p -65.98 151.21 47.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.928 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.78 -134.74 1.8 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.356 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.7 pttp -86.03 -3.8 59.02 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -136.42 -24.09 1.23 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.22 145.99 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.683 0.674 . . . . 0.0 110.171 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -101.37 -179.55 4.06 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.699 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.31 73.13 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -79.88 2.53 22.93 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.796 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.01 27.78 15.41 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.087 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -82.56 132.42 35.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 117.588 0.694 . . . . 0.0 110.149 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.3 mt -110.44 109.94 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.606 0.241 . . . . 0.0 110.782 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -114.07 138.86 49.84 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mt -131.65 130.57 22.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 118.563 0.62 . . . . 0.0 111.883 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -46.93 -39.8 25.03 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.433 1.422 . . . . 0.0 113.957 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.05 -29.69 70.47 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.669 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 tt -70.79 -41.07 72.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.804 0.335 . . . . 0.0 111.008 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -67.36 -27.07 66.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.381 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -105.57 -3.64 22.11 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.878 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.424 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.8 t90 -62.82 124.07 20.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.671 0.748 . . . . 0.0 110.16 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -91.65 126.05 36.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.561 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -79.92 125.45 81.96 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 119.032 -0.508 . . . . 0.0 110.119 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -109.12 92.68 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 120.823 1.33 . . . . 0.0 112.454 -2.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -114.11 -61.26 1.77 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.401 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.426 ' O ' ' CG ' ' A' ' 123' ' ' ASP . 15.7 t -69.99 -30.76 68.17 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.689 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 122' ' ' SER . 4.6 p-10 48.89 -175.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.622 0.725 . . . . 0.0 111.947 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 tt -71.84 -43.5 65.42 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.711 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.53 -37.76 50.94 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.09 -41.42 98.49 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.8 tp -59.14 -40.87 86.83 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -73.16 -45.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.577 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.78 -33.22 68.41 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.097 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 67.4 t -68.61 -37.75 78.08 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 53.2 tpp -59.79 -42.45 93.41 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -66.3 -44.5 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.603 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.4 t -74.2 -40.83 51.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.5 p -78.66 -13.62 13.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.678 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -108.49 -17.59 13.94 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.436 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.66 -27.53 70.01 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 107.435 -2.266 . . . . 0.0 107.435 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -65.29 -35.83 82.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.019 -0.59 . . . . 0.0 110.618 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -166.88 84.89 0.86 Allowed Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -47.78 114.65 1.15 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.327 1.351 . . . . 0.0 109.852 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.33 -21.05 27.71 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.797 1.665 . . . . 0.0 111.235 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.67 147.08 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.094 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 20.2 p90 . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.723 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.446 -0.657 0 CA-C-O 121.39 0.614 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.18 151.79 19.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 93.0 mt-10 -62.6 -41.89 99.25 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.358 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.4 m -59.05 -45.03 91.78 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.017 0.913 . . . . 0.0 109.58 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -64.91 -36.5 84.56 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.207 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.2 tp -56.58 -40.02 74.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 3.3 mptp? -62.46 -42.78 99.72 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.844 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -66.32 -33.4 75.64 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.894 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.49 -36.02 76.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.036 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 m -120.02 30.96 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 111.162 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.1 p -69.27 -12.9 62.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.727 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -85.6 -12.92 50.31 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 121.016 -0.273 . . . . 0.0 111.386 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -71.94 151.13 43.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.005 0.431 . . . . 0.0 111.109 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -70.94 -38.07 72.87 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -111.28 64.22 0.61 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -66.81 -30.35 70.52 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.44 -42.97 78.08 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.09 -38.33 61.26 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.784 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.2 m -62.58 -41.79 99.16 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.057 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.4 t -71.29 -46.14 66.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.439 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -63.98 -44.06 93.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.333 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -29.35 68.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.385 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 p -70.14 -37.83 75.37 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.717 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.77 -43.32 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -60.63 -40.25 91.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.29 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.4 t -70.1 -42.55 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.99 -16.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.22 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.7 m -80.86 -49.41 11.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.6 tp -83.19 -37.15 24.02 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.269 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.36 68.45 0.7 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.467 0.651 . . . . 0.0 109.381 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -58.39 -18.9 31.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.944 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.18 -21.08 66.72 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.458 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 tp -93.78 113.51 25.57 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -109.87 125.25 31.57 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 119.451 1.023 . . . . 0.0 112.352 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -80.31 138.68 12.65 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.655 1.57 . . . . 0.0 113.149 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.37 156.56 39.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.8 tp -97.1 107.56 20.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -110.04 130.19 55.57 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.071 0.462 . . . . 0.0 111.609 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.8 p -79.89 131.87 35.95 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.4 t80 . . . . . 0 C--O 1.238 0.47 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.115 -178.897 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 121.107 0.479 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.21 105.64 13.46 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.057 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.2 mt -119.29 125.19 48.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.105 0.479 . . . . 0.0 110.01 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -92.83 138.42 31.5 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.606 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -127.44 152.22 47.82 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.18 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.4 mt -97.37 130.11 44.55 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.3 m -141.2 137.63 32.77 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.15 -144.08 8.76 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.9 p -136.81 159.71 41.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 pt -132.19 115.22 15.1 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.074 176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -70.54 125.41 11.71 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.164 1.243 . . . . 0.0 110.293 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.1 t -126.37 121.85 23.78 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.057 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.72 148.7 41.96 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.414 2.076 . . . . 0.0 110.936 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.449 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -163.42 109.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.442 0.639 . . . . 0.0 111.522 -178.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 52.86 37.91 25.4 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.712 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.54 82.01 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -119.34 130.71 55.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -115.29 132.29 56.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.957 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -112.51 148.94 33.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.883 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -94.42 106.42 18.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.09 116.25 66.03 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -85.17 124.94 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.808 2.339 . . . . 0.0 110.25 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 72' ' ' ILE . 24.6 pt -134.98 148.7 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.572 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.1 m -121.77 123.14 41.12 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.475 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.95 112.81 25.94 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.232 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -105.7 125.29 50.82 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 75.5 mt -92.38 139.33 30.71 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.24 157.95 27.69 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -69.37 -7.66 39.46 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.268 -0.27 . . . . 0.0 111.509 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.57 2.29 23.91 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.916 0.389 . . . . 0.0 110.979 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 46.1 t80 -57.89 147.79 61.97 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.442 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 1.7 Cg_endo -91.22 13.71 52.29 Favored 'Cis proline' 0 N--CA 1.515 2.743 0 CA-C-N 120.975 1.384 . . . . 0.0 114.653 0.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -80.04 -2.61 44.98 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.052 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.83 140.33 33.03 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -66.27 143.11 69.39 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 CA-C-N 121.56 1.593 . . . . 0.0 111.014 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.67 141.38 9.76 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.153 1.902 . . . . 0.0 112.26 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -93.07 129.7 43.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.6 t -120.65 141.8 50.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.763 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -127.67 132.16 49.72 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.581 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.444 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 42.8 t -90.41 131.8 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.01 100.02 2.62 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.128 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 64.7 Cg_endo -82.36 166.35 16.08 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 122.222 1.948 . . . . 0.0 112.837 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -145.71 171.3 14.95 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.8 p -57.32 -25.46 59.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 119.866 -0.734 . . . . 0.0 112.036 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 96.7 p -95.14 3.42 54.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.702 0.683 . . . . 0.0 110.794 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 39.3 ttm -141.93 122.02 13.78 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.048 0.452 . . . . 0.0 109.84 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 95.2 m -107.0 140.95 38.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.443 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.403 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 3.9 tp -75.43 120.74 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -110.64 101.12 9.79 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.7 p -58.31 151.69 19.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.591 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.47 -132.13 1.49 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 119.774 -1.203 . . . . 0.0 112.644 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -86.81 -3.5 59.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -138.92 -25.94 0.86 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 119.402 1.001 . . . . 0.0 113.616 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 t -111.95 135.46 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 119.218 0.917 . . . . 0.0 110.198 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -90.54 -159.97 0.66 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.547 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.39 -8.24 55.34 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.8 -6.14 16.92 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.78 11.47 37.6 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.974 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -72.77 135.98 45.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.399 0.599 . . . . 0.0 110.063 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 69.9 mt -114.8 115.49 49.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 O-C-N 123.311 0.382 . . . . 0.0 110.718 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -115.21 138.77 50.56 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mp -130.88 130.96 22.96 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.475 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.71 -32.45 55.24 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.125 1.217 . . . . 0.0 113.184 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -67.41 -30.12 69.79 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.26 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.77 -41.22 83.63 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.208 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -64.3 -34.31 77.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.2 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -100.81 2.71 41.41 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.539 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -68.72 124.21 23.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.921 0.867 . . . . 0.0 110.17 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -94.37 124.85 38.64 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.522 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -80.83 125.3 80.48 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.643 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -108.98 92.19 0.03 OUTLIER 'Cis proline' 0 N--CA 1.5 1.867 0 CA-C-N 120.791 1.318 . . . . 0.0 112.799 -2.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.88 -59.99 1.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.613 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -65.13 -40.93 95.12 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.412 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 58.54 164.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.25 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 mt -50.89 -48.57 60.39 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.311 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.72 -36.72 26.4 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.74 -40.65 98.72 Favored Glycine 0 N--CA 1.477 1.42 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 tp -62.53 -41.73 99.06 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -74.69 -45.87 43.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.619 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -68.85 -36.74 78.52 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.665 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.99 -40.3 85.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.873 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.8 ttm -58.23 -43.24 87.63 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.3 -35.2 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.74 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.4 t -89.64 -50.1 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.677 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.7 p -65.21 -13.85 15.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.832 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -106.78 -17.23 14.27 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.586 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.89 -27.89 73.51 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.82 -34.72 79.03 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.785 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -165.91 85.43 0.97 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -45.7 113.32 0.54 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.37 1.38 . . . . 0.0 110.533 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.6 0.44 8.68 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.511 1.474 . . . . 0.0 111.548 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.24 123.56 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.285 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.6 t . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 120.908 0.385 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -95.21 157.65 15.8 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 86.6 mt-10 -63.13 -41.92 99.4 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.118 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.1 t -59.71 -49.87 76.06 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.044 0.926 . . . . 0.0 109.383 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -62.69 -28.2 69.77 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.744 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.417 ' O ' HG22 ' A' ' 12' ' ' VAL . 59.3 tp -59.77 -42.67 93.8 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.9 mptp? -58.82 -39.89 82.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.148 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.11 -31.0 72.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.781 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 ptp -86.39 -14.78 42.39 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.622 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -125.94 16.5 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.83 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.3 t -59.78 -21.98 61.53 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.496 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -84.04 -15.96 45.64 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -70.09 152.18 44.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.003 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -70.02 -37.64 75.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.838 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 40.8 m-85 -110.65 60.66 0.61 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.564 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -66.44 -20.73 66.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.125 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -77.04 -52.06 9.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.8 tp -67.93 -41.0 83.24 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.151 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.2 m -61.13 -47.03 88.13 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.778 0.323 . . . . 0.0 110.789 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.3 t -63.25 -42.83 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.654 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -55.31 23.43 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 118.834 -1.147 . . . . 0.0 110.526 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -61.37 -31.83 71.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.367 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -66.86 -35.26 79.62 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.31 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.0 t -57.77 -44.03 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.19 -39.88 88.11 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.307 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.1 t -69.84 -43.36 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.25 -17.4 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.567 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.2 m -82.35 -49.05 10.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.192 0.52 . . . . 0.0 109.617 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.89 -38.99 24.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.525 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -110.2 67.44 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -56.14 -18.92 11.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.953 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.31 -21.54 66.72 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.038 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 tp -94.15 113.18 25.08 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.19 119.02 43.2 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 119.181 0.9 . . . . 0.0 112.091 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.29 137.53 15.14 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 CA-C-N 120.653 1.269 . . . . 0.0 112.282 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.19 150.9 32.07 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.1 tp -97.78 119.3 36.13 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.113 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -135.43 135.44 40.58 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.016 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.0 t -64.22 139.97 58.82 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.37 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.014 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 121.435 0.636 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -77.07 121.74 23.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.264 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -124.04 144.51 49.8 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.054 0.454 . . . . 0.0 110.31 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -100.2 141.22 33.33 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.646 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -133.08 154.28 50.71 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.388 0.613 . . . . 0.0 111.863 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.49 124.94 37.82 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.575 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.4 m -139.29 136.98 35.46 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.44 -145.6 10.13 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.836 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 p -134.61 159.74 40.27 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.83 116.21 15.82 Favored Pre-proline 0 N--CA 1.471 0.594 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.178 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -71.97 124.4 10.08 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 N-CA-C 109.538 -0.986 . . . . 0.0 109.538 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.42 121.35 24.89 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.891 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.39 149.03 55.92 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.197 1.931 . . . . 0.0 110.429 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.7 109.7 1.09 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.521 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.96 40.59 25.62 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.439 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.72 13.84 80.22 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -134.71 127.86 31.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.5 m -112.02 133.1 54.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.84 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -113.89 150.63 33.37 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -95.16 108.72 20.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.21 116.16 65.9 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.34 124.77 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.658 2.238 . . . . 0.0 110.75 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 72' ' ' ILE . 26.9 pt -132.79 147.99 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 119.421 -0.911 . . . . 0.0 111.994 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 63.8 m -123.88 121.58 35.73 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.071 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.81 114.41 28.61 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.489 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -102.1 115.29 30.23 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.1 mt -85.9 135.15 33.8 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -80.28 155.34 27.33 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -60.68 -17.18 46.18 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.746 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.61 -3.02 50.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.523 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -57.09 144.42 69.23 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -92.04 9.13 60.74 Favored 'Cis proline' 0 N--CA 1.521 3.101 0 N-CA-C 115.936 1.475 . . . . 0.0 115.936 0.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.409 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 42.7 m-85 -76.94 -11.97 59.88 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.636 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.86 127.17 27.11 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.511 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -49.39 132.49 29.47 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 CA-C-N 121.21 1.468 . . . . 0.0 112.467 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.04 143.83 8.14 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 122.574 2.183 . . . . 0.0 111.878 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.43 132.97 40.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.39 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 46.1 t -116.47 143.57 45.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.176 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -127.89 129.95 47.74 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.954 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.28 121.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.82 107.53 1.35 Allowed Pre-proline 0 N--CA 1.474 0.744 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.019 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.03 156.64 13.27 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 CA-C-N 120.675 1.277 . . . . 0.0 112.772 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -136.14 171.69 14.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.43 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.8 t -58.55 -40.67 83.69 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.5 m -96.79 20.73 10.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.037 0.835 . . . . 0.0 111.126 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.0 ttm -137.96 141.16 40.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.29 162.76 32.65 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.174 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.9 mt -97.95 103.43 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -90.59 109.96 21.11 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.8 p -59.85 147.4 38.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.282 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.88 -145.3 4.15 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.518 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -64.14 -27.5 69.12 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -132.63 -15.63 2.72 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 119.167 -1.013 . . . . 0.0 113.214 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.8 t -91.93 129.27 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.438 1.017 . . . . 0.0 111.375 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 108' ' ' LYS . 36.9 p-10 -89.72 -168.79 2.24 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.71 -22.79 25.83 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.683 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -82.24 -8.0 59.63 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.623 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.21 -0.7 62.18 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.098 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.404 ' N ' ' OD1' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -63.71 143.58 57.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.436 HG21 HD12 ' A' ' 109' ' ' ILE . 97.3 mt -110.87 122.46 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -176.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -99.86 139.91 34.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.4 mt -139.55 117.92 8.78 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.83 -29.47 63.17 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.553 1.502 . . . . 0.0 114.056 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -69.23 -30.76 68.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.875 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.75 -41.05 68.92 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.043 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -72.3 -25.5 61.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.309 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -102.23 -4.69 25.33 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.483 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 7.2 t90 -53.07 121.32 7.2 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.94 0.876 . . . . 0.0 110.503 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -96.42 106.61 18.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.491 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -61.95 125.26 84.72 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.133 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -111.05 90.78 0.03 OUTLIER 'Cis proline' 0 N--CA 1.488 1.201 0 CA-C-N 120.676 1.277 . . . . 0.0 112.831 -3.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -114.59 -55.2 2.51 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.428 -0.509 . . . . 0.0 112.142 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 p -70.54 -39.42 74.03 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.387 0.613 . . . . 0.0 110.767 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 t70 59.28 165.59 0.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.408 0.623 . . . . 0.0 111.091 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.9 tt -62.2 -43.68 98.29 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.12 -36.32 50.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.27 -39.52 97.82 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.2 tp -59.48 -40.99 88.78 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -75.32 -49.91 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.206 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -63.74 -37.7 88.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.161 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.29 -38.59 82.19 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 C-N-CA 119.465 -0.894 . . . . 0.0 108.712 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.4 tpp -58.48 -43.3 88.92 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.11 -43.54 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.453 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.3 t -77.78 -42.02 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.7 p -75.91 -13.22 14.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.014 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -104.81 -18.37 14.26 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.602 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.31 -20.83 79.44 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -68.72 -36.16 78.08 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.653 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -164.47 90.91 1.03 Allowed Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -44.9 109.96 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.304 1.336 . . . . 0.0 110.382 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.02 -26.14 73.81 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.77 1.647 . . . . 0.0 109.942 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.58 146.91 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.957 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 9.0 p90 . . . . . 0 N--CA 1.476 0.829 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.997 -179.86 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.443 -0.779 0 CA-C-O 121.401 0.62 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 p -100.46 158.12 16.14 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.4 mt-10 -62.76 -42.04 99.5 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.525 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 t -59.81 -48.7 80.63 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.839 0.828 . . . . 0.0 109.593 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -62.42 -31.98 72.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.307 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.1 tp -57.86 -40.61 80.56 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.7 mptp? -60.83 -41.79 96.46 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.441 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.06 -37.84 86.53 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.465 0.65 . . . . 0.0 109.902 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -69.83 -38.57 76.58 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.477 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 m -112.65 16.1 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -65.13 -25.51 67.79 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.368 0.604 . . . . 0.0 109.987 178.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.05 -13.57 62.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.037 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -82.22 159.93 23.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -81.9 -27.67 33.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.781 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CZ ' ' CE1' ' A' ' 82' ' ' TYR . 62.5 m-85 -113.77 58.57 0.67 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -65.59 -24.93 67.19 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -79.46 -50.45 10.76 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 121.419 -0.801 . . . . 0.0 112.168 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 tp -65.27 -40.62 94.15 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.548 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -61.56 -46.48 89.72 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.301 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.6 t -61.36 -45.03 99.45 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 CA-C-O 121.089 0.471 . . . . 0.0 110.166 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -40.15 91.4 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.705 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -38.13 80.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.328 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.7 p -67.58 -33.73 75.6 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.738 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.07 -44.81 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.519 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -60.77 -37.49 82.05 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.098 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.77 -44.18 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.93 -22.11 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.004 -1.079 . . . . 0.0 111.615 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.2 m -72.62 -43.64 63.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.939 0.4 . . . . 0.0 110.645 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.0 -38.64 15.33 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.749 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.7 66.74 0.65 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -55.99 -17.85 7.83 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.093 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.38 -21.38 66.61 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.966 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 tp -89.69 113.62 25.14 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -109.11 125.39 31.63 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-N 119.686 1.13 . . . . 0.0 111.829 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.68 136.31 13.53 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.323 1.348 . . . . 0.0 112.66 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.3 133.65 68.28 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.8 tp -83.11 118.7 23.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.94 132.89 50.75 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.3 m -62.44 140.42 58.58 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.625 -177.713 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.0 ttm105 . . . . . 0 CA--C 1.517 -0.316 0 CA-C-O 121.05 0.452 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -72.97 117.33 14.57 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.3 tp -115.91 121.85 43.56 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -83.81 137.04 33.9 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -132.71 154.73 49.89 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.29 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.6 mt -102.2 122.26 43.85 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.8 m -135.1 137.52 42.91 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.19 -147.05 10.7 Favored Glycine 0 N--CA 1.47 0.955 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.909 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 p -132.75 158.45 42.37 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.6 116.99 16.3 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.168 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -71.28 128.02 14.13 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.832 1.021 . . . . 0.0 109.801 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 74.4 t -127.1 119.52 22.22 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.696 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -64.48 146.1 88.85 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.064 1.842 . . . . 0.0 109.534 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -161.83 106.96 1.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.867 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.4 36.53 13.36 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.83 -6.98 79.25 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.438 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -117.5 146.08 43.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.0 m -123.31 134.36 54.06 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.951 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -116.62 149.92 38.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.27 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.71 105.26 17.38 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.9 120.58 65.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.55 123.59 3.39 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.818 2.345 . . . . 0.0 110.88 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.438 HD13 HG22 ' A' ' 72' ' ' ILE . 32.5 pt -128.96 146.04 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 119.131 -1.027 . . . . 0.0 112.168 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.4 m -120.54 122.47 40.68 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-O 121.67 0.747 . . . . 0.0 109.634 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.19 112.51 25.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.165 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -107.67 123.41 48.47 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.1 mt -90.88 130.98 36.78 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.659 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mt -72.72 153.31 41.21 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.376 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -60.33 -12.79 10.08 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p -103.28 -1.22 29.16 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -48.23 146.24 4.68 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -95.6 19.46 33.06 Favored 'Cis proline' 0 N--CA 1.517 2.885 0 N-CA-C 116.616 1.737 . . . . 0.0 116.616 2.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.424 ' CE1' ' CZ ' ' A' ' 17' ' ' TYR . 46.3 m-85 -80.52 -1.03 40.14 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.192 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.31 126.13 24.65 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.601 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -50.87 137.49 43.19 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 121.66 1.629 . . . . 0.0 109.67 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.81 144.13 19.05 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 121.824 1.682 . . . . 0.0 111.852 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mt -88.46 130.6 37.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.596 0.713 . . . . 0.0 109.276 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.8 t -119.53 136.97 54.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.496 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -123.67 129.86 51.76 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.376 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.0 t -93.11 120.97 43.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -63.56 107.27 1.19 Allowed Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.689 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -84.13 158.71 13.32 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.549 1.5 . . . . 0.0 112.262 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.7 p -139.15 174.48 10.47 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.928 0.394 . . . . 0.0 110.66 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -59.35 -39.92 84.76 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -101.12 12.08 38.28 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.985 0.811 . . . . 0.0 111.174 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 8.7 mmm -130.54 119.98 23.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.68 162.71 17.97 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.181 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.0 mt -97.79 108.02 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -91.19 106.62 18.64 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.7 p -62.55 142.35 58.02 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.49 -139.29 2.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.157 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -66.46 -25.71 66.85 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -133.32 -20.85 2.08 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.2 t -91.93 133.56 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.241 0.928 . . . . 0.0 111.332 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -98.13 -168.72 1.7 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.001 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.82 -29.66 29.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -84.19 3.13 36.53 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.821 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.45 6.18 58.72 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.432 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -59.13 137.47 57.94 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.991 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -114.95 112.98 42.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.633 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -99.9 140.73 33.69 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.2 mt -137.77 121.68 11.77 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.832 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.06 -39.02 25.26 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.666 1.577 . . . . 0.0 113.611 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -61.55 -31.27 71.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.666 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.89 -42.78 84.93 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.472 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -62.46 -36.48 82.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.604 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -95.74 -0.22 51.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.654 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -62.76 125.27 23.39 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.796 0.807 . . . . 0.0 110.228 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -109.03 106.84 16.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.858 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -60.64 124.05 77.16 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.451 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -108.57 91.67 0.03 OUTLIER 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 120.354 1.162 . . . . 0.0 112.646 -2.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -113.49 -62.77 1.54 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.392 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.0 t -67.13 -41.17 86.61 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.23 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.8 t70 68.04 166.27 0.24 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.751 0.786 . . . . 0.0 112.008 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 tt -64.11 -44.58 91.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.319 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.42 -38.45 59.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.07 -40.48 98.57 Favored Glycine 0 N--CA 1.478 1.499 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.7 tp -59.75 -41.17 90.41 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.54 -46.98 46.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.854 -0.738 . . . . 0.0 111.886 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -68.16 -35.72 78.5 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.08 -37.5 79.91 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.1 tpp -58.9 -44.34 91.19 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -32.52 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.734 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.54 -46.04 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.343 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.5 p -70.1 -13.79 17.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.988 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -103.25 -17.26 15.4 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.258 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.13 -31.05 54.01 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.73 -37.9 89.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.745 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -155.85 82.26 3.7 Favored Pre-proline 0 N--CA 1.447 -0.603 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -44.49 112.36 0.35 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.818 1.679 . . . . 0.0 111.144 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.21 -22.32 46.92 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.656 1.57 . . . . 0.0 111.698 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.8 m -128.48 140.49 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.853 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.2 p90 . . . . . 0 N--CA 1.473 0.703 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.107 -179.642 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 CA--C 1.514 -0.428 0 CA-C-O 121.077 0.465 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -93.54 161.13 14.49 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 3.2 mm-40 -65.82 -43.04 89.79 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.837 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -59.57 -48.52 81.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 122.034 0.921 . . . . 0.0 109.126 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -62.9 -29.09 70.5 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.9 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 11' ' ' MET . 65.9 tp -60.32 -42.24 95.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.728 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.438 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.6 mptp? -59.69 -39.39 84.39 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.898 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -61.76 -33.88 74.86 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.408 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.405 ' HG2' ' HA ' ' A' ' 8' ' ' LEU . 17.5 ptp -85.48 -13.3 49.54 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -128.16 16.98 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.882 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -61.06 -38.25 85.52 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.111 0.481 . . . . 0.0 111.222 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -62.58 -18.72 62.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.825 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -72.26 153.15 41.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.92 0.391 . . . . 0.0 111.52 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -78.68 -29.21 45.44 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.016 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.412 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 45.0 m-85 -112.2 55.32 0.68 Allowed 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.987 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -63.65 -27.55 69.3 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.73 -52.18 22.59 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -40.09 83.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.324 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.3 m -61.73 -46.81 88.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.093 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.34 -46.95 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.034 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 tmt_? -63.22 -41.75 99.18 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.426 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -66.7 -37.99 85.85 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.258 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.5 p -64.17 -33.86 76.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.07 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.58 -44.75 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.097 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -60.58 -37.82 82.57 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.902 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.97 -44.08 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.89 -18.76 8.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 118.807 -1.157 . . . . 0.0 111.447 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.3 m -74.27 -44.81 51.3 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.068 0.461 . . . . 0.0 110.07 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.7 tp -87.02 -37.86 17.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.407 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -114.56 67.58 0.69 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.864 0.364 . . . . 0.0 110.252 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -56.3 -17.33 7.38 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.084 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -65.65 -21.0 66.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.896 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.0 tp -95.99 113.65 25.28 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -114.44 136.74 22.38 Favored Pre-proline 0 C--N 1.357 0.923 0 CA-C-N 119.596 1.089 . . . . 0.0 111.614 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -79.75 136.75 12.26 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.003 1.802 . . . . 0.0 113.033 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.7 t -129.21 138.07 55.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.7 tp -89.51 113.69 25.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.115 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -119.84 139.64 52.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.407 0.622 . . . . 0.0 112.417 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.1 m -71.71 140.79 49.74 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.463 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.7 t80 . . . . . 0 N--CA 1.476 0.859 0 CA-C-N 118.388 0.54 . . . . 0.0 110.077 179.85 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.3 ttm-85 . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 120.949 0.404 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -79.14 122.6 26.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.523 0.678 . . . . 0.0 109.883 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.0 tp -120.99 124.38 44.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.693 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -85.28 140.76 30.58 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.014 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -136.73 147.0 46.47 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.012 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.7 mt -92.96 127.45 38.47 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.4 m -138.81 138.68 37.78 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.26 -143.09 8.19 Favored Glycine 0 N--CA 1.466 0.661 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.459 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.1 p -134.36 160.14 38.87 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.37 116.11 15.16 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.036 -0.983 . . . . 0.0 108.927 177.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -69.58 123.28 10.0 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 120.822 1.015 . . . . 0.0 110.691 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.0 t -124.0 106.76 31.11 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.113 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.75 147.02 13.48 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 123.307 2.671 . . . . 0.0 113.21 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -163.93 118.84 1.55 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.953 0.882 . . . . 0.0 111.282 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.67 41.0 25.37 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 -1.44 87.05 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.419 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -119.28 129.29 54.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.239 0.52 . . . . 0.0 109.841 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.5 m -120.82 129.62 53.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.499 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -108.59 145.28 35.11 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.963 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.35 100.72 12.46 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.68 118.09 68.99 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.04 124.12 2.08 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.779 2.319 . . . . 0.0 110.417 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.408 HG21 HD11 ' A' ' 72' ' ' ILE . 29.3 pt -134.23 148.63 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.182 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.0 m -118.48 122.03 41.72 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 109.533 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.48 106.12 17.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.996 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -94.18 129.82 40.64 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.26 141.81 30.71 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.228 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.14 145.61 30.03 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -57.68 -9.87 1.37 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.4 p -114.89 17.31 17.02 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.9 0.381 . . . . 0.0 111.876 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -57.74 143.08 77.16 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -93.41 7.56 57.2 Favored 'Cis proline' 0 N--CA 1.515 2.792 0 CA-C-N 120.99 1.389 . . . . 0.0 115.303 0.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.412 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 36.9 m-85 -73.86 -7.65 53.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.046 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.58 115.12 37.65 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -49.98 134.66 36.08 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 CA-C-N 121.062 1.415 . . . . 0.0 112.373 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.23 143.95 14.34 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.216 1.944 . . . . 0.0 111.684 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.57 152.1 4.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.247 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.7 t -138.52 135.7 35.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.026 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -118.4 128.7 54.88 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.816 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.415 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 61.2 t -89.69 129.66 40.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.97 99.94 2.54 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 123.267 0.355 . . . . 0.0 110.945 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 43.8 Cg_endo -84.89 150.88 11.14 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.652 1.568 . . . . 0.0 113.058 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.2 p -116.25 168.08 10.44 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.719 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.4 m -56.03 -34.05 65.51 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.3 m -87.3 20.89 2.61 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.781 0.718 . . . . 0.0 110.591 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 30.9 ttm -144.76 146.58 32.22 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.0 m -124.56 140.7 52.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.7 tp -85.84 103.97 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.243 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -87.82 102.14 14.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.258 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 74.2 p -72.21 148.68 45.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.612 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -172.86 -138.97 2.72 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -87.89 -3.84 58.89 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -122.21 -30.28 4.04 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.294 0.952 . . . . 0.0 112.242 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 t -112.04 134.65 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.882 0.765 . . . . 0.0 109.268 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -93.01 162.04 14.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.031 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.95 -32.44 73.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.467 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -76.93 -6.23 51.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.7 5.62 59.93 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.844 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.15 147.48 40.44 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.424 HD12 HG22 ' A' ' 109' ' ' ILE . 86.0 mt -106.36 121.44 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.125 0.488 . . . . 0.0 111.236 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -102.35 120.27 40.22 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mt -126.75 122.34 23.47 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.258 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.04 -30.08 85.4 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 121.474 1.449 . . . . 0.0 114.363 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -66.67 -31.0 71.39 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.815 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 tt -69.59 -41.36 75.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.967 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -66.98 -28.3 68.15 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.375 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -104.29 1.59 30.56 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.521 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -68.95 125.94 28.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.872 0.844 . . . . 0.0 110.221 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -98.07 130.16 44.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.03 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -79.06 124.27 84.71 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.537 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -112.06 92.1 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.563 0 CA-C-N 120.929 1.367 . . . . 0.0 112.786 -2.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -113.77 -52.8 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.088 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.9 p -74.62 -40.07 61.76 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.368 0.604 . . . . 0.0 110.694 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 59.47 164.65 0.05 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.956 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 tp -58.29 -44.94 88.72 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.104 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.0 tp -52.72 -35.43 55.77 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.7 -38.97 96.31 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.9 tp -58.91 -40.3 84.1 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.487 -0.419 . . . . 0.0 111.877 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -76.53 -45.71 32.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.343 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -69.2 -34.34 74.73 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.67 -38.58 81.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 48.1 tpp -60.67 -44.0 97.0 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.73 -38.27 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.385 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.7 t -82.25 -48.25 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.17 -16.17 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.717 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -107.27 -19.68 13.52 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.001 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.93 -34.61 90.4 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -62.91 -37.89 88.77 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.997 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -154.87 90.38 3.06 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -45.87 116.59 1.48 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.419 1.412 . . . . 0.0 110.609 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.92 -14.5 35.65 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.627 1.552 . . . . 0.0 111.54 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.24 133.2 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.332 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.807 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 120.999 0.428 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -95.66 158.41 15.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.407 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 88.8 mt-10 -65.28 -39.21 92.29 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.65 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.8 m -60.08 -41.98 93.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.352 1.072 . . . . 0.0 109.139 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -68.5 -39.64 81.19 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.052 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 tp -53.74 -33.53 56.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 13' ' ' SER . 4.7 mmtt -68.11 -47.7 67.48 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.031 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.98 -34.87 73.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.633 0.73 . . . . 0.0 110.216 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.9 mmm -64.51 -37.06 86.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.042 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -122.17 23.91 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.565 0.221 . . . . 0.0 110.941 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 9' ' ' LYS . 99.9 p -66.24 -23.72 66.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.543 0.211 . . . . 0.0 111.345 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -77.53 -18.74 56.72 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.326 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -69.93 143.34 52.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.469 0.652 . . . . 0.0 111.603 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -21.74 64.05 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.339 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 96.7 m-85 -121.89 55.43 1.11 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.591 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -65.34 -26.18 67.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 119.871 -0.732 . . . . 0.0 112.808 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -67.02 -56.13 11.43 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -65.68 -40.3 92.2 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.47 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.3 m -61.95 -49.68 75.18 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.708 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.26 -47.56 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 120.513 0.197 . . . . 0.0 110.74 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -65.1 -40.9 95.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.37 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -63.99 -38.75 92.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.694 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.2 p -66.91 -38.69 86.71 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.74 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.7 t -56.58 -44.39 80.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.489 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -62.86 -39.52 94.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.702 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.6 t -66.78 -44.09 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.95 -13.12 12.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.3 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -80.98 -48.68 11.93 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.788 0.328 . . . . 0.0 110.589 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.5 tp -88.09 -36.59 16.84 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.399 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -109.78 66.19 0.63 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -57.17 -19.16 18.79 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.134 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -66.46 -18.18 65.21 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.384 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 tp -98.26 113.51 25.47 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -110.63 135.87 20.69 Favored Pre-proline 0 C--N 1.354 0.801 0 CA-C-N 119.354 0.979 . . . . 0.0 111.391 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.87 139.41 22.07 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.462 1.441 . . . . 0.0 111.794 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 p -133.79 147.06 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.3 tp -99.1 119.67 38.22 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.585 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -121.69 135.77 54.95 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.039 0.447 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.5 p -70.92 139.79 50.8 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.0 t80 . . . . . 0 C--O 1.236 0.374 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.725 -179.569 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 110.097 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -85.1 106.32 16.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.6 mt -110.13 142.9 40.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.454 0.645 . . . . 0.0 111.349 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 55.3 ttp -105.61 142.42 35.38 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.804 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -136.35 154.47 50.83 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.561 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 mt -95.41 120.18 35.2 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.3 m -132.9 135.19 45.43 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.22 -149.21 11.94 Favored Glycine 0 N--CA 1.464 0.51 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.481 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.0 p -133.11 158.36 42.99 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 pt -129.12 116.03 18.82 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.27 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -72.48 125.6 10.82 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 N-CA-C 109.495 -1.002 . . . . 0.0 109.495 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.17 126.77 21.65 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 119.688 -0.805 . . . . 0.0 112.001 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.83 148.66 46.49 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.271 1.981 . . . . 0.0 110.498 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.93 112.61 1.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.609 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.96 32.01 11.93 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.88 -0.513 . . . . 0.0 111.857 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.51 -10.21 67.91 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -110.32 137.78 47.58 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.9 m -115.27 131.72 56.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.671 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -114.6 152.38 31.92 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.296 0.569 . . . . 0.0 110.906 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -98.92 103.81 15.8 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.13 118.67 68.68 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -85.55 126.45 3.06 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.786 2.324 . . . . 0.0 110.944 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.418 HD12 HG23 ' A' ' 72' ' ' ILE . 30.5 pt -133.74 149.86 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.819 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 m -124.05 122.55 38.18 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.762 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.2 112.22 25.14 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.315 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -103.01 125.41 49.75 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.2 mt -88.12 140.04 29.89 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.898 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 tp -93.91 143.69 26.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -48.27 -18.29 0.2 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.68 16.94 25.19 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -69.84 144.58 93.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -92.87 4.27 60.21 Favored 'Cis proline' 0 N--CA 1.514 2.694 0 CA-C-N 121.426 1.545 . . . . 0.0 115.422 1.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 36.0 m-85 -73.34 -15.62 61.38 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.637 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.23 120.26 44.81 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.71 134.4 33.95 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.253 1.483 . . . . 0.0 111.701 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.08 145.11 21.72 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.956 1.77 . . . . 0.0 110.76 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.33 131.52 41.89 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 119.179 -1.009 . . . . 0.0 109.545 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.7 m -111.86 137.83 49.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.672 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -126.5 128.26 46.64 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.225 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.53 127.52 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.48 109.04 12.51 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.72 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.25 161.56 13.25 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 122.149 1.899 . . . . 0.0 112.882 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.9 p -133.43 173.24 11.69 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.7 m -57.94 -39.27 77.63 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 120.136 -0.626 . . . . 0.0 112.252 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.7 p -92.24 0.52 57.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.64 0.654 . . . . 0.0 111.866 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -130.66 125.59 34.39 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.97 167.44 10.66 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.348 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.8 mm -92.73 105.3 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.546 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -86.71 108.66 18.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.498 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.6 p -67.42 140.16 57.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.418 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.63 -146.78 4.41 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -71.55 -22.2 61.79 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -123.8 -25.0 4.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.329 -0.949 . . . . 0.0 112.914 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.2 t -91.25 131.39 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.423 1.01 . . . . 0.0 110.671 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -95.31 -163.4 1.04 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.605 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.08 -13.53 47.04 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.39 -1.55 23.14 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.371 -0.206 . . . . 0.0 110.735 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.76 0.08 42.36 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.767 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.66 128.99 24.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.707 0.754 . . . . 0.0 109.898 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.414 HD13 HG23 ' A' ' 109' ' ' ILE . 96.8 mt -109.36 114.5 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 O-C-N 123.264 0.353 . . . . 0.0 110.411 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -96.87 134.3 40.37 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 33.1 mt -137.71 118.86 10.61 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.859 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -47.51 -38.91 28.61 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 121.793 1.662 . . . . 0.0 114.037 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.83 -29.55 69.56 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.174 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.62 -43.76 75.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.743 0.306 . . . . 0.0 111.645 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -69.35 -28.23 66.03 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.689 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -103.97 4.3 34.43 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.989 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.417 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.0 t90 -68.62 121.65 16.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.717 0.77 . . . . 0.0 109.683 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -90.49 122.9 33.73 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.245 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -79.56 126.78 80.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.738 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -107.7 92.67 0.04 OUTLIER 'Cis proline' 0 N--CA 1.499 1.801 0 CA-C-N 120.802 1.322 . . . . 0.0 112.649 -2.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -115.12 -61.31 1.77 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.586 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.3 t -68.97 -33.82 74.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.762 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 p30 47.82 -177.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.82 0.819 . . . . 0.0 111.962 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 tt -68.28 -39.56 82.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.137 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.2 tt -57.79 -38.74 76.03 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.28 97.46 Favored Glycine 0 N--CA 1.479 1.561 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.0 tp -58.22 -40.57 82.01 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.427 -0.455 . . . . 0.0 111.768 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -72.71 -49.43 40.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.848 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -65.54 -35.96 82.39 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.86 -37.39 79.34 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 60.9 tpp -58.54 -43.64 89.33 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -42.77 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.564 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.8 t -77.19 -44.07 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.62 -13.64 16.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.015 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -105.85 -17.59 14.32 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.209 -0.996 . . . . 0.0 109.703 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.69 -34.44 89.64 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.03 -35.5 81.38 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.604 -0.298 . . . . 0.0 110.711 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -155.95 116.52 2.23 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.47 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -75.12 120.48 6.05 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 N-CA-C 108.648 -1.328 . . . . 0.0 108.648 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.94 -19.05 46.57 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.066 1.177 . . . . 0.0 111.217 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.92 147.95 29.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.56 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.4 p90 . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.66 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.9 t . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 121.21 0.528 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.1 156.01 16.8 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 57.7 mp0 -63.0 -41.51 99.6 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.97 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.8 p -57.38 -47.99 80.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.165 0.984 . . . . 0.0 109.379 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -62.79 -34.52 77.43 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.778 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.1 tp -55.97 -38.39 70.33 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 3.1 mptp? -63.64 -42.8 98.09 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.331 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.47 -36.36 83.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.142 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.61 -36.76 84.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.947 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.8 23.18 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.795 0.331 . . . . 0.0 111.45 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 t -58.8 -25.42 63.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.575 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -64.84 -21.45 66.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.709 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -67.89 150.57 48.39 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.95 -29.6 70.75 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.058 0.456 . . . . 0.0 112.175 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.494 ' CD2' ' N ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -138.0 69.03 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.097 0.959 . . . . 0.0 111.73 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -57.69 -25.31 60.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.89 -41.67 97.65 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.027 -0.42 . . . . 0.0 111.497 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 tp -71.68 -43.32 66.2 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.447 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 m -62.69 -46.77 86.61 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.33 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.8 t -62.43 -44.1 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 120.6 0.238 . . . . 0.0 110.428 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.17 -41.99 89.71 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.682 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.83 -39.57 93.79 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.248 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.9 p -67.89 -38.33 82.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.46 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.15 -44.12 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.496 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -60.72 -38.75 86.15 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.138 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.37 -45.3 70.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -84.78 -22.43 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.989 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.8 m -72.18 -45.68 59.38 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.81 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.3 tp -84.47 -37.74 21.0 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.11 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -114.43 66.93 0.68 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -57.76 -17.58 16.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.323 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -65.65 -16.34 63.64 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.26 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 tp -96.36 125.58 40.96 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -118.27 129.27 25.47 Favored Pre-proline 0 C--N 1.359 0.995 0 CA-C-N 119.814 1.188 . . . . 0.0 111.955 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.09 140.23 15.63 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 121.855 1.703 . . . . 0.0 112.592 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.2 p -136.84 141.2 41.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.221 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.2 tp -82.66 119.22 24.02 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -119.75 137.81 53.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.212 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.5 m -76.39 141.23 41.52 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.8 t80 . . . . . 0 C--O 1.239 0.51 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.994 -179.284 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.5 ttm-85 . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 121.216 0.532 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -87.74 111.23 21.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.226 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.8 mt -111.53 140.03 46.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.413 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -92.75 138.33 31.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -130.05 153.15 48.74 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.023 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.88 119.16 34.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.6 m -130.23 136.81 49.6 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.928 0.394 . . . . 0.0 112.021 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.46 -147.96 13.61 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.606 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.0 p -133.29 161.09 35.42 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.46 116.6 18.53 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.494 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -72.39 126.08 11.3 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 CA-C-N 120.037 1.049 . . . . 0.0 110.193 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.0 t -128.13 125.87 23.54 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.583 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.67 150.0 55.88 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.184 1.923 . . . . 0.0 110.294 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -162.84 106.5 1.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.31 0.576 . . . . 0.0 111.746 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 52.68 39.29 28.16 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.939 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.88 -2.37 74.82 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -119.64 134.16 55.35 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -114.59 131.92 56.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.063 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -113.34 150.05 33.14 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.668 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -94.12 107.05 19.01 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.22 116.23 65.89 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.356 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.31 124.69 4.88 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 122.553 2.168 . . . . 0.0 111.381 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.4 pt -135.89 148.68 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.918 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 63.0 m -125.24 125.04 42.96 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.4 0.619 . . . . 0.0 109.884 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.62 115.75 30.69 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.304 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -103.8 126.33 50.85 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.2 mt -94.5 139.82 30.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.217 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mt -79.65 160.12 26.46 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -59.94 -13.96 13.53 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 p -120.77 18.01 11.89 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.424 ' CD1' ' HA ' ' A' ' 81' ' ' PRO . 4.4 t80 -59.5 148.14 74.81 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.424 ' HA ' ' CD1' ' A' ' 80' ' ' TYR . 20.0 Cg_endo -92.89 10.26 56.32 Favored 'Cis proline' 0 N--CA 1.509 2.417 0 CA-C-N 121.333 1.512 . . . . 0.0 115.415 -0.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.63 -16.97 64.44 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 118.665 -1.214 . . . . 0.0 110.695 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.14 128.06 26.28 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.362 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -46.81 129.62 14.68 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 CA-C-N 121.269 1.489 . . . . 0.0 113.179 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -82.78 148.67 13.93 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.634 2.223 . . . . 0.0 111.401 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.45 153.8 3.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.601 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.11 136.24 24.88 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.624 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -120.42 137.79 54.12 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.703 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.459 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -88.04 125.18 41.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -64.22 104.61 0.55 Allowed Pre-proline 0 N--CA 1.475 0.805 0 CA-C-O 119.162 -0.446 . . . . 0.0 110.631 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 48.3 Cg_endo -88.93 157.99 5.95 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.56 1.507 . . . . 0.0 112.783 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.9 t -157.44 161.67 38.94 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.289 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.6 m -56.36 -23.02 34.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -98.45 6.66 47.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.653 0.66 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.8 mmm -131.37 140.14 49.63 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.1 m -128.77 147.37 50.78 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.744 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 93.2 mt -101.09 117.12 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.083 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -101.41 106.89 18.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.3 p -57.47 148.44 23.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.754 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -161.26 -140.36 2.86 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.116 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -88.45 -3.42 58.83 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -135.46 -29.14 1.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.619 1.099 . . . . 0.0 113.617 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.29 144.31 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 119.036 0.835 . . . . 0.0 110.247 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -98.09 159.6 14.83 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.04 79.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.418 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -73.92 -5.51 41.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.169 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.62 6.23 58.49 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.418 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 143.1 34.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.939 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 98.3 mt -106.55 119.88 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.177 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.23 139.67 50.95 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.03 126.25 18.55 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 118.49 0.586 . . . . 0.0 112.183 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.68 -38.87 37.62 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 121.735 1.623 . . . . 0.0 114.07 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -62.43 -31.83 72.59 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.861 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 tt -69.66 -41.59 75.35 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.371 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -66.3 -29.09 69.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.606 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -101.54 -3.29 28.75 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.694 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.404 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.1 t90 -67.56 127.5 32.96 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.924 0.868 . . . . 0.0 110.475 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.37 130.24 43.53 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.776 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -80.21 126.13 79.9 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.33 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -108.33 93.59 0.04 OUTLIER 'Cis proline' 0 N--CA 1.498 1.787 0 CA-C-N 120.794 1.319 . . . . 0.0 112.539 -2.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -113.99 -62.39 1.6 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.308 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.1 p -70.3 -40.11 74.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.159 0.504 . . . . 0.0 110.297 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.2 t70 65.76 167.67 0.2 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.418 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.47 -43.86 97.79 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.11 -36.4 60.71 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.65 -40.19 98.42 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.3 tp -60.46 -40.76 92.34 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -75.98 -47.14 33.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.597 -176.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -67.97 -35.57 78.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.65 -39.39 80.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.7 ttm -59.01 -45.26 91.13 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.68 -43.28 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.351 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 73.6 t -75.25 -39.68 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.4 p -72.32 -17.45 18.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.54 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -110.13 -17.77 13.48 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.575 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.19 -35.55 91.71 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 107.146 -2.382 . . . . 0.0 107.146 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.99 -34.2 77.86 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.556 -0.822 . . . . 0.0 110.608 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -157.95 90.75 2.26 Favored Pre-proline 0 C--N 1.333 -0.125 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.526 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -50.23 114.15 1.31 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.776 0.984 . . . . 0.0 110.128 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.26 -13.29 28.19 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.471 1.447 . . . . 0.0 111.154 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.1 m -131.64 138.88 51.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.343 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.4 p90 . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.672 179.716 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.2 t . . . . . 0 N--CA 1.45 -0.475 0 CA-C-O 121.264 0.554 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -96.58 156.0 16.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.46 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 93.9 mt-10 -62.79 -40.53 97.62 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.145 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -58.76 -47.0 86.17 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 122.219 1.009 . . . . 0.0 109.052 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -61.57 -36.49 80.81 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.002 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.0 tp -55.3 -39.54 70.04 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 3.2 mptp? -60.65 -43.31 97.75 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.867 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -67.94 -26.32 65.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.735 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.03 -34.61 43.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.52 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.17 17.64 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.711 0.291 . . . . 0.0 110.789 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.67 -11.51 60.24 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.656 0.265 . . . . 0.0 111.302 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -85.22 -12.85 51.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.453 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -77.75 152.47 33.59 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.408 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -64.93 -39.13 93.03 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.076 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 25.0 m-85 -114.58 70.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 122.404 -0.185 . . . . 0.0 111.077 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -69.04 -27.31 65.54 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -72.74 -46.56 52.86 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.79 -39.6 73.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.969 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.7 m -61.19 -45.71 93.46 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.872 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.1 t -61.86 -45.9 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 120.839 0.352 . . . . 0.0 110.483 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -43.05 99.65 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.873 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -65.16 -37.12 86.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.943 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.5 p -67.38 -37.36 83.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.922 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.49 -43.62 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -60.4 -39.04 85.91 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.411 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -70.58 -42.75 78.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -21.92 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.191 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.0 m -72.46 -42.9 64.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.046 0.451 . . . . 0.0 110.311 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.8 tp -88.75 -34.52 17.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.092 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -118.24 68.85 0.78 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -57.32 -20.59 29.59 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.159 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -65.84 -15.05 62.55 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.755 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 tp -96.95 112.43 24.19 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.12 129.52 23.84 Favored Pre-proline 0 C--N 1.358 0.937 0 CA-C-N 119.572 1.078 . . . . 0.0 112.334 -177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -82.92 135.64 7.74 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.603 1.535 . . . . 0.0 112.834 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.84 155.58 41.54 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.7 tp -95.21 117.6 30.53 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -121.42 134.74 55.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.907 0.384 . . . . 0.0 111.9 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.5 t -71.99 136.72 46.85 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.445 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.864 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 121.192 0.52 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -83.97 116.99 23.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.213 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.9 mt -117.23 145.09 44.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.086 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -98.93 138.23 36.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.849 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -130.08 151.12 50.96 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.479 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 mt -97.59 129.57 44.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.1 m -145.3 138.5 26.43 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.85 -141.9 7.31 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.485 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.5 p -133.41 158.92 41.83 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.59 116.18 18.32 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.848 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -70.98 123.85 10.07 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 CA-C-N 119.886 0.995 . . . . 0.0 110.001 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.1 t -130.67 125.71 21.59 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.909 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.09 147.39 42.83 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.281 1.987 . . . . 0.0 110.634 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -163.48 116.08 1.49 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 55.93 28.29 12.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.448 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.68 -5.74 77.03 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -112.93 142.51 45.52 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.9 m -120.29 131.93 55.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.884 0.374 . . . . 0.0 111.74 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -115.11 152.02 33.29 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.98 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -96.52 104.93 16.95 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.7 117.13 68.0 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.94 124.31 3.84 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.711 2.274 . . . . 0.0 111.12 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.5 pt -135.72 148.69 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.973 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.3 m -121.43 123.55 42.35 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-O 121.839 0.828 . . . . 0.0 110.12 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.97 117.0 32.9 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.349 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -107.72 126.23 52.35 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.5 mt -92.87 139.36 30.62 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.838 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mt -85.42 152.58 23.12 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.66 -16.05 14.5 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.906 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.2 10.75 31.79 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -65.3 144.54 99.02 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -91.05 3.84 67.11 Favored 'Cis proline' 0 N--CA 1.515 2.786 0 CA-C-N 121.219 1.471 . . . . 0.0 115.726 1.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.428 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 18.8 m-85 -71.54 -20.67 62.0 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.945 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.06 126.64 30.1 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.826 -0.607 . . . . 0.0 109.695 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -49.08 131.48 26.06 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 CA-C-N 121.235 1.477 . . . . 0.0 112.403 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.16 145.53 11.01 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.463 2.109 . . . . 0.0 111.784 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.79 147.44 5.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.241 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.8 t -139.57 132.58 29.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.56 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -121.88 130.86 53.69 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.66 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 m -82.83 145.93 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -93.56 99.1 3.03 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.871 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.03 157.25 34.3 Favored 'Trans proline' 0 N--CA 1.504 2.118 0 C-N-CA 121.482 1.455 . . . . 0.0 112.738 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 p -139.24 176.17 8.93 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.1 t -59.79 -43.86 94.2 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 m -88.18 11.84 15.3 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.795 0.725 . . . . 0.0 111.493 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.2 mmm -129.13 138.46 51.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.66 146.03 48.52 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.813 -178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.6 mm -88.2 103.43 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.077 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -95.58 110.9 22.93 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.9 p -69.65 155.97 39.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.687 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.89 -135.01 2.24 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.826 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -86.38 -1.24 57.37 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -134.97 -27.31 1.26 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.665 1.12 . . . . 0.0 113.729 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.55 134.81 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 118.931 0.787 . . . . 0.0 110.215 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -87.2 -172.57 4.01 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.418 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.13 0.34 56.14 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.978 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -109.04 -5.67 15.94 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.745 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.89 -3.44 57.26 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.534 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 145.22 47.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.408 0.604 . . . . 0.0 110.446 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.5 mt -108.92 122.12 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.434 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.61 130.65 56.86 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mt -123.99 124.23 26.02 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.251 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -49.15 -36.9 37.59 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 121.739 1.626 . . . . 0.0 113.865 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.423 ' CG ' ' N ' ' A' ' 114' ' ' LEU . 1.2 p90 -60.07 -33.0 71.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.079 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.423 ' N ' ' CG ' ' A' ' 113' ' ' TYR . 1.5 tt -70.89 -41.23 71.59 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.918 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -64.17 -26.37 68.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.633 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -113.78 11.52 18.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.495 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -72.19 125.99 28.67 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.924 0.868 . . . . 0.0 109.996 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -96.57 127.89 42.99 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.784 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -81.6 126.49 75.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 119.069 -0.491 . . . . 0.0 110.112 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -108.94 92.35 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.707 0 CA-C-N 120.756 1.306 . . . . 0.0 112.43 -2.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.26 -61.96 1.66 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.504 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.5 t -67.94 -42.11 81.5 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.087 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 t70 66.98 165.84 0.22 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.487 0.66 . . . . 0.0 111.7 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 tt -65.79 -43.71 87.94 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.663 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.81 -38.54 72.72 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.24 -39.12 96.75 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.4 tp -56.95 -40.28 76.15 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.889 -0.183 . . . . 0.0 111.431 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -73.98 -47.82 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.941 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -66.42 -35.0 79.22 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.41 -39.02 81.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.0 tpp -58.24 -42.13 85.7 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.62 -39.55 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.597 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -79.09 -46.82 23.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.6 -14.21 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.138 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -104.75 -19.09 14.04 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.18 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.43 -32.05 60.3 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -63.89 -38.87 92.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.817 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -157.67 81.66 3.08 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -49.1 109.31 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.266 1.311 . . . . 0.0 110.76 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.64 -23.47 40.6 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.456 1.437 . . . . 0.0 110.462 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 m -120.09 140.41 44.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.29 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.7 p90 . . . . . 0 CA--C 1.538 0.507 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.297 -179.008 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.445 -0.685 0 CA-C-O 121.391 0.615 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -103.74 157.84 16.8 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.422 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 97.7 mt-10 -65.04 -40.45 94.81 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.266 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -63.26 -41.51 99.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.355 1.074 . . . . 0.0 109.214 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -69.97 -29.93 67.16 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.657 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.6 tp -61.9 -39.65 92.71 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -58.85 -43.22 90.73 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.074 -0.967 . . . . 0.0 108.657 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -60.43 -35.52 76.02 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.298 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 13.5 ptp -83.33 -10.58 58.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.172 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -130.9 19.21 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.01 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.7 p -66.44 -18.22 65.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.558 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.82 -13.15 40.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.98 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.401 ' CZ ' HD23 ' A' ' 52' ' ' LEU . 33.7 m-85 -72.9 148.64 44.17 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.527 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -66.57 -37.82 85.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.799 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 19.8 m-85 -108.18 61.92 0.61 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.428 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -64.76 -27.31 68.81 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -76.68 -53.03 8.55 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.11 -38.77 82.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.084 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -60.77 -47.45 86.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.698 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.08 -44.62 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -40.53 97.87 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.115 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.13 -38.44 91.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.059 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.8 p -68.27 -34.33 75.99 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.923 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.68 -45.64 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.742 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -61.31 -39.07 89.13 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.471 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.64 -43.09 71.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.57 -20.13 7.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.698 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.5 m -78.07 -46.97 19.4 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.992 0.425 . . . . 0.0 110.848 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.8 tp -88.65 -36.0 16.49 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.842 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -111.97 68.14 0.66 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -59.38 -18.15 36.22 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.671 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -65.22 -21.88 66.81 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.855 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 tp -95.51 115.26 27.18 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.72 132.76 22.11 Favored Pre-proline 0 C--N 1.356 0.881 0 CA-C-N 119.828 1.194 . . . . 0.0 112.104 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.39 135.3 11.82 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.424 1.416 . . . . 0.0 112.46 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.1 t -127.87 136.27 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.55 119.24 24.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -129.91 137.25 50.28 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.9 t -68.6 137.98 54.69 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.206 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 . . . . . 0 C--O 1.235 0.294 0 CA-C-O 121.359 0.6 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -80.39 120.5 24.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.741 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.401 HD23 ' CZ ' ' A' ' 15' ' ' TYR . 77.7 mt -122.22 140.01 53.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.553 0.692 . . . . 0.0 110.817 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 62.0 ttp -84.51 148.66 26.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.424 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -134.2 151.53 51.36 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.296 0.57 . . . . 0.0 111.689 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.66 116.02 31.74 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.5 m -134.47 137.13 43.7 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.27 -143.24 7.99 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.593 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.8 p -135.27 161.25 35.92 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.31 116.07 15.22 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.206 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -72.35 125.87 11.14 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 120.935 1.09 . . . . 0.0 110.092 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.6 t -129.48 124.43 21.96 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 119.744 -0.783 . . . . 0.0 112.329 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.56 145.85 48.11 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.137 1.891 . . . . 0.0 110.162 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -163.57 114.78 1.4 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.932 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.23 32.09 12.78 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.82 -6.86 72.36 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -113.79 148.51 36.42 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -125.2 132.58 52.99 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.609 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -115.47 152.09 33.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.138 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -97.09 103.88 15.85 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.33 116.98 67.83 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -82.18 127.26 5.22 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 122.516 2.144 . . . . 0.0 111.062 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 72' ' ' ILE . 29.6 pt -137.1 149.13 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 118.939 -1.105 . . . . 0.0 112.577 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.46 123.05 40.4 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-O 121.513 0.673 . . . . 0.0 110.057 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.32 103.68 13.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.646 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -90.69 124.05 34.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 119.046 -1.062 . . . . 0.0 108.3 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -91.98 138.64 31.38 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mt -88.9 155.46 19.51 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.28 -16.26 32.54 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.629 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.04 0.43 51.57 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.669 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -65.03 143.03 98.82 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -89.34 4.15 69.62 Favored 'Cis proline' 0 N--CA 1.517 2.892 0 CA-C-N 120.975 1.384 . . . . 0.0 115.299 1.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 12.0 m-85 -68.85 -23.13 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.242 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.86 126.3 30.15 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.959 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.19 137.48 37.88 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 CA-C-N 121.263 1.487 . . . . 0.0 111.555 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.03 144.1 11.8 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.387 2.058 . . . . 0.0 111.771 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.49 131.55 40.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.65 0.738 . . . . 0.0 109.406 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 38.7 t -118.28 142.0 47.94 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.326 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -127.93 127.64 43.68 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.103 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.455 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 57.9 t -85.79 131.92 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -87.35 101.76 2.61 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.979 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 79.4 Cg_endo -82.03 159.36 18.18 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.39 1.393 . . . . 0.0 112.206 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 p -123.39 168.13 12.93 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.06 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.2 m -56.75 -36.09 69.37 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.433 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.0 m -88.36 2.59 52.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.854 0.752 . . . . 0.0 112.295 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -129.54 140.15 51.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.68 156.81 26.46 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.631 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 tp -85.25 109.98 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-O 121.262 0.553 . . . . 0.0 109.96 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -97.53 101.39 12.9 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.033 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.7 p -65.54 151.18 47.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.883 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -166.23 -143.75 3.85 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.663 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.403 ' O ' ' CZ ' ' A' ' 110' ' ' TYR . 24.8 pttm -65.96 -18.96 65.69 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -131.86 -26.67 1.95 Allowed 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.4 t -93.78 137.66 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.667 1.121 . . . . 0.0 111.36 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -100.97 177.51 4.93 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.417 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.58 -38.55 87.28 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -86.41 -0.37 55.83 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.843 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.69 21.56 18.66 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.722 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -75.79 136.84 40.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.687 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 88.7 mt -117.26 125.2 73.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.95 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CZ ' ' O ' ' A' ' 101' ' ' LYS . 30.2 p90 -136.44 148.87 47.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mp -143.45 140.03 17.12 Favored Pre-proline 0 CA--C 1.555 1.152 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.257 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.424 ' HA ' ' ND1' ' A' ' 115' ' ' HIS . 50.4 Cg_exo -46.43 -38.64 21.24 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 C-N-CA 121.954 1.769 . . . . 0.0 113.792 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.69 -31.94 73.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.073 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.24 -43.08 64.91 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.424 ' ND1' ' HA ' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -68.96 -27.01 65.35 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.78 -177.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -97.65 1.12 48.32 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.293 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -60.13 126.51 27.79 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.766 0.793 . . . . 0.0 110.657 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -104.46 96.29 6.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.619 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -55.64 122.84 47.97 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.309 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -108.0 91.97 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 120.304 1.144 . . . . 0.0 113.019 -2.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -110.43 -58.83 2.03 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.483 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.1 p -71.02 -39.72 72.19 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.355 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 t70 69.32 164.09 0.24 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.355 0.598 . . . . 0.0 112.095 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tt -66.15 -44.28 84.57 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.326 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tp -56.12 -37.95 70.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.67 -39.42 97.39 Favored Glycine 0 N--CA 1.477 1.391 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.4 tp -58.68 -41.17 85.59 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.605 -0.35 . . . . 0.0 111.902 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -72.71 -47.74 48.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.954 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -67.71 -34.73 77.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.5 t -67.91 -39.2 81.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.055 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.404 ' SD ' ' CE1' ' A' ' 135' ' ' PHE . 44.5 tpp -58.14 -41.47 83.77 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.67 -44.14 98.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.562 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.74 -44.21 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.52 -14.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.177 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.404 ' CE1' ' SD ' ' A' ' 131' ' ' MET . 11.6 m-30 -105.38 -17.78 14.33 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.547 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.95 -22.97 72.59 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -76.43 -27.31 56.18 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.578 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -161.73 83.77 1.75 Allowed Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -46.99 119.25 3.26 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.341 1.361 . . . . 0.0 110.407 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.47 -18.61 43.57 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 120.875 1.05 . . . . 0.0 110.856 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.76 147.86 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.526 -179.589 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.442 -0.859 0 CA-C-O 121.679 0.752 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.05 149.65 24.99 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 56.0 mp0 -61.23 -42.3 98.37 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.768 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.6 m -57.73 -46.92 83.79 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.364 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -63.07 -34.08 76.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.87 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.7 tp -55.83 -38.66 70.32 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.3 mptp? -61.22 -42.52 98.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.757 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.57 -37.21 86.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.362 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -66.01 -37.01 84.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.149 -177.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 m -119.43 28.91 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.658 0.266 . . . . 0.0 111.213 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.2 p -64.95 -22.66 67.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -74.71 -15.5 60.78 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.921 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -71.09 152.25 43.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.016 0.436 . . . . 0.0 111.437 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -75.47 -29.22 59.53 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.12 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.407 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 35.7 m-85 -117.94 61.77 0.76 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.148 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 ptt-85 -64.65 -29.62 70.63 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.98 -44.03 70.25 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tp -74.74 -41.28 60.42 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.392 -0.923 . . . . 0.0 109.813 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.0 m -61.19 -47.99 83.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.616 0.246 . . . . 0.0 111.154 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 t -61.32 -45.49 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.397 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -63.4 -43.0 98.81 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.653 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.59 -36.28 83.3 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.682 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.7 p -67.31 -38.58 85.21 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.543 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -57.44 -43.43 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -60.05 -41.3 92.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.101 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.85 -43.07 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -15.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.452 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.3 m -85.04 -46.95 10.69 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.128 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.9 tp -83.14 -35.88 25.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.259 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -115.47 68.4 0.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.039 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -57.03 -20.84 26.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.091 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -65.15 -22.02 66.86 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.685 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 tp -93.17 115.2 27.84 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -111.11 133.59 21.28 Favored Pre-proline 0 C--N 1.357 0.904 0 CA-C-N 119.713 1.142 . . . . 0.0 111.937 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.69 133.01 10.13 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.194 1.263 . . . . 0.0 112.028 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -126.93 134.27 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.4 tp -81.82 113.89 20.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -123.64 137.36 54.74 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 83.1 p -71.63 148.02 46.97 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.465 0.286 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.599 179.784 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 C--O 1.234 0.241 0 CA-C-O 121.196 0.522 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -83.37 106.43 15.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.213 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 70.2 mt -114.26 140.64 48.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.401 0.62 . . . . 0.0 110.927 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 57.7 ttp -84.41 148.83 26.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.321 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.478 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 4.5 t30 -124.74 161.34 26.61 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.991 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.15 112.78 19.94 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -138.58 139.94 38.82 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.45 -143.66 8.26 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.761 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.8 p -134.9 159.19 42.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -130.8 115.74 16.89 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.283 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.14 125.06 10.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 N-CA-C 109.405 -1.037 . . . . 0.0 109.405 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.0 t -126.97 121.86 23.05 Favored Pre-proline 0 C--O 1.24 0.605 0 C-N-CA 119.834 -0.746 . . . . 0.0 112.285 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.27 146.49 51.16 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.074 1.85 . . . . 0.0 110.287 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -162.74 107.9 1.15 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.102 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.77 37.92 25.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.551 -0.46 . . . . 0.0 112.205 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.17 -0.77 82.95 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -118.5 138.26 52.63 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.2 m -121.35 132.56 54.84 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.483 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -115.96 149.58 38.55 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.121 0.486 . . . . 0.0 111.261 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -94.88 100.47 12.34 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.67 115.35 62.66 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.237 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.64 127.87 4.45 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.753 2.302 . . . . 0.0 111.158 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.438 HD13 HG23 ' A' ' 72' ' ' ILE . 25.1 pt -135.27 148.7 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.411 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.1 m -116.62 124.23 49.27 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.354 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.53 112.25 24.04 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.204 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.478 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 70.1 m95 -96.03 130.25 43.08 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.224 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.25 134.64 41.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tp -94.16 143.82 26.04 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.87 -16.86 0.47 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.37 9.97 40.91 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.421 -0.512 . . . . 0.0 112.316 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -65.7 143.49 98.59 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -92.0 3.36 63.15 Favored 'Cis proline' 0 N--CA 1.517 2.865 0 CA-C-N 121.033 1.405 . . . . 0.0 115.256 1.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.407 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 17.2 m-85 -69.78 -21.02 63.45 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.465 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.37 118.92 53.48 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.52 135.99 33.25 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 CA-C-N 121.182 1.458 . . . . 0.0 111.423 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.51 140.86 17.29 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.817 1.678 . . . . 0.0 111.199 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.78 152.89 4.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.155 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 13.1 t -140.93 140.37 34.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.093 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -131.32 129.72 41.8 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.771 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.59 134.77 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -100.17 101.2 13.68 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.647 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -90.15 127.57 1.47 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.874 1.716 . . . . 0.0 113.197 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.3 p -77.19 172.54 13.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.8 p -55.86 -28.64 57.46 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.9 m -95.64 -2.2 48.64 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.945 0.793 . . . . 0.0 111.579 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 52.9 tpp -93.25 134.35 35.53 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 85.1 m -108.16 133.22 52.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.79 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.5 tp -93.95 109.07 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.08 0.467 . . . . 0.0 109.816 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -92.85 100.13 12.66 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.673 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 74.0 p -66.91 148.44 51.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.985 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -172.96 -150.6 7.49 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.26 -20.44 64.79 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 47.3 m170 -115.35 -30.38 6.28 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 119.028 0.831 . . . . 0.0 113.008 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.1 t -100.78 138.36 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 CA-C-N 119.24 0.927 . . . . 0.0 110.58 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -93.85 -169.72 2.16 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.421 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.59 -30.94 22.91 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -92.08 0.34 57.46 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.993 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.84 6.02 37.97 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.104 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -64.04 148.46 49.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.693 0.747 . . . . 0.0 110.181 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.1 mt -116.44 122.82 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 110.718 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.62 121.22 44.22 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.98 116.52 22.04 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.945 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -48.98 -36.88 35.93 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.581 1.521 . . . . 0.0 113.69 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -31.51 71.56 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.477 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 tt -69.46 -41.71 75.86 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.89 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -65.57 -28.47 69.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.017 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -109.84 3.77 21.02 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.679 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.403 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.1 t90 -64.84 125.03 23.54 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.038 0.923 . . . . 0.0 110.076 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -95.81 127.1 41.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.816 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -81.28 126.65 76.18 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 119.026 -0.512 . . . . 0.0 110.514 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -109.4 91.39 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.674 0 CA-C-N 120.677 1.277 . . . . 0.0 112.453 -2.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.3 -62.75 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 t -67.74 -37.26 81.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.699 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 51.4 175.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.061 0.934 . . . . 0.0 112.143 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.94 -44.33 96.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.821 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.6 -38.71 64.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.64 -39.63 98.14 Favored Glycine 0 N--CA 1.482 1.704 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.4 tp -58.25 -40.65 82.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.435 -0.45 . . . . 0.0 111.829 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -74.34 -48.16 37.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.948 -176.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -68.77 -35.15 76.7 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.4 t -67.92 -40.07 82.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.5 ttm -58.39 -42.8 87.92 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.17 -41.12 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.475 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.26 -47.73 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.6 p -66.7 -14.45 17.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.501 -178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -106.91 -20.12 13.42 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.358 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.7 -35.2 91.64 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.16 -37.31 86.99 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.957 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -154.56 83.96 3.95 Favored Pre-proline 0 N--CA 1.451 -0.393 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.139 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -45.35 117.59 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.689 1.593 . . . . 0.0 110.939 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.71 -4.97 16.23 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.504 1.469 . . . . 0.0 111.4 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.7 m -120.46 157.38 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.708 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.8 t80 . . . . . 0 N--CA 1.478 0.934 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.247 -179.686 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 121.158 0.504 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -94.54 156.54 16.4 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.445 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.8 mt-10 -63.3 -40.91 98.66 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.111 -1.035 . . . . 0.0 111.329 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -60.18 -47.21 86.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.237 1.018 . . . . 0.0 108.633 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -63.11 -30.64 71.75 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.38 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 tp -58.86 -41.05 86.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 10.8 mptt -60.5 -41.84 95.13 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.657 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.35 -37.09 82.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.354 0.597 . . . . 0.0 110.621 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.9 -36.28 77.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.566 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 m -113.61 20.91 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.61 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.7 t -68.85 -4.48 16.46 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.353 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.98 -11.19 17.56 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -67.65 160.12 28.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.883 0.373 . . . . 0.0 110.675 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -70.88 -39.43 72.84 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.705 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.16 74.15 1.02 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.813 -0.176 . . . . 0.0 110.965 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -72.12 -21.61 61.45 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -79.19 -47.63 15.66 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.754 -0.592 . . . . 0.0 111.864 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 tp -70.15 -40.6 74.68 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.478 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 83.2 m -60.93 -48.09 83.42 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.55 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.8 t -62.83 -45.49 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 120.666 0.269 . . . . 0.0 110.899 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -41.63 97.26 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.135 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -37.76 84.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.742 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.6 p -66.28 -33.73 76.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.437 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.2 t -59.65 -45.45 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.286 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -61.66 -38.76 88.94 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.913 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.71 -46.43 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.66 -21.21 7.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.475 -178.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 79.8 m -70.91 -40.87 71.9 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.069 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.09 -36.56 16.85 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.448 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -117.75 69.63 0.78 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -57.8 -19.68 30.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.703 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -65.47 -19.17 65.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.412 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 tp -90.15 116.6 28.28 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -112.32 132.72 21.99 Favored Pre-proline 0 C--N 1.358 0.97 0 CA-C-N 120.1 1.318 . . . . 0.0 111.775 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.04 135.63 11.2 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.588 1.525 . . . . 0.0 112.973 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.6 t -129.66 136.56 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.0 tp -82.74 125.19 30.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.95 158.89 24.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.033 0.444 . . . . 0.0 111.149 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m -97.01 125.17 41.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.472 0.65 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.592 -179.176 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 . . . . . 0 C--O 1.234 0.262 0 CA-C-O 121.061 0.458 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.27 113.79 10.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.706 0.765 . . . . 0.0 110.347 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 tp -111.5 123.05 49.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -83.34 143.46 30.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.899 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.87 160.33 37.28 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.041 0.448 . . . . 0.0 111.738 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.0 mt -111.44 117.66 33.66 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -132.8 137.49 46.8 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.97 -146.19 10.79 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.375 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.9 p -134.41 159.16 41.93 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.88 116.6 18.09 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.229 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -67.11 123.32 10.77 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 N-CA-C 109.527 -0.99 . . . . 0.0 109.527 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.03 118.04 22.07 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.991 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.93 149.58 77.71 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.991 1.794 . . . . 0.0 111.315 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -162.8 111.98 1.36 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.935 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 45.85 45.03 11.51 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.3 -4.55 76.61 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.683 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -118.93 162.26 18.81 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.6 m -129.35 130.03 45.54 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.787 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -106.0 144.73 32.3 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.579 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.03 103.29 14.81 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.5 mp -91.18 117.35 67.81 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -85.1 124.46 2.9 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 123.023 2.482 . . . . 0.0 110.214 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 72' ' ' ILE . 27.9 pt -135.82 150.11 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 118.955 -1.098 . . . . 0.0 112.56 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.1 m -121.55 124.77 45.2 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.215 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 mp -103.13 107.58 18.44 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.436 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -96.06 125.63 40.73 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 67.8 mt -95.21 129.89 42.15 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.804 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 mt -73.72 149.99 41.49 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.47 -14.05 11.1 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.433 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.89 -8.74 36.33 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -53.92 145.83 30.91 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -91.4 12.11 55.99 Favored 'Cis proline' 0 N--CA 1.513 2.668 0 CA-C-N 120.682 1.279 . . . . 0.0 115.187 0.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -73.23 -12.97 61.05 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.724 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -121.23 129.53 25.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.068 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -49.38 138.18 30.6 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 CA-C-N 121.591 1.604 . . . . 0.0 111.844 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.48 144.05 15.7 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.056 1.837 . . . . 0.0 111.473 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mt -96.47 135.98 28.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 121.308 0.575 . . . . 0.0 110.118 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 48.9 t -111.99 149.29 32.2 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.611 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.85 126.53 30.69 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.623 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -84.95 123.5 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.81 108.48 2.71 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-O 119.05 -0.5 . . . . 0.0 109.901 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.77 155.89 7.47 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.619 1.546 . . . . 0.0 113.455 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 p -137.59 163.88 30.13 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.2 p -59.63 -26.77 65.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.863 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.7 p -90.74 -3.19 57.64 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.961 0.8 . . . . 0.0 111.244 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 41.4 ttm -124.11 142.05 51.53 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.23 159.16 35.17 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.836 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 85.8 mt -96.04 101.88 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -96.15 111.88 23.79 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.1 p -61.51 141.67 57.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.315 0.579 . . . . 0.0 111.392 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.37 -135.42 2.57 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.342 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -88.27 -3.33 58.87 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -138.4 -33.52 0.67 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.218 0.917 . . . . 0.0 112.446 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.62 138.59 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.375 0.989 . . . . 0.0 110.429 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -96.17 -161.51 0.87 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.375 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.91 -35.82 23.79 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.681 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -83.16 -1.79 53.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.546 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.07 8.51 47.53 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.504 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -62.51 137.49 58.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.365 0.583 . . . . 0.0 111.033 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.2 mt -114.63 113.22 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 102' ' ' HIS . 53.3 p90 -113.46 139.82 48.61 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 177.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.15 130.55 21.35 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.462 -176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -46.35 -39.91 22.0 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 121.664 1.576 . . . . 0.0 114.277 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -62.97 -31.3 72.39 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.863 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.08 -42.48 76.14 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.632 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.08 -28.49 66.56 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.026 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -95.46 -6.15 41.39 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.446 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -57.85 126.99 29.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.912 0.863 . . . . 0.0 110.656 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -104.63 102.96 12.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.98 -1.464 . . . . 0.0 108.435 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 60.5 t60 -60.88 123.91 77.26 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.038 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 5.8 Cg_endo -108.27 91.9 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 120.704 1.287 . . . . 0.0 113.211 -2.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -112.98 -60.59 1.86 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.423 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.0 t -67.48 -41.83 83.93 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.53 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 69.67 159.22 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.04 0.448 . . . . 0.0 111.634 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.99 -44.68 94.36 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 63.0 tp -53.8 -33.04 54.83 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.6 -40.67 98.9 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.2 tp -60.69 -39.68 89.37 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.93 -44.08 24.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.903 -177.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -68.68 -37.0 79.26 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.9 t -68.11 -42.93 85.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 C-N-CA 118.992 -1.083 . . . . 0.0 108.518 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.5 ttm -55.97 -44.89 78.96 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.81 -32.26 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.043 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 63.0 t -94.46 -48.98 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 119.556 -0.857 . . . . 0.0 113.118 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.4 p -80.33 -11.11 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -93.52 -13.22 28.06 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.427 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -95.23 -5.2 60.76 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -65.99 -36.05 82.25 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.214 0.507 . . . . 0.0 110.428 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -157.26 82.79 3.07 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -44.82 106.58 0.09 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.563 1.508 . . . . 0.0 111.365 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.03 -12.0 31.54 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.835 1.69 . . . . 0.0 111.282 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.15 146.94 32.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.869 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.5 p90 . . . . . 0 N--CA 1.47 0.548 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.521 -179.736 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 121.303 0.573 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -101.77 156.61 17.4 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.46 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 94.5 mt-10 -62.71 -41.38 99.12 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.235 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 t -60.17 -46.17 90.6 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.941 0.876 . . . . 0.0 109.327 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -65.78 -28.4 68.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.059 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.425 ' O ' HG21 ' A' ' 12' ' ' VAL . 59.3 tp -61.83 -39.61 92.42 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -65.42 -40.72 93.68 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.987 178.276 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.96 -37.15 81.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.47 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.8 ptp -76.14 -11.47 59.94 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.547 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 8' ' ' LEU . 10.2 m -142.35 31.71 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.459 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.5 p -72.01 -24.7 61.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.225 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.96 -13.51 55.86 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.792 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.0 151.49 26.21 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.972 0.415 . . . . 0.0 110.744 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -70.51 -37.49 74.15 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 21.3 m-85 -114.66 65.68 0.68 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.3 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -64.91 -34.11 77.61 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.57 -42.08 83.15 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.85 -38.79 61.89 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.825 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.1 m -61.68 -43.27 99.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.408 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.5 t -72.7 -46.14 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.176 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -42.09 97.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.345 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -69.1 -30.99 69.41 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.706 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -70.39 -39.36 74.56 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.969 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.29 -45.57 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -39.5 91.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.9 t -66.17 -43.59 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.8 -13.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.412 -178.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 p -82.99 -51.04 7.93 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.419 0.628 . . . . 0.0 109.786 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.2 tp -81.38 -37.67 27.82 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.466 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.92 68.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -58.63 -19.85 42.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.825 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.11 -21.12 66.76 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.244 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 tp -93.16 113.96 26.34 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -109.94 126.97 27.91 Favored Pre-proline 0 C--N 1.356 0.866 0 CA-C-N 119.385 0.993 . . . . 0.0 112.157 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.94 134.68 10.77 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.553 1.502 . . . . 0.0 112.88 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.4 t -124.07 135.33 63.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.6 tp -82.84 118.32 23.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.6 136.23 53.04 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.787 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.1 p -84.35 119.11 24.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.3 t80 . . . . . 0 N--CA 1.469 0.475 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.283 -178.621 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.425 0 CA-C-O 121.537 0.684 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -79.56 106.52 11.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.027 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tp -116.54 121.45 41.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -91.77 136.38 33.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.643 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -127.32 150.82 49.42 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.887 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.0 mt -99.73 123.05 43.6 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.5 m -133.7 137.14 45.13 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.76 -149.37 13.73 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.738 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -133.98 159.77 39.74 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 pt -134.22 116.3 13.16 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.998 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.5 126.93 10.63 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 120.908 1.072 . . . . 0.0 110.394 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.63 118.56 15.75 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.369 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.62 149.7 90.23 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.282 1.988 . . . . 0.0 110.257 177.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -162.7 107.51 1.14 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.201 0.524 . . . . 0.0 111.686 -178.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 52.3 38.82 25.9 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.105 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.61 81.78 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -122.14 131.63 54.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.9 m -113.02 130.97 55.95 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.847 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -112.97 150.49 31.8 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.871 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -95.15 104.4 16.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.55 115.3 62.97 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -86.46 125.74 2.55 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.965 2.443 . . . . 0.0 110.958 177.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.437 HD12 HG22 ' A' ' 72' ' ' ILE . 31.9 pt -133.81 148.6 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.758 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 54.0 m -121.7 122.05 38.69 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.999 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.89 115.9 31.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.147 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -107.52 127.1 53.32 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.5 mt -94.56 135.69 35.72 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.207 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mt -79.76 151.23 30.49 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -61.49 -13.01 17.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.122 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.61 0.46 39.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.138 0.494 . . . . 0.0 111.397 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.425 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 56.6 t80 -55.93 146.24 49.52 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.425 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 6.9 Cg_endo -93.51 7.83 56.48 Favored 'Cis proline' 0 N--CA 1.509 2.388 0 CA-C-N 120.765 1.309 . . . . 0.0 114.042 1.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.445 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 7.2 m-85 -70.3 -18.77 63.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.75 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.93 137.77 19.89 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.31 140.95 66.4 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 CA-C-N 121.531 1.583 . . . . 0.0 111.196 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.21 142.86 12.32 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.236 1.958 . . . . 0.0 112.242 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.18 130.66 41.91 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.014 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.4 t -113.52 137.73 51.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.285 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -123.08 127.13 48.31 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.531 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.58 121.96 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -63.11 108.43 1.73 Allowed Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 119.161 -0.447 . . . . 0.0 110.021 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -84.23 160.7 13.27 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 121.627 1.551 . . . . 0.0 113.04 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.8 p -142.54 165.1 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.789 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.6 p -58.21 -35.22 71.33 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.153 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 t -88.3 -22.28 23.97 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.748 -0.595 . . . . 0.0 110.814 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 41.1 tpp -89.12 135.87 33.33 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.968 0.413 . . . . 0.0 110.192 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 84.0 m -125.61 141.22 52.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.594 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.6 mt -90.05 105.82 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -89.6 102.78 15.46 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.1 p -64.44 152.46 41.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.28 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.44 -137.43 2.28 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.154 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -65.3 -23.98 67.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -136.22 -16.85 1.61 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.8 t -100.32 132.09 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.508 1.049 . . . . 0.0 111.15 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -93.21 -160.99 0.8 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.56 -21.26 25.51 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -89.72 -9.49 49.22 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.924 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.96 12.23 30.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.683 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -66.4 139.09 57.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.387 0.593 . . . . 0.0 109.952 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.421 HD12 HG21 ' A' ' 109' ' ' ILE . 96.5 mt -113.57 118.61 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.48 0.488 . . . . 0.0 111.752 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -102.49 140.13 37.18 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 27.8 mt -138.35 120.22 10.53 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.779 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.33 -38.95 27.28 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.357 1.371 . . . . 0.0 113.465 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -30.63 71.63 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.491 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.33 -41.17 73.57 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -69.44 -22.77 63.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.167 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -112.63 9.75 19.38 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.97 178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.0 t90 -76.93 123.45 26.31 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.944 0.878 . . . . 0.0 109.729 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -93.72 124.91 38.03 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.821 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -79.37 125.82 82.37 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.651 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -108.32 92.84 0.04 OUTLIER 'Cis proline' 0 N--CA 1.497 1.717 0 CA-C-N 120.774 1.312 . . . . 0.0 112.529 -2.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -114.32 -61.75 1.7 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.361 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.3 t -68.51 -31.96 71.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.905 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 48.49 -178.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.811 0.815 . . . . 0.0 111.806 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.8 tt -68.36 -40.28 81.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.747 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -40.99 68.37 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.39 -39.46 97.79 Favored Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.6 tp -58.69 -41.38 86.11 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -72.85 -48.88 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 119.884 -0.727 . . . . 0.0 112.063 -176.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -66.41 -35.59 80.68 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.47 -38.19 78.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.735 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 60.8 tpp -58.8 -42.49 89.22 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -34.81 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.912 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.8 t -90.83 -45.12 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 6.2 p -66.05 -15.63 19.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.88 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -104.41 -19.23 14.12 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.196 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.72 -36.99 93.03 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.5 -40.54 95.85 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.133 -0.533 . . . . 0.0 110.9 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -153.45 84.62 4.27 Favored Pre-proline 0 CA--C 1.52 -0.199 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -48.3 120.35 4.94 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.983 1.122 . . . . 0.0 110.138 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.93 -21.29 28.24 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.493 1.462 . . . . 0.0 111.887 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.33 140.88 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.154 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 6.4 p90 . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.395 -179.359 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 121.027 0.442 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.78 155.07 17.9 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.453 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 92.2 mt-10 -61.38 -43.19 99.29 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.254 -0.979 . . . . 0.0 112.017 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 t -58.47 -46.16 87.18 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.935 0.874 . . . . 0.0 108.984 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -62.9 -36.54 83.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.357 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.8 tp -55.73 -43.45 76.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.0 mptp? -61.3 -42.88 99.39 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.309 0.576 . . . . 0.0 109.528 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -61.1 -36.52 79.92 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.332 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.88 -37.72 73.03 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.723 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -112.12 24.37 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.736 0.303 . . . . 0.0 110.879 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.2 t -62.39 -37.87 87.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.022 0.439 . . . . 0.0 110.963 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -60.12 -21.91 62.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.601 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -63.88 157.57 24.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.112 0.482 . . . . 0.0 111.662 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.88 -37.9 54.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.621 177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 14.8 m-85 -113.94 64.61 0.66 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.356 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -61.79 -25.64 67.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -76.59 -51.97 10.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.04 -39.94 90.57 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.307 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.9 m -60.55 -47.56 85.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.166 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.6 t -66.24 -45.1 90.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.54 -41.92 98.06 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.485 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -67.51 -35.3 78.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.2 p -67.65 -37.6 82.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.63 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.29 -45.61 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -37.63 80.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.5 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.89 -46.55 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.11 -13.76 12.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.169 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 p -76.36 -50.96 12.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.045 0.45 . . . . 0.0 109.864 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.9 tp -82.37 -37.57 25.43 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.34 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -112.08 66.67 0.64 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm -55.59 -17.21 5.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.465 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -69.07 -15.19 63.39 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.176 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 tp -94.4 113.22 25.06 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -110.11 124.29 33.83 Favored Pre-proline 0 C--N 1.356 0.89 0 CA-C-N 119.474 1.034 . . . . 0.0 111.978 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.53 136.37 9.73 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 121.697 1.598 . . . . 0.0 113.202 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.04 156.34 42.68 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 110.397 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.7 tp -92.28 118.69 31.14 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -124.43 132.81 53.51 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.321 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.8 p -76.86 137.38 39.14 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 N--CA 1.473 0.717 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.962 179.683 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 . . . . . 0 N--CA 1.467 0.395 0 CA-C-O 121.088 0.47 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.83 118.81 19.03 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.303 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 mt -121.48 140.7 51.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.557 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -96.92 137.71 35.59 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.322 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -130.49 151.2 51.23 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.457 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.4 mt -95.09 126.7 40.6 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.9 m -137.69 136.38 37.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.74 -147.11 11.55 Favored Glycine 0 N--CA 1.466 0.65 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.655 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.1 p -132.49 158.09 42.96 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -129.9 117.03 18.14 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.092 177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -72.23 123.49 9.24 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 119.947 1.017 . . . . 0.0 110.099 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.0 t -123.67 113.12 28.91 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.631 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.84 147.53 89.53 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.228 1.952 . . . . 0.0 109.695 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -163.57 107.4 1.01 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.63 -178.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.51 43.35 27.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.068 0.461 . . . . 0.0 111.557 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.01 14.76 76.2 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -134.69 125.6 27.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.2 m -113.26 131.18 56.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.997 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -112.59 149.23 33.06 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.466 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.79 100.08 11.83 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.6 117.69 68.85 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.314 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.81 123.81 2.9 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.453 2.102 . . . . 0.0 110.415 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.405 HD12 HG23 ' A' ' 72' ' ' ILE . 21.3 pt -131.6 147.12 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.349 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 67.4 m -121.08 123.12 41.57 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.205 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.33 109.62 21.31 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.144 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -99.49 125.35 45.22 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.01 140.85 29.04 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.257 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -84.18 155.11 22.7 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -62.53 -17.19 59.27 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.908 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.25 3.51 40.95 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.986 0.422 . . . . 0.0 111.718 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -59.16 145.37 81.03 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -91.59 8.64 62.81 Favored 'Cis proline' 0 N--CA 1.519 2.99 0 CA-C-N 121.019 1.4 . . . . 0.0 115.246 1.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.414 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 22.6 m-85 -74.46 -13.02 60.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.436 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.2 129.56 24.45 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.564 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -49.67 134.34 33.65 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 CA-C-N 121.205 1.466 . . . . 0.0 112.169 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.15 146.16 17.73 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.037 1.825 . . . . 0.0 111.886 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.49 151.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.79 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 50.1 t -134.78 142.07 46.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.665 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -127.09 131.21 50.91 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.086 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.404 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 57.6 t -97.44 123.62 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -76.37 106.26 3.09 Favored Pre-proline 0 N--CA 1.476 0.87 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.56 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 48.5 Cg_endo -90.61 128.66 1.42 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 CA-C-N 121.146 1.445 . . . . 0.0 113.548 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.5 p -81.15 168.95 17.99 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 88.1 p -59.27 -22.53 61.31 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 t -106.55 22.17 16.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.871 0.76 . . . . 0.0 110.946 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 42.5 ttm -133.52 144.73 49.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -131.22 163.71 27.16 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.864 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -89.35 103.37 13.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.484 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -89.0 110.09 20.83 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.5 p -68.19 138.28 55.49 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.341 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.36 -141.82 3.54 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.249 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -70.84 -23.93 62.43 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.418 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 38.4 p-80 -130.4 -16.79 3.43 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.2 t -91.72 137.27 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.855 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -93.71 175.78 6.61 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.56 -39.07 93.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -91.15 4.78 51.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.11 10.27 49.28 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.99 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -67.82 140.96 56.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.7 mt -118.35 116.44 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CE2' ' HA ' ' A' ' 102' ' ' HIS . 0.5 OUTLIER -116.88 142.94 46.28 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 mp -133.7 131.41 21.18 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.79 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.1 -32.62 40.2 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 121.154 1.236 . . . . 0.0 113.693 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -65.76 -30.44 71.09 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.509 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.92 -41.45 74.63 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.229 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -67.94 -28.03 67.12 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.227 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -102.35 0.56 34.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.338 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.412 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.7 t90 -69.37 124.16 23.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.959 0.885 . . . . 0.0 109.985 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -95.34 125.0 39.67 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.158 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -76.7 125.64 86.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.409 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -108.85 92.03 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.65 0 CA-C-N 120.937 1.37 . . . . 0.0 112.36 -2.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -114.12 -61.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.936 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.1 t -66.64 -40.75 88.84 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.794 0.331 . . . . 0.0 111.277 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 59.07 168.15 0.06 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.787 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.7 tt -60.04 -42.1 93.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.69 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.0 tt -52.63 -37.64 58.76 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.31 97.08 Favored Glycine 0 N--CA 1.477 1.37 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.7 tp -60.51 -40.25 90.73 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -75.57 -48.85 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.644 -176.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -67.01 -35.48 80.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.0 t -69.12 -39.7 79.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 51.7 ttm -57.85 -44.73 86.75 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -61.0 -36.42 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.792 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -88.77 -47.27 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.4 p -66.75 -13.79 16.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.197 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.418 ' CE2' ' CD2' ' A' ' 102' ' ' HIS . 9.8 m-30 -101.83 -17.08 16.37 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.441 177.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.22 -26.74 71.74 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.96 -31.76 72.85 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.199 -0.501 . . . . 0.0 110.547 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -166.58 84.43 0.91 Allowed Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.257 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -46.6 121.83 5.2 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.225 1.283 . . . . 0.0 109.844 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.13 -14.93 35.51 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.458 1.439 . . . . 0.0 112.427 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 m -131.42 151.2 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.245 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.7 p90 . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.374 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 121.005 0.431 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.34 155.13 17.03 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.419 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 92.3 mt-10 -62.16 -41.08 97.95 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -57.1 -48.45 78.58 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.054 0.93 . . . . 0.0 109.398 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -64.05 -30.8 71.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.518 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.14 -39.07 81.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.764 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 12.0 mptt -59.56 -42.79 93.25 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.669 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.71 -25.48 64.79 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.996 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.92 -28.92 35.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.893 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.6 23.83 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 120.903 0.382 . . . . 0.0 110.489 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 t -67.06 -39.04 86.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.153 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -62.03 -17.72 58.25 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.823 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -69.6 158.87 34.47 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.478 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -88.86 -9.86 50.11 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.91 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -132.88 56.12 1.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 119.532 -0.271 . . . . 0.0 110.302 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -61.11 -32.43 72.11 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.33 -50.86 64.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.92 -41.96 73.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.099 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.2 m -61.51 -47.08 87.26 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 121.161 -0.216 . . . . 0.0 111.238 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.4 t -61.04 -46.51 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -60.32 -45.1 94.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.805 0.812 . . . . 0.0 110.586 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -68.23 -34.43 76.22 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.506 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.6 p -67.81 -33.66 75.23 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.408 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.57 -44.96 94.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 C-N-CA 118.951 -1.1 . . . . 0.0 108.167 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -60.87 -37.32 81.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.011 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.2 t -68.83 -45.63 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.88 -17.25 8.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.702 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -76.8 -49.87 14.83 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.183 0.516 . . . . 0.0 109.709 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.9 tp -76.61 -39.91 51.03 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.643 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -113.85 67.77 0.68 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -53.75 -20.34 5.45 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.522 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -65.69 -21.33 66.53 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.57 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.1 tp -89.64 117.59 28.63 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -115.05 126.52 27.75 Favored Pre-proline 0 C--N 1.356 0.879 0 CA-C-N 119.618 1.099 . . . . 0.0 111.916 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.51 135.1 14.41 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 CA-C-N 120.379 1.171 . . . . 0.0 112.232 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.17 136.64 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.9 tp -85.15 116.32 23.45 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -119.48 133.69 55.57 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.107 0.479 . . . . 0.0 111.76 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.2 m -68.24 138.74 55.8 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.9 t80 . . . . . 0 N--CA 1.467 0.389 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.532 -179.873 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 121.272 0.558 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.58 118.7 19.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.029 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.6 tp -116.99 121.03 40.21 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.2 ttp -84.62 142.91 29.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.025 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -133.51 162.15 32.67 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.384 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -108.5 123.39 48.82 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.9 m -140.6 139.07 34.85 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.0 -148.59 14.93 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.187 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.6 p -132.67 161.02 35.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.822 -0.689 . . . . 0.0 112.334 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 pt -131.05 116.03 16.69 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.995 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.17 126.23 9.73 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 CA-C-N 119.689 0.925 . . . . 0.0 109.945 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.0 129.84 21.94 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.795 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.94 150.03 48.23 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.388 2.059 . . . . 0.0 110.876 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -163.97 112.04 1.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.971 0.415 . . . . 0.0 111.955 -178.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? 49.88 44.52 25.24 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.448 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.81 18.38 68.36 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -137.6 127.11 25.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.5 m -111.44 130.78 55.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.455 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -112.67 150.81 30.95 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.734 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -94.61 105.04 16.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.67 116.57 66.71 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.47 124.62 3.68 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.196 1.93 . . . . 0.0 110.849 177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.7 pt -132.32 148.0 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.958 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.0 t -125.76 120.19 29.94 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.37 116.94 33.37 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.56 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -105.48 118.36 36.38 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.0 mt -88.11 135.9 33.22 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.611 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.2 150.42 24.82 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -59.64 -15.32 18.24 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.315 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 p -100.75 7.77 43.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.541 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -66.46 144.05 98.49 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -92.08 3.88 63.09 Favored 'Cis proline' 0 N--CA 1.518 2.962 0 N-CA-C 116.13 1.55 . . . . 0.0 116.13 1.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -73.77 -17.12 61.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.467 1.031 . . . . 0.0 109.922 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.52 131.16 21.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.51 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -59.54 131.02 38.13 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 CA-C-N 121.319 1.507 . . . . 0.0 112.28 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.15 145.23 12.17 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.371 2.047 . . . . 0.0 111.545 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.9 129.89 48.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.0 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 42.7 t -110.82 144.08 40.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.627 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -126.53 127.4 45.25 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.438 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.494 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 71.7 t -82.44 137.36 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -93.87 96.12 1.55 Allowed Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.135 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 97.7 Cg_endo -78.9 160.98 27.25 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 C-N-CA 121.711 1.607 . . . . 0.0 112.794 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 t -148.37 167.22 25.81 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.661 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.9 p -58.46 -27.59 64.52 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 62.6 m -94.06 6.54 48.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.974 0.806 . . . . 0.0 110.972 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 82.8 mmm -130.99 144.1 51.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.3 m -121.44 145.04 48.33 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.568 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.2 tt -113.25 122.22 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.32 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.65 98.22 6.91 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.1 p -55.23 140.72 37.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.695 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.11 -142.2 3.33 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.431 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -65.46 -25.49 67.53 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -119.03 -30.29 5.04 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 119.322 0.965 . . . . 0.0 113.207 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.4 t -96.4 134.21 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.313 0.961 . . . . 0.0 110.925 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -98.68 160.47 14.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.287 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.12 85.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.053 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.31 -7.14 34.47 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.119 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.85 8.01 58.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.747 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.61 151.53 34.32 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.153 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.2 mt -109.18 122.03 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.481 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -99.64 130.96 45.91 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.1 mt -134.33 108.37 11.27 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.89 -177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -48.52 -34.26 25.73 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.971 1.781 . . . . 0.0 114.475 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -62.29 -29.24 70.29 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.337 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.58 -41.09 80.16 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.422 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -65.81 -31.67 72.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.459 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -96.65 -8.4 31.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.336 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -54.1 124.83 16.82 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.898 0.856 . . . . 0.0 109.967 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -107.69 106.26 16.51 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.739 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -58.23 123.55 66.09 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.721 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -109.63 91.74 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.549 0 CA-C-N 120.707 1.288 . . . . 0.0 112.496 -3.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.88 -62.66 1.56 Allowed 'General case' 0 C--O 1.232 0.149 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.4 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.8 m -67.8 -41.04 83.75 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.136 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 60.62 163.5 0.06 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.527 0.679 . . . . 0.0 111.53 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.24 -45.91 91.6 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.246 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.6 tp -54.68 -33.65 61.16 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.41 -40.54 97.86 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 tp -58.01 -40.0 79.71 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -75.73 -47.16 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.745 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -66.73 -35.74 80.82 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.19 -38.38 80.95 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.1 tpp -58.66 -44.06 90.02 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.8 -35.05 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.744 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -86.3 -47.27 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.774 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.58 -13.68 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.221 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -103.58 -16.34 15.55 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.646 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -84.58 -23.76 49.17 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -66.44 -29.22 69.3 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.349 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -161.55 84.25 1.76 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.704 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -45.38 108.16 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.324 1.349 . . . . 0.0 110.925 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.11 -17.87 35.73 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.652 1.568 . . . . 0.0 110.982 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.28 138.41 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.458 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.5 p90 . . . . . 0 N--CA 1.471 0.624 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.577 -179.568 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.1 t . . . . . 0 N--CA 1.447 -0.616 0 CA-C-O 121.203 0.525 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 t -98.28 153.98 18.13 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.505 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 37.2 mp0 -60.13 -42.6 95.16 Favored 'General case' 0 C--O 1.214 -0.795 0 C-N-CA 118.43 -1.308 . . . . 0.0 110.947 -178.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.8 m -53.38 -45.94 69.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.825 0.822 . . . . 0.0 109.651 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -63.5 -38.06 89.67 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.601 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.08 -42.07 72.34 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.505 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -59.67 -40.1 86.68 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.94 -32.43 70.7 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.05 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -73.55 -31.72 63.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.456 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.36 20.76 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.687 0.28 . . . . 0.0 111.333 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -61.31 -37.94 85.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.365 0.602 . . . . 0.0 110.298 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -60.22 -21.15 61.46 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.612 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -74.49 151.87 39.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.915 0.388 . . . . 0.0 111.889 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -70.93 -37.15 72.88 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.985 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.401 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 39.1 m-85 -109.14 60.84 0.6 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 121.25 -0.18 . . . . 0.0 111.448 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -67.37 -24.74 65.73 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -75.12 -50.0 17.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.93 -40.14 83.38 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.647 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.5 m -61.2 -46.73 89.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.247 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.5 t -61.85 -44.4 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-O 120.821 0.343 . . . . 0.0 110.155 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -62.93 -41.6 99.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.209 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -66.42 -37.73 85.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.676 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.7 p -66.19 -37.13 84.86 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.299 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.18 -45.08 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 C-N-CA 118.849 -1.14 . . . . 0.0 108.506 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -61.28 -37.83 84.57 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.251 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.9 t -71.27 -43.41 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.05 -23.1 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.386 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.1 m -72.19 -44.5 62.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.046 0.451 . . . . 0.0 110.264 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.9 tp -88.73 -40.68 13.06 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.417 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.55 67.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -56.83 -17.19 8.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.029 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -66.08 -14.6 62.02 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.59 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 tp -102.42 113.03 26.02 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -110.07 137.12 20.45 Favored Pre-proline 0 C--N 1.36 1.024 0 CA-C-N 119.921 1.237 . . . . 0.0 112.182 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.13 139.92 10.89 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.004 1.803 . . . . 0.0 112.423 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.53 139.22 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.072 0.463 . . . . 0.0 109.794 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.2 tp -83.74 122.41 28.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.175 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -129.7 140.61 51.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.981 0.42 . . . . 0.0 112.073 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.7 t -94.05 115.29 27.6 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.71 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 . . . . . 0 C--O 1.238 0.481 0 CA-C-O 121.294 0.569 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -67.62 118.51 10.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.395 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -125.53 142.53 51.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.955 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 49.8 ttp -90.93 144.57 25.54 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.11 152.76 51.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.551 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.8 mt -104.41 117.89 35.29 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -132.32 136.79 47.13 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.26 -143.95 8.34 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.424 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 p -136.34 159.31 42.16 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.27 116.03 16.43 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.031 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -72.32 125.85 11.13 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 120.867 1.044 . . . . 0.0 110.793 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.5 t -128.77 115.91 19.3 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.578 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.31 150.63 15.4 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 122.718 2.279 . . . . 0.0 112.224 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.02 115.05 1.32 Allowed 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.258 0.551 . . . . 0.0 111.229 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.95 39.44 22.84 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.862 -0.523 . . . . 0.0 112.119 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 0.79 90.05 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.139 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.412 ' ND2' ' CZ ' ' A' ' 68' ' ' TYR . 1.7 t30 -119.89 128.78 53.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 109.896 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.2 m -119.26 132.04 55.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.502 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.412 ' CZ ' ' ND2' ' A' ' 66' ' ' ASN . 67.5 m-85 -115.75 150.88 36.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.916 0.388 . . . . 0.0 110.574 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.6 100.94 12.61 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.37 116.98 67.92 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.464 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -82.29 126.27 4.82 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 122.718 2.279 . . . . 0.0 110.687 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.405 HD13 HG23 ' A' ' 72' ' ' ILE . 26.4 pt -133.35 147.96 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 118.943 -1.103 . . . . 0.0 112.502 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.6 m -121.89 123.42 41.69 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.365 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.07 109.92 21.89 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.42 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -96.08 128.98 43.46 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 mp -99.42 140.08 34.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.13 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tp -95.14 140.56 29.9 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.71 -17.1 0.09 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.17 12.43 37.01 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -69.08 143.41 94.21 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -91.68 4.51 64.91 Favored 'Cis proline' 0 N--CA 1.516 2.806 0 CA-C-N 120.928 1.367 . . . . 0.0 114.501 0.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.401 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.4 m-85 -67.73 -18.93 65.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.378 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.08 120.98 40.6 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.201 178.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -49.55 136.41 33.37 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 CA-C-N 121.235 1.477 . . . . 0.0 111.859 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.62 144.7 14.2 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.337 2.025 . . . . 0.0 111.277 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 mp -97.76 132.77 41.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-O 121.591 0.71 . . . . 0.0 109.789 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 33.8 t -106.41 154.86 20.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.529 -177.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.1 128.76 30.75 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.053 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.05 124.13 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -75.28 108.12 5.12 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.187 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -85.64 159.24 10.68 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.267 1.311 . . . . 0.0 112.454 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -129.24 164.86 22.55 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 m -58.6 -39.84 81.56 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.2 m -84.74 -0.68 54.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.85 0.75 . . . . 0.0 111.581 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 32.8 ttm -120.92 145.92 47.18 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -131.39 163.07 28.7 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.588 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.4 mt -95.8 103.59 14.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -87.32 113.52 23.12 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.149 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.5 p -68.52 147.74 51.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.256 0.55 . . . . 0.0 110.479 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.87 -145.16 4.28 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -79.47 -7.53 58.5 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -133.11 -30.46 1.34 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.14 0.882 . . . . 0.0 112.297 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.2 t -97.03 139.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.48 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -94.83 -174.61 3.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.661 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.32 -35.03 21.72 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -83.86 5.46 25.14 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.957 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.13 13.12 50.32 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.346 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -75.52 136.26 40.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.779 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 91.7 mt -110.8 114.98 48.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 140.86 49.2 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 mp -134.43 128.63 19.29 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.01 -176.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -49.02 -35.16 31.49 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 121.388 1.392 . . . . 0.0 113.384 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -32.42 71.92 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.23 -41.93 76.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.273 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -63.68 -31.06 72.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.016 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -108.42 9.95 27.53 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.769 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -65.57 127.25 31.13 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.688 0.756 . . . . 0.0 110.439 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.39 122.17 43.75 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.453 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -75.82 125.93 87.71 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.626 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -109.85 91.27 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.718 0 CA-C-N 120.597 1.249 . . . . 0.0 112.626 -2.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -113.19 -59.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.538 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.2 p -68.85 -34.74 75.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.138 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 p30 49.21 178.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.603 0.716 . . . . 0.0 111.613 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 tt -66.0 -40.59 91.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.379 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 tt -56.77 -40.36 75.73 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.86 -39.87 97.48 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.0 tp -58.69 -40.77 84.59 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 122.265 -0.55 . . . . 0.0 111.556 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -76.61 -48.89 25.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.096 -0.642 . . . . 0.0 112.314 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -66.71 -34.0 76.87 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.6 -38.33 78.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 48.7 tpp -58.9 -44.1 91.14 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -61.64 -40.84 88.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.888 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -82.46 -47.86 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 120.002 -0.679 . . . . 0.0 112.543 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.2 p -66.75 -14.06 17.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.072 -178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -109.22 -18.43 13.61 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.91 88.52 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -63.66 -34.91 78.9 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-N 115.294 -0.453 . . . . 0.0 110.489 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -156.63 84.08 3.16 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.327 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -43.96 107.42 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.679 1.586 . . . . 0.0 111.018 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.03 -24.23 47.77 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.105 1.87 . . . . 0.0 111.578 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.6 m -128.33 147.33 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.565 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.0 p90 . . . . . 0 N--CA 1.474 0.727 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.542 179.865 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 N--CA 1.449 -0.515 0 CA-C-O 121.052 0.453 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.82 153.56 18.79 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.496 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 95.3 mt-10 -61.72 -42.17 98.59 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.099 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.0 t -56.78 -46.49 81.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.19 0.995 . . . . 0.0 108.649 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -61.18 -39.07 88.8 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.144 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.6 tp -56.12 -42.19 76.47 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.6 mptp? -60.14 -40.65 90.57 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -28.19 67.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.69 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.39 -30.51 37.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.99 -178.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.61 19.71 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.577 0.227 . . . . 0.0 111.387 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -61.05 -38.1 84.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.53 0.681 . . . . 0.0 110.306 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -60.2 -26.06 66.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.122 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.408 ' HE2' ' O ' ' A' ' 77' ' ' LEU . 40.3 m-85 -67.36 159.4 29.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.716 0.293 . . . . 0.0 110.941 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -80.33 -29.92 38.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.811 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -116.89 58.04 0.78 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -63.59 -28.51 69.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.3 -47.41 61.26 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.1 tp -70.27 -40.25 74.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.501 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.8 m -62.94 -46.14 89.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.4 t -63.28 -45.6 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 120.695 0.283 . . . . 0.0 110.991 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -63.14 -43.52 98.11 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.154 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -66.68 -37.43 84.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.995 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.1 p -64.76 -36.94 85.94 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.976 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -57.32 -45.03 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -60.98 -40.41 93.34 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.998 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -68.0 -43.6 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.38 -23.77 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.217 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.5 m -74.48 -44.54 51.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.009 0.433 . . . . 0.0 110.595 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -85.32 -36.61 20.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.666 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.86 68.38 0.72 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -57.01 -19.39 18.12 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.539 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.81 -21.55 66.8 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.067 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.9 tp -90.24 113.32 25.11 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -108.98 125.12 32.3 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 119.439 1.018 . . . . 0.0 111.77 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.09 137.58 17.38 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.32 1.347 . . . . 0.0 112.102 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.18 143.99 37.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 120.968 0.414 . . . . 0.0 110.264 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.5 tp -91.63 122.01 33.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.533 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -131.47 139.5 49.36 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.088 0.47 . . . . 0.0 111.965 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 t -68.82 136.22 52.37 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.2 t80 . . . . . 0 N--CA 1.465 0.321 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.163 -179.978 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -79.83 120.1 23.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.558 0.694 . . . . 0.0 110.623 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.8 mt -116.18 142.51 46.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.907 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -101.37 137.12 40.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.097 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -129.34 151.08 50.38 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.744 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.8 mt -95.16 122.34 37.73 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.2 m -133.65 136.02 44.52 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.81 -144.54 9.16 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.859 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -135.18 160.47 38.26 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -129.32 116.14 18.62 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.924 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -73.55 124.24 9.2 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 120.661 0.907 . . . . 0.0 109.887 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.4 t -123.76 117.72 27.36 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.03 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.5 146.77 50.58 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.334 2.022 . . . . 0.0 110.753 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.404 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -162.88 108.97 1.17 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.514 -178.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.01 35.12 21.3 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 122.022 -0.424 . . . . 0.0 111.411 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.65 -2.74 77.69 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -113.57 135.1 54.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.6 m -120.28 132.27 55.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.034 0.445 . . . . 0.0 111.993 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -111.02 147.53 34.56 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.807 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -95.26 100.53 12.31 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 mp -86.92 115.42 62.46 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.034 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.38 123.37 3.87 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.874 2.383 . . . . 0.0 111.058 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 72' ' ' ILE . 35.2 pt -136.49 149.12 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.935 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 53.7 m -123.92 122.42 37.91 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.568 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.64 121.6 39.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.025 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -111.23 119.43 38.89 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.12 139.97 32.09 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.034 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.408 ' O ' ' HE2' ' A' ' 15' ' ' TYR . 2.8 mt -89.28 149.38 23.09 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -56.69 -16.58 6.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.619 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.0 5.41 43.1 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.156 0.503 . . . . 0.0 111.788 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -63.77 144.08 97.99 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -90.19 5.32 68.53 Favored 'Cis proline' 0 N--CA 1.514 2.693 0 CA-C-N 121.004 1.394 . . . . 0.0 115.227 1.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -70.07 -25.02 63.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.865 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.3 138.2 19.47 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.37 141.67 75.66 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 CA-C-N 121.767 1.667 . . . . 0.0 111.304 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -82.52 142.87 11.91 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.016 1.81 . . . . 0.0 111.878 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.55 135.34 28.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 42.2 t -112.09 139.93 47.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.839 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.1 124.98 44.31 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.943 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -84.41 144.48 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -98.29 98.21 5.48 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 119.221 -0.418 . . . . 0.0 110.318 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -80.79 160.18 21.5 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.256 1.304 . . . . 0.0 111.921 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 t -137.34 161.68 35.62 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.2 t -54.64 -39.37 67.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.177 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.6 t -76.64 -2.25 31.74 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.536 0.607 . . . . 0.0 111.956 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.3 mtp -130.13 145.47 51.7 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.73 163.35 23.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.596 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.3 mm -90.77 110.04 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.567 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -95.09 104.75 16.63 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 34.3 p -67.73 138.17 56.04 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.684 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.76 -133.64 1.93 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -86.09 -7.26 58.72 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -134.84 -23.09 1.59 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.62 134.59 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 119.6 1.091 . . . . 0.0 110.635 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -84.72 -168.29 2.14 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.59 -34.54 19.85 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.683 -0.636 . . . . 0.0 112.399 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -88.81 1.26 55.57 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.736 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.01 -8.43 38.89 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.465 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 131.67 23.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.243 0.522 . . . . 0.0 110.172 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.5 mt -97.67 121.5 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.928 0.395 . . . . 0.0 110.535 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.87 119.43 38.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 mt -126.57 113.42 22.91 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.59 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -48.42 -38.27 34.54 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 121.962 1.775 . . . . 0.0 114.25 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -63.82 -31.51 72.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.22 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.29 -42.23 79.78 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.793 0.33 . . . . 0.0 110.927 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -67.1 -29.26 68.96 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.687 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -104.36 7.15 35.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.229 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -71.6 127.25 31.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 122.033 0.92 . . . . 0.0 110.651 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -97.41 124.72 41.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.824 -1.534 . . . . 0.0 108.217 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -80.25 126.64 78.7 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 119.133 -0.46 . . . . 0.0 110.539 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -108.8 93.36 0.03 OUTLIER 'Cis proline' 0 N--CA 1.498 1.755 0 CA-C-N 120.631 1.261 . . . . 0.0 112.778 -2.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -113.69 -60.7 1.85 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.722 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.2 p -69.99 -31.8 69.67 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.0 p30 48.46 179.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.73 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 tt -66.88 -43.31 83.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.983 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.9 -40.69 63.73 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.1 -39.67 97.93 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.0 -41.38 87.53 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -75.41 -46.88 36.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 119.796 -0.761 . . . . 0.0 111.766 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -36.59 75.73 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.219 -0.992 . . . . 0.0 108.626 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.49 -42.24 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.197 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 56.6 ttm -57.16 -43.47 82.57 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -59.79 -26.51 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.702 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.5 t -94.99 -54.61 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 11.2 p -63.8 -13.71 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.394 -0.191 . . . . 0.0 111.317 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -100.59 -16.92 17.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.433 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.8 -25.36 60.48 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -65.29 -34.5 78.49 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -158.37 83.67 2.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -44.25 111.44 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.716 1.611 . . . . 0.0 110.984 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.49 -14.98 27.84 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 121.741 1.627 . . . . 0.0 111.519 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.8 m -127.49 139.53 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.643 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 39.2 p90 . . . . . 0 N--CA 1.472 0.673 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.953 -179.004 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.3 t . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 120.884 0.373 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.48 153.54 19.04 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.488 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 28.5 mp0 -62.64 -41.44 99.03 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.849 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.1 m -58.18 -46.02 86.49 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.083 0.944 . . . . 0.0 108.834 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.19 -34.58 77.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.548 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.408 ' O ' HG21 ' A' ' 12' ' ' VAL . 11.0 tp -57.66 -36.94 72.56 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.4 mptp? -61.71 -44.61 96.6 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.464 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -64.39 -36.36 83.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.34 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -33.67 73.11 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 8' ' ' LEU . 2.4 m -114.0 20.98 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 122.021 -0.425 . . . . 0.0 110.906 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -60.55 -37.67 82.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.194 0.521 . . . . 0.0 111.13 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -62.96 -13.45 34.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.896 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -76.42 155.01 34.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.942 0.401 . . . . 0.0 111.365 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -72.28 -36.9 69.11 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.88 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -113.06 65.16 0.64 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.289 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -63.66 -25.52 68.25 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.93 -54.03 8.81 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 tp -64.29 -38.63 91.73 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.535 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 95.9 m -61.66 -48.2 81.9 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.752 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.62 -47.96 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 120.751 0.31 . . . . 0.0 111.161 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -62.7 -42.03 99.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.106 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.6 -39.1 93.51 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.305 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.1 p -68.05 -37.7 81.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.736 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -55.23 -43.05 69.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -60.57 -39.6 88.58 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.47 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.7 t -72.55 -40.67 63.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.17 -23.71 6.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.261 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.2 m -73.85 -48.7 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.097 0.475 . . . . 0.0 109.833 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.4 tp -84.39 -38.85 19.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.989 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -112.9 65.72 0.64 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.208 0.528 . . . . 0.0 109.986 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -58.62 -14.6 8.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -64.2 -20.92 66.35 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.9 tp -94.54 113.8 25.69 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -107.87 129.31 24.32 Favored Pre-proline 0 C--N 1.357 0.916 0 CA-C-N 120.094 1.315 . . . . 0.0 111.716 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -84.39 137.04 6.81 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 121.804 1.669 . . . . 0.0 112.991 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.35 154.39 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.2 tp -94.99 126.11 40.11 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.407 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.9 161.62 26.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.48 0.657 . . . . 0.0 112.091 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -97.64 124.59 42.0 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.358 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.125 0 CA-C-N 118.306 0.503 . . . . 0.0 109.892 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.029 0.443 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.82 121.33 23.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.91 0.862 . . . . 0.0 109.976 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.8 tp -120.31 131.91 55.08 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.316 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.2 ttp -91.03 137.77 32.11 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.884 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -131.23 152.04 50.89 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.2 mt -100.96 130.47 46.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.1 m -145.55 137.88 25.69 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.071 0.463 . . . . 0.0 111.857 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.71 -145.21 9.34 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.279 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.4 p -131.26 158.15 41.39 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 pt -132.48 116.33 15.1 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.608 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -69.03 124.16 11.09 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 CA-C-N 119.98 1.029 . . . . 0.0 110.849 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.8 t -127.6 112.59 20.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.259 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.18 151.6 20.78 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.879 2.386 . . . . 0.0 112.62 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -163.5 115.03 1.43 Allowed 'General case' 0 CA--C 1.56 1.343 0 CA-C-O 121.546 0.689 . . . . 0.0 111.23 179.046 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 49.97 38.93 17.57 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.86 -4.49 85.67 Favored Glycine 0 N--CA 1.473 1.151 0 O-C-N 121.727 -0.608 . . . . 0.0 113.025 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -119.6 130.29 55.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.97 0.414 . . . . 0.0 109.98 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.8 m -118.25 131.41 56.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.685 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -113.28 149.29 34.08 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.949 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -97.13 102.64 14.46 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.39 119.15 69.62 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.39 128.58 4.16 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.784 2.323 . . . . 0.0 110.624 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 72' ' ' ILE . 23.1 pt -134.5 147.5 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.971 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 69.3 m -120.62 122.48 40.6 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 121.534 0.683 . . . . 0.0 110.021 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.19 114.4 28.51 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.326 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -105.23 122.99 47.08 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 63.4 mt -93.86 131.12 39.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.738 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mt -74.82 149.43 39.65 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -56.9 -14.18 3.28 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.577 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.6 0.29 36.07 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -51.79 144.71 18.42 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -93.62 10.1 53.6 Favored 'Cis proline' 0 N--CA 1.516 2.81 0 CA-C-N 120.842 1.336 . . . . 0.0 115.369 0.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -75.45 -12.0 60.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.235 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.17 121.81 35.74 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.88 137.65 35.21 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 CA-C-N 121.182 1.458 . . . . 0.0 111.995 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.12 142.11 12.06 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.19 1.927 . . . . 0.0 111.488 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.31 133.43 40.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.699 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.3 t -114.69 143.45 45.02 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.017 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -127.86 131.14 49.5 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.681 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.7 t -103.92 126.31 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.14 101.78 5.32 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.957 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -83.82 129.24 4.73 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.622 1.548 . . . . 0.0 113.254 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.4 p -80.91 165.54 21.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.7 p -59.27 -25.07 63.77 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -99.51 23.76 9.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.971 0.805 . . . . 0.0 109.888 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.7 ttm -129.64 139.41 51.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.888 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.6 m -115.64 133.06 56.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.019 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.4 tp -84.26 106.94 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.971 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -87.22 99.27 11.83 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.352 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.6 p -67.67 143.11 56.14 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.74 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.76 -152.45 6.9 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -74.59 -15.63 60.83 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -114.15 -27.35 7.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.65 136.09 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -100.07 175.78 5.63 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.15 93.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -79.34 -17.84 53.71 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.02 33.78 2.71 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.215 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -82.21 148.48 28.4 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.61 116.01 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.604 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.36 116.61 32.45 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 mt -126.05 113.71 24.13 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 118.249 0.477 . . . . 0.0 110.942 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -48.21 -37.55 31.57 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.733 1.622 . . . . 0.0 114.661 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.409 ' CG ' ' N ' ' A' ' 114' ' ' LEU . 1.7 p90 -61.47 -32.24 72.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.652 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.409 ' N ' ' CG ' ' A' ' 113' ' ' TYR . 0.8 OUTLIER -68.55 -41.5 79.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.717 -178.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -62.99 -33.86 76.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.628 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -101.03 2.88 40.95 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.163 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -52.5 123.08 10.12 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.992 0.901 . . . . 0.0 110.221 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -101.58 100.22 10.6 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.797 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -57.03 122.29 52.24 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.897 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -111.66 91.24 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.576 0 CA-C-N 120.687 1.281 . . . . 0.0 112.235 -3.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -114.96 -51.63 2.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.984 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.3 m -71.24 -41.33 70.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.983 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t70 66.53 165.04 0.2 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.585 0.707 . . . . 0.0 111.807 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 21.9 tp -67.05 -41.13 87.01 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.694 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.3 tp -59.69 -37.28 78.39 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.87 -39.6 97.12 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.2 tp -57.37 -39.51 76.17 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -72.08 -49.3 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.619 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -66.92 -35.68 80.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 118.661 -1.216 . . . . 0.0 108.683 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.25 -38.63 83.0 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 C-N-CA 119.432 -0.907 . . . . 0.0 108.864 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.7 tpp -60.49 -43.12 97.36 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.92 -36.64 76.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.683 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.5 t -81.59 -41.5 18.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.1 p -77.71 -15.62 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.784 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -107.3 -18.08 13.97 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.393 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.88 -27.1 69.64 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -66.47 -27.56 67.89 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.635 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -168.18 89.72 0.66 Allowed Pre-proline 0 C--O 1.232 0.15 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -44.76 119.35 2.28 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.67 1.58 . . . . 0.0 110.588 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.97 -16.3 32.46 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.561 1.507 . . . . 0.0 111.448 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.17 140.37 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.337 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 26.6 p90 . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.817 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 121.586 0.707 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -104.96 153.81 20.93 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.0 mt-10 -59.47 -42.48 92.16 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.109 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.2 m -58.23 -47.89 82.09 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.952 0.882 . . . . 0.0 109.355 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -62.57 -34.42 76.94 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.95 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.2 tp -56.09 -39.27 71.89 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 11.0 mptt -61.05 -43.95 98.13 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.557 0.694 . . . . 0.0 109.613 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.03 -36.32 83.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.617 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mmm -66.92 -37.04 83.6 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.619 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -115.73 23.46 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.526 0.203 . . . . 0.0 111.245 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.3 p -66.62 -18.13 65.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.705 0.288 . . . . 0.0 111.029 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -77.41 -20.78 54.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.121 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -72.47 149.88 43.79 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -66.23 -40.04 89.99 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.789 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -110.56 64.21 0.61 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.783 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -65.24 -27.74 68.87 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.37 -49.48 33.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.37 -41.7 93.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.634 -0.827 . . . . 0.0 109.389 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -60.22 -48.49 81.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.156 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.8 t -63.55 -46.02 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 120.536 0.208 . . . . 0.0 111.445 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.74 -42.74 99.36 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.619 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -34.19 72.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.541 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.9 p -66.21 -38.49 88.09 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.4 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.64 -45.42 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -61.24 -38.77 87.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.327 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.12 -46.05 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.81 -13.5 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.33 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 p -76.33 -52.09 10.64 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.0 tp -85.03 -38.15 19.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.416 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -108.89 64.26 0.61 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.135 0.493 . . . . 0.0 109.89 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -55.31 -18.82 7.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.534 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -65.5 -22.55 66.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.364 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.0 tp -91.18 113.86 26.23 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -110.69 132.24 21.69 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.576 1.08 . . . . 0.0 111.805 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.43 135.01 9.15 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 122.242 1.961 . . . . 0.0 112.94 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -131.56 137.01 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.4 tp -82.41 121.77 27.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.27 160.04 24.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.731 0.3 . . . . 0.0 110.925 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m -99.8 131.68 45.63 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.0 t80 . . . . . 0 N--CA 1.47 0.538 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.141 -179.5 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 . . . . . 0 CA--C 1.514 -0.409 0 CA-C-O 121.433 0.635 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.16 122.97 28.03 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.672 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.4 mt -122.29 144.17 49.16 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.936 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 57.9 ttp -97.43 139.09 33.88 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.84 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -132.35 150.55 52.13 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 121.161 0.505 . . . . 0.0 111.254 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 mt -98.38 124.19 42.92 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 m -134.97 138.62 44.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.68 -145.33 9.65 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.58 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.6 p -133.27 159.39 40.37 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 pt -133.73 116.56 13.77 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.38 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -70.95 127.56 13.8 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 CA-C-N 120.058 1.057 . . . . 0.0 110.014 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 89.8 t -127.31 118.1 21.7 Favored Pre-proline 0 C--N 1.347 0.485 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.284 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.29 142.23 37.04 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.885 1.723 . . . . 0.0 110.066 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -159.77 113.46 2.24 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.888 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 60.84 25.37 15.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.755 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.86 -13.23 67.36 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.563 ' C ' ' OD1' ' A' ' 66' ' ' ASN . 3.1 p-10 -99.85 169.96 8.86 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.1 m -139.88 133.98 31.01 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.515 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -121.08 148.62 43.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.304 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.34 106.66 18.92 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.7 115.41 64.48 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.215 -177.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.56 126.3 4.66 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.304 2.003 . . . . 0.0 110.376 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.0 pt -133.97 150.44 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 119.156 -1.018 . . . . 0.0 112.091 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.6 m -121.61 120.68 35.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.81 115.68 31.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.929 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -109.24 128.05 54.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.8 mt -97.3 142.02 29.69 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.043 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -87.45 151.41 23.07 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -58.92 -15.16 11.48 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.87 5.48 33.02 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.204 0.526 . . . . 0.0 112.233 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -60.93 145.59 88.76 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -92.42 10.26 57.56 Favored 'Cis proline' 0 N--CA 1.516 2.798 0 CA-C-N 120.856 1.341 . . . . 0.0 114.753 0.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.59 -12.17 60.67 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.84 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.48 127.78 26.49 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.66 -0.686 . . . . 0.0 109.408 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -49.39 134.28 31.72 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 CA-C-N 121.192 1.461 . . . . 0.0 112.217 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.9 142.12 15.51 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.366 2.044 . . . . 0.0 111.274 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.6 mt -98.75 135.67 32.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.088 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.3 t -121.66 145.98 47.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.023 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -125.71 134.48 51.78 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.159 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.8 p -95.65 127.92 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -69.3 107.42 2.15 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -84.8 155.91 11.73 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.268 1.312 . . . . 0.0 113.147 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.3 p -129.01 169.85 14.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.062 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.7 m -59.18 -39.59 83.03 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -89.92 -3.61 57.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.617 0.644 . . . . 0.0 111.53 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.7 ttm -116.23 137.15 52.39 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.22 165.83 20.59 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.109 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 70.2 mt -111.27 108.78 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.716 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -97.52 126.91 43.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.9 p -72.01 143.6 49.11 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.92 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.54 -142.18 3.5 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.752 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -66.0 -26.6 67.62 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -133.68 -26.67 1.57 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.72 132.08 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 119.477 1.035 . . . . 0.0 110.536 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -98.97 175.41 5.94 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.45 77.42 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -74.94 -9.83 58.91 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.415 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.69 5.29 55.45 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.156 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 147.26 53.73 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.468 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.74 125.13 73.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -99.7 137.82 37.65 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.2 mt -136.61 116.57 10.87 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.441 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -47.56 -37.36 26.37 Favored 'Trans proline' 0 N--CA 1.504 2.091 0 C-N-CA 122.075 1.85 . . . . 0.0 114.505 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -61.09 -29.37 69.71 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.679 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tt -69.8 -43.16 72.64 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.489 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -68.05 -27.61 66.67 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.378 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -103.86 3.91 34.31 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.932 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . 0.479 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.6 t90 -70.16 120.05 15.26 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.806 0.812 . . . . 0.0 109.742 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -88.05 129.51 35.26 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.161 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -78.81 124.06 85.11 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.463 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -111.04 93.1 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.664 0 CA-C-N 120.953 1.376 . . . . 0.0 111.63 -3.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -113.6 -56.17 2.43 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.115 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.5 t -74.3 -34.61 63.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.773 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 47.02 -176.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.707 0.765 . . . . 0.0 111.621 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.52 -40.59 76.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.306 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.1 tt -55.68 -39.51 71.07 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.58 -39.86 98.4 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.4 tp -57.6 -40.28 78.74 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.19 -49.96 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.816 -176.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -64.78 -35.92 82.63 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.5 t -68.25 -37.27 77.77 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.4 tpp -58.32 -43.04 88.0 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.65 -39.63 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.13 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.9 t -81.48 -47.32 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.7 p -67.71 -15.47 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.34 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -106.57 -19.34 13.7 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.138 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.21 -37.29 93.85 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -64.88 -36.87 85.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.762 -0.719 . . . . 0.0 110.687 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -158.1 81.99 2.9 Favored Pre-proline 0 CA--C 1.52 -0.195 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -51.04 128.88 26.34 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 120.709 0.939 . . . . 0.0 109.731 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.43 -15.25 34.56 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.469 1.446 . . . . 0.0 112.142 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.1 m -132.64 153.72 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.974 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.6 t . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.084 0.469 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -95.68 158.36 15.48 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.46 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 94.9 mt-10 -63.34 -41.73 98.89 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.267 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -60.33 -48.29 82.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.225 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -63.51 -27.73 69.47 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.152 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 tp -61.23 -41.69 97.31 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 3.4 mptp? -59.27 -38.95 81.38 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.208 0.528 . . . . 0.0 109.824 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.61 -34.69 76.08 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.128 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.8 ptp -84.31 -14.58 49.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.808 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.34 17.97 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.413 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.9 t -61.92 -37.75 85.85 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.817 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -64.6 -19.82 65.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.875 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -72.11 152.64 42.2 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -75.44 -26.14 58.05 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.675 0.274 . . . . 0.0 110.683 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -120.67 60.36 0.9 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.403 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -64.77 -25.42 67.91 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -71.7 -55.82 6.97 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mt -64.39 -39.72 94.4 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.088 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.4 m -62.47 -47.85 82.2 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.876 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.8 t -62.56 -47.24 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 120.837 0.351 . . . . 0.0 110.673 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -40.44 95.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.044 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -63.42 -39.55 94.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.583 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.5 p -70.48 -35.56 73.33 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.252 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.89 -44.37 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -62.0 -39.78 93.4 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.485 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.6 t -70.76 -43.43 77.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.01 -17.94 8.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.517 -177.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.9 m -82.7 -47.2 12.27 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.092 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.7 tp -87.9 -37.8 16.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.937 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -109.12 65.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -59.0 -16.95 20.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.973 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -64.95 -21.1 66.78 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.116 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.1 tp -98.16 124.01 42.5 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -118.07 129.28 25.47 Favored Pre-proline 0 C--N 1.36 1.061 0 CA-C-N 120.221 1.373 . . . . 0.0 111.946 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -80.89 136.53 10.58 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 121.593 1.529 . . . . 0.0 112.81 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.39 135.59 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.9 tp -83.1 122.14 27.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.02 151.24 48.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.219 0.533 . . . . 0.0 112.041 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m -98.68 119.33 37.23 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.1 t80 . . . . . 0 N--CA 1.47 0.55 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.992 -178.604 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.516 -0.346 0 CA-C-O 121.462 0.648 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -76.33 116.1 16.69 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.323 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.4 mt -122.86 138.31 54.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 64.2 ttp -84.29 139.55 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.137 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -125.88 156.4 39.71 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.198 0.523 . . . . 0.0 110.897 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.99 117.69 34.85 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.0 m -134.13 137.99 44.92 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.088 0.471 . . . . 0.0 112.159 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.27 -149.65 15.31 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.896 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.9 p -132.01 158.94 40.21 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.58 115.97 14.86 Favored Pre-proline 0 C--O 1.237 0.433 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.416 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.74 125.46 10.01 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.8 1.0 . . . . 0.0 110.197 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.73 119.34 25.77 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.875 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.63 147.42 57.27 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.187 1.925 . . . . 0.0 109.675 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.41 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -163.74 108.79 1.04 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.339 -177.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 49.65 44.23 24.47 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.79 13.89 75.36 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.36 -0.924 . . . . 0.0 110.839 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -134.77 131.15 37.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -117.4 132.47 56.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.847 0.356 . . . . 0.0 111.797 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -112.68 148.88 33.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.99 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.95 102.46 14.26 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.22 116.28 66.12 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.262 -177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.9 127.55 4.2 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.654 2.236 . . . . 0.0 110.308 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.429 HD13 HG23 ' A' ' 72' ' ' ILE . 26.4 pt -134.57 146.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.541 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 84.8 m -120.57 121.63 38.8 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.83 120.09 39.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.664 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -104.39 117.94 35.4 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.3 mt -84.56 137.69 33.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mt -88.36 154.91 20.01 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.8 p30 -63.4 -13.83 43.92 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.501 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 p -99.24 -4.35 32.17 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -55.83 145.11 54.1 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -91.18 6.29 66.54 Favored 'Cis proline' 0 N--CA 1.514 2.732 0 CA-C-N 121.121 1.436 . . . . 0.0 115.697 1.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -71.27 -19.2 62.38 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.974 -1.09 . . . . 0.0 110.349 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.21 139.5 21.95 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.056 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.0 142.76 63.22 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 CA-C-N 121.665 1.63 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 142.84 17.31 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.955 1.77 . . . . 0.0 111.906 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -92.41 134.59 29.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 39.0 t -107.78 144.35 35.06 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.765 -177.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.56 126.06 43.04 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.272 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.39 130.31 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 99.36 3.53 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 123.44 0.463 . . . . 0.0 109.873 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -86.85 148.09 8.25 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.387 1.391 . . . . 0.0 113.23 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.3 p -95.95 165.27 12.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.553 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t -55.16 -19.11 6.93 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.2 t -105.52 15.65 26.73 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.002 0.819 . . . . 0.0 111.572 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.4 mtp -132.77 141.83 48.71 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.43 163.64 22.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.063 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.3 mm -93.02 101.98 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -84.89 104.71 15.08 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.802 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.7 p -72.61 150.07 43.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.349 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.5 -137.49 2.3 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.769 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -67.73 -21.08 65.31 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.57 -29.54 1.53 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.884 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.2 t -88.97 140.3 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.739 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -103.16 176.45 5.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.441 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.33 94.2 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -88.39 0.3 56.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.292 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.48 11.74 46.95 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.259 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -64.46 141.47 58.76 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.466 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.44 HD12 HG23 ' A' ' 109' ' ' ILE . 96.9 mt -109.49 115.57 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.072 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -104.57 136.23 44.5 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mt -135.17 124.84 16.62 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.3 -32.7 52.34 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.365 1.376 . . . . 0.0 113.519 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -67.51 -31.8 72.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.75 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.02 -41.67 74.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.162 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -71.16 -26.54 63.03 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.29 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -100.71 -0.75 36.72 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.22 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -53.97 126.01 20.91 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 122.055 0.931 . . . . 0.0 110.733 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -97.98 94.5 6.9 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.239 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 57.8 t60 -59.68 124.51 76.38 Favored Pre-proline 0 C--N 1.323 -0.556 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.067 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 9.6 Cg_endo -108.88 91.71 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.708 0 CA-C-N 120.454 1.198 . . . . 0.0 112.948 -2.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -113.07 -58.16 2.19 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.463 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.6 t -67.37 -40.6 85.78 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.314 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 64.37 166.21 0.15 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.741 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.03 -41.84 97.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.4 tt -57.17 -36.16 70.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.28 -39.8 96.54 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.74 -40.79 93.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.17 -47.59 35.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.683 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -68.81 -36.48 78.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.021 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 79.4 t -66.85 -39.75 84.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.081 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.1 ttm -58.73 -44.5 90.49 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.26 -34.97 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.815 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.8 t -90.36 -46.22 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.9 p -68.91 -13.31 17.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.723 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -103.76 -15.17 15.81 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.024 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.88 -24.92 75.94 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -70.45 -34.53 72.55 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.595 0.236 . . . . 0.0 111.012 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -162.38 83.13 1.64 Allowed Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -49.17 124.18 11.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.222 1.281 . . . . 0.0 110.752 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.9 -18.56 24.38 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.741 1.627 . . . . 0.0 112.019 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.11 146.03 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.151 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 22.3 p90 . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.861 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.02 124.96 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.467 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -94.58 158.43 15.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.427 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 95.4 mt-10 -64.14 -41.15 97.3 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.196 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.3 m -58.58 -47.43 84.33 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.165 0.984 . . . . 0.0 108.985 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -63.32 -33.64 75.96 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.874 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.7 tp -56.3 -38.49 71.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.6 mptp? -60.73 -42.8 98.04 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.367 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.1 -37.73 88.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.617 0.722 . . . . 0.0 110.884 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.3 mmm -67.54 -36.68 81.46 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.114 -177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.87 19.69 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.651 0.263 . . . . 0.0 111.116 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.7 p -64.56 -21.78 66.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.806 0.336 . . . . 0.0 110.532 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -72.06 -23.01 61.29 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.984 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.409 ' CZ ' HD21 ' A' ' 52' ' ' LEU . 30.2 m-85 -77.44 160.18 28.89 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.849 0.357 . . . . 0.0 110.365 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.6 -21.19 24.15 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.305 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.16 47.53 1.12 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 122.324 -0.235 . . . . 0.0 110.766 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -58.27 -24.65 60.12 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -73.61 -53.79 9.65 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.6 tp -65.13 -39.7 93.43 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.722 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.1 m -63.08 -48.68 77.55 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.338 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.3 t -61.5 -46.42 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 120.635 0.255 . . . . 0.0 110.47 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -62.63 -44.91 95.08 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.647 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -64.21 -36.88 85.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.948 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 35.3 p -64.81 -34.3 78.04 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.736 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.69 -44.91 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -61.37 -38.02 85.49 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.408 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.72 -44.73 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.95 -21.57 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.354 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.5 m -73.47 -45.88 51.52 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.535 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.0 tp -88.47 -39.27 14.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.032 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -111.07 66.97 0.63 Allowed 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -56.99 -17.64 10.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.288 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -66.85 -14.87 63.18 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.87 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.8 tp -99.98 114.27 27.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.1 ttpp -108.89 131.86 21.53 Favored Pre-proline 0 C--N 1.356 0.874 0 CA-C-N 119.521 1.055 . . . . 0.0 112.007 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.1 133.42 11.0 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.49 1.46 . . . . 0.0 112.535 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.4 t -133.96 139.36 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 110.71 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 11.1 tp -81.93 136.27 35.32 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -140.6 154.48 46.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.144 0.497 . . . . 0.0 111.27 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.6 m -91.56 131.46 36.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -118.85 133.99 55.46 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.818 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.0 t -110.37 122.55 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.75 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -92.51 161.57 14.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.0 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -61.83 -30.29 70.74 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.987 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -64.27 -16.47 62.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.75 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.3 -11.54 65.35 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.9 m -76.24 142.35 41.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.2 m -116.22 143.98 44.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.211 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -142.78 136.69 29.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.07 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -82.12 119.3 23.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.848 0.832 . . . . 0.0 109.733 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.409 HD21 ' CZ ' ' A' ' 15' ' ' TYR . 61.3 mt -121.44 146.71 46.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.791 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 53.5 ttp -97.54 142.79 28.94 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.682 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -135.81 152.85 51.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.452 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.5 mt -95.45 123.58 39.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.45 ' CG2' H183 ' A' ' 201' ' ' 4N1 . 97.4 m -135.89 136.61 40.67 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.16 -146.69 11.47 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.522 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.1 p -132.84 159.4 39.93 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.77 116.48 18.18 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.895 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -70.56 124.81 11.1 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 CA-C-N 120.017 1.042 . . . . 0.0 109.942 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.1 t -125.56 118.43 24.62 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 119.671 -0.812 . . . . 0.0 113.015 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.7 142.22 52.19 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.944 1.763 . . . . 0.0 109.813 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -163.08 117.54 1.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.48 26.39 10.83 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.299 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.93 -5.62 78.44 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -112.97 142.78 45.27 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -121.65 132.26 54.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.775 0.321 . . . . 0.0 111.818 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -115.9 151.74 34.76 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.523 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -95.69 106.29 18.38 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 mp -90.83 118.56 68.71 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.79 122.1 2.24 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.601 2.201 . . . . 0.0 110.534 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.424 HG21 HD12 ' A' ' 72' ' ' ILE . 31.9 pt -134.44 149.51 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.796 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.1 m -123.5 127.9 49.01 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.947 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.71 115.49 30.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.868 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -103.69 125.81 50.42 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.6 mt -90.84 138.64 31.43 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.0 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.51 146.44 36.38 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -56.79 -14.99 3.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.476 0.58 . . . . 0.0 111.679 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.4 p -106.03 13.11 29.65 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.259 0.552 . . . . 0.0 111.536 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.406 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 60.1 t80 -61.4 144.39 92.07 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.406 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 24.4 Cg_endo -92.23 8.09 61.35 Favored 'Cis proline' 0 N--CA 1.514 2.721 0 CA-C-N 121.216 1.47 . . . . 0.0 115.623 1.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -71.51 -15.28 62.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.853 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.82 137.76 19.85 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.24 143.82 66.07 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 121.579 1.6 . . . . 0.0 110.751 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.82 138.9 13.57 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.444 1.43 . . . . 0.0 111.893 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 mt -95.2 131.73 41.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 40.3 t -110.06 150.75 28.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.066 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -133.28 127.05 32.81 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.535 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.3 t -96.1 121.56 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.576 ' HE2' H171 ' A' ' 201' ' ' 4N1 . 13.4 mptt -68.95 109.69 4.74 Favored Pre-proline 0 N--CA 1.476 0.846 0 CA-C-O 119.167 -0.444 . . . . 0.0 111.15 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.21 164.71 11.26 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.577 1.518 . . . . 0.0 112.238 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.7 p -139.31 172.85 12.22 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.7 m -57.95 -41.19 82.33 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.86 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.9 m -90.29 -11.89 39.44 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.897 0.771 . . . . 0.0 111.733 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.0 tpp -108.91 124.45 50.69 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.15 165.33 14.32 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.353 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.2 mt -96.16 110.59 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -90.98 102.14 14.9 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.4 p -59.83 142.71 52.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.314 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -158.33 -144.15 3.86 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.705 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -65.95 -27.48 68.19 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -128.96 -7.79 4.93 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 119.047 -1.061 . . . . 0.0 113.407 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 40.3 t -108.21 126.56 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.167 0.894 . . . . 0.0 111.736 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -88.65 -161.41 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.76 -20.83 25.62 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.863 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -90.23 -1.79 57.97 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.728 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.9 11.73 56.26 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.855 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -63.01 140.56 58.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.527 0.664 . . . . 0.0 109.667 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 98.7 mt -116.6 117.99 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.107 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -102.38 137.29 40.83 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 26.8 mt -136.64 116.61 10.85 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.317 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.14 -38.25 24.66 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 121.844 1.696 . . . . 0.0 114.519 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.402 ' CD2' ' N ' ' A' ' 114' ' ' LEU . 1.3 p90 -61.53 -29.73 70.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.512 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 1.7 tt -69.56 -42.53 74.44 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.717 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -65.03 -29.29 70.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.309 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -107.44 13.56 26.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.071 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.424 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 6.5 t90 -76.43 121.96 23.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.75 0.786 . . . . 0.0 110.36 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -92.42 128.08 38.14 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.277 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -84.34 125.47 71.91 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.424 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -108.8 91.93 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.705 0 CA-C-N 120.866 1.345 . . . . 0.0 112.628 -2.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -113.77 -58.83 2.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.778 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.1 p -67.19 -39.02 86.3 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.52 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 58.95 161.69 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.474 0.654 . . . . 0.0 111.829 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.7 tt -58.39 -41.17 84.24 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.194 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.9 tp -56.75 -38.13 72.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.68 -39.69 98.24 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 tp -59.07 -38.98 80.73 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.02 -47.53 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.579 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -66.08 -36.83 84.26 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.6 t -66.89 -37.82 80.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.9 tpp -59.0 -43.03 91.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.82 -26.07 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.621 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.2 t -94.63 -52.05 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.5 p -64.77 -13.72 15.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 122.547 0.339 . . . . 0.0 111.402 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -101.98 -17.64 16.01 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.255 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.55 -28.07 60.14 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -64.81 -35.48 81.23 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.332 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -163.49 84.6 1.35 Allowed Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -44.06 112.6 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.497 1.465 . . . . 0.0 110.665 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -65.35 -20.44 61.71 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.358 1.372 . . . . 0.0 110.427 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.9 m -127.72 150.11 33.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -157.84 163.54 37.87 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.03 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.4 m -91.85 121.36 33.39 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.307 0.575 . . . . 0.0 111.333 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 57.2 ttm-85 -111.58 114.33 52.61 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.594 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo . . . . . 0 N--CA 1.497 1.681 0 C-N-CA 122.195 1.93 . . . . 0.0 112.55 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.576 H171 ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.4 t -89.07 133.85 30.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.076 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.48 154.57 18.13 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.467 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 39.9 mt-10 -62.18 -40.61 96.62 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.954 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.8 t -58.83 -47.7 83.9 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 122.148 0.975 . . . . 0.0 109.269 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -64.51 -30.4 71.43 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.855 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.2 tp -60.0 -37.05 78.56 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.467 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -62.8 -43.27 99.24 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.432 178.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.31 -37.44 83.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.94 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -37.51 87.71 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.017 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -119.39 24.82 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.883 0.373 . . . . 0.0 111.856 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.5 t -64.59 -37.17 86.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.07 0.462 . . . . 0.0 111.147 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.22 -12.38 60.87 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.89 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -77.99 159.55 28.72 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -81.86 -26.87 33.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.651 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -116.19 55.24 0.81 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 119.67 -0.205 . . . . 0.0 110.809 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 ptt-85 -63.76 -24.7 67.87 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -53.88 8.56 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.038 -0.414 . . . . 0.0 111.709 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -42.88 96.6 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.117 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.0 m -60.61 -48.07 83.4 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.419 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 32.6 t -61.05 -44.74 98.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -41.4 98.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.566 -0.853 . . . . 0.0 109.784 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -39.2 89.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.071 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 p -65.72 -37.86 87.58 Favored 'General case' 0 CA--C 1.507 -0.673 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.461 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.85 -43.99 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.486 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -61.86 -37.91 86.29 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.025 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.1 t -71.23 -43.11 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.82 -20.27 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.114 -178.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -78.31 -47.54 17.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -84.23 -39.74 18.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.794 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -110.56 66.98 0.63 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -58.08 -16.58 13.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.82 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -65.34 -22.0 66.77 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.826 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 tp -91.84 114.29 26.78 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -108.26 123.21 38.17 Favored Pre-proline 0 C--N 1.357 0.926 0 CA-C-N 119.551 1.069 . . . . 0.0 111.663 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.89 134.09 9.37 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.383 1.388 . . . . 0.0 112.976 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.9 155.3 41.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 110.711 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -86.97 122.43 30.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.992 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -125.07 133.06 53.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.584 0.23 . . . . 0.0 111.21 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.592 ' OG ' H102 ' A' ' 201' ' ' 4N1 . 96.3 p -69.48 146.09 52.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -135.22 134.49 40.11 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.425 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.2 t -121.1 125.66 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.254 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -96.28 166.42 11.73 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.733 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.26 -38.06 82.35 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.762 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -62.84 -13.93 39.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.261 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.4 -3.94 64.05 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.9 m -71.78 144.9 49.02 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.148 0.499 . . . . 0.0 110.326 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.4 m -125.04 144.15 50.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.449 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -161.17 143.67 12.38 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.999 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.7 121.59 17.48 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.92 126.43 39.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.962 0.411 . . . . 0.0 109.914 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.9 ttp -84.55 150.48 25.19 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.922 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -138.73 157.28 46.38 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.318 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mt -108.36 125.05 51.28 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.581 ' CG2' H182 ' A' ' 201' ' ' 4N1 . 96.4 m -140.33 139.2 35.36 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.977 0.418 . . . . 0.0 112.12 -177.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.19 -149.51 15.05 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.628 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.0 p -131.75 159.21 39.12 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -130.25 116.53 17.68 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.9 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -70.79 125.97 12.15 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 CA-C-N 119.892 0.997 . . . . 0.0 109.878 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.0 t -130.02 127.32 22.68 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.573 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.09 149.64 52.71 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.092 1.861 . . . . 0.0 110.452 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -161.63 106.42 1.28 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.338 0.589 . . . . 0.0 111.889 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 51.15 39.58 23.84 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.914 -0.491 . . . . 0.0 111.951 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.22 -0.55 83.73 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -121.13 132.16 54.69 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -110.09 131.04 55.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.659 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -113.89 151.43 32.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.621 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -97.96 104.07 16.07 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.98 117.09 67.92 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.11 124.88 3.91 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.525 2.15 . . . . 0.0 110.919 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.4 pt -132.67 147.96 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.613 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.5 m -123.01 126.13 46.55 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-O 121.385 0.612 . . . . 0.0 110.0 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.09 109.97 22.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.506 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.496 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 91.0 m95 -98.38 121.62 40.55 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.657 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.8 mt -89.7 144.28 26.12 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.874 -178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mt -88.76 154.48 20.25 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -60.13 -17.68 42.07 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.524 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -100.47 1.32 41.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.732 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -53.81 145.77 30.13 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -92.37 12.07 53.97 Favored 'Cis proline' 0 N--CA 1.519 2.994 0 N-CA-C 116.061 1.524 . . . . 0.0 116.061 1.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -80.78 -2.38 46.86 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.296 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.82 122.83 26.32 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 118.555 -0.736 . . . . 0.0 109.08 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.76 132.66 21.58 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 CA-C-N 121.313 1.505 . . . . 0.0 112.505 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.32 144.27 14.41 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 122.382 2.054 . . . . 0.0 111.474 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.55 132.9 42.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.881 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 41.8 t -110.33 151.21 27.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.642 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -131.69 127.39 36.79 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.325 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 56.7 t -90.76 123.77 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -71.12 110.21 6.84 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 119.338 -0.363 . . . . 0.0 111.334 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -85.73 157.87 10.46 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.901 1.734 . . . . 0.0 113.218 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.2 p -135.78 165.59 25.25 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.93 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.2 p -60.32 -24.57 65.11 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -104.19 13.53 32.13 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.93 0.786 . . . . 0.0 110.728 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.24 148.15 50.8 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -133.59 165.98 23.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 120.156 -0.617 . . . . 0.0 110.438 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 90.3 mt -103.27 105.76 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -94.77 108.64 20.65 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.238 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 82.3 p -65.98 151.21 47.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.928 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.78 -134.74 1.8 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.356 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.7 pttp -86.03 -3.8 59.02 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -136.42 -24.09 1.23 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.22 145.99 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.683 0.674 . . . . 0.0 110.171 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -101.37 -179.55 4.06 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.699 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.31 73.13 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -79.88 2.53 22.93 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.796 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.01 27.78 15.41 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.087 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -82.56 132.42 35.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 117.588 0.694 . . . . 0.0 110.149 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.3 mt -110.44 109.94 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.606 0.241 . . . . 0.0 110.782 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -114.07 138.86 49.84 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mt -131.65 130.57 22.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 118.563 0.62 . . . . 0.0 111.883 -177.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -46.93 -39.8 25.03 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.433 1.422 . . . . 0.0 113.957 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.05 -29.69 70.47 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.669 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 tt -70.79 -41.07 72.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.804 0.335 . . . . 0.0 111.008 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -67.36 -27.07 66.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.381 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -105.57 -3.64 22.11 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.878 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.424 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.8 t90 -62.82 124.07 20.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.671 0.748 . . . . 0.0 110.16 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -91.65 126.05 36.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.561 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -79.92 125.45 81.96 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 119.032 -0.508 . . . . 0.0 110.119 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -109.12 92.68 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 120.823 1.33 . . . . 0.0 112.454 -2.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -114.11 -61.26 1.77 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.401 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.426 ' O ' ' CG ' ' A' ' 123' ' ' ASP . 15.7 t -69.99 -30.76 68.17 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.689 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 122' ' ' SER . 4.6 p-10 48.89 -175.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.622 0.725 . . . . 0.0 111.947 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 tt -71.84 -43.5 65.42 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.711 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.53 -37.76 50.94 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.09 -41.42 98.49 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.8 tp -59.14 -40.87 86.83 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -73.16 -45.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.577 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.78 -33.22 68.41 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.097 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 67.4 t -68.61 -37.75 78.08 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 53.2 tpp -59.79 -42.45 93.41 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -66.3 -44.5 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.603 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.4 t -74.2 -40.83 51.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.5 p -78.66 -13.62 13.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.678 -177.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -108.49 -17.59 13.94 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.436 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.66 -27.53 70.01 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 107.435 -2.266 . . . . 0.0 107.435 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -65.29 -35.83 82.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.019 -0.59 . . . . 0.0 110.618 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -166.88 84.89 0.86 Allowed Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -47.78 114.65 1.15 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.327 1.351 . . . . 0.0 109.852 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.33 -21.05 27.71 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.797 1.665 . . . . 0.0 111.235 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.67 147.08 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.094 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -155.72 161.93 40.63 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 74.9 m -87.51 121.48 30.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.223 0.535 . . . . 0.0 111.046 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.2 ttm-85 -112.71 105.08 56.08 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.61 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo . . . . . 0 N--CA 1.494 1.539 0 C-N-CA 121.81 1.674 . . . . 0.0 112.098 179.817 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.592 H102 ' OG ' ' A' ' 41' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.46 142.68 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.555 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.18 151.79 19.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 93.0 mt-10 -62.6 -41.89 99.25 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.358 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.4 m -59.05 -45.03 91.78 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.017 0.913 . . . . 0.0 109.58 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -64.91 -36.5 84.56 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.207 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.2 tp -56.58 -40.02 74.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 3.3 mptp? -62.46 -42.78 99.72 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.844 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -66.32 -33.4 75.64 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.894 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.49 -36.02 76.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.036 -178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 m -120.02 30.96 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 111.162 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.1 p -69.27 -12.9 62.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.727 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -85.6 -12.92 50.31 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 121.016 -0.273 . . . . 0.0 111.386 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -71.94 151.13 43.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.005 0.431 . . . . 0.0 111.109 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -70.94 -38.07 72.87 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -111.28 64.22 0.61 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -66.81 -30.35 70.52 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.44 -42.97 78.08 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.09 -38.33 61.26 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.784 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.2 m -62.58 -41.79 99.16 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.057 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 45.4 t -71.29 -46.14 66.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.439 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -63.98 -44.06 93.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.333 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.27 -29.35 68.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.385 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.2 p -70.14 -37.83 75.37 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.717 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.77 -43.32 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -60.63 -40.25 91.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.29 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.4 t -70.1 -42.55 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.99 -16.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.22 -178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.7 m -80.86 -49.41 11.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.6 tp -83.19 -37.15 24.02 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.269 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.36 68.45 0.7 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.467 0.651 . . . . 0.0 109.381 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -58.39 -18.9 31.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.944 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.18 -21.08 66.72 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.458 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 tp -93.78 113.51 25.57 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -109.87 125.25 31.57 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 119.451 1.023 . . . . 0.0 112.352 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -80.31 138.68 12.65 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.655 1.57 . . . . 0.0 113.149 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.37 156.56 39.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.8 tp -97.1 107.56 20.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -110.04 130.19 55.57 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.071 0.462 . . . . 0.0 111.609 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.8 p -79.89 131.87 35.95 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -115.6 138.73 50.77 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.115 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.26 124.22 65.77 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.816 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -96.01 172.64 7.87 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.63 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -60.54 -39.06 86.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.135 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -67.41 -15.34 63.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.834 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.94 -9.86 63.87 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.9 m -65.91 149.18 50.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.042 0.448 . . . . 0.0 110.083 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.5 t -121.1 142.62 49.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.84 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -143.26 150.36 39.17 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.697 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.21 105.64 13.46 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.057 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 15.2 mt -119.29 125.19 48.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.105 0.479 . . . . 0.0 110.01 177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -92.83 138.42 31.5 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.606 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -127.44 152.22 47.82 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.18 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.4 mt -97.37 130.11 44.55 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.591 HG23 H183 ' A' ' 201' ' ' 4N1 . 69.3 m -141.2 137.63 32.77 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.15 -144.08 8.76 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.9 p -136.81 159.71 41.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 pt -132.19 115.22 15.1 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.074 176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -70.54 125.41 11.71 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.164 1.243 . . . . 0.0 110.293 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.1 t -126.37 121.85 23.78 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.057 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.72 148.7 41.96 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.414 2.076 . . . . 0.0 110.936 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.449 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -163.42 109.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.442 0.639 . . . . 0.0 111.522 -178.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 52.86 37.91 25.4 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.712 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.54 82.01 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -119.34 130.71 55.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -115.29 132.29 56.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.957 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -112.51 148.94 33.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.883 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -94.42 106.42 18.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.09 116.25 66.03 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -176.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -85.17 124.94 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.808 2.339 . . . . 0.0 110.25 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 72' ' ' ILE . 24.6 pt -134.98 148.7 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.572 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.1 m -121.77 123.14 41.12 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.475 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.95 112.81 25.94 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.232 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -105.7 125.29 50.82 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 75.5 mt -92.38 139.33 30.71 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.24 157.95 27.69 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -69.37 -7.66 39.46 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.268 -0.27 . . . . 0.0 111.509 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.57 2.29 23.91 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.916 0.389 . . . . 0.0 110.979 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 46.1 t80 -57.89 147.79 61.97 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.442 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 1.7 Cg_endo -91.22 13.71 52.29 Favored 'Cis proline' 0 N--CA 1.515 2.743 0 CA-C-N 120.975 1.384 . . . . 0.0 114.653 0.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -80.04 -2.61 44.98 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.052 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.83 140.33 33.03 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -66.27 143.11 69.39 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 CA-C-N 121.56 1.593 . . . . 0.0 111.014 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.67 141.38 9.76 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.153 1.902 . . . . 0.0 112.26 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -93.07 129.7 43.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.6 t -120.65 141.8 50.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.763 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -127.67 132.16 49.72 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.581 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.444 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 42.8 t -90.41 131.8 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.01 100.02 2.62 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.128 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 64.7 Cg_endo -82.36 166.35 16.08 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 122.222 1.948 . . . . 0.0 112.837 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -145.71 171.3 14.95 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.8 p -57.32 -25.46 59.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 119.866 -0.734 . . . . 0.0 112.036 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 96.7 p -95.14 3.42 54.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.702 0.683 . . . . 0.0 110.794 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 39.3 ttm -141.93 122.02 13.78 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.048 0.452 . . . . 0.0 109.84 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 95.2 m -107.0 140.95 38.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.443 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.403 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 3.9 tp -75.43 120.74 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -110.64 101.12 9.79 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.7 p -58.31 151.69 19.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.591 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.47 -132.13 1.49 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 119.774 -1.203 . . . . 0.0 112.644 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -86.81 -3.5 59.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -138.92 -25.94 0.86 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 119.402 1.001 . . . . 0.0 113.616 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 t -111.95 135.46 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 119.218 0.917 . . . . 0.0 110.198 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -90.54 -159.97 0.66 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.547 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.39 -8.24 55.34 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.8 -6.14 16.92 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.78 11.47 37.6 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.974 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -72.77 135.98 45.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.399 0.599 . . . . 0.0 110.063 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 69.9 mt -114.8 115.49 49.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 O-C-N 123.311 0.382 . . . . 0.0 110.718 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -115.21 138.77 50.56 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mp -130.88 130.96 22.96 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.475 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.71 -32.45 55.24 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.125 1.217 . . . . 0.0 113.184 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -67.41 -30.12 69.79 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.26 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.77 -41.22 83.63 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.208 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -64.3 -34.31 77.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.2 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -100.81 2.71 41.41 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.539 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -68.72 124.21 23.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.921 0.867 . . . . 0.0 110.17 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -94.37 124.85 38.64 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.522 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 56.2 t60 -80.83 125.3 80.48 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.643 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -108.98 92.19 0.03 OUTLIER 'Cis proline' 0 N--CA 1.5 1.867 0 CA-C-N 120.791 1.318 . . . . 0.0 112.799 -2.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.88 -59.99 1.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.613 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -65.13 -40.93 95.12 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.412 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 58.54 164.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.25 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 mt -50.89 -48.57 60.39 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.311 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.72 -36.72 26.4 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.74 -40.65 98.72 Favored Glycine 0 N--CA 1.477 1.42 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 tp -62.53 -41.73 99.06 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -74.69 -45.87 43.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.619 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -68.85 -36.74 78.52 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.665 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.99 -40.3 85.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.873 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.8 ttm -58.23 -43.24 87.63 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.3 -35.2 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.74 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.4 t -89.64 -50.1 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.677 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.7 p -65.21 -13.85 15.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.832 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -106.78 -17.23 14.27 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.586 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.89 -27.89 73.51 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.82 -34.72 79.03 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.785 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -165.91 85.43 0.97 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -45.7 113.32 0.54 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.37 1.38 . . . . 0.0 110.533 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.6 0.44 8.68 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.511 1.474 . . . . 0.0 111.548 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.24 123.56 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -160.17 165.51 31.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.285 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.2 125.18 40.54 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.003 0.43 . . . . 0.0 110.94 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -111.49 114.1 53.02 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.55 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.499 1.849 0 C-N-CA 121.76 1.64 . . . . 0.0 111.974 -179.926 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.591 H183 HG23 ' A' ' 56' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.6 t -105.39 130.11 57.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.821 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -95.21 157.65 15.8 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 86.6 mt-10 -63.13 -41.92 99.4 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.118 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.1 t -59.71 -49.87 76.06 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.044 0.926 . . . . 0.0 109.383 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -62.69 -28.2 69.77 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.744 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.417 ' O ' HG22 ' A' ' 12' ' ' VAL . 59.3 tp -59.77 -42.67 93.8 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.9 mptp? -58.82 -39.89 82.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.148 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.11 -31.0 72.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.781 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 ptp -86.39 -14.78 42.39 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.622 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -125.94 16.5 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.83 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.3 t -59.78 -21.98 61.53 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.496 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -84.04 -15.96 45.64 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -70.09 152.18 44.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.003 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -70.02 -37.64 75.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.838 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 40.8 m-85 -110.65 60.66 0.61 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.564 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -66.44 -20.73 66.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.125 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -77.04 -52.06 9.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.8 tp -67.93 -41.0 83.24 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.151 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.2 m -61.13 -47.03 88.13 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.778 0.323 . . . . 0.0 110.789 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.3 t -63.25 -42.83 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.654 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -55.31 23.43 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 118.834 -1.147 . . . . 0.0 110.526 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -61.37 -31.83 71.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.367 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.5 p -66.86 -35.26 79.62 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.31 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.0 t -57.77 -44.03 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.19 -39.88 88.11 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.307 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.1 t -69.84 -43.36 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.25 -17.4 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.567 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.2 m -82.35 -49.05 10.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.192 0.52 . . . . 0.0 109.617 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.89 -38.99 24.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.525 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -110.2 67.44 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -56.14 -18.92 11.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.953 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.31 -21.54 66.72 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.038 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 tp -94.15 113.18 25.08 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.19 119.02 43.2 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 119.181 0.9 . . . . 0.0 112.091 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.29 137.53 15.14 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 CA-C-N 120.653 1.269 . . . . 0.0 112.282 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 m -126.19 150.9 32.07 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.1 tp -97.78 119.3 36.13 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.113 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -135.43 135.44 40.58 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.016 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.0 t -64.22 139.97 58.82 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -127.06 143.35 51.3 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.014 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.1 t -120.6 126.63 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.296 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -104.3 155.53 18.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.259 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.1 p-10 -60.84 -19.06 59.17 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.584 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -68.68 -13.03 62.1 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.196 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.14 -17.91 58.43 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.2 t -74.45 146.56 42.73 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.166 0.508 . . . . 0.0 110.2 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.2 m -119.19 141.23 49.06 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.942 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -159.21 136.84 10.08 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.908 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -77.07 121.74 23.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.264 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -124.04 144.51 49.8 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.054 0.454 . . . . 0.0 110.31 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -100.2 141.22 33.33 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.646 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -133.08 154.28 50.71 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.388 0.613 . . . . 0.0 111.863 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -93.49 124.94 37.82 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.575 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.571 HG23 H183 ' A' ' 201' ' ' 4N1 . 53.4 m -139.29 136.98 35.46 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.44 -145.6 10.13 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.836 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 p -134.61 159.74 40.27 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.83 116.21 15.82 Favored Pre-proline 0 N--CA 1.471 0.594 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.178 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -71.97 124.4 10.08 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 N-CA-C 109.538 -0.986 . . . . 0.0 109.538 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.42 121.35 24.89 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.891 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.39 149.03 55.92 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.197 1.931 . . . . 0.0 110.429 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.7 109.7 1.09 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.521 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.96 40.59 25.62 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.439 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.72 13.84 80.22 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -134.71 127.86 31.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.5 m -112.02 133.1 54.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.84 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -113.89 150.63 33.37 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -95.16 108.72 20.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.21 116.16 65.9 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.34 124.77 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.658 2.238 . . . . 0.0 110.75 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 72' ' ' ILE . 26.9 pt -132.79 147.99 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 119.421 -0.911 . . . . 0.0 111.994 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 63.8 m -123.88 121.58 35.73 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.071 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.81 114.41 28.61 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.489 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 48.3 m95 -102.1 115.29 30.23 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.1 mt -85.9 135.15 33.8 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -80.28 155.34 27.33 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -60.68 -17.18 46.18 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.746 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.61 -3.02 50.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.523 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -57.09 144.42 69.23 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -92.04 9.13 60.74 Favored 'Cis proline' 0 N--CA 1.521 3.101 0 N-CA-C 115.936 1.475 . . . . 0.0 115.936 0.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.409 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 42.7 m-85 -76.94 -11.97 59.88 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.636 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.86 127.17 27.11 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.511 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -49.39 132.49 29.47 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 CA-C-N 121.21 1.468 . . . . 0.0 112.467 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -86.04 143.83 8.14 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 122.574 2.183 . . . . 0.0 111.878 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.43 132.97 40.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.39 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 46.1 t -116.47 143.57 45.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.176 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -127.89 129.95 47.74 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.954 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.28 121.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.82 107.53 1.35 Allowed Pre-proline 0 N--CA 1.474 0.744 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.019 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.03 156.64 13.27 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 CA-C-N 120.675 1.277 . . . . 0.0 112.772 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -136.14 171.69 14.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.43 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.8 t -58.55 -40.67 83.69 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.5 m -96.79 20.73 10.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.037 0.835 . . . . 0.0 111.126 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.0 ttm -137.96 141.16 40.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.29 162.76 32.65 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.174 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.9 mt -97.95 103.43 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -90.59 109.96 21.11 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.8 p -59.85 147.4 38.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.282 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.88 -145.3 4.15 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.518 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -64.14 -27.5 69.12 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -132.63 -15.63 2.72 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 119.167 -1.013 . . . . 0.0 113.214 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 23.8 t -91.93 129.27 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.438 1.017 . . . . 0.0 111.375 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 108' ' ' LYS . 36.9 p-10 -89.72 -168.79 2.24 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.71 -22.79 25.83 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.683 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -82.24 -8.0 59.63 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.623 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.21 -0.7 62.18 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.098 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.404 ' N ' ' OD1' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -63.71 143.58 57.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.436 HG21 HD12 ' A' ' 109' ' ' ILE . 97.3 mt -110.87 122.46 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -176.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -99.86 139.91 34.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 28.4 mt -139.55 117.92 8.78 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.83 -29.47 63.17 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.553 1.502 . . . . 0.0 114.056 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -69.23 -30.76 68.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.875 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.75 -41.05 68.92 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.043 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -72.3 -25.5 61.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.309 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -102.23 -4.69 25.33 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.483 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 7.2 t90 -53.07 121.32 7.2 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.94 0.876 . . . . 0.0 110.503 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -96.42 106.61 18.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.491 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -61.95 125.26 84.72 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.133 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -111.05 90.78 0.03 OUTLIER 'Cis proline' 0 N--CA 1.488 1.201 0 CA-C-N 120.676 1.277 . . . . 0.0 112.831 -3.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -114.59 -55.2 2.51 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.428 -0.509 . . . . 0.0 112.142 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 p -70.54 -39.42 74.03 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.387 0.613 . . . . 0.0 110.767 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 t70 59.28 165.59 0.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.408 0.623 . . . . 0.0 111.091 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.9 tt -62.2 -43.68 98.29 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.12 -36.32 50.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.27 -39.52 97.82 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.2 tp -59.48 -40.99 88.78 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -75.32 -49.91 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.206 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -63.74 -37.7 88.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.161 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.29 -38.59 82.19 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 C-N-CA 119.465 -0.894 . . . . 0.0 108.712 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.4 tpp -58.48 -43.3 88.92 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.11 -43.54 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.453 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.3 t -77.78 -42.02 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.7 p -75.91 -13.22 14.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.014 -177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -104.81 -18.37 14.26 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.602 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.31 -20.83 79.44 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -68.72 -36.16 78.08 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.653 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -164.47 90.91 1.03 Allowed Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -44.9 109.96 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.304 1.336 . . . . 0.0 110.382 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -58.02 -26.14 73.81 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.77 1.647 . . . . 0.0 109.942 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.58 146.91 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.957 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -152.64 160.23 43.19 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.997 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 41.0 m -79.83 111.74 16.44 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 120.952 0.406 . . . . 0.0 111.027 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 26.7 ttp-105 -113.44 105.6 54.98 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.173 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo . . . . . 0 N--CA 1.498 1.753 0 C-N-CA 121.85 1.7 . . . . 0.0 112.339 -179.766 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.571 H183 HG23 ' A' ' 56' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -58.5 141.09 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 121.401 0.62 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 p -100.46 158.12 16.14 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.4 mt-10 -62.76 -42.04 99.5 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.525 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 t -59.81 -48.7 80.63 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.839 0.828 . . . . 0.0 109.593 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -62.42 -31.98 72.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.307 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.1 tp -57.86 -40.61 80.56 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.7 mptp? -60.83 -41.79 96.46 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.441 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.06 -37.84 86.53 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.465 0.65 . . . . 0.0 109.902 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -69.83 -38.57 76.58 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.477 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 m -112.65 16.1 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -65.13 -25.51 67.79 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.368 0.604 . . . . 0.0 109.987 178.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.05 -13.57 62.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.037 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -82.22 159.93 23.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -81.9 -27.67 33.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.781 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CZ ' ' CE1' ' A' ' 82' ' ' TYR . 62.5 m-85 -113.77 58.57 0.67 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -65.59 -24.93 67.19 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -79.46 -50.45 10.76 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 121.419 -0.801 . . . . 0.0 112.168 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 tp -65.27 -40.62 94.15 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.548 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -61.56 -46.48 89.72 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.301 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.6 t -61.36 -45.03 99.45 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 CA-C-O 121.089 0.471 . . . . 0.0 110.166 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -40.15 91.4 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.705 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -38.13 80.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.328 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.7 p -67.58 -33.73 75.6 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.738 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.07 -44.81 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.519 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -60.77 -37.49 82.05 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.098 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.77 -44.18 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.93 -22.11 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.004 -1.079 . . . . 0.0 111.615 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.2 m -72.62 -43.64 63.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.939 0.4 . . . . 0.0 110.645 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.0 -38.64 15.33 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.749 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.7 66.74 0.65 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -55.99 -17.85 7.83 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.093 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.38 -21.38 66.61 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.966 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.9 tp -89.69 113.62 25.14 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -109.11 125.39 31.63 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-N 119.686 1.13 . . . . 0.0 111.829 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.68 136.31 13.53 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.323 1.348 . . . . 0.0 112.66 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.3 133.65 68.28 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.8 tp -83.11 118.7 23.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.94 132.89 50.75 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.3 m -62.44 140.42 58.58 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -133.91 141.4 47.33 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.625 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.9 t -112.9 124.47 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.683 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -88.91 161.18 16.81 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -61.19 -23.8 65.85 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.745 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -75.35 -11.55 60.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.003 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.15 -14.78 63.35 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.1 m -67.62 141.1 56.86 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.7 m -113.68 138.66 49.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.824 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.0 ttm105 -150.68 139.85 21.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.89 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -72.97 117.33 14.57 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 13.3 tp -115.91 121.85 43.56 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -83.81 137.04 33.9 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -132.71 154.73 49.89 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.29 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.6 mt -102.2 122.26 43.85 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.532 HG22 H181 ' A' ' 201' ' ' 4N1 . 54.8 m -135.1 137.52 42.91 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.19 -147.05 10.7 Favored Glycine 0 N--CA 1.47 0.955 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.909 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 p -132.75 158.45 42.37 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.6 116.99 16.3 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.168 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -71.28 128.02 14.13 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.832 1.021 . . . . 0.0 109.801 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 74.4 t -127.1 119.52 22.22 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.696 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -64.48 146.1 88.85 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.064 1.842 . . . . 0.0 109.534 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -161.83 106.96 1.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.867 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.4 36.53 13.36 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.83 -6.98 79.25 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.438 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -117.5 146.08 43.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.0 m -123.31 134.36 54.06 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.951 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -116.62 149.92 38.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.27 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.71 105.26 17.38 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.9 120.58 65.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.55 123.59 3.39 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.818 2.345 . . . . 0.0 110.88 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.438 HD13 HG22 ' A' ' 72' ' ' ILE . 32.5 pt -128.96 146.04 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 119.131 -1.027 . . . . 0.0 112.168 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.4 m -120.54 122.47 40.68 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-O 121.67 0.747 . . . . 0.0 109.634 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.19 112.51 25.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.165 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -107.67 123.41 48.47 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.1 mt -90.88 130.98 36.78 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.659 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mt -72.72 153.31 41.21 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.376 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -60.33 -12.79 10.08 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p -103.28 -1.22 29.16 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -48.23 146.24 4.68 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -95.6 19.46 33.06 Favored 'Cis proline' 0 N--CA 1.517 2.885 0 N-CA-C 116.616 1.737 . . . . 0.0 116.616 2.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.424 ' CE1' ' CZ ' ' A' ' 17' ' ' TYR . 46.3 m-85 -80.52 -1.03 40.14 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.192 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.31 126.13 24.65 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.601 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -50.87 137.49 43.19 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 121.66 1.629 . . . . 0.0 109.67 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.81 144.13 19.05 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 121.824 1.682 . . . . 0.0 111.852 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mt -88.46 130.6 37.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.596 0.713 . . . . 0.0 109.276 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.8 t -119.53 136.97 54.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.496 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -123.67 129.86 51.76 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.376 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.0 t -93.11 120.97 43.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -63.56 107.27 1.19 Allowed Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.689 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -84.13 158.71 13.32 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.549 1.5 . . . . 0.0 112.262 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.7 p -139.15 174.48 10.47 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.928 0.394 . . . . 0.0 110.66 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -59.35 -39.92 84.76 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -101.12 12.08 38.28 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.985 0.811 . . . . 0.0 111.174 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 8.7 mmm -130.54 119.98 23.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -118.68 162.71 17.97 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.181 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.0 mt -97.79 108.02 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -91.19 106.62 18.64 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.7 p -62.55 142.35 58.02 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.49 -139.29 2.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.157 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -66.46 -25.71 66.85 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -133.32 -20.85 2.08 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 22.2 t -91.93 133.56 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.241 0.928 . . . . 0.0 111.332 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -98.13 -168.72 1.7 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.001 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.82 -29.66 29.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -84.19 3.13 36.53 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.821 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.45 6.18 58.72 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.432 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -59.13 137.47 57.94 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.991 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -114.95 112.98 42.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.633 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -99.9 140.73 33.69 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.2 mt -137.77 121.68 11.77 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.832 -178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.06 -39.02 25.26 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.666 1.577 . . . . 0.0 113.611 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -61.55 -31.27 71.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.666 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.89 -42.78 84.93 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.472 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -62.46 -36.48 82.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.604 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -95.74 -0.22 51.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.654 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -62.76 125.27 23.39 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.796 0.807 . . . . 0.0 110.228 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -109.03 106.84 16.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.858 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -60.64 124.05 77.16 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.451 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -108.57 91.67 0.03 OUTLIER 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 120.354 1.162 . . . . 0.0 112.646 -2.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -113.49 -62.77 1.54 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.392 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.0 t -67.13 -41.17 86.61 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.23 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.8 t70 68.04 166.27 0.24 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.751 0.786 . . . . 0.0 112.008 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 tt -64.11 -44.58 91.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.319 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.42 -38.45 59.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.07 -40.48 98.57 Favored Glycine 0 N--CA 1.478 1.499 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.7 tp -59.75 -41.17 90.41 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.54 -46.98 46.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.854 -0.738 . . . . 0.0 111.886 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -68.16 -35.72 78.5 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.08 -37.5 79.91 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.1 tpp -58.9 -44.34 91.19 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.41 -32.52 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.734 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.54 -46.04 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.343 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.5 p -70.1 -13.79 17.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.988 -178.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -103.25 -17.26 15.4 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.258 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.13 -31.05 54.01 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.73 -37.9 89.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.745 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -155.85 82.26 3.7 Favored Pre-proline 0 N--CA 1.447 -0.603 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -44.49 112.36 0.35 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.818 1.679 . . . . 0.0 111.144 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -67.21 -22.32 46.92 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.656 1.57 . . . . 0.0 111.698 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.8 m -128.48 140.49 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.853 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -155.24 161.52 41.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.107 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.94 122.18 35.04 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.719 0.295 . . . . 0.0 110.336 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.8 ttm-85 -111.62 126.96 27.59 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.859 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 N--CA 1.498 1.737 0 C-N-CA 121.965 1.777 . . . . 0.0 112.265 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.532 H181 HG22 ' A' ' 56' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.7 t -103.22 131.67 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.638 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -93.54 161.13 14.49 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.438 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 3.2 mm-40 -65.82 -43.04 89.79 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.837 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -59.57 -48.52 81.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 122.034 0.921 . . . . 0.0 109.126 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -62.9 -29.09 70.5 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.9 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.405 ' HA ' ' HG2' ' A' ' 11' ' ' MET . 65.9 tp -60.32 -42.24 95.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.728 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.438 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.6 mptp? -59.69 -39.39 84.39 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.898 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -61.76 -33.88 74.86 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.408 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.405 ' HG2' ' HA ' ' A' ' 8' ' ' LEU . 17.5 ptp -85.48 -13.3 49.54 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -128.16 16.98 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.882 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -61.06 -38.25 85.52 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.111 0.481 . . . . 0.0 111.222 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -62.58 -18.72 62.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.825 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -72.26 153.15 41.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.92 0.391 . . . . 0.0 111.52 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -78.68 -29.21 45.44 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.016 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.412 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 45.0 m-85 -112.2 55.32 0.68 Allowed 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.987 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -63.65 -27.55 69.3 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.73 -52.18 22.59 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -40.09 83.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.324 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.3 m -61.73 -46.81 88.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.093 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.34 -46.95 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.034 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 tmt_? -63.22 -41.75 99.18 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.426 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -66.7 -37.99 85.85 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.258 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 16.5 p -64.17 -33.86 76.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.07 179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.58 -44.75 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.097 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -60.58 -37.82 82.57 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.902 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.6 t -69.97 -44.08 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.89 -18.76 8.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 118.807 -1.157 . . . . 0.0 111.447 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.3 m -74.27 -44.81 51.3 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.068 0.461 . . . . 0.0 110.07 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.7 tp -87.02 -37.86 17.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.407 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -114.56 67.58 0.69 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.864 0.364 . . . . 0.0 110.252 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -56.3 -17.33 7.38 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.084 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -65.65 -21.0 66.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.896 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.0 tp -95.99 113.65 25.28 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -114.44 136.74 22.38 Favored Pre-proline 0 C--N 1.357 0.923 0 CA-C-N 119.596 1.089 . . . . 0.0 111.614 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -79.75 136.75 12.26 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.003 1.802 . . . . 0.0 113.033 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.7 t -129.21 138.07 55.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.7 tp -89.51 113.69 25.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.115 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -119.84 139.64 52.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.407 0.622 . . . . 0.0 112.417 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.1 m -71.71 140.79 49.74 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.463 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -122.81 136.52 54.9 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.388 0.54 . . . . 0.0 110.077 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.8 t -117.43 124.98 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.712 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -98.35 156.9 16.51 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -63.55 -28.16 69.75 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.741 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -62.77 -18.51 62.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.711 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.0 -9.31 56.48 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 85.4 p -76.85 166.85 22.79 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.9 p -139.86 155.21 47.34 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.754 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.3 ttm-85 -162.58 139.94 8.1 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.769 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -79.14 122.6 26.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.523 0.678 . . . . 0.0 109.883 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 12.0 tp -120.99 124.38 44.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.693 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -85.28 140.76 30.58 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.014 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -136.73 147.0 46.47 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.012 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.7 mt -92.96 127.45 38.47 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.574 HG23 H183 ' A' ' 201' ' ' 4N1 . 38.4 m -138.81 138.68 37.78 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -176.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.26 -143.09 8.19 Favored Glycine 0 N--CA 1.466 0.661 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.459 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.1 p -134.36 160.14 38.87 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.37 116.11 15.16 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.036 -0.983 . . . . 0.0 108.927 177.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -69.58 123.28 10.0 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 120.822 1.015 . . . . 0.0 110.691 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.0 t -124.0 106.76 31.11 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.113 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.75 147.02 13.48 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 123.307 2.671 . . . . 0.0 113.21 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -163.93 118.84 1.55 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.953 0.882 . . . . 0.0 111.282 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.67 41.0 25.37 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 -1.44 87.05 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.419 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -119.28 129.29 54.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.239 0.52 . . . . 0.0 109.841 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.5 m -120.82 129.62 53.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.499 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -108.59 145.28 35.11 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.963 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.35 100.72 12.46 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.68 118.09 68.99 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.04 124.12 2.08 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.779 2.319 . . . . 0.0 110.417 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.408 HG21 HD11 ' A' ' 72' ' ' ILE . 29.3 pt -134.23 148.63 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.182 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.401 ' SG ' H182 ' A' ' 201' ' ' 4N1 . 93.0 m -118.48 122.03 41.72 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 109.533 177.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.48 106.12 17.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.996 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -94.18 129.82 40.64 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.26 141.81 30.71 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.228 -177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.14 145.61 30.03 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -57.68 -9.87 1.37 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.4 p -114.89 17.31 17.02 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.9 0.381 . . . . 0.0 111.876 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -57.74 143.08 77.16 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -93.41 7.56 57.2 Favored 'Cis proline' 0 N--CA 1.515 2.792 0 CA-C-N 120.99 1.389 . . . . 0.0 115.303 0.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.412 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 36.9 m-85 -73.86 -7.65 53.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.046 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.58 115.12 37.65 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -49.98 134.66 36.08 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 CA-C-N 121.062 1.415 . . . . 0.0 112.373 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.23 143.95 14.34 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.216 1.944 . . . . 0.0 111.684 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.57 152.1 4.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.247 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.7 t -138.52 135.7 35.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.026 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -118.4 128.7 54.88 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.816 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.415 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 61.2 t -89.69 129.66 40.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.97 99.94 2.54 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 123.267 0.355 . . . . 0.0 110.945 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 43.8 Cg_endo -84.89 150.88 11.14 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.652 1.568 . . . . 0.0 113.058 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.2 p -116.25 168.08 10.44 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.719 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.4 m -56.03 -34.05 65.51 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.3 m -87.3 20.89 2.61 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.781 0.718 . . . . 0.0 110.591 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 30.9 ttm -144.76 146.58 32.22 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.0 m -124.56 140.7 52.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.7 tp -85.84 103.97 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.243 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -87.82 102.14 14.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.258 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 74.2 p -72.21 148.68 45.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.612 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -172.86 -138.97 2.72 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -87.89 -3.84 58.89 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -122.21 -30.28 4.04 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.294 0.952 . . . . 0.0 112.242 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 t -112.04 134.65 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.882 0.765 . . . . 0.0 109.268 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -93.01 162.04 14.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.031 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.95 -32.44 73.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.467 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -76.93 -6.23 51.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.7 5.62 59.93 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.844 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.15 147.48 40.44 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.424 HD12 HG22 ' A' ' 109' ' ' ILE . 86.0 mt -106.36 121.44 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.125 0.488 . . . . 0.0 111.236 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -102.35 120.27 40.22 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mt -126.75 122.34 23.47 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.258 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.04 -30.08 85.4 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 121.474 1.449 . . . . 0.0 114.363 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -66.67 -31.0 71.39 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.815 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 tt -69.59 -41.36 75.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.967 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -66.98 -28.3 68.15 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.375 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -104.29 1.59 30.56 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.521 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -68.95 125.94 28.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.872 0.844 . . . . 0.0 110.221 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -98.07 130.16 44.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.03 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -79.06 124.27 84.71 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.537 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -112.06 92.1 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.563 0 CA-C-N 120.929 1.367 . . . . 0.0 112.786 -2.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -113.77 -52.8 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.088 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.9 p -74.62 -40.07 61.76 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.368 0.604 . . . . 0.0 110.694 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 59.47 164.65 0.05 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.956 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.2 tp -58.29 -44.94 88.72 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.104 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 9.0 tp -52.72 -35.43 55.77 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.7 -38.97 96.31 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.9 tp -58.91 -40.3 84.1 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.487 -0.419 . . . . 0.0 111.877 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -76.53 -45.71 32.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.343 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -69.2 -34.34 74.73 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.67 -38.58 81.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 48.1 tpp -60.67 -44.0 97.0 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.73 -38.27 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.385 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.7 t -82.25 -48.25 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.5 p -69.17 -16.17 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.717 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -107.27 -19.68 13.52 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.001 176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.93 -34.61 90.4 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -62.91 -37.89 88.77 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.997 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -154.87 90.38 3.06 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -45.87 116.59 1.48 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.419 1.412 . . . . 0.0 110.609 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.92 -14.5 35.65 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.627 1.552 . . . . 0.0 111.54 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.24 133.2 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.332 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -161.07 163.5 31.46 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.44 127.67 50.77 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.371 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -110.99 121.55 40.44 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.365 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo . . . . . 0 N--CA 1.493 1.49 0 C-N-CA 122.109 1.873 . . . . 0.0 112.247 179.285 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.574 H183 HG23 ' A' ' 56' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t -106.15 130.35 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.02 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -95.66 158.41 15.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.407 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 88.8 mt-10 -65.28 -39.21 92.29 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.65 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.8 m -60.08 -41.98 93.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.352 1.072 . . . . 0.0 109.139 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -68.5 -39.64 81.19 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.052 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 tp -53.74 -33.53 56.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 13' ' ' SER . 4.7 mmtt -68.11 -47.7 67.48 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.031 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.98 -34.87 73.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.633 0.73 . . . . 0.0 110.216 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.9 mmm -64.51 -37.06 86.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.042 -178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -122.17 23.91 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.565 0.221 . . . . 0.0 110.941 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 9' ' ' LYS . 99.9 p -66.24 -23.72 66.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.543 0.211 . . . . 0.0 111.345 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -77.53 -18.74 56.72 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.326 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -69.93 143.34 52.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.469 0.652 . . . . 0.0 111.603 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -21.74 64.05 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.339 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 96.7 m-85 -121.89 55.43 1.11 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.591 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -65.34 -26.18 67.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 119.871 -0.732 . . . . 0.0 112.808 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -67.02 -56.13 11.43 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 13.0 mt -65.68 -40.3 92.2 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.47 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.3 m -61.95 -49.68 75.18 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.708 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.26 -47.56 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 120.513 0.197 . . . . 0.0 110.74 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -65.1 -40.9 95.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.37 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -63.99 -38.75 92.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.694 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 26.2 p -66.91 -38.69 86.71 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.74 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.7 t -56.58 -44.39 80.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.489 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -62.86 -39.52 94.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.702 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 51.6 t -66.78 -44.09 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.95 -13.12 12.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.3 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 p -80.98 -48.68 11.93 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.788 0.328 . . . . 0.0 110.589 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.5 tp -88.09 -36.59 16.84 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.399 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -109.78 66.19 0.63 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -57.17 -19.16 18.79 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.134 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -66.46 -18.18 65.21 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.384 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 tp -98.26 113.51 25.47 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -110.63 135.87 20.69 Favored Pre-proline 0 C--N 1.354 0.801 0 CA-C-N 119.354 0.979 . . . . 0.0 111.391 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.87 139.41 22.07 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.462 1.441 . . . . 0.0 111.794 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 p -133.79 147.06 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.3 tp -99.1 119.67 38.22 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.585 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -121.69 135.77 54.95 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.039 0.447 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.532 ' HG ' H101 ' A' ' 201' ' ' 4N1 . 90.5 p -70.92 139.79 50.8 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -123.78 134.03 53.72 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.725 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.1 t -112.25 127.42 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.308 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -97.69 161.22 13.87 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.811 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -61.07 -38.12 85.1 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.588 0.232 . . . . 0.0 111.457 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.11 -16.57 60.43 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.59 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.78 -5.12 56.52 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.9 p -71.67 166.15 22.5 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 t -128.99 146.13 51.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.341 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.04 134.12 19.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.097 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -85.1 106.32 16.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 36.6 mt -110.13 142.9 40.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.454 0.645 . . . . 0.0 111.349 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 55.3 ttp -105.61 142.42 35.38 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.804 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -136.35 154.47 50.83 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.561 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 mt -95.41 120.18 35.2 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.465 HG23 H182 ' A' ' 201' ' ' 4N1 . 72.3 m -132.9 135.19 45.43 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.22 -149.21 11.94 Favored Glycine 0 N--CA 1.464 0.51 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.481 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.0 p -133.11 158.36 42.99 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 pt -129.12 116.03 18.82 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.27 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -72.48 125.6 10.82 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 N-CA-C 109.495 -1.002 . . . . 0.0 109.495 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.17 126.77 21.65 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 119.688 -0.805 . . . . 0.0 112.001 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.83 148.66 46.49 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.271 1.981 . . . . 0.0 110.498 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.93 112.61 1.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.609 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.96 32.01 11.93 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.88 -0.513 . . . . 0.0 111.857 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.51 -10.21 67.91 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -110.32 137.78 47.58 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.9 m -115.27 131.72 56.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.671 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -114.6 152.38 31.92 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.296 0.569 . . . . 0.0 110.906 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -98.92 103.81 15.8 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.13 118.67 68.68 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -85.55 126.45 3.06 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.786 2.324 . . . . 0.0 110.944 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.418 HD12 HG23 ' A' ' 72' ' ' ILE . 30.5 pt -133.74 149.86 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.819 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 m -124.05 122.55 38.18 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.762 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.2 112.22 25.14 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.315 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -103.01 125.41 49.75 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.2 mt -88.12 140.04 29.89 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.898 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 tp -93.91 143.69 26.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -48.27 -18.29 0.2 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.68 16.94 25.19 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -69.84 144.58 93.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -92.87 4.27 60.21 Favored 'Cis proline' 0 N--CA 1.514 2.694 0 CA-C-N 121.426 1.545 . . . . 0.0 115.422 1.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 36.0 m-85 -73.34 -15.62 61.38 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.637 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.23 120.26 44.81 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.71 134.4 33.95 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.253 1.483 . . . . 0.0 111.701 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.08 145.11 21.72 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.956 1.77 . . . . 0.0 110.76 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.33 131.52 41.89 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 119.179 -1.009 . . . . 0.0 109.545 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.7 m -111.86 137.83 49.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.672 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -126.5 128.26 46.64 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.225 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.53 127.52 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.48 109.04 12.51 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.72 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.25 161.56 13.25 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 122.149 1.899 . . . . 0.0 112.882 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.9 p -133.43 173.24 11.69 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.7 m -57.94 -39.27 77.63 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 120.136 -0.626 . . . . 0.0 112.252 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.7 p -92.24 0.52 57.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.64 0.654 . . . . 0.0 111.866 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -130.66 125.59 34.39 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.97 167.44 10.66 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.348 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.8 mm -92.73 105.3 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.546 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -86.71 108.66 18.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.498 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.6 p -67.42 140.16 57.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.418 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.63 -146.78 4.41 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -71.55 -22.2 61.79 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -123.8 -25.0 4.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.329 -0.949 . . . . 0.0 112.914 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 14.2 t -91.25 131.39 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.423 1.01 . . . . 0.0 110.671 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -95.31 -163.4 1.04 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.605 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.08 -13.53 47.04 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.39 -1.55 23.14 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.371 -0.206 . . . . 0.0 110.735 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.76 0.08 42.36 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.767 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.66 128.99 24.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.707 0.754 . . . . 0.0 109.898 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.414 HD13 HG23 ' A' ' 109' ' ' ILE . 96.8 mt -109.36 114.5 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 O-C-N 123.264 0.353 . . . . 0.0 110.411 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -96.87 134.3 40.37 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 33.1 mt -137.71 118.86 10.61 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.859 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -47.51 -38.91 28.61 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 121.793 1.662 . . . . 0.0 114.037 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.83 -29.55 69.56 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.174 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.62 -43.76 75.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.743 0.306 . . . . 0.0 111.645 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -69.35 -28.23 66.03 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.689 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -103.97 4.3 34.43 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.989 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.417 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.0 t90 -68.62 121.65 16.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.717 0.77 . . . . 0.0 109.683 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -90.49 122.9 33.73 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.245 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -79.56 126.78 80.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.738 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -107.7 92.67 0.04 OUTLIER 'Cis proline' 0 N--CA 1.499 1.801 0 CA-C-N 120.802 1.322 . . . . 0.0 112.649 -2.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -115.12 -61.31 1.77 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.586 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.3 t -68.97 -33.82 74.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.762 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 p30 47.82 -177.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.82 0.819 . . . . 0.0 111.962 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.7 tt -68.28 -39.56 82.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.137 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 8.2 tt -57.79 -38.74 76.03 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.28 97.46 Favored Glycine 0 N--CA 1.479 1.561 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.0 tp -58.22 -40.57 82.01 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.427 -0.455 . . . . 0.0 111.768 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -72.71 -49.43 40.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.848 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -65.54 -35.96 82.39 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.86 -37.39 79.34 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 60.9 tpp -58.54 -43.64 89.33 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -42.77 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.564 179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.8 t -77.19 -44.07 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 p -73.62 -13.64 16.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.015 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.6 m-30 -105.85 -17.59 14.32 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.209 -0.996 . . . . 0.0 109.703 177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.69 -34.44 89.64 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.03 -35.5 81.38 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.604 -0.298 . . . . 0.0 110.711 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -155.95 116.52 2.23 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.47 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -75.12 120.48 6.05 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 N-CA-C 108.648 -1.328 . . . . 0.0 108.648 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.94 -19.05 46.57 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.066 1.177 . . . . 0.0 111.217 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.92 147.95 29.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.56 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -155.38 165.68 35.87 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.4 p -77.59 121.0 23.33 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.375 0.607 . . . . 0.0 111.414 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -113.15 123.07 34.21 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.743 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo . . . . . 0 N--CA 1.499 1.846 0 C-N-CA 121.775 1.65 . . . . 0.0 112.014 -179.738 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.532 H101 ' HG ' ' A' ' 41' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.9 t -96.3 130.03 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.791 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.1 156.01 16.8 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 57.7 mp0 -63.0 -41.51 99.6 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.97 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.8 p -57.38 -47.99 80.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.165 0.984 . . . . 0.0 109.379 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -62.79 -34.52 77.43 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.778 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.1 tp -55.97 -38.39 70.33 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 3.1 mptp? -63.64 -42.8 98.09 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.331 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.47 -36.36 83.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.142 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.61 -36.76 84.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.947 -178.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.8 23.18 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.795 0.331 . . . . 0.0 111.45 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 t -58.8 -25.42 63.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.575 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -64.84 -21.45 66.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.709 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -67.89 150.57 48.39 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.95 -29.6 70.75 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.058 0.456 . . . . 0.0 112.175 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.494 ' CD2' ' N ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -138.0 69.03 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.097 0.959 . . . . 0.0 111.73 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -57.69 -25.31 60.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.89 -41.67 97.65 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.027 -0.42 . . . . 0.0 111.497 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 tp -71.68 -43.32 66.2 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.447 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 m -62.69 -46.77 86.61 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.33 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.8 t -62.43 -44.1 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 120.6 0.238 . . . . 0.0 110.428 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.17 -41.99 89.71 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.682 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.83 -39.57 93.79 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.248 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.9 p -67.89 -38.33 82.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.46 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.15 -44.12 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.496 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -60.72 -38.75 86.15 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.138 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.37 -45.3 70.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -84.78 -22.43 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.989 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.8 m -72.18 -45.68 59.38 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.81 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.3 tp -84.47 -37.74 21.0 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.11 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -114.43 66.93 0.68 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -57.76 -17.58 16.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.323 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -65.65 -16.34 63.64 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.26 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 tp -96.36 125.58 40.96 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -118.27 129.27 25.47 Favored Pre-proline 0 C--N 1.359 0.995 0 CA-C-N 119.814 1.188 . . . . 0.0 111.955 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.09 140.23 15.63 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 121.855 1.703 . . . . 0.0 112.592 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.2 p -136.84 141.2 41.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.221 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.2 tp -82.66 119.22 24.02 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -119.75 137.81 53.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.212 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.5 m -76.39 141.23 41.52 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -126.38 134.91 50.92 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.994 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -110.4 125.6 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.391 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -99.09 164.95 11.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.575 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -60.38 -41.95 94.83 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.714 0.292 . . . . 0.0 110.951 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -66.0 -14.72 62.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.512 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.18 -7.76 58.71 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.2 t -62.52 143.18 57.48 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.148 0.499 . . . . 0.0 110.027 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -115.7 140.03 49.58 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.051 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.5 ttm-85 -153.75 139.02 17.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.652 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -87.74 111.23 21.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.226 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.8 mt -111.53 140.03 46.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.413 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -92.75 138.33 31.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -130.05 153.15 48.74 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.023 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.88 119.16 34.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.537 HG22 H182 ' A' ' 201' ' ' 4N1 . 99.6 m -130.23 136.81 49.6 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.928 0.394 . . . . 0.0 112.021 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.46 -147.96 13.61 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.606 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.0 p -133.29 161.09 35.42 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.46 116.6 18.53 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.494 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -72.39 126.08 11.3 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 CA-C-N 120.037 1.049 . . . . 0.0 110.193 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.0 t -128.13 125.87 23.54 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.583 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.67 150.0 55.88 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.184 1.923 . . . . 0.0 110.294 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -162.84 106.5 1.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.31 0.576 . . . . 0.0 111.746 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 52.68 39.29 28.16 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.939 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.88 -2.37 74.82 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -119.64 134.16 55.35 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -114.59 131.92 56.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.063 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -113.34 150.05 33.14 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.668 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -94.12 107.05 19.01 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.5 mp -90.22 116.23 65.89 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.356 -177.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.31 124.69 4.88 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 122.553 2.168 . . . . 0.0 111.381 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.4 pt -135.89 148.68 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.918 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 63.0 m -125.24 125.04 42.96 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.4 0.619 . . . . 0.0 109.884 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.62 115.75 30.69 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.304 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -103.8 126.33 50.85 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.2 mt -94.5 139.82 30.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.217 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mt -79.65 160.12 26.46 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -59.94 -13.96 13.53 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 p -120.77 18.01 11.89 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.424 ' CD1' ' HA ' ' A' ' 81' ' ' PRO . 4.4 t80 -59.5 148.14 74.81 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.424 ' HA ' ' CD1' ' A' ' 80' ' ' TYR . 20.0 Cg_endo -92.89 10.26 56.32 Favored 'Cis proline' 0 N--CA 1.509 2.417 0 CA-C-N 121.333 1.512 . . . . 0.0 115.415 -0.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.63 -16.97 64.44 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 118.665 -1.214 . . . . 0.0 110.695 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.14 128.06 26.28 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.362 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -46.81 129.62 14.68 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 CA-C-N 121.269 1.489 . . . . 0.0 113.179 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -82.78 148.67 13.93 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.634 2.223 . . . . 0.0 111.401 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -96.45 153.8 3.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.601 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.11 136.24 24.88 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.624 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -120.42 137.79 54.12 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.703 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.459 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -88.04 125.18 41.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -64.22 104.61 0.55 Allowed Pre-proline 0 N--CA 1.475 0.805 0 CA-C-O 119.162 -0.446 . . . . 0.0 110.631 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 48.3 Cg_endo -88.93 157.99 5.95 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.56 1.507 . . . . 0.0 112.783 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.9 t -157.44 161.67 38.94 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.289 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.6 m -56.36 -23.02 34.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -98.45 6.66 47.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.653 0.66 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.8 mmm -131.37 140.14 49.63 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.1 m -128.77 147.37 50.78 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.744 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 93.2 mt -101.09 117.12 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.083 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -101.41 106.89 18.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.3 p -57.47 148.44 23.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.754 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -161.26 -140.36 2.86 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.116 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -88.45 -3.42 58.83 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -135.46 -29.14 1.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.619 1.099 . . . . 0.0 113.617 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.29 144.31 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 119.036 0.835 . . . . 0.0 110.247 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -98.09 159.6 14.83 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.04 79.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.418 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -73.92 -5.51 41.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.169 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.62 6.23 58.49 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.418 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 143.1 34.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.939 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 98.3 mt -106.55 119.88 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.177 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.23 139.67 50.95 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.03 126.25 18.55 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 118.49 0.586 . . . . 0.0 112.183 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.68 -38.87 37.62 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 121.735 1.623 . . . . 0.0 114.07 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -62.43 -31.83 72.59 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.861 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 tt -69.66 -41.59 75.35 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.371 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -66.3 -29.09 69.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.606 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -101.54 -3.29 28.75 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.694 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.404 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.1 t90 -67.56 127.5 32.96 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.924 0.868 . . . . 0.0 110.475 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.37 130.24 43.53 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.776 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -80.21 126.13 79.9 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.33 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -108.33 93.59 0.04 OUTLIER 'Cis proline' 0 N--CA 1.498 1.787 0 CA-C-N 120.794 1.319 . . . . 0.0 112.539 -2.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -113.99 -62.39 1.6 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.308 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.1 p -70.3 -40.11 74.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.159 0.504 . . . . 0.0 110.297 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.2 t70 65.76 167.67 0.2 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.418 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.3 tt -62.47 -43.86 97.79 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.11 -36.4 60.71 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.65 -40.19 98.42 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.3 tp -60.46 -40.76 92.34 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -75.98 -47.14 33.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.597 -176.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -67.97 -35.57 78.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.1 t -68.65 -39.39 80.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 177.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.7 ttm -59.01 -45.26 91.13 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.68 -43.28 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.351 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 73.6 t -75.25 -39.68 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.4 p -72.32 -17.45 18.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.54 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -110.13 -17.77 13.48 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.575 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.19 -35.55 91.71 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 107.146 -2.382 . . . . 0.0 107.146 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.99 -34.2 77.86 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.556 -0.822 . . . . 0.0 110.608 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -157.95 90.75 2.26 Favored Pre-proline 0 C--N 1.333 -0.125 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.526 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -50.23 114.15 1.31 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.776 0.984 . . . . 0.0 110.128 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.26 -13.29 28.19 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.471 1.447 . . . . 0.0 111.154 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.1 m -131.64 138.88 51.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.343 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -160.19 164.16 33.05 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.672 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 66.4 m -93.1 126.37 38.16 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.246 0.546 . . . . 0.0 111.02 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -112.92 103.19 55.58 Favored Pre-proline 0 N--CA 1.444 -0.736 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.795 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo . . . . . 0 N--CA 1.497 1.685 0 C-N-CA 121.877 1.718 . . . . 0.0 112.143 179.6 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.537 H182 HG22 ' A' ' 56' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.2 t -100.75 129.75 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.722 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -96.58 156.0 16.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.46 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 93.9 mt-10 -62.79 -40.53 97.62 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.145 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -58.76 -47.0 86.17 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 122.219 1.009 . . . . 0.0 109.052 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -61.57 -36.49 80.81 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.002 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.0 tp -55.3 -39.54 70.04 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 3.2 mptp? -60.65 -43.31 97.75 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.867 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -67.94 -26.32 65.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.735 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -79.03 -34.61 43.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.52 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -113.17 17.64 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.711 0.291 . . . . 0.0 110.789 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.67 -11.51 60.24 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.656 0.265 . . . . 0.0 111.302 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -85.22 -12.85 51.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.453 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -77.75 152.47 33.59 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.408 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -64.93 -39.13 93.03 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.076 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 25.0 m-85 -114.58 70.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 122.404 -0.185 . . . . 0.0 111.077 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -69.04 -27.31 65.54 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -72.74 -46.56 52.86 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.79 -39.6 73.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.969 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.7 m -61.19 -45.71 93.46 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.872 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.1 t -61.86 -45.9 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 120.839 0.352 . . . . 0.0 110.483 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -43.05 99.65 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.873 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -65.16 -37.12 86.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.943 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.5 p -67.38 -37.36 83.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.922 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.49 -43.62 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -60.4 -39.04 85.91 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.411 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -70.58 -42.75 78.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.27 -21.92 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.191 -177.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.0 m -72.46 -42.9 64.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.046 0.451 . . . . 0.0 110.311 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.8 tp -88.75 -34.52 17.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.092 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -118.24 68.85 0.78 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -57.32 -20.59 29.59 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.159 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -65.84 -15.05 62.55 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.755 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 tp -96.95 112.43 24.19 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.12 129.52 23.84 Favored Pre-proline 0 C--N 1.358 0.937 0 CA-C-N 119.572 1.078 . . . . 0.0 112.334 -177.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -82.92 135.64 7.74 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.603 1.535 . . . . 0.0 112.834 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.84 155.58 41.54 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.7 tp -95.21 117.6 30.53 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -121.42 134.74 55.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.907 0.384 . . . . 0.0 111.9 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.5 t -71.99 136.72 46.85 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -118.27 124.31 47.54 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.864 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.1 t -110.2 124.85 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.926 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -104.18 166.7 10.24 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.893 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -60.49 -38.0 82.88 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.488 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.54 -15.87 59.17 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.843 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.72 -8.88 66.16 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.8 t -67.35 145.04 55.49 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -125.08 139.18 54.02 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.414 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -150.02 136.95 19.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.109 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 pm0 -83.97 116.99 23.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.213 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 69.9 mt -117.23 145.09 44.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.086 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -98.93 138.23 36.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.849 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -130.08 151.12 50.96 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.479 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 mt -97.59 129.57 44.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.581 HG22 H182 ' A' ' 201' ' ' 4N1 . 24.1 m -145.3 138.5 26.43 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.85 -141.9 7.31 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.485 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.5 p -133.41 158.92 41.83 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.59 116.18 18.32 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.848 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -70.98 123.85 10.07 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 CA-C-N 119.886 0.995 . . . . 0.0 110.001 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.1 t -130.67 125.71 21.59 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.909 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.09 147.39 42.83 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.281 1.987 . . . . 0.0 110.634 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -163.48 116.08 1.49 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 55.93 28.29 12.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.448 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.68 -5.74 77.03 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -112.93 142.51 45.52 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.9 m -120.29 131.93 55.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.884 0.374 . . . . 0.0 111.74 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -115.11 152.02 33.29 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.98 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -96.52 104.93 16.95 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.7 117.13 68.0 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.94 124.31 3.84 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.711 2.274 . . . . 0.0 111.12 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.5 pt -135.72 148.69 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.973 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.3 m -121.43 123.55 42.35 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-O 121.839 0.828 . . . . 0.0 110.12 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.97 117.0 32.9 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.349 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -107.72 126.23 52.35 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.5 mt -92.87 139.36 30.62 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.838 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mt -85.42 152.58 23.12 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.66 -16.05 14.5 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.906 -178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.2 10.75 31.79 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -65.3 144.54 99.02 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -91.05 3.84 67.11 Favored 'Cis proline' 0 N--CA 1.515 2.786 0 CA-C-N 121.219 1.471 . . . . 0.0 115.726 1.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.428 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 18.8 m-85 -71.54 -20.67 62.0 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.945 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.06 126.64 30.1 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.826 -0.607 . . . . 0.0 109.695 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -49.08 131.48 26.06 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 CA-C-N 121.235 1.477 . . . . 0.0 112.403 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.16 145.53 11.01 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.463 2.109 . . . . 0.0 111.784 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.79 147.44 5.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.241 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.8 t -139.57 132.58 29.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.56 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -121.88 130.86 53.69 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.66 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.4 m -82.83 145.93 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -93.56 99.1 3.03 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.871 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.03 157.25 34.3 Favored 'Trans proline' 0 N--CA 1.504 2.118 0 C-N-CA 121.482 1.455 . . . . 0.0 112.738 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 p -139.24 176.17 8.93 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.1 t -59.79 -43.86 94.2 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 m -88.18 11.84 15.3 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.795 0.725 . . . . 0.0 111.493 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.2 mmm -129.13 138.46 51.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.66 146.03 48.52 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.813 -178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.6 mm -88.2 103.43 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.077 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -95.58 110.9 22.93 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.9 p -69.65 155.97 39.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.687 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.89 -135.01 2.24 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.826 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -86.38 -1.24 57.37 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -134.97 -27.31 1.26 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.665 1.12 . . . . 0.0 113.729 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -110.55 134.81 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 118.931 0.787 . . . . 0.0 110.215 178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -87.2 -172.57 4.01 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.418 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.13 0.34 56.14 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.978 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -109.04 -5.67 15.94 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.745 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.89 -3.44 57.26 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.534 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 145.22 47.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.408 0.604 . . . . 0.0 110.446 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.5 mt -108.92 122.12 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.434 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.61 130.65 56.86 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.1 mt -123.99 124.23 26.02 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.251 -176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -49.15 -36.9 37.59 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 121.739 1.626 . . . . 0.0 113.865 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.423 ' CG ' ' N ' ' A' ' 114' ' ' LEU . 1.2 p90 -60.07 -33.0 71.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.079 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.423 ' N ' ' CG ' ' A' ' 113' ' ' TYR . 1.5 tt -70.89 -41.23 71.59 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.918 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -64.17 -26.37 68.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.633 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -113.78 11.52 18.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.495 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -72.19 125.99 28.67 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.924 0.868 . . . . 0.0 109.996 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -96.57 127.89 42.99 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.784 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -81.6 126.49 75.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 119.069 -0.491 . . . . 0.0 110.112 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -108.94 92.35 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.707 0 CA-C-N 120.756 1.306 . . . . 0.0 112.43 -2.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.26 -61.96 1.66 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.504 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.5 t -67.94 -42.11 81.5 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.087 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 t70 66.98 165.84 0.22 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.487 0.66 . . . . 0.0 111.7 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.7 tt -65.79 -43.71 87.94 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.663 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.81 -38.54 72.72 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.24 -39.12 96.75 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.4 tp -56.95 -40.28 76.15 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.889 -0.183 . . . . 0.0 111.431 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -73.98 -47.82 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.941 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -66.42 -35.0 79.22 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.41 -39.02 81.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.0 tpp -58.24 -42.13 85.7 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.62 -39.55 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.597 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -79.09 -46.82 23.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.6 -14.21 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.138 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -104.75 -19.09 14.04 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.18 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.43 -32.05 60.3 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -63.89 -38.87 92.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.817 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -157.67 81.66 3.08 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -49.1 109.31 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.266 1.311 . . . . 0.0 110.76 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.64 -23.47 40.6 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.456 1.437 . . . . 0.0 110.462 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 m -120.09 140.41 44.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.29 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -159.57 164.19 34.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.297 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.4 m -105.81 130.17 53.85 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.853 0.358 . . . . 0.0 110.72 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.13 132.2 22.16 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.445 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo . . . . . 0 N--CA 1.494 1.538 0 C-N-CA 121.791 1.661 . . . . 0.0 111.982 179.434 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.581 H182 HG22 ' A' ' 56' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 p -71.23 139.3 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 121.391 0.615 . . . . 0.0 110.805 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -103.74 157.84 16.8 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.422 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 97.7 mt-10 -65.04 -40.45 94.81 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.266 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -63.26 -41.51 99.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.355 1.074 . . . . 0.0 109.214 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -69.97 -29.93 67.16 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.657 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.6 tp -61.9 -39.65 92.71 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -58.85 -43.22 90.73 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.074 -0.967 . . . . 0.0 108.657 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -60.43 -35.52 76.02 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.298 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 13.5 ptp -83.33 -10.58 58.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.172 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -130.9 19.21 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.01 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.7 p -66.44 -18.22 65.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.558 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.82 -13.15 40.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.98 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.401 ' CZ ' HD23 ' A' ' 52' ' ' LEU . 33.7 m-85 -72.9 148.64 44.17 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.527 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -66.57 -37.82 85.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.799 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 19.8 m-85 -108.18 61.92 0.61 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.428 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.4 ptp85 -64.76 -27.31 68.81 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -76.68 -53.03 8.55 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.11 -38.77 82.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.084 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -60.77 -47.45 86.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.698 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.08 -44.62 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -40.53 97.87 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.115 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.13 -38.44 91.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.059 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.8 p -68.27 -34.33 75.99 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.923 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.68 -45.64 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.742 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -61.31 -39.07 89.13 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.471 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.64 -43.09 71.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.57 -20.13 7.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.698 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.5 m -78.07 -46.97 19.4 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.992 0.425 . . . . 0.0 110.848 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 22.8 tp -88.65 -36.0 16.49 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.842 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -111.97 68.14 0.66 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -59.38 -18.15 36.22 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.671 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -65.22 -21.88 66.81 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.855 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.3 tp -95.51 115.26 27.18 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.72 132.76 22.11 Favored Pre-proline 0 C--N 1.356 0.881 0 CA-C-N 119.828 1.194 . . . . 0.0 112.104 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.39 135.3 11.82 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.424 1.416 . . . . 0.0 112.46 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.1 t -127.87 136.27 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.55 119.24 24.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -129.91 137.25 50.28 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.9 t -68.6 137.98 54.69 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.56 133.45 53.98 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.206 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.2 t -120.78 126.63 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.992 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -100.79 159.51 15.13 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.178 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.59 -35.44 72.42 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 122.369 -0.207 . . . . 0.0 110.934 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -61.38 -15.36 35.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.876 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.71 -13.45 60.94 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.0 t -65.75 141.81 58.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.2 p -121.9 138.74 54.28 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.546 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -161.23 138.69 9.05 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.359 0.6 . . . . 0.0 110.79 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -80.39 120.5 24.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.741 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.401 HD23 ' CZ ' ' A' ' 15' ' ' TYR . 77.7 mt -122.22 140.01 53.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.553 0.692 . . . . 0.0 110.817 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 62.0 ttp -84.51 148.66 26.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.424 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -134.2 151.53 51.36 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.296 0.57 . . . . 0.0 111.689 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.66 116.02 31.74 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.578 HG23 H182 ' A' ' 201' ' ' 4N1 . 84.5 m -134.47 137.13 43.7 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.27 -143.24 7.99 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.593 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.8 p -135.27 161.25 35.92 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.31 116.07 15.22 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.206 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -72.35 125.87 11.14 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 120.935 1.09 . . . . 0.0 110.092 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.6 t -129.48 124.43 21.96 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 119.744 -0.783 . . . . 0.0 112.329 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.56 145.85 48.11 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.137 1.891 . . . . 0.0 110.162 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -163.57 114.78 1.4 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.932 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.23 32.09 12.78 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.82 -6.86 72.36 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -113.79 148.51 36.42 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -125.2 132.58 52.99 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.609 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -115.47 152.09 33.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.138 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -97.09 103.88 15.85 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.33 116.98 67.83 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -82.18 127.26 5.22 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 122.516 2.144 . . . . 0.0 111.062 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 72' ' ' ILE . 29.6 pt -137.1 149.13 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 118.939 -1.105 . . . . 0.0 112.577 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.46 123.05 40.4 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-O 121.513 0.673 . . . . 0.0 110.057 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.32 103.68 13.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.646 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -90.69 124.05 34.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 119.046 -1.062 . . . . 0.0 108.3 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -91.98 138.64 31.38 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mt -88.9 155.46 19.51 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.28 -16.26 32.54 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.629 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.04 0.43 51.57 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.669 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -65.03 143.03 98.82 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -89.34 4.15 69.62 Favored 'Cis proline' 0 N--CA 1.517 2.892 0 CA-C-N 120.975 1.384 . . . . 0.0 115.299 1.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 12.0 m-85 -68.85 -23.13 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.242 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.86 126.3 30.15 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.959 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.19 137.48 37.88 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 CA-C-N 121.263 1.487 . . . . 0.0 111.555 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.03 144.1 11.8 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.387 2.058 . . . . 0.0 111.771 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.49 131.55 40.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.65 0.738 . . . . 0.0 109.406 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 38.7 t -118.28 142.0 47.94 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.326 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -127.93 127.64 43.68 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.103 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.455 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 57.9 t -85.79 131.92 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -87.35 101.76 2.61 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.979 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 79.4 Cg_endo -82.03 159.36 18.18 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.39 1.393 . . . . 0.0 112.206 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 p -123.39 168.13 12.93 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.06 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.2 m -56.75 -36.09 69.37 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.433 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.0 m -88.36 2.59 52.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.854 0.752 . . . . 0.0 112.295 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -129.54 140.15 51.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.68 156.81 26.46 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.631 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.7 tp -85.25 109.98 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-O 121.262 0.553 . . . . 0.0 109.96 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -97.53 101.39 12.9 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.033 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.7 p -65.54 151.18 47.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.883 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -166.23 -143.75 3.85 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.663 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.403 ' O ' ' CZ ' ' A' ' 110' ' ' TYR . 24.8 pttm -65.96 -18.96 65.69 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -131.86 -26.67 1.95 Allowed 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 13.4 t -93.78 137.66 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.667 1.121 . . . . 0.0 111.36 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -100.97 177.51 4.93 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.417 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.58 -38.55 87.28 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -86.41 -0.37 55.83 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.843 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.69 21.56 18.66 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.722 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -75.79 136.84 40.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.687 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 88.7 mt -117.26 125.2 73.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.95 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CZ ' ' O ' ' A' ' 101' ' ' LYS . 30.2 p90 -136.44 148.87 47.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mp -143.45 140.03 17.12 Favored Pre-proline 0 CA--C 1.555 1.152 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.257 -175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.424 ' HA ' ' ND1' ' A' ' 115' ' ' HIS . 50.4 Cg_exo -46.43 -38.64 21.24 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 C-N-CA 121.954 1.769 . . . . 0.0 113.792 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.69 -31.94 73.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.073 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.24 -43.08 64.91 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.424 ' ND1' ' HA ' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -68.96 -27.01 65.35 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.78 -177.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -97.65 1.12 48.32 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.293 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -60.13 126.51 27.79 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.766 0.793 . . . . 0.0 110.657 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -104.46 96.29 6.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.619 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -55.64 122.84 47.97 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.309 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -108.0 91.97 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 120.304 1.144 . . . . 0.0 113.019 -2.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -110.43 -58.83 2.03 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.483 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.1 p -71.02 -39.72 72.19 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.355 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 t70 69.32 164.09 0.24 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.355 0.598 . . . . 0.0 112.095 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.4 tt -66.15 -44.28 84.57 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.326 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tp -56.12 -37.95 70.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.67 -39.42 97.39 Favored Glycine 0 N--CA 1.477 1.391 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 32.4 tp -58.68 -41.17 85.59 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.605 -0.35 . . . . 0.0 111.902 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -72.71 -47.74 48.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.954 -176.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -67.71 -34.73 77.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.5 t -67.91 -39.2 81.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.055 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.404 ' SD ' ' CE1' ' A' ' 135' ' ' PHE . 44.5 tpp -58.14 -41.47 83.77 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.67 -44.14 98.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.562 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.74 -44.21 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 8.7 p -73.52 -14.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.177 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.404 ' CE1' ' SD ' ' A' ' 131' ' ' MET . 11.6 m-30 -105.38 -17.78 14.33 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.547 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.95 -22.97 72.59 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -76.43 -27.31 56.18 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.578 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -161.73 83.77 1.75 Allowed Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -46.99 119.25 3.26 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.341 1.361 . . . . 0.0 110.407 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.47 -18.61 43.57 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 120.875 1.05 . . . . 0.0 110.856 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.76 147.86 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -158.75 164.86 35.47 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.526 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 67.1 m -86.87 120.76 28.5 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.164 0.507 . . . . 0.0 111.15 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -112.03 111.88 53.14 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.044 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.494 1.543 0 C-N-CA 122.126 1.884 . . . . 0.0 112.292 -179.614 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.578 H182 HG23 ' A' ' 56' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p -88.55 146.44 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-O 121.679 0.752 . . . . 0.0 111.079 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.05 149.65 24.99 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.408 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 56.0 mp0 -61.23 -42.3 98.37 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.768 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.6 m -57.73 -46.92 83.79 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.364 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -63.07 -34.08 76.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.87 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.7 tp -55.83 -38.66 70.32 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.3 mptp? -61.22 -42.52 98.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.757 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.57 -37.21 86.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.362 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -66.01 -37.01 84.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.149 -177.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 m -119.43 28.91 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.658 0.266 . . . . 0.0 111.213 -179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.2 p -64.95 -22.66 67.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -74.71 -15.5 60.78 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.921 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -71.09 152.25 43.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.016 0.436 . . . . 0.0 111.437 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -75.47 -29.22 59.53 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.12 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.407 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 35.7 m-85 -117.94 61.77 0.76 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.148 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 ptt-85 -64.65 -29.62 70.63 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.98 -44.03 70.25 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tp -74.74 -41.28 60.42 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.392 -0.923 . . . . 0.0 109.813 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.0 m -61.19 -47.99 83.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.616 0.246 . . . . 0.0 111.154 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.2 t -61.32 -45.49 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.397 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -63.4 -43.0 98.81 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.653 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.59 -36.28 83.3 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.682 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.7 p -67.31 -38.58 85.21 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.543 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -57.44 -43.43 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -60.05 -41.3 92.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.101 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.85 -43.07 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.56 -15.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.452 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.3 m -85.04 -46.95 10.69 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.128 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.9 tp -83.14 -35.88 25.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.259 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -115.47 68.4 0.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.039 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -57.03 -20.84 26.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.091 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -65.15 -22.02 66.86 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.685 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 tp -93.17 115.2 27.84 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -111.11 133.59 21.28 Favored Pre-proline 0 C--N 1.357 0.904 0 CA-C-N 119.713 1.142 . . . . 0.0 111.937 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.69 133.01 10.13 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.194 1.263 . . . . 0.0 112.028 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -126.93 134.27 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.4 tp -81.82 113.89 20.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -123.64 137.36 54.74 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 83.1 p -71.63 148.02 46.97 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -133.09 134.59 44.48 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.599 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.5 t -119.43 126.42 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.2 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.71 164.22 12.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.863 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -64.73 -19.4 65.76 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -85.83 3.55 41.08 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.186 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.53 -5.96 81.79 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.509 -0.637 . . . . 0.0 111.509 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.4 t -71.18 142.21 50.67 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.168 0.509 . . . . 0.0 109.951 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.0 m -124.96 145.94 49.62 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.643 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -158.98 140.37 13.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.145 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -83.37 106.43 15.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.213 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 70.2 mt -114.26 140.64 48.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.401 0.62 . . . . 0.0 110.927 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 57.7 ttp -84.41 148.83 26.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.321 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.478 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 4.5 t30 -124.74 161.34 26.61 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.991 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -119.15 112.78 19.94 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -138.58 139.94 38.82 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.45 -143.66 8.26 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.761 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.8 p -134.9 159.19 42.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -130.8 115.74 16.89 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.283 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.14 125.06 10.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 N-CA-C 109.405 -1.037 . . . . 0.0 109.405 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.0 t -126.97 121.86 23.05 Favored Pre-proline 0 C--O 1.24 0.605 0 C-N-CA 119.834 -0.746 . . . . 0.0 112.285 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.27 146.49 51.16 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.074 1.85 . . . . 0.0 110.287 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -162.74 107.9 1.15 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.102 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.77 37.92 25.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.551 -0.46 . . . . 0.0 112.205 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.17 -0.77 82.95 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -118.5 138.26 52.63 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.2 m -121.35 132.56 54.84 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.483 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -115.96 149.58 38.55 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.121 0.486 . . . . 0.0 111.261 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -94.88 100.47 12.34 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.67 115.35 62.66 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.237 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.64 127.87 4.45 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.753 2.302 . . . . 0.0 111.158 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.438 HD13 HG23 ' A' ' 72' ' ' ILE . 25.1 pt -135.27 148.7 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.411 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.1 m -116.62 124.23 49.27 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.354 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.53 112.25 24.04 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.204 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.478 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 70.1 m95 -96.03 130.25 43.08 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.224 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.25 134.64 41.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tp -94.16 143.82 26.04 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.87 -16.86 0.47 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.37 9.97 40.91 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.421 -0.512 . . . . 0.0 112.316 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -65.7 143.49 98.59 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -92.0 3.36 63.15 Favored 'Cis proline' 0 N--CA 1.517 2.865 0 CA-C-N 121.033 1.405 . . . . 0.0 115.256 1.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.407 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 17.2 m-85 -69.78 -21.02 63.45 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.465 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.37 118.92 53.48 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.52 135.99 33.25 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 CA-C-N 121.182 1.458 . . . . 0.0 111.423 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.51 140.86 17.29 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.817 1.678 . . . . 0.0 111.199 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.78 152.89 4.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.155 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 13.1 t -140.93 140.37 34.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.093 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -131.32 129.72 41.8 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.771 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.59 134.77 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.6 ' NZ ' H181 ' A' ' 201' ' ' 4N1 . 11.5 ttmt -100.17 101.2 13.68 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.647 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -90.15 127.57 1.47 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.874 1.716 . . . . 0.0 113.197 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.3 p -77.19 172.54 13.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.8 p -55.86 -28.64 57.46 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.9 m -95.64 -2.2 48.64 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.945 0.793 . . . . 0.0 111.579 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 52.9 tpp -93.25 134.35 35.53 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 85.1 m -108.16 133.22 52.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.79 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 2.5 tp -93.95 109.07 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.08 0.467 . . . . 0.0 109.816 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -92.85 100.13 12.66 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.673 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 74.0 p -66.91 148.44 51.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.985 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -172.96 -150.6 7.49 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.26 -20.44 64.79 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 47.3 m170 -115.35 -30.38 6.28 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 119.028 0.831 . . . . 0.0 113.008 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.1 t -100.78 138.36 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 CA-C-N 119.24 0.927 . . . . 0.0 110.58 177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -93.85 -169.72 2.16 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.421 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.59 -30.94 22.91 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -92.08 0.34 57.46 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.993 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.84 6.02 37.97 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.104 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -64.04 148.46 49.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.693 0.747 . . . . 0.0 110.181 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 84.1 mt -116.44 122.82 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 110.718 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.62 121.22 44.22 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.98 116.52 22.04 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.945 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -48.98 -36.88 35.93 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.581 1.521 . . . . 0.0 113.69 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -31.51 71.56 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.477 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 tt -69.46 -41.71 75.86 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.89 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -65.57 -28.47 69.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.017 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -109.84 3.77 21.02 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.679 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.403 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.1 t90 -64.84 125.03 23.54 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.038 0.923 . . . . 0.0 110.076 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -95.81 127.1 41.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.816 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -81.28 126.65 76.18 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 119.026 -0.512 . . . . 0.0 110.514 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -109.4 91.39 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.674 0 CA-C-N 120.677 1.277 . . . . 0.0 112.453 -2.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.3 -62.75 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 t -67.74 -37.26 81.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.699 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 51.4 175.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.061 0.934 . . . . 0.0 112.143 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.1 tt -62.94 -44.33 96.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.821 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.6 -38.71 64.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.64 -39.63 98.14 Favored Glycine 0 N--CA 1.482 1.704 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 178.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.4 tp -58.25 -40.65 82.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.435 -0.45 . . . . 0.0 111.829 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -74.34 -48.16 37.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.948 -176.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -68.77 -35.15 76.7 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 63.4 t -67.92 -40.07 82.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.5 ttm -58.39 -42.8 87.92 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.17 -41.12 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.475 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.26 -47.73 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.6 p -66.7 -14.45 17.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.501 -178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -106.91 -20.12 13.42 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.358 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.7 -35.2 91.64 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.16 -37.31 86.99 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.957 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -154.56 83.96 3.95 Favored Pre-proline 0 N--CA 1.451 -0.393 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.139 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -45.35 117.59 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.689 1.593 . . . . 0.0 110.939 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.71 -4.97 16.23 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.504 1.469 . . . . 0.0 111.4 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.7 m -120.46 157.38 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.708 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -150.96 140.67 21.74 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.247 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.5 m -84.05 112.35 20.13 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.833 0.349 . . . . 0.0 110.677 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -111.42 109.38 56.26 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.228 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 N--CA 1.494 1.556 0 C-N-CA 121.916 1.744 . . . . 0.0 112.376 -179.732 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.6 H181 ' NZ ' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t -79.16 130.93 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.659 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -94.54 156.54 16.4 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.445 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.8 mt-10 -63.3 -40.91 98.66 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.111 -1.035 . . . . 0.0 111.329 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -60.18 -47.21 86.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.237 1.018 . . . . 0.0 108.633 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -63.11 -30.64 71.75 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.38 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 tp -58.86 -41.05 86.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 10.8 mptt -60.5 -41.84 95.13 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.657 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.35 -37.09 82.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.354 0.597 . . . . 0.0 110.621 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.9 -36.28 77.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.566 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 m -113.61 20.91 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.61 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.7 t -68.85 -4.48 16.46 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.353 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.98 -11.19 17.56 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -67.65 160.12 28.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.883 0.373 . . . . 0.0 110.675 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -70.88 -39.43 72.84 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.705 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.16 74.15 1.02 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.813 -0.176 . . . . 0.0 110.965 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -72.12 -21.61 61.45 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -79.19 -47.63 15.66 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.754 -0.592 . . . . 0.0 111.864 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 tp -70.15 -40.6 74.68 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.478 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 83.2 m -60.93 -48.09 83.42 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.55 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.8 t -62.83 -45.49 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 120.666 0.269 . . . . 0.0 110.899 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -41.63 97.26 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.135 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -37.76 84.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.742 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.6 p -66.28 -33.73 76.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.437 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.2 t -59.65 -45.45 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.286 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -61.66 -38.76 88.94 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.913 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.71 -46.43 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -86.66 -21.21 7.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.475 -178.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 79.8 m -70.91 -40.87 71.9 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.069 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.09 -36.56 16.85 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.448 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -117.75 69.63 0.78 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -57.8 -19.68 30.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.703 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -65.47 -19.17 65.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.412 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 tp -90.15 116.6 28.28 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -112.32 132.72 21.99 Favored Pre-proline 0 C--N 1.358 0.97 0 CA-C-N 120.1 1.318 . . . . 0.0 111.775 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.04 135.63 11.2 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.588 1.525 . . . . 0.0 112.973 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.6 t -129.66 136.56 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.0 tp -82.74 125.19 30.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.95 158.89 24.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.033 0.444 . . . . 0.0 111.149 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m -97.01 125.17 41.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -110.42 133.29 53.42 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.592 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.8 t -119.6 125.36 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.292 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -97.05 171.1 8.69 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.622 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -60.56 -39.03 86.46 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.805 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -67.47 -8.94 37.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.862 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.03 -10.21 74.91 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.1 t -62.43 141.55 58.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.6 p -116.19 150.54 37.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.989 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -160.41 134.02 6.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.115 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.27 113.79 10.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.706 0.765 . . . . 0.0 110.347 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.0 tp -111.5 123.05 49.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -83.34 143.46 30.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.899 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.87 160.33 37.28 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.041 0.448 . . . . 0.0 111.738 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.0 mt -111.44 117.66 33.66 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -132.8 137.49 46.8 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.97 -146.19 10.79 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.375 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.9 p -134.41 159.16 41.93 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.88 116.6 18.09 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.229 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -67.11 123.32 10.77 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 N-CA-C 109.527 -0.99 . . . . 0.0 109.527 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.03 118.04 22.07 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.991 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.93 149.58 77.71 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.991 1.794 . . . . 0.0 111.315 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -162.8 111.98 1.36 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.935 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 45.85 45.03 11.51 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.3 -4.55 76.61 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.683 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -118.93 162.26 18.81 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.6 m -129.35 130.03 45.54 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.787 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -106.0 144.73 32.3 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.579 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.03 103.29 14.81 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.5 mp -91.18 117.35 67.81 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -85.1 124.46 2.9 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 123.023 2.482 . . . . 0.0 110.214 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 72' ' ' ILE . 27.9 pt -135.82 150.11 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 118.955 -1.098 . . . . 0.0 112.56 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.1 m -121.55 124.77 45.2 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.215 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 mp -103.13 107.58 18.44 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.436 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -96.06 125.63 40.73 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 67.8 mt -95.21 129.89 42.15 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.804 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 mt -73.72 149.99 41.49 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.47 -14.05 11.1 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.433 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.89 -8.74 36.33 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -53.92 145.83 30.91 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -91.4 12.11 55.99 Favored 'Cis proline' 0 N--CA 1.513 2.668 0 CA-C-N 120.682 1.279 . . . . 0.0 115.187 0.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -73.23 -12.97 61.05 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.724 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -121.23 129.53 25.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.068 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -49.38 138.18 30.6 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 CA-C-N 121.591 1.604 . . . . 0.0 111.844 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.48 144.05 15.7 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.056 1.837 . . . . 0.0 111.473 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mt -96.47 135.98 28.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 121.308 0.575 . . . . 0.0 110.118 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 48.9 t -111.99 149.29 32.2 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.611 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.85 126.53 30.69 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.623 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -84.95 123.5 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.422 ' HE3' H181 ' A' ' 201' ' ' 4N1 . 0.0 OUTLIER -67.81 108.48 2.71 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-O 119.05 -0.5 . . . . 0.0 109.901 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.77 155.89 7.47 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.619 1.546 . . . . 0.0 113.455 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 p -137.59 163.88 30.13 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.2 p -59.63 -26.77 65.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.863 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.7 p -90.74 -3.19 57.64 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.961 0.8 . . . . 0.0 111.244 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 41.4 ttm -124.11 142.05 51.53 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.23 159.16 35.17 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.836 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 85.8 mt -96.04 101.88 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -96.15 111.88 23.79 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.1 p -61.51 141.67 57.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.315 0.579 . . . . 0.0 111.392 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.37 -135.42 2.57 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.342 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -88.27 -3.33 58.87 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -138.4 -33.52 0.67 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.218 0.917 . . . . 0.0 112.446 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.62 138.59 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.375 0.989 . . . . 0.0 110.429 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -96.17 -161.51 0.87 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.375 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.91 -35.82 23.79 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.681 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -83.16 -1.79 53.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.546 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.07 8.51 47.53 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.504 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -62.51 137.49 58.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.365 0.583 . . . . 0.0 111.033 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.2 mt -114.63 113.22 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 102' ' ' HIS . 53.3 p90 -113.46 139.82 48.61 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 177.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mp -133.15 130.55 21.35 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.462 -176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -46.35 -39.91 22.0 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 121.664 1.576 . . . . 0.0 114.277 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -62.97 -31.3 72.39 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.863 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.08 -42.48 76.14 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.632 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.08 -28.49 66.56 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.026 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -95.46 -6.15 41.39 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.446 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -57.85 126.99 29.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.912 0.863 . . . . 0.0 110.656 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -104.63 102.96 12.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.98 -1.464 . . . . 0.0 108.435 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 60.5 t60 -60.88 123.91 77.26 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.038 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 5.8 Cg_endo -108.27 91.9 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 120.704 1.287 . . . . 0.0 113.211 -2.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -112.98 -60.59 1.86 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.423 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.0 t -67.48 -41.83 83.93 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.53 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 69.67 159.22 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.04 0.448 . . . . 0.0 111.634 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.99 -44.68 94.36 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 63.0 tp -53.8 -33.04 54.83 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -63.6 -40.67 98.9 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.2 tp -60.69 -39.68 89.37 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.93 -44.08 24.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.903 -177.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -68.68 -37.0 79.26 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 64.9 t -68.11 -42.93 85.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 C-N-CA 118.992 -1.083 . . . . 0.0 108.518 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.5 ttm -55.97 -44.89 78.96 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.81 -32.26 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.043 178.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 63.0 t -94.46 -48.98 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 119.556 -0.857 . . . . 0.0 113.118 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.4 p -80.33 -11.11 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -93.52 -13.22 28.06 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.427 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -95.23 -5.2 60.76 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -65.99 -36.05 82.25 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.214 0.507 . . . . 0.0 110.428 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -157.26 82.79 3.07 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -44.82 106.58 0.09 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.563 1.508 . . . . 0.0 111.365 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.03 -12.0 31.54 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.835 1.69 . . . . 0.0 111.282 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.15 146.94 32.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.869 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -160.05 160.41 33.15 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.521 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.2 m -89.5 121.52 31.79 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.897 0.379 . . . . 0.0 110.454 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -112.08 121.74 38.65 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.781 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo . . . . . 0 N--CA 1.497 1.684 0 C-N-CA 121.703 1.602 . . . . 0.0 112.158 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.422 H181 ' HE3' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.4 p -60.42 140.33 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.561 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -101.77 156.61 17.4 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.46 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 94.5 mt-10 -62.71 -41.38 99.12 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.235 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 t -60.17 -46.17 90.6 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.941 0.876 . . . . 0.0 109.327 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -65.78 -28.4 68.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.059 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.425 ' O ' HG21 ' A' ' 12' ' ' VAL . 59.3 tp -61.83 -39.61 92.42 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -65.42 -40.72 93.68 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.987 178.276 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.96 -37.15 81.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.47 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 19.8 ptp -76.14 -11.47 59.94 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.547 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 8' ' ' LEU . 10.2 m -142.35 31.71 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.459 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.5 p -72.01 -24.7 61.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.225 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.96 -13.51 55.86 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.792 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.0 151.49 26.21 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.972 0.415 . . . . 0.0 110.744 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -70.51 -37.49 74.15 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 21.3 m-85 -114.66 65.68 0.68 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.3 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -64.91 -34.11 77.61 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.57 -42.08 83.15 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.85 -38.79 61.89 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.825 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.1 m -61.68 -43.27 99.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.408 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.5 t -72.7 -46.14 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.176 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -42.09 97.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.345 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -69.1 -30.99 69.41 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.706 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.0 p -70.39 -39.36 74.56 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.969 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -56.29 -45.57 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -39.5 91.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.9 t -66.17 -43.59 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.8 -13.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.412 -178.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 p -82.99 -51.04 7.93 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.419 0.628 . . . . 0.0 109.786 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.2 tp -81.38 -37.67 27.82 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.466 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.92 68.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -58.63 -19.85 42.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.825 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.11 -21.12 66.76 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.244 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 tp -93.16 113.96 26.34 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -109.94 126.97 27.91 Favored Pre-proline 0 C--N 1.356 0.866 0 CA-C-N 119.385 0.993 . . . . 0.0 112.157 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.94 134.68 10.77 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.553 1.502 . . . . 0.0 112.88 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.4 t -124.07 135.33 63.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.6 tp -82.84 118.32 23.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.6 136.23 53.04 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.787 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.1 p -84.35 119.11 24.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -99.83 136.37 39.84 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.283 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.8 t -111.48 123.61 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.512 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -101.56 165.19 11.37 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.424 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -60.2 -36.88 78.65 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.631 0.253 . . . . 0.0 111.317 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.83 -18.47 62.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.482 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.96 -8.96 61.46 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.5 t -73.86 146.88 43.77 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.122 0.486 . . . . 0.0 110.31 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 98.1 p -104.85 155.99 18.42 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.539 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.06 135.96 13.71 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.537 0.684 . . . . 0.0 110.529 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -79.56 106.52 11.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.027 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tp -116.54 121.45 41.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -91.77 136.38 33.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.643 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -127.32 150.82 49.42 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.887 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.0 mt -99.73 123.05 43.6 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.443 ' CG2' H182 ' A' ' 201' ' ' 4N1 . 97.5 m -133.7 137.14 45.13 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.76 -149.37 13.73 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.738 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -133.98 159.77 39.74 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 pt -134.22 116.3 13.16 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.998 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.5 126.93 10.63 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 120.908 1.072 . . . . 0.0 110.394 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.63 118.56 15.75 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.369 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.62 149.7 90.23 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.282 1.988 . . . . 0.0 110.257 177.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -162.7 107.51 1.14 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.201 0.524 . . . . 0.0 111.686 -178.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 52.3 38.82 25.9 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.105 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.61 81.78 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -122.14 131.63 54.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.9 m -113.02 130.97 55.95 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.847 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -112.97 150.49 31.8 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.871 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -95.15 104.4 16.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.55 115.3 62.97 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -86.46 125.74 2.55 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.965 2.443 . . . . 0.0 110.958 177.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.437 HD12 HG22 ' A' ' 72' ' ' ILE . 31.9 pt -133.81 148.6 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.758 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 54.0 m -121.7 122.05 38.69 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.999 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.89 115.9 31.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.147 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -107.52 127.1 53.32 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.5 mt -94.56 135.69 35.72 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.207 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mt -79.76 151.23 30.49 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -61.49 -13.01 17.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.122 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.61 0.46 39.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.138 0.494 . . . . 0.0 111.397 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.425 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 56.6 t80 -55.93 146.24 49.52 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.425 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 6.9 Cg_endo -93.51 7.83 56.48 Favored 'Cis proline' 0 N--CA 1.509 2.388 0 CA-C-N 120.765 1.309 . . . . 0.0 114.042 1.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.445 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 7.2 m-85 -70.3 -18.77 63.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.75 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.93 137.77 19.89 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.31 140.95 66.4 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 CA-C-N 121.531 1.583 . . . . 0.0 111.196 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.21 142.86 12.32 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.236 1.958 . . . . 0.0 112.242 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.18 130.66 41.91 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.014 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.4 t -113.52 137.73 51.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.285 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -123.08 127.13 48.31 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.531 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.58 121.96 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -63.11 108.43 1.73 Allowed Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 119.161 -0.447 . . . . 0.0 110.021 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -84.23 160.7 13.27 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 121.627 1.551 . . . . 0.0 113.04 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.8 p -142.54 165.1 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.789 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.6 p -58.21 -35.22 71.33 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.153 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 t -88.3 -22.28 23.97 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.748 -0.595 . . . . 0.0 110.814 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 41.1 tpp -89.12 135.87 33.33 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.968 0.413 . . . . 0.0 110.192 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 84.0 m -125.61 141.22 52.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.594 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.6 mt -90.05 105.82 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -89.6 102.78 15.46 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.1 p -64.44 152.46 41.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.28 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.44 -137.43 2.28 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.154 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -65.3 -23.98 67.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -136.22 -16.85 1.61 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.8 t -100.32 132.09 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.508 1.049 . . . . 0.0 111.15 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -93.21 -160.99 0.8 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.56 -21.26 25.51 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -89.72 -9.49 49.22 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.924 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.96 12.23 30.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.683 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -66.4 139.09 57.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.387 0.593 . . . . 0.0 109.952 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.421 HD12 HG21 ' A' ' 109' ' ' ILE . 96.5 mt -113.57 118.61 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.48 0.488 . . . . 0.0 111.752 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -102.49 140.13 37.18 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 27.8 mt -138.35 120.22 10.53 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.779 -177.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.33 -38.95 27.28 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.357 1.371 . . . . 0.0 113.465 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -30.63 71.63 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.491 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.33 -41.17 73.57 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -69.44 -22.77 63.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.167 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -112.63 9.75 19.38 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.97 178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.0 t90 -76.93 123.45 26.31 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.944 0.878 . . . . 0.0 109.729 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -93.72 124.91 38.03 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.821 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -79.37 125.82 82.37 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.651 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -108.32 92.84 0.04 OUTLIER 'Cis proline' 0 N--CA 1.497 1.717 0 CA-C-N 120.774 1.312 . . . . 0.0 112.529 -2.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -114.32 -61.75 1.7 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.361 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.3 t -68.51 -31.96 71.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.905 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 48.49 -178.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.811 0.815 . . . . 0.0 111.806 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.8 tt -68.36 -40.28 81.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.747 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.28 -40.99 68.37 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.39 -39.46 97.79 Favored Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.6 tp -58.69 -41.38 86.11 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -72.85 -48.88 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 119.884 -0.727 . . . . 0.0 112.063 -176.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -66.41 -35.59 80.68 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.47 -38.19 78.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.735 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 60.8 tpp -58.8 -42.49 89.22 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -34.81 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.912 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.8 t -90.83 -45.12 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 6.2 p -66.05 -15.63 19.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.88 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -104.41 -19.23 14.12 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.196 177.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.72 -36.99 93.03 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.5 -40.54 95.85 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.133 -0.533 . . . . 0.0 110.9 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -153.45 84.62 4.27 Favored Pre-proline 0 CA--C 1.52 -0.199 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -48.3 120.35 4.94 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.983 1.122 . . . . 0.0 110.138 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.93 -21.29 28.24 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.493 1.462 . . . . 0.0 111.887 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.33 140.88 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.154 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -158.89 165.49 34.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.395 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.13 112.09 12.22 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 120.831 0.348 . . . . 0.0 110.821 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -111.96 115.3 50.8 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.639 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo . . . . . 0 N--CA 1.497 1.708 0 C-N-CA 121.679 1.586 . . . . 0.0 112.072 179.745 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.443 H182 ' CG2' ' A' ' 56' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t -105.29 130.04 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.481 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.78 155.07 17.9 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.453 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 92.2 mt-10 -61.38 -43.19 99.29 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.254 -0.979 . . . . 0.0 112.017 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 t -58.47 -46.16 87.18 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.935 0.874 . . . . 0.0 108.984 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -62.9 -36.54 83.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.357 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 41.8 tp -55.73 -43.45 76.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.0 mptp? -61.3 -42.88 99.39 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.309 0.576 . . . . 0.0 109.528 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -61.1 -36.52 79.92 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.332 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -70.88 -37.72 73.03 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.723 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.3 m -112.12 24.37 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.736 0.303 . . . . 0.0 110.879 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.2 t -62.39 -37.87 87.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.022 0.439 . . . . 0.0 110.963 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -60.12 -21.91 62.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.601 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -63.88 157.57 24.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.112 0.482 . . . . 0.0 111.662 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.88 -37.9 54.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.621 177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 14.8 m-85 -113.94 64.61 0.66 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.356 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -61.79 -25.64 67.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -76.59 -51.97 10.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.04 -39.94 90.57 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.307 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.9 m -60.55 -47.56 85.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.166 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.6 t -66.24 -45.1 90.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.54 -41.92 98.06 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.485 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -67.51 -35.3 78.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.2 p -67.65 -37.6 82.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.63 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -57.29 -45.61 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -37.63 80.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.5 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.7 t -68.89 -46.55 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.11 -13.76 12.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.169 -178.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 p -76.36 -50.96 12.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.045 0.45 . . . . 0.0 109.864 177.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 48.9 tp -82.37 -37.57 25.43 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.34 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -112.08 66.67 0.64 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm -55.59 -17.21 5.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.465 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -69.07 -15.19 63.39 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.176 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 tp -94.4 113.22 25.06 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -110.11 124.29 33.83 Favored Pre-proline 0 C--N 1.356 0.89 0 CA-C-N 119.474 1.034 . . . . 0.0 111.978 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.53 136.37 9.73 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 121.697 1.598 . . . . 0.0 113.202 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.04 156.34 42.68 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 110.397 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.7 tp -92.28 118.69 31.14 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -124.43 132.81 53.51 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.321 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.478 ' HG ' H103 ' A' ' 201' ' ' 4N1 . 79.8 p -76.86 137.38 39.14 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.81 136.34 54.05 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.962 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.6 t -114.85 127.01 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.048 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -105.99 168.44 9.13 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.852 0.358 . . . . 0.0 111.264 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -60.47 -37.29 80.55 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.937 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -63.34 -11.88 25.79 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.753 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.93 -13.06 67.87 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.6 t -74.45 145.87 43.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.5 p -128.52 153.65 46.96 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.904 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -152.58 137.95 17.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.542 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.83 118.81 19.03 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.303 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 mt -121.48 140.7 51.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.557 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -96.92 137.71 35.59 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.322 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -130.49 151.2 51.23 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.457 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.4 mt -95.09 126.7 40.6 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.58 HG22 H181 ' A' ' 201' ' ' 4N1 . 96.9 m -137.69 136.38 37.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.74 -147.11 11.55 Favored Glycine 0 N--CA 1.466 0.65 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.655 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.1 p -132.49 158.09 42.96 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -129.9 117.03 18.14 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.092 177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -72.23 123.49 9.24 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 119.947 1.017 . . . . 0.0 110.099 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.0 t -123.67 113.12 28.91 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.631 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.84 147.53 89.53 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.228 1.952 . . . . 0.0 109.695 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -163.57 107.4 1.01 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.63 -178.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.51 43.35 27.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.068 0.461 . . . . 0.0 111.557 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.01 14.76 76.2 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -134.69 125.6 27.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.2 m -113.26 131.18 56.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.997 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -112.59 149.23 33.06 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.466 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.79 100.08 11.83 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.6 117.69 68.85 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.314 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.81 123.81 2.9 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.453 2.102 . . . . 0.0 110.415 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.405 HD12 HG23 ' A' ' 72' ' ' ILE . 21.3 pt -131.6 147.12 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.349 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 67.4 m -121.08 123.12 41.57 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.205 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.33 109.62 21.31 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.144 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -99.49 125.35 45.22 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.01 140.85 29.04 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.257 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -84.18 155.11 22.7 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -62.53 -17.19 59.27 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.908 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.25 3.51 40.95 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.986 0.422 . . . . 0.0 111.718 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -59.16 145.37 81.03 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -91.59 8.64 62.81 Favored 'Cis proline' 0 N--CA 1.519 2.99 0 CA-C-N 121.019 1.4 . . . . 0.0 115.246 1.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.414 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 22.6 m-85 -74.46 -13.02 60.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.436 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.2 129.56 24.45 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.564 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -49.67 134.34 33.65 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 CA-C-N 121.205 1.466 . . . . 0.0 112.169 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.15 146.16 17.73 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.037 1.825 . . . . 0.0 111.886 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.49 151.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.79 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 50.1 t -134.78 142.07 46.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.665 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -127.09 131.21 50.91 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.086 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.404 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 57.6 t -97.44 123.62 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -76.37 106.26 3.09 Favored Pre-proline 0 N--CA 1.476 0.87 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.56 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 48.5 Cg_endo -90.61 128.66 1.42 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 CA-C-N 121.146 1.445 . . . . 0.0 113.548 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.5 p -81.15 168.95 17.99 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 88.1 p -59.27 -22.53 61.31 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 t -106.55 22.17 16.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.871 0.76 . . . . 0.0 110.946 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 42.5 ttm -133.52 144.73 49.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -131.22 163.71 27.16 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.864 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.7 mm -89.35 103.37 13.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.484 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -89.0 110.09 20.83 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.5 p -68.19 138.28 55.49 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.341 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.36 -141.82 3.54 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.249 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -70.84 -23.93 62.43 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.418 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 38.4 p-80 -130.4 -16.79 3.43 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.2 t -91.72 137.27 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.855 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -93.71 175.78 6.61 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.56 -39.07 93.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -91.15 4.78 51.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.11 10.27 49.28 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.99 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -67.82 140.96 56.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 62.7 mt -118.35 116.44 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CE2' ' HA ' ' A' ' 102' ' ' HIS . 0.5 OUTLIER -116.88 142.94 46.28 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 mp -133.7 131.41 21.18 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.79 -177.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.1 -32.62 40.2 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 121.154 1.236 . . . . 0.0 113.693 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -65.76 -30.44 71.09 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.509 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.92 -41.45 74.63 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.229 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -67.94 -28.03 67.12 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.227 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -102.35 0.56 34.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.338 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.412 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.7 t90 -69.37 124.16 23.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.959 0.885 . . . . 0.0 109.985 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -95.34 125.0 39.67 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.158 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -76.7 125.64 86.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.409 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -108.85 92.03 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.65 0 CA-C-N 120.937 1.37 . . . . 0.0 112.36 -2.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -114.12 -61.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.936 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.1 t -66.64 -40.75 88.84 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.794 0.331 . . . . 0.0 111.277 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 59.07 168.15 0.06 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.787 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 6.7 tt -60.04 -42.1 93.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.69 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.0 tt -52.63 -37.64 58.76 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.36 -39.31 97.08 Favored Glycine 0 N--CA 1.477 1.37 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.7 tp -60.51 -40.25 90.73 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -75.57 -48.85 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.644 -176.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -67.01 -35.48 80.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.0 t -69.12 -39.7 79.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 51.7 ttm -57.85 -44.73 86.75 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -61.0 -36.42 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.792 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -88.77 -47.27 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 5.4 p -66.75 -13.79 16.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.197 -178.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.418 ' CE2' ' CD2' ' A' ' 102' ' ' HIS . 9.8 m-30 -101.83 -17.08 16.37 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.441 177.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.22 -26.74 71.74 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.96 -31.76 72.85 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.199 -0.501 . . . . 0.0 110.547 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -166.58 84.43 0.91 Allowed Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.257 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -46.6 121.83 5.2 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.225 1.283 . . . . 0.0 109.844 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.13 -14.93 35.51 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.458 1.439 . . . . 0.0 112.427 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 m -131.42 151.2 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.245 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -154.36 160.56 41.76 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.1 112.42 19.14 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.911 0.386 . . . . 0.0 111.184 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -112.35 108.69 54.49 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.863 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo . . . . . 0 N--CA 1.498 1.77 0 C-N-CA 122.036 1.824 . . . . 0.0 112.647 -179.854 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.58 H181 HG22 ' A' ' 56' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.22 129.9 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.581 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.34 155.13 17.03 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.419 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 92.3 mt-10 -62.16 -41.08 97.95 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -57.1 -48.45 78.58 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.054 0.93 . . . . 0.0 109.398 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -64.05 -30.8 71.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.518 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.3 tp -59.14 -39.07 81.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.764 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 12.0 mptt -59.56 -42.79 93.25 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.669 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.71 -25.48 64.79 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.996 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.92 -28.92 35.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.893 -178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.6 23.83 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 120.903 0.382 . . . . 0.0 110.489 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 t -67.06 -39.04 86.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.153 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -62.03 -17.72 58.25 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.823 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -69.6 158.87 34.47 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.478 -179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -88.86 -9.86 50.11 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.91 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -132.88 56.12 1.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 119.532 -0.271 . . . . 0.0 110.302 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -61.11 -32.43 72.11 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.33 -50.86 64.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.92 -41.96 73.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.099 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.2 m -61.51 -47.08 87.26 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 121.161 -0.216 . . . . 0.0 111.238 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 37.4 t -61.04 -46.51 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -60.32 -45.1 94.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.805 0.812 . . . . 0.0 110.586 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -68.23 -34.43 76.22 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.506 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.6 p -67.81 -33.66 75.23 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.408 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.57 -44.96 94.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 C-N-CA 118.951 -1.1 . . . . 0.0 108.167 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -60.87 -37.32 81.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.011 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.2 t -68.83 -45.63 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.88 -17.25 8.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.702 -178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -76.8 -49.87 14.83 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.183 0.516 . . . . 0.0 109.709 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.9 tp -76.61 -39.91 51.03 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.643 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -113.85 67.77 0.68 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -53.75 -20.34 5.45 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.522 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -65.69 -21.33 66.53 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.57 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.1 tp -89.64 117.59 28.63 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -115.05 126.52 27.75 Favored Pre-proline 0 C--N 1.356 0.879 0 CA-C-N 119.618 1.099 . . . . 0.0 111.916 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.51 135.1 14.41 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 CA-C-N 120.379 1.171 . . . . 0.0 112.232 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.17 136.64 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 16.9 tp -85.15 116.32 23.45 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -119.48 133.69 55.57 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.107 0.479 . . . . 0.0 111.76 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.2 m -68.24 138.74 55.8 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -122.0 135.72 54.86 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.532 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.5 t -114.26 127.77 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.724 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -105.17 165.71 10.91 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.338 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.0 p-10 -65.64 -15.45 62.78 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -80.07 -10.38 59.76 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.798 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.42 -8.85 78.96 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.8 m -80.92 157.97 25.41 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.8 p -119.38 151.53 38.34 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.524 0.678 . . . . 0.0 111.448 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 -152.97 131.69 12.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.089 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.58 118.7 19.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.029 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 19.6 tp -116.99 121.03 40.21 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.2 ttp -84.62 142.91 29.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.025 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -133.51 162.15 32.67 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.384 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -108.5 123.39 48.82 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.556 HG22 H183 ' A' ' 201' ' ' 4N1 . 31.9 m -140.6 139.07 34.85 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.0 -148.59 14.93 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.187 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.6 p -132.67 161.02 35.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.822 -0.689 . . . . 0.0 112.334 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 pt -131.05 116.03 16.69 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.995 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.17 126.23 9.73 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 CA-C-N 119.689 0.925 . . . . 0.0 109.945 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.0 129.84 21.94 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.795 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.94 150.03 48.23 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.388 2.059 . . . . 0.0 110.876 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -163.97 112.04 1.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.971 0.415 . . . . 0.0 111.955 -178.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? 49.88 44.52 25.24 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.448 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.81 18.38 68.36 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -137.6 127.11 25.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.5 m -111.44 130.78 55.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.455 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -112.67 150.81 30.95 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.734 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -94.61 105.04 16.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -90.67 116.57 66.71 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.47 124.62 3.68 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.196 1.93 . . . . 0.0 110.849 177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.7 pt -132.32 148.0 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.958 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.0 t -125.76 120.19 29.94 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.37 116.94 33.37 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.56 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -105.48 118.36 36.38 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.0 mt -88.11 135.9 33.22 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.611 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.2 150.42 24.82 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -59.64 -15.32 18.24 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.315 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 p -100.75 7.77 43.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.541 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -66.46 144.05 98.49 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -92.08 3.88 63.09 Favored 'Cis proline' 0 N--CA 1.518 2.962 0 N-CA-C 116.13 1.55 . . . . 0.0 116.13 1.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -73.77 -17.12 61.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.467 1.031 . . . . 0.0 109.922 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.52 131.16 21.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.51 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -59.54 131.02 38.13 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 CA-C-N 121.319 1.507 . . . . 0.0 112.28 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.15 145.23 12.17 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.371 2.047 . . . . 0.0 111.545 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.9 129.89 48.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.0 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 42.7 t -110.82 144.08 40.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.627 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -126.53 127.4 45.25 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.438 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.494 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 71.7 t -82.44 137.36 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -93.87 96.12 1.55 Allowed Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.135 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 97.7 Cg_endo -78.9 160.98 27.25 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 C-N-CA 121.711 1.607 . . . . 0.0 112.794 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.5 t -148.37 167.22 25.81 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.661 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.9 p -58.46 -27.59 64.52 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 62.6 m -94.06 6.54 48.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.974 0.806 . . . . 0.0 110.972 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 82.8 mmm -130.99 144.1 51.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.3 m -121.44 145.04 48.33 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.568 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.2 tt -113.25 122.22 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.32 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.65 98.22 6.91 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.1 p -55.23 140.72 37.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.695 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.11 -142.2 3.33 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.431 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -65.46 -25.49 67.53 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -119.03 -30.29 5.04 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 119.322 0.965 . . . . 0.0 113.207 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.4 t -96.4 134.21 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.313 0.961 . . . . 0.0 110.925 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -98.68 160.47 14.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.287 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.12 85.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.053 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.31 -7.14 34.47 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.119 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.85 8.01 58.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.747 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.61 151.53 34.32 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.153 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.2 mt -109.18 122.03 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.481 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -99.64 130.96 45.91 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.1 mt -134.33 108.37 11.27 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.89 -177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -48.52 -34.26 25.73 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.971 1.781 . . . . 0.0 114.475 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -62.29 -29.24 70.29 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.337 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.58 -41.09 80.16 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.422 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -65.81 -31.67 72.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.459 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -96.65 -8.4 31.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.336 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -54.1 124.83 16.82 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.898 0.856 . . . . 0.0 109.967 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -107.69 106.26 16.51 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.739 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -58.23 123.55 66.09 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.721 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -109.63 91.74 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.549 0 CA-C-N 120.707 1.288 . . . . 0.0 112.496 -3.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.88 -62.66 1.56 Allowed 'General case' 0 C--O 1.232 0.149 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.4 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.8 m -67.8 -41.04 83.75 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.136 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 60.62 163.5 0.06 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.527 0.679 . . . . 0.0 111.53 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.8 tt -60.24 -45.91 91.6 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.246 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 13.6 tp -54.68 -33.65 61.16 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -64.41 -40.54 97.86 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 tp -58.01 -40.0 79.71 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -75.73 -47.16 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.745 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -66.73 -35.74 80.82 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.19 -38.38 80.95 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.1 tpp -58.66 -44.06 90.02 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -62.8 -35.05 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.744 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -86.3 -47.27 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.774 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.58 -13.68 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.221 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -103.58 -16.34 15.55 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.646 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -84.58 -23.76 49.17 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -66.44 -29.22 69.3 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.349 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -161.55 84.25 1.76 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.704 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -45.38 108.16 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.324 1.349 . . . . 0.0 110.925 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.11 -17.87 35.73 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.652 1.568 . . . . 0.0 110.982 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.28 138.41 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.458 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -160.35 160.59 32.56 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.577 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.6 m -93.11 129.5 39.06 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.961 0.41 . . . . 0.0 110.436 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 45.9 ttm-85 -112.97 103.46 55.67 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.06 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 N--CA 1.489 1.226 0 C-N-CA 121.875 1.717 . . . . 0.0 111.924 179.623 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.556 H183 HG22 ' A' ' 56' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.1 t -105.29 128.57 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.203 0.525 . . . . 0.0 110.617 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 t -98.28 153.98 18.13 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.505 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 37.2 mp0 -60.13 -42.6 95.16 Favored 'General case' 0 C--O 1.214 -0.795 0 C-N-CA 118.43 -1.308 . . . . 0.0 110.947 -178.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.8 m -53.38 -45.94 69.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.825 0.822 . . . . 0.0 109.651 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -63.5 -38.06 89.67 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.601 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.4 tp -55.08 -42.07 72.34 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.505 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -59.67 -40.1 86.68 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.94 -32.43 70.7 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.05 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -73.55 -31.72 63.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.456 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.36 20.76 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.687 0.28 . . . . 0.0 111.333 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -61.31 -37.94 85.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.365 0.602 . . . . 0.0 110.298 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -60.22 -21.15 61.46 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.612 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -74.49 151.87 39.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.915 0.388 . . . . 0.0 111.889 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -70.93 -37.15 72.88 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.985 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.401 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 39.1 m-85 -109.14 60.84 0.6 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 121.25 -0.18 . . . . 0.0 111.448 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -67.37 -24.74 65.73 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -75.12 -50.0 17.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.93 -40.14 83.38 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.647 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.5 m -61.2 -46.73 89.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.247 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 41.5 t -61.85 -44.4 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-O 120.821 0.343 . . . . 0.0 110.155 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -62.93 -41.6 99.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.209 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -66.42 -37.73 85.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.676 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 38.7 p -66.19 -37.13 84.86 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.299 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.18 -45.08 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 C-N-CA 118.849 -1.14 . . . . 0.0 108.506 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -61.28 -37.83 84.57 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.251 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.9 t -71.27 -43.41 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.05 -23.1 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.386 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.1 m -72.19 -44.5 62.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.046 0.451 . . . . 0.0 110.264 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.9 tp -88.73 -40.68 13.06 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.417 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.55 67.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -56.83 -17.19 8.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.029 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -66.08 -14.6 62.02 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.59 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 tp -102.42 113.03 26.02 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -110.07 137.12 20.45 Favored Pre-proline 0 C--N 1.36 1.024 0 CA-C-N 119.921 1.237 . . . . 0.0 112.182 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.13 139.92 10.89 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.004 1.803 . . . . 0.0 112.423 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.53 139.22 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.072 0.463 . . . . 0.0 109.794 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.2 tp -83.74 122.41 28.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.175 -178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -129.7 140.61 51.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.981 0.42 . . . . 0.0 112.073 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.502 ' O ' H103 ' A' ' 201' ' ' 4N1 . 41.7 t -94.05 115.29 27.6 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -128.13 156.8 42.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.71 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.7 t -100.37 124.44 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -72.67 166.72 22.25 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.778 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -60.89 -36.07 78.27 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.652 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.09 -18.22 63.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.224 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.97 -17.9 44.06 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.8 t -72.36 148.28 45.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 96.9 p -114.44 152.18 32.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.315 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -158.16 137.91 12.1 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.294 0.569 . . . . 0.0 111.389 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -67.62 118.51 10.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.395 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -125.53 142.53 51.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.955 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 49.8 ttp -90.93 144.57 25.54 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.11 152.76 51.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.551 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.8 mt -104.41 117.89 35.29 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.566 HG22 H182 ' A' ' 201' ' ' 4N1 . 88.5 m -132.32 136.79 47.13 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.26 -143.95 8.34 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.424 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 p -136.34 159.31 42.16 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.27 116.03 16.43 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.031 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -72.32 125.85 11.13 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 120.867 1.044 . . . . 0.0 110.793 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.5 t -128.77 115.91 19.3 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.578 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.31 150.63 15.4 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 122.718 2.279 . . . . 0.0 112.224 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.02 115.05 1.32 Allowed 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.258 0.551 . . . . 0.0 111.229 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.95 39.44 22.84 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.862 -0.523 . . . . 0.0 112.119 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 0.79 90.05 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.139 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.412 ' ND2' ' CZ ' ' A' ' 68' ' ' TYR . 1.7 t30 -119.89 128.78 53.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 109.896 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.2 m -119.26 132.04 55.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.502 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.412 ' CZ ' ' ND2' ' A' ' 66' ' ' ASN . 67.5 m-85 -115.75 150.88 36.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.916 0.388 . . . . 0.0 110.574 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.6 100.94 12.61 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.37 116.98 67.92 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.464 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -82.29 126.27 4.82 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 122.718 2.279 . . . . 0.0 110.687 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.405 HD13 HG23 ' A' ' 72' ' ' ILE . 26.4 pt -133.35 147.96 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 118.943 -1.103 . . . . 0.0 112.502 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.6 m -121.89 123.42 41.69 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.365 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.07 109.92 21.89 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.42 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -96.08 128.98 43.46 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 mp -99.42 140.08 34.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.13 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tp -95.14 140.56 29.9 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.71 -17.1 0.09 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.17 12.43 37.01 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -69.08 143.41 94.21 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -91.68 4.51 64.91 Favored 'Cis proline' 0 N--CA 1.516 2.806 0 CA-C-N 120.928 1.367 . . . . 0.0 114.501 0.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.4 m-85 -67.73 -18.93 65.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.378 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.08 120.98 40.6 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.201 178.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -49.55 136.41 33.37 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 CA-C-N 121.235 1.477 . . . . 0.0 111.859 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.62 144.7 14.2 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.337 2.025 . . . . 0.0 111.277 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 mp -97.76 132.77 41.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-O 121.591 0.71 . . . . 0.0 109.789 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 33.8 t -106.41 154.86 20.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.529 -177.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.1 128.76 30.75 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.053 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.05 124.13 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.581 ' HE2' H181 ' A' ' 201' ' ' 4N1 . 7.0 mtmt -75.28 108.12 5.12 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.187 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -85.64 159.24 10.68 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.267 1.311 . . . . 0.0 112.454 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -129.24 164.86 22.55 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 m -58.6 -39.84 81.56 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.2 m -84.74 -0.68 54.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.85 0.75 . . . . 0.0 111.581 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 32.8 ttm -120.92 145.92 47.18 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -131.39 163.07 28.7 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.588 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.4 mt -95.8 103.59 14.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -87.32 113.52 23.12 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.149 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.5 p -68.52 147.74 51.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.256 0.55 . . . . 0.0 110.479 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.87 -145.16 4.28 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -79.47 -7.53 58.5 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -133.11 -30.46 1.34 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.14 0.882 . . . . 0.0 112.297 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.2 t -97.03 139.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.48 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -94.83 -174.61 3.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.661 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.32 -35.03 21.72 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -83.86 5.46 25.14 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.957 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.13 13.12 50.32 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.346 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -75.52 136.26 40.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.779 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 91.7 mt -110.8 114.98 48.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 140.86 49.2 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 mp -134.43 128.63 19.29 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.01 -176.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -49.02 -35.16 31.49 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 121.388 1.392 . . . . 0.0 113.384 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -32.42 71.92 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.23 -41.93 76.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.273 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -63.68 -31.06 72.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.016 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -108.42 9.95 27.53 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.769 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -65.57 127.25 31.13 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.688 0.756 . . . . 0.0 110.439 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.39 122.17 43.75 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.453 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -75.82 125.93 87.71 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.626 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -109.85 91.27 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.718 0 CA-C-N 120.597 1.249 . . . . 0.0 112.626 -2.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -113.19 -59.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.538 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 27.2 p -68.85 -34.74 75.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.138 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 p30 49.21 178.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.603 0.716 . . . . 0.0 111.613 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.5 tt -66.0 -40.59 91.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.379 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.9 tt -56.77 -40.36 75.73 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.86 -39.87 97.48 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.0 tp -58.69 -40.77 84.59 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 122.265 -0.55 . . . . 0.0 111.556 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -76.61 -48.89 25.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.096 -0.642 . . . . 0.0 112.314 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -66.71 -34.0 76.87 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.6 -38.33 78.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 48.7 tpp -58.9 -44.1 91.14 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -61.64 -40.84 88.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.888 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -82.46 -47.86 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 120.002 -0.679 . . . . 0.0 112.543 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.2 p -66.75 -14.06 17.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.072 -178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -109.22 -18.43 13.61 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.91 88.52 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -63.66 -34.91 78.9 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-N 115.294 -0.453 . . . . 0.0 110.489 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -156.63 84.08 3.16 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.327 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -43.96 107.42 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.679 1.586 . . . . 0.0 111.018 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.03 -24.23 47.77 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.105 1.87 . . . . 0.0 111.578 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.6 m -128.33 147.33 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.565 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -160.47 158.63 29.67 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.542 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.08 107.94 5.7 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -111.04 109.99 56.9 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.885 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo . . . . . 0 N--CA 1.496 1.629 0 C-N-CA 122.08 1.853 . . . . 0.0 112.317 -179.859 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.581 H181 ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -103.26 129.5 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.15 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.82 153.56 18.79 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.496 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 95.3 mt-10 -61.72 -42.17 98.59 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.099 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.0 t -56.78 -46.49 81.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.19 0.995 . . . . 0.0 108.649 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -61.18 -39.07 88.8 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.144 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.6 tp -56.12 -42.19 76.47 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.6 mptp? -60.14 -40.65 90.57 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -28.19 67.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.69 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.39 -30.51 37.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.99 -178.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.61 19.71 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.577 0.227 . . . . 0.0 111.387 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -61.05 -38.1 84.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.53 0.681 . . . . 0.0 110.306 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -60.2 -26.06 66.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.122 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.408 ' HE2' ' O ' ' A' ' 77' ' ' LEU . 40.3 m-85 -67.36 159.4 29.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.716 0.293 . . . . 0.0 110.941 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -80.33 -29.92 38.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.811 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -116.89 58.04 0.78 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -63.59 -28.51 69.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.3 -47.41 61.26 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.1 tp -70.27 -40.25 74.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.501 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.8 m -62.94 -46.14 89.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 14.4 t -63.28 -45.6 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 120.695 0.283 . . . . 0.0 110.991 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -63.14 -43.52 98.11 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.154 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -66.68 -37.43 84.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.995 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.1 p -64.76 -36.94 85.94 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.976 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -57.32 -45.03 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -60.98 -40.41 93.34 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.998 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -68.0 -43.6 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.38 -23.77 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.217 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.5 m -74.48 -44.54 51.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.009 0.433 . . . . 0.0 110.595 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -85.32 -36.61 20.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.666 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.86 68.38 0.72 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -57.01 -19.39 18.12 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.539 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.81 -21.55 66.8 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.067 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.9 tp -90.24 113.32 25.11 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -108.98 125.12 32.3 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 119.439 1.018 . . . . 0.0 111.77 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.09 137.58 17.38 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.32 1.347 . . . . 0.0 112.102 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.18 143.99 37.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 120.968 0.414 . . . . 0.0 110.264 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.5 tp -91.63 122.01 33.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.533 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -131.47 139.5 49.36 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.088 0.47 . . . . 0.0 111.965 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 t -68.82 136.22 52.37 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -121.06 138.16 54.31 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.163 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.8 t -111.12 126.1 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.221 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -95.38 161.48 14.06 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.625 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -68.24 -13.24 62.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -88.42 -4.39 58.65 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.22 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.32 -13.01 68.26 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.2 t -72.39 142.68 48.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.0 t -116.73 141.31 48.37 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.214 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -148.19 137.73 22.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.641 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -79.83 120.1 23.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.558 0.694 . . . . 0.0 110.623 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.8 mt -116.18 142.51 46.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.907 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -101.37 137.12 40.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.097 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -129.34 151.08 50.38 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.744 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.8 mt -95.16 122.34 37.73 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.58 HG21 H182 ' A' ' 201' ' ' 4N1 . 96.2 m -133.65 136.02 44.52 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.81 -144.54 9.16 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.859 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -135.18 160.47 38.26 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -129.32 116.14 18.62 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.924 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -73.55 124.24 9.2 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 120.661 0.907 . . . . 0.0 109.887 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.4 t -123.76 117.72 27.36 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.03 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.5 146.77 50.58 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.334 2.022 . . . . 0.0 110.753 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.404 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -162.88 108.97 1.17 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.514 -178.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.01 35.12 21.3 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 122.022 -0.424 . . . . 0.0 111.411 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.65 -2.74 77.69 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -113.57 135.1 54.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.6 m -120.28 132.27 55.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.034 0.445 . . . . 0.0 111.993 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -111.02 147.53 34.56 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.807 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -95.26 100.53 12.31 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 mp -86.92 115.42 62.46 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.034 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.38 123.37 3.87 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.874 2.383 . . . . 0.0 111.058 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 72' ' ' ILE . 35.2 pt -136.49 149.12 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.935 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 53.7 m -123.92 122.42 37.91 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.568 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.64 121.6 39.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.025 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -111.23 119.43 38.89 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.12 139.97 32.09 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.034 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.408 ' O ' ' HE2' ' A' ' 15' ' ' TYR . 2.8 mt -89.28 149.38 23.09 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -56.69 -16.58 6.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.619 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.0 5.41 43.1 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.156 0.503 . . . . 0.0 111.788 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -63.77 144.08 97.99 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -90.19 5.32 68.53 Favored 'Cis proline' 0 N--CA 1.514 2.693 0 CA-C-N 121.004 1.394 . . . . 0.0 115.227 1.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -70.07 -25.02 63.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.865 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.3 138.2 19.47 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.37 141.67 75.66 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 CA-C-N 121.767 1.667 . . . . 0.0 111.304 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -82.52 142.87 11.91 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.016 1.81 . . . . 0.0 111.878 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.55 135.34 28.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 42.2 t -112.09 139.93 47.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.839 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.1 124.98 44.31 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.943 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -84.41 144.48 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.546 ' HZ2' H213 ' A' ' 201' ' ' 4N1 . 6.2 mttt -98.29 98.21 5.48 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 119.221 -0.418 . . . . 0.0 110.318 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -80.79 160.18 21.5 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.256 1.304 . . . . 0.0 111.921 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 t -137.34 161.68 35.62 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.2 t -54.64 -39.37 67.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.177 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.6 t -76.64 -2.25 31.74 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.536 0.607 . . . . 0.0 111.956 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.3 mtp -130.13 145.47 51.7 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.73 163.35 23.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.596 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 3.3 mm -90.77 110.04 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.567 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -95.09 104.75 16.63 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 34.3 p -67.73 138.17 56.04 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.684 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.76 -133.64 1.93 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -86.09 -7.26 58.72 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -134.84 -23.09 1.59 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.62 134.59 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 119.6 1.091 . . . . 0.0 110.635 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -84.72 -168.29 2.14 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.59 -34.54 19.85 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.683 -0.636 . . . . 0.0 112.399 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -88.81 1.26 55.57 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.736 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.01 -8.43 38.89 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.465 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 131.67 23.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.243 0.522 . . . . 0.0 110.172 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.5 mt -97.67 121.5 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.928 0.395 . . . . 0.0 110.535 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.87 119.43 38.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.1 mt -126.57 113.42 22.91 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.59 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -48.42 -38.27 34.54 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 121.962 1.775 . . . . 0.0 114.25 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -63.82 -31.51 72.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.22 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.29 -42.23 79.78 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.793 0.33 . . . . 0.0 110.927 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -67.1 -29.26 68.96 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.687 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -104.36 7.15 35.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.229 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -71.6 127.25 31.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 122.033 0.92 . . . . 0.0 110.651 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -97.41 124.72 41.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.824 -1.534 . . . . 0.0 108.217 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -80.25 126.64 78.7 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 119.133 -0.46 . . . . 0.0 110.539 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -108.8 93.36 0.03 OUTLIER 'Cis proline' 0 N--CA 1.498 1.755 0 CA-C-N 120.631 1.261 . . . . 0.0 112.778 -2.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -113.69 -60.7 1.85 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.722 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.2 p -69.99 -31.8 69.67 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.0 p30 48.46 179.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.73 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 tt -66.88 -43.31 83.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.983 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.9 -40.69 63.73 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.1 -39.67 97.93 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.0 -41.38 87.53 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -75.41 -46.88 36.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 119.796 -0.761 . . . . 0.0 111.766 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -36.59 75.73 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.219 -0.992 . . . . 0.0 108.626 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.6 t -65.49 -42.24 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.197 177.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 56.6 ttm -57.16 -43.47 82.57 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -59.79 -26.51 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.702 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.5 t -94.99 -54.61 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 11.2 p -63.8 -13.71 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.394 -0.191 . . . . 0.0 111.317 -178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -100.59 -16.92 17.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.433 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.8 -25.36 60.48 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -65.29 -34.5 78.49 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -158.37 83.67 2.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -44.25 111.44 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.716 1.611 . . . . 0.0 110.984 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.49 -14.98 27.84 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 121.741 1.627 . . . . 0.0 111.519 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.8 m -127.49 139.53 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.643 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -159.41 160.61 35.06 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.953 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.1 m -99.56 121.86 41.79 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.099 0.476 . . . . 0.0 111.287 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -111.85 116.45 49.8 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.147 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 N--CA 1.495 1.588 0 C-N-CA 121.801 1.668 . . . . 0.0 111.957 179.748 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.58 H182 HG21 ' A' ' 56' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.3 t -105.28 129.93 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.439 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.48 153.54 19.04 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.488 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 28.5 mp0 -62.64 -41.44 99.03 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.849 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.1 m -58.18 -46.02 86.49 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.083 0.944 . . . . 0.0 108.834 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.19 -34.58 77.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.548 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.408 ' O ' HG21 ' A' ' 12' ' ' VAL . 11.0 tp -57.66 -36.94 72.56 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.4 mptp? -61.71 -44.61 96.6 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.464 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -64.39 -36.36 83.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.34 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -33.67 73.11 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 8' ' ' LEU . 2.4 m -114.0 20.98 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 122.021 -0.425 . . . . 0.0 110.906 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -60.55 -37.67 82.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.194 0.521 . . . . 0.0 111.13 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -62.96 -13.45 34.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.896 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -76.42 155.01 34.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.942 0.401 . . . . 0.0 111.365 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -72.28 -36.9 69.11 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.88 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -113.06 65.16 0.64 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.289 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -63.66 -25.52 68.25 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.93 -54.03 8.81 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 tp -64.29 -38.63 91.73 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.535 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 95.9 m -61.66 -48.2 81.9 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.752 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.62 -47.96 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 120.751 0.31 . . . . 0.0 111.161 179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -62.7 -42.03 99.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.106 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.6 -39.1 93.51 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.305 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.1 p -68.05 -37.7 81.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.736 178.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -55.23 -43.05 69.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -60.57 -39.6 88.58 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.47 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.7 t -72.55 -40.67 63.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.17 -23.71 6.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.261 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.2 m -73.85 -48.7 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.097 0.475 . . . . 0.0 109.833 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 16.4 tp -84.39 -38.85 19.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.989 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -112.9 65.72 0.64 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.208 0.528 . . . . 0.0 109.986 178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -58.62 -14.6 8.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -64.2 -20.92 66.35 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.9 tp -94.54 113.8 25.69 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -107.87 129.31 24.32 Favored Pre-proline 0 C--N 1.357 0.916 0 CA-C-N 120.094 1.315 . . . . 0.0 111.716 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -84.39 137.04 6.81 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 121.804 1.669 . . . . 0.0 112.991 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.35 154.39 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.2 tp -94.99 126.11 40.11 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.407 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.9 161.62 26.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.48 0.657 . . . . 0.0 112.091 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -97.64 124.59 42.0 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.358 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.63 131.55 54.78 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 118.306 0.503 . . . . 0.0 109.892 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.8 t -117.31 123.18 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.59 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -104.09 156.16 18.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -58.89 -27.97 65.71 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.717 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.84 -16.38 61.19 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.665 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.1 -8.73 67.61 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.5 m -74.76 150.61 39.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.2 p -130.72 154.63 47.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.123 0.487 . . . . 0.0 110.777 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 -161.5 136.01 7.09 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.223 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.82 121.33 23.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.91 0.862 . . . . 0.0 109.976 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.8 tp -120.31 131.91 55.08 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.316 -177.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.2 ttp -91.03 137.77 32.11 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.884 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -131.23 152.04 50.89 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.2 mt -100.96 130.47 46.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.507 HG23 H181 ' A' ' 201' ' ' 4N1 . 51.1 m -145.55 137.88 25.69 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.071 0.463 . . . . 0.0 111.857 -177.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.71 -145.21 9.34 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.279 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.4 p -131.26 158.15 41.39 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.4 pt -132.48 116.33 15.1 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.608 177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -69.03 124.16 11.09 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 CA-C-N 119.98 1.029 . . . . 0.0 110.849 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.8 t -127.6 112.59 20.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.259 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.18 151.6 20.78 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.879 2.386 . . . . 0.0 112.62 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -163.5 115.03 1.43 Allowed 'General case' 0 CA--C 1.56 1.343 0 CA-C-O 121.546 0.689 . . . . 0.0 111.23 179.046 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 49.97 38.93 17.57 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.86 -4.49 85.67 Favored Glycine 0 N--CA 1.473 1.151 0 O-C-N 121.727 -0.608 . . . . 0.0 113.025 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -119.6 130.29 55.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.97 0.414 . . . . 0.0 109.98 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.8 m -118.25 131.41 56.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.685 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -113.28 149.29 34.08 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.949 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -97.13 102.64 14.46 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -89.39 119.15 69.62 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.39 128.58 4.16 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.784 2.323 . . . . 0.0 110.624 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 72' ' ' ILE . 23.1 pt -134.5 147.5 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.971 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.489 ' SG ' H183 ' A' ' 201' ' ' 4N1 . 69.3 m -120.62 122.48 40.6 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 121.534 0.683 . . . . 0.0 110.021 178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.19 114.4 28.51 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.326 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -105.23 122.99 47.08 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 63.4 mt -93.86 131.12 39.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.738 -177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mt -74.82 149.43 39.65 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -56.9 -14.18 3.28 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.577 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.6 0.29 36.07 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -51.79 144.71 18.42 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -93.62 10.1 53.6 Favored 'Cis proline' 0 N--CA 1.516 2.81 0 CA-C-N 120.842 1.336 . . . . 0.0 115.369 0.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -75.45 -12.0 60.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.235 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.17 121.81 35.74 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.88 137.65 35.21 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 CA-C-N 121.182 1.458 . . . . 0.0 111.995 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.12 142.11 12.06 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.19 1.927 . . . . 0.0 111.488 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.31 133.43 40.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.699 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.3 t -114.69 143.45 45.02 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.017 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -127.86 131.14 49.5 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.681 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.7 t -103.92 126.31 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.14 101.78 5.32 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.957 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -83.82 129.24 4.73 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.622 1.548 . . . . 0.0 113.254 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.4 p -80.91 165.54 21.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.7 p -59.27 -25.07 63.77 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -99.51 23.76 9.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.971 0.805 . . . . 0.0 109.888 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.7 ttm -129.64 139.41 51.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.888 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.6 m -115.64 133.06 56.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.019 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 1.4 tp -84.26 106.94 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.971 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -87.22 99.27 11.83 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.352 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.6 p -67.67 143.11 56.14 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.74 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.76 -152.45 6.9 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -74.59 -15.63 60.83 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -114.15 -27.35 7.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.0 t -106.65 136.09 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -100.07 175.78 5.63 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.15 93.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -79.34 -17.84 53.71 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.02 33.78 2.71 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.215 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -82.21 148.48 28.4 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.61 116.01 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.604 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.36 116.61 32.45 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 mt -126.05 113.71 24.13 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 118.249 0.477 . . . . 0.0 110.942 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -48.21 -37.55 31.57 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.733 1.622 . . . . 0.0 114.661 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.409 ' CG ' ' N ' ' A' ' 114' ' ' LEU . 1.7 p90 -61.47 -32.24 72.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.652 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.409 ' N ' ' CG ' ' A' ' 113' ' ' TYR . 0.8 OUTLIER -68.55 -41.5 79.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.717 -178.969 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -62.99 -33.86 76.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.628 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -101.03 2.88 40.95 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.163 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -52.5 123.08 10.12 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.992 0.901 . . . . 0.0 110.221 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -101.58 100.22 10.6 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.797 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -57.03 122.29 52.24 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.897 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -111.66 91.24 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.576 0 CA-C-N 120.687 1.281 . . . . 0.0 112.235 -3.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -114.96 -51.63 2.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.984 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.3 m -71.24 -41.33 70.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.983 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t70 66.53 165.04 0.2 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.585 0.707 . . . . 0.0 111.807 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 21.9 tp -67.05 -41.13 87.01 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.694 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.3 tp -59.69 -37.28 78.39 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.87 -39.6 97.12 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.2 tp -57.37 -39.51 76.17 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -72.08 -49.3 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.619 -177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -66.92 -35.68 80.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 118.661 -1.216 . . . . 0.0 108.683 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -64.25 -38.63 83.0 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 C-N-CA 119.432 -0.907 . . . . 0.0 108.864 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.7 tpp -60.49 -43.12 97.36 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -67.92 -36.64 76.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.683 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.5 t -81.59 -41.5 18.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.1 p -77.71 -15.62 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.784 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -107.3 -18.08 13.97 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.393 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.88 -27.1 69.64 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -66.47 -27.56 67.89 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.635 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -168.18 89.72 0.66 Allowed Pre-proline 0 C--O 1.232 0.15 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -44.76 119.35 2.28 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.67 1.58 . . . . 0.0 110.588 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.97 -16.3 32.46 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.561 1.507 . . . . 0.0 111.448 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.17 140.37 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.337 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -159.52 160.7 34.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.2 m -106.77 130.23 54.51 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.708 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -112.25 113.69 51.33 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.177 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.495 1.578 0 C-N-CA 122.063 1.842 . . . . 0.0 112.187 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.526 H183 ' S20' ' A' ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.9 p -63.64 143.38 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-O 121.586 0.707 . . . . 0.0 110.957 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -104.96 153.81 20.93 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.0 mt-10 -59.47 -42.48 92.16 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.109 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.2 m -58.23 -47.89 82.09 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.952 0.882 . . . . 0.0 109.355 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -62.57 -34.42 76.94 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.95 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.2 tp -56.09 -39.27 71.89 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 11.0 mptt -61.05 -43.95 98.13 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.557 0.694 . . . . 0.0 109.613 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.03 -36.32 83.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.617 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mmm -66.92 -37.04 83.6 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.619 -178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -115.73 23.46 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.526 0.203 . . . . 0.0 111.245 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.3 p -66.62 -18.13 65.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.705 0.288 . . . . 0.0 111.029 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -77.41 -20.78 54.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.121 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -72.47 149.88 43.79 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -66.23 -40.04 89.99 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.789 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -110.56 64.21 0.61 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.783 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -65.24 -27.74 68.87 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.37 -49.48 33.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.37 -41.7 93.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.634 -0.827 . . . . 0.0 109.389 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -60.22 -48.49 81.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.156 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.8 t -63.55 -46.02 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 120.536 0.208 . . . . 0.0 111.445 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.74 -42.74 99.36 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.619 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -34.19 72.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.541 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.9 p -66.21 -38.49 88.09 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.4 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.2 t -57.64 -45.42 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -61.24 -38.77 87.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.327 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -67.12 -46.05 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.81 -13.5 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.33 -178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.0 p -76.33 -52.09 10.64 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.0 tp -85.03 -38.15 19.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.416 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -108.89 64.26 0.61 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.135 0.493 . . . . 0.0 109.89 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -55.31 -18.82 7.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.534 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -65.5 -22.55 66.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.364 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.0 tp -91.18 113.86 26.23 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -110.69 132.24 21.69 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.576 1.08 . . . . 0.0 111.805 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -81.43 135.01 9.15 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 122.242 1.961 . . . . 0.0 112.94 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -131.56 137.01 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 15.4 tp -82.41 121.77 27.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.27 160.04 24.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.731 0.3 . . . . 0.0 110.925 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m -99.8 131.68 45.63 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -116.44 136.11 53.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.141 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.8 t -109.56 121.21 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.767 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -94.61 159.65 14.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -66.15 -12.87 58.62 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.331 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -82.8 -9.14 59.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.398 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.35 -8.11 79.53 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.5 m -83.12 145.04 29.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.037 0.446 . . . . 0.0 109.925 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.9 t -113.25 142.23 46.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.15 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -144.4 134.7 24.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.265 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.16 122.97 28.03 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.672 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.4 mt -122.29 144.17 49.16 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.936 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 57.9 ttp -97.43 139.09 33.88 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.84 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -132.35 150.55 52.13 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 121.161 0.505 . . . . 0.0 111.254 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 mt -98.38 124.19 42.92 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.598 HG21 H181 ' A' ' 201' ' ' 4N1 . 23.2 m -134.97 138.62 44.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.68 -145.33 9.65 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.58 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.6 p -133.27 159.39 40.37 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 pt -133.73 116.56 13.77 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.38 177.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -70.95 127.56 13.8 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 CA-C-N 120.058 1.057 . . . . 0.0 110.014 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 89.8 t -127.31 118.1 21.7 Favored Pre-proline 0 C--N 1.347 0.485 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.284 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.29 142.23 37.04 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.885 1.723 . . . . 0.0 110.066 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -159.77 113.46 2.24 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.888 -178.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 60.84 25.37 15.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.755 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.86 -13.23 67.36 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.563 ' C ' ' OD1' ' A' ' 66' ' ' ASN . 3.1 p-10 -99.85 169.96 8.86 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.1 m -139.88 133.98 31.01 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.515 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -121.08 148.62 43.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.304 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.34 106.66 18.92 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 mp -91.7 115.41 64.48 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.215 -177.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.56 126.3 4.66 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.304 2.003 . . . . 0.0 110.376 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 27.0 pt -133.97 150.44 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 119.156 -1.018 . . . . 0.0 112.091 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.6 m -121.61 120.68 35.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.81 115.68 31.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.929 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -109.24 128.05 54.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.8 mt -97.3 142.02 29.69 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.043 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -87.45 151.41 23.07 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -58.92 -15.16 11.48 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.87 5.48 33.02 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.204 0.526 . . . . 0.0 112.233 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -60.93 145.59 88.76 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -92.42 10.26 57.56 Favored 'Cis proline' 0 N--CA 1.516 2.798 0 CA-C-N 120.856 1.341 . . . . 0.0 114.753 0.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.59 -12.17 60.67 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.84 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.48 127.78 26.49 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.66 -0.686 . . . . 0.0 109.408 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -49.39 134.28 31.72 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 CA-C-N 121.192 1.461 . . . . 0.0 112.217 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.9 142.12 15.51 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.366 2.044 . . . . 0.0 111.274 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.6 mt -98.75 135.67 32.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.088 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.3 t -121.66 145.98 47.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.023 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -125.71 134.48 51.78 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.159 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.8 p -95.65 127.92 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.625 ' HE3' H213 ' A' ' 201' ' ' 4N1 . 4.2 tttm -69.3 107.42 2.15 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -84.8 155.91 11.73 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.268 1.312 . . . . 0.0 113.147 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.3 p -129.01 169.85 14.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.062 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.7 m -59.18 -39.59 83.03 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -89.92 -3.61 57.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.617 0.644 . . . . 0.0 111.53 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.7 ttm -116.23 137.15 52.39 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -129.22 165.83 20.59 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.109 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 70.2 mt -111.27 108.78 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.716 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -97.52 126.91 43.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.9 p -72.01 143.6 49.11 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.92 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.54 -142.18 3.5 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.752 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -66.0 -26.6 67.62 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -133.68 -26.67 1.57 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.72 132.08 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 119.477 1.035 . . . . 0.0 110.536 -179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -98.97 175.41 5.94 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.45 77.42 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -74.94 -9.83 58.91 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.415 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.69 5.29 55.45 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.156 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 147.26 53.73 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.468 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.8 mt -120.74 125.13 73.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -99.7 137.82 37.65 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.2 mt -136.61 116.57 10.87 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.441 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -47.56 -37.36 26.37 Favored 'Trans proline' 0 N--CA 1.504 2.091 0 C-N-CA 122.075 1.85 . . . . 0.0 114.505 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -61.09 -29.37 69.71 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.679 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.2 tt -69.8 -43.16 72.64 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.489 -178.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -68.05 -27.61 66.67 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.378 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -103.86 3.91 34.31 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.932 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . 0.479 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.6 t90 -70.16 120.05 15.26 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.806 0.812 . . . . 0.0 109.742 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -88.05 129.51 35.26 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.161 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -78.81 124.06 85.11 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.463 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -111.04 93.1 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.664 0 CA-C-N 120.953 1.376 . . . . 0.0 111.63 -3.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -113.6 -56.17 2.43 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.115 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.5 t -74.3 -34.61 63.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.773 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 47.02 -176.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.707 0.765 . . . . 0.0 111.621 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.52 -40.59 76.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.306 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.1 tt -55.68 -39.51 71.07 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -62.58 -39.86 98.4 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.4 tp -57.6 -40.28 78.74 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.19 -49.96 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.816 -176.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.6 tp-100 -64.78 -35.92 82.63 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.5 t -68.25 -37.27 77.77 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.4 tpp -58.32 -43.04 88.0 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.65 -39.63 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.13 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.9 t -81.48 -47.32 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.7 p -67.71 -15.47 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.34 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 10.8 m-30 -106.57 -19.34 13.7 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.138 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.21 -37.29 93.85 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -64.88 -36.87 85.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.762 -0.719 . . . . 0.0 110.687 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -158.1 81.99 2.9 Favored Pre-proline 0 CA--C 1.52 -0.195 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -51.04 128.88 26.34 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 120.709 0.939 . . . . 0.0 109.731 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.43 -15.25 34.56 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.469 1.446 . . . . 0.0 112.142 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.1 m -132.64 153.72 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.974 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.35 166.08 34.05 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 28.3 m -85.78 121.94 29.16 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.122 0.487 . . . . 0.0 111.414 -178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -111.73 110.66 54.73 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.99 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 N--CA 1.495 1.592 0 C-N-CA 121.919 1.746 . . . . 0.0 112.079 -179.912 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.625 H213 ' HE3' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.6 t -89.21 129.87 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.767 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -95.68 158.36 15.48 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.46 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 94.9 mt-10 -63.34 -41.73 98.89 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.267 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -60.33 -48.29 82.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.225 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -63.51 -27.73 69.47 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.152 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 tp -61.23 -41.69 97.31 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 3.4 mptp? -59.27 -38.95 81.38 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.208 0.528 . . . . 0.0 109.824 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.61 -34.69 76.08 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.128 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.8 ptp -84.31 -14.58 49.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.808 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.34 17.97 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.413 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.9 t -61.92 -37.75 85.85 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.817 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -64.6 -19.82 65.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.875 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -72.11 152.64 42.2 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -75.44 -26.14 58.05 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.675 0.274 . . . . 0.0 110.683 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -120.67 60.36 0.9 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.403 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.8 ptt180 -64.77 -25.42 67.91 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -71.7 -55.82 6.97 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mt -64.39 -39.72 94.4 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.088 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.4 m -62.47 -47.85 82.2 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.876 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.8 t -62.56 -47.24 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 120.837 0.351 . . . . 0.0 110.673 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -40.44 95.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.044 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -63.42 -39.55 94.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.583 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 57.5 p -70.48 -35.56 73.33 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.252 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.89 -44.37 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -62.0 -39.78 93.4 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.485 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.6 t -70.76 -43.43 77.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.01 -17.94 8.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.517 -177.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.9 m -82.7 -47.2 12.27 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.092 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.7 tp -87.9 -37.8 16.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.937 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -109.12 65.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -59.0 -16.95 20.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.973 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -64.95 -21.1 66.78 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.116 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.1 tp -98.16 124.01 42.5 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -118.07 129.28 25.47 Favored Pre-proline 0 C--N 1.36 1.061 0 CA-C-N 120.221 1.373 . . . . 0.0 111.946 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -80.89 136.53 10.58 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 121.593 1.529 . . . . 0.0 112.81 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.39 135.59 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.9 tp -83.1 122.14 27.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.02 151.24 48.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.219 0.533 . . . . 0.0 112.041 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m -98.68 119.33 37.23 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -103.94 139.09 39.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.992 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.2 t -115.16 124.23 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.862 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -95.33 166.12 12.04 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.318 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.42 -39.72 84.4 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.653 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -65.66 -9.41 27.09 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.819 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.43 -11.98 69.51 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.8 m -61.45 136.08 57.9 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.6 m -122.35 140.08 53.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.116 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.44 129.58 11.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.055 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -76.33 116.1 16.69 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.323 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.4 mt -122.86 138.31 54.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 64.2 ttp -84.29 139.55 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.137 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -125.88 156.4 39.71 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.198 0.523 . . . . 0.0 110.897 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.99 117.69 34.85 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.0 m -134.13 137.99 44.92 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.088 0.471 . . . . 0.0 112.159 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.27 -149.65 15.31 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.896 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.9 p -132.01 158.94 40.21 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.58 115.97 14.86 Favored Pre-proline 0 C--O 1.237 0.433 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.416 177.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.74 125.46 10.01 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.8 1.0 . . . . 0.0 110.197 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.73 119.34 25.77 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.875 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.63 147.42 57.27 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.187 1.925 . . . . 0.0 109.675 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.41 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -163.74 108.79 1.04 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.339 -177.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 49.65 44.23 24.47 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.79 13.89 75.36 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.36 -0.924 . . . . 0.0 110.839 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -134.77 131.15 37.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -117.4 132.47 56.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.847 0.356 . . . . 0.0 111.797 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -112.68 148.88 33.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.99 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.95 102.46 14.26 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.7 mp -91.22 116.28 66.12 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.262 -177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.9 127.55 4.2 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.654 2.236 . . . . 0.0 110.308 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.429 HD13 HG23 ' A' ' 72' ' ' ILE . 26.4 pt -134.57 146.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.541 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 84.8 m -120.57 121.63 38.8 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.83 120.09 39.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.664 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -104.39 117.94 35.4 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.3 mt -84.56 137.69 33.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mt -88.36 154.91 20.01 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.8 p30 -63.4 -13.83 43.92 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.501 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 p -99.24 -4.35 32.17 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -55.83 145.11 54.1 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -91.18 6.29 66.54 Favored 'Cis proline' 0 N--CA 1.514 2.732 0 CA-C-N 121.121 1.436 . . . . 0.0 115.697 1.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -71.27 -19.2 62.38 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.974 -1.09 . . . . 0.0 110.349 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.21 139.5 21.95 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.056 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.0 142.76 63.22 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 CA-C-N 121.665 1.63 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 142.84 17.31 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.955 1.77 . . . . 0.0 111.906 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -92.41 134.59 29.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 39.0 t -107.78 144.35 35.06 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.765 -177.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.56 126.06 43.04 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.272 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.3 t -98.39 130.31 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.64 ' HE2' H171 ' A' ' 201' ' ' 4N1 . 0.0 OUTLIER -93.93 99.36 3.53 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 123.44 0.463 . . . . 0.0 109.873 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -86.85 148.09 8.25 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.387 1.391 . . . . 0.0 113.23 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.3 p -95.95 165.27 12.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.553 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t -55.16 -19.11 6.93 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.2 t -105.52 15.65 26.73 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.002 0.819 . . . . 0.0 111.572 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.4 mtp -132.77 141.83 48.71 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -125.43 163.64 22.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.063 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.3 mm -93.02 101.98 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -84.89 104.71 15.08 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.802 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.7 p -72.61 150.07 43.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.349 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.5 -137.49 2.3 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.769 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -67.73 -21.08 65.31 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.57 -29.54 1.53 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.884 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.2 t -88.97 140.3 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.739 179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -103.16 176.45 5.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.441 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.33 94.2 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -88.39 0.3 56.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.292 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.48 11.74 46.95 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.259 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -64.46 141.47 58.76 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.466 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.44 HD12 HG23 ' A' ' 109' ' ' ILE . 96.9 mt -109.49 115.57 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.072 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -104.57 136.23 44.5 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.1 mt -135.17 124.84 16.62 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.3 -32.7 52.34 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.365 1.376 . . . . 0.0 113.519 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -67.51 -31.8 72.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.75 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.02 -41.67 74.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.162 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -71.16 -26.54 63.03 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.29 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -100.71 -0.75 36.72 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.22 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -53.97 126.01 20.91 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 122.055 0.931 . . . . 0.0 110.733 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -97.98 94.5 6.9 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.239 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 57.8 t60 -59.68 124.51 76.38 Favored Pre-proline 0 C--N 1.323 -0.556 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.067 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 9.6 Cg_endo -108.88 91.71 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.708 0 CA-C-N 120.454 1.198 . . . . 0.0 112.948 -2.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -113.07 -58.16 2.19 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.463 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.6 t -67.37 -40.6 85.78 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.314 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 64.37 166.21 0.15 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.741 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.03 -41.84 97.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.4 tt -57.17 -36.16 70.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -60.28 -39.8 96.54 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.74 -40.79 93.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.17 -47.59 35.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.683 -176.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -68.81 -36.48 78.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.021 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 79.4 t -66.85 -39.75 84.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.081 177.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.1 ttm -58.73 -44.5 90.49 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.26 -34.97 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.815 179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.8 t -90.36 -46.22 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.9 p -68.91 -13.31 17.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.723 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -103.76 -15.17 15.81 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.024 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.88 -24.92 75.94 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -70.45 -34.53 72.55 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.595 0.236 . . . . 0.0 111.012 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -162.38 83.13 1.64 Allowed Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -49.17 124.18 11.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.222 1.281 . . . . 0.0 110.752 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.9 -18.56 24.38 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.741 1.627 . . . . 0.0 112.019 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.11 146.03 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.151 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -159.47 162.29 35.58 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.3 m -85.46 118.29 24.89 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.101 0.477 . . . . 0.0 111.599 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.0 131.21 23.27 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.1 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo . . . . . 0 N--CA 1.491 1.364 0 C-N-CA 121.601 1.534 . . . . 0.0 112.195 -179.741 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' 4N1 . . . . . 0.64 H171 ' HE2' ' A' ' 90' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.4 t . . . . . 0 N--CA 1.449 -0.476 0 CA-C-O 120.892 0.377 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -94.58 158.43 15.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.468 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 95.4 mt-10 -64.14 -41.15 97.3 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.196 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.3 m -58.58 -47.43 84.33 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.165 0.984 . . . . 0.0 108.985 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -63.32 -33.64 75.96 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.874 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.741 HD23 HG13 ' A' ' 22' ' ' VAL . 12.7 tp -56.3 -38.49 71.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.6 mptp? -60.73 -42.8 98.04 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.367 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.1 -37.73 88.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.617 0.722 . . . . 0.0 110.884 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.767 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.3 mmm -67.54 -36.68 81.46 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.114 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -111.87 19.69 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.651 0.263 . . . . 0.0 111.116 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.7 p -64.56 -21.78 66.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.806 0.336 . . . . 0.0 110.532 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -72.06 -23.01 61.29 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.984 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.49 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 30.2 m-85 -77.44 160.18 28.89 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.849 0.357 . . . . 0.0 110.365 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.6 -21.19 24.15 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.305 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.16 47.53 1.12 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 122.324 -0.235 . . . . 0.0 110.766 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -58.27 -24.65 60.12 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -73.61 -53.79 9.65 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.6 tp -65.13 -39.7 93.43 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.722 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 25' ' ' THR . 77.1 m -63.08 -48.68 77.55 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.338 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.741 HG13 HD23 ' A' ' 8' ' ' LEU . 25.3 t -61.5 -46.42 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 120.635 0.255 . . . . 0.0 110.47 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -62.63 -44.91 95.08 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.647 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -64.21 -36.88 85.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.948 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.63 ' O ' HG23 ' A' ' 29' ' ' ILE . 35.3 p -64.81 -34.3 78.04 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.736 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.69 -44.91 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -61.37 -38.02 85.49 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.408 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.517 HG21 HD22 ' A' ' 124' ' ' LEU . 73.3 t -70.72 -44.73 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.95 -21.57 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.354 -178.001 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.5 m -73.47 -45.88 51.52 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.535 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.776 HD23 HD21 ' A' ' 125' ' ' LEU . 30.0 tp -88.47 -39.27 14.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.032 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -111.07 66.97 0.63 Allowed 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -56.99 -17.64 10.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.288 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -66.85 -14.87 63.18 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.87 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.45 HD23 HD13 ' A' ' 55' ' ' LEU . 1.8 tp -99.98 114.27 27.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.1 ttpp -108.89 131.86 21.53 Favored Pre-proline 0 C--N 1.356 0.874 0 CA-C-N 119.521 1.055 . . . . 0.0 112.007 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.1 133.42 11.0 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.49 1.46 . . . . 0.0 112.535 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.4 t -133.96 139.36 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 110.71 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.767 HD13 ' SD ' ' A' ' 11' ' ' MET . 11.1 tp -81.93 136.27 35.32 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -140.6 154.48 46.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.144 0.497 . . . . 0.0 111.27 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.6 m -91.56 131.46 36.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.9 t80 . . . . . 0 C--O 1.236 0.381 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.818 179.821 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 121.121 0.486 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -82.12 119.3 23.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.848 0.832 . . . . 0.0 109.733 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.49 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 61.3 mt -121.44 146.71 46.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.791 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.457 ' SD ' HD11 ' A' ' 8' ' ' LEU . 53.5 ttp -97.54 142.79 28.94 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.682 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.495 ' ND2' ' CZ3' ' A' ' 75' ' ' TRP . 34.0 m-20 -135.81 152.85 51.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.452 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.45 HD13 HD23 ' A' ' 35' ' ' LEU . 8.5 mt -95.45 123.58 39.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -135.89 136.61 40.67 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.16 -146.69 11.47 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.522 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.1 p -132.84 159.4 39.93 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.439 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.3 pt -129.77 116.48 18.18 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.895 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -70.56 124.81 11.1 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 CA-C-N 120.017 1.042 . . . . 0.0 109.942 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.1 t -125.56 118.43 24.62 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 119.671 -0.812 . . . . 0.0 113.015 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.7 142.22 52.19 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.944 1.763 . . . . 0.0 109.813 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -163.08 117.54 1.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.48 26.39 10.83 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.299 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.93 -5.62 78.44 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -112.97 142.78 45.27 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -121.65 132.26 54.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.775 0.321 . . . . 0.0 111.818 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -115.9 151.74 34.76 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.523 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -95.69 106.29 18.38 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.532 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -90.83 118.56 68.71 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.79 122.1 2.24 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.601 2.201 . . . . 0.0 110.534 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.532 HG23 HG22 ' A' ' 70' ' ' ILE . 31.9 pt -134.44 149.51 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.796 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.1 m -123.5 127.9 49.01 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.947 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.71 115.49 30.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.868 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.495 ' CZ3' ' ND2' ' A' ' 54' ' ' ASN . 60.3 m95 -103.69 125.81 50.42 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.6 mt -90.84 138.64 31.43 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.0 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.51 146.44 36.38 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -56.79 -14.99 3.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.476 0.58 . . . . 0.0 111.679 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.4 p -106.03 13.11 29.65 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.259 0.552 . . . . 0.0 111.536 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -61.4 144.39 92.07 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -92.23 8.09 61.35 Favored 'Cis proline' 0 N--CA 1.514 2.721 0 CA-C-N 121.216 1.47 . . . . 0.0 115.623 1.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -71.51 -15.28 62.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.853 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.82 137.76 19.85 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.24 143.82 66.07 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 121.579 1.6 . . . . 0.0 110.751 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.82 138.9 13.57 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.444 1.43 . . . . 0.0 111.893 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 mt -95.2 131.73 41.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 40.3 t -110.06 150.75 28.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.066 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -133.28 127.05 32.81 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.535 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.3 t -96.1 121.56 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -68.95 109.69 4.74 Favored Pre-proline 0 N--CA 1.476 0.846 0 CA-C-O 119.167 -0.444 . . . . 0.0 111.15 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.21 164.71 11.26 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.577 1.518 . . . . 0.0 112.238 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.7 p -139.31 172.85 12.22 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.7 m -57.95 -41.19 82.33 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.86 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.9 m -90.29 -11.89 39.44 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.897 0.771 . . . . 0.0 111.733 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.0 tpp -108.91 124.45 50.69 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.459 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -119.15 165.33 14.32 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.353 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.459 ' N ' HG23 ' A' ' 96' ' ' THR . 87.2 mt -96.16 110.59 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -90.98 102.14 14.9 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.4 p -59.83 142.71 52.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.314 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -158.33 -144.15 3.86 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.705 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -65.95 -27.48 68.19 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.528 ' NE2' HG23 ' A' ' 103' ' ' VAL . 16.9 p-80 -128.96 -7.79 4.93 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 119.047 -1.061 . . . . 0.0 113.407 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.681 HG21 ' HB2' ' A' ' 140' ' ' PRO . 40.3 t -108.21 126.56 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.167 0.894 . . . . 0.0 111.736 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 103' ' ' VAL . 32.6 p-10 -88.65 -161.41 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.76 -20.83 25.62 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.863 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -90.23 -1.79 57.97 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.728 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.9 11.73 56.26 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.855 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -63.01 140.56 58.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.527 0.664 . . . . 0.0 109.667 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 98.7 mt -116.6 117.99 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.107 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -102.38 137.29 40.83 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.961 HD22 HG11 ' A' ' 134' ' ' VAL . 26.8 mt -136.64 116.61 10.85 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.317 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.14 -38.25 24.66 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 121.844 1.696 . . . . 0.0 114.519 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.402 ' CD2' ' N ' ' A' ' 114' ' ' LEU . 1.3 p90 -61.53 -29.73 70.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.512 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 1.7 tt -69.56 -42.53 74.44 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.717 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -65.03 -29.29 70.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.309 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -107.44 13.56 26.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.071 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.424 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 6.5 t90 -76.43 121.96 23.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.75 0.786 . . . . 0.0 110.36 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -92.42 128.08 38.14 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.277 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 85.4 t60 -84.34 125.47 71.91 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.424 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 15.7 Cg_endo -108.8 91.93 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.705 0 CA-C-N 120.866 1.345 . . . . 0.0 112.628 -2.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -113.77 -58.83 2.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.778 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.1 p -67.19 -39.02 86.3 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.52 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 58.95 161.69 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.474 0.654 . . . . 0.0 111.829 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.517 HD22 HG21 ' A' ' 28' ' ' VAL . 4.7 tt -58.39 -41.17 84.24 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.194 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.776 HD21 HD23 ' A' ' 31' ' ' LEU . 7.9 tp -56.75 -38.13 72.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.68 -39.69 98.24 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 tp -59.07 -38.98 80.73 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.413 HD12 HD13 ' A' ' 35' ' ' LEU . 1.1 mm -73.02 -47.53 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.579 -177.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -66.08 -36.83 84.26 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 126' ' ' GLY . 78.6 t -66.89 -37.82 80.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.9 tpp -59.0 -43.03 91.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.439 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -62.82 -26.07 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.621 178.388 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.2 t -94.63 -52.05 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.961 HG11 HD22 ' A' ' 111' ' ' LEU . 5.5 p -64.77 -13.72 15.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 122.547 0.339 . . . . 0.0 111.402 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.453 ' CD1' HG13 ' A' ' 134' ' ' VAL . 6.6 m-30 -101.98 -17.64 16.01 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.255 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.55 -28.07 60.14 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -64.81 -35.48 81.23 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.332 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -163.49 84.6 1.35 Allowed Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -44.06 112.6 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.497 1.465 . . . . 0.0 110.665 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.681 ' HB2' HG21 ' A' ' 103' ' ' VAL . 28.8 Cg_endo -65.35 -20.44 61.71 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.358 1.372 . . . . 0.0 110.427 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.9 m -127.72 150.11 33.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 16.7 p90 . . . . . 0 N--CA 1.471 0.608 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.03 -179.513 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.406 HG22 ' HE1' ' A' ' 11' ' ' MET . 87.4 t . . . . . 0 CA--C 1.515 -0.398 0 CA-C-O 121.298 0.571 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.48 154.57 18.13 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.513 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 39.9 mt-10 -62.18 -40.61 96.62 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.954 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.8 t -58.83 -47.7 83.9 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 122.148 0.975 . . . . 0.0 109.269 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -64.51 -30.4 71.43 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.855 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.858 HD23 HG13 ' A' ' 22' ' ' VAL . 10.2 tp -60.0 -37.05 78.56 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -62.8 -43.27 99.24 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.432 178.418 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.31 -37.44 83.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.94 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.503 ' SD ' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -64.01 -37.51 87.71 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.017 -178.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -119.39 24.82 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.883 0.373 . . . . 0.0 111.856 -178.852 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.5 t -64.59 -37.17 86.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.07 0.462 . . . . 0.0 111.147 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.22 -12.38 60.87 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.89 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.488 ' CE1' HG12 ' A' ' 12' ' ' VAL . 10.4 m-85 -77.99 159.55 28.72 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -81.86 -26.87 33.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.651 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -116.19 55.24 0.81 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 119.67 -0.205 . . . . 0.0 110.809 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 ptt-85 -63.76 -24.7 67.87 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -53.88 8.56 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.038 -0.414 . . . . 0.0 111.709 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -42.88 96.6 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.117 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.0 m -60.61 -48.07 83.4 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.419 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.858 HG13 HD23 ' A' ' 8' ' ' LEU . 32.6 t -61.05 -44.74 98.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -41.4 98.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.566 -0.853 . . . . 0.0 109.784 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -39.2 89.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.071 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 29' ' ' ILE . 41.4 p -65.72 -37.86 87.58 Favored 'General case' 0 CA--C 1.507 -0.673 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.461 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.85 -43.99 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.486 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -61.86 -37.91 86.29 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.025 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.1 t -71.23 -43.11 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.82 -20.27 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.114 -178.306 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -78.31 -47.54 17.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.647 ' O ' HD13 ' A' ' 31' ' ' LEU . 2.8 tm? -84.23 -39.74 18.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.794 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -110.56 66.98 0.63 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -58.08 -16.58 13.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.82 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -65.34 -22.0 66.77 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.826 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 tp -91.84 114.29 26.78 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -108.26 123.21 38.17 Favored Pre-proline 0 C--N 1.357 0.926 0 CA-C-N 119.551 1.069 . . . . 0.0 111.663 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.89 134.09 9.37 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.383 1.388 . . . . 0.0 112.976 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.9 155.3 41.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 110.711 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.503 HD12 ' SD ' ' A' ' 11' ' ' MET . 0.9 OUTLIER -86.97 122.43 30.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.992 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -125.07 133.06 53.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.584 0.23 . . . . 0.0 111.21 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.3 p -69.48 146.09 52.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.237 0.443 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.425 -179.107 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 . . . . . 0 N--CA 1.468 0.435 0 CA-C-O 120.966 0.412 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.7 121.59 17.48 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -128.92 126.43 39.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.962 0.411 . . . . 0.0 109.914 -178.4 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.407 ' HB2' ' HB3' ' A' ' 11' ' ' MET . 61.9 ttp -84.55 150.48 25.19 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.922 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -138.73 157.28 46.38 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.318 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mt -108.36 125.05 51.28 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.4 m -140.33 139.2 35.36 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.977 0.418 . . . . 0.0 112.12 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.19 -149.51 15.05 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.628 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.504 HG21 ' OD1' ' A' ' 69' ' ' ASN . 23.0 p -131.75 159.21 39.12 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.499 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.2 pt -130.25 116.53 17.68 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.9 177.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -70.79 125.97 12.15 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 CA-C-N 119.892 0.997 . . . . 0.0 109.878 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.0 t -130.02 127.32 22.68 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.573 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.09 149.64 52.71 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.092 1.861 . . . . 0.0 110.452 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -161.63 106.42 1.28 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.338 0.589 . . . . 0.0 111.889 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 51.15 39.58 23.84 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.914 -0.491 . . . . 0.0 111.951 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.22 -0.55 83.73 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -121.13 132.16 54.69 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -110.09 131.04 55.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.659 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -113.89 151.43 32.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.621 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.504 ' OD1' HG21 ' A' ' 58' ' ' THR . 3.7 t-20 -97.96 104.07 16.07 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.508 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -88.98 117.09 67.92 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.11 124.88 3.91 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.525 2.15 . . . . 0.0 110.919 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 70' ' ' ILE . 26.4 pt -132.67 147.96 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.613 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.5 m -123.01 126.13 46.55 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-O 121.385 0.612 . . . . 0.0 110.0 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.09 109.97 22.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.506 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.523 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 91.0 m95 -98.38 121.62 40.55 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.657 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.464 ' O ' HD21 ' A' ' 52' ' ' LEU . 72.8 mt -89.7 144.28 26.12 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.874 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mt -88.76 154.48 20.25 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -60.13 -17.68 42.07 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.524 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -100.47 1.32 41.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.732 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -53.81 145.77 30.13 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -92.37 12.07 53.97 Favored 'Cis proline' 0 N--CA 1.519 2.994 0 N-CA-C 116.061 1.524 . . . . 0.0 116.061 1.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -80.78 -2.38 46.86 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.296 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -123.82 122.83 26.32 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 118.555 -0.736 . . . . 0.0 109.08 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.76 132.66 21.58 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 CA-C-N 121.313 1.505 . . . . 0.0 112.505 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.32 144.27 14.41 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 122.382 2.054 . . . . 0.0 111.474 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.55 132.9 42.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.881 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 41.8 t -110.33 151.21 27.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.642 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -131.69 127.39 36.79 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.325 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.652 ' CG2' HD11 ' A' ' 109' ' ' ILE . 56.7 t -90.76 123.77 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -71.12 110.21 6.84 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 119.338 -0.363 . . . . 0.0 111.334 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -85.73 157.87 10.46 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.901 1.734 . . . . 0.0 113.218 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.2 p -135.78 165.59 25.25 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.93 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.2 p -60.32 -24.57 65.11 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -104.19 13.53 32.13 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.93 0.786 . . . . 0.0 110.728 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.24 148.15 50.8 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.476 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -133.59 165.98 23.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 120.156 -0.617 . . . . 0.0 110.438 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.476 ' N ' HG23 ' A' ' 96' ' ' THR . 90.3 mt -103.27 105.76 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -94.77 108.64 20.65 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.238 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 82.3 p -65.98 151.21 47.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.928 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.78 -134.74 1.8 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.356 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 101' ' ' LYS . 6.7 pttp -86.03 -3.8 59.02 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -136.42 -24.09 1.23 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.22 145.99 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.683 0.674 . . . . 0.0 110.171 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -101.37 -179.55 4.06 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.699 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.31 73.13 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -79.88 2.53 22.93 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.796 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.01 27.78 15.41 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.087 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -82.56 132.42 35.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 117.588 0.694 . . . . 0.0 110.149 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.652 HD11 ' CG2' ' A' ' 89' ' ' VAL . 96.3 mt -110.44 109.94 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.606 0.241 . . . . 0.0 110.782 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -114.07 138.86 49.84 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.548 ' CD2' HG11 ' A' ' 134' ' ' VAL . 1.1 mt -131.65 130.57 22.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 118.563 0.62 . . . . 0.0 111.883 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -46.93 -39.8 25.03 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.433 1.422 . . . . 0.0 113.957 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.05 -29.69 70.47 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.669 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 tt -70.79 -41.07 72.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.804 0.335 . . . . 0.0 111.008 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -67.36 -27.07 66.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.381 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -105.57 -3.64 22.11 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.878 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.424 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.8 t90 -62.82 124.07 20.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.671 0.748 . . . . 0.0 110.16 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -91.65 126.05 36.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.561 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -79.92 125.45 81.96 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 119.032 -0.508 . . . . 0.0 110.119 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -109.12 92.68 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 120.823 1.33 . . . . 0.0 112.454 -2.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -114.11 -61.26 1.77 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.401 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.426 ' O ' ' CG ' ' A' ' 123' ' ' ASP . 15.7 t -69.99 -30.76 68.17 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.689 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 122' ' ' SER . 4.6 p-10 48.89 -175.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.622 0.725 . . . . 0.0 111.947 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 tt -71.84 -43.5 65.42 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.711 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 125' ' ' LEU . 0.6 OUTLIER -51.53 -37.76 50.94 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -64.09 -41.42 98.49 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.8 tp -59.14 -40.87 86.83 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -73.16 -45.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.577 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.78 -33.22 68.41 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.097 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.573 ' O ' HG12 ' A' ' 134' ' ' VAL . 67.4 t -68.61 -37.75 78.08 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 53.2 tpp -59.79 -42.45 93.41 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.1 mp -66.3 -44.5 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.603 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.4 t -74.2 -40.83 51.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.6 HG13 ' CD1' ' A' ' 135' ' ' PHE . 2.5 p -78.66 -13.62 13.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.678 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.6 ' CD1' HG13 ' A' ' 134' ' ' VAL . 10.3 m-30 -108.49 -17.59 13.94 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.436 178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.66 -27.53 70.01 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 107.435 -2.266 . . . . 0.0 107.435 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -65.29 -35.83 82.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.019 -0.59 . . . . 0.0 110.618 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -166.88 84.89 0.86 Allowed Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -47.78 114.65 1.15 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.327 1.351 . . . . 0.0 109.852 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.33 -21.05 27.71 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.797 1.665 . . . . 0.0 111.235 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.67 147.08 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.094 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 20.2 p90 . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.723 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.446 -0.657 0 CA-C-O 121.39 0.614 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.18 151.79 19.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.514 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 93.0 mt-10 -62.6 -41.89 99.25 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.358 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.4 m -59.05 -45.03 91.78 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.017 0.913 . . . . 0.0 109.58 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -64.91 -36.5 84.56 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.207 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.946 HD23 HG13 ' A' ' 22' ' ' VAL . 38.2 tp -56.58 -40.02 74.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.768 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 3.3 mptp? -62.46 -42.78 99.72 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.844 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -66.32 -33.4 75.64 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.894 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.583 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -69.49 -36.02 76.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.036 -178.318 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 8' ' ' LEU . 1.6 m -120.02 30.96 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 111.162 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.1 p -69.27 -12.9 62.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.727 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -85.6 -12.92 50.31 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 121.016 -0.273 . . . . 0.0 111.386 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.456 ' CE1' HD23 ' A' ' 52' ' ' LEU . 5.8 m-85 -71.94 151.13 43.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.005 0.431 . . . . 0.0 111.109 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -70.94 -38.07 72.87 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -111.28 64.22 0.61 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.478 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.5 ptp85 -66.81 -30.35 70.52 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.44 -42.97 78.08 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.09 -38.33 61.26 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.784 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 25' ' ' THR . 99.2 m -62.58 -41.79 99.16 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.057 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.946 HG13 HD23 ' A' ' 8' ' ' LEU . 45.4 t -71.29 -46.14 66.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.439 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -63.98 -44.06 93.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.333 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.554 ' OE2' HD12 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -68.27 -29.35 68.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.385 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 21' ' ' THR . 28.2 p -70.14 -37.83 75.37 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.717 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.77 -43.32 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -60.63 -40.25 91.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.29 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.465 HG21 ' HB3' ' A' ' 124' ' ' LEU . 68.4 t -70.1 -42.55 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.99 -16.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.22 -178.59 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.7 m -80.86 -49.41 11.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.6 tp -83.19 -37.15 24.02 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.269 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.36 68.45 0.7 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.467 0.651 . . . . 0.0 109.381 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -58.39 -18.9 31.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.944 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.18 -21.08 66.72 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.458 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.525 HD23 HD13 ' A' ' 55' ' ' LEU . 2.4 tp -93.78 113.51 25.57 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -109.87 125.25 31.57 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 119.451 1.023 . . . . 0.0 112.352 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -80.31 138.68 12.65 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.655 1.57 . . . . 0.0 113.149 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.37 156.56 39.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.583 HD13 ' SD ' ' A' ' 11' ' ' MET . 22.8 tp -97.1 107.56 20.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -110.04 130.19 55.57 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.071 0.462 . . . . 0.0 111.609 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.8 p -79.89 131.87 35.95 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.4 t80 . . . . . 0 C--O 1.238 0.47 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.115 -178.897 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 121.107 0.479 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.21 105.64 13.46 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.057 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.456 HD23 ' CE1' ' A' ' 15' ' ' TYR . 15.2 mt -119.29 125.19 48.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.105 0.479 . . . . 0.0 110.01 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -92.83 138.42 31.5 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.606 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -127.44 152.22 47.82 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.18 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.525 HD13 HD23 ' A' ' 35' ' ' LEU . 7.4 mt -97.37 130.11 44.55 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.3 m -141.2 137.63 32.77 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.15 -144.08 8.76 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.405 HG21 ' OD1' ' A' ' 69' ' ' ASN . 22.9 p -136.81 159.71 41.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.5 pt -132.19 115.22 15.1 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.074 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -70.54 125.41 11.71 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.164 1.243 . . . . 0.0 110.293 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.1 t -126.37 121.85 23.78 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.057 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.72 148.7 41.96 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.414 2.076 . . . . 0.0 110.936 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.449 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -163.42 109.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.442 0.639 . . . . 0.0 111.522 -178.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 52.86 37.91 25.4 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.712 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.54 82.01 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -119.34 130.71 55.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -115.29 132.29 56.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.957 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -112.51 148.94 33.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.883 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.405 ' OD1' HG21 ' A' ' 58' ' ' THR . 5.4 t-20 -94.42 106.42 18.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.472 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -91.09 116.25 66.03 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -85.17 124.94 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.808 2.339 . . . . 0.0 110.25 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.472 HG23 HG22 ' A' ' 70' ' ' ILE . 24.6 pt -134.98 148.7 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.572 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.1 m -121.77 123.14 41.12 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.475 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.95 112.81 25.94 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.232 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -105.7 125.29 50.82 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 75.5 mt -92.38 139.33 30.71 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.24 157.95 27.69 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -69.37 -7.66 39.46 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.268 -0.27 . . . . 0.0 111.509 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.57 2.29 23.91 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.916 0.389 . . . . 0.0 110.979 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.421 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 46.1 t80 -57.89 147.79 61.97 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 1.7 Cg_endo -91.22 13.71 52.29 Favored 'Cis proline' 0 N--CA 1.515 2.743 0 CA-C-N 120.975 1.384 . . . . 0.0 114.653 0.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -80.04 -2.61 44.98 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.052 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.83 140.33 33.03 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -66.27 143.11 69.39 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 CA-C-N 121.56 1.593 . . . . 0.0 111.014 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.67 141.38 9.76 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.153 1.902 . . . . 0.0 112.26 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -93.07 129.7 43.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.465 ' SG ' HD12 ' A' ' 109' ' ' ILE . 52.6 t -120.65 141.8 50.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.763 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -127.67 132.16 49.72 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.581 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.475 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 42.8 t -90.41 131.8 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.01 100.02 2.62 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.128 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 64.7 Cg_endo -82.36 166.35 16.08 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 122.222 1.948 . . . . 0.0 112.837 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -145.71 171.3 14.95 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.8 p -57.32 -25.46 59.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 119.866 -0.734 . . . . 0.0 112.036 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 96.7 p -95.14 3.42 54.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.702 0.683 . . . . 0.0 110.794 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 39.3 ttm -141.93 122.02 13.78 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.048 0.452 . . . . 0.0 109.84 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 95.2 m -107.0 140.95 38.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.443 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 97' ' ' ILE . 3.9 tp -75.43 120.74 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -110.64 101.12 9.79 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.7 p -58.31 151.69 19.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.591 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.47 -132.13 1.49 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 119.774 -1.203 . . . . 0.0 112.644 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -86.81 -3.5 59.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -138.92 -25.94 0.86 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 119.402 1.001 . . . . 0.0 113.616 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 t -111.95 135.46 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 119.218 0.917 . . . . 0.0 110.198 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -90.54 -159.97 0.66 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.547 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.39 -8.24 55.34 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.8 -6.14 16.92 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.78 11.47 37.6 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.974 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -72.77 135.98 45.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.399 0.599 . . . . 0.0 110.063 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.465 HD12 ' SG ' ' A' ' 87' ' ' CYS . 69.9 mt -114.8 115.49 49.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 O-C-N 123.311 0.382 . . . . 0.0 110.718 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -115.21 138.77 50.56 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 134' ' ' VAL . 1.3 mp -130.88 130.96 22.96 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.475 -176.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.71 -32.45 55.24 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.125 1.217 . . . . 0.0 113.184 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -67.41 -30.12 69.79 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.26 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.77 -41.22 83.63 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.208 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -64.3 -34.31 77.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.2 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -100.81 2.71 41.41 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.539 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -68.72 124.21 23.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.921 0.867 . . . . 0.0 110.17 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -94.37 124.85 38.64 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.522 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 15.5 t-80 -80.83 125.3 80.48 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.643 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 9.5 Cg_endo -108.98 92.19 0.03 OUTLIER 'Cis proline' 0 N--CA 1.5 1.867 0 CA-C-N 120.791 1.318 . . . . 0.0 112.799 -2.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.88 -59.99 1.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.613 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -65.13 -40.93 95.12 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.412 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 58.54 164.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.25 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.554 HD12 ' OE2' ' A' ' 24' ' ' GLU . 1.4 mt -50.89 -48.57 60.39 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.311 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.72 -36.72 26.4 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -63.74 -40.65 98.72 Favored Glycine 0 N--CA 1.477 1.42 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 tp -62.53 -41.73 99.06 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -74.69 -45.87 43.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.619 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -68.85 -36.74 78.52 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.665 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 134' ' ' VAL . 56.1 t -66.99 -40.3 85.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.873 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.8 ttm -58.23 -43.24 87.63 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.434 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -60.3 -35.2 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.74 178.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.4 t -89.64 -50.1 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.677 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.534 HG13 ' CD1' ' A' ' 135' ' ' PHE . 4.7 p -65.21 -13.85 15.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.832 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.534 ' CD1' HG13 ' A' ' 134' ' ' VAL . 13.5 m-30 -106.78 -17.23 14.27 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.586 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.89 -27.89 73.51 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.82 -34.72 79.03 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.785 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -165.91 85.43 0.97 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -45.7 113.32 0.54 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.37 1.38 . . . . 0.0 110.533 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.6 0.44 8.68 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.511 1.474 . . . . 0.0 111.548 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.24 123.56 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.285 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.419 HG13 ' HE3' ' A' ' 11' ' ' MET . 85.6 t . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 120.908 0.385 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -95.21 157.65 15.8 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 86.6 mt-10 -63.13 -41.92 99.4 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.118 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.1 t -59.71 -49.87 76.06 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.044 0.926 . . . . 0.0 109.383 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -62.69 -28.2 69.77 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.744 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.814 HD23 HG13 ' A' ' 22' ' ' VAL . 59.3 tp -59.77 -42.67 93.8 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.766 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.9 mptp? -58.82 -39.89 82.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.148 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.11 -31.0 72.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.781 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.596 ' CB ' HD13 ' A' ' 39' ' ' LEU . 14.6 ptp -86.39 -14.78 42.39 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.622 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.679 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -125.94 16.5 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.83 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.3 t -59.78 -21.98 61.53 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.496 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -84.04 -15.96 45.64 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -70.09 152.18 44.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.003 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -70.02 -37.64 75.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.838 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 40.8 m-85 -110.65 60.66 0.61 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.564 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.4 ptp180 -66.44 -20.73 66.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.125 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -77.04 -52.06 9.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.8 tp -67.93 -41.0 83.24 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.151 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.677 ' O ' HG23 ' A' ' 25' ' ' THR . 66.2 m -61.13 -47.03 88.13 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.778 0.323 . . . . 0.0 110.789 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.814 HG13 HD23 ' A' ' 8' ' ' LEU . 40.3 t -63.25 -42.83 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.654 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -55.31 23.43 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 118.834 -1.147 . . . . 0.0 110.526 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -61.37 -31.83 71.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.367 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 21' ' ' THR . 23.5 p -66.86 -35.26 79.62 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.31 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 22' ' ' VAL . 53.0 t -57.77 -44.03 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.19 -39.88 88.11 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.307 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 124' ' ' LEU . 79.1 t -69.84 -43.36 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -88.25 -17.4 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.567 -178.827 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.2 m -82.35 -49.05 10.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.192 0.52 . . . . 0.0 109.617 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.531 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.3 tm? -81.89 -38.99 24.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.525 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -110.2 67.44 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -56.14 -18.92 11.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.953 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.31 -21.54 66.72 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.038 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.562 HD13 HD12 ' A' ' 128' ' ' ILE . 1.6 tp -94.15 113.18 25.08 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.19 119.02 43.2 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 119.181 0.9 . . . . 0.0 112.091 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 92.5 Cg_endo -78.29 137.53 15.14 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 CA-C-N 120.653 1.269 . . . . 0.0 112.282 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.539 HG23 ' OD1' ' A' ' 40' ' ' ASP . 27.0 m -126.19 150.9 32.07 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.596 HD13 ' CB ' ' A' ' 11' ' ' MET . 44.1 tp -97.78 119.3 36.13 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.113 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.539 ' OD1' HG23 ' A' ' 38' ' ' VAL . 10.5 m-20 -135.43 135.44 40.58 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.016 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.0 t -64.22 139.97 58.82 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.37 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.014 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 121.435 0.636 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -77.07 121.74 23.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.264 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -124.04 144.51 49.8 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.054 0.454 . . . . 0.0 110.31 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -100.2 141.22 33.33 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.646 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.413 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 6.2 p-10 -133.08 154.28 50.71 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.388 0.613 . . . . 0.0 111.863 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.481 ' HG ' HD23 ' A' ' 35' ' ' LEU . 4.6 mm? -93.49 124.94 37.82 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.575 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.4 m -139.29 136.98 35.46 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.44 -145.6 10.13 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.836 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 p -134.61 159.74 40.27 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 59' ' ' ILE . 1.3 pt -131.83 116.21 15.82 Favored Pre-proline 0 N--CA 1.471 0.594 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.178 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -71.97 124.4 10.08 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 N-CA-C 109.538 -0.986 . . . . 0.0 109.538 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.42 121.35 24.89 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.891 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.39 149.03 55.92 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.197 1.931 . . . . 0.0 110.429 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.7 109.7 1.09 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.521 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.96 40.59 25.62 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.439 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.72 13.84 80.22 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -134.71 127.86 31.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.5 m -112.02 133.1 54.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.84 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -113.89 150.63 33.37 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -95.16 108.72 20.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.492 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -97.21 116.16 65.9 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.34 124.77 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.658 2.238 . . . . 0.0 110.75 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.492 HG23 HG22 ' A' ' 70' ' ' ILE . 26.9 pt -132.79 147.99 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 119.421 -0.911 . . . . 0.0 111.994 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 63.8 m -123.88 121.58 35.73 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.071 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.81 114.41 28.61 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.489 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.413 ' CE3' ' HB3' ' A' ' 54' ' ' ASN . 48.3 m95 -102.1 115.29 30.23 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.1 mt -85.9 135.15 33.8 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -80.28 155.34 27.33 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -60.68 -17.18 46.18 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.746 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.61 -3.02 50.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.523 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -57.09 144.42 69.23 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.41 ' HG2' ' CD2' ' A' ' 119' ' ' HIS . 25.0 Cg_endo -92.04 9.13 60.74 Favored 'Cis proline' 0 N--CA 1.521 3.101 0 N-CA-C 115.936 1.475 . . . . 0.0 115.936 0.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.409 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 42.7 m-85 -76.94 -11.97 59.88 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.636 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.86 127.17 27.11 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.511 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -49.39 132.49 29.47 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 CA-C-N 121.21 1.468 . . . . 0.0 112.467 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HD2' HD11 ' A' ' 114' ' ' LEU . 96.6 Cg_endo -86.04 143.83 8.14 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 122.574 2.183 . . . . 0.0 111.878 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 86' ' ' ILE . 1.4 mp -97.43 132.97 40.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.39 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 46.1 t -116.47 143.57 45.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.176 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -127.89 129.95 47.74 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.954 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.28 121.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.82 107.53 1.35 Allowed Pre-proline 0 N--CA 1.474 0.744 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.019 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.03 156.64 13.27 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 CA-C-N 120.675 1.277 . . . . 0.0 112.772 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -136.14 171.69 14.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.43 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.8 t -58.55 -40.67 83.69 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.5 m -96.79 20.73 10.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.037 0.835 . . . . 0.0 111.126 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.0 ttm -137.96 141.16 40.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -137.29 162.76 32.65 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.174 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.433 ' N ' HG23 ' A' ' 96' ' ' THR . 67.9 mt -97.95 103.43 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -90.59 109.96 21.11 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.8 p -59.85 147.4 38.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.282 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.88 -145.3 4.15 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.518 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -64.14 -27.5 69.12 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.515 ' NE2' HG23 ' A' ' 103' ' ' VAL . 13.1 p-80 -132.63 -15.63 2.72 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 119.167 -1.013 . . . . 0.0 113.214 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.517 HG21 ' CB ' ' A' ' 140' ' ' PRO . 23.8 t -91.93 129.27 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.438 1.017 . . . . 0.0 111.375 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.429 ' O ' HG12 ' A' ' 103' ' ' VAL . 36.9 p-10 -89.72 -168.79 2.24 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.71 -22.79 25.83 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.683 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -82.24 -8.0 59.63 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.623 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.21 -0.7 62.18 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.098 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.404 ' N ' ' OD1' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -63.71 143.58 57.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -110.87 122.46 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -99.86 139.91 34.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.606 HD22 HG11 ' A' ' 134' ' ' VAL . 28.4 mt -139.55 117.92 8.78 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.83 -29.47 63.17 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.553 1.502 . . . . 0.0 114.056 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -69.23 -30.76 68.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.875 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.434 HD11 ' HD2' ' A' ' 85' ' ' PRO . 1.1 tt -71.75 -41.05 68.92 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.043 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -72.3 -25.5 61.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.309 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -102.23 -4.69 25.33 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.483 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 7.2 t90 -53.07 121.32 7.2 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.94 0.876 . . . . 0.0 110.503 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -96.42 106.61 18.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.491 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 44.9 t-80 -61.95 125.26 84.72 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.133 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 21.8 Cg_endo -111.05 90.78 0.03 OUTLIER 'Cis proline' 0 N--CA 1.488 1.201 0 CA-C-N 120.676 1.277 . . . . 0.0 112.831 -3.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -114.59 -55.2 2.51 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.428 -0.509 . . . . 0.0 112.142 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 p -70.54 -39.42 74.03 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.387 0.613 . . . . 0.0 110.767 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 t70 59.28 165.59 0.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.408 0.623 . . . . 0.0 111.091 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.9 tt -62.2 -43.68 98.29 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.566 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -52.12 -36.32 50.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.27 -39.52 97.82 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.2 tp -59.48 -40.99 88.78 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.562 HD12 HD13 ' A' ' 35' ' ' LEU . 1.2 mm -75.32 -49.91 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.206 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -63.74 -37.7 88.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.161 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 134' ' ' VAL . 54.4 t -66.29 -38.59 82.19 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 C-N-CA 119.465 -0.894 . . . . 0.0 108.712 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.4 tpp -58.48 -43.3 88.92 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.11 -43.54 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.453 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.3 t -77.78 -42.02 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.606 HG11 HD22 ' A' ' 111' ' ' LEU . 3.7 p -75.91 -13.22 14.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.014 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.526 ' CD1' HG13 ' A' ' 134' ' ' VAL . 6.2 m-30 -104.81 -18.37 14.26 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.602 177.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.31 -20.83 79.44 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -68.72 -36.16 78.08 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.653 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -164.47 90.91 1.03 Allowed Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -44.9 109.96 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.304 1.336 . . . . 0.0 110.382 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.517 ' CB ' HG21 ' A' ' 103' ' ' VAL . 34.9 Cg_exo -58.02 -26.14 73.81 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.77 1.647 . . . . 0.0 109.942 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.58 146.91 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.957 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 9.0 p90 . . . . . 0 N--CA 1.476 0.829 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.997 -179.86 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.443 -0.779 0 CA-C-O 121.401 0.62 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 p -100.46 158.12 16.14 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.492 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.4 mt-10 -62.76 -42.04 99.5 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.525 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 t -59.81 -48.7 80.63 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.839 0.828 . . . . 0.0 109.593 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -62.42 -31.98 72.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.307 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.846 HD23 HG13 ' A' ' 22' ' ' VAL . 25.1 tp -57.86 -40.61 80.56 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.538 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.7 mptp? -60.83 -41.79 96.46 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.441 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.06 -37.84 86.53 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.465 0.65 . . . . 0.0 109.902 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.797 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -69.83 -38.57 76.58 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.477 -177.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.3 m -112.65 16.1 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -65.13 -25.51 67.79 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.368 0.604 . . . . 0.0 109.987 178.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.05 -13.57 62.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.037 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.476 ' CE1' HG12 ' A' ' 12' ' ' VAL . 14.2 m-85 -82.22 159.93 23.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -81.9 -27.67 33.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.781 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CZ ' ' CE1' ' A' ' 82' ' ' TYR . 62.5 m-85 -113.77 58.57 0.67 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -65.59 -24.93 67.19 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -79.46 -50.45 10.76 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 121.419 -0.801 . . . . 0.0 112.168 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 20' ' ' LEU . 13.0 tp -65.27 -40.62 94.15 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.548 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -61.56 -46.48 89.72 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.301 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.846 HG13 HD23 ' A' ' 8' ' ' LEU . 7.6 t -61.36 -45.03 99.45 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 CA-C-O 121.089 0.471 . . . . 0.0 110.166 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -40.15 91.4 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.705 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -38.13 80.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.328 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 29' ' ' ILE . 17.7 p -67.58 -33.73 75.6 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.738 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.07 -44.81 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.519 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -60.77 -37.49 82.05 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.098 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.438 HG21 HD13 ' A' ' 124' ' ' LEU . 78.9 t -70.77 -44.18 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.93 -22.11 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.004 -1.079 . . . . 0.0 111.615 -178.299 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.2 m -72.62 -43.64 63.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.939 0.4 . . . . 0.0 110.645 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -88.0 -38.64 15.33 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.749 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.7 66.74 0.65 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -55.99 -17.85 7.83 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.093 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.38 -21.38 66.61 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.966 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.471 HD23 HD13 ' A' ' 55' ' ' LEU . 3.9 tp -89.69 113.62 25.14 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -109.11 125.39 31.63 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-N 119.686 1.13 . . . . 0.0 111.829 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.68 136.31 13.53 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.323 1.348 . . . . 0.0 112.66 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.3 133.65 68.28 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.797 HD13 ' SD ' ' A' ' 11' ' ' MET . 21.8 tp -83.11 118.7 23.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.94 132.89 50.75 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.3 m -62.44 140.42 58.58 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.625 -177.713 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.0 ttm105 . . . . . 0 CA--C 1.517 -0.316 0 CA-C-O 121.05 0.452 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -72.97 117.33 14.57 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.419 HD21 ' O ' ' A' ' 76' ' ' LEU . 13.3 tp -115.91 121.85 43.56 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -83.81 137.04 33.9 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -132.71 154.73 49.89 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.29 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.471 HD13 HD23 ' A' ' 35' ' ' LEU . 7.6 mt -102.2 122.26 43.85 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.8 m -135.1 137.52 42.91 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.19 -147.05 10.7 Favored Glycine 0 N--CA 1.47 0.955 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.909 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 p -132.75 158.45 42.37 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.447 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.3 pt -131.6 116.99 16.3 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.168 177.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -71.28 128.02 14.13 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.832 1.021 . . . . 0.0 109.801 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 74.4 t -127.1 119.52 22.22 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.696 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -64.48 146.1 88.85 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.064 1.842 . . . . 0.0 109.534 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -161.83 106.96 1.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.867 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.4 36.53 13.36 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.83 -6.98 79.25 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.438 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -117.5 146.08 43.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.0 m -123.31 134.36 54.06 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.951 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -116.62 149.92 38.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.27 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.71 105.26 17.38 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.452 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -93.9 120.58 65.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.55 123.59 3.39 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.818 2.345 . . . . 0.0 110.88 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.452 HG23 HG22 ' A' ' 70' ' ' ILE . 32.5 pt -128.96 146.04 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 119.131 -1.027 . . . . 0.0 112.168 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.4 m -120.54 122.47 40.68 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-O 121.67 0.747 . . . . 0.0 109.634 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.19 112.51 25.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.165 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -107.67 123.41 48.47 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.419 ' O ' HD21 ' A' ' 52' ' ' LEU . 62.1 mt -90.88 130.98 36.78 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.659 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mt -72.72 153.31 41.21 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.376 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -60.33 -12.79 10.08 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p -103.28 -1.22 29.16 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -48.23 146.24 4.68 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -95.6 19.46 33.06 Favored 'Cis proline' 0 N--CA 1.517 2.885 0 N-CA-C 116.616 1.737 . . . . 0.0 116.616 2.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.424 ' CE1' ' CZ ' ' A' ' 17' ' ' TYR . 46.3 m-85 -80.52 -1.03 40.14 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.192 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.31 126.13 24.65 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.601 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -50.87 137.49 43.19 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 121.66 1.629 . . . . 0.0 109.67 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.81 144.13 19.05 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 121.824 1.682 . . . . 0.0 111.852 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mt -88.46 130.6 37.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.596 0.713 . . . . 0.0 109.276 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.8 t -119.53 136.97 54.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.496 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -123.67 129.86 51.76 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.376 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.0 t -93.11 120.97 43.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -63.56 107.27 1.19 Allowed Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.689 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -84.13 158.71 13.32 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.549 1.5 . . . . 0.0 112.262 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.7 p -139.15 174.48 10.47 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.928 0.394 . . . . 0.0 110.66 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -59.35 -39.92 84.76 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -101.12 12.08 38.28 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.985 0.811 . . . . 0.0 111.174 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 8.7 mmm -130.54 119.98 23.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -118.68 162.71 17.97 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.181 -178.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.448 ' N ' HG23 ' A' ' 96' ' ' THR . 80.0 mt -97.79 108.02 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -91.19 106.62 18.64 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.7 p -62.55 142.35 58.02 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.49 -139.29 2.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.157 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -66.46 -25.71 66.85 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.544 ' NE2' HG23 ' A' ' 103' ' ' VAL . 5.9 p-80 -133.32 -20.85 2.08 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.627 HG21 ' HB2' ' A' ' 140' ' ' PRO . 22.2 t -91.93 133.56 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.241 0.928 . . . . 0.0 111.332 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -98.13 -168.72 1.7 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.001 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.82 -29.66 29.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -84.19 3.13 36.53 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.821 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.45 6.18 58.72 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.432 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -59.13 137.47 57.94 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.991 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -114.95 112.98 42.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.633 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -99.9 140.73 33.69 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.962 HD22 HG11 ' A' ' 134' ' ' VAL . 32.2 mt -137.77 121.68 11.77 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.832 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.06 -39.02 25.26 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.666 1.577 . . . . 0.0 113.611 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -61.55 -31.27 71.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.666 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.89 -42.78 84.93 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.472 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -62.46 -36.48 82.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.604 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -95.74 -0.22 51.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.654 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -62.76 125.27 23.39 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.796 0.807 . . . . 0.0 110.228 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -109.03 106.84 16.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.858 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 17.9 t-80 -60.64 124.05 77.16 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.451 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 7.8 Cg_endo -108.57 91.67 0.03 OUTLIER 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 120.354 1.162 . . . . 0.0 112.646 -2.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -113.49 -62.77 1.54 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.392 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.0 t -67.13 -41.17 86.61 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.23 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.8 t70 68.04 166.27 0.24 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.751 0.786 . . . . 0.0 112.008 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.2 tt -64.11 -44.58 91.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.319 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 125' ' ' LEU . 0.6 OUTLIER -52.42 -38.45 59.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.521 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.07 -40.48 98.57 Favored Glycine 0 N--CA 1.478 1.499 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.7 tp -59.75 -41.17 90.41 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.54 -46.98 46.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.854 -0.738 . . . . 0.0 111.886 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -68.16 -35.72 78.5 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 134' ' ' VAL . 53.4 t -66.08 -37.5 79.91 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.1 tpp -58.9 -44.34 91.19 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.447 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -63.41 -32.52 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.734 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.54 -46.04 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.343 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.962 HG11 HD22 ' A' ' 111' ' ' LEU . 4.5 p -70.1 -13.79 17.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.988 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.482 ' CD1' HG13 ' A' ' 134' ' ' VAL . 6.0 m-30 -103.25 -17.26 15.4 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.258 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.13 -31.05 54.01 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.73 -37.9 89.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.745 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -155.85 82.26 3.7 Favored Pre-proline 0 N--CA 1.447 -0.603 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -44.49 112.36 0.35 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.818 1.679 . . . . 0.0 111.144 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.627 ' HB2' HG21 ' A' ' 103' ' ' VAL . 32.2 Cg_endo -67.21 -22.32 46.92 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.656 1.57 . . . . 0.0 111.698 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.8 m -128.48 140.49 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.853 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.2 p90 . . . . . 0 N--CA 1.473 0.703 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.107 -179.642 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 CA--C 1.514 -0.428 0 CA-C-O 121.077 0.465 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -93.54 161.13 14.49 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.486 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 3.2 mm-40 -65.82 -43.04 89.79 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.837 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -59.57 -48.52 81.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 122.034 0.921 . . . . 0.0 109.126 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -62.9 -29.09 70.5 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.9 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.848 HD23 HG13 ' A' ' 22' ' ' VAL . 65.9 tp -60.32 -42.24 95.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.728 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.635 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.6 mptp? -59.69 -39.39 84.39 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.898 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -61.76 -33.88 74.86 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.408 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.691 ' CB ' HD13 ' A' ' 39' ' ' LEU . 17.5 ptp -85.48 -13.3 49.54 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.4 m -128.16 16.98 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.882 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -61.06 -38.25 85.52 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.111 0.481 . . . . 0.0 111.222 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -62.58 -18.72 62.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.825 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -72.26 153.15 41.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.92 0.391 . . . . 0.0 111.52 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -78.68 -29.21 45.44 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.016 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.412 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 45.0 m-85 -112.2 55.32 0.68 Allowed 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.987 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 22' ' ' VAL . 17.4 ptt180 -63.65 -27.55 69.3 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.73 -52.18 22.59 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -40.09 83.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.324 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.3 m -61.73 -46.81 88.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.093 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.848 HG13 HD23 ' A' ' 8' ' ' LEU . 51.7 t -64.34 -46.95 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.034 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 tmt_? -63.22 -41.75 99.18 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.426 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -66.7 -37.99 85.85 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.258 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.644 ' O ' HG23 ' A' ' 29' ' ' ILE . 16.5 p -64.17 -33.86 76.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.07 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.58 -44.75 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.097 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -60.58 -37.82 82.57 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.902 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.615 HG21 HD23 ' A' ' 124' ' ' LEU . 73.6 t -69.97 -44.08 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.89 -18.76 8.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 118.807 -1.157 . . . . 0.0 111.447 -178.475 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.3 m -74.27 -44.81 51.3 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.068 0.461 . . . . 0.0 110.07 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.783 HD23 HD21 ' A' ' 125' ' ' LEU . 24.7 tp -87.02 -37.86 17.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.407 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -114.56 67.58 0.69 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.864 0.364 . . . . 0.0 110.252 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -56.3 -17.33 7.38 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.084 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -65.65 -21.0 66.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.896 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.433 ' CD2' HD13 ' A' ' 55' ' ' LEU . 2.0 tp -95.99 113.65 25.28 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -114.44 136.74 22.38 Favored Pre-proline 0 C--N 1.357 0.923 0 CA-C-N 119.596 1.089 . . . . 0.0 111.614 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -79.75 136.75 12.26 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.003 1.802 . . . . 0.0 113.033 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.7 t -129.21 138.07 55.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.691 HD13 ' CB ' ' A' ' 11' ' ' MET . 22.7 tp -89.51 113.69 25.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.115 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -119.84 139.64 52.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.407 0.622 . . . . 0.0 112.417 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.1 m -71.71 140.79 49.74 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.463 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.7 t80 . . . . . 0 N--CA 1.476 0.859 0 CA-C-N 118.388 0.54 . . . . 0.0 110.077 179.85 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.3 ttm-85 . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 120.949 0.404 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -79.14 122.6 26.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.523 0.678 . . . . 0.0 109.883 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.549 HD23 ' HE3' ' A' ' 75' ' ' TRP . 12.0 tp -120.99 124.38 44.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.693 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -85.28 140.76 30.58 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.014 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -136.73 147.0 46.47 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.012 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 35' ' ' LEU . 6.7 mt -92.96 127.45 38.47 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.4 m -138.81 138.68 37.78 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.26 -143.09 8.19 Favored Glycine 0 N--CA 1.466 0.661 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.459 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.1 p -134.36 160.14 38.87 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -132.37 116.11 15.16 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.036 -0.983 . . . . 0.0 108.927 177.022 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -69.58 123.28 10.0 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 120.822 1.015 . . . . 0.0 110.691 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.0 t -124.0 106.76 31.11 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.113 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.75 147.02 13.48 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 123.307 2.671 . . . . 0.0 113.21 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -163.93 118.84 1.55 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.953 0.882 . . . . 0.0 111.282 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.67 41.0 25.37 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 -1.44 87.05 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.419 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -119.28 129.29 54.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.239 0.52 . . . . 0.0 109.841 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.5 m -120.82 129.62 53.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.499 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -108.59 145.28 35.11 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.963 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -95.35 100.72 12.46 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.515 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -88.68 118.09 68.99 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.04 124.12 2.08 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.779 2.319 . . . . 0.0 110.417 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.515 HG23 HG22 ' A' ' 70' ' ' ILE . 29.3 pt -134.23 148.63 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.182 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.0 m -118.48 122.03 41.72 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 109.533 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.48 106.12 17.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.996 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.549 ' HE3' HD23 ' A' ' 52' ' ' LEU . 53.8 m95 -94.18 129.82 40.64 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.536 ' O ' HD21 ' A' ' 52' ' ' LEU . 1.3 mp -98.26 141.81 30.71 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.228 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.14 145.61 30.03 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -57.68 -9.87 1.37 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.4 p -114.89 17.31 17.02 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.9 0.381 . . . . 0.0 111.876 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -57.74 143.08 77.16 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -93.41 7.56 57.2 Favored 'Cis proline' 0 N--CA 1.515 2.792 0 CA-C-N 120.99 1.389 . . . . 0.0 115.303 0.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.412 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 36.9 m-85 -73.86 -7.65 53.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.046 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.58 115.12 37.65 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -49.98 134.66 36.08 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 CA-C-N 121.062 1.415 . . . . 0.0 112.373 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.23 143.95 14.34 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.216 1.944 . . . . 0.0 111.684 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.482 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -98.57 152.1 4.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.247 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.7 t -138.52 135.7 35.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.026 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -118.4 128.7 54.88 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.816 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.445 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 61.2 t -89.69 129.66 40.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.97 99.94 2.54 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 123.267 0.355 . . . . 0.0 110.945 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 43.8 Cg_endo -84.89 150.88 11.14 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.652 1.568 . . . . 0.0 113.058 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.2 p -116.25 168.08 10.44 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.719 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.4 m -56.03 -34.05 65.51 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.3 m -87.3 20.89 2.61 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.781 0.718 . . . . 0.0 110.591 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 30.9 ttm -144.76 146.58 32.22 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.0 m -124.56 140.7 52.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 97' ' ' ILE . 1.7 tp -85.84 103.97 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.243 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -87.82 102.14 14.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.258 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 74.2 p -72.21 148.68 45.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.612 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -172.86 -138.97 2.72 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -87.89 -3.84 58.89 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -122.21 -30.28 4.04 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.294 0.952 . . . . 0.0 112.242 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 t -112.04 134.65 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.882 0.765 . . . . 0.0 109.268 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -93.01 162.04 14.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.031 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.95 -32.44 73.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.467 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -76.93 -6.23 51.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.7 5.62 59.93 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.844 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.15 147.48 40.44 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.5 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 86.0 mt -106.36 121.44 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.125 0.488 . . . . 0.0 111.236 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -102.35 120.27 40.22 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mt -126.75 122.34 23.47 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.258 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.04 -30.08 85.4 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 121.474 1.449 . . . . 0.0 114.363 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -66.67 -31.0 71.39 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.815 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 tt -69.59 -41.36 75.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.967 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -66.98 -28.3 68.15 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.375 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -104.29 1.59 30.56 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.521 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -68.95 125.94 28.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.872 0.844 . . . . 0.0 110.221 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -98.07 130.16 44.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.03 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 11.8 t-160 -79.06 124.27 84.71 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.537 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 12.1 Cg_endo -112.06 92.1 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.563 0 CA-C-N 120.929 1.367 . . . . 0.0 112.786 -2.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -113.77 -52.8 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.088 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.9 p -74.62 -40.07 61.76 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.368 0.604 . . . . 0.0 110.694 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 59.47 164.65 0.05 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.956 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.615 HD23 HG21 ' A' ' 28' ' ' VAL . 6.2 tp -58.29 -44.94 88.72 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.104 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.783 HD21 HD23 ' A' ' 31' ' ' LEU . 9.0 tp -52.72 -35.43 55.77 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -64.7 -38.97 96.31 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.9 tp -58.91 -40.3 84.1 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.487 -0.419 . . . . 0.0 111.877 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -76.53 -45.71 32.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.343 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -69.2 -34.34 74.73 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 126' ' ' GLY . 55.7 t -66.67 -38.58 81.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 48.1 tpp -60.67 -44.0 97.0 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.434 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.1 mp -63.73 -38.27 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.385 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.7 t -82.25 -48.25 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 130' ' ' VAL . 2.5 p -69.17 -16.17 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.717 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.5 ' HZ ' HG23 ' A' ' 109' ' ' ILE . 12.6 m-30 -107.27 -19.68 13.52 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.001 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.93 -34.61 90.4 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -62.91 -37.89 88.77 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.997 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -154.87 90.38 3.06 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -45.87 116.59 1.48 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.419 1.412 . . . . 0.0 110.609 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.92 -14.5 35.65 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.627 1.552 . . . . 0.0 111.54 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.24 133.2 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.332 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.807 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 120.999 0.428 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -95.66 158.41 15.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -65.28 -39.21 92.29 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.65 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.8 m -60.08 -41.98 93.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.352 1.072 . . . . 0.0 109.139 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -68.5 -39.64 81.19 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.052 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.034 HD23 HG13 ' A' ' 22' ' ' VAL . 12.1 tp -53.74 -33.53 56.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.442 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 4.7 mmtt -68.11 -47.7 67.48 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.031 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.98 -34.87 73.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.633 0.73 . . . . 0.0 110.216 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.829 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.9 mmm -64.51 -37.06 86.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.042 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -122.17 23.91 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.565 0.221 . . . . 0.0 110.941 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 9' ' ' LYS . 99.9 p -66.24 -23.72 66.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.543 0.211 . . . . 0.0 111.345 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -77.53 -18.74 56.72 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.326 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.525 ' OH ' HD22 ' A' ' 52' ' ' LEU . 39.1 m-85 -69.93 143.34 52.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.469 0.652 . . . . 0.0 111.603 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -21.74 64.05 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.339 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 96.7 m-85 -121.89 55.43 1.11 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.591 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.7 ptp180 -65.34 -26.18 67.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 119.871 -0.732 . . . . 0.0 112.808 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -67.02 -56.13 11.43 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 20' ' ' LEU . 13.0 mt -65.68 -40.3 92.2 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.47 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 25' ' ' THR . 75.3 m -61.95 -49.68 75.18 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.708 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.034 HG13 HD23 ' A' ' 8' ' ' LEU . 53.3 t -64.26 -47.56 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 120.513 0.197 . . . . 0.0 110.74 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -65.1 -40.9 95.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.37 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -63.99 -38.75 92.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.694 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.664 ' O ' HG23 ' A' ' 29' ' ' ILE . 26.2 p -66.91 -38.69 86.71 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.74 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 30' ' ' THR . 55.7 t -56.58 -44.39 80.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.489 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -62.86 -39.52 94.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.702 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 124' ' ' LEU . 51.6 t -66.78 -44.09 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -81.95 -13.12 12.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.3 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.8 p -80.98 -48.68 11.93 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.788 0.328 . . . . 0.0 110.589 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 125' ' ' LEU . 32.5 tp -88.09 -36.59 16.84 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.399 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -109.78 66.19 0.63 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -57.17 -19.16 18.79 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.134 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -66.46 -18.18 65.21 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.384 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.599 HD13 HD12 ' A' ' 128' ' ' ILE . 2.6 tp -98.26 113.51 25.47 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -110.63 135.87 20.69 Favored Pre-proline 0 C--N 1.354 0.801 0 CA-C-N 119.354 0.979 . . . . 0.0 111.391 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.87 139.41 22.07 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.462 1.441 . . . . 0.0 111.794 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 p -133.79 147.06 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.829 HD13 ' SD ' ' A' ' 11' ' ' MET . 22.3 tp -99.1 119.67 38.22 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.585 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -121.69 135.77 54.95 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.039 0.447 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.5 p -70.92 139.79 50.8 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.0 t80 . . . . . 0 C--O 1.236 0.374 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.725 -179.569 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 110.097 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.611 ' CG ' HD11 ' A' ' 39' ' ' LEU . 7.0 tp10 -85.1 106.32 16.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.525 HD22 ' OH ' ' A' ' 15' ' ' TYR . 36.6 mt -110.13 142.9 40.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.454 0.645 . . . . 0.0 111.349 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.474 ' SD ' HD12 ' A' ' 8' ' ' LEU . 55.3 ttp -105.61 142.42 35.38 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.804 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -136.35 154.47 50.83 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.561 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.453 HD13 HD23 ' A' ' 35' ' ' LEU . 7.3 mt -95.41 120.18 35.2 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.3 m -132.9 135.19 45.43 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.22 -149.21 11.94 Favored Glycine 0 N--CA 1.464 0.51 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.481 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.0 p -133.11 158.36 42.99 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.433 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.5 pt -129.12 116.03 18.82 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.27 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -72.48 125.6 10.82 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 N-CA-C 109.495 -1.002 . . . . 0.0 109.495 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.17 126.77 21.65 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 119.688 -0.805 . . . . 0.0 112.001 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.83 148.66 46.49 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.271 1.981 . . . . 0.0 110.498 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.93 112.61 1.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.609 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.96 32.01 11.93 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.88 -0.513 . . . . 0.0 111.857 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.51 -10.21 67.91 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -110.32 137.78 47.58 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.9 m -115.27 131.72 56.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.671 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -114.6 152.38 31.92 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.296 0.569 . . . . 0.0 110.906 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -98.92 103.81 15.8 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.447 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -91.13 118.67 68.68 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -85.55 126.45 3.06 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.786 2.324 . . . . 0.0 110.944 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.447 HG23 HG22 ' A' ' 70' ' ' ILE . 30.5 pt -133.74 149.86 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.819 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 m -124.05 122.55 38.18 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.762 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.2 112.22 25.14 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.315 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -103.01 125.41 49.75 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.2 mt -88.12 140.04 29.89 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.898 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 tp -93.91 143.69 26.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -48.27 -18.29 0.2 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.68 16.94 25.19 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -69.84 144.58 93.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -92.87 4.27 60.21 Favored 'Cis proline' 0 N--CA 1.514 2.694 0 CA-C-N 121.426 1.545 . . . . 0.0 115.422 1.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 36.0 m-85 -73.34 -15.62 61.38 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.637 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.23 120.26 44.81 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.71 134.4 33.95 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.253 1.483 . . . . 0.0 111.701 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.08 145.11 21.72 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.956 1.77 . . . . 0.0 110.76 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.33 131.52 41.89 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 119.179 -1.009 . . . . 0.0 109.545 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.7 m -111.86 137.83 49.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.672 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -126.5 128.26 46.64 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.225 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.53 127.52 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.48 109.04 12.51 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.72 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.25 161.56 13.25 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 122.149 1.899 . . . . 0.0 112.882 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.9 p -133.43 173.24 11.69 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.7 m -57.94 -39.27 77.63 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 120.136 -0.626 . . . . 0.0 112.252 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.7 p -92.24 0.52 57.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.64 0.654 . . . . 0.0 111.866 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -130.66 125.59 34.39 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.474 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -113.97 167.44 10.66 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.348 -179.681 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.474 ' N ' HG23 ' A' ' 96' ' ' THR . 5.8 mm -92.73 105.3 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.546 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -86.71 108.66 18.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.498 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.6 p -67.42 140.16 57.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.418 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.63 -146.78 4.41 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -71.55 -22.2 61.79 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.554 ' NE2' HG23 ' A' ' 103' ' ' VAL . 3.2 p-80 -123.8 -25.0 4.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.329 -0.949 . . . . 0.0 112.914 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.554 HG23 ' NE2' ' A' ' 102' ' ' HIS . 14.2 t -91.25 131.39 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.423 1.01 . . . . 0.0 110.671 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -95.31 -163.4 1.04 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.605 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.08 -13.53 47.04 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.39 -1.55 23.14 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.371 -0.206 . . . . 0.0 110.735 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.76 0.08 42.36 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.767 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.66 128.99 24.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.707 0.754 . . . . 0.0 109.898 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.36 114.5 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 O-C-N 123.264 0.353 . . . . 0.0 110.411 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -96.87 134.3 40.37 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.756 HD22 HG11 ' A' ' 134' ' ' VAL . 33.1 mt -137.71 118.86 10.61 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.859 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -47.51 -38.91 28.61 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 121.793 1.662 . . . . 0.0 114.037 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.83 -29.55 69.56 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.174 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.62 -43.76 75.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.743 0.306 . . . . 0.0 111.645 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -69.35 -28.23 66.03 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.689 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -103.97 4.3 34.43 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.989 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.417 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.0 t90 -68.62 121.65 16.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.717 0.77 . . . . 0.0 109.683 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -90.49 122.9 33.73 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.245 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -79.56 126.78 80.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.738 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -107.7 92.67 0.04 OUTLIER 'Cis proline' 0 N--CA 1.499 1.801 0 CA-C-N 120.802 1.322 . . . . 0.0 112.649 -2.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -115.12 -61.31 1.77 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.586 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.3 t -68.97 -33.82 74.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.762 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 p30 47.82 -177.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.82 0.819 . . . . 0.0 111.962 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 28' ' ' VAL . 2.7 tt -68.28 -39.56 82.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.137 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.414 HD11 HD23 ' A' ' 31' ' ' LEU . 8.2 tt -57.79 -38.74 76.03 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -63.55 -39.28 97.46 Favored Glycine 0 N--CA 1.479 1.561 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.0 tp -58.22 -40.57 82.01 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.427 -0.455 . . . . 0.0 111.768 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.599 HD12 HD13 ' A' ' 35' ' ' LEU . 1.1 mm -72.71 -49.43 40.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.848 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -65.54 -35.96 82.39 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 126' ' ' GLY . 53.4 t -66.86 -37.39 79.34 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 60.9 tpp -58.54 -43.64 89.33 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.433 HD11 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -63.07 -42.77 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.564 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.8 t -77.19 -44.07 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.756 HG11 HD22 ' A' ' 111' ' ' LEU . 2.6 p -73.62 -13.64 16.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.015 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.547 ' CD1' HG13 ' A' ' 134' ' ' VAL . 6.6 m-30 -105.85 -17.59 14.32 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.209 -0.996 . . . . 0.0 109.703 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.69 -34.44 89.64 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.03 -35.5 81.38 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.604 -0.298 . . . . 0.0 110.711 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -155.95 116.52 2.23 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.47 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -75.12 120.48 6.05 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 N-CA-C 108.648 -1.328 . . . . 0.0 108.648 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.524 ' CB ' HG21 ' A' ' 103' ' ' VAL . 36.3 Cg_endo -67.94 -19.05 46.57 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.066 1.177 . . . . 0.0 111.217 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.92 147.95 29.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.56 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.4 p90 . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.66 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.9 t . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 121.21 0.528 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.1 156.01 16.8 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.504 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 57.7 mp0 -63.0 -41.51 99.6 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.97 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.8 p -57.38 -47.99 80.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.165 0.984 . . . . 0.0 109.379 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -62.79 -34.52 77.43 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.778 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.939 HD23 HG13 ' A' ' 22' ' ' VAL . 21.1 tp -55.97 -38.39 70.33 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.625 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 3.1 mptp? -63.64 -42.8 98.09 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.331 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.47 -36.36 83.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.142 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.807 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.61 -36.76 84.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.947 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -119.8 23.18 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.795 0.331 . . . . 0.0 111.45 -179.109 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 t -58.8 -25.42 63.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.575 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -64.84 -21.45 66.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.709 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.422 ' HE1' HD23 ' A' ' 52' ' ' LEU . 2.6 m-85 -67.89 150.57 48.39 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.95 -29.6 70.75 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.058 0.456 . . . . 0.0 112.175 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' HD2' ' H ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -138.0 69.03 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.097 0.959 . . . . 0.0 111.73 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -57.69 -25.31 60.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.89 -41.67 97.65 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.027 -0.42 . . . . 0.0 111.497 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 tp -71.68 -43.32 66.2 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.447 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 m -62.69 -46.77 86.61 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.33 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.939 HG13 HD23 ' A' ' 8' ' ' LEU . 40.8 t -62.43 -44.1 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 120.6 0.238 . . . . 0.0 110.428 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.17 -41.99 89.71 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.682 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.83 -39.57 93.79 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.248 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.606 ' O ' HG23 ' A' ' 29' ' ' ILE . 40.9 p -67.89 -38.33 82.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.46 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.15 -44.12 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.496 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -60.72 -38.75 86.15 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.138 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.37 -45.3 70.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -84.78 -22.43 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.989 -178.142 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.8 m -72.18 -45.68 59.38 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.81 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.3 tp -84.47 -37.74 21.0 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.11 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -114.43 66.93 0.68 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -57.76 -17.58 16.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.323 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -65.65 -16.34 63.64 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.26 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 tp -96.36 125.58 40.96 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -118.27 129.27 25.47 Favored Pre-proline 0 C--N 1.359 0.995 0 CA-C-N 119.814 1.188 . . . . 0.0 111.955 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.09 140.23 15.63 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 121.855 1.703 . . . . 0.0 112.592 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.2 p -136.84 141.2 41.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.221 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.807 HD13 ' SD ' ' A' ' 11' ' ' MET . 14.2 tp -82.66 119.22 24.02 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.442 ' HB2' ' ND2' ' A' ' 54' ' ' ASN . 97.2 m-20 -119.75 137.81 53.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.212 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.5 m -76.39 141.23 41.52 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.8 t80 . . . . . 0 C--O 1.239 0.51 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.994 -179.284 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.5 ttm-85 . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 121.216 0.532 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -87.74 111.23 21.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.226 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.422 HD23 ' HE1' ' A' ' 15' ' ' TYR . 25.8 mt -111.53 140.03 46.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.413 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -92.75 138.33 31.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.496 ' ND2' ' CZ3' ' A' ' 75' ' ' TRP . 45.4 m-20 -130.05 153.15 48.74 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.023 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.88 119.16 34.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.6 m -130.23 136.81 49.6 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.928 0.394 . . . . 0.0 112.021 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.46 -147.96 13.61 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.606 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.564 HG21 ' OD1' ' A' ' 69' ' ' ASN . 22.0 p -133.29 161.09 35.42 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.46 116.6 18.53 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.494 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -72.39 126.08 11.3 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 CA-C-N 120.037 1.049 . . . . 0.0 110.193 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.0 t -128.13 125.87 23.54 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.583 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.67 150.0 55.88 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.184 1.923 . . . . 0.0 110.294 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -162.84 106.5 1.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.31 0.576 . . . . 0.0 111.746 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 52.68 39.29 28.16 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.939 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.88 -2.37 74.82 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -119.64 134.16 55.35 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -114.59 131.92 56.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.063 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -113.34 150.05 33.14 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.668 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.564 ' OD1' HG21 ' A' ' 58' ' ' THR . 4.6 t-20 -94.12 107.05 19.01 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.516 HG22 HG23 ' A' ' 72' ' ' ILE . 1.5 mp -90.22 116.23 65.89 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.356 -177.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.31 124.69 4.88 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 122.553 2.168 . . . . 0.0 111.381 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.516 HG23 HG22 ' A' ' 70' ' ' ILE . 31.4 pt -135.89 148.68 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.918 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 63.0 m -125.24 125.04 42.96 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.4 0.619 . . . . 0.0 109.884 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.62 115.75 30.69 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.304 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.496 ' CZ3' ' ND2' ' A' ' 54' ' ' ASN . 61.1 m95 -103.8 126.33 50.85 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.2 mt -94.5 139.82 30.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.217 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mt -79.65 160.12 26.46 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -59.94 -13.96 13.53 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 p -120.77 18.01 11.89 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -59.5 148.14 74.81 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.403 ' HD2' ' OH ' ' A' ' 17' ' ' TYR . 20.0 Cg_endo -92.89 10.26 56.32 Favored 'Cis proline' 0 N--CA 1.509 2.417 0 CA-C-N 121.333 1.512 . . . . 0.0 115.415 -0.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.63 -16.97 64.44 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 118.665 -1.214 . . . . 0.0 110.695 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -116.14 128.06 26.28 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.362 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -46.81 129.62 14.68 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 CA-C-N 121.269 1.489 . . . . 0.0 113.179 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -82.78 148.67 13.93 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.634 2.223 . . . . 0.0 111.401 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -96.45 153.8 3.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.601 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.11 136.24 24.88 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.624 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -120.42 137.79 54.12 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.703 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.46 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -88.04 125.18 41.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -64.22 104.61 0.55 Allowed Pre-proline 0 N--CA 1.475 0.805 0 CA-C-O 119.162 -0.446 . . . . 0.0 110.631 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 48.3 Cg_endo -88.93 157.99 5.95 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.56 1.507 . . . . 0.0 112.783 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.9 t -157.44 161.67 38.94 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.289 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.6 m -56.36 -23.02 34.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -98.45 6.66 47.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.653 0.66 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.8 mmm -131.37 140.14 49.63 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.1 m -128.77 147.37 50.78 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.744 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 93.2 mt -101.09 117.12 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.083 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -101.41 106.89 18.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.3 p -57.47 148.44 23.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.754 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -161.26 -140.36 2.86 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.116 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -88.45 -3.42 58.83 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -135.46 -29.14 1.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.619 1.099 . . . . 0.0 113.617 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.29 144.31 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 119.036 0.835 . . . . 0.0 110.247 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -98.09 159.6 14.83 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.04 79.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.418 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -73.92 -5.51 41.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.169 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.62 6.23 58.49 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.418 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 143.1 34.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.939 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 98.3 mt -106.55 119.88 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.177 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.23 139.67 50.95 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.03 126.25 18.55 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 118.49 0.586 . . . . 0.0 112.183 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.68 -38.87 37.62 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 121.735 1.623 . . . . 0.0 114.07 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -62.43 -31.83 72.59 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.861 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 tt -69.66 -41.59 75.35 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.371 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -66.3 -29.09 69.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.606 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -101.54 -3.29 28.75 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.694 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.404 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.1 t90 -67.56 127.5 32.96 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.924 0.868 . . . . 0.0 110.475 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.37 130.24 43.53 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.776 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 78.7 t60 -80.21 126.13 79.9 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.33 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 13.2 Cg_endo -108.33 93.59 0.04 OUTLIER 'Cis proline' 0 N--CA 1.498 1.787 0 CA-C-N 120.794 1.319 . . . . 0.0 112.539 -2.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -113.99 -62.39 1.6 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.308 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.1 p -70.3 -40.11 74.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.159 0.504 . . . . 0.0 110.297 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.2 t70 65.76 167.67 0.2 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.418 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.3 tt -62.47 -43.86 97.79 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.452 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -53.11 -36.4 60.71 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.182 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.65 -40.19 98.42 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.3 tp -60.46 -40.76 92.34 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -75.98 -47.14 33.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.597 -176.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.492 ' NE2' HG21 ' A' ' 132' ' ' ILE . 67.3 tp60 -67.97 -35.57 78.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 126' ' ' GLY . 61.1 t -68.65 -39.39 80.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.7 ttm -59.01 -45.26 91.13 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.492 HG21 ' NE2' ' A' ' 129' ' ' GLN . 1.1 mp -60.68 -43.28 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.351 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 73.6 t -75.25 -39.68 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.4 p -72.32 -17.45 18.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.54 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -110.13 -17.77 13.48 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.575 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.19 -35.55 91.71 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 107.146 -2.382 . . . . 0.0 107.146 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.99 -34.2 77.86 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.556 -0.822 . . . . 0.0 110.608 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -157.95 90.75 2.26 Favored Pre-proline 0 C--N 1.333 -0.125 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.526 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -50.23 114.15 1.31 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.776 0.984 . . . . 0.0 110.128 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.26 -13.29 28.19 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.471 1.447 . . . . 0.0 111.154 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.1 m -131.64 138.88 51.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.343 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.4 p90 . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.672 179.716 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.415 HG13 ' HE2' ' A' ' 11' ' ' MET . 98.2 t . . . . . 0 N--CA 1.45 -0.475 0 CA-C-O 121.264 0.554 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -96.58 156.0 16.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.499 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 93.9 mt-10 -62.79 -40.53 97.62 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.145 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -58.76 -47.0 86.17 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 122.219 1.009 . . . . 0.0 109.052 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -61.57 -36.49 80.81 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.002 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.883 HD23 HG13 ' A' ' 22' ' ' VAL . 25.0 tp -55.3 -39.54 70.04 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.608 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 3.2 mptp? -60.65 -43.31 97.75 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.867 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -67.94 -26.32 65.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.735 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.743 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -79.03 -34.61 43.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.52 -178.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -113.17 17.64 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.711 0.291 . . . . 0.0 110.789 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.67 -11.51 60.24 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.656 0.265 . . . . 0.0 111.302 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -85.22 -12.85 51.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.453 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.71 ' OH ' HD22 ' A' ' 52' ' ' LEU . 40.2 m-85 -77.75 152.47 33.59 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.408 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -64.93 -39.13 93.03 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.076 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 25.0 m-85 -114.58 70.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 122.404 -0.185 . . . . 0.0 111.077 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -69.04 -27.31 65.54 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -72.74 -46.56 52.86 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.79 -39.6 73.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.969 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.7 m -61.19 -45.71 93.46 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.872 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.883 HG13 HD23 ' A' ' 8' ' ' LEU . 30.1 t -61.86 -45.9 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 120.839 0.352 . . . . 0.0 110.483 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -43.05 99.65 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.873 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -65.16 -37.12 86.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.943 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 29' ' ' ILE . 39.5 p -67.38 -37.36 83.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.922 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.49 -43.62 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -60.4 -39.04 85.91 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.411 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -70.58 -42.75 78.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.27 -21.92 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.191 -177.802 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.0 m -72.46 -42.9 64.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.046 0.451 . . . . 0.0 110.311 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.844 HD23 HD21 ' A' ' 125' ' ' LEU . 33.8 tp -88.75 -34.52 17.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.092 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -118.24 68.85 0.78 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -57.32 -20.59 29.59 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.159 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -65.84 -15.05 62.55 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.755 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.458 ' CD2' HD13 ' A' ' 55' ' ' LEU . 2.7 tp -96.95 112.43 24.19 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.12 129.52 23.84 Favored Pre-proline 0 C--N 1.358 0.937 0 CA-C-N 119.572 1.078 . . . . 0.0 112.334 -177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -82.92 135.64 7.74 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.603 1.535 . . . . 0.0 112.834 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.84 155.58 41.54 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.743 HD13 ' SD ' ' A' ' 11' ' ' MET . 15.7 tp -95.21 117.6 30.53 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -121.42 134.74 55.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.907 0.384 . . . . 0.0 111.9 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.5 t -71.99 136.72 46.85 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.445 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.864 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 121.192 0.52 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 51' ' ' GLU . 17.4 pm0 -83.97 116.99 23.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.213 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.71 HD22 ' OH ' ' A' ' 15' ' ' TYR . 69.9 mt -117.23 145.09 44.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.086 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -98.93 138.23 36.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.849 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -130.08 151.12 50.96 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.479 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.458 HD13 ' CD2' ' A' ' 35' ' ' LEU . 6.2 mt -97.59 129.57 44.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.1 m -145.3 138.5 26.43 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.85 -141.9 7.31 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.485 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.5 p -133.41 158.92 41.83 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.458 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -129.59 116.18 18.32 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.848 177.296 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -70.98 123.85 10.07 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 CA-C-N 119.886 0.995 . . . . 0.0 110.001 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.1 t -130.67 125.71 21.59 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.909 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.09 147.39 42.83 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.281 1.987 . . . . 0.0 110.634 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -163.48 116.08 1.49 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 55.93 28.29 12.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.448 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.68 -5.74 77.03 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -112.93 142.51 45.52 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.9 m -120.29 131.93 55.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.884 0.374 . . . . 0.0 111.74 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -115.11 152.02 33.29 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.98 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -96.52 104.93 16.95 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.517 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -88.7 117.13 68.0 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.94 124.31 3.84 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.711 2.274 . . . . 0.0 111.12 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.517 HG23 HG22 ' A' ' 70' ' ' ILE . 29.5 pt -135.72 148.69 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.973 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.3 m -121.43 123.55 42.35 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-O 121.839 0.828 . . . . 0.0 110.12 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.97 117.0 32.9 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.349 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -107.72 126.23 52.35 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.5 mt -92.87 139.36 30.62 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.838 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mt -85.42 152.58 23.12 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.492 ' OD1' HD21 ' A' ' 52' ' ' LEU . 95.9 m-20 -58.66 -16.05 14.5 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.906 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.2 10.75 31.79 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -65.3 144.54 99.02 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.427 ' HG2' ' CD2' ' A' ' 119' ' ' HIS . 28.7 Cg_endo -91.05 3.84 67.11 Favored 'Cis proline' 0 N--CA 1.515 2.786 0 CA-C-N 121.219 1.471 . . . . 0.0 115.726 1.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.428 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 18.8 m-85 -71.54 -20.67 62.0 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.945 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.06 126.64 30.1 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.826 -0.607 . . . . 0.0 109.695 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -49.08 131.48 26.06 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 CA-C-N 121.235 1.477 . . . . 0.0 112.403 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.16 145.53 11.01 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.463 2.109 . . . . 0.0 111.784 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.479 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -91.79 147.44 5.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.241 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' A' ' 109' ' ' ILE . 53.8 t -139.57 132.58 29.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.56 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -121.88 130.86 53.69 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.66 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.491 HG13 HD11 ' A' ' 109' ' ' ILE . 11.4 m -82.83 145.93 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -93.56 99.1 3.03 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.871 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 87.3 Cg_endo -77.03 157.25 34.3 Favored 'Trans proline' 0 N--CA 1.504 2.118 0 C-N-CA 121.482 1.455 . . . . 0.0 112.738 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 p -139.24 176.17 8.93 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.1 t -59.79 -43.86 94.2 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 m -88.18 11.84 15.3 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.795 0.725 . . . . 0.0 111.493 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.2 mmm -129.13 138.46 51.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.66 146.03 48.52 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.813 -178.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.411 HG23 HG11 ' A' ' 103' ' ' VAL . 6.6 mm -88.2 103.43 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.077 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -95.58 110.9 22.93 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.9 p -69.65 155.97 39.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.687 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.89 -135.01 2.24 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.826 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -86.38 -1.24 57.37 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -134.97 -27.31 1.26 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.665 1.12 . . . . 0.0 113.729 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.411 HG11 HG23 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -110.55 134.81 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 118.931 0.787 . . . . 0.0 110.215 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -87.2 -172.57 4.01 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.418 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.13 0.34 56.14 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.978 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -109.04 -5.67 15.94 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.745 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.89 -3.44 57.26 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.534 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 145.22 47.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.408 0.604 . . . . 0.0 110.446 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.491 HD11 HG13 ' A' ' 89' ' ' VAL . 97.5 mt -108.92 122.12 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.434 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.61 130.65 56.86 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.553 ' CD2' HG11 ' A' ' 134' ' ' VAL . 1.1 mt -123.99 124.23 26.02 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.251 -176.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -49.15 -36.9 37.59 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 121.739 1.626 . . . . 0.0 113.865 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.465 ' OH ' HD13 ' A' ' 127' ' ' LEU . 1.2 p90 -60.07 -33.0 71.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.079 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.423 ' N ' ' CG ' ' A' ' 113' ' ' TYR . 1.5 tt -70.89 -41.23 71.59 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.918 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -64.17 -26.37 68.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.633 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -113.78 11.52 18.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.495 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -72.19 125.99 28.67 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.924 0.868 . . . . 0.0 109.996 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -96.57 127.89 42.99 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.784 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.427 ' CD2' ' HG2' ' A' ' 81' ' ' PRO . 39.4 t-80 -81.6 126.49 75.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 119.069 -0.491 . . . . 0.0 110.112 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -108.94 92.35 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.707 0 CA-C-N 120.756 1.306 . . . . 0.0 112.43 -2.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -113.26 -61.96 1.66 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.504 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.5 t -67.94 -42.11 81.5 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.087 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 t70 66.98 165.84 0.22 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.487 0.66 . . . . 0.0 111.7 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.7 tt -65.79 -43.71 87.94 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.663 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.844 HD21 HD23 ' A' ' 31' ' ' LEU . 21.3 tp -56.81 -38.54 72.72 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.24 -39.12 96.75 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.465 HD13 ' OH ' ' A' ' 113' ' ' TYR . 33.4 tp -56.95 -40.28 76.15 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.889 -0.183 . . . . 0.0 111.431 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -73.98 -47.82 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.941 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -66.42 -35.0 79.22 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.58 ' O ' HG12 ' A' ' 134' ' ' VAL . 62.9 t -67.41 -39.02 81.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.0 tpp -58.24 -42.13 85.7 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.458 HD11 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -63.62 -39.55 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.597 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -79.09 -46.82 23.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 130' ' ' VAL . 9.9 p -71.6 -14.21 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.138 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.466 ' CD1' HG13 ' A' ' 134' ' ' VAL . 5.6 m-30 -104.75 -19.09 14.04 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.18 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.43 -32.05 60.3 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -63.89 -38.87 92.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.817 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -157.67 81.66 3.08 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -49.1 109.31 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.266 1.311 . . . . 0.0 110.76 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.64 -23.47 40.6 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.456 1.437 . . . . 0.0 110.462 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 m -120.09 140.41 44.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.29 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.7 p90 . . . . . 0 CA--C 1.538 0.507 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.297 -179.008 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.445 -0.685 0 CA-C-O 121.391 0.615 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -103.74 157.84 16.8 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 97.7 mt-10 -65.04 -40.45 94.81 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.266 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -63.26 -41.51 99.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.355 1.074 . . . . 0.0 109.214 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -69.97 -29.93 67.16 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.657 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.036 HD23 HG13 ' A' ' 22' ' ' VAL . 51.6 tp -61.9 -39.65 92.71 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.698 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -58.85 -43.22 90.73 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.074 -0.967 . . . . 0.0 108.657 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -60.43 -35.52 76.02 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.298 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.734 ' CB ' HD13 ' A' ' 39' ' ' LEU . 13.5 ptp -83.33 -10.58 58.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.172 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.878 HG22 ' O ' ' A' ' 8' ' ' LEU . 16.2 m -130.9 19.21 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.01 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.7 p -66.44 -18.22 65.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.558 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.82 -13.15 40.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.98 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -72.9 148.64 44.17 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.527 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -66.57 -37.82 85.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.799 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 19.8 m-85 -108.18 61.92 0.61 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.428 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.4 ptp85 -64.76 -27.31 68.81 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -76.68 -53.03 8.55 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.11 -38.77 82.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.084 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -60.77 -47.45 86.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.698 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.036 HG13 HD23 ' A' ' 8' ' ' LEU . 38.9 t -61.08 -44.62 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -40.53 97.87 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.115 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.13 -38.44 91.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.059 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.647 ' O ' HG23 ' A' ' 29' ' ' ILE . 48.8 p -68.27 -34.33 75.99 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.923 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.68 -45.64 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.742 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -61.31 -39.07 89.13 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.471 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.64 -43.09 71.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.57 -20.13 7.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.698 -178.139 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.5 m -78.07 -46.97 19.4 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.992 0.425 . . . . 0.0 110.848 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.599 HD23 HD21 ' A' ' 125' ' ' LEU . 22.8 tp -88.65 -36.0 16.49 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.842 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -111.97 68.14 0.66 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -59.38 -18.15 36.22 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.671 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -65.22 -21.88 66.81 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.855 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.641 HD13 HD12 ' A' ' 128' ' ' ILE . 1.3 tp -95.51 115.26 27.18 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.72 132.76 22.11 Favored Pre-proline 0 C--N 1.356 0.881 0 CA-C-N 119.828 1.194 . . . . 0.0 112.104 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.39 135.3 11.82 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.424 1.416 . . . . 0.0 112.46 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.1 t -127.87 136.27 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.734 HD13 ' CB ' ' A' ' 11' ' ' MET . 38.1 tp -84.55 119.24 24.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -129.91 137.25 50.28 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.9 t -68.6 137.98 54.69 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.206 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 . . . . . 0 C--O 1.235 0.294 0 CA-C-O 121.359 0.6 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -80.39 120.5 24.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.741 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 52' ' ' LEU . 77.7 mt -122.22 140.01 53.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.553 0.692 . . . . 0.0 110.817 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.455 ' SD ' HD11 ' A' ' 8' ' ' LEU . 62.0 ttp -84.51 148.66 26.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.424 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -134.2 151.53 51.36 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.296 0.57 . . . . 0.0 111.689 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.498 ' HG ' HD23 ' A' ' 35' ' ' LEU . 3.2 mm? -102.66 116.02 31.74 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.5 m -134.47 137.13 43.7 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.27 -143.24 7.99 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.593 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.493 HG21 ' OD1' ' A' ' 69' ' ' ASN . 19.8 p -135.27 161.25 35.92 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.43 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.2 pt -132.31 116.07 15.22 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.206 177.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -72.35 125.87 11.14 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 120.935 1.09 . . . . 0.0 110.092 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.6 t -129.48 124.43 21.96 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 119.744 -0.783 . . . . 0.0 112.329 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.56 145.85 48.11 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.137 1.891 . . . . 0.0 110.162 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -163.57 114.78 1.4 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.932 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.23 32.09 12.78 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.82 -6.86 72.36 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -113.79 148.51 36.42 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -125.2 132.58 52.99 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.609 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -115.47 152.09 33.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.138 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.493 ' OD1' HG21 ' A' ' 58' ' ' THR . 3.8 t-20 -97.09 103.88 15.85 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.494 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -88.33 116.98 67.83 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -82.18 127.26 5.22 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 122.516 2.144 . . . . 0.0 111.062 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.494 HG23 HG22 ' A' ' 70' ' ' ILE . 29.6 pt -137.1 149.13 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 118.939 -1.105 . . . . 0.0 112.577 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.46 123.05 40.4 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-O 121.513 0.673 . . . . 0.0 110.057 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.32 103.68 13.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.646 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -90.69 124.05 34.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 119.046 -1.062 . . . . 0.0 108.3 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -91.98 138.64 31.38 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mt -88.9 155.46 19.51 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.28 -16.26 32.54 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.629 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.04 0.43 51.57 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.669 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -65.03 143.03 98.82 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HG2' ' CE1' ' A' ' 119' ' ' HIS . 41.5 Cg_endo -89.34 4.15 69.62 Favored 'Cis proline' 0 N--CA 1.517 2.892 0 CA-C-N 120.975 1.384 . . . . 0.0 115.299 1.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 12.0 m-85 -68.85 -23.13 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.242 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.86 126.3 30.15 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.959 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.19 137.48 37.88 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 CA-C-N 121.263 1.487 . . . . 0.0 111.555 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.03 144.1 11.8 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.387 2.058 . . . . 0.0 111.771 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.49 131.55 40.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.65 0.738 . . . . 0.0 109.406 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 38.7 t -118.28 142.0 47.94 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.326 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -127.93 127.64 43.68 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.103 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.585 ' CG2' HD11 ' A' ' 109' ' ' ILE . 57.9 t -85.79 131.92 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -87.35 101.76 2.61 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.979 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 79.4 Cg_endo -82.03 159.36 18.18 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.39 1.393 . . . . 0.0 112.206 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 p -123.39 168.13 12.93 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.06 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.2 m -56.75 -36.09 69.37 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.433 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.0 m -88.36 2.59 52.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.854 0.752 . . . . 0.0 112.295 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -129.54 140.15 51.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.68 156.81 26.46 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.631 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 97' ' ' ILE . 2.7 tp -85.25 109.98 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-O 121.262 0.553 . . . . 0.0 109.96 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -97.53 101.39 12.9 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.033 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.7 p -65.54 151.18 47.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.883 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -166.23 -143.75 3.85 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.663 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.403 ' O ' ' CZ ' ' A' ' 110' ' ' TYR . 24.8 pttm -65.96 -18.96 65.69 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -131.86 -26.67 1.95 Allowed 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.602 HG21 ' HB2' ' A' ' 140' ' ' PRO . 13.4 t -93.78 137.66 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.667 1.121 . . . . 0.0 111.36 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -100.97 177.51 4.93 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.417 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.58 -38.55 87.28 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -86.41 -0.37 55.83 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.843 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.69 21.56 18.66 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.722 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -75.79 136.84 40.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.687 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.585 HD11 ' CG2' ' A' ' 89' ' ' VAL . 88.7 mt -117.26 125.2 73.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.95 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CZ ' ' O ' ' A' ' 101' ' ' LYS . 30.2 p90 -136.44 148.87 47.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.73 HD23 HG11 ' A' ' 134' ' ' VAL . 3.3 mp -143.45 140.03 17.12 Favored Pre-proline 0 CA--C 1.555 1.152 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.257 -175.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.476 ' HA ' ' ND1' ' A' ' 115' ' ' HIS . 50.4 Cg_exo -46.43 -38.64 21.24 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 C-N-CA 121.954 1.769 . . . . 0.0 113.792 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.46 ' OH ' HD13 ' A' ' 127' ' ' LEU . 0.4 OUTLIER -63.69 -31.94 73.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.073 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.24 -43.08 64.91 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.476 ' ND1' ' HA ' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -68.96 -27.01 65.35 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.78 -177.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -97.65 1.12 48.32 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.293 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -60.13 126.51 27.79 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.766 0.793 . . . . 0.0 110.657 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -104.46 96.29 6.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.619 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 65.0 t60 -55.64 122.84 47.97 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.309 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 8.5 Cg_endo -108.0 91.97 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 120.304 1.144 . . . . 0.0 113.019 -2.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -110.43 -58.83 2.03 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.483 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.1 p -71.02 -39.72 72.19 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.355 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 t70 69.32 164.09 0.24 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.355 0.598 . . . . 0.0 112.095 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.4 tt -66.15 -44.28 84.57 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.326 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.599 HD21 HD23 ' A' ' 31' ' ' LEU . 2.6 tp -56.12 -37.95 70.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.67 -39.42 97.39 Favored Glycine 0 N--CA 1.477 1.391 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.46 HD13 ' OH ' ' A' ' 113' ' ' TYR . 32.4 tp -58.68 -41.17 85.59 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.605 -0.35 . . . . 0.0 111.902 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.641 HD12 HD13 ' A' ' 35' ' ' LEU . 1.1 mm -72.71 -47.74 48.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.954 -176.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.553 ' NE2' HG21 ' A' ' 132' ' ' ILE . 49.8 tp60 -67.71 -34.73 77.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.668 ' O ' HG12 ' A' ' 134' ' ' VAL . 64.5 t -67.91 -39.2 81.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.055 177.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.404 ' SD ' ' CE1' ' A' ' 135' ' ' PHE . 44.5 tpp -58.14 -41.47 83.77 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.553 HG21 ' NE2' ' A' ' 129' ' ' GLN . 1.1 mp -63.67 -44.14 98.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.562 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.74 -44.21 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.73 HG11 HD23 ' A' ' 111' ' ' LEU . 8.7 p -73.52 -14.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.177 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.464 ' CD2' HG13 ' A' ' 134' ' ' VAL . 11.6 m-30 -105.38 -17.78 14.33 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.547 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.95 -22.97 72.59 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -76.43 -27.31 56.18 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.578 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -161.73 83.77 1.75 Allowed Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -46.99 119.25 3.26 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.341 1.361 . . . . 0.0 110.407 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.602 ' HB2' HG21 ' A' ' 103' ' ' VAL . 37.7 Cg_endo -68.47 -18.61 43.57 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 120.875 1.05 . . . . 0.0 110.856 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.76 147.86 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.526 -179.589 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.432 HG11 ' HG2' ' A' ' 37' ' ' PRO . 7.4 p . . . . . 0 N--CA 1.442 -0.859 0 CA-C-O 121.679 0.752 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.05 149.65 24.99 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.441 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 56.0 mp0 -61.23 -42.3 98.37 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.768 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.6 m -57.73 -46.92 83.79 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.364 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -63.07 -34.08 76.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.87 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.697 HD23 HG13 ' A' ' 22' ' ' VAL . 11.7 tp -55.83 -38.66 70.32 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.605 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.3 mptp? -61.22 -42.52 98.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.757 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.57 -37.21 86.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.362 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.784 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -66.01 -37.01 84.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.149 -177.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.6 m -119.43 28.91 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.658 0.266 . . . . 0.0 111.213 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.2 p -64.95 -22.66 67.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -74.71 -15.5 60.78 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.921 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -71.09 152.25 43.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.016 0.436 . . . . 0.0 111.437 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -75.47 -29.22 59.53 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.12 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.407 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 35.7 m-85 -117.94 61.77 0.76 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.148 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 ptt-85 -64.65 -29.62 70.63 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.98 -44.03 70.25 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tp -74.74 -41.28 60.42 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.392 -0.923 . . . . 0.0 109.813 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 25' ' ' THR . 96.0 m -61.19 -47.99 83.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.616 0.246 . . . . 0.0 111.154 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.697 HG13 HD23 ' A' ' 8' ' ' LEU . 14.2 t -61.32 -45.49 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.397 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -63.4 -43.0 98.81 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.653 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.59 -36.28 83.3 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.682 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.657 ' O ' HG23 ' A' ' 29' ' ' ILE . 40.7 p -67.31 -38.58 85.21 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.543 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -57.44 -43.43 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -60.05 -41.3 92.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.101 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 124' ' ' LEU . 77.5 t -68.85 -43.07 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -87.56 -15.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.452 -178.579 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.3 m -85.04 -46.95 10.69 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.128 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.9 tp -83.14 -35.88 25.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.259 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -115.47 68.4 0.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.039 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -57.03 -20.84 26.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.091 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -65.15 -22.02 66.86 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.685 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.543 HD13 HD12 ' A' ' 128' ' ' ILE . 1.4 tp -93.17 115.2 27.84 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -111.11 133.59 21.28 Favored Pre-proline 0 C--N 1.357 0.904 0 CA-C-N 119.713 1.142 . . . . 0.0 111.937 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 97.5 Cg_endo -79.69 133.01 10.13 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.194 1.263 . . . . 0.0 112.028 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -126.93 134.27 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.784 HD13 ' SD ' ' A' ' 11' ' ' MET . 24.4 tp -81.82 113.89 20.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -123.64 137.36 54.74 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 83.1 p -71.63 148.02 46.97 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.465 0.286 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.599 179.784 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 C--O 1.234 0.241 0 CA-C-O 121.196 0.522 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.492 ' HG3' HD11 ' A' ' 39' ' ' LEU . 8.0 tp10 -83.37 106.43 15.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.213 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 52' ' ' LEU . 70.2 mt -114.26 140.64 48.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.401 0.62 . . . . 0.0 110.927 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.499 ' SD ' HD11 ' A' ' 8' ' ' LEU . 57.7 ttp -84.41 148.83 26.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.321 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 4.5 t30 -124.74 161.34 26.61 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.991 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.525 ' HA ' HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -119.15 112.78 19.94 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -138.58 139.94 38.82 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.45 -143.66 8.26 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.761 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.8 p -134.9 159.19 42.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.438 HD13 HG21 ' A' ' 59' ' ' ILE . 1.2 pt -130.8 115.74 16.89 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.283 177.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.14 125.06 10.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 N-CA-C 109.405 -1.037 . . . . 0.0 109.405 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.0 t -126.97 121.86 23.05 Favored Pre-proline 0 C--O 1.24 0.605 0 C-N-CA 119.834 -0.746 . . . . 0.0 112.285 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.27 146.49 51.16 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.074 1.85 . . . . 0.0 110.287 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -162.74 107.9 1.15 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.102 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.77 37.92 25.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.551 -0.46 . . . . 0.0 112.205 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.17 -0.77 82.95 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -118.5 138.26 52.63 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.2 m -121.35 132.56 54.84 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.483 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -115.96 149.58 38.55 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.121 0.486 . . . . 0.0 111.261 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -94.88 100.47 12.34 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.442 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -87.67 115.35 62.66 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.237 -177.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.64 127.87 4.45 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.753 2.302 . . . . 0.0 111.158 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.442 HG23 HG22 ' A' ' 70' ' ' ILE . 25.1 pt -135.27 148.7 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.411 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.1 m -116.62 124.23 49.27 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.354 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.53 112.25 24.04 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.204 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.517 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 70.1 m95 -96.03 130.25 43.08 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.224 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.25 134.64 41.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tp -94.16 143.82 26.04 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.87 -16.86 0.47 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.37 9.97 40.91 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.421 -0.512 . . . . 0.0 112.316 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -65.7 143.49 98.59 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -92.0 3.36 63.15 Favored 'Cis proline' 0 N--CA 1.517 2.865 0 CA-C-N 121.033 1.405 . . . . 0.0 115.256 1.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.407 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 17.2 m-85 -69.78 -21.02 63.45 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.465 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.37 118.92 53.48 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.52 135.99 33.25 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 CA-C-N 121.182 1.458 . . . . 0.0 111.423 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.51 140.86 17.29 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.817 1.678 . . . . 0.0 111.199 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -79.78 152.89 4.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.155 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 13.1 t -140.93 140.37 34.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.093 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -131.32 129.72 41.8 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.771 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.59 134.77 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -100.17 101.2 13.68 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.647 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -90.15 127.57 1.47 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.874 1.716 . . . . 0.0 113.197 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.3 p -77.19 172.54 13.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.8 p -55.86 -28.64 57.46 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.9 m -95.64 -2.2 48.64 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.945 0.793 . . . . 0.0 111.579 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 52.9 tpp -93.25 134.35 35.53 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 85.1 m -108.16 133.22 52.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.79 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.555 HG23 ' O ' ' A' ' 97' ' ' ILE . 2.5 tp -93.95 109.07 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.08 0.467 . . . . 0.0 109.816 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -92.85 100.13 12.66 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.673 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 74.0 p -66.91 148.44 51.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.985 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -172.96 -150.6 7.49 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.26 -20.44 64.79 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -115.35 -30.38 6.28 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 119.028 0.831 . . . . 0.0 113.008 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.581 HG21 ' HB2' ' A' ' 140' ' ' PRO . 4.1 t -100.78 138.36 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 CA-C-N 119.24 0.927 . . . . 0.0 110.58 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.407 ' O ' HG12 ' A' ' 103' ' ' VAL . 18.2 t0 -93.85 -169.72 2.16 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.421 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.59 -30.94 22.91 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -92.08 0.34 57.46 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.993 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.84 6.02 37.97 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.104 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -64.04 148.46 49.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.693 0.747 . . . . 0.0 110.181 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.432 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 84.1 mt -116.44 122.82 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 110.718 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.62 121.22 44.22 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.408 ' CD2' HG11 ' A' ' 134' ' ' VAL . 1.2 mt -126.98 116.52 22.04 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.945 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -48.98 -36.88 35.93 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.581 1.521 . . . . 0.0 113.69 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -31.51 71.56 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.477 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 tt -69.46 -41.71 75.86 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.89 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -65.57 -28.47 69.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.017 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -109.84 3.77 21.02 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.679 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.403 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.1 t90 -64.84 125.03 23.54 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.038 0.923 . . . . 0.0 110.076 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -95.81 127.1 41.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.816 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -81.28 126.65 76.18 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 119.026 -0.512 . . . . 0.0 110.514 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -109.4 91.39 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.674 0 CA-C-N 120.677 1.277 . . . . 0.0 112.453 -2.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.3 -62.75 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 t -67.74 -37.26 81.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.699 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 51.4 175.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.061 0.934 . . . . 0.0 112.143 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.1 tt -62.94 -44.33 96.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.821 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -53.6 -38.71 64.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.64 -39.63 98.14 Favored Glycine 0 N--CA 1.482 1.704 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.4 tp -58.25 -40.65 82.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.435 -0.45 . . . . 0.0 111.829 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.543 HD12 HD13 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -74.34 -48.16 37.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.948 -176.738 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.58 ' NE2' HG21 ' A' ' 132' ' ' ILE . 65.4 tp60 -68.77 -35.15 76.7 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 126' ' ' GLY . 63.4 t -67.92 -40.07 82.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 178.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.5 ttm -58.39 -42.8 87.92 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.58 HG21 ' NE2' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -61.17 -41.12 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.475 178.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.26 -47.73 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.476 HG13 ' CD2' ' A' ' 135' ' ' PHE . 4.6 p -66.7 -14.45 17.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.501 -178.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.476 ' CD2' HG13 ' A' ' 134' ' ' VAL . 15.4 m-30 -106.91 -20.12 13.42 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.358 177.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.7 -35.2 91.64 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.16 -37.31 86.99 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.957 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -154.56 83.96 3.95 Favored Pre-proline 0 N--CA 1.451 -0.393 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.139 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -45.35 117.59 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.689 1.593 . . . . 0.0 110.939 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.581 ' HB2' HG21 ' A' ' 103' ' ' VAL . 59.7 Cg_endo -74.71 -4.97 16.23 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.504 1.469 . . . . 0.0 111.4 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.7 m -120.46 157.38 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.708 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.8 t80 . . . . . 0 N--CA 1.478 0.934 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.247 -179.686 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 121.158 0.504 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -94.54 156.54 16.4 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.8 mt-10 -63.3 -40.91 98.66 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.111 -1.035 . . . . 0.0 111.329 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -60.18 -47.21 86.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.237 1.018 . . . . 0.0 108.633 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -63.11 -30.64 71.75 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.38 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.901 HD23 HG13 ' A' ' 22' ' ' VAL . 38.7 tp -58.86 -41.05 86.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 10.8 mptt -60.5 -41.84 95.13 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.657 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.35 -37.09 82.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.354 0.597 . . . . 0.0 110.621 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.761 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -68.9 -36.28 77.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.566 -178.37 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.0 m -113.61 20.91 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.61 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.7 t -68.85 -4.48 16.46 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.353 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -103.98 -11.19 17.56 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.02 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.705 ' CE1' HG12 ' A' ' 12' ' ' VAL . 17.9 m-85 -67.65 160.12 28.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.883 0.373 . . . . 0.0 110.675 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -70.88 -39.43 72.84 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.705 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.16 74.15 1.02 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.813 -0.176 . . . . 0.0 110.965 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -72.12 -21.61 61.45 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -79.19 -47.63 15.66 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.754 -0.592 . . . . 0.0 111.864 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 tp -70.15 -40.6 74.68 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.478 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 83.2 m -60.93 -48.09 83.42 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.55 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.901 HG13 HD23 ' A' ' 8' ' ' LEU . 30.8 t -62.83 -45.49 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 120.666 0.269 . . . . 0.0 110.899 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -41.63 97.26 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.135 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -37.76 84.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.742 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.632 ' O ' HG23 ' A' ' 29' ' ' ILE . 13.6 p -66.28 -33.73 76.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.437 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.2 t -59.65 -45.45 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.286 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -61.66 -38.76 88.94 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.913 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.71 -46.43 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.66 -21.21 7.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.475 -178.493 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 79.8 m -70.91 -40.87 71.9 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.069 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -88.09 -36.56 16.85 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.448 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -117.75 69.63 0.78 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -57.8 -19.68 30.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.703 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -65.47 -19.17 65.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.412 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 tp -90.15 116.6 28.28 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -112.32 132.72 21.99 Favored Pre-proline 0 C--N 1.358 0.97 0 CA-C-N 120.1 1.318 . . . . 0.0 111.775 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.04 135.63 11.2 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.588 1.525 . . . . 0.0 112.973 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.6 t -129.66 136.56 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.761 HD13 ' SD ' ' A' ' 11' ' ' MET . 16.0 tp -82.74 125.19 30.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.95 158.89 24.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.033 0.444 . . . . 0.0 111.149 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m -97.01 125.17 41.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.472 0.65 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.592 -179.176 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 . . . . . 0 C--O 1.234 0.262 0 CA-C-O 121.061 0.458 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.27 113.79 10.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.706 0.765 . . . . 0.0 110.347 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.485 HD21 ' O ' ' A' ' 76' ' ' LEU . 20.0 tp -111.5 123.05 49.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -83.34 143.46 30.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.899 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.412 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -132.87 160.33 37.28 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.041 0.448 . . . . 0.0 111.738 -178.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.0 mt -111.44 117.66 33.66 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -132.8 137.49 46.8 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.97 -146.19 10.79 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.375 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.9 p -134.41 159.16 41.93 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.88 116.6 18.09 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.229 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -67.11 123.32 10.77 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 N-CA-C 109.527 -0.99 . . . . 0.0 109.527 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.03 118.04 22.07 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.991 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.93 149.58 77.71 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.991 1.794 . . . . 0.0 111.315 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -162.8 111.98 1.36 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.935 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 45.85 45.03 11.51 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.3 -4.55 76.61 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.683 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -118.93 162.26 18.81 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.6 m -129.35 130.03 45.54 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.787 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -106.0 144.73 32.3 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.579 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -100.03 103.29 14.81 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.534 HG22 HG23 ' A' ' 72' ' ' ILE . 1.5 mp -91.18 117.35 67.81 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -85.1 124.46 2.9 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 123.023 2.482 . . . . 0.0 110.214 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.534 HG23 HG22 ' A' ' 70' ' ' ILE . 27.9 pt -135.82 150.11 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 118.955 -1.098 . . . . 0.0 112.56 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.1 m -121.55 124.77 45.2 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.215 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 mp -103.13 107.58 18.44 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.436 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.459 ' HE3' HD23 ' A' ' 52' ' ' LEU . 86.1 m95 -96.06 125.63 40.73 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.485 ' O ' HD21 ' A' ' 52' ' ' LEU . 67.8 mt -95.21 129.89 42.15 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.804 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 mt -73.72 149.99 41.49 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.47 -14.05 11.1 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.433 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.89 -8.74 36.33 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.404 ' OH ' HD12 ' A' ' 124' ' ' LEU . 25.8 t80 -53.92 145.83 30.91 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -91.4 12.11 55.99 Favored 'Cis proline' 0 N--CA 1.513 2.668 0 CA-C-N 120.682 1.279 . . . . 0.0 115.187 0.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -73.23 -12.97 61.05 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.724 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -121.23 129.53 25.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.068 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -49.38 138.18 30.6 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 CA-C-N 121.591 1.604 . . . . 0.0 111.844 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.48 144.05 15.7 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.056 1.837 . . . . 0.0 111.473 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mt -96.47 135.98 28.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 121.308 0.575 . . . . 0.0 110.118 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.428 ' SG ' HD12 ' A' ' 109' ' ' ILE . 48.9 t -111.99 149.29 32.2 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.611 -178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.85 126.53 30.69 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.623 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -84.95 123.5 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.81 108.48 2.71 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-O 119.05 -0.5 . . . . 0.0 109.901 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.77 155.89 7.47 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.619 1.546 . . . . 0.0 113.455 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 p -137.59 163.88 30.13 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.2 p -59.63 -26.77 65.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.863 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.7 p -90.74 -3.19 57.64 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.961 0.8 . . . . 0.0 111.244 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 41.4 ttm -124.11 142.05 51.53 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.23 159.16 35.17 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.836 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 85.8 mt -96.04 101.88 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -96.15 111.88 23.79 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.1 p -61.51 141.67 57.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.315 0.579 . . . . 0.0 111.392 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.37 -135.42 2.57 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.342 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -88.27 -3.33 58.87 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -138.4 -33.52 0.67 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.218 0.917 . . . . 0.0 112.446 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.62 138.59 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.375 0.989 . . . . 0.0 110.429 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -96.17 -161.51 0.87 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.375 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.91 -35.82 23.79 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.681 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -83.16 -1.79 53.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.546 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.07 8.51 47.53 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.504 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -62.51 137.49 58.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.365 0.583 . . . . 0.0 111.033 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.428 HD12 ' SG ' ' A' ' 87' ' ' CYS . 60.2 mt -114.63 113.22 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.442 ' CZ ' ' HA ' ' A' ' 102' ' ' HIS . 53.3 p90 -113.46 139.82 48.61 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 177.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.427 HD11 HG22 ' A' ' 109' ' ' ILE . 1.3 mp -133.15 130.55 21.35 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.462 -176.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -46.35 -39.91 22.0 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 121.664 1.576 . . . . 0.0 114.277 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -62.97 -31.3 72.39 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.863 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.08 -42.48 76.14 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.632 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.08 -28.49 66.56 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.026 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -95.46 -6.15 41.39 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.446 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -57.85 126.99 29.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.912 0.863 . . . . 0.0 110.656 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -104.63 102.96 12.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.98 -1.464 . . . . 0.0 108.435 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 60.5 t60 -60.88 123.91 77.26 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.038 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 5.8 Cg_endo -108.27 91.9 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 120.704 1.287 . . . . 0.0 113.211 -2.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -112.98 -60.59 1.86 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.423 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.0 t -67.48 -41.83 83.93 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.53 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 69.67 159.22 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.04 0.448 . . . . 0.0 111.634 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 124' ' ' LEU . 5.0 tt -59.99 -44.68 94.36 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 63.0 tp -53.8 -33.04 54.83 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.45 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -63.6 -40.67 98.9 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.2 tp -60.69 -39.68 89.37 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.93 -44.08 24.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.903 -177.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.476 ' NE2' HG21 ' A' ' 132' ' ' ILE . 45.1 tp60 -68.68 -37.0 79.26 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 126' ' ' GLY . 64.9 t -68.11 -42.93 85.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 C-N-CA 118.992 -1.083 . . . . 0.0 108.518 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.5 ttm -55.97 -44.89 78.96 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.476 HG21 ' NE2' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -54.81 -32.26 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.043 178.43 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.409 HG23 HG22 ' A' ' 132' ' ' ILE . 63.0 t -94.46 -48.98 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 119.556 -0.857 . . . . 0.0 113.118 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.4 p -80.33 -11.11 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -93.52 -13.22 28.06 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.427 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -95.23 -5.2 60.76 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -65.99 -36.05 82.25 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.214 0.507 . . . . 0.0 110.428 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -157.26 82.79 3.07 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -44.82 106.58 0.09 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.563 1.508 . . . . 0.0 111.365 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.03 -12.0 31.54 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.835 1.69 . . . . 0.0 111.282 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.15 146.94 32.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.869 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.5 p90 . . . . . 0 N--CA 1.47 0.548 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.521 -179.736 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 121.303 0.573 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -101.77 156.61 17.4 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.509 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 94.5 mt-10 -62.71 -41.38 99.12 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.235 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 t -60.17 -46.17 90.6 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.941 0.876 . . . . 0.0 109.327 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -65.78 -28.4 68.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.059 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.985 HD23 HG13 ' A' ' 22' ' ' VAL . 59.3 tp -61.83 -39.61 92.42 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -65.42 -40.72 93.68 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.987 178.276 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.96 -37.15 81.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.47 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.567 ' SD ' HD12 ' A' ' 8' ' ' LEU . 19.8 ptp -76.14 -11.47 59.94 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.547 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 8' ' ' LEU . 10.2 m -142.35 31.71 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.459 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.5 p -72.01 -24.7 61.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.225 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.96 -13.51 55.86 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.792 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.0 151.49 26.21 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.972 0.415 . . . . 0.0 110.744 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -70.51 -37.49 74.15 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 21.3 m-85 -114.66 65.68 0.68 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.3 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.522 ' O ' HG23 ' A' ' 22' ' ' VAL . 15.9 ptt180 -64.91 -34.11 77.61 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.57 -42.08 83.15 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.85 -38.79 61.89 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.825 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 25' ' ' THR . 66.1 m -61.68 -43.27 99.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.408 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.985 HG13 HD23 ' A' ' 8' ' ' LEU . 79.5 t -72.7 -46.14 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.176 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -42.09 97.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.345 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.7 pp20? -69.1 -30.99 69.41 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.706 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.66 ' O ' HG23 ' A' ' 29' ' ' ILE . 24.0 p -70.39 -39.36 74.56 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.969 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 30' ' ' THR . 55.4 t -56.29 -45.57 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -39.5 91.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 24' ' ' GLU . 63.9 t -66.17 -43.59 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -83.8 -13.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.412 -178.594 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 26' ' ' VAL . 7.9 p -82.99 -51.04 7.93 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.419 0.628 . . . . 0.0 109.786 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.2 tp -81.38 -37.67 27.82 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.466 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.92 68.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -58.63 -19.85 42.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.825 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.11 -21.12 66.76 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.244 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.481 ' CD2' HD13 ' A' ' 55' ' ' LEU . 2.8 tp -93.16 113.96 26.34 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -109.94 126.97 27.91 Favored Pre-proline 0 C--N 1.356 0.866 0 CA-C-N 119.385 0.993 . . . . 0.0 112.157 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.94 134.68 10.77 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.553 1.502 . . . . 0.0 112.88 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.4 t -124.07 135.33 63.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.504 HD13 ' CB ' ' A' ' 11' ' ' MET . 21.6 tp -82.84 118.32 23.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.6 136.23 53.04 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.787 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.1 p -84.35 119.11 24.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.3 t80 . . . . . 0 N--CA 1.469 0.475 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.283 -178.621 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.425 0 CA-C-O 121.537 0.684 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -79.56 106.52 11.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.027 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tp -116.54 121.45 41.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -91.77 136.38 33.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.643 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -127.32 150.82 49.42 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.887 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.481 HD13 ' CD2' ' A' ' 35' ' ' LEU . 8.0 mt -99.73 123.05 43.6 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.5 m -133.7 137.14 45.13 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.76 -149.37 13.73 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.738 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.413 HG21 ' OD1' ' A' ' 69' ' ' ASN . 19.6 p -133.98 159.77 39.74 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.443 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.3 pt -134.22 116.3 13.16 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.998 177.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.5 126.93 10.63 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 120.908 1.072 . . . . 0.0 110.394 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.63 118.56 15.75 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.369 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.62 149.7 90.23 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.282 1.988 . . . . 0.0 110.257 177.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -162.7 107.51 1.14 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.201 0.524 . . . . 0.0 111.686 -178.293 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 52.3 38.82 25.9 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.105 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.61 81.78 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -122.14 131.63 54.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.9 m -113.02 130.97 55.95 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.847 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -112.97 150.49 31.8 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.871 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.413 ' OD1' HG21 ' A' ' 58' ' ' THR . 5.3 t-20 -95.15 104.4 16.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.426 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -88.55 115.3 62.97 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -86.46 125.74 2.55 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.965 2.443 . . . . 0.0 110.958 177.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.426 HG23 HG22 ' A' ' 70' ' ' ILE . 31.9 pt -133.81 148.6 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.758 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 54.0 m -121.7 122.05 38.69 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.999 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.89 115.9 31.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.147 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -107.52 127.1 53.32 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.5 mt -94.56 135.69 35.72 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.207 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mt -79.76 151.23 30.49 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -61.49 -13.01 17.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.122 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.61 0.46 39.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.138 0.494 . . . . 0.0 111.397 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -55.93 146.24 49.52 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -93.51 7.83 56.48 Favored 'Cis proline' 0 N--CA 1.509 2.388 0 CA-C-N 120.765 1.309 . . . . 0.0 114.042 1.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.445 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 7.2 m-85 -70.3 -18.77 63.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.75 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.93 137.77 19.89 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.31 140.95 66.4 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 CA-C-N 121.531 1.583 . . . . 0.0 111.196 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.21 142.86 12.32 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.236 1.958 . . . . 0.0 112.242 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.18 130.66 41.91 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.014 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.4 t -113.52 137.73 51.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.285 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -123.08 127.13 48.31 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.531 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.58 121.96 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -63.11 108.43 1.73 Allowed Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 119.161 -0.447 . . . . 0.0 110.021 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -84.23 160.7 13.27 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 121.627 1.551 . . . . 0.0 113.04 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.8 p -142.54 165.1 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.789 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.6 p -58.21 -35.22 71.33 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.153 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 t -88.3 -22.28 23.97 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.748 -0.595 . . . . 0.0 110.814 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 41.1 tpp -89.12 135.87 33.33 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.968 0.413 . . . . 0.0 110.192 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 84.0 m -125.61 141.22 52.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.594 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.6 mt -90.05 105.82 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -89.6 102.78 15.46 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 104' ' ' ASP . 69.1 p -64.44 152.46 41.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.28 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.44 -137.43 2.28 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.154 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -65.3 -23.98 67.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.519 ' NE2' HG23 ' A' ' 103' ' ' VAL . 10.5 p-80 -136.22 -16.85 1.61 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.719 HG21 ' HB2' ' A' ' 140' ' ' PRO . 6.8 t -100.32 132.09 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.508 1.049 . . . . 0.0 111.15 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.435 ' O ' HG22 ' A' ' 99' ' ' THR . 15.9 p-10 -93.21 -160.99 0.8 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.56 -21.26 25.51 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -89.72 -9.49 49.22 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.924 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.96 12.23 30.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.683 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -66.4 139.09 57.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.387 0.593 . . . . 0.0 109.952 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.5 mt -113.57 118.61 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.48 0.488 . . . . 0.0 111.752 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -102.49 140.13 37.18 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.667 HD22 HG11 ' A' ' 134' ' ' VAL . 27.8 mt -138.35 120.22 10.53 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.779 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.33 -38.95 27.28 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.357 1.371 . . . . 0.0 113.465 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -30.63 71.63 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.491 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.33 -41.17 73.57 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -69.44 -22.77 63.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.167 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -112.63 9.75 19.38 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.97 178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.0 t90 -76.93 123.45 26.31 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.944 0.878 . . . . 0.0 109.729 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -93.72 124.91 38.03 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.821 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 27.1 t-80 -79.37 125.82 82.37 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.651 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 12.2 Cg_endo -108.32 92.84 0.04 OUTLIER 'Cis proline' 0 N--CA 1.497 1.717 0 CA-C-N 120.774 1.312 . . . . 0.0 112.529 -2.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -114.32 -61.75 1.7 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.361 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.3 t -68.51 -31.96 71.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.905 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 48.49 -178.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.811 0.815 . . . . 0.0 111.806 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.432 HD22 HG21 ' A' ' 28' ' ' VAL . 4.8 tt -68.36 -40.28 81.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.747 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.465 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -54.28 -40.99 68.37 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.514 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.39 -39.46 97.79 Favored Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.6 tp -58.69 -41.38 86.11 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.437 HD12 HD13 ' A' ' 35' ' ' LEU . 1.2 mm -72.85 -48.88 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 119.884 -0.727 . . . . 0.0 112.063 -176.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.536 ' NE2' HG21 ' A' ' 132' ' ' ILE . 59.6 tp60 -66.41 -35.59 80.68 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 126' ' ' GLY . 53.4 t -68.47 -38.19 78.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.735 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 60.8 tpp -58.8 -42.49 89.22 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.536 HG21 ' NE2' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -61.71 -34.81 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.912 179.467 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.8 t -90.83 -45.12 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.667 HG11 HD22 ' A' ' 111' ' ' LEU . 6.2 p -66.05 -15.63 19.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.88 -177.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.414 ' CD2' HG13 ' A' ' 134' ' ' VAL . 12.0 m-30 -104.41 -19.23 14.12 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.196 177.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.72 -36.99 93.03 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.5 -40.54 95.85 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.133 -0.533 . . . . 0.0 110.9 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -153.45 84.62 4.27 Favored Pre-proline 0 CA--C 1.52 -0.199 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -48.3 120.35 4.94 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.983 1.122 . . . . 0.0 110.138 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.719 ' HB2' HG21 ' A' ' 103' ' ' VAL . 47.6 Cg_endo -70.93 -21.29 28.24 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.493 1.462 . . . . 0.0 111.887 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.33 140.88 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.154 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 6.4 p90 . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.395 -179.359 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 121.027 0.442 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.78 155.07 17.9 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.49 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 92.2 mt-10 -61.38 -43.19 99.29 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.254 -0.979 . . . . 0.0 112.017 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 t -58.47 -46.16 87.18 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.935 0.874 . . . . 0.0 108.984 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -62.9 -36.54 83.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.357 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.924 HD23 HG13 ' A' ' 22' ' ' VAL . 41.8 tp -55.73 -43.45 76.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.533 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.0 mptp? -61.3 -42.88 99.39 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.309 0.576 . . . . 0.0 109.528 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -61.1 -36.52 79.92 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.332 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.789 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -70.88 -37.72 73.03 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.723 -178.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 8' ' ' LEU . 3.3 m -112.12 24.37 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.736 0.303 . . . . 0.0 110.879 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.2 t -62.39 -37.87 87.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.022 0.439 . . . . 0.0 110.963 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -60.12 -21.91 62.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.601 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -63.88 157.57 24.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.112 0.482 . . . . 0.0 111.662 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.88 -37.9 54.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.621 177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 14.8 m-85 -113.94 64.61 0.66 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.356 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -61.79 -25.64 67.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -76.59 -51.97 10.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.04 -39.94 90.57 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.307 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.9 m -60.55 -47.56 85.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.166 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.924 HG13 HD23 ' A' ' 8' ' ' LEU . 12.6 t -66.24 -45.1 90.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.54 -41.92 98.06 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.485 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -67.51 -35.3 78.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 29' ' ' ILE . 22.2 p -67.65 -37.6 82.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.63 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 30' ' ' THR . 53.9 t -57.29 -45.61 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -37.63 80.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.5 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.692 HG21 HD22 ' A' ' 124' ' ' LEU . 54.7 t -68.89 -46.55 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -81.11 -13.76 12.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.169 -178.424 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.6 p -76.36 -50.96 12.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.045 0.45 . . . . 0.0 109.864 177.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.485 HD23 HD11 ' A' ' 125' ' ' LEU . 48.9 tp -82.37 -37.57 25.43 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.34 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -112.08 66.67 0.64 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm -55.59 -17.21 5.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.465 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -69.07 -15.19 63.39 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.176 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.477 ' CD2' HD13 ' A' ' 55' ' ' LEU . 2.6 tp -94.4 113.22 25.06 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -110.11 124.29 33.83 Favored Pre-proline 0 C--N 1.356 0.89 0 CA-C-N 119.474 1.034 . . . . 0.0 111.978 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.53 136.37 9.73 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 121.697 1.598 . . . . 0.0 113.202 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.04 156.34 42.68 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 110.397 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.789 HD13 ' SD ' ' A' ' 11' ' ' MET . 13.7 tp -92.28 118.69 31.14 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -124.43 132.81 53.51 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.321 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.8 p -76.86 137.38 39.14 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 N--CA 1.473 0.717 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.962 179.683 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 . . . . . 0 N--CA 1.467 0.395 0 CA-C-O 121.088 0.47 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.83 118.81 19.03 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.303 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 mt -121.48 140.7 51.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.557 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -96.92 137.71 35.59 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.322 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -130.49 151.2 51.23 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.457 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.477 HD13 ' CD2' ' A' ' 35' ' ' LEU . 5.4 mt -95.09 126.7 40.6 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.9 m -137.69 136.38 37.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.74 -147.11 11.55 Favored Glycine 0 N--CA 1.466 0.65 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.655 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.1 p -132.49 158.09 42.96 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -129.9 117.03 18.14 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.092 177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -72.23 123.49 9.24 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 119.947 1.017 . . . . 0.0 110.099 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.0 t -123.67 113.12 28.91 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.631 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.84 147.53 89.53 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.228 1.952 . . . . 0.0 109.695 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -163.57 107.4 1.01 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.63 -178.709 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.51 43.35 27.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.068 0.461 . . . . 0.0 111.557 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.01 14.76 76.2 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -134.69 125.6 27.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.2 m -113.26 131.18 56.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.997 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -112.59 149.23 33.06 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.466 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -95.79 100.08 11.83 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.523 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -87.6 117.69 68.85 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.314 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.81 123.81 2.9 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.453 2.102 . . . . 0.0 110.415 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.523 HG23 HG22 ' A' ' 70' ' ' ILE . 21.3 pt -131.6 147.12 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.349 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 67.4 m -121.08 123.12 41.57 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.205 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.33 109.62 21.31 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.144 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -99.49 125.35 45.22 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.01 140.85 29.04 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.257 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -84.18 155.11 22.7 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -62.53 -17.19 59.27 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.908 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.25 3.51 40.95 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.986 0.422 . . . . 0.0 111.718 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -59.16 145.37 81.03 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -91.59 8.64 62.81 Favored 'Cis proline' 0 N--CA 1.519 2.99 0 CA-C-N 121.019 1.4 . . . . 0.0 115.246 1.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.414 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 22.6 m-85 -74.46 -13.02 60.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.436 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.2 129.56 24.45 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.564 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -49.67 134.34 33.65 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 CA-C-N 121.205 1.466 . . . . 0.0 112.169 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.15 146.16 17.73 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.037 1.825 . . . . 0.0 111.886 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.446 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -95.49 151.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.79 -179.596 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.451 ' SG ' HD12 ' A' ' 109' ' ' ILE . 50.1 t -134.78 142.07 46.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.665 -178.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -127.09 131.21 50.91 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.086 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.408 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 57.6 t -97.44 123.62 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -76.37 106.26 3.09 Favored Pre-proline 0 N--CA 1.476 0.87 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.56 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 48.5 Cg_endo -90.61 128.66 1.42 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 CA-C-N 121.146 1.445 . . . . 0.0 113.548 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.5 p -81.15 168.95 17.99 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 88.1 p -59.27 -22.53 61.31 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 t -106.55 22.17 16.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.871 0.76 . . . . 0.0 110.946 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 42.5 ttm -133.52 144.73 49.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.43 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -131.22 163.71 27.16 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.864 179.526 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.43 ' N ' HG23 ' A' ' 96' ' ' THR . 5.7 mm -89.35 103.37 13.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.484 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -89.0 110.09 20.83 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.5 p -68.19 138.28 55.49 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.341 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.36 -141.82 3.54 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.249 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -70.84 -23.93 62.43 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.418 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 38.4 p-80 -130.4 -16.79 3.43 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.434 HG21 ' HB2' ' A' ' 140' ' ' PRO . 2.2 t -91.72 137.27 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.855 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -93.71 175.78 6.61 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.56 -39.07 93.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -91.15 4.78 51.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.11 10.27 49.28 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.99 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -67.82 140.96 56.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.451 HD12 ' SG ' ' A' ' 87' ' ' CYS . 62.7 mt -118.35 116.44 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.872 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.408 ' CE2' ' HA ' ' A' ' 102' ' ' HIS . 0.5 OUTLIER -116.88 142.94 46.28 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.569 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.637 HD23 HG11 ' A' ' 134' ' ' VAL . 1.8 mp -133.7 131.41 21.18 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.79 -177.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.1 -32.62 40.2 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 121.154 1.236 . . . . 0.0 113.693 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -65.76 -30.44 71.09 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.509 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.92 -41.45 74.63 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.229 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -67.94 -28.03 67.12 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.227 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -102.35 0.56 34.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.338 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.412 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.7 t90 -69.37 124.16 23.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.959 0.885 . . . . 0.0 109.985 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -95.34 125.0 39.67 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.158 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -76.7 125.64 86.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.409 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -108.85 92.03 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.65 0 CA-C-N 120.937 1.37 . . . . 0.0 112.36 -2.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -114.12 -61.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.936 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.1 t -66.64 -40.75 88.84 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.794 0.331 . . . . 0.0 111.277 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 59.07 168.15 0.06 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.787 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.692 HD22 HG21 ' A' ' 28' ' ' VAL . 6.7 tt -60.04 -42.1 93.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.69 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 125' ' ' LEU . 5.0 tt -52.63 -37.64 58.76 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.488 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.36 -39.31 97.08 Favored Glycine 0 N--CA 1.477 1.37 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.7 tp -60.51 -40.25 90.73 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -75.57 -48.85 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.644 -176.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.547 ' NE2' HG21 ' A' ' 132' ' ' ILE . 58.6 tp60 -67.01 -35.48 80.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.616 ' O ' HG12 ' A' ' 134' ' ' VAL . 60.0 t -69.12 -39.7 79.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.414 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 51.7 ttm -57.85 -44.73 86.75 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.547 HG21 ' NE2' ' A' ' 129' ' ' GLN . 1.1 mp -61.0 -36.42 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.792 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -88.77 -47.27 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.637 HG11 HD23 ' A' ' 111' ' ' LEU . 5.4 p -66.75 -13.79 16.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.197 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.622 ' CD2' HG13 ' A' ' 134' ' ' VAL . 9.8 m-30 -101.83 -17.08 16.37 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.441 177.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.22 -26.74 71.74 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.96 -31.76 72.85 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.199 -0.501 . . . . 0.0 110.547 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -166.58 84.43 0.91 Allowed Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.257 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -46.6 121.83 5.2 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.225 1.283 . . . . 0.0 109.844 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.434 ' HB2' HG21 ' A' ' 103' ' ' VAL . 47.6 Cg_endo -70.13 -14.93 35.51 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.458 1.439 . . . . 0.0 112.427 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 m -131.42 151.2 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.245 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.7 p90 . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.374 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 121.005 0.431 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.34 155.13 17.03 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 92.3 mt-10 -62.16 -41.08 97.95 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -57.1 -48.45 78.58 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.054 0.93 . . . . 0.0 109.398 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -64.05 -30.8 71.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.518 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.866 HD23 HG13 ' A' ' 22' ' ' VAL . 13.3 tp -59.14 -39.07 81.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.764 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 12.0 mptt -59.56 -42.79 93.25 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.669 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.71 -25.48 64.79 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.996 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.728 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -80.92 -28.92 35.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.893 -178.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -116.6 23.83 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 120.903 0.382 . . . . 0.0 110.489 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 t -67.06 -39.04 86.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.153 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -62.03 -17.72 58.25 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.823 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.486 ' CE1' HG12 ' A' ' 12' ' ' VAL . 22.6 m-85 -69.6 158.87 34.47 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.478 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -88.86 -9.86 50.11 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.91 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -132.88 56.12 1.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 119.532 -0.271 . . . . 0.0 110.302 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.425 ' O ' HG23 ' A' ' 22' ' ' VAL . 15.5 ptt180 -61.11 -32.43 72.11 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -177.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.33 -50.86 64.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.92 -41.96 73.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.099 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.2 m -61.51 -47.08 87.26 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 121.161 -0.216 . . . . 0.0 111.238 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.866 HG13 HD23 ' A' ' 8' ' ' LEU . 37.4 t -61.04 -46.51 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -60.32 -45.1 94.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.805 0.812 . . . . 0.0 110.586 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -68.23 -34.43 76.22 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.506 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.599 ' O ' HG23 ' A' ' 29' ' ' ILE . 5.6 p -67.81 -33.66 75.23 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.408 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.57 -44.96 94.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 C-N-CA 118.951 -1.1 . . . . 0.0 108.167 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -60.87 -37.32 81.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.011 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.2 t -68.83 -45.63 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.88 -17.25 8.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.702 -178.385 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -76.8 -49.87 14.83 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.183 0.516 . . . . 0.0 109.709 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.819 HD23 HD21 ' A' ' 125' ' ' LEU . 38.9 tp -76.61 -39.91 51.03 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.643 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -113.85 67.77 0.68 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -53.75 -20.34 5.45 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.522 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -65.69 -21.33 66.53 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.57 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.1 tp -89.64 117.59 28.63 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -115.05 126.52 27.75 Favored Pre-proline 0 C--N 1.356 0.879 0 CA-C-N 119.618 1.099 . . . . 0.0 111.916 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.51 135.1 14.41 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 CA-C-N 120.379 1.171 . . . . 0.0 112.232 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.17 136.64 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.728 HD13 ' SD ' ' A' ' 11' ' ' MET . 16.9 tp -85.15 116.32 23.45 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.529 ' HB2' HD22 ' A' ' 54' ' ' ASN . 99.9 m-20 -119.48 133.69 55.57 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.107 0.479 . . . . 0.0 111.76 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.2 m -68.24 138.74 55.8 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.9 t80 . . . . . 0 N--CA 1.467 0.389 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.532 -179.873 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 121.272 0.558 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.58 118.7 19.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.029 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.577 HD21 ' O ' ' A' ' 76' ' ' LEU . 19.6 tp -116.99 121.03 40.21 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.2 ttp -84.62 142.91 29.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.025 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.529 HD22 ' HB2' ' A' ' 40' ' ' ASP . 4.8 m-20 -133.51 162.15 32.67 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.384 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 55' ' ' LEU . 3.4 mm? -108.5 123.39 48.82 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.9 m -140.6 139.07 34.85 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.0 -148.59 14.93 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.187 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.6 p -132.67 161.02 35.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.822 -0.689 . . . . 0.0 112.334 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.416 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.4 pt -131.05 116.03 16.69 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.995 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.17 126.23 9.73 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 CA-C-N 119.689 0.925 . . . . 0.0 109.945 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.0 129.84 21.94 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.795 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.94 150.03 48.23 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.388 2.059 . . . . 0.0 110.876 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -163.97 112.04 1.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.971 0.415 . . . . 0.0 111.955 -178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? 49.88 44.52 25.24 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.448 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.81 18.38 68.36 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -137.6 127.11 25.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.5 m -111.44 130.78 55.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.455 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -112.67 150.81 30.95 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.734 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -94.61 105.04 16.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.495 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -90.67 116.57 66.71 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.47 124.62 3.68 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.196 1.93 . . . . 0.0 110.849 177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.495 HG23 HG22 ' A' ' 70' ' ' ILE . 26.7 pt -132.32 148.0 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.958 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.0 t -125.76 120.19 29.94 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.37 116.94 33.37 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.56 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.552 ' HE3' HD23 ' A' ' 52' ' ' LEU . 46.9 m95 -105.48 118.36 36.38 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.577 ' O ' HD21 ' A' ' 52' ' ' LEU . 59.0 mt -88.11 135.9 33.22 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.611 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -85.2 150.42 24.82 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.744 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -59.64 -15.32 18.24 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.315 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 p -100.75 7.77 43.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.541 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -66.46 144.05 98.49 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -92.08 3.88 63.09 Favored 'Cis proline' 0 N--CA 1.518 2.962 0 N-CA-C 116.13 1.55 . . . . 0.0 116.13 1.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -73.77 -17.12 61.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.467 1.031 . . . . 0.0 109.922 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -107.52 131.16 21.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.51 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -59.54 131.02 38.13 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 CA-C-N 121.319 1.507 . . . . 0.0 112.28 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.15 145.23 12.17 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.371 2.047 . . . . 0.0 111.545 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.9 129.89 48.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.0 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' CYS . . . . . 0.461 ' SG ' HD12 ' A' ' 109' ' ' ILE . 42.7 t -110.82 144.08 40.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.627 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -126.53 127.4 45.25 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.438 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.53 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 71.7 t -82.44 137.36 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -93.87 96.12 1.55 Allowed Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.135 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 97.7 Cg_endo -78.9 160.98 27.25 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 C-N-CA 121.711 1.607 . . . . 0.0 112.794 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.407 HG22 ' HB2' ' A' ' 95' ' ' MET . 5.5 t -148.37 167.22 25.81 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.661 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.9 p -58.46 -27.59 64.52 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 62.6 m -94.06 6.54 48.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.974 0.806 . . . . 0.0 110.972 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.407 ' HB2' HG22 ' A' ' 92' ' ' THR . 82.8 mmm -130.99 144.1 51.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.3 m -121.44 145.04 48.33 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.568 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 97' ' ' ILE . 12.2 tt -113.25 122.22 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.32 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.65 98.22 6.91 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.1 p -55.23 140.72 37.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.695 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.11 -142.2 3.33 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.431 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -65.46 -25.49 67.53 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -119.03 -30.29 5.04 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 119.322 0.965 . . . . 0.0 113.207 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.4 t -96.4 134.21 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.313 0.961 . . . . 0.0 110.925 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -98.68 160.47 14.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.287 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.12 85.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.053 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.31 -7.14 34.47 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.119 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.85 8.01 58.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.747 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.61 151.53 34.32 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.153 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.461 HD12 ' SG ' ' A' ' 87' ' ' CYS . 76.2 mt -109.18 122.03 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.481 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.44 ' HH ' ' CE1' ' A' ' 115' ' ' HIS . 0.9 OUTLIER -99.64 130.96 45.91 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.644 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.449 HD22 HG11 ' A' ' 134' ' ' VAL . 16.1 mt -134.33 108.37 11.27 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.89 -177.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -48.52 -34.26 25.73 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.971 1.781 . . . . 0.0 114.475 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -62.29 -29.24 70.29 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.337 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.58 -41.09 80.16 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.422 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.44 ' CE1' ' HH ' ' A' ' 110' ' ' TYR . 2.0 m-70 -65.81 -31.67 72.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.459 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -96.65 -8.4 31.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.336 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -54.1 124.83 16.82 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.898 0.856 . . . . 0.0 109.967 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -107.69 106.26 16.51 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.739 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 34.1 t-80 -58.23 123.55 66.09 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.721 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 20.3 Cg_endo -109.63 91.74 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.549 0 CA-C-N 120.707 1.288 . . . . 0.0 112.496 -3.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.88 -62.66 1.56 Allowed 'General case' 0 C--O 1.232 0.149 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.4 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.8 m -67.8 -41.04 83.75 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.136 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 60.62 163.5 0.06 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.527 0.679 . . . . 0.0 111.53 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.8 tt -60.24 -45.91 91.6 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.246 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.819 HD21 HD23 ' A' ' 31' ' ' LEU . 13.6 tp -54.68 -33.65 61.16 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -64.41 -40.54 97.86 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 tp -58.01 -40.0 79.71 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -75.73 -47.16 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.745 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.427 ' OE1' HG21 ' A' ' 132' ' ' ILE . 7.6 tp-100 -66.73 -35.74 80.82 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 126' ' ' GLY . 54.5 t -67.19 -38.38 80.95 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.1 tpp -58.66 -44.06 90.02 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.427 HG21 ' OE1' ' A' ' 129' ' ' GLN . 0.9 OUTLIER -62.8 -35.05 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.744 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -86.3 -47.27 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.774 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.449 HG11 HD22 ' A' ' 111' ' ' LEU . 3.8 p -69.58 -13.68 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.221 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.404 ' HD1' HG13 ' A' ' 134' ' ' VAL . 4.2 m-30 -103.58 -16.34 15.55 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.646 177.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -84.58 -23.76 49.17 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -66.44 -29.22 69.3 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.349 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -161.55 84.25 1.76 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.704 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -45.38 108.16 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.324 1.349 . . . . 0.0 110.925 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.11 -17.87 35.73 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.652 1.568 . . . . 0.0 110.982 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.28 138.41 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.458 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.5 p90 . . . . . 0 N--CA 1.471 0.624 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.577 -179.568 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.1 t . . . . . 0 N--CA 1.447 -0.616 0 CA-C-O 121.203 0.525 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 t -98.28 153.98 18.13 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.55 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 37.2 mp0 -60.13 -42.6 95.16 Favored 'General case' 0 C--O 1.214 -0.795 0 C-N-CA 118.43 -1.308 . . . . 0.0 110.947 -178.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.8 m -53.38 -45.94 69.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.825 0.822 . . . . 0.0 109.651 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -63.5 -38.06 89.67 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.601 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.912 HD23 HG13 ' A' ' 22' ' ' VAL . 15.4 tp -55.08 -42.07 72.34 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.55 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -59.67 -40.1 86.68 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.94 -32.43 70.7 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.05 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.831 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -73.55 -31.72 63.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.456 -178.566 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -115.36 20.76 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.687 0.28 . . . . 0.0 111.333 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -61.31 -37.94 85.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.365 0.602 . . . . 0.0 110.298 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -60.22 -21.15 61.46 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.612 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.417 ' OH ' HD22 ' A' ' 52' ' ' LEU . 37.0 m-85 -74.49 151.87 39.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.915 0.388 . . . . 0.0 111.889 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -70.93 -37.15 72.88 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.985 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.401 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 39.1 m-85 -109.14 60.84 0.6 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 121.25 -0.18 . . . . 0.0 111.448 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.0 ptp180 -67.37 -24.74 65.73 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -75.12 -50.0 17.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.93 -40.14 83.38 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.647 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.5 m -61.2 -46.73 89.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.247 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.912 HG13 HD23 ' A' ' 8' ' ' LEU . 41.5 t -61.85 -44.4 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-O 120.821 0.343 . . . . 0.0 110.155 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -62.93 -41.6 99.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.209 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -66.42 -37.73 85.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.676 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.646 ' O ' HG23 ' A' ' 29' ' ' ILE . 38.7 p -66.19 -37.13 84.86 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.299 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.18 -45.08 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 C-N-CA 118.849 -1.14 . . . . 0.0 108.506 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -61.28 -37.83 84.57 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.251 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.57 HG21 HD22 ' A' ' 124' ' ' LEU . 79.9 t -71.27 -43.41 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.05 -23.1 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.386 -178.035 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.1 m -72.19 -44.5 62.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.046 0.451 . . . . 0.0 110.264 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.738 HD23 HD11 ' A' ' 125' ' ' LEU . 23.9 tp -88.73 -40.68 13.06 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.417 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.55 67.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -56.83 -17.19 8.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.029 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -66.08 -14.6 62.02 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.59 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 tp -102.42 113.03 26.02 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -110.07 137.12 20.45 Favored Pre-proline 0 C--N 1.36 1.024 0 CA-C-N 119.921 1.237 . . . . 0.0 112.182 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.13 139.92 10.89 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.004 1.803 . . . . 0.0 112.423 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.53 139.22 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.072 0.463 . . . . 0.0 109.794 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.831 HD13 ' SD ' ' A' ' 11' ' ' MET . 14.2 tp -83.74 122.41 28.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.175 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -129.7 140.61 51.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.981 0.42 . . . . 0.0 112.073 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.7 t -94.05 115.29 27.6 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.476 ' CD2' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.71 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 . . . . . 0 C--O 1.238 0.481 0 CA-C-O 121.294 0.569 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -67.62 118.51 10.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.395 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.476 HD12 ' CD2' ' A' ' 42' ' ' TYR . 14.9 mt -125.53 142.53 51.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.955 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 49.8 ttp -90.93 144.57 25.54 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.11 152.76 51.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.551 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.8 mt -104.41 117.89 35.29 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -132.32 136.79 47.13 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.26 -143.95 8.34 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.424 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 p -136.34 159.31 42.16 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.449 HD13 HG21 ' A' ' 59' ' ' ILE . 1.3 pt -131.27 116.03 16.43 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.031 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -72.32 125.85 11.13 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 120.867 1.044 . . . . 0.0 110.793 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.5 t -128.77 115.91 19.3 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.578 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.31 150.63 15.4 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 122.718 2.279 . . . . 0.0 112.224 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.02 115.05 1.32 Allowed 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.258 0.551 . . . . 0.0 111.229 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.95 39.44 22.84 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.862 -0.523 . . . . 0.0 112.119 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 0.79 90.05 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.139 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -119.89 128.78 53.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 109.896 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.2 m -119.26 132.04 55.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.502 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -115.75 150.88 36.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.916 0.388 . . . . 0.0 110.574 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -95.6 100.94 12.61 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.489 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -87.37 116.98 67.92 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.464 -177.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -82.29 126.27 4.82 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 122.718 2.279 . . . . 0.0 110.687 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.489 HG23 HG22 ' A' ' 70' ' ' ILE . 26.4 pt -133.35 147.96 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 118.943 -1.103 . . . . 0.0 112.502 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.6 m -121.89 123.42 41.69 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.365 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.07 109.92 21.89 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.42 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -96.08 128.98 43.46 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 mp -99.42 140.08 34.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.13 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tp -95.14 140.56 29.9 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.71 -17.1 0.09 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.17 12.43 37.01 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -69.08 143.41 94.21 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -91.68 4.51 64.91 Favored 'Cis proline' 0 N--CA 1.516 2.806 0 CA-C-N 120.928 1.367 . . . . 0.0 114.501 0.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.401 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.4 m-85 -67.73 -18.93 65.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.378 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.08 120.98 40.6 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.201 178.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -49.55 136.41 33.37 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 CA-C-N 121.235 1.477 . . . . 0.0 111.859 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.62 144.7 14.2 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.337 2.025 . . . . 0.0 111.277 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 mp -97.76 132.77 41.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-O 121.591 0.71 . . . . 0.0 109.789 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 33.8 t -106.41 154.86 20.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.529 -177.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.1 128.76 30.75 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.053 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.63 ' CG2' HD11 ' A' ' 109' ' ' ILE . 58.9 t -98.05 124.13 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -75.28 108.12 5.12 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.187 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -85.64 159.24 10.68 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.267 1.311 . . . . 0.0 112.454 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -129.24 164.86 22.55 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 m -58.6 -39.84 81.56 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.2 m -84.74 -0.68 54.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.85 0.75 . . . . 0.0 111.581 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 32.8 ttm -120.92 145.92 47.18 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -131.39 163.07 28.7 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.588 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.444 ' N ' HG23 ' A' ' 96' ' ' THR . 72.4 mt -95.8 103.59 14.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -87.32 113.52 23.12 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.149 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.5 p -68.52 147.74 51.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.256 0.55 . . . . 0.0 110.479 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.87 -145.16 4.28 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -79.47 -7.53 58.5 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -133.11 -30.46 1.34 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.14 0.882 . . . . 0.0 112.297 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.2 t -97.03 139.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.48 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -94.83 -174.61 3.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.661 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.32 -35.03 21.72 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -83.86 5.46 25.14 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.957 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.13 13.12 50.32 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.346 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -75.52 136.26 40.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.779 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.63 HD11 ' CG2' ' A' ' 89' ' ' VAL . 91.7 mt -110.8 114.98 48.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 140.86 49.2 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.624 HD23 HG11 ' A' ' 134' ' ' VAL . 1.6 mp -134.43 128.63 19.29 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.01 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -49.02 -35.16 31.49 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 121.388 1.392 . . . . 0.0 113.384 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -32.42 71.92 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.23 -41.93 76.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.273 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -63.68 -31.06 72.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.016 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -108.42 9.95 27.53 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.769 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -65.57 127.25 31.13 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.688 0.756 . . . . 0.0 110.439 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.39 122.17 43.75 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.453 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 12.8 t-80 -75.82 125.93 87.71 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.626 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 7.4 Cg_endo -109.85 91.27 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.718 0 CA-C-N 120.597 1.249 . . . . 0.0 112.626 -2.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -113.19 -59.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.538 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.403 ' O ' ' HA3' ' A' ' 126' ' ' GLY . 27.2 p -68.85 -34.74 75.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.138 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 p30 49.21 178.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.603 0.716 . . . . 0.0 111.613 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.57 HD22 HG21 ' A' ' 28' ' ' VAL . 1.5 tt -66.0 -40.59 91.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.379 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.738 HD11 HD23 ' A' ' 31' ' ' LEU . 2.9 tt -56.77 -40.36 75.73 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -60.86 -39.87 97.48 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.0 tp -58.69 -40.77 84.59 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 122.265 -0.55 . . . . 0.0 111.556 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -76.61 -48.89 25.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.096 -0.642 . . . . 0.0 112.314 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -66.71 -34.0 76.87 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.618 ' O ' HG12 ' A' ' 134' ' ' VAL . 58.5 t -68.6 -38.33 78.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 48.7 tpp -58.9 -44.1 91.14 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -61.64 -40.84 88.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.888 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -82.46 -47.86 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 120.002 -0.679 . . . . 0.0 112.543 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.624 HG11 HD23 ' A' ' 111' ' ' LEU . 4.2 p -66.75 -14.06 17.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.072 -178.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.472 ' CD1' HG13 ' A' ' 134' ' ' VAL . 11.8 m-30 -109.22 -18.43 13.61 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.91 88.52 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -63.66 -34.91 78.9 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-N 115.294 -0.453 . . . . 0.0 110.489 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -156.63 84.08 3.16 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.327 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -43.96 107.42 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.679 1.586 . . . . 0.0 111.018 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.03 -24.23 47.77 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.105 1.87 . . . . 0.0 111.578 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.6 m -128.33 147.33 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.565 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.0 p90 . . . . . 0 N--CA 1.474 0.727 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.542 179.865 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 N--CA 1.449 -0.515 0 CA-C-O 121.052 0.453 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.82 153.56 18.79 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.541 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 95.3 mt-10 -61.72 -42.17 98.59 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.099 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.0 t -56.78 -46.49 81.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.19 0.995 . . . . 0.0 108.649 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -61.18 -39.07 88.8 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.144 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.784 HD23 HG13 ' A' ' 22' ' ' VAL . 27.6 tp -56.12 -42.19 76.47 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.6 mptp? -60.14 -40.65 90.57 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -28.19 67.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.69 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.653 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -80.39 -30.51 37.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.99 -178.296 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -118.61 19.71 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.577 0.227 . . . . 0.0 111.387 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -61.05 -38.1 84.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.53 0.681 . . . . 0.0 110.306 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -60.2 -26.06 66.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.122 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.686 ' OH ' HD22 ' A' ' 52' ' ' LEU . 40.3 m-85 -67.36 159.4 29.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.716 0.293 . . . . 0.0 110.941 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -80.33 -29.92 38.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.811 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -116.89 58.04 0.78 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -63.59 -28.51 69.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.3 -47.41 61.26 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.1 tp -70.27 -40.25 74.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.501 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 25' ' ' THR . 98.8 m -62.94 -46.14 89.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.784 HG13 HD23 ' A' ' 8' ' ' LEU . 14.4 t -63.28 -45.6 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 120.695 0.283 . . . . 0.0 110.991 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -63.14 -43.52 98.11 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.154 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -66.68 -37.43 84.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.995 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.667 ' O ' HG23 ' A' ' 29' ' ' ILE . 28.1 p -64.76 -36.94 85.94 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.976 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -57.32 -45.03 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -60.98 -40.41 93.34 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.998 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -68.0 -43.6 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.38 -23.77 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.217 -178.05 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.5 m -74.48 -44.54 51.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.009 0.433 . . . . 0.0 110.595 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.663 ' O ' HD13 ' A' ' 31' ' ' LEU . 2.8 tm? -85.32 -36.61 20.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.666 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.86 68.38 0.72 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -57.01 -19.39 18.12 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.539 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.81 -21.55 66.8 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.067 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.457 HD23 HD13 ' A' ' 55' ' ' LEU . 2.9 tp -90.24 113.32 25.11 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -108.98 125.12 32.3 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 119.439 1.018 . . . . 0.0 111.77 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.09 137.58 17.38 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.32 1.347 . . . . 0.0 112.102 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.18 143.99 37.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 120.968 0.414 . . . . 0.0 110.264 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.653 HD13 ' SD ' ' A' ' 11' ' ' MET . 17.5 tp -91.63 122.01 33.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.533 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -131.47 139.5 49.36 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.088 0.47 . . . . 0.0 111.965 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 t -68.82 136.22 52.37 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.2 t80 . . . . . 0 N--CA 1.465 0.321 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.163 -179.978 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -79.83 120.1 23.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.558 0.694 . . . . 0.0 110.623 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.686 HD22 ' OH ' ' A' ' 15' ' ' TYR . 39.8 mt -116.18 142.51 46.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.907 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -101.37 137.12 40.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.097 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -129.34 151.08 50.38 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.744 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.457 HD13 HD23 ' A' ' 35' ' ' LEU . 6.8 mt -95.16 122.34 37.73 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.2 m -133.65 136.02 44.52 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.81 -144.54 9.16 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.859 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -135.18 160.47 38.26 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.414 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.2 pt -129.32 116.14 18.62 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.924 177.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -73.55 124.24 9.2 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 120.661 0.907 . . . . 0.0 109.887 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.4 t -123.76 117.72 27.36 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.03 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.5 146.77 50.58 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.334 2.022 . . . . 0.0 110.753 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.404 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -162.88 108.97 1.17 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.514 -178.74 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.01 35.12 21.3 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 122.022 -0.424 . . . . 0.0 111.411 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.65 -2.74 77.69 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -113.57 135.1 54.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.6 m -120.28 132.27 55.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.034 0.445 . . . . 0.0 111.993 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -111.02 147.53 34.56 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.807 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -95.26 100.53 12.31 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.521 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -86.92 115.42 62.46 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.034 -177.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.38 123.37 3.87 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.874 2.383 . . . . 0.0 111.058 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.521 HG23 HG22 ' A' ' 70' ' ' ILE . 35.2 pt -136.49 149.12 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.935 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 53.7 m -123.92 122.42 37.91 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.568 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.4 HD22 HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -97.64 121.6 39.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.025 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -111.23 119.43 38.89 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.12 139.97 32.09 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.034 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' O ' ' HE2' ' A' ' 15' ' ' TYR . 2.8 mt -89.28 149.38 23.09 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -56.69 -16.58 6.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.619 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.0 5.41 43.1 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.156 0.503 . . . . 0.0 111.788 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -63.77 144.08 97.99 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -90.19 5.32 68.53 Favored 'Cis proline' 0 N--CA 1.514 2.693 0 CA-C-N 121.004 1.394 . . . . 0.0 115.227 1.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -70.07 -25.02 63.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.865 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.3 138.2 19.47 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.37 141.67 75.66 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 CA-C-N 121.767 1.667 . . . . 0.0 111.304 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -82.52 142.87 11.91 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.016 1.81 . . . . 0.0 111.878 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.55 135.34 28.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 42.2 t -112.09 139.93 47.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.839 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.1 124.98 44.31 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.943 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -84.41 144.48 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -98.29 98.21 5.48 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 119.221 -0.418 . . . . 0.0 110.318 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -80.79 160.18 21.5 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.256 1.304 . . . . 0.0 111.921 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 t -137.34 161.68 35.62 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.2 t -54.64 -39.37 67.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.177 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.6 t -76.64 -2.25 31.74 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.536 0.607 . . . . 0.0 111.956 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.3 mtp -130.13 145.47 51.7 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.443 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -126.73 163.35 23.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.596 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.443 ' N ' HG23 ' A' ' 96' ' ' THR . 3.3 mm -90.77 110.04 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.567 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -95.09 104.75 16.63 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 34.3 p -67.73 138.17 56.04 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.684 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.76 -133.64 1.93 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -86.09 -7.26 58.72 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -134.84 -23.09 1.59 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 140' ' ' PRO . 2.3 t -91.62 134.59 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 119.6 1.091 . . . . 0.0 110.635 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.428 ' O ' HG12 ' A' ' 103' ' ' VAL . 15.3 t0 -84.72 -168.29 2.14 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.59 -34.54 19.85 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.683 -0.636 . . . . 0.0 112.399 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -88.81 1.26 55.57 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.736 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.01 -8.43 38.89 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.465 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 131.67 23.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.243 0.522 . . . . 0.0 110.172 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.408 HG22 ' HG ' ' A' ' 111' ' ' LEU . 76.5 mt -97.67 121.5 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.928 0.395 . . . . 0.0 110.535 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.87 119.43 38.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.424 ' CD2' HG11 ' A' ' 134' ' ' VAL . 7.1 mt -126.57 113.42 22.91 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.59 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -48.42 -38.27 34.54 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 121.962 1.775 . . . . 0.0 114.25 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -63.82 -31.51 72.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.22 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.29 -42.23 79.78 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.793 0.33 . . . . 0.0 110.927 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -67.1 -29.26 68.96 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.687 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -104.36 7.15 35.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.229 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -71.6 127.25 31.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 122.033 0.92 . . . . 0.0 110.651 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -97.41 124.72 41.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.824 -1.534 . . . . 0.0 108.217 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -80.25 126.64 78.7 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 119.133 -0.46 . . . . 0.0 110.539 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -108.8 93.36 0.03 OUTLIER 'Cis proline' 0 N--CA 1.498 1.755 0 CA-C-N 120.631 1.261 . . . . 0.0 112.778 -2.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -113.69 -60.7 1.85 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.722 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.2 p -69.99 -31.8 69.67 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.0 p30 48.46 179.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.73 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 tt -66.88 -43.31 83.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.983 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.553 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -52.9 -40.69 63.73 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.341 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.1 -39.67 97.93 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.0 -41.38 87.53 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -75.41 -46.88 36.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 119.796 -0.761 . . . . 0.0 111.766 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -36.59 75.73 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.219 -0.992 . . . . 0.0 108.626 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 126' ' ' GLY . 55.6 t -65.49 -42.24 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.197 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 56.6 ttm -57.16 -43.47 82.57 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.414 HD11 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -59.79 -26.51 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.702 178.285 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.5 t -94.99 -54.61 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 130' ' ' VAL . 11.2 p -63.8 -13.71 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.394 -0.191 . . . . 0.0 111.317 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -100.59 -16.92 17.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.433 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.8 -25.36 60.48 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -65.29 -34.5 78.49 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -158.37 83.67 2.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -44.25 111.44 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.716 1.611 . . . . 0.0 110.984 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HB2' HG21 ' A' ' 103' ' ' VAL . 56.9 Cg_endo -72.49 -14.98 27.84 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 121.741 1.627 . . . . 0.0 111.519 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.8 m -127.49 139.53 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.643 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 39.2 p90 . . . . . 0 N--CA 1.472 0.673 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.953 -179.004 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.3 t . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 120.884 0.373 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.48 153.54 19.04 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.527 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 28.5 mp0 -62.64 -41.44 99.03 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.849 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.1 m -58.18 -46.02 86.49 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.083 0.944 . . . . 0.0 108.834 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.19 -34.58 77.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.548 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.677 HD23 HG13 ' A' ' 22' ' ' VAL . 11.0 tp -57.66 -36.94 72.56 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.527 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.4 mptp? -61.71 -44.61 96.6 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.464 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -64.39 -36.36 83.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.34 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.655 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -69.55 -33.67 73.11 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.79 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.4 m -114.0 20.98 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 122.021 -0.425 . . . . 0.0 110.906 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -60.55 -37.67 82.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.194 0.521 . . . . 0.0 111.13 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -62.96 -13.45 34.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.896 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -76.42 155.01 34.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.942 0.401 . . . . 0.0 111.365 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -72.28 -36.9 69.11 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.88 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -113.06 65.16 0.64 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.289 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -63.66 -25.52 68.25 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.93 -54.03 8.81 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 tp -64.29 -38.63 91.73 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.535 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 25' ' ' THR . 95.9 m -61.66 -48.2 81.9 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.752 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.677 HG13 HD23 ' A' ' 8' ' ' LEU . 27.3 t -62.62 -47.96 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 120.751 0.31 . . . . 0.0 111.161 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -62.7 -42.03 99.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.106 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.6 -39.1 93.51 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.305 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.648 ' O ' HG23 ' A' ' 29' ' ' ILE . 40.1 p -68.05 -37.7 81.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.736 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -55.23 -43.05 69.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -60.57 -39.6 88.58 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.47 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.62 ' HA ' HD13 ' A' ' 125' ' ' LEU . 68.7 t -72.55 -40.67 63.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -88.17 -23.71 6.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.261 -178.13 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.2 m -73.85 -48.7 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.097 0.475 . . . . 0.0 109.833 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.929 HD23 HD21 ' A' ' 125' ' ' LEU . 16.4 tp -84.39 -38.85 19.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.989 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.733 ' HD1' HD11 ' A' ' 125' ' ' LEU . 2.3 m-85 -112.9 65.72 0.64 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.208 0.528 . . . . 0.0 109.986 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -58.62 -14.6 8.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -64.2 -20.92 66.35 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.534 HD23 HD13 ' A' ' 55' ' ' LEU . 2.9 tp -94.54 113.8 25.69 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -107.87 129.31 24.32 Favored Pre-proline 0 C--N 1.357 0.916 0 CA-C-N 120.094 1.315 . . . . 0.0 111.716 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -84.39 137.04 6.81 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 121.804 1.669 . . . . 0.0 112.991 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.35 154.39 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.655 HD13 ' SD ' ' A' ' 11' ' ' MET . 15.2 tp -94.99 126.11 40.11 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.407 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.9 161.62 26.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.48 0.657 . . . . 0.0 112.091 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -97.64 124.59 42.0 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.358 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.125 0 CA-C-N 118.306 0.503 . . . . 0.0 109.892 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.029 0.443 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.82 121.33 23.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.91 0.862 . . . . 0.0 109.976 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.508 HD21 ' O ' ' A' ' 76' ' ' LEU . 11.8 tp -120.31 131.91 55.08 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.316 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.2 ttp -91.03 137.77 32.11 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.884 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -131.23 152.04 50.89 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.534 HD13 HD23 ' A' ' 35' ' ' LEU . 9.2 mt -100.96 130.47 46.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.1 m -145.55 137.88 25.69 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.071 0.463 . . . . 0.0 111.857 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.71 -145.21 9.34 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.279 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.4 p -131.26 158.15 41.39 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.659 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.4 pt -132.48 116.33 15.1 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.608 177.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -69.03 124.16 11.09 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 CA-C-N 119.98 1.029 . . . . 0.0 110.849 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.8 t -127.6 112.59 20.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.259 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.18 151.6 20.78 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.879 2.386 . . . . 0.0 112.62 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -163.5 115.03 1.43 Allowed 'General case' 0 CA--C 1.56 1.343 0 CA-C-O 121.546 0.689 . . . . 0.0 111.23 179.046 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 49.97 38.93 17.57 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.86 -4.49 85.67 Favored Glycine 0 N--CA 1.473 1.151 0 O-C-N 121.727 -0.608 . . . . 0.0 113.025 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -119.6 130.29 55.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.97 0.414 . . . . 0.0 109.98 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.8 m -118.25 131.41 56.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.685 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -113.28 149.29 34.08 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.949 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -97.13 102.64 14.46 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.453 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -89.39 119.15 69.62 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.39 128.58 4.16 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.784 2.323 . . . . 0.0 110.624 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.453 HG23 HG22 ' A' ' 70' ' ' ILE . 23.1 pt -134.5 147.5 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.971 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 69.3 m -120.62 122.48 40.6 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 121.534 0.683 . . . . 0.0 110.021 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.19 114.4 28.51 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.326 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -105.23 122.99 47.08 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.508 ' O ' HD21 ' A' ' 52' ' ' LEU . 63.4 mt -93.86 131.12 39.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.738 -177.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mt -74.82 149.43 39.65 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -56.9 -14.18 3.28 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.577 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.6 0.29 36.07 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -51.79 144.71 18.42 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HG2' ' CD2' ' A' ' 119' ' ' HIS . 29.0 Cg_endo -93.62 10.1 53.6 Favored 'Cis proline' 0 N--CA 1.516 2.81 0 CA-C-N 120.842 1.336 . . . . 0.0 115.369 0.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -75.45 -12.0 60.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.235 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.17 121.81 35.74 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.88 137.65 35.21 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 CA-C-N 121.182 1.458 . . . . 0.0 111.995 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.12 142.11 12.06 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.19 1.927 . . . . 0.0 111.488 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.31 133.43 40.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.699 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.3 t -114.69 143.45 45.02 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.017 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -127.86 131.14 49.5 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.681 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.7 t -103.92 126.31 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.14 101.78 5.32 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.957 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -83.82 129.24 4.73 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.622 1.548 . . . . 0.0 113.254 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.4 p -80.91 165.54 21.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.7 p -59.27 -25.07 63.77 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -99.51 23.76 9.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.971 0.805 . . . . 0.0 109.888 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.7 ttm -129.64 139.41 51.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.888 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.6 m -115.64 133.06 56.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.019 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 97' ' ' ILE . 1.4 tp -84.26 106.94 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.971 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -87.22 99.27 11.83 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.352 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.6 p -67.67 143.11 56.14 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.74 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.76 -152.45 6.9 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -74.59 -15.63 60.83 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -114.15 -27.35 7.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.578 HG21 ' HB2' ' A' ' 140' ' ' PRO . 2.0 t -106.65 136.09 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -100.07 175.78 5.63 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.15 93.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -79.34 -17.84 53.71 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.02 33.78 2.71 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.215 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -82.21 148.48 28.4 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.61 116.01 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.604 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.36 116.61 32.45 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 mt -126.05 113.71 24.13 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 118.249 0.477 . . . . 0.0 110.942 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -48.21 -37.55 31.57 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.733 1.622 . . . . 0.0 114.661 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.43 ' OH ' HD13 ' A' ' 127' ' ' LEU . 1.7 p90 -61.47 -32.24 72.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.652 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.409 ' N ' ' CG ' ' A' ' 113' ' ' TYR . 0.8 OUTLIER -68.55 -41.5 79.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.717 -178.969 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -62.99 -33.86 76.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.628 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -101.03 2.88 40.95 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.163 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -52.5 123.08 10.12 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.992 0.901 . . . . 0.0 110.221 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -101.58 100.22 10.6 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.797 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 81' ' ' PRO . 23.5 t-80 -57.03 122.29 52.24 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.897 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -111.66 91.24 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.576 0 CA-C-N 120.687 1.281 . . . . 0.0 112.235 -3.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -114.96 -51.63 2.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.984 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.3 m -71.24 -41.33 70.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.983 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t70 66.53 165.04 0.2 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.585 0.707 . . . . 0.0 111.807 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.459 HD23 HG21 ' A' ' 28' ' ' VAL . 21.9 tp -67.05 -41.13 87.01 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.694 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.929 HD21 HD23 ' A' ' 31' ' ' LEU . 30.3 tp -59.69 -37.28 78.39 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -60.87 -39.6 97.12 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.43 HD13 ' OH ' ' A' ' 113' ' ' TYR . 31.2 tp -57.37 -39.51 76.17 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.416 HD12 HD13 ' A' ' 35' ' ' LEU . 1.2 mm -72.08 -49.3 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.619 -177.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -66.92 -35.68 80.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 118.661 -1.216 . . . . 0.0 108.683 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 126' ' ' GLY . 54.6 t -64.25 -38.63 83.0 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 C-N-CA 119.432 -0.907 . . . . 0.0 108.864 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.7 tpp -60.49 -43.12 97.36 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.659 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.1 mp -67.92 -36.64 76.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.683 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.5 t -81.59 -41.5 18.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.47 HG13 ' CD2' ' A' ' 135' ' ' PHE . 2.1 p -77.71 -15.62 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.784 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.47 ' CD2' HG13 ' A' ' 134' ' ' VAL . 13.8 m-30 -107.3 -18.08 13.97 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.393 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.88 -27.1 69.64 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -66.47 -27.56 67.89 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.635 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -168.18 89.72 0.66 Allowed Pre-proline 0 C--O 1.232 0.15 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -44.76 119.35 2.28 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.67 1.58 . . . . 0.0 110.588 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.578 ' HB2' HG21 ' A' ' 103' ' ' VAL . 55.3 Cg_endo -70.97 -16.3 32.46 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.561 1.507 . . . . 0.0 111.448 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.17 140.37 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.337 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 26.6 p90 . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.817 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.515 HG11 ' HG2' ' A' ' 37' ' ' PRO . 3.9 p . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 121.586 0.707 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -104.96 153.81 20.93 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.0 mt-10 -59.47 -42.48 92.16 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.109 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.2 m -58.23 -47.89 82.09 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.952 0.882 . . . . 0.0 109.355 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -62.57 -34.42 76.94 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.95 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.819 HD23 HG13 ' A' ' 22' ' ' VAL . 13.2 tp -56.09 -39.27 71.89 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 11.0 mptt -61.05 -43.95 98.13 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.557 0.694 . . . . 0.0 109.613 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.03 -36.32 83.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.617 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.78 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.4 mmm -66.92 -37.04 83.6 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.619 -178.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -115.73 23.46 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.526 0.203 . . . . 0.0 111.245 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.3 p -66.62 -18.13 65.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.705 0.288 . . . . 0.0 111.029 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -77.41 -20.78 54.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.121 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -72.47 149.88 43.79 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -66.23 -40.04 89.99 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.789 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -110.56 64.21 0.61 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.783 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -65.24 -27.74 68.87 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.37 -49.48 33.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.37 -41.7 93.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.634 -0.827 . . . . 0.0 109.389 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 25' ' ' THR . 53.1 m -60.22 -48.49 81.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.156 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.819 HG13 HD23 ' A' ' 8' ' ' LEU . 20.8 t -63.55 -46.02 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 120.536 0.208 . . . . 0.0 111.445 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.74 -42.74 99.36 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.619 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -34.19 72.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.541 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 29' ' ' ILE . 24.9 p -66.21 -38.49 88.09 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.4 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 30' ' ' THR . 53.2 t -57.64 -45.42 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -61.24 -38.77 87.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.327 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.516 HG21 HD22 ' A' ' 124' ' ' LEU . 55.2 t -67.12 -46.05 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -81.81 -13.5 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.33 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.0 p -76.33 -52.09 10.64 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.0 tp -85.03 -38.15 19.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.416 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -108.89 64.26 0.61 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.135 0.493 . . . . 0.0 109.89 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -55.31 -18.82 7.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.534 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -65.5 -22.55 66.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.364 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.55 HD23 HD13 ' A' ' 55' ' ' LEU . 2.0 tp -91.18 113.86 26.23 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -110.69 132.24 21.69 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.576 1.08 . . . . 0.0 111.805 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.515 ' HG2' HG11 ' A' ' 3' ' ' VAL . 43.5 Cg_endo -81.43 135.01 9.15 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 122.242 1.961 . . . . 0.0 112.94 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -131.56 137.01 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.78 HD13 ' SD ' ' A' ' 11' ' ' MET . 15.4 tp -82.41 121.77 27.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.27 160.04 24.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.731 0.3 . . . . 0.0 110.925 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m -99.8 131.68 45.63 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.0 t80 . . . . . 0 N--CA 1.47 0.538 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.141 -179.5 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 . . . . . 0 CA--C 1.514 -0.409 0 CA-C-O 121.433 0.635 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.16 122.97 28.03 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.672 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 52' ' ' LEU . 51.4 mt -122.29 144.17 49.16 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.936 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.491 ' SD ' HD11 ' A' ' 8' ' ' LEU . 57.9 ttp -97.43 139.09 33.88 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.84 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -132.35 150.55 52.13 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 121.161 0.505 . . . . 0.0 111.254 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.55 HD13 HD23 ' A' ' 35' ' ' LEU . 7.0 mt -98.38 124.19 42.92 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 m -134.97 138.62 44.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.68 -145.33 9.65 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.58 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.6 p -133.27 159.39 40.37 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.42 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.1 pt -133.73 116.56 13.77 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.38 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -70.95 127.56 13.8 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 CA-C-N 120.058 1.057 . . . . 0.0 110.014 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 89.8 t -127.31 118.1 21.7 Favored Pre-proline 0 C--N 1.347 0.485 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.284 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.29 142.23 37.04 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.885 1.723 . . . . 0.0 110.066 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.402 ' HD2' ' OD1' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -159.77 113.46 2.24 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.888 -178.826 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 60.84 25.37 15.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.755 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.86 -13.23 67.36 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.563 ' C ' ' OD1' ' A' ' 66' ' ' ASN . 3.1 p-10 -99.85 169.96 8.86 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.1 m -139.88 133.98 31.01 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.515 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -121.08 148.62 43.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.304 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -96.34 106.66 18.92 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.544 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -91.7 115.41 64.48 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.215 -177.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.56 126.3 4.66 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.304 2.003 . . . . 0.0 110.376 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.544 HG23 HG22 ' A' ' 70' ' ' ILE . 27.0 pt -133.97 150.44 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 119.156 -1.018 . . . . 0.0 112.091 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.6 m -121.61 120.68 35.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.81 115.68 31.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.929 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -109.24 128.05 54.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.8 mt -97.3 142.02 29.69 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.043 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -87.45 151.41 23.07 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -58.92 -15.16 11.48 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.87 5.48 33.02 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.204 0.526 . . . . 0.0 112.233 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -60.93 145.59 88.76 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -92.42 10.26 57.56 Favored 'Cis proline' 0 N--CA 1.516 2.798 0 CA-C-N 120.856 1.341 . . . . 0.0 114.753 0.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.59 -12.17 60.67 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.84 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.48 127.78 26.49 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.66 -0.686 . . . . 0.0 109.408 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -49.39 134.28 31.72 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 CA-C-N 121.192 1.461 . . . . 0.0 112.217 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.416 ' HD2' HD11 ' A' ' 114' ' ' LEU . 86.3 Cg_endo -79.9 142.12 15.51 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.366 2.044 . . . . 0.0 111.274 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.6 mt -98.75 135.67 32.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.088 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.3 t -121.66 145.98 47.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.023 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -125.71 134.48 51.78 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.159 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.403 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.8 p -95.65 127.92 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -69.3 107.42 2.15 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 44.5 Cg_endo -84.8 155.91 11.73 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.268 1.312 . . . . 0.0 113.147 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.3 p -129.01 169.85 14.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.062 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.7 m -59.18 -39.59 83.03 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -89.92 -3.61 57.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.617 0.644 . . . . 0.0 111.53 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.7 ttm -116.23 137.15 52.39 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -129.22 165.83 20.59 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.109 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.469 ' N ' HG23 ' A' ' 96' ' ' THR . 70.2 mt -111.27 108.78 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.716 178.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -97.52 126.91 43.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.9 p -72.01 143.6 49.11 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.92 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.54 -142.18 3.5 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.752 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -66.0 -26.6 67.62 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.484 ' NE2' HG23 ' A' ' 103' ' ' VAL . 20.5 p-80 -133.68 -26.67 1.57 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.484 HG23 ' NE2' ' A' ' 102' ' ' HIS . 0.9 OUTLIER -92.72 132.08 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 119.477 1.035 . . . . 0.0 110.536 -179.177 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -98.97 175.41 5.94 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.45 77.42 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -74.94 -9.83 58.91 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.415 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.69 5.29 55.45 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.156 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 147.26 53.73 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.468 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.527 HD13 ' CZ ' ' A' ' 135' ' ' PHE . 96.8 mt -120.74 125.13 73.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -99.7 137.82 37.65 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.679 HD22 HG11 ' A' ' 134' ' ' VAL . 29.2 mt -136.61 116.57 10.87 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.441 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -47.56 -37.36 26.37 Favored 'Trans proline' 0 N--CA 1.504 2.091 0 C-N-CA 122.075 1.85 . . . . 0.0 114.505 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -61.09 -29.37 69.71 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.679 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.416 HD11 ' HD2' ' A' ' 85' ' ' PRO . 1.2 tt -69.8 -43.16 72.64 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.489 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -68.05 -27.61 66.67 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.378 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -103.86 3.91 34.31 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.932 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TRP . . . . . 0.479 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.6 t90 -70.16 120.05 15.26 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.806 0.812 . . . . 0.0 109.742 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -88.05 129.51 35.26 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.161 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 46.4 t-80 -78.81 124.06 85.11 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.463 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 14.0 Cg_endo -111.04 93.1 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.664 0 CA-C-N 120.953 1.376 . . . . 0.0 111.63 -3.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -113.6 -56.17 2.43 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.115 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.5 t -74.3 -34.61 63.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.773 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 47.02 -176.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.707 0.765 . . . . 0.0 111.621 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -69.52 -40.59 76.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.306 -179.369 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.1 tt -55.68 -39.51 71.07 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.58 -39.86 98.4 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.4 tp -57.6 -40.28 78.74 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.444 HD12 HD13 ' A' ' 35' ' ' LEU . 1.1 mm -73.19 -49.96 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.816 -176.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.56 ' NE2' HG21 ' A' ' 132' ' ' ILE . 69.0 tp60 -64.78 -35.92 82.63 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 126' ' ' GLY . 73.5 t -68.25 -37.27 77.77 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.4 tpp -58.32 -43.04 88.0 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.56 HG21 ' NE2' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -62.65 -39.63 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.13 178.675 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.9 t -81.48 -47.32 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.679 HG11 HD22 ' A' ' 111' ' ' LEU . 4.7 p -67.71 -15.47 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.34 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.527 ' CZ ' HD13 ' A' ' 109' ' ' ILE . 10.8 m-30 -106.57 -19.34 13.7 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.138 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.21 -37.29 93.85 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -64.88 -36.87 85.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.762 -0.719 . . . . 0.0 110.687 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -158.1 81.99 2.9 Favored Pre-proline 0 CA--C 1.52 -0.195 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -51.04 128.88 26.34 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 120.709 0.939 . . . . 0.0 109.731 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.43 -15.25 34.56 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.469 1.446 . . . . 0.0 112.142 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.1 m -132.64 153.72 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.974 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.485 HG13 ' HE3' ' A' ' 11' ' ' MET . 76.6 t . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.084 0.469 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -95.68 158.36 15.48 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.502 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 94.9 mt-10 -63.34 -41.73 98.89 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.267 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -60.33 -48.29 82.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.225 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -63.51 -27.73 69.47 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.152 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.938 HD23 HG13 ' A' ' 22' ' ' VAL . 38.7 tp -61.23 -41.69 97.31 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.658 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 3.4 mptp? -59.27 -38.95 81.38 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.208 0.528 . . . . 0.0 109.824 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.61 -34.69 76.08 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.128 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.792 ' CB ' HD13 ' A' ' 39' ' ' LEU . 11.8 ptp -84.31 -14.58 49.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.808 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -126.34 17.97 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.413 179.34 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.9 t -61.92 -37.75 85.85 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.817 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -64.6 -19.82 65.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.875 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.449 ' CE1' HG12 ' A' ' 12' ' ' VAL . 35.9 m-85 -72.11 152.64 42.2 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -75.44 -26.14 58.05 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.675 0.274 . . . . 0.0 110.683 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -120.67 60.36 0.9 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.403 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 22' ' ' VAL . 19.8 ptt180 -64.77 -25.42 67.91 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -71.7 -55.82 6.97 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mt -64.39 -39.72 94.4 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.088 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.4 m -62.47 -47.85 82.2 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.876 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.938 HG13 HD23 ' A' ' 8' ' ' LEU . 25.8 t -62.56 -47.24 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 120.837 0.351 . . . . 0.0 110.673 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -40.44 95.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.044 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -63.42 -39.55 94.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.583 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 29' ' ' ILE . 57.5 p -70.48 -35.56 73.33 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.252 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 22' ' ' VAL . 59.7 t -56.89 -44.37 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -62.0 -39.78 93.4 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.485 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.57 HG21 HD22 ' A' ' 124' ' ' LEU . 76.6 t -70.76 -43.43 77.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.01 -17.94 8.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.517 -177.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.9 m -82.7 -47.2 12.27 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.092 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.589 HD23 HD11 ' A' ' 125' ' ' LEU . 32.7 tp -87.9 -37.8 16.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.937 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -109.12 65.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -59.0 -16.95 20.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.973 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -64.95 -21.1 66.78 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.116 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.584 HD13 HD12 ' A' ' 128' ' ' ILE . 2.1 tp -98.16 124.01 42.5 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -118.07 129.28 25.47 Favored Pre-proline 0 C--N 1.36 1.061 0 CA-C-N 120.221 1.373 . . . . 0.0 111.946 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -80.89 136.53 10.58 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 121.593 1.529 . . . . 0.0 112.81 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.39 135.59 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.792 HD13 ' CB ' ' A' ' 11' ' ' MET . 40.9 tp -83.1 122.14 27.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.02 151.24 48.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.219 0.533 . . . . 0.0 112.041 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m -98.68 119.33 37.23 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.1 t80 . . . . . 0 N--CA 1.47 0.55 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.992 -178.604 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.516 -0.346 0 CA-C-O 121.462 0.648 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -76.33 116.1 16.69 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.323 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.4 mt -122.86 138.31 54.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.454 ' SD ' HD11 ' A' ' 8' ' ' LEU . 64.2 ttp -84.29 139.55 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.137 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -125.88 156.4 39.71 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.198 0.523 . . . . 0.0 110.897 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.5 mm? -108.99 117.69 34.85 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.0 m -134.13 137.99 44.92 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.088 0.471 . . . . 0.0 112.159 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.27 -149.65 15.31 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.896 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.9 p -132.01 158.94 40.21 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.433 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.2 pt -132.58 115.97 14.86 Favored Pre-proline 0 C--O 1.237 0.433 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.416 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.74 125.46 10.01 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.8 1.0 . . . . 0.0 110.197 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.73 119.34 25.77 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.875 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.63 147.42 57.27 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.187 1.925 . . . . 0.0 109.675 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.41 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -163.74 108.79 1.04 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.339 -177.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 49.65 44.23 24.47 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.79 13.89 75.36 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.36 -0.924 . . . . 0.0 110.839 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -134.77 131.15 37.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -117.4 132.47 56.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.847 0.356 . . . . 0.0 111.797 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -112.68 148.88 33.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.99 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.95 102.46 14.26 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.447 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -91.22 116.28 66.12 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.262 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.9 127.55 4.2 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.654 2.236 . . . . 0.0 110.308 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.447 HG23 HG22 ' A' ' 70' ' ' ILE . 26.4 pt -134.57 146.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.541 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 84.8 m -120.57 121.63 38.8 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.83 120.09 39.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.664 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -104.39 117.94 35.4 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.3 mt -84.56 137.69 33.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mt -88.36 154.91 20.01 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.8 p30 -63.4 -13.83 43.92 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.501 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 p -99.24 -4.35 32.17 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -55.83 145.11 54.1 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.447 ' HG2' ' CE1' ' A' ' 119' ' ' HIS . 31.7 Cg_endo -91.18 6.29 66.54 Favored 'Cis proline' 0 N--CA 1.514 2.732 0 CA-C-N 121.121 1.436 . . . . 0.0 115.697 1.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -71.27 -19.2 62.38 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.974 -1.09 . . . . 0.0 110.349 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.21 139.5 21.95 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.056 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.0 142.76 63.22 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 CA-C-N 121.665 1.63 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 142.84 17.31 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.955 1.77 . . . . 0.0 111.906 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -92.41 134.59 29.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 39.0 t -107.78 144.35 35.06 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.765 -177.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.56 126.06 43.04 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.272 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.42 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 57.3 t -98.39 130.31 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 99.36 3.53 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 123.44 0.463 . . . . 0.0 109.873 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 44.2 Cg_endo -86.85 148.09 8.25 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.387 1.391 . . . . 0.0 113.23 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.3 p -95.95 165.27 12.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.553 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t -55.16 -19.11 6.93 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.2 t -105.52 15.65 26.73 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.002 0.819 . . . . 0.0 111.572 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.4 mtp -132.77 141.83 48.71 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -125.43 163.64 22.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.063 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.458 ' N ' HG23 ' A' ' 96' ' ' THR . 4.3 mm -93.02 101.98 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -84.89 104.71 15.08 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.802 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.7 p -72.61 150.07 43.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.349 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.5 -137.49 2.3 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.769 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -67.73 -21.08 65.31 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.531 ' CE1' HG23 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -132.57 -29.54 1.53 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.884 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.683 HG21 ' HB2' ' A' ' 140' ' ' PRO . 6.2 t -88.97 140.3 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.739 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -103.16 176.45 5.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.441 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.33 94.2 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -88.39 0.3 56.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.292 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.48 11.74 46.95 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.259 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -64.46 141.47 58.76 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.466 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.49 115.57 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.072 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.42 ' C ' ' HG ' ' A' ' 111' ' ' LEU . 27.5 m-85 -104.57 136.23 44.5 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.42 ' HG ' ' C ' ' A' ' 110' ' ' TYR . 2.1 mt -135.17 124.84 16.62 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.3 -32.7 52.34 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.365 1.376 . . . . 0.0 113.519 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -67.51 -31.8 72.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.75 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.02 -41.67 74.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.162 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -71.16 -26.54 63.03 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.29 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -100.71 -0.75 36.72 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.22 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -53.97 126.01 20.91 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 122.055 0.931 . . . . 0.0 110.733 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -97.98 94.5 6.9 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.239 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.447 ' CE1' ' HG2' ' A' ' 81' ' ' PRO . 15.7 t-80 -59.68 124.51 76.38 Favored Pre-proline 0 C--N 1.323 -0.556 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.067 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 9.6 Cg_endo -108.88 91.71 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.708 0 CA-C-N 120.454 1.198 . . . . 0.0 112.948 -2.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -113.07 -58.16 2.19 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.463 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.6 t -67.37 -40.6 85.78 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.314 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 64.37 166.21 0.15 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.741 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.57 HD22 HG21 ' A' ' 28' ' ' VAL . 7.8 tt -61.03 -41.84 97.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.589 HD11 HD23 ' A' ' 31' ' ' LEU . 5.4 tt -57.17 -36.16 70.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -60.28 -39.8 96.54 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.74 -40.79 93.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.584 HD12 HD13 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -75.17 -47.59 35.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.683 -176.649 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -68.81 -36.48 78.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.021 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 134' ' ' VAL . 79.4 t -66.85 -39.75 84.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.081 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.1 ttm -58.73 -44.5 90.49 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.433 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -60.26 -34.97 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.815 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.8 t -90.36 -46.22 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.543 HG13 ' CD2' ' A' ' 135' ' ' PHE . 4.9 p -68.91 -13.31 17.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.723 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.543 ' CD2' HG13 ' A' ' 134' ' ' VAL . 12.6 m-30 -103.76 -15.17 15.81 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.024 178.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.88 -24.92 75.94 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -70.45 -34.53 72.55 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.595 0.236 . . . . 0.0 111.012 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -162.38 83.13 1.64 Allowed Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -49.17 124.18 11.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.222 1.281 . . . . 0.0 110.752 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.683 ' HB2' HG21 ' A' ' 103' ' ' VAL . 57.1 Cg_endo -72.9 -18.56 24.38 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.741 1.627 . . . . 0.0 112.019 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.11 146.03 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.151 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 22.3 p90 . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.861 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.02 124.96 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.467 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -94.58 158.43 15.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.468 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 95.4 mt-10 -64.14 -41.15 97.3 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.196 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.3 m -58.58 -47.43 84.33 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.165 0.984 . . . . 0.0 108.985 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -63.32 -33.64 75.96 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.874 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.741 HD23 HG13 ' A' ' 22' ' ' VAL . 12.7 tp -56.3 -38.49 71.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.6 mptp? -60.73 -42.8 98.04 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.367 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.1 -37.73 88.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.617 0.722 . . . . 0.0 110.884 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.767 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.3 mmm -67.54 -36.68 81.46 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.114 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -111.87 19.69 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.651 0.263 . . . . 0.0 111.116 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.7 p -64.56 -21.78 66.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.806 0.336 . . . . 0.0 110.532 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -72.06 -23.01 61.29 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.984 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.49 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 30.2 m-85 -77.44 160.18 28.89 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.849 0.357 . . . . 0.0 110.365 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.6 -21.19 24.15 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.305 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.16 47.53 1.12 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 122.324 -0.235 . . . . 0.0 110.766 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -58.27 -24.65 60.12 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -73.61 -53.79 9.65 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.6 tp -65.13 -39.7 93.43 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.722 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 25' ' ' THR . 77.1 m -63.08 -48.68 77.55 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.338 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.741 HG13 HD23 ' A' ' 8' ' ' LEU . 25.3 t -61.5 -46.42 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 120.635 0.255 . . . . 0.0 110.47 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -62.63 -44.91 95.08 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.647 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -64.21 -36.88 85.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.948 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.63 ' O ' HG23 ' A' ' 29' ' ' ILE . 35.3 p -64.81 -34.3 78.04 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.736 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.69 -44.91 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -61.37 -38.02 85.49 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.408 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.517 HG21 HD22 ' A' ' 124' ' ' LEU . 73.3 t -70.72 -44.73 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.95 -21.57 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.354 -178.001 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.5 m -73.47 -45.88 51.52 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.535 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.776 HD23 HD21 ' A' ' 125' ' ' LEU . 30.0 tp -88.47 -39.27 14.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.032 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -111.07 66.97 0.63 Allowed 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -56.99 -17.64 10.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.288 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -66.85 -14.87 63.18 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.87 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.45 HD23 HD13 ' A' ' 55' ' ' LEU . 1.8 tp -99.98 114.27 27.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.1 ttpp -108.89 131.86 21.53 Favored Pre-proline 0 C--N 1.356 0.874 0 CA-C-N 119.521 1.055 . . . . 0.0 112.007 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.1 133.42 11.0 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.49 1.46 . . . . 0.0 112.535 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.4 t -133.96 139.36 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 110.71 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.767 HD13 ' SD ' ' A' ' 11' ' ' MET . 11.1 tp -81.93 136.27 35.32 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -140.6 154.48 46.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.144 0.497 . . . . 0.0 111.27 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.6 m -91.56 131.46 36.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -118.85 133.99 55.46 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.818 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.0 t -110.37 122.55 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.75 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -92.51 161.57 14.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.0 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -61.83 -30.29 70.74 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.987 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -64.27 -16.47 62.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.75 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.3 -11.54 65.35 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.9 m -76.24 142.35 41.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.2 m -116.22 143.98 44.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.211 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -142.78 136.69 29.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.07 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -82.12 119.3 23.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.848 0.832 . . . . 0.0 109.733 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.49 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 61.3 mt -121.44 146.71 46.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.791 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.457 ' SD ' HD11 ' A' ' 8' ' ' LEU . 53.5 ttp -97.54 142.79 28.94 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.682 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.495 ' ND2' ' CZ3' ' A' ' 75' ' ' TRP . 34.0 m-20 -135.81 152.85 51.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.452 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.45 HD13 HD23 ' A' ' 35' ' ' LEU . 8.5 mt -95.45 123.58 39.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -135.89 136.61 40.67 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.16 -146.69 11.47 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.522 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.1 p -132.84 159.4 39.93 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.439 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.3 pt -129.77 116.48 18.18 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.895 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -70.56 124.81 11.1 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 CA-C-N 120.017 1.042 . . . . 0.0 109.942 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.1 t -125.56 118.43 24.62 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 119.671 -0.812 . . . . 0.0 113.015 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.7 142.22 52.19 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.944 1.763 . . . . 0.0 109.813 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -163.08 117.54 1.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.48 26.39 10.83 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.299 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.93 -5.62 78.44 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -112.97 142.78 45.27 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -121.65 132.26 54.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.775 0.321 . . . . 0.0 111.818 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -115.9 151.74 34.76 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.523 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -95.69 106.29 18.38 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.532 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -90.83 118.56 68.71 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.79 122.1 2.24 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.601 2.201 . . . . 0.0 110.534 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.532 HG23 HG22 ' A' ' 70' ' ' ILE . 31.9 pt -134.44 149.51 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.796 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.1 m -123.5 127.9 49.01 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.947 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.71 115.49 30.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.868 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.495 ' CZ3' ' ND2' ' A' ' 54' ' ' ASN . 60.3 m95 -103.69 125.81 50.42 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.6 mt -90.84 138.64 31.43 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.0 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.51 146.44 36.38 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -56.79 -14.99 3.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.476 0.58 . . . . 0.0 111.679 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.4 p -106.03 13.11 29.65 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.259 0.552 . . . . 0.0 111.536 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -61.4 144.39 92.07 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -92.23 8.09 61.35 Favored 'Cis proline' 0 N--CA 1.514 2.721 0 CA-C-N 121.216 1.47 . . . . 0.0 115.623 1.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -71.51 -15.28 62.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.853 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.82 137.76 19.85 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.24 143.82 66.07 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 121.579 1.6 . . . . 0.0 110.751 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.82 138.9 13.57 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.444 1.43 . . . . 0.0 111.893 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 mt -95.2 131.73 41.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 40.3 t -110.06 150.75 28.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.066 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -133.28 127.05 32.81 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.535 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.3 t -96.1 121.56 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -68.95 109.69 4.74 Favored Pre-proline 0 N--CA 1.476 0.846 0 CA-C-O 119.167 -0.444 . . . . 0.0 111.15 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.21 164.71 11.26 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.577 1.518 . . . . 0.0 112.238 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.7 p -139.31 172.85 12.22 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.7 m -57.95 -41.19 82.33 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.86 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.9 m -90.29 -11.89 39.44 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.897 0.771 . . . . 0.0 111.733 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.0 tpp -108.91 124.45 50.69 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.459 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -119.15 165.33 14.32 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.353 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.459 ' N ' HG23 ' A' ' 96' ' ' THR . 87.2 mt -96.16 110.59 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -90.98 102.14 14.9 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.4 p -59.83 142.71 52.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.314 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -158.33 -144.15 3.86 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.705 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -65.95 -27.48 68.19 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.528 ' NE2' HG23 ' A' ' 103' ' ' VAL . 16.9 p-80 -128.96 -7.79 4.93 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 119.047 -1.061 . . . . 0.0 113.407 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.681 HG21 ' HB2' ' A' ' 140' ' ' PRO . 40.3 t -108.21 126.56 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.167 0.894 . . . . 0.0 111.736 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 103' ' ' VAL . 32.6 p-10 -88.65 -161.41 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.76 -20.83 25.62 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.863 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -90.23 -1.79 57.97 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.728 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.9 11.73 56.26 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.855 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -63.01 140.56 58.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.527 0.664 . . . . 0.0 109.667 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 98.7 mt -116.6 117.99 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.107 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -102.38 137.29 40.83 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.961 HD22 HG11 ' A' ' 134' ' ' VAL . 26.8 mt -136.64 116.61 10.85 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.317 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.14 -38.25 24.66 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 121.844 1.696 . . . . 0.0 114.519 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.402 ' CD2' ' N ' ' A' ' 114' ' ' LEU . 1.3 p90 -61.53 -29.73 70.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.512 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 1.7 tt -69.56 -42.53 74.44 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.717 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -65.03 -29.29 70.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.309 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -107.44 13.56 26.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.071 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.424 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 6.5 t90 -76.43 121.96 23.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.75 0.786 . . . . 0.0 110.36 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -92.42 128.08 38.14 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.277 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 85.4 t60 -84.34 125.47 71.91 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.424 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 15.7 Cg_endo -108.8 91.93 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.705 0 CA-C-N 120.866 1.345 . . . . 0.0 112.628 -2.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -113.77 -58.83 2.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.778 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.1 p -67.19 -39.02 86.3 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.52 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 58.95 161.69 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.474 0.654 . . . . 0.0 111.829 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.517 HD22 HG21 ' A' ' 28' ' ' VAL . 4.7 tt -58.39 -41.17 84.24 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.194 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.776 HD21 HD23 ' A' ' 31' ' ' LEU . 7.9 tp -56.75 -38.13 72.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.68 -39.69 98.24 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 tp -59.07 -38.98 80.73 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.413 HD12 HD13 ' A' ' 35' ' ' LEU . 1.1 mm -73.02 -47.53 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.579 -177.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -66.08 -36.83 84.26 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 126' ' ' GLY . 78.6 t -66.89 -37.82 80.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.9 tpp -59.0 -43.03 91.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.439 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -62.82 -26.07 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.621 178.388 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.2 t -94.63 -52.05 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.961 HG11 HD22 ' A' ' 111' ' ' LEU . 5.5 p -64.77 -13.72 15.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 122.547 0.339 . . . . 0.0 111.402 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.453 ' CD1' HG13 ' A' ' 134' ' ' VAL . 6.6 m-30 -101.98 -17.64 16.01 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.255 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.55 -28.07 60.14 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -64.81 -35.48 81.23 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.332 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -163.49 84.6 1.35 Allowed Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -44.06 112.6 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.497 1.465 . . . . 0.0 110.665 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.681 ' HB2' HG21 ' A' ' 103' ' ' VAL . 28.8 Cg_endo -65.35 -20.44 61.71 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.358 1.372 . . . . 0.0 110.427 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.9 m -127.72 150.11 33.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -157.84 163.54 37.87 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.03 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.4 m -91.85 121.36 33.39 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.307 0.575 . . . . 0.0 111.333 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 57.2 ttm-85 -111.58 114.33 52.61 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.594 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo . . . . . 0 N--CA 1.497 1.681 0 C-N-CA 122.195 1.93 . . . . 0.0 112.55 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.406 HG22 ' HE1' ' A' ' 11' ' ' MET . 87.4 t -89.07 133.85 30.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.076 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.48 154.57 18.13 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.513 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 39.9 mt-10 -62.18 -40.61 96.62 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.954 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.8 t -58.83 -47.7 83.9 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 122.148 0.975 . . . . 0.0 109.269 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -64.51 -30.4 71.43 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.855 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.858 HD23 HG13 ' A' ' 22' ' ' VAL . 10.2 tp -60.0 -37.05 78.56 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -62.8 -43.27 99.24 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.432 178.418 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.31 -37.44 83.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.94 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.503 ' SD ' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -64.01 -37.51 87.71 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.017 -178.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -119.39 24.82 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.883 0.373 . . . . 0.0 111.856 -178.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.5 t -64.59 -37.17 86.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.07 0.462 . . . . 0.0 111.147 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.22 -12.38 60.87 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.89 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.488 ' CE1' HG12 ' A' ' 12' ' ' VAL . 10.4 m-85 -77.99 159.55 28.72 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -81.86 -26.87 33.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.651 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -116.19 55.24 0.81 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 119.67 -0.205 . . . . 0.0 110.809 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 ptt-85 -63.76 -24.7 67.87 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -53.88 8.56 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.038 -0.414 . . . . 0.0 111.709 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -42.88 96.6 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.117 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.0 m -60.61 -48.07 83.4 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.419 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.858 HG13 HD23 ' A' ' 8' ' ' LEU . 32.6 t -61.05 -44.74 98.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -41.4 98.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.566 -0.853 . . . . 0.0 109.784 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -39.2 89.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.071 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 29' ' ' ILE . 41.4 p -65.72 -37.86 87.58 Favored 'General case' 0 CA--C 1.507 -0.673 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.461 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.85 -43.99 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.486 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -61.86 -37.91 86.29 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.025 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.1 t -71.23 -43.11 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.82 -20.27 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.114 -178.306 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -78.31 -47.54 17.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.647 ' O ' HD13 ' A' ' 31' ' ' LEU . 2.8 tm? -84.23 -39.74 18.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.794 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -110.56 66.98 0.63 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -58.08 -16.58 13.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.82 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -65.34 -22.0 66.77 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.826 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 tp -91.84 114.29 26.78 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -108.26 123.21 38.17 Favored Pre-proline 0 C--N 1.357 0.926 0 CA-C-N 119.551 1.069 . . . . 0.0 111.663 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.89 134.09 9.37 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.383 1.388 . . . . 0.0 112.976 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.9 155.3 41.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 110.711 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.503 HD12 ' SD ' ' A' ' 11' ' ' MET . 0.9 OUTLIER -86.97 122.43 30.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.992 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -125.07 133.06 53.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.584 0.23 . . . . 0.0 111.21 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.3 p -69.48 146.09 52.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -135.22 134.49 40.11 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.425 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.2 t -121.1 125.66 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.254 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -96.28 166.42 11.73 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.733 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.26 -38.06 82.35 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.762 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -62.84 -13.93 39.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.261 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.4 -3.94 64.05 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.9 m -71.78 144.9 49.02 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.148 0.499 . . . . 0.0 110.326 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.4 m -125.04 144.15 50.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.449 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -161.17 143.67 12.38 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.999 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.7 121.59 17.48 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -128.92 126.43 39.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.962 0.411 . . . . 0.0 109.914 -178.4 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.407 ' HB2' ' HB3' ' A' ' 11' ' ' MET . 61.9 ttp -84.55 150.48 25.19 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.922 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -138.73 157.28 46.38 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.318 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mt -108.36 125.05 51.28 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.4 m -140.33 139.2 35.36 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.977 0.418 . . . . 0.0 112.12 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.19 -149.51 15.05 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.628 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.504 HG21 ' OD1' ' A' ' 69' ' ' ASN . 23.0 p -131.75 159.21 39.12 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.499 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.2 pt -130.25 116.53 17.68 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.9 177.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -70.79 125.97 12.15 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 CA-C-N 119.892 0.997 . . . . 0.0 109.878 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.0 t -130.02 127.32 22.68 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.573 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.09 149.64 52.71 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.092 1.861 . . . . 0.0 110.452 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -161.63 106.42 1.28 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.338 0.589 . . . . 0.0 111.889 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 51.15 39.58 23.84 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.914 -0.491 . . . . 0.0 111.951 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.22 -0.55 83.73 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -121.13 132.16 54.69 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -110.09 131.04 55.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.659 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -113.89 151.43 32.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.621 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.504 ' OD1' HG21 ' A' ' 58' ' ' THR . 3.7 t-20 -97.96 104.07 16.07 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.508 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -88.98 117.09 67.92 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.11 124.88 3.91 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.525 2.15 . . . . 0.0 110.919 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 70' ' ' ILE . 26.4 pt -132.67 147.96 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.613 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.5 m -123.01 126.13 46.55 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-O 121.385 0.612 . . . . 0.0 110.0 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.09 109.97 22.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.506 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.523 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 91.0 m95 -98.38 121.62 40.55 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.657 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.464 ' O ' HD21 ' A' ' 52' ' ' LEU . 72.8 mt -89.7 144.28 26.12 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.874 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mt -88.76 154.48 20.25 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -60.13 -17.68 42.07 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.524 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -100.47 1.32 41.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.732 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -53.81 145.77 30.13 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -92.37 12.07 53.97 Favored 'Cis proline' 0 N--CA 1.519 2.994 0 N-CA-C 116.061 1.524 . . . . 0.0 116.061 1.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -80.78 -2.38 46.86 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.296 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -123.82 122.83 26.32 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 118.555 -0.736 . . . . 0.0 109.08 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.76 132.66 21.58 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 CA-C-N 121.313 1.505 . . . . 0.0 112.505 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.32 144.27 14.41 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 122.382 2.054 . . . . 0.0 111.474 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.55 132.9 42.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.881 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 41.8 t -110.33 151.21 27.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.642 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -131.69 127.39 36.79 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.325 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.652 ' CG2' HD11 ' A' ' 109' ' ' ILE . 56.7 t -90.76 123.77 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -71.12 110.21 6.84 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 119.338 -0.363 . . . . 0.0 111.334 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -85.73 157.87 10.46 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.901 1.734 . . . . 0.0 113.218 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.2 p -135.78 165.59 25.25 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.93 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.2 p -60.32 -24.57 65.11 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -104.19 13.53 32.13 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.93 0.786 . . . . 0.0 110.728 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.24 148.15 50.8 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.476 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -133.59 165.98 23.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 120.156 -0.617 . . . . 0.0 110.438 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.476 ' N ' HG23 ' A' ' 96' ' ' THR . 90.3 mt -103.27 105.76 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -94.77 108.64 20.65 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.238 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 82.3 p -65.98 151.21 47.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.928 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.78 -134.74 1.8 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.356 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 101' ' ' LYS . 6.7 pttp -86.03 -3.8 59.02 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -136.42 -24.09 1.23 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.22 145.99 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.683 0.674 . . . . 0.0 110.171 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -101.37 -179.55 4.06 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.699 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.31 73.13 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -79.88 2.53 22.93 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.796 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.01 27.78 15.41 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.087 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -82.56 132.42 35.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 117.588 0.694 . . . . 0.0 110.149 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.652 HD11 ' CG2' ' A' ' 89' ' ' VAL . 96.3 mt -110.44 109.94 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.606 0.241 . . . . 0.0 110.782 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -114.07 138.86 49.84 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.548 ' CD2' HG11 ' A' ' 134' ' ' VAL . 1.1 mt -131.65 130.57 22.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 118.563 0.62 . . . . 0.0 111.883 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -46.93 -39.8 25.03 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.433 1.422 . . . . 0.0 113.957 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.05 -29.69 70.47 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.669 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 tt -70.79 -41.07 72.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.804 0.335 . . . . 0.0 111.008 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -67.36 -27.07 66.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.381 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -105.57 -3.64 22.11 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.878 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.424 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.8 t90 -62.82 124.07 20.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.671 0.748 . . . . 0.0 110.16 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -91.65 126.05 36.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.561 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -79.92 125.45 81.96 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 119.032 -0.508 . . . . 0.0 110.119 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -109.12 92.68 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 120.823 1.33 . . . . 0.0 112.454 -2.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -114.11 -61.26 1.77 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.401 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.426 ' O ' ' CG ' ' A' ' 123' ' ' ASP . 15.7 t -69.99 -30.76 68.17 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.689 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 122' ' ' SER . 4.6 p-10 48.89 -175.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.622 0.725 . . . . 0.0 111.947 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 tt -71.84 -43.5 65.42 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.711 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 125' ' ' LEU . 0.6 OUTLIER -51.53 -37.76 50.94 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -64.09 -41.42 98.49 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.8 tp -59.14 -40.87 86.83 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -73.16 -45.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.577 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.78 -33.22 68.41 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.097 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.573 ' O ' HG12 ' A' ' 134' ' ' VAL . 67.4 t -68.61 -37.75 78.08 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 53.2 tpp -59.79 -42.45 93.41 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.1 mp -66.3 -44.5 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.603 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.4 t -74.2 -40.83 51.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.6 HG13 ' CD1' ' A' ' 135' ' ' PHE . 2.5 p -78.66 -13.62 13.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.678 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.6 ' CD1' HG13 ' A' ' 134' ' ' VAL . 10.3 m-30 -108.49 -17.59 13.94 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.436 178.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.66 -27.53 70.01 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 107.435 -2.266 . . . . 0.0 107.435 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -65.29 -35.83 82.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.019 -0.59 . . . . 0.0 110.618 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -166.88 84.89 0.86 Allowed Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -47.78 114.65 1.15 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.327 1.351 . . . . 0.0 109.852 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.33 -21.05 27.71 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.797 1.665 . . . . 0.0 111.235 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.67 147.08 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.094 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -155.72 161.93 40.63 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 74.9 m -87.51 121.48 30.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.223 0.535 . . . . 0.0 111.046 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.2 ttm-85 -112.71 105.08 56.08 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.61 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo . . . . . 0 N--CA 1.494 1.539 0 C-N-CA 121.81 1.674 . . . . 0.0 112.098 179.817 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.46 142.68 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.555 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.18 151.79 19.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.514 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 93.0 mt-10 -62.6 -41.89 99.25 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.358 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.4 m -59.05 -45.03 91.78 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.017 0.913 . . . . 0.0 109.58 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -64.91 -36.5 84.56 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.207 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.946 HD23 HG13 ' A' ' 22' ' ' VAL . 38.2 tp -56.58 -40.02 74.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.768 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 3.3 mptp? -62.46 -42.78 99.72 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.844 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -66.32 -33.4 75.64 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.894 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.583 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -69.49 -36.02 76.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.036 -178.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 8' ' ' LEU . 1.6 m -120.02 30.96 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 111.162 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.1 p -69.27 -12.9 62.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.727 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -85.6 -12.92 50.31 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 121.016 -0.273 . . . . 0.0 111.386 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.456 ' CE1' HD23 ' A' ' 52' ' ' LEU . 5.8 m-85 -71.94 151.13 43.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.005 0.431 . . . . 0.0 111.109 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -70.94 -38.07 72.87 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -111.28 64.22 0.61 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.478 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.5 ptp85 -66.81 -30.35 70.52 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.44 -42.97 78.08 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.09 -38.33 61.26 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.784 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 25' ' ' THR . 99.2 m -62.58 -41.79 99.16 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.057 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.946 HG13 HD23 ' A' ' 8' ' ' LEU . 45.4 t -71.29 -46.14 66.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.439 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -63.98 -44.06 93.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.333 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.554 ' OE2' HD12 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -68.27 -29.35 68.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.385 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 21' ' ' THR . 28.2 p -70.14 -37.83 75.37 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.717 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.77 -43.32 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -60.63 -40.25 91.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.29 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.465 HG21 ' HB3' ' A' ' 124' ' ' LEU . 68.4 t -70.1 -42.55 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.99 -16.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.22 -178.59 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.7 m -80.86 -49.41 11.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.6 tp -83.19 -37.15 24.02 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.269 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.36 68.45 0.7 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.467 0.651 . . . . 0.0 109.381 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -58.39 -18.9 31.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.944 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.18 -21.08 66.72 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.458 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.525 HD23 HD13 ' A' ' 55' ' ' LEU . 2.4 tp -93.78 113.51 25.57 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -109.87 125.25 31.57 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 119.451 1.023 . . . . 0.0 112.352 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -80.31 138.68 12.65 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.655 1.57 . . . . 0.0 113.149 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.37 156.56 39.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.583 HD13 ' SD ' ' A' ' 11' ' ' MET . 22.8 tp -97.1 107.56 20.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -110.04 130.19 55.57 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.071 0.462 . . . . 0.0 111.609 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.8 p -79.89 131.87 35.95 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -115.6 138.73 50.77 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.115 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.26 124.22 65.77 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.816 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -96.01 172.64 7.87 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.63 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -60.54 -39.06 86.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.135 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -67.41 -15.34 63.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.834 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.94 -9.86 63.87 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.9 m -65.91 149.18 50.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.042 0.448 . . . . 0.0 110.083 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.5 t -121.1 142.62 49.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.84 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -143.26 150.36 39.17 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.697 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.21 105.64 13.46 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.057 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.456 HD23 ' CE1' ' A' ' 15' ' ' TYR . 15.2 mt -119.29 125.19 48.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.105 0.479 . . . . 0.0 110.01 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -92.83 138.42 31.5 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.606 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -127.44 152.22 47.82 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.18 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.525 HD13 HD23 ' A' ' 35' ' ' LEU . 7.4 mt -97.37 130.11 44.55 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.3 m -141.2 137.63 32.77 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.15 -144.08 8.76 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.405 HG21 ' OD1' ' A' ' 69' ' ' ASN . 22.9 p -136.81 159.71 41.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.5 pt -132.19 115.22 15.1 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.074 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -70.54 125.41 11.71 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.164 1.243 . . . . 0.0 110.293 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.1 t -126.37 121.85 23.78 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.057 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.72 148.7 41.96 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.414 2.076 . . . . 0.0 110.936 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.449 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -163.42 109.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.442 0.639 . . . . 0.0 111.522 -178.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 52.86 37.91 25.4 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.712 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.54 82.01 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -119.34 130.71 55.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -115.29 132.29 56.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.957 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -112.51 148.94 33.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.883 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.405 ' OD1' HG21 ' A' ' 58' ' ' THR . 5.4 t-20 -94.42 106.42 18.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.472 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -91.09 116.25 66.03 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -85.17 124.94 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.808 2.339 . . . . 0.0 110.25 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.472 HG23 HG22 ' A' ' 70' ' ' ILE . 24.6 pt -134.98 148.7 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.572 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.1 m -121.77 123.14 41.12 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.475 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.95 112.81 25.94 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.232 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -105.7 125.29 50.82 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 75.5 mt -92.38 139.33 30.71 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.24 157.95 27.69 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -69.37 -7.66 39.46 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.268 -0.27 . . . . 0.0 111.509 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.57 2.29 23.91 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.916 0.389 . . . . 0.0 110.979 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.421 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 46.1 t80 -57.89 147.79 61.97 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 1.7 Cg_endo -91.22 13.71 52.29 Favored 'Cis proline' 0 N--CA 1.515 2.743 0 CA-C-N 120.975 1.384 . . . . 0.0 114.653 0.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -80.04 -2.61 44.98 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.052 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.83 140.33 33.03 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -66.27 143.11 69.39 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 CA-C-N 121.56 1.593 . . . . 0.0 111.014 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.67 141.38 9.76 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.153 1.902 . . . . 0.0 112.26 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -93.07 129.7 43.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.465 ' SG ' HD12 ' A' ' 109' ' ' ILE . 52.6 t -120.65 141.8 50.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.763 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -127.67 132.16 49.72 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.581 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.475 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 42.8 t -90.41 131.8 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.01 100.02 2.62 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.128 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 64.7 Cg_endo -82.36 166.35 16.08 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 122.222 1.948 . . . . 0.0 112.837 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -145.71 171.3 14.95 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.8 p -57.32 -25.46 59.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 119.866 -0.734 . . . . 0.0 112.036 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 96.7 p -95.14 3.42 54.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.702 0.683 . . . . 0.0 110.794 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 39.3 ttm -141.93 122.02 13.78 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.048 0.452 . . . . 0.0 109.84 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 95.2 m -107.0 140.95 38.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.443 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 97' ' ' ILE . 3.9 tp -75.43 120.74 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -110.64 101.12 9.79 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.7 p -58.31 151.69 19.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.591 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.47 -132.13 1.49 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 119.774 -1.203 . . . . 0.0 112.644 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -86.81 -3.5 59.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -138.92 -25.94 0.86 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 119.402 1.001 . . . . 0.0 113.616 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 t -111.95 135.46 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 119.218 0.917 . . . . 0.0 110.198 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -90.54 -159.97 0.66 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.547 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.39 -8.24 55.34 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.8 -6.14 16.92 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.78 11.47 37.6 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.974 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -72.77 135.98 45.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.399 0.599 . . . . 0.0 110.063 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.465 HD12 ' SG ' ' A' ' 87' ' ' CYS . 69.9 mt -114.8 115.49 49.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 O-C-N 123.311 0.382 . . . . 0.0 110.718 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -115.21 138.77 50.56 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 134' ' ' VAL . 1.3 mp -130.88 130.96 22.96 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.475 -176.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.71 -32.45 55.24 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.125 1.217 . . . . 0.0 113.184 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -67.41 -30.12 69.79 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.26 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.77 -41.22 83.63 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.208 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -64.3 -34.31 77.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.2 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -100.81 2.71 41.41 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.539 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -68.72 124.21 23.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.921 0.867 . . . . 0.0 110.17 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -94.37 124.85 38.64 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.522 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 15.5 t-80 -80.83 125.3 80.48 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.643 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 9.5 Cg_endo -108.98 92.19 0.03 OUTLIER 'Cis proline' 0 N--CA 1.5 1.867 0 CA-C-N 120.791 1.318 . . . . 0.0 112.799 -2.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.88 -59.99 1.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.613 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -65.13 -40.93 95.12 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.412 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 58.54 164.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.25 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.554 HD12 ' OE2' ' A' ' 24' ' ' GLU . 1.4 mt -50.89 -48.57 60.39 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.311 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.72 -36.72 26.4 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -63.74 -40.65 98.72 Favored Glycine 0 N--CA 1.477 1.42 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 tp -62.53 -41.73 99.06 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -74.69 -45.87 43.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.619 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -68.85 -36.74 78.52 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.665 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 134' ' ' VAL . 56.1 t -66.99 -40.3 85.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.873 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.8 ttm -58.23 -43.24 87.63 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.434 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -60.3 -35.2 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.74 178.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.4 t -89.64 -50.1 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.677 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.534 HG13 ' CD1' ' A' ' 135' ' ' PHE . 4.7 p -65.21 -13.85 15.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.832 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.534 ' CD1' HG13 ' A' ' 134' ' ' VAL . 13.5 m-30 -106.78 -17.23 14.27 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.586 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.89 -27.89 73.51 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.82 -34.72 79.03 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.785 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -165.91 85.43 0.97 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -45.7 113.32 0.54 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.37 1.38 . . . . 0.0 110.533 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.6 0.44 8.68 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.511 1.474 . . . . 0.0 111.548 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.24 123.56 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -160.17 165.51 31.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.285 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.2 125.18 40.54 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.003 0.43 . . . . 0.0 110.94 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -111.49 114.1 53.02 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.55 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.499 1.849 0 C-N-CA 121.76 1.64 . . . . 0.0 111.974 -179.926 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.419 HG13 ' HE3' ' A' ' 11' ' ' MET . 85.6 t -105.39 130.11 57.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.821 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -95.21 157.65 15.8 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 86.6 mt-10 -63.13 -41.92 99.4 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.118 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.1 t -59.71 -49.87 76.06 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.044 0.926 . . . . 0.0 109.383 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -62.69 -28.2 69.77 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.744 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.814 HD23 HG13 ' A' ' 22' ' ' VAL . 59.3 tp -59.77 -42.67 93.8 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.766 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.9 mptp? -58.82 -39.89 82.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.148 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.11 -31.0 72.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.781 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.596 ' CB ' HD13 ' A' ' 39' ' ' LEU . 14.6 ptp -86.39 -14.78 42.39 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.622 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.679 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -125.94 16.5 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.83 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.3 t -59.78 -21.98 61.53 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.496 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -84.04 -15.96 45.64 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -70.09 152.18 44.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.003 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -70.02 -37.64 75.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.838 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 40.8 m-85 -110.65 60.66 0.61 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.564 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.4 ptp180 -66.44 -20.73 66.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.125 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -77.04 -52.06 9.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.8 tp -67.93 -41.0 83.24 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.151 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.677 ' O ' HG23 ' A' ' 25' ' ' THR . 66.2 m -61.13 -47.03 88.13 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.778 0.323 . . . . 0.0 110.789 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.814 HG13 HD23 ' A' ' 8' ' ' LEU . 40.3 t -63.25 -42.83 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.654 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -55.31 23.43 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 118.834 -1.147 . . . . 0.0 110.526 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -61.37 -31.83 71.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.367 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 21' ' ' THR . 23.5 p -66.86 -35.26 79.62 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.31 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 22' ' ' VAL . 53.0 t -57.77 -44.03 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.19 -39.88 88.11 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.307 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 124' ' ' LEU . 79.1 t -69.84 -43.36 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -88.25 -17.4 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.567 -178.827 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.2 m -82.35 -49.05 10.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.192 0.52 . . . . 0.0 109.617 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.531 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.3 tm? -81.89 -38.99 24.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.525 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -110.2 67.44 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -56.14 -18.92 11.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.953 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.31 -21.54 66.72 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.038 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.562 HD13 HD12 ' A' ' 128' ' ' ILE . 1.6 tp -94.15 113.18 25.08 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.19 119.02 43.2 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 119.181 0.9 . . . . 0.0 112.091 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 92.5 Cg_endo -78.29 137.53 15.14 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 CA-C-N 120.653 1.269 . . . . 0.0 112.282 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.539 HG23 ' OD1' ' A' ' 40' ' ' ASP . 27.0 m -126.19 150.9 32.07 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.596 HD13 ' CB ' ' A' ' 11' ' ' MET . 44.1 tp -97.78 119.3 36.13 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.113 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.539 ' OD1' HG23 ' A' ' 38' ' ' VAL . 10.5 m-20 -135.43 135.44 40.58 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.016 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.0 t -64.22 139.97 58.82 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -127.06 143.35 51.3 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.014 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.1 t -120.6 126.63 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.296 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -104.3 155.53 18.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.259 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.1 p-10 -60.84 -19.06 59.17 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.584 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -68.68 -13.03 62.1 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.196 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.14 -17.91 58.43 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.2 t -74.45 146.56 42.73 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.166 0.508 . . . . 0.0 110.2 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.2 m -119.19 141.23 49.06 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.942 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -159.21 136.84 10.08 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.908 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -77.07 121.74 23.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.264 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -124.04 144.51 49.8 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.054 0.454 . . . . 0.0 110.31 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -100.2 141.22 33.33 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.646 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.413 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 6.2 p-10 -133.08 154.28 50.71 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.388 0.613 . . . . 0.0 111.863 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.481 ' HG ' HD23 ' A' ' 35' ' ' LEU . 4.6 mm? -93.49 124.94 37.82 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.575 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.4 m -139.29 136.98 35.46 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.44 -145.6 10.13 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.836 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 p -134.61 159.74 40.27 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 59' ' ' ILE . 1.3 pt -131.83 116.21 15.82 Favored Pre-proline 0 N--CA 1.471 0.594 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.178 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -71.97 124.4 10.08 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 N-CA-C 109.538 -0.986 . . . . 0.0 109.538 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.42 121.35 24.89 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.891 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.39 149.03 55.92 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.197 1.931 . . . . 0.0 110.429 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.7 109.7 1.09 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.521 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.96 40.59 25.62 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.439 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.72 13.84 80.22 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -134.71 127.86 31.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.5 m -112.02 133.1 54.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.84 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -113.89 150.63 33.37 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -95.16 108.72 20.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.492 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -97.21 116.16 65.9 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.34 124.77 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.658 2.238 . . . . 0.0 110.75 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.492 HG23 HG22 ' A' ' 70' ' ' ILE . 26.9 pt -132.79 147.99 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 119.421 -0.911 . . . . 0.0 111.994 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 63.8 m -123.88 121.58 35.73 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.071 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.81 114.41 28.61 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.489 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.413 ' CE3' ' HB3' ' A' ' 54' ' ' ASN . 48.3 m95 -102.1 115.29 30.23 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.1 mt -85.9 135.15 33.8 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -80.28 155.34 27.33 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -60.68 -17.18 46.18 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.746 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.61 -3.02 50.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.523 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -57.09 144.42 69.23 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.41 ' HG2' ' CD2' ' A' ' 119' ' ' HIS . 25.0 Cg_endo -92.04 9.13 60.74 Favored 'Cis proline' 0 N--CA 1.521 3.101 0 N-CA-C 115.936 1.475 . . . . 0.0 115.936 0.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.409 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 42.7 m-85 -76.94 -11.97 59.88 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.636 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.86 127.17 27.11 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.511 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -49.39 132.49 29.47 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 CA-C-N 121.21 1.468 . . . . 0.0 112.467 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HD2' HD11 ' A' ' 114' ' ' LEU . 96.6 Cg_endo -86.04 143.83 8.14 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 122.574 2.183 . . . . 0.0 111.878 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 86' ' ' ILE . 1.4 mp -97.43 132.97 40.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.39 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 46.1 t -116.47 143.57 45.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.176 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -127.89 129.95 47.74 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.954 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.28 121.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.82 107.53 1.35 Allowed Pre-proline 0 N--CA 1.474 0.744 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.019 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.03 156.64 13.27 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 CA-C-N 120.675 1.277 . . . . 0.0 112.772 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -136.14 171.69 14.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.43 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.8 t -58.55 -40.67 83.69 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.5 m -96.79 20.73 10.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.037 0.835 . . . . 0.0 111.126 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.0 ttm -137.96 141.16 40.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -137.29 162.76 32.65 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.174 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.433 ' N ' HG23 ' A' ' 96' ' ' THR . 67.9 mt -97.95 103.43 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -90.59 109.96 21.11 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.8 p -59.85 147.4 38.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.282 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.88 -145.3 4.15 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.518 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -64.14 -27.5 69.12 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.515 ' NE2' HG23 ' A' ' 103' ' ' VAL . 13.1 p-80 -132.63 -15.63 2.72 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 119.167 -1.013 . . . . 0.0 113.214 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.517 HG21 ' CB ' ' A' ' 140' ' ' PRO . 23.8 t -91.93 129.27 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.438 1.017 . . . . 0.0 111.375 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.429 ' O ' HG12 ' A' ' 103' ' ' VAL . 36.9 p-10 -89.72 -168.79 2.24 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.71 -22.79 25.83 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.683 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -82.24 -8.0 59.63 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.623 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.21 -0.7 62.18 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.098 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.404 ' N ' ' OD1' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -63.71 143.58 57.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -110.87 122.46 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -99.86 139.91 34.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.606 HD22 HG11 ' A' ' 134' ' ' VAL . 28.4 mt -139.55 117.92 8.78 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.83 -29.47 63.17 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.553 1.502 . . . . 0.0 114.056 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -69.23 -30.76 68.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.875 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.434 HD11 ' HD2' ' A' ' 85' ' ' PRO . 1.1 tt -71.75 -41.05 68.92 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.043 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -72.3 -25.5 61.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.309 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -102.23 -4.69 25.33 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.483 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 7.2 t90 -53.07 121.32 7.2 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.94 0.876 . . . . 0.0 110.503 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -96.42 106.61 18.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.491 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 44.9 t-80 -61.95 125.26 84.72 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.133 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 21.8 Cg_endo -111.05 90.78 0.03 OUTLIER 'Cis proline' 0 N--CA 1.488 1.201 0 CA-C-N 120.676 1.277 . . . . 0.0 112.831 -3.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -114.59 -55.2 2.51 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.428 -0.509 . . . . 0.0 112.142 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 p -70.54 -39.42 74.03 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.387 0.613 . . . . 0.0 110.767 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 t70 59.28 165.59 0.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.408 0.623 . . . . 0.0 111.091 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.9 tt -62.2 -43.68 98.29 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.566 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -52.12 -36.32 50.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.27 -39.52 97.82 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.2 tp -59.48 -40.99 88.78 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.562 HD12 HD13 ' A' ' 35' ' ' LEU . 1.2 mm -75.32 -49.91 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.206 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -63.74 -37.7 88.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.161 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 134' ' ' VAL . 54.4 t -66.29 -38.59 82.19 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 C-N-CA 119.465 -0.894 . . . . 0.0 108.712 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.4 tpp -58.48 -43.3 88.92 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.11 -43.54 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.453 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.3 t -77.78 -42.02 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.606 HG11 HD22 ' A' ' 111' ' ' LEU . 3.7 p -75.91 -13.22 14.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.014 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.526 ' CD1' HG13 ' A' ' 134' ' ' VAL . 6.2 m-30 -104.81 -18.37 14.26 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.602 177.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.31 -20.83 79.44 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -68.72 -36.16 78.08 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.653 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -164.47 90.91 1.03 Allowed Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -44.9 109.96 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.304 1.336 . . . . 0.0 110.382 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.517 ' CB ' HG21 ' A' ' 103' ' ' VAL . 34.9 Cg_exo -58.02 -26.14 73.81 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.77 1.647 . . . . 0.0 109.942 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.58 146.91 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.957 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -152.64 160.23 43.19 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.997 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 41.0 m -79.83 111.74 16.44 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 120.952 0.406 . . . . 0.0 111.027 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 26.7 ttp-105 -113.44 105.6 54.98 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.173 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo . . . . . 0 N--CA 1.498 1.753 0 C-N-CA 121.85 1.7 . . . . 0.0 112.339 -179.766 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -58.5 141.09 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 121.401 0.62 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 p -100.46 158.12 16.14 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.492 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.4 mt-10 -62.76 -42.04 99.5 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.525 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 t -59.81 -48.7 80.63 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.839 0.828 . . . . 0.0 109.593 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -62.42 -31.98 72.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.307 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.846 HD23 HG13 ' A' ' 22' ' ' VAL . 25.1 tp -57.86 -40.61 80.56 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.538 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.7 mptp? -60.83 -41.79 96.46 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.441 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.06 -37.84 86.53 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.465 0.65 . . . . 0.0 109.902 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.797 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -69.83 -38.57 76.58 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.477 -177.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.3 m -112.65 16.1 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -65.13 -25.51 67.79 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.368 0.604 . . . . 0.0 109.987 178.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.05 -13.57 62.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.037 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.476 ' CE1' HG12 ' A' ' 12' ' ' VAL . 14.2 m-85 -82.22 159.93 23.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -81.9 -27.67 33.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.781 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CZ ' ' CE1' ' A' ' 82' ' ' TYR . 62.5 m-85 -113.77 58.57 0.67 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -65.59 -24.93 67.19 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -79.46 -50.45 10.76 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 121.419 -0.801 . . . . 0.0 112.168 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 20' ' ' LEU . 13.0 tp -65.27 -40.62 94.15 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.548 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -61.56 -46.48 89.72 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.301 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.846 HG13 HD23 ' A' ' 8' ' ' LEU . 7.6 t -61.36 -45.03 99.45 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 CA-C-O 121.089 0.471 . . . . 0.0 110.166 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -40.15 91.4 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.705 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -38.13 80.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.328 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 29' ' ' ILE . 17.7 p -67.58 -33.73 75.6 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.738 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.07 -44.81 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.519 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.1 m-20 -60.77 -37.49 82.05 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.098 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.438 HG21 HD13 ' A' ' 124' ' ' LEU . 78.9 t -70.77 -44.18 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.93 -22.11 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.004 -1.079 . . . . 0.0 111.615 -178.299 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.2 m -72.62 -43.64 63.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.939 0.4 . . . . 0.0 110.645 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -88.0 -38.64 15.33 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.749 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.7 66.74 0.65 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -55.99 -17.85 7.83 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.093 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.38 -21.38 66.61 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.966 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.471 HD23 HD13 ' A' ' 55' ' ' LEU . 3.9 tp -89.69 113.62 25.14 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -109.11 125.39 31.63 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-N 119.686 1.13 . . . . 0.0 111.829 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.68 136.31 13.53 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.323 1.348 . . . . 0.0 112.66 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.3 133.65 68.28 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.797 HD13 ' SD ' ' A' ' 11' ' ' MET . 21.8 tp -83.11 118.7 23.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.94 132.89 50.75 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.3 m -62.44 140.42 58.58 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -133.91 141.4 47.33 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.625 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.9 t -112.9 124.47 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.683 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -88.91 161.18 16.81 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -61.19 -23.8 65.85 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.745 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -75.35 -11.55 60.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.003 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.15 -14.78 63.35 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.1 m -67.62 141.1 56.86 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.7 m -113.68 138.66 49.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.824 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.0 ttm105 -150.68 139.85 21.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.89 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -72.97 117.33 14.57 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.419 HD21 ' O ' ' A' ' 76' ' ' LEU . 13.3 tp -115.91 121.85 43.56 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -83.81 137.04 33.9 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -132.71 154.73 49.89 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.29 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.471 HD13 HD23 ' A' ' 35' ' ' LEU . 7.6 mt -102.2 122.26 43.85 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.8 m -135.1 137.52 42.91 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.19 -147.05 10.7 Favored Glycine 0 N--CA 1.47 0.955 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.909 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 p -132.75 158.45 42.37 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.447 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.3 pt -131.6 116.99 16.3 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.168 177.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -71.28 128.02 14.13 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.832 1.021 . . . . 0.0 109.801 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 74.4 t -127.1 119.52 22.22 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.696 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -64.48 146.1 88.85 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.064 1.842 . . . . 0.0 109.534 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -161.83 106.96 1.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.867 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.4 36.53 13.36 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.83 -6.98 79.25 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.438 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -117.5 146.08 43.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.0 m -123.31 134.36 54.06 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.951 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -116.62 149.92 38.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.27 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.71 105.26 17.38 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.452 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -93.9 120.58 65.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.55 123.59 3.39 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.818 2.345 . . . . 0.0 110.88 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.452 HG23 HG22 ' A' ' 70' ' ' ILE . 32.5 pt -128.96 146.04 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 119.131 -1.027 . . . . 0.0 112.168 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.4 m -120.54 122.47 40.68 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-O 121.67 0.747 . . . . 0.0 109.634 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.19 112.51 25.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.165 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -107.67 123.41 48.47 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.419 ' O ' HD21 ' A' ' 52' ' ' LEU . 62.1 mt -90.88 130.98 36.78 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.659 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mt -72.72 153.31 41.21 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.376 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -60.33 -12.79 10.08 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p -103.28 -1.22 29.16 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -48.23 146.24 4.68 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -95.6 19.46 33.06 Favored 'Cis proline' 0 N--CA 1.517 2.885 0 N-CA-C 116.616 1.737 . . . . 0.0 116.616 2.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.424 ' CE1' ' CZ ' ' A' ' 17' ' ' TYR . 46.3 m-85 -80.52 -1.03 40.14 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.192 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.31 126.13 24.65 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.601 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -50.87 137.49 43.19 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 121.66 1.629 . . . . 0.0 109.67 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.81 144.13 19.05 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 121.824 1.682 . . . . 0.0 111.852 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mt -88.46 130.6 37.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.596 0.713 . . . . 0.0 109.276 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.8 t -119.53 136.97 54.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.496 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -123.67 129.86 51.76 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.376 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.0 t -93.11 120.97 43.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -63.56 107.27 1.19 Allowed Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.689 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -84.13 158.71 13.32 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.549 1.5 . . . . 0.0 112.262 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.7 p -139.15 174.48 10.47 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.928 0.394 . . . . 0.0 110.66 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -59.35 -39.92 84.76 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -101.12 12.08 38.28 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.985 0.811 . . . . 0.0 111.174 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 8.7 mmm -130.54 119.98 23.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -118.68 162.71 17.97 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.181 -178.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.448 ' N ' HG23 ' A' ' 96' ' ' THR . 80.0 mt -97.79 108.02 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -91.19 106.62 18.64 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.7 p -62.55 142.35 58.02 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.49 -139.29 2.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.157 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -66.46 -25.71 66.85 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.544 ' NE2' HG23 ' A' ' 103' ' ' VAL . 5.9 p-80 -133.32 -20.85 2.08 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.627 HG21 ' HB2' ' A' ' 140' ' ' PRO . 22.2 t -91.93 133.56 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.241 0.928 . . . . 0.0 111.332 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -98.13 -168.72 1.7 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.001 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.82 -29.66 29.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -84.19 3.13 36.53 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.821 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.45 6.18 58.72 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.432 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -59.13 137.47 57.94 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.991 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -114.95 112.98 42.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.633 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -99.9 140.73 33.69 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.962 HD22 HG11 ' A' ' 134' ' ' VAL . 32.2 mt -137.77 121.68 11.77 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.832 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.06 -39.02 25.26 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.666 1.577 . . . . 0.0 113.611 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -61.55 -31.27 71.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.666 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.89 -42.78 84.93 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.472 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -62.46 -36.48 82.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.604 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -95.74 -0.22 51.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.654 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -62.76 125.27 23.39 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.796 0.807 . . . . 0.0 110.228 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -109.03 106.84 16.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.858 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 17.9 t-80 -60.64 124.05 77.16 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.451 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 7.8 Cg_endo -108.57 91.67 0.03 OUTLIER 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 120.354 1.162 . . . . 0.0 112.646 -2.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -113.49 -62.77 1.54 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.392 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.0 t -67.13 -41.17 86.61 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.23 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.8 t70 68.04 166.27 0.24 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.751 0.786 . . . . 0.0 112.008 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.2 tt -64.11 -44.58 91.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.319 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 125' ' ' LEU . 0.6 OUTLIER -52.42 -38.45 59.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.521 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.07 -40.48 98.57 Favored Glycine 0 N--CA 1.478 1.499 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.7 tp -59.75 -41.17 90.41 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.54 -46.98 46.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.854 -0.738 . . . . 0.0 111.886 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -68.16 -35.72 78.5 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 134' ' ' VAL . 53.4 t -66.08 -37.5 79.91 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.1 tpp -58.9 -44.34 91.19 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.447 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -63.41 -32.52 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.734 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.54 -46.04 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.343 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.962 HG11 HD22 ' A' ' 111' ' ' LEU . 4.5 p -70.1 -13.79 17.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.988 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.482 ' CD1' HG13 ' A' ' 134' ' ' VAL . 6.0 m-30 -103.25 -17.26 15.4 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.258 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.13 -31.05 54.01 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.73 -37.9 89.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.745 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -155.85 82.26 3.7 Favored Pre-proline 0 N--CA 1.447 -0.603 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -44.49 112.36 0.35 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.818 1.679 . . . . 0.0 111.144 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.627 ' HB2' HG21 ' A' ' 103' ' ' VAL . 32.2 Cg_endo -67.21 -22.32 46.92 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.656 1.57 . . . . 0.0 111.698 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.8 m -128.48 140.49 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.853 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -155.24 161.52 41.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.107 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.94 122.18 35.04 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.719 0.295 . . . . 0.0 110.336 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.8 ttm-85 -111.62 126.96 27.59 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.859 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 N--CA 1.498 1.737 0 C-N-CA 121.965 1.777 . . . . 0.0 112.265 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.7 t -103.22 131.67 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.638 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -93.54 161.13 14.49 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.486 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 3.2 mm-40 -65.82 -43.04 89.79 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.837 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -59.57 -48.52 81.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 122.034 0.921 . . . . 0.0 109.126 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -62.9 -29.09 70.5 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.9 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.848 HD23 HG13 ' A' ' 22' ' ' VAL . 65.9 tp -60.32 -42.24 95.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.728 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.635 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.6 mptp? -59.69 -39.39 84.39 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.898 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -61.76 -33.88 74.86 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.408 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.691 ' CB ' HD13 ' A' ' 39' ' ' LEU . 17.5 ptp -85.48 -13.3 49.54 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.4 m -128.16 16.98 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.882 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -61.06 -38.25 85.52 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.111 0.481 . . . . 0.0 111.222 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -62.58 -18.72 62.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.825 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -72.26 153.15 41.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.92 0.391 . . . . 0.0 111.52 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -78.68 -29.21 45.44 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.016 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.412 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 45.0 m-85 -112.2 55.32 0.68 Allowed 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.987 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 22' ' ' VAL . 17.4 ptt180 -63.65 -27.55 69.3 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.73 -52.18 22.59 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -40.09 83.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.324 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.3 m -61.73 -46.81 88.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.093 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.848 HG13 HD23 ' A' ' 8' ' ' LEU . 51.7 t -64.34 -46.95 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.034 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 tmt_? -63.22 -41.75 99.18 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.426 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -66.7 -37.99 85.85 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.258 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.644 ' O ' HG23 ' A' ' 29' ' ' ILE . 16.5 p -64.17 -33.86 76.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.07 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.58 -44.75 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.097 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -60.58 -37.82 82.57 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.902 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.615 HG21 HD23 ' A' ' 124' ' ' LEU . 73.6 t -69.97 -44.08 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.89 -18.76 8.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 118.807 -1.157 . . . . 0.0 111.447 -178.475 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.3 m -74.27 -44.81 51.3 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.068 0.461 . . . . 0.0 110.07 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.783 HD23 HD21 ' A' ' 125' ' ' LEU . 24.7 tp -87.02 -37.86 17.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.407 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -114.56 67.58 0.69 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.864 0.364 . . . . 0.0 110.252 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -56.3 -17.33 7.38 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.084 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -65.65 -21.0 66.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.896 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.433 ' CD2' HD13 ' A' ' 55' ' ' LEU . 2.0 tp -95.99 113.65 25.28 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -114.44 136.74 22.38 Favored Pre-proline 0 C--N 1.357 0.923 0 CA-C-N 119.596 1.089 . . . . 0.0 111.614 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -79.75 136.75 12.26 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.003 1.802 . . . . 0.0 113.033 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.7 t -129.21 138.07 55.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.691 HD13 ' CB ' ' A' ' 11' ' ' MET . 22.7 tp -89.51 113.69 25.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.115 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -119.84 139.64 52.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.407 0.622 . . . . 0.0 112.417 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.1 m -71.71 140.79 49.74 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.463 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -122.81 136.52 54.9 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.388 0.54 . . . . 0.0 110.077 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.8 t -117.43 124.98 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.712 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -98.35 156.9 16.51 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -63.55 -28.16 69.75 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.741 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -62.77 -18.51 62.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.711 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.0 -9.31 56.48 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 85.4 p -76.85 166.85 22.79 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.9 p -139.86 155.21 47.34 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.754 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.3 ttm-85 -162.58 139.94 8.1 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.769 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -79.14 122.6 26.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.523 0.678 . . . . 0.0 109.883 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.549 HD23 ' HE3' ' A' ' 75' ' ' TRP . 12.0 tp -120.99 124.38 44.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.693 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -85.28 140.76 30.58 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.014 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -136.73 147.0 46.47 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.012 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 35' ' ' LEU . 6.7 mt -92.96 127.45 38.47 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.4 m -138.81 138.68 37.78 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.26 -143.09 8.19 Favored Glycine 0 N--CA 1.466 0.661 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.459 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.1 p -134.36 160.14 38.87 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -132.37 116.11 15.16 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.036 -0.983 . . . . 0.0 108.927 177.022 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -69.58 123.28 10.0 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 120.822 1.015 . . . . 0.0 110.691 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.0 t -124.0 106.76 31.11 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.113 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.75 147.02 13.48 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 123.307 2.671 . . . . 0.0 113.21 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -163.93 118.84 1.55 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.953 0.882 . . . . 0.0 111.282 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.67 41.0 25.37 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 -1.44 87.05 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.419 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -119.28 129.29 54.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.239 0.52 . . . . 0.0 109.841 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.5 m -120.82 129.62 53.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.499 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -108.59 145.28 35.11 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.963 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -95.35 100.72 12.46 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.515 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -88.68 118.09 68.99 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.04 124.12 2.08 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.779 2.319 . . . . 0.0 110.417 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.515 HG23 HG22 ' A' ' 70' ' ' ILE . 29.3 pt -134.23 148.63 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.182 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.0 m -118.48 122.03 41.72 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 109.533 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.48 106.12 17.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.996 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.549 ' HE3' HD23 ' A' ' 52' ' ' LEU . 53.8 m95 -94.18 129.82 40.64 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.536 ' O ' HD21 ' A' ' 52' ' ' LEU . 1.3 mp -98.26 141.81 30.71 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.228 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.14 145.61 30.03 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -57.68 -9.87 1.37 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.4 p -114.89 17.31 17.02 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.9 0.381 . . . . 0.0 111.876 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -57.74 143.08 77.16 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -93.41 7.56 57.2 Favored 'Cis proline' 0 N--CA 1.515 2.792 0 CA-C-N 120.99 1.389 . . . . 0.0 115.303 0.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.412 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 36.9 m-85 -73.86 -7.65 53.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.046 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.58 115.12 37.65 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -49.98 134.66 36.08 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 CA-C-N 121.062 1.415 . . . . 0.0 112.373 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.23 143.95 14.34 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.216 1.944 . . . . 0.0 111.684 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.482 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -98.57 152.1 4.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.247 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.7 t -138.52 135.7 35.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.026 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -118.4 128.7 54.88 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.816 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.445 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 61.2 t -89.69 129.66 40.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.97 99.94 2.54 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 123.267 0.355 . . . . 0.0 110.945 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 43.8 Cg_endo -84.89 150.88 11.14 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.652 1.568 . . . . 0.0 113.058 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.2 p -116.25 168.08 10.44 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.719 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.4 m -56.03 -34.05 65.51 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.3 m -87.3 20.89 2.61 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.781 0.718 . . . . 0.0 110.591 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 30.9 ttm -144.76 146.58 32.22 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.0 m -124.56 140.7 52.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 97' ' ' ILE . 1.7 tp -85.84 103.97 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.243 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -87.82 102.14 14.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.258 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 74.2 p -72.21 148.68 45.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.612 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -172.86 -138.97 2.72 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -87.89 -3.84 58.89 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -122.21 -30.28 4.04 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.294 0.952 . . . . 0.0 112.242 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 t -112.04 134.65 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.882 0.765 . . . . 0.0 109.268 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -93.01 162.04 14.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.031 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.95 -32.44 73.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.467 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -76.93 -6.23 51.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.7 5.62 59.93 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.844 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.15 147.48 40.44 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.5 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 86.0 mt -106.36 121.44 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.125 0.488 . . . . 0.0 111.236 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -102.35 120.27 40.22 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mt -126.75 122.34 23.47 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.258 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.04 -30.08 85.4 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 121.474 1.449 . . . . 0.0 114.363 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -66.67 -31.0 71.39 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.815 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 tt -69.59 -41.36 75.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.967 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -66.98 -28.3 68.15 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.375 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -104.29 1.59 30.56 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.521 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -68.95 125.94 28.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.872 0.844 . . . . 0.0 110.221 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -98.07 130.16 44.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.03 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 11.8 t-160 -79.06 124.27 84.71 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.537 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 12.1 Cg_endo -112.06 92.1 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.563 0 CA-C-N 120.929 1.367 . . . . 0.0 112.786 -2.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -113.77 -52.8 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.088 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.9 p -74.62 -40.07 61.76 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.368 0.604 . . . . 0.0 110.694 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 59.47 164.65 0.05 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.956 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.615 HD23 HG21 ' A' ' 28' ' ' VAL . 6.2 tp -58.29 -44.94 88.72 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.104 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.783 HD21 HD23 ' A' ' 31' ' ' LEU . 9.0 tp -52.72 -35.43 55.77 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -64.7 -38.97 96.31 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.9 tp -58.91 -40.3 84.1 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.487 -0.419 . . . . 0.0 111.877 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -76.53 -45.71 32.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.343 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -69.2 -34.34 74.73 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 126' ' ' GLY . 55.7 t -66.67 -38.58 81.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 48.1 tpp -60.67 -44.0 97.0 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.434 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.1 mp -63.73 -38.27 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.385 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.7 t -82.25 -48.25 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 130' ' ' VAL . 2.5 p -69.17 -16.17 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.717 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.5 ' HZ ' HG23 ' A' ' 109' ' ' ILE . 12.6 m-30 -107.27 -19.68 13.52 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.001 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.93 -34.61 90.4 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -62.91 -37.89 88.77 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.997 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -154.87 90.38 3.06 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -45.87 116.59 1.48 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.419 1.412 . . . . 0.0 110.609 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.92 -14.5 35.65 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.627 1.552 . . . . 0.0 111.54 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.24 133.2 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.332 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -161.07 163.5 31.46 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.44 127.67 50.77 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.371 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -110.99 121.55 40.44 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.365 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo . . . . . 0 N--CA 1.493 1.49 0 C-N-CA 122.109 1.873 . . . . 0.0 112.247 179.285 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t -106.15 130.35 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.02 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -95.66 158.41 15.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -65.28 -39.21 92.29 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.65 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.8 m -60.08 -41.98 93.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.352 1.072 . . . . 0.0 109.139 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -68.5 -39.64 81.19 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.052 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.034 HD23 HG13 ' A' ' 22' ' ' VAL . 12.1 tp -53.74 -33.53 56.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.442 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 4.7 mmtt -68.11 -47.7 67.48 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.031 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.98 -34.87 73.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.633 0.73 . . . . 0.0 110.216 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.829 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.9 mmm -64.51 -37.06 86.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.042 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -122.17 23.91 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.565 0.221 . . . . 0.0 110.941 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 9' ' ' LYS . 99.9 p -66.24 -23.72 66.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.543 0.211 . . . . 0.0 111.345 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -77.53 -18.74 56.72 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.326 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.525 ' OH ' HD22 ' A' ' 52' ' ' LEU . 39.1 m-85 -69.93 143.34 52.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.469 0.652 . . . . 0.0 111.603 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -21.74 64.05 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.339 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 96.7 m-85 -121.89 55.43 1.11 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.591 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.7 ptp180 -65.34 -26.18 67.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 119.871 -0.732 . . . . 0.0 112.808 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -67.02 -56.13 11.43 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 20' ' ' LEU . 13.0 mt -65.68 -40.3 92.2 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.47 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 25' ' ' THR . 75.3 m -61.95 -49.68 75.18 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.708 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.034 HG13 HD23 ' A' ' 8' ' ' LEU . 53.3 t -64.26 -47.56 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 120.513 0.197 . . . . 0.0 110.74 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -65.1 -40.9 95.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.37 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -63.99 -38.75 92.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.694 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.664 ' O ' HG23 ' A' ' 29' ' ' ILE . 26.2 p -66.91 -38.69 86.71 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.74 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 30' ' ' THR . 55.7 t -56.58 -44.39 80.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.489 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.6 m-20 -62.86 -39.52 94.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.702 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 124' ' ' LEU . 51.6 t -66.78 -44.09 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -81.95 -13.12 12.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.3 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.8 p -80.98 -48.68 11.93 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.788 0.328 . . . . 0.0 110.589 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 125' ' ' LEU . 32.5 tp -88.09 -36.59 16.84 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.399 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -109.78 66.19 0.63 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -57.17 -19.16 18.79 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.134 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -66.46 -18.18 65.21 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.384 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.599 HD13 HD12 ' A' ' 128' ' ' ILE . 2.6 tp -98.26 113.51 25.47 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -110.63 135.87 20.69 Favored Pre-proline 0 C--N 1.354 0.801 0 CA-C-N 119.354 0.979 . . . . 0.0 111.391 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.87 139.41 22.07 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.462 1.441 . . . . 0.0 111.794 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 p -133.79 147.06 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.829 HD13 ' SD ' ' A' ' 11' ' ' MET . 22.3 tp -99.1 119.67 38.22 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.585 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -121.69 135.77 54.95 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.039 0.447 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.5 p -70.92 139.79 50.8 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -123.78 134.03 53.72 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.725 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.1 t -112.25 127.42 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.308 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -97.69 161.22 13.87 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.811 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -61.07 -38.12 85.1 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.588 0.232 . . . . 0.0 111.457 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.11 -16.57 60.43 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.59 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.78 -5.12 56.52 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.9 p -71.67 166.15 22.5 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 t -128.99 146.13 51.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.341 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.04 134.12 19.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.097 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.611 ' CG ' HD11 ' A' ' 39' ' ' LEU . 7.0 tp10 -85.1 106.32 16.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.525 HD22 ' OH ' ' A' ' 15' ' ' TYR . 36.6 mt -110.13 142.9 40.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.454 0.645 . . . . 0.0 111.349 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.474 ' SD ' HD12 ' A' ' 8' ' ' LEU . 55.3 ttp -105.61 142.42 35.38 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.804 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -136.35 154.47 50.83 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.561 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.453 HD13 HD23 ' A' ' 35' ' ' LEU . 7.3 mt -95.41 120.18 35.2 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.3 m -132.9 135.19 45.43 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.22 -149.21 11.94 Favored Glycine 0 N--CA 1.464 0.51 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.481 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.0 p -133.11 158.36 42.99 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.433 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.5 pt -129.12 116.03 18.82 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.27 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -72.48 125.6 10.82 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 N-CA-C 109.495 -1.002 . . . . 0.0 109.495 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.17 126.77 21.65 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 119.688 -0.805 . . . . 0.0 112.001 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.83 148.66 46.49 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.271 1.981 . . . . 0.0 110.498 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.93 112.61 1.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.609 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.96 32.01 11.93 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.88 -0.513 . . . . 0.0 111.857 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.51 -10.21 67.91 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -110.32 137.78 47.58 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.9 m -115.27 131.72 56.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.671 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -114.6 152.38 31.92 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.296 0.569 . . . . 0.0 110.906 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -98.92 103.81 15.8 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.447 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -91.13 118.67 68.68 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -85.55 126.45 3.06 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.786 2.324 . . . . 0.0 110.944 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.447 HG23 HG22 ' A' ' 70' ' ' ILE . 30.5 pt -133.74 149.86 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.819 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 m -124.05 122.55 38.18 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.762 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.2 112.22 25.14 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.315 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -103.01 125.41 49.75 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.2 mt -88.12 140.04 29.89 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.898 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 tp -93.91 143.69 26.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -48.27 -18.29 0.2 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.68 16.94 25.19 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -69.84 144.58 93.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -92.87 4.27 60.21 Favored 'Cis proline' 0 N--CA 1.514 2.694 0 CA-C-N 121.426 1.545 . . . . 0.0 115.422 1.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 36.0 m-85 -73.34 -15.62 61.38 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.637 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.23 120.26 44.81 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.71 134.4 33.95 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.253 1.483 . . . . 0.0 111.701 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.08 145.11 21.72 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.956 1.77 . . . . 0.0 110.76 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.33 131.52 41.89 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 119.179 -1.009 . . . . 0.0 109.545 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.7 m -111.86 137.83 49.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.672 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -126.5 128.26 46.64 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.225 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.53 127.52 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.48 109.04 12.51 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.72 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.25 161.56 13.25 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 122.149 1.899 . . . . 0.0 112.882 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.9 p -133.43 173.24 11.69 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.7 m -57.94 -39.27 77.63 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 120.136 -0.626 . . . . 0.0 112.252 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.7 p -92.24 0.52 57.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.64 0.654 . . . . 0.0 111.866 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -130.66 125.59 34.39 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.474 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -113.97 167.44 10.66 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.348 -179.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.474 ' N ' HG23 ' A' ' 96' ' ' THR . 5.8 mm -92.73 105.3 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.546 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -86.71 108.66 18.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.498 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.6 p -67.42 140.16 57.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.418 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.63 -146.78 4.41 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -71.55 -22.2 61.79 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.554 ' NE2' HG23 ' A' ' 103' ' ' VAL . 3.2 p-80 -123.8 -25.0 4.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.329 -0.949 . . . . 0.0 112.914 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.554 HG23 ' NE2' ' A' ' 102' ' ' HIS . 14.2 t -91.25 131.39 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.423 1.01 . . . . 0.0 110.671 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -95.31 -163.4 1.04 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.605 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.08 -13.53 47.04 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.39 -1.55 23.14 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.371 -0.206 . . . . 0.0 110.735 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.76 0.08 42.36 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.767 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.66 128.99 24.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.707 0.754 . . . . 0.0 109.898 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.36 114.5 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 O-C-N 123.264 0.353 . . . . 0.0 110.411 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -96.87 134.3 40.37 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.756 HD22 HG11 ' A' ' 134' ' ' VAL . 33.1 mt -137.71 118.86 10.61 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.859 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -47.51 -38.91 28.61 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 121.793 1.662 . . . . 0.0 114.037 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.83 -29.55 69.56 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.174 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.62 -43.76 75.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.743 0.306 . . . . 0.0 111.645 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -69.35 -28.23 66.03 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.689 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -103.97 4.3 34.43 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.989 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.417 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.0 t90 -68.62 121.65 16.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.717 0.77 . . . . 0.0 109.683 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -90.49 122.9 33.73 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.245 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -79.56 126.78 80.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.738 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -107.7 92.67 0.04 OUTLIER 'Cis proline' 0 N--CA 1.499 1.801 0 CA-C-N 120.802 1.322 . . . . 0.0 112.649 -2.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -115.12 -61.31 1.77 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.586 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.3 t -68.97 -33.82 74.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.762 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 p30 47.82 -177.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.82 0.819 . . . . 0.0 111.962 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 28' ' ' VAL . 2.7 tt -68.28 -39.56 82.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.137 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.414 HD11 HD23 ' A' ' 31' ' ' LEU . 8.2 tt -57.79 -38.74 76.03 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -63.55 -39.28 97.46 Favored Glycine 0 N--CA 1.479 1.561 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.0 tp -58.22 -40.57 82.01 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.427 -0.455 . . . . 0.0 111.768 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.599 HD12 HD13 ' A' ' 35' ' ' LEU . 1.1 mm -72.71 -49.43 40.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.848 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.7 tp60 -65.54 -35.96 82.39 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 126' ' ' GLY . 53.4 t -66.86 -37.39 79.34 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 60.9 tpp -58.54 -43.64 89.33 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.433 HD11 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -63.07 -42.77 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.564 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.8 t -77.19 -44.07 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.756 HG11 HD22 ' A' ' 111' ' ' LEU . 2.6 p -73.62 -13.64 16.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.015 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.547 ' CD1' HG13 ' A' ' 134' ' ' VAL . 6.6 m-30 -105.85 -17.59 14.32 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.209 -0.996 . . . . 0.0 109.703 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.69 -34.44 89.64 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.03 -35.5 81.38 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.604 -0.298 . . . . 0.0 110.711 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -155.95 116.52 2.23 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.47 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -75.12 120.48 6.05 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 N-CA-C 108.648 -1.328 . . . . 0.0 108.648 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.524 ' CB ' HG21 ' A' ' 103' ' ' VAL . 36.3 Cg_endo -67.94 -19.05 46.57 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.066 1.177 . . . . 0.0 111.217 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.92 147.95 29.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.56 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -155.38 165.68 35.87 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.4 p -77.59 121.0 23.33 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.375 0.607 . . . . 0.0 111.414 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -113.15 123.07 34.21 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.743 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo . . . . . 0 N--CA 1.499 1.846 0 C-N-CA 121.775 1.65 . . . . 0.0 112.014 -179.738 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.9 t -96.3 130.03 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.791 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.1 156.01 16.8 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.504 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 57.7 mp0 -63.0 -41.51 99.6 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.97 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.8 p -57.38 -47.99 80.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.165 0.984 . . . . 0.0 109.379 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -62.79 -34.52 77.43 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.778 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.939 HD23 HG13 ' A' ' 22' ' ' VAL . 21.1 tp -55.97 -38.39 70.33 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.625 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 3.1 mptp? -63.64 -42.8 98.09 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.331 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.47 -36.36 83.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.142 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.807 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.61 -36.76 84.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.947 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -119.8 23.18 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.795 0.331 . . . . 0.0 111.45 -179.109 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 t -58.8 -25.42 63.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.575 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -64.84 -21.45 66.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.709 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.422 ' HE1' HD23 ' A' ' 52' ' ' LEU . 2.6 m-85 -67.89 150.57 48.39 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.95 -29.6 70.75 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.058 0.456 . . . . 0.0 112.175 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' HD2' ' H ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -138.0 69.03 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.097 0.959 . . . . 0.0 111.73 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -57.69 -25.31 60.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.89 -41.67 97.65 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.027 -0.42 . . . . 0.0 111.497 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 tp -71.68 -43.32 66.2 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.447 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 m -62.69 -46.77 86.61 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.33 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.939 HG13 HD23 ' A' ' 8' ' ' LEU . 40.8 t -62.43 -44.1 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 120.6 0.238 . . . . 0.0 110.428 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.17 -41.99 89.71 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.682 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.83 -39.57 93.79 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.248 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.606 ' O ' HG23 ' A' ' 29' ' ' ILE . 40.9 p -67.89 -38.33 82.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.46 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.15 -44.12 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.496 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -60.72 -38.75 86.15 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.138 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.37 -45.3 70.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -84.78 -22.43 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.989 -178.142 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.8 m -72.18 -45.68 59.38 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.81 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.3 tp -84.47 -37.74 21.0 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.11 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -114.43 66.93 0.68 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -57.76 -17.58 16.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.323 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -65.65 -16.34 63.64 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.26 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 tp -96.36 125.58 40.96 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -118.27 129.27 25.47 Favored Pre-proline 0 C--N 1.359 0.995 0 CA-C-N 119.814 1.188 . . . . 0.0 111.955 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.09 140.23 15.63 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 121.855 1.703 . . . . 0.0 112.592 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.2 p -136.84 141.2 41.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.221 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.807 HD13 ' SD ' ' A' ' 11' ' ' MET . 14.2 tp -82.66 119.22 24.02 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' HB2' ' ND2' ' A' ' 54' ' ' ASN . 97.2 m-20 -119.75 137.81 53.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.212 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.5 m -76.39 141.23 41.52 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -126.38 134.91 50.92 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.994 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -110.4 125.6 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.391 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -99.09 164.95 11.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.575 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -60.38 -41.95 94.83 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.714 0.292 . . . . 0.0 110.951 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -66.0 -14.72 62.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.512 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.18 -7.76 58.71 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.2 t -62.52 143.18 57.48 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.148 0.499 . . . . 0.0 110.027 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -115.7 140.03 49.58 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.051 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.5 ttm-85 -153.75 139.02 17.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.652 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -87.74 111.23 21.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.226 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.422 HD23 ' HE1' ' A' ' 15' ' ' TYR . 25.8 mt -111.53 140.03 46.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.413 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -92.75 138.33 31.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.496 ' ND2' ' CZ3' ' A' ' 75' ' ' TRP . 45.4 m-20 -130.05 153.15 48.74 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.023 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.88 119.16 34.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.6 m -130.23 136.81 49.6 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.928 0.394 . . . . 0.0 112.021 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.46 -147.96 13.61 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.606 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.564 HG21 ' OD1' ' A' ' 69' ' ' ASN . 22.0 p -133.29 161.09 35.42 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.46 116.6 18.53 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.494 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -72.39 126.08 11.3 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 CA-C-N 120.037 1.049 . . . . 0.0 110.193 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.0 t -128.13 125.87 23.54 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.583 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.67 150.0 55.88 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.184 1.923 . . . . 0.0 110.294 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -162.84 106.5 1.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.31 0.576 . . . . 0.0 111.746 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 52.68 39.29 28.16 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.939 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.88 -2.37 74.82 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -119.64 134.16 55.35 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -114.59 131.92 56.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.063 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -113.34 150.05 33.14 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.668 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.564 ' OD1' HG21 ' A' ' 58' ' ' THR . 4.6 t-20 -94.12 107.05 19.01 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.516 HG22 HG23 ' A' ' 72' ' ' ILE . 1.5 mp -90.22 116.23 65.89 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.356 -177.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.31 124.69 4.88 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 122.553 2.168 . . . . 0.0 111.381 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.516 HG23 HG22 ' A' ' 70' ' ' ILE . 31.4 pt -135.89 148.68 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.918 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 63.0 m -125.24 125.04 42.96 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.4 0.619 . . . . 0.0 109.884 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.62 115.75 30.69 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.304 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.496 ' CZ3' ' ND2' ' A' ' 54' ' ' ASN . 61.1 m95 -103.8 126.33 50.85 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.2 mt -94.5 139.82 30.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.217 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mt -79.65 160.12 26.46 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -59.94 -13.96 13.53 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 p -120.77 18.01 11.89 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -59.5 148.14 74.81 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.403 ' HD2' ' OH ' ' A' ' 17' ' ' TYR . 20.0 Cg_endo -92.89 10.26 56.32 Favored 'Cis proline' 0 N--CA 1.509 2.417 0 CA-C-N 121.333 1.512 . . . . 0.0 115.415 -0.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.63 -16.97 64.44 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 118.665 -1.214 . . . . 0.0 110.695 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -116.14 128.06 26.28 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.362 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -46.81 129.62 14.68 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 CA-C-N 121.269 1.489 . . . . 0.0 113.179 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -82.78 148.67 13.93 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.634 2.223 . . . . 0.0 111.401 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -96.45 153.8 3.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.601 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.11 136.24 24.88 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.624 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -120.42 137.79 54.12 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.703 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.46 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -88.04 125.18 41.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -64.22 104.61 0.55 Allowed Pre-proline 0 N--CA 1.475 0.805 0 CA-C-O 119.162 -0.446 . . . . 0.0 110.631 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 48.3 Cg_endo -88.93 157.99 5.95 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.56 1.507 . . . . 0.0 112.783 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.9 t -157.44 161.67 38.94 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.289 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.6 m -56.36 -23.02 34.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -98.45 6.66 47.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.653 0.66 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.8 mmm -131.37 140.14 49.63 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.1 m -128.77 147.37 50.78 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.744 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 93.2 mt -101.09 117.12 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.083 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -101.41 106.89 18.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.3 p -57.47 148.44 23.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.754 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -161.26 -140.36 2.86 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.116 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -88.45 -3.42 58.83 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -135.46 -29.14 1.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.619 1.099 . . . . 0.0 113.617 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.29 144.31 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 119.036 0.835 . . . . 0.0 110.247 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -98.09 159.6 14.83 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.04 79.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.418 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -73.92 -5.51 41.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.169 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.62 6.23 58.49 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.418 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 143.1 34.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.939 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 98.3 mt -106.55 119.88 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.177 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.23 139.67 50.95 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.03 126.25 18.55 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 118.49 0.586 . . . . 0.0 112.183 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.68 -38.87 37.62 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 121.735 1.623 . . . . 0.0 114.07 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -62.43 -31.83 72.59 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.861 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 tt -69.66 -41.59 75.35 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.371 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -66.3 -29.09 69.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.606 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -101.54 -3.29 28.75 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.694 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.404 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.1 t90 -67.56 127.5 32.96 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.924 0.868 . . . . 0.0 110.475 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.37 130.24 43.53 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.776 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 78.7 t60 -80.21 126.13 79.9 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.33 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 13.2 Cg_endo -108.33 93.59 0.04 OUTLIER 'Cis proline' 0 N--CA 1.498 1.787 0 CA-C-N 120.794 1.319 . . . . 0.0 112.539 -2.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -113.99 -62.39 1.6 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.308 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.1 p -70.3 -40.11 74.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.159 0.504 . . . . 0.0 110.297 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.2 t70 65.76 167.67 0.2 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.418 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.3 tt -62.47 -43.86 97.79 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.452 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -53.11 -36.4 60.71 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.182 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.65 -40.19 98.42 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.3 tp -60.46 -40.76 92.34 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -75.98 -47.14 33.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.597 -176.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.492 ' NE2' HG21 ' A' ' 132' ' ' ILE . 67.3 tp60 -67.97 -35.57 78.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 126' ' ' GLY . 61.1 t -68.65 -39.39 80.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.7 ttm -59.01 -45.26 91.13 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.492 HG21 ' NE2' ' A' ' 129' ' ' GLN . 1.1 mp -60.68 -43.28 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.351 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 73.6 t -75.25 -39.68 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.4 p -72.32 -17.45 18.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.54 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -110.13 -17.77 13.48 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.575 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.19 -35.55 91.71 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 107.146 -2.382 . . . . 0.0 107.146 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.99 -34.2 77.86 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.556 -0.822 . . . . 0.0 110.608 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -157.95 90.75 2.26 Favored Pre-proline 0 C--N 1.333 -0.125 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.526 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -50.23 114.15 1.31 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.776 0.984 . . . . 0.0 110.128 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.26 -13.29 28.19 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.471 1.447 . . . . 0.0 111.154 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.1 m -131.64 138.88 51.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.343 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -160.19 164.16 33.05 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.672 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 66.4 m -93.1 126.37 38.16 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.246 0.546 . . . . 0.0 111.02 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -112.92 103.19 55.58 Favored Pre-proline 0 N--CA 1.444 -0.736 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.795 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo . . . . . 0 N--CA 1.497 1.685 0 C-N-CA 121.877 1.718 . . . . 0.0 112.143 179.6 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.415 HG13 ' HE2' ' A' ' 11' ' ' MET . 98.2 t -100.75 129.75 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.722 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -96.58 156.0 16.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.499 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 93.9 mt-10 -62.79 -40.53 97.62 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.145 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -58.76 -47.0 86.17 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 122.219 1.009 . . . . 0.0 109.052 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -61.57 -36.49 80.81 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.002 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.883 HD23 HG13 ' A' ' 22' ' ' VAL . 25.0 tp -55.3 -39.54 70.04 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.608 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 3.2 mptp? -60.65 -43.31 97.75 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.867 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -67.94 -26.32 65.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.735 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.743 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -79.03 -34.61 43.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.52 -178.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -113.17 17.64 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.711 0.291 . . . . 0.0 110.789 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.67 -11.51 60.24 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.656 0.265 . . . . 0.0 111.302 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -85.22 -12.85 51.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.453 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.71 ' OH ' HD22 ' A' ' 52' ' ' LEU . 40.2 m-85 -77.75 152.47 33.59 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.408 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -64.93 -39.13 93.03 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.076 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 25.0 m-85 -114.58 70.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 122.404 -0.185 . . . . 0.0 111.077 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -69.04 -27.31 65.54 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -72.74 -46.56 52.86 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.79 -39.6 73.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.969 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.7 m -61.19 -45.71 93.46 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.872 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.883 HG13 HD23 ' A' ' 8' ' ' LEU . 30.1 t -61.86 -45.9 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 120.839 0.352 . . . . 0.0 110.483 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -43.05 99.65 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.873 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -65.16 -37.12 86.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.943 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 29' ' ' ILE . 39.5 p -67.38 -37.36 83.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.922 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.49 -43.62 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.1 m-20 -60.4 -39.04 85.91 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.411 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -70.58 -42.75 78.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.27 -21.92 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.191 -177.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.0 m -72.46 -42.9 64.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.046 0.451 . . . . 0.0 110.311 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.844 HD23 HD21 ' A' ' 125' ' ' LEU . 33.8 tp -88.75 -34.52 17.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.092 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -118.24 68.85 0.78 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -57.32 -20.59 29.59 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.159 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -65.84 -15.05 62.55 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.755 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.458 ' CD2' HD13 ' A' ' 55' ' ' LEU . 2.7 tp -96.95 112.43 24.19 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.12 129.52 23.84 Favored Pre-proline 0 C--N 1.358 0.937 0 CA-C-N 119.572 1.078 . . . . 0.0 112.334 -177.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -82.92 135.64 7.74 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.603 1.535 . . . . 0.0 112.834 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.84 155.58 41.54 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.743 HD13 ' SD ' ' A' ' 11' ' ' MET . 15.7 tp -95.21 117.6 30.53 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -121.42 134.74 55.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.907 0.384 . . . . 0.0 111.9 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.5 t -71.99 136.72 46.85 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -118.27 124.31 47.54 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.864 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.1 t -110.2 124.85 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.926 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -104.18 166.7 10.24 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.893 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -60.49 -38.0 82.88 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.488 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.54 -15.87 59.17 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.843 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.72 -8.88 66.16 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.8 t -67.35 145.04 55.49 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -125.08 139.18 54.02 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.414 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -150.02 136.95 19.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.109 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 51' ' ' GLU . 17.4 pm0 -83.97 116.99 23.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.213 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.71 HD22 ' OH ' ' A' ' 15' ' ' TYR . 69.9 mt -117.23 145.09 44.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.086 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -98.93 138.23 36.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.849 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -130.08 151.12 50.96 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.479 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.458 HD13 ' CD2' ' A' ' 35' ' ' LEU . 6.2 mt -97.59 129.57 44.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.1 m -145.3 138.5 26.43 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.85 -141.9 7.31 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.485 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.5 p -133.41 158.92 41.83 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.458 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -129.59 116.18 18.32 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.848 177.296 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -70.98 123.85 10.07 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 CA-C-N 119.886 0.995 . . . . 0.0 110.001 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.1 t -130.67 125.71 21.59 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.909 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.09 147.39 42.83 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.281 1.987 . . . . 0.0 110.634 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -163.48 116.08 1.49 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 55.93 28.29 12.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.448 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.68 -5.74 77.03 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -112.93 142.51 45.52 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.9 m -120.29 131.93 55.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.884 0.374 . . . . 0.0 111.74 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -115.11 152.02 33.29 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.98 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -96.52 104.93 16.95 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.517 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -88.7 117.13 68.0 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.94 124.31 3.84 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.711 2.274 . . . . 0.0 111.12 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.517 HG23 HG22 ' A' ' 70' ' ' ILE . 29.5 pt -135.72 148.69 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.973 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.3 m -121.43 123.55 42.35 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-O 121.839 0.828 . . . . 0.0 110.12 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.97 117.0 32.9 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.349 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -107.72 126.23 52.35 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.5 mt -92.87 139.36 30.62 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.838 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mt -85.42 152.58 23.12 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.492 ' OD1' HD21 ' A' ' 52' ' ' LEU . 95.9 m-20 -58.66 -16.05 14.5 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.906 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.2 10.75 31.79 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -65.3 144.54 99.02 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.427 ' HG2' ' CD2' ' A' ' 119' ' ' HIS . 28.7 Cg_endo -91.05 3.84 67.11 Favored 'Cis proline' 0 N--CA 1.515 2.786 0 CA-C-N 121.219 1.471 . . . . 0.0 115.726 1.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.428 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 18.8 m-85 -71.54 -20.67 62.0 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.945 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.06 126.64 30.1 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.826 -0.607 . . . . 0.0 109.695 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -49.08 131.48 26.06 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 CA-C-N 121.235 1.477 . . . . 0.0 112.403 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.16 145.53 11.01 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.463 2.109 . . . . 0.0 111.784 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.479 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -91.79 147.44 5.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.241 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' A' ' 109' ' ' ILE . 53.8 t -139.57 132.58 29.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.56 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -121.88 130.86 53.69 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.66 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.491 HG13 HD11 ' A' ' 109' ' ' ILE . 11.4 m -82.83 145.93 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -93.56 99.1 3.03 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.871 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 87.3 Cg_endo -77.03 157.25 34.3 Favored 'Trans proline' 0 N--CA 1.504 2.118 0 C-N-CA 121.482 1.455 . . . . 0.0 112.738 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 p -139.24 176.17 8.93 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.1 t -59.79 -43.86 94.2 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 m -88.18 11.84 15.3 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.795 0.725 . . . . 0.0 111.493 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.2 mmm -129.13 138.46 51.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.66 146.03 48.52 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.813 -178.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.411 HG23 HG11 ' A' ' 103' ' ' VAL . 6.6 mm -88.2 103.43 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.077 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -95.58 110.9 22.93 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.9 p -69.65 155.97 39.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.687 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.89 -135.01 2.24 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.826 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -86.38 -1.24 57.37 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 71.2 m-70 -134.97 -27.31 1.26 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.665 1.12 . . . . 0.0 113.729 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.411 HG11 HG23 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -110.55 134.81 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 118.931 0.787 . . . . 0.0 110.215 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -87.2 -172.57 4.01 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.418 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.13 0.34 56.14 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.978 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -109.04 -5.67 15.94 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.745 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.89 -3.44 57.26 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.534 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 145.22 47.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.408 0.604 . . . . 0.0 110.446 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.491 HD11 HG13 ' A' ' 89' ' ' VAL . 97.5 mt -108.92 122.12 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.434 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.61 130.65 56.86 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.553 ' CD2' HG11 ' A' ' 134' ' ' VAL . 1.1 mt -123.99 124.23 26.02 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.251 -176.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -49.15 -36.9 37.59 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 121.739 1.626 . . . . 0.0 113.865 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.465 ' OH ' HD13 ' A' ' 127' ' ' LEU . 1.2 p90 -60.07 -33.0 71.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.079 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.423 ' N ' ' CG ' ' A' ' 113' ' ' TYR . 1.5 tt -70.89 -41.23 71.59 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.918 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -64.17 -26.37 68.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.633 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -113.78 11.52 18.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.495 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -72.19 125.99 28.67 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.924 0.868 . . . . 0.0 109.996 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -96.57 127.89 42.99 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.784 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.427 ' CD2' ' HG2' ' A' ' 81' ' ' PRO . 39.4 t-80 -81.6 126.49 75.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 119.069 -0.491 . . . . 0.0 110.112 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -108.94 92.35 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.707 0 CA-C-N 120.756 1.306 . . . . 0.0 112.43 -2.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -113.26 -61.96 1.66 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.504 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.5 t -67.94 -42.11 81.5 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.087 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 t70 66.98 165.84 0.22 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.487 0.66 . . . . 0.0 111.7 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.7 tt -65.79 -43.71 87.94 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.663 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.844 HD21 HD23 ' A' ' 31' ' ' LEU . 21.3 tp -56.81 -38.54 72.72 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.24 -39.12 96.75 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.465 HD13 ' OH ' ' A' ' 113' ' ' TYR . 33.4 tp -56.95 -40.28 76.15 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.889 -0.183 . . . . 0.0 111.431 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -73.98 -47.82 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.941 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -66.42 -35.0 79.22 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.58 ' O ' HG12 ' A' ' 134' ' ' VAL . 62.9 t -67.41 -39.02 81.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.0 tpp -58.24 -42.13 85.7 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.458 HD11 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -63.62 -39.55 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.597 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -79.09 -46.82 23.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 130' ' ' VAL . 9.9 p -71.6 -14.21 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.138 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.466 ' CD1' HG13 ' A' ' 134' ' ' VAL . 5.6 m-30 -104.75 -19.09 14.04 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.18 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.43 -32.05 60.3 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -63.89 -38.87 92.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.817 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -157.67 81.66 3.08 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -49.1 109.31 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.266 1.311 . . . . 0.0 110.76 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.64 -23.47 40.6 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.456 1.437 . . . . 0.0 110.462 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 m -120.09 140.41 44.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.29 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -159.57 164.19 34.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.297 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.4 m -105.81 130.17 53.85 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.853 0.358 . . . . 0.0 110.72 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.13 132.2 22.16 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.445 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo . . . . . 0 N--CA 1.494 1.538 0 C-N-CA 121.791 1.661 . . . . 0.0 111.982 179.434 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 p -71.23 139.3 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 121.391 0.615 . . . . 0.0 110.805 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -103.74 157.84 16.8 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 97.7 mt-10 -65.04 -40.45 94.81 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.266 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -63.26 -41.51 99.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.355 1.074 . . . . 0.0 109.214 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -69.97 -29.93 67.16 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.657 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.036 HD23 HG13 ' A' ' 22' ' ' VAL . 51.6 tp -61.9 -39.65 92.71 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.698 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -58.85 -43.22 90.73 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.074 -0.967 . . . . 0.0 108.657 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -60.43 -35.52 76.02 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.298 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.734 ' CB ' HD13 ' A' ' 39' ' ' LEU . 13.5 ptp -83.33 -10.58 58.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.172 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.878 HG22 ' O ' ' A' ' 8' ' ' LEU . 16.2 m -130.9 19.21 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.01 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.7 p -66.44 -18.22 65.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.558 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.82 -13.15 40.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.98 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -72.9 148.64 44.17 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.527 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -66.57 -37.82 85.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.799 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 19.8 m-85 -108.18 61.92 0.61 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.428 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.4 ptp85 -64.76 -27.31 68.81 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -76.68 -53.03 8.55 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.11 -38.77 82.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.084 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -60.77 -47.45 86.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.698 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.036 HG13 HD23 ' A' ' 8' ' ' LEU . 38.9 t -61.08 -44.62 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -40.53 97.87 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.115 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.13 -38.44 91.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.059 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.647 ' O ' HG23 ' A' ' 29' ' ' ILE . 48.8 p -68.27 -34.33 75.99 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.923 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.68 -45.64 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.742 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -61.31 -39.07 89.13 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.471 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.64 -43.09 71.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.57 -20.13 7.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.698 -178.139 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.5 m -78.07 -46.97 19.4 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.992 0.425 . . . . 0.0 110.848 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.599 HD23 HD21 ' A' ' 125' ' ' LEU . 22.8 tp -88.65 -36.0 16.49 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.842 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -111.97 68.14 0.66 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -59.38 -18.15 36.22 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.671 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -65.22 -21.88 66.81 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.855 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.641 HD13 HD12 ' A' ' 128' ' ' ILE . 1.3 tp -95.51 115.26 27.18 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.72 132.76 22.11 Favored Pre-proline 0 C--N 1.356 0.881 0 CA-C-N 119.828 1.194 . . . . 0.0 112.104 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.39 135.3 11.82 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.424 1.416 . . . . 0.0 112.46 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.1 t -127.87 136.27 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.734 HD13 ' CB ' ' A' ' 11' ' ' MET . 38.1 tp -84.55 119.24 24.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -129.91 137.25 50.28 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.9 t -68.6 137.98 54.69 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.56 133.45 53.98 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.206 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.2 t -120.78 126.63 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.992 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -100.79 159.51 15.13 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.178 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.59 -35.44 72.42 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 122.369 -0.207 . . . . 0.0 110.934 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -61.38 -15.36 35.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.876 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.71 -13.45 60.94 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.0 t -65.75 141.81 58.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.2 p -121.9 138.74 54.28 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.546 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -161.23 138.69 9.05 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.359 0.6 . . . . 0.0 110.79 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -80.39 120.5 24.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.741 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 52' ' ' LEU . 77.7 mt -122.22 140.01 53.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.553 0.692 . . . . 0.0 110.817 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.455 ' SD ' HD11 ' A' ' 8' ' ' LEU . 62.0 ttp -84.51 148.66 26.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.424 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -134.2 151.53 51.36 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.296 0.57 . . . . 0.0 111.689 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.498 ' HG ' HD23 ' A' ' 35' ' ' LEU . 3.2 mm? -102.66 116.02 31.74 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.5 m -134.47 137.13 43.7 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.27 -143.24 7.99 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.593 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.493 HG21 ' OD1' ' A' ' 69' ' ' ASN . 19.8 p -135.27 161.25 35.92 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.43 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.2 pt -132.31 116.07 15.22 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.206 177.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -72.35 125.87 11.14 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 120.935 1.09 . . . . 0.0 110.092 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.6 t -129.48 124.43 21.96 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 119.744 -0.783 . . . . 0.0 112.329 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.56 145.85 48.11 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.137 1.891 . . . . 0.0 110.162 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -163.57 114.78 1.4 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.932 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.23 32.09 12.78 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.82 -6.86 72.36 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -113.79 148.51 36.42 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -125.2 132.58 52.99 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.609 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -115.47 152.09 33.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.138 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.493 ' OD1' HG21 ' A' ' 58' ' ' THR . 3.8 t-20 -97.09 103.88 15.85 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.494 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -88.33 116.98 67.83 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -82.18 127.26 5.22 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 122.516 2.144 . . . . 0.0 111.062 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.494 HG23 HG22 ' A' ' 70' ' ' ILE . 29.6 pt -137.1 149.13 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 118.939 -1.105 . . . . 0.0 112.577 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.46 123.05 40.4 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-O 121.513 0.673 . . . . 0.0 110.057 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.32 103.68 13.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.646 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -90.69 124.05 34.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 119.046 -1.062 . . . . 0.0 108.3 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -91.98 138.64 31.38 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mt -88.9 155.46 19.51 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.28 -16.26 32.54 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.629 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.04 0.43 51.57 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.669 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -65.03 143.03 98.82 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HG2' ' CE1' ' A' ' 119' ' ' HIS . 41.5 Cg_endo -89.34 4.15 69.62 Favored 'Cis proline' 0 N--CA 1.517 2.892 0 CA-C-N 120.975 1.384 . . . . 0.0 115.299 1.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 12.0 m-85 -68.85 -23.13 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.242 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.86 126.3 30.15 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.959 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.19 137.48 37.88 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 CA-C-N 121.263 1.487 . . . . 0.0 111.555 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.03 144.1 11.8 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.387 2.058 . . . . 0.0 111.771 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.49 131.55 40.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.65 0.738 . . . . 0.0 109.406 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 38.7 t -118.28 142.0 47.94 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.326 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -127.93 127.64 43.68 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.103 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.585 ' CG2' HD11 ' A' ' 109' ' ' ILE . 57.9 t -85.79 131.92 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -87.35 101.76 2.61 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.979 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 79.4 Cg_endo -82.03 159.36 18.18 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.39 1.393 . . . . 0.0 112.206 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 p -123.39 168.13 12.93 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.06 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.2 m -56.75 -36.09 69.37 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.433 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.0 m -88.36 2.59 52.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.854 0.752 . . . . 0.0 112.295 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -129.54 140.15 51.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.68 156.81 26.46 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.631 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 97' ' ' ILE . 2.7 tp -85.25 109.98 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-O 121.262 0.553 . . . . 0.0 109.96 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -97.53 101.39 12.9 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.033 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.7 p -65.54 151.18 47.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.883 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -166.23 -143.75 3.85 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.663 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.403 ' O ' ' CZ ' ' A' ' 110' ' ' TYR . 24.8 pttm -65.96 -18.96 65.69 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -131.86 -26.67 1.95 Allowed 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.602 HG21 ' HB2' ' A' ' 140' ' ' PRO . 13.4 t -93.78 137.66 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.667 1.121 . . . . 0.0 111.36 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -100.97 177.51 4.93 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.417 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.58 -38.55 87.28 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -86.41 -0.37 55.83 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.843 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.69 21.56 18.66 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.722 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -75.79 136.84 40.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.687 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.585 HD11 ' CG2' ' A' ' 89' ' ' VAL . 88.7 mt -117.26 125.2 73.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.95 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CZ ' ' O ' ' A' ' 101' ' ' LYS . 30.2 p90 -136.44 148.87 47.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.73 HD23 HG11 ' A' ' 134' ' ' VAL . 3.3 mp -143.45 140.03 17.12 Favored Pre-proline 0 CA--C 1.555 1.152 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.257 -175.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.476 ' HA ' ' ND1' ' A' ' 115' ' ' HIS . 50.4 Cg_exo -46.43 -38.64 21.24 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 C-N-CA 121.954 1.769 . . . . 0.0 113.792 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.46 ' OH ' HD13 ' A' ' 127' ' ' LEU . 0.4 OUTLIER -63.69 -31.94 73.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.073 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.24 -43.08 64.91 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.476 ' ND1' ' HA ' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -68.96 -27.01 65.35 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.78 -177.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -97.65 1.12 48.32 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.293 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -60.13 126.51 27.79 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.766 0.793 . . . . 0.0 110.657 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -104.46 96.29 6.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.619 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 65.0 t60 -55.64 122.84 47.97 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.309 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 8.5 Cg_endo -108.0 91.97 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 120.304 1.144 . . . . 0.0 113.019 -2.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -110.43 -58.83 2.03 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.483 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.1 p -71.02 -39.72 72.19 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.355 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 t70 69.32 164.09 0.24 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.355 0.598 . . . . 0.0 112.095 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.4 tt -66.15 -44.28 84.57 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.326 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.599 HD21 HD23 ' A' ' 31' ' ' LEU . 2.6 tp -56.12 -37.95 70.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.67 -39.42 97.39 Favored Glycine 0 N--CA 1.477 1.391 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.46 HD13 ' OH ' ' A' ' 113' ' ' TYR . 32.4 tp -58.68 -41.17 85.59 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.605 -0.35 . . . . 0.0 111.902 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.641 HD12 HD13 ' A' ' 35' ' ' LEU . 1.1 mm -72.71 -47.74 48.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.954 -176.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.553 ' NE2' HG21 ' A' ' 132' ' ' ILE . 49.8 tp60 -67.71 -34.73 77.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.668 ' O ' HG12 ' A' ' 134' ' ' VAL . 64.5 t -67.91 -39.2 81.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.055 177.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.404 ' SD ' ' CE1' ' A' ' 135' ' ' PHE . 44.5 tpp -58.14 -41.47 83.77 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.553 HG21 ' NE2' ' A' ' 129' ' ' GLN . 1.1 mp -63.67 -44.14 98.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.562 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.74 -44.21 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.73 HG11 HD23 ' A' ' 111' ' ' LEU . 8.7 p -73.52 -14.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.177 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.464 ' CD2' HG13 ' A' ' 134' ' ' VAL . 11.6 m-30 -105.38 -17.78 14.33 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.547 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.95 -22.97 72.59 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -76.43 -27.31 56.18 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.578 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -161.73 83.77 1.75 Allowed Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -46.99 119.25 3.26 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.341 1.361 . . . . 0.0 110.407 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.602 ' HB2' HG21 ' A' ' 103' ' ' VAL . 37.7 Cg_endo -68.47 -18.61 43.57 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 120.875 1.05 . . . . 0.0 110.856 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.76 147.86 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -158.75 164.86 35.47 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.526 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 67.1 m -86.87 120.76 28.5 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.164 0.507 . . . . 0.0 111.15 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -112.03 111.88 53.14 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.044 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.494 1.543 0 C-N-CA 122.126 1.884 . . . . 0.0 112.292 -179.614 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.432 HG11 ' HG2' ' A' ' 37' ' ' PRO . 7.4 p -88.55 146.44 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-O 121.679 0.752 . . . . 0.0 111.079 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.05 149.65 24.99 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.441 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 56.0 mp0 -61.23 -42.3 98.37 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.768 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.6 m -57.73 -46.92 83.79 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.364 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -63.07 -34.08 76.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.87 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.697 HD23 HG13 ' A' ' 22' ' ' VAL . 11.7 tp -55.83 -38.66 70.32 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.605 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.3 mptp? -61.22 -42.52 98.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.757 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.57 -37.21 86.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.362 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.784 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -66.01 -37.01 84.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.149 -177.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.6 m -119.43 28.91 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.658 0.266 . . . . 0.0 111.213 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.2 p -64.95 -22.66 67.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -74.71 -15.5 60.78 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.921 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -71.09 152.25 43.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.016 0.436 . . . . 0.0 111.437 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -75.47 -29.22 59.53 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.12 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.407 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 35.7 m-85 -117.94 61.77 0.76 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.148 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 ptt-85 -64.65 -29.62 70.63 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.98 -44.03 70.25 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tp -74.74 -41.28 60.42 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.392 -0.923 . . . . 0.0 109.813 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 25' ' ' THR . 96.0 m -61.19 -47.99 83.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.616 0.246 . . . . 0.0 111.154 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.697 HG13 HD23 ' A' ' 8' ' ' LEU . 14.2 t -61.32 -45.49 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.397 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -63.4 -43.0 98.81 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.653 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.59 -36.28 83.3 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.682 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.657 ' O ' HG23 ' A' ' 29' ' ' ILE . 40.7 p -67.31 -38.58 85.21 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.543 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -57.44 -43.43 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -60.05 -41.3 92.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.101 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 124' ' ' LEU . 77.5 t -68.85 -43.07 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -87.56 -15.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.452 -178.579 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.3 m -85.04 -46.95 10.69 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.128 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.9 tp -83.14 -35.88 25.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.259 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -115.47 68.4 0.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.039 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -57.03 -20.84 26.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.091 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -65.15 -22.02 66.86 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.685 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.543 HD13 HD12 ' A' ' 128' ' ' ILE . 1.4 tp -93.17 115.2 27.84 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -111.11 133.59 21.28 Favored Pre-proline 0 C--N 1.357 0.904 0 CA-C-N 119.713 1.142 . . . . 0.0 111.937 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 97.5 Cg_endo -79.69 133.01 10.13 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.194 1.263 . . . . 0.0 112.028 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -126.93 134.27 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.784 HD13 ' SD ' ' A' ' 11' ' ' MET . 24.4 tp -81.82 113.89 20.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -123.64 137.36 54.74 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 83.1 p -71.63 148.02 46.97 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -133.09 134.59 44.48 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.599 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.5 t -119.43 126.42 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.2 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.71 164.22 12.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.863 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -64.73 -19.4 65.76 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -85.83 3.55 41.08 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.186 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.53 -5.96 81.79 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.509 -0.637 . . . . 0.0 111.509 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.4 t -71.18 142.21 50.67 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.168 0.509 . . . . 0.0 109.951 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.0 m -124.96 145.94 49.62 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.643 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -158.98 140.37 13.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.145 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.492 ' HG3' HD11 ' A' ' 39' ' ' LEU . 8.0 tp10 -83.37 106.43 15.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.213 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 52' ' ' LEU . 70.2 mt -114.26 140.64 48.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.401 0.62 . . . . 0.0 110.927 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.499 ' SD ' HD11 ' A' ' 8' ' ' LEU . 57.7 ttp -84.41 148.83 26.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.321 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 4.5 t30 -124.74 161.34 26.61 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.991 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.525 ' HA ' HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -119.15 112.78 19.94 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -138.58 139.94 38.82 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.45 -143.66 8.26 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.761 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.8 p -134.9 159.19 42.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.438 HD13 HG21 ' A' ' 59' ' ' ILE . 1.2 pt -130.8 115.74 16.89 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.283 177.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.14 125.06 10.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 N-CA-C 109.405 -1.037 . . . . 0.0 109.405 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.0 t -126.97 121.86 23.05 Favored Pre-proline 0 C--O 1.24 0.605 0 C-N-CA 119.834 -0.746 . . . . 0.0 112.285 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.27 146.49 51.16 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.074 1.85 . . . . 0.0 110.287 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -162.74 107.9 1.15 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.102 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.77 37.92 25.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.551 -0.46 . . . . 0.0 112.205 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.17 -0.77 82.95 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -118.5 138.26 52.63 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.2 m -121.35 132.56 54.84 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.483 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -115.96 149.58 38.55 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.121 0.486 . . . . 0.0 111.261 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -94.88 100.47 12.34 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.442 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -87.67 115.35 62.66 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.237 -177.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.64 127.87 4.45 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.753 2.302 . . . . 0.0 111.158 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.442 HG23 HG22 ' A' ' 70' ' ' ILE . 25.1 pt -135.27 148.7 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.411 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.1 m -116.62 124.23 49.27 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.354 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.53 112.25 24.04 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.204 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.517 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 70.1 m95 -96.03 130.25 43.08 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.224 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.25 134.64 41.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tp -94.16 143.82 26.04 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.87 -16.86 0.47 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.37 9.97 40.91 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.421 -0.512 . . . . 0.0 112.316 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -65.7 143.49 98.59 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -92.0 3.36 63.15 Favored 'Cis proline' 0 N--CA 1.517 2.865 0 CA-C-N 121.033 1.405 . . . . 0.0 115.256 1.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.407 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 17.2 m-85 -69.78 -21.02 63.45 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.465 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.37 118.92 53.48 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.52 135.99 33.25 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 CA-C-N 121.182 1.458 . . . . 0.0 111.423 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.51 140.86 17.29 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.817 1.678 . . . . 0.0 111.199 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -79.78 152.89 4.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.155 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 13.1 t -140.93 140.37 34.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.093 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -131.32 129.72 41.8 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.771 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.59 134.77 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -100.17 101.2 13.68 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.647 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -90.15 127.57 1.47 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.874 1.716 . . . . 0.0 113.197 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.3 p -77.19 172.54 13.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.8 p -55.86 -28.64 57.46 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.9 m -95.64 -2.2 48.64 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.945 0.793 . . . . 0.0 111.579 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 52.9 tpp -93.25 134.35 35.53 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 85.1 m -108.16 133.22 52.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.79 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.555 HG23 ' O ' ' A' ' 97' ' ' ILE . 2.5 tp -93.95 109.07 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.08 0.467 . . . . 0.0 109.816 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -92.85 100.13 12.66 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.673 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 74.0 p -66.91 148.44 51.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.985 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -172.96 -150.6 7.49 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.26 -20.44 64.79 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -115.35 -30.38 6.28 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 119.028 0.831 . . . . 0.0 113.008 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.581 HG21 ' HB2' ' A' ' 140' ' ' PRO . 4.1 t -100.78 138.36 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 CA-C-N 119.24 0.927 . . . . 0.0 110.58 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.407 ' O ' HG12 ' A' ' 103' ' ' VAL . 18.2 t0 -93.85 -169.72 2.16 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.421 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.59 -30.94 22.91 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -92.08 0.34 57.46 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.993 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.84 6.02 37.97 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.104 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -64.04 148.46 49.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.693 0.747 . . . . 0.0 110.181 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.432 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 84.1 mt -116.44 122.82 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 110.718 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.62 121.22 44.22 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.408 ' CD2' HG11 ' A' ' 134' ' ' VAL . 1.2 mt -126.98 116.52 22.04 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.945 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -48.98 -36.88 35.93 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.581 1.521 . . . . 0.0 113.69 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -31.51 71.56 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.477 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 tt -69.46 -41.71 75.86 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.89 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -65.57 -28.47 69.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.017 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -109.84 3.77 21.02 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.679 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.403 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.1 t90 -64.84 125.03 23.54 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.038 0.923 . . . . 0.0 110.076 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -95.81 127.1 41.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.816 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 -81.28 126.65 76.18 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 119.026 -0.512 . . . . 0.0 110.514 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -109.4 91.39 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.674 0 CA-C-N 120.677 1.277 . . . . 0.0 112.453 -2.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.3 -62.75 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 t -67.74 -37.26 81.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.699 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 51.4 175.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.061 0.934 . . . . 0.0 112.143 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.1 tt -62.94 -44.33 96.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.821 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -53.6 -38.71 64.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.64 -39.63 98.14 Favored Glycine 0 N--CA 1.482 1.704 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.4 tp -58.25 -40.65 82.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.435 -0.45 . . . . 0.0 111.829 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.543 HD12 HD13 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -74.34 -48.16 37.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.948 -176.738 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.58 ' NE2' HG21 ' A' ' 132' ' ' ILE . 65.4 tp60 -68.77 -35.15 76.7 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 126' ' ' GLY . 63.4 t -67.92 -40.07 82.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 178.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.5 ttm -58.39 -42.8 87.92 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.58 HG21 ' NE2' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -61.17 -41.12 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.475 178.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.26 -47.73 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.476 HG13 ' CD2' ' A' ' 135' ' ' PHE . 4.6 p -66.7 -14.45 17.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.501 -178.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.476 ' CD2' HG13 ' A' ' 134' ' ' VAL . 15.4 m-30 -106.91 -20.12 13.42 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.358 177.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.7 -35.2 91.64 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.16 -37.31 86.99 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.957 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -154.56 83.96 3.95 Favored Pre-proline 0 N--CA 1.451 -0.393 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.139 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -45.35 117.59 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.689 1.593 . . . . 0.0 110.939 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.581 ' HB2' HG21 ' A' ' 103' ' ' VAL . 59.7 Cg_endo -74.71 -4.97 16.23 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.504 1.469 . . . . 0.0 111.4 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.7 m -120.46 157.38 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.708 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -150.96 140.67 21.74 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.247 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.5 m -84.05 112.35 20.13 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.833 0.349 . . . . 0.0 110.677 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -111.42 109.38 56.26 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.228 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 N--CA 1.494 1.556 0 C-N-CA 121.916 1.744 . . . . 0.0 112.376 -179.732 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t -79.16 130.93 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.659 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -94.54 156.54 16.4 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.8 mt-10 -63.3 -40.91 98.66 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.111 -1.035 . . . . 0.0 111.329 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -60.18 -47.21 86.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.237 1.018 . . . . 0.0 108.633 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -63.11 -30.64 71.75 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.38 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.901 HD23 HG13 ' A' ' 22' ' ' VAL . 38.7 tp -58.86 -41.05 86.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 10.8 mptt -60.5 -41.84 95.13 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.657 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.35 -37.09 82.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.354 0.597 . . . . 0.0 110.621 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.761 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -68.9 -36.28 77.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.566 -178.37 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.0 m -113.61 20.91 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.61 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.7 t -68.85 -4.48 16.46 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.353 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -103.98 -11.19 17.56 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.02 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.705 ' CE1' HG12 ' A' ' 12' ' ' VAL . 17.9 m-85 -67.65 160.12 28.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.883 0.373 . . . . 0.0 110.675 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -70.88 -39.43 72.84 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.705 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.16 74.15 1.02 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.813 -0.176 . . . . 0.0 110.965 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -72.12 -21.61 61.45 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -79.19 -47.63 15.66 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.754 -0.592 . . . . 0.0 111.864 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 tp -70.15 -40.6 74.68 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.478 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 83.2 m -60.93 -48.09 83.42 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.55 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.901 HG13 HD23 ' A' ' 8' ' ' LEU . 30.8 t -62.83 -45.49 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 120.666 0.269 . . . . 0.0 110.899 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -41.63 97.26 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.135 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -37.76 84.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.742 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.632 ' O ' HG23 ' A' ' 29' ' ' ILE . 13.6 p -66.28 -33.73 76.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.437 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.2 t -59.65 -45.45 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.286 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -61.66 -38.76 88.94 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.913 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.71 -46.43 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.66 -21.21 7.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.475 -178.493 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 79.8 m -70.91 -40.87 71.9 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.069 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -88.09 -36.56 16.85 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.448 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -117.75 69.63 0.78 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -57.8 -19.68 30.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.703 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -65.47 -19.17 65.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.412 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 tp -90.15 116.6 28.28 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -112.32 132.72 21.99 Favored Pre-proline 0 C--N 1.358 0.97 0 CA-C-N 120.1 1.318 . . . . 0.0 111.775 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.04 135.63 11.2 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.588 1.525 . . . . 0.0 112.973 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.6 t -129.66 136.56 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.761 HD13 ' SD ' ' A' ' 11' ' ' MET . 16.0 tp -82.74 125.19 30.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.95 158.89 24.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.033 0.444 . . . . 0.0 111.149 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m -97.01 125.17 41.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -110.42 133.29 53.42 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.592 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.8 t -119.6 125.36 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.292 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -97.05 171.1 8.69 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.622 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -60.56 -39.03 86.46 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.805 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -67.47 -8.94 37.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.862 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.03 -10.21 74.91 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.1 t -62.43 141.55 58.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.6 p -116.19 150.54 37.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.989 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -160.41 134.02 6.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.115 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.27 113.79 10.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.706 0.765 . . . . 0.0 110.347 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.485 HD21 ' O ' ' A' ' 76' ' ' LEU . 20.0 tp -111.5 123.05 49.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -83.34 143.46 30.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.899 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.412 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -132.87 160.33 37.28 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.041 0.448 . . . . 0.0 111.738 -178.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.0 mt -111.44 117.66 33.66 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -132.8 137.49 46.8 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.97 -146.19 10.79 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.375 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.9 p -134.41 159.16 41.93 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.88 116.6 18.09 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.229 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -67.11 123.32 10.77 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 N-CA-C 109.527 -0.99 . . . . 0.0 109.527 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.03 118.04 22.07 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.991 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.93 149.58 77.71 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.991 1.794 . . . . 0.0 111.315 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -162.8 111.98 1.36 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.935 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 45.85 45.03 11.51 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.3 -4.55 76.61 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.683 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -118.93 162.26 18.81 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.6 m -129.35 130.03 45.54 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.787 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -106.0 144.73 32.3 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.579 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -100.03 103.29 14.81 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.534 HG22 HG23 ' A' ' 72' ' ' ILE . 1.5 mp -91.18 117.35 67.81 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -85.1 124.46 2.9 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 123.023 2.482 . . . . 0.0 110.214 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.534 HG23 HG22 ' A' ' 70' ' ' ILE . 27.9 pt -135.82 150.11 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 118.955 -1.098 . . . . 0.0 112.56 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.1 m -121.55 124.77 45.2 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.215 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 mp -103.13 107.58 18.44 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.436 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.459 ' HE3' HD23 ' A' ' 52' ' ' LEU . 86.1 m95 -96.06 125.63 40.73 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.485 ' O ' HD21 ' A' ' 52' ' ' LEU . 67.8 mt -95.21 129.89 42.15 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.804 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 mt -73.72 149.99 41.49 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.47 -14.05 11.1 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.433 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.89 -8.74 36.33 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.404 ' OH ' HD12 ' A' ' 124' ' ' LEU . 25.8 t80 -53.92 145.83 30.91 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -91.4 12.11 55.99 Favored 'Cis proline' 0 N--CA 1.513 2.668 0 CA-C-N 120.682 1.279 . . . . 0.0 115.187 0.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -73.23 -12.97 61.05 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.724 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -121.23 129.53 25.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.068 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -49.38 138.18 30.6 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 CA-C-N 121.591 1.604 . . . . 0.0 111.844 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.48 144.05 15.7 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.056 1.837 . . . . 0.0 111.473 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mt -96.47 135.98 28.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 121.308 0.575 . . . . 0.0 110.118 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.428 ' SG ' HD12 ' A' ' 109' ' ' ILE . 48.9 t -111.99 149.29 32.2 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.611 -178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.85 126.53 30.69 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.623 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -84.95 123.5 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.81 108.48 2.71 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-O 119.05 -0.5 . . . . 0.0 109.901 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.77 155.89 7.47 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.619 1.546 . . . . 0.0 113.455 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 p -137.59 163.88 30.13 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.2 p -59.63 -26.77 65.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.863 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.7 p -90.74 -3.19 57.64 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.961 0.8 . . . . 0.0 111.244 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 41.4 ttm -124.11 142.05 51.53 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.23 159.16 35.17 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.836 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 85.8 mt -96.04 101.88 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -96.15 111.88 23.79 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.1 p -61.51 141.67 57.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.315 0.579 . . . . 0.0 111.392 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.37 -135.42 2.57 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.342 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -88.27 -3.33 58.87 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -138.4 -33.52 0.67 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.218 0.917 . . . . 0.0 112.446 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.62 138.59 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.375 0.989 . . . . 0.0 110.429 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -96.17 -161.51 0.87 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.375 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.91 -35.82 23.79 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.681 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -83.16 -1.79 53.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.546 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.07 8.51 47.53 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.504 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -62.51 137.49 58.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.365 0.583 . . . . 0.0 111.033 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.428 HD12 ' SG ' ' A' ' 87' ' ' CYS . 60.2 mt -114.63 113.22 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.442 ' CZ ' ' HA ' ' A' ' 102' ' ' HIS . 53.3 p90 -113.46 139.82 48.61 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 177.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.427 HD11 HG22 ' A' ' 109' ' ' ILE . 1.3 mp -133.15 130.55 21.35 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.462 -176.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -46.35 -39.91 22.0 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 121.664 1.576 . . . . 0.0 114.277 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -62.97 -31.3 72.39 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.863 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.08 -42.48 76.14 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.632 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.08 -28.49 66.56 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.026 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -95.46 -6.15 41.39 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.446 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -57.85 126.99 29.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.912 0.863 . . . . 0.0 110.656 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -104.63 102.96 12.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.98 -1.464 . . . . 0.0 108.435 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 60.5 t60 -60.88 123.91 77.26 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.038 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 5.8 Cg_endo -108.27 91.9 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 120.704 1.287 . . . . 0.0 113.211 -2.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -112.98 -60.59 1.86 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.423 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.0 t -67.48 -41.83 83.93 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.53 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 69.67 159.22 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.04 0.448 . . . . 0.0 111.634 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 124' ' ' LEU . 5.0 tt -59.99 -44.68 94.36 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 63.0 tp -53.8 -33.04 54.83 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.45 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -63.6 -40.67 98.9 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.2 tp -60.69 -39.68 89.37 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.93 -44.08 24.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.903 -177.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.476 ' NE2' HG21 ' A' ' 132' ' ' ILE . 45.1 tp60 -68.68 -37.0 79.26 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 126' ' ' GLY . 64.9 t -68.11 -42.93 85.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 C-N-CA 118.992 -1.083 . . . . 0.0 108.518 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.5 ttm -55.97 -44.89 78.96 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.476 HG21 ' NE2' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -54.81 -32.26 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.043 178.43 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.409 HG23 HG22 ' A' ' 132' ' ' ILE . 63.0 t -94.46 -48.98 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 119.556 -0.857 . . . . 0.0 113.118 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.4 p -80.33 -11.11 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -93.52 -13.22 28.06 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.427 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -95.23 -5.2 60.76 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -65.99 -36.05 82.25 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.214 0.507 . . . . 0.0 110.428 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -157.26 82.79 3.07 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -44.82 106.58 0.09 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.563 1.508 . . . . 0.0 111.365 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.03 -12.0 31.54 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.835 1.69 . . . . 0.0 111.282 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.15 146.94 32.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.869 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -160.05 160.41 33.15 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.521 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.2 m -89.5 121.52 31.79 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.897 0.379 . . . . 0.0 110.454 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -112.08 121.74 38.65 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.781 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo . . . . . 0 N--CA 1.497 1.684 0 C-N-CA 121.703 1.602 . . . . 0.0 112.158 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.4 p -60.42 140.33 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.561 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -101.77 156.61 17.4 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.509 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 94.5 mt-10 -62.71 -41.38 99.12 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.235 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 t -60.17 -46.17 90.6 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.941 0.876 . . . . 0.0 109.327 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -65.78 -28.4 68.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.059 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.985 HD23 HG13 ' A' ' 22' ' ' VAL . 59.3 tp -61.83 -39.61 92.42 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -65.42 -40.72 93.68 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.987 178.276 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.96 -37.15 81.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.47 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.567 ' SD ' HD12 ' A' ' 8' ' ' LEU . 19.8 ptp -76.14 -11.47 59.94 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.547 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 8' ' ' LEU . 10.2 m -142.35 31.71 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.459 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.5 p -72.01 -24.7 61.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.225 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.96 -13.51 55.86 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.792 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.0 151.49 26.21 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.972 0.415 . . . . 0.0 110.744 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -70.51 -37.49 74.15 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 21.3 m-85 -114.66 65.68 0.68 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.3 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.522 ' O ' HG23 ' A' ' 22' ' ' VAL . 15.9 ptt180 -64.91 -34.11 77.61 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.57 -42.08 83.15 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.85 -38.79 61.89 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.825 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 25' ' ' THR . 66.1 m -61.68 -43.27 99.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.408 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.985 HG13 HD23 ' A' ' 8' ' ' LEU . 79.5 t -72.7 -46.14 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.176 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -42.09 97.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.345 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.7 pp20? -69.1 -30.99 69.41 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.706 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.66 ' O ' HG23 ' A' ' 29' ' ' ILE . 24.0 p -70.39 -39.36 74.56 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.969 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 30' ' ' THR . 55.4 t -56.29 -45.57 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -39.5 91.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 24' ' ' GLU . 63.9 t -66.17 -43.59 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -83.8 -13.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.412 -178.594 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 26' ' ' VAL . 7.9 p -82.99 -51.04 7.93 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.419 0.628 . . . . 0.0 109.786 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.2 tp -81.38 -37.67 27.82 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.466 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.92 68.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -58.63 -19.85 42.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.825 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.11 -21.12 66.76 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.244 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.481 ' CD2' HD13 ' A' ' 55' ' ' LEU . 2.8 tp -93.16 113.96 26.34 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -109.94 126.97 27.91 Favored Pre-proline 0 C--N 1.356 0.866 0 CA-C-N 119.385 0.993 . . . . 0.0 112.157 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.94 134.68 10.77 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.553 1.502 . . . . 0.0 112.88 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.4 t -124.07 135.33 63.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.504 HD13 ' CB ' ' A' ' 11' ' ' MET . 21.6 tp -82.84 118.32 23.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.6 136.23 53.04 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.787 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.1 p -84.35 119.11 24.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -99.83 136.37 39.84 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.283 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.8 t -111.48 123.61 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.512 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -101.56 165.19 11.37 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.424 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -60.2 -36.88 78.65 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.631 0.253 . . . . 0.0 111.317 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.83 -18.47 62.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.482 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.96 -8.96 61.46 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.5 t -73.86 146.88 43.77 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.122 0.486 . . . . 0.0 110.31 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 98.1 p -104.85 155.99 18.42 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.539 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.06 135.96 13.71 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.537 0.684 . . . . 0.0 110.529 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -79.56 106.52 11.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.027 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tp -116.54 121.45 41.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -91.77 136.38 33.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.643 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -127.32 150.82 49.42 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.887 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.481 HD13 ' CD2' ' A' ' 35' ' ' LEU . 8.0 mt -99.73 123.05 43.6 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.5 m -133.7 137.14 45.13 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.76 -149.37 13.73 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.738 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.413 HG21 ' OD1' ' A' ' 69' ' ' ASN . 19.6 p -133.98 159.77 39.74 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.443 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.3 pt -134.22 116.3 13.16 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.998 177.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.5 126.93 10.63 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 120.908 1.072 . . . . 0.0 110.394 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.63 118.56 15.75 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.369 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.62 149.7 90.23 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.282 1.988 . . . . 0.0 110.257 177.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -162.7 107.51 1.14 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.201 0.524 . . . . 0.0 111.686 -178.293 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 52.3 38.82 25.9 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.105 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.61 81.78 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -122.14 131.63 54.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.9 m -113.02 130.97 55.95 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.847 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -112.97 150.49 31.8 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.871 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.413 ' OD1' HG21 ' A' ' 58' ' ' THR . 5.3 t-20 -95.15 104.4 16.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.426 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -88.55 115.3 62.97 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -86.46 125.74 2.55 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.965 2.443 . . . . 0.0 110.958 177.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.426 HG23 HG22 ' A' ' 70' ' ' ILE . 31.9 pt -133.81 148.6 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.758 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 54.0 m -121.7 122.05 38.69 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.999 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.89 115.9 31.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.147 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -107.52 127.1 53.32 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.5 mt -94.56 135.69 35.72 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.207 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mt -79.76 151.23 30.49 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -61.49 -13.01 17.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.122 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.61 0.46 39.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.138 0.494 . . . . 0.0 111.397 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -55.93 146.24 49.52 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -93.51 7.83 56.48 Favored 'Cis proline' 0 N--CA 1.509 2.388 0 CA-C-N 120.765 1.309 . . . . 0.0 114.042 1.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.445 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 7.2 m-85 -70.3 -18.77 63.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.75 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.93 137.77 19.89 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.31 140.95 66.4 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 CA-C-N 121.531 1.583 . . . . 0.0 111.196 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.21 142.86 12.32 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.236 1.958 . . . . 0.0 112.242 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.18 130.66 41.91 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.014 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.4 t -113.52 137.73 51.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.285 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -123.08 127.13 48.31 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.531 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.58 121.96 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -63.11 108.43 1.73 Allowed Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 119.161 -0.447 . . . . 0.0 110.021 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -84.23 160.7 13.27 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 121.627 1.551 . . . . 0.0 113.04 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.8 p -142.54 165.1 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.789 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.6 p -58.21 -35.22 71.33 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.153 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 t -88.3 -22.28 23.97 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.748 -0.595 . . . . 0.0 110.814 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 41.1 tpp -89.12 135.87 33.33 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.968 0.413 . . . . 0.0 110.192 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 84.0 m -125.61 141.22 52.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.594 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.6 mt -90.05 105.82 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -89.6 102.78 15.46 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 104' ' ' ASP . 69.1 p -64.44 152.46 41.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.28 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.44 -137.43 2.28 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.154 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -65.3 -23.98 67.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.519 ' NE2' HG23 ' A' ' 103' ' ' VAL . 10.5 p-80 -136.22 -16.85 1.61 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.719 HG21 ' HB2' ' A' ' 140' ' ' PRO . 6.8 t -100.32 132.09 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.508 1.049 . . . . 0.0 111.15 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.435 ' O ' HG22 ' A' ' 99' ' ' THR . 15.9 p-10 -93.21 -160.99 0.8 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.56 -21.26 25.51 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -89.72 -9.49 49.22 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.924 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.96 12.23 30.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.683 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -66.4 139.09 57.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.387 0.593 . . . . 0.0 109.952 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.5 mt -113.57 118.61 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.48 0.488 . . . . 0.0 111.752 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -102.49 140.13 37.18 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.667 HD22 HG11 ' A' ' 134' ' ' VAL . 27.8 mt -138.35 120.22 10.53 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.779 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.33 -38.95 27.28 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.357 1.371 . . . . 0.0 113.465 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -30.63 71.63 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.491 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.33 -41.17 73.57 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -69.44 -22.77 63.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.167 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -112.63 9.75 19.38 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.97 178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.0 t90 -76.93 123.45 26.31 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.944 0.878 . . . . 0.0 109.729 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -93.72 124.91 38.03 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.821 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 27.1 t-80 -79.37 125.82 82.37 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.651 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 12.2 Cg_endo -108.32 92.84 0.04 OUTLIER 'Cis proline' 0 N--CA 1.497 1.717 0 CA-C-N 120.774 1.312 . . . . 0.0 112.529 -2.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -114.32 -61.75 1.7 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.361 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.3 t -68.51 -31.96 71.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.905 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 48.49 -178.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.811 0.815 . . . . 0.0 111.806 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.432 HD22 HG21 ' A' ' 28' ' ' VAL . 4.8 tt -68.36 -40.28 81.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.747 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.465 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -54.28 -40.99 68.37 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.514 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.39 -39.46 97.79 Favored Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.6 tp -58.69 -41.38 86.11 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.437 HD12 HD13 ' A' ' 35' ' ' LEU . 1.2 mm -72.85 -48.88 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 119.884 -0.727 . . . . 0.0 112.063 -176.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.536 ' NE2' HG21 ' A' ' 132' ' ' ILE . 59.6 tp60 -66.41 -35.59 80.68 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 126' ' ' GLY . 53.4 t -68.47 -38.19 78.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.735 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 60.8 tpp -58.8 -42.49 89.22 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.536 HG21 ' NE2' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -61.71 -34.81 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.912 179.467 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.8 t -90.83 -45.12 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.667 HG11 HD22 ' A' ' 111' ' ' LEU . 6.2 p -66.05 -15.63 19.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.88 -177.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.414 ' CD2' HG13 ' A' ' 134' ' ' VAL . 12.0 m-30 -104.41 -19.23 14.12 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.196 177.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.72 -36.99 93.03 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.5 -40.54 95.85 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.133 -0.533 . . . . 0.0 110.9 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -153.45 84.62 4.27 Favored Pre-proline 0 CA--C 1.52 -0.199 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -48.3 120.35 4.94 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.983 1.122 . . . . 0.0 110.138 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.719 ' HB2' HG21 ' A' ' 103' ' ' VAL . 47.6 Cg_endo -70.93 -21.29 28.24 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.493 1.462 . . . . 0.0 111.887 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.33 140.88 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.154 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -158.89 165.49 34.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.395 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.13 112.09 12.22 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 120.831 0.348 . . . . 0.0 110.821 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -111.96 115.3 50.8 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.639 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo . . . . . 0 N--CA 1.497 1.708 0 C-N-CA 121.679 1.586 . . . . 0.0 112.072 179.745 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t -105.29 130.04 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.481 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.78 155.07 17.9 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.49 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 92.2 mt-10 -61.38 -43.19 99.29 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.254 -0.979 . . . . 0.0 112.017 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 t -58.47 -46.16 87.18 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.935 0.874 . . . . 0.0 108.984 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -62.9 -36.54 83.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.357 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.924 HD23 HG13 ' A' ' 22' ' ' VAL . 41.8 tp -55.73 -43.45 76.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.533 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.0 mptp? -61.3 -42.88 99.39 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.309 0.576 . . . . 0.0 109.528 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -61.1 -36.52 79.92 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.332 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.789 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -70.88 -37.72 73.03 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.723 -178.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 8' ' ' LEU . 3.3 m -112.12 24.37 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.736 0.303 . . . . 0.0 110.879 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.2 t -62.39 -37.87 87.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.022 0.439 . . . . 0.0 110.963 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -60.12 -21.91 62.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.601 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -63.88 157.57 24.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.112 0.482 . . . . 0.0 111.662 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.88 -37.9 54.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.621 177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 14.8 m-85 -113.94 64.61 0.66 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.356 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -61.79 -25.64 67.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -76.59 -51.97 10.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.04 -39.94 90.57 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.307 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.9 m -60.55 -47.56 85.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.166 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.924 HG13 HD23 ' A' ' 8' ' ' LEU . 12.6 t -66.24 -45.1 90.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.54 -41.92 98.06 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.485 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -67.51 -35.3 78.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 29' ' ' ILE . 22.2 p -67.65 -37.6 82.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.63 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 30' ' ' THR . 53.9 t -57.29 -45.61 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -37.63 80.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.5 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.692 HG21 HD22 ' A' ' 124' ' ' LEU . 54.7 t -68.89 -46.55 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -81.11 -13.76 12.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.169 -178.424 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.6 p -76.36 -50.96 12.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.045 0.45 . . . . 0.0 109.864 177.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.485 HD23 HD11 ' A' ' 125' ' ' LEU . 48.9 tp -82.37 -37.57 25.43 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.34 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -112.08 66.67 0.64 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm -55.59 -17.21 5.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.465 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -69.07 -15.19 63.39 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.176 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.477 ' CD2' HD13 ' A' ' 55' ' ' LEU . 2.6 tp -94.4 113.22 25.06 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -110.11 124.29 33.83 Favored Pre-proline 0 C--N 1.356 0.89 0 CA-C-N 119.474 1.034 . . . . 0.0 111.978 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.53 136.37 9.73 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 121.697 1.598 . . . . 0.0 113.202 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.04 156.34 42.68 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 110.397 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.789 HD13 ' SD ' ' A' ' 11' ' ' MET . 13.7 tp -92.28 118.69 31.14 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -124.43 132.81 53.51 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.321 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.8 p -76.86 137.38 39.14 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.81 136.34 54.05 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.962 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.6 t -114.85 127.01 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.048 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -105.99 168.44 9.13 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.852 0.358 . . . . 0.0 111.264 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -60.47 -37.29 80.55 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.937 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -63.34 -11.88 25.79 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.753 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.93 -13.06 67.87 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.6 t -74.45 145.87 43.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.5 p -128.52 153.65 46.96 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.904 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -152.58 137.95 17.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.542 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.83 118.81 19.03 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.303 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 mt -121.48 140.7 51.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.557 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -96.92 137.71 35.59 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.322 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -130.49 151.2 51.23 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.457 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.477 HD13 ' CD2' ' A' ' 35' ' ' LEU . 5.4 mt -95.09 126.7 40.6 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.9 m -137.69 136.38 37.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.74 -147.11 11.55 Favored Glycine 0 N--CA 1.466 0.65 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.655 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.1 p -132.49 158.09 42.96 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -129.9 117.03 18.14 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.092 177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -72.23 123.49 9.24 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 119.947 1.017 . . . . 0.0 110.099 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.0 t -123.67 113.12 28.91 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.631 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.84 147.53 89.53 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.228 1.952 . . . . 0.0 109.695 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -163.57 107.4 1.01 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.63 -178.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.51 43.35 27.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.068 0.461 . . . . 0.0 111.557 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.01 14.76 76.2 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -134.69 125.6 27.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.2 m -113.26 131.18 56.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.997 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -112.59 149.23 33.06 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.466 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -95.79 100.08 11.83 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.523 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -87.6 117.69 68.85 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.314 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.81 123.81 2.9 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.453 2.102 . . . . 0.0 110.415 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.523 HG23 HG22 ' A' ' 70' ' ' ILE . 21.3 pt -131.6 147.12 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.349 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 67.4 m -121.08 123.12 41.57 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.205 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.33 109.62 21.31 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.144 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -99.49 125.35 45.22 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.01 140.85 29.04 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.257 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -84.18 155.11 22.7 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -62.53 -17.19 59.27 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.908 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.25 3.51 40.95 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.986 0.422 . . . . 0.0 111.718 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -59.16 145.37 81.03 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -91.59 8.64 62.81 Favored 'Cis proline' 0 N--CA 1.519 2.99 0 CA-C-N 121.019 1.4 . . . . 0.0 115.246 1.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.414 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 22.6 m-85 -74.46 -13.02 60.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.436 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.2 129.56 24.45 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.564 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -49.67 134.34 33.65 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 CA-C-N 121.205 1.466 . . . . 0.0 112.169 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.15 146.16 17.73 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.037 1.825 . . . . 0.0 111.886 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.446 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -95.49 151.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.79 -179.596 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.451 ' SG ' HD12 ' A' ' 109' ' ' ILE . 50.1 t -134.78 142.07 46.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.665 -178.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -127.09 131.21 50.91 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.086 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.408 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 57.6 t -97.44 123.62 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -76.37 106.26 3.09 Favored Pre-proline 0 N--CA 1.476 0.87 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.56 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 48.5 Cg_endo -90.61 128.66 1.42 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 CA-C-N 121.146 1.445 . . . . 0.0 113.548 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.5 p -81.15 168.95 17.99 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 88.1 p -59.27 -22.53 61.31 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 t -106.55 22.17 16.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.871 0.76 . . . . 0.0 110.946 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 42.5 ttm -133.52 144.73 49.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.43 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -131.22 163.71 27.16 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.864 179.526 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.43 ' N ' HG23 ' A' ' 96' ' ' THR . 5.7 mm -89.35 103.37 13.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.484 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -89.0 110.09 20.83 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.5 p -68.19 138.28 55.49 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.341 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.36 -141.82 3.54 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.249 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -70.84 -23.93 62.43 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.418 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 38.4 p-80 -130.4 -16.79 3.43 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.434 HG21 ' HB2' ' A' ' 140' ' ' PRO . 2.2 t -91.72 137.27 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.855 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -93.71 175.78 6.61 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.56 -39.07 93.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -91.15 4.78 51.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.11 10.27 49.28 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.99 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -67.82 140.96 56.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.451 HD12 ' SG ' ' A' ' 87' ' ' CYS . 62.7 mt -118.35 116.44 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.872 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.408 ' CE2' ' HA ' ' A' ' 102' ' ' HIS . 0.5 OUTLIER -116.88 142.94 46.28 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.569 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.637 HD23 HG11 ' A' ' 134' ' ' VAL . 1.8 mp -133.7 131.41 21.18 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.79 -177.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.1 -32.62 40.2 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 121.154 1.236 . . . . 0.0 113.693 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -65.76 -30.44 71.09 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.509 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.92 -41.45 74.63 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.229 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -67.94 -28.03 67.12 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.227 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -102.35 0.56 34.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.338 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.412 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.7 t90 -69.37 124.16 23.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.959 0.885 . . . . 0.0 109.985 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -95.34 125.0 39.67 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.158 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -76.7 125.64 86.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.409 -179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -108.85 92.03 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.65 0 CA-C-N 120.937 1.37 . . . . 0.0 112.36 -2.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -114.12 -61.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.936 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.1 t -66.64 -40.75 88.84 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.794 0.331 . . . . 0.0 111.277 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 59.07 168.15 0.06 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.787 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.692 HD22 HG21 ' A' ' 28' ' ' VAL . 6.7 tt -60.04 -42.1 93.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.69 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 125' ' ' LEU . 5.0 tt -52.63 -37.64 58.76 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.488 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.36 -39.31 97.08 Favored Glycine 0 N--CA 1.477 1.37 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.7 tp -60.51 -40.25 90.73 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -75.57 -48.85 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.644 -176.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.547 ' NE2' HG21 ' A' ' 132' ' ' ILE . 58.6 tp60 -67.01 -35.48 80.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.616 ' O ' HG12 ' A' ' 134' ' ' VAL . 60.0 t -69.12 -39.7 79.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.414 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 51.7 ttm -57.85 -44.73 86.75 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.547 HG21 ' NE2' ' A' ' 129' ' ' GLN . 1.1 mp -61.0 -36.42 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.792 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -88.77 -47.27 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.637 HG11 HD23 ' A' ' 111' ' ' LEU . 5.4 p -66.75 -13.79 16.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.197 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.622 ' CD2' HG13 ' A' ' 134' ' ' VAL . 9.8 m-30 -101.83 -17.08 16.37 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.441 177.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.22 -26.74 71.74 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.96 -31.76 72.85 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.199 -0.501 . . . . 0.0 110.547 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -166.58 84.43 0.91 Allowed Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.257 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -46.6 121.83 5.2 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.225 1.283 . . . . 0.0 109.844 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.434 ' HB2' HG21 ' A' ' 103' ' ' VAL . 47.6 Cg_endo -70.13 -14.93 35.51 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.458 1.439 . . . . 0.0 112.427 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 m -131.42 151.2 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.245 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -154.36 160.56 41.76 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.1 112.42 19.14 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.911 0.386 . . . . 0.0 111.184 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -112.35 108.69 54.49 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.863 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo . . . . . 0 N--CA 1.498 1.77 0 C-N-CA 122.036 1.824 . . . . 0.0 112.647 -179.854 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.22 129.9 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.581 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.34 155.13 17.03 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 92.3 mt-10 -62.16 -41.08 97.95 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -57.1 -48.45 78.58 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.054 0.93 . . . . 0.0 109.398 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -64.05 -30.8 71.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.518 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.866 HD23 HG13 ' A' ' 22' ' ' VAL . 13.3 tp -59.14 -39.07 81.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.764 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 12.0 mptt -59.56 -42.79 93.25 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.669 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.71 -25.48 64.79 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.996 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.728 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -80.92 -28.92 35.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.893 -178.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -116.6 23.83 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 120.903 0.382 . . . . 0.0 110.489 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 t -67.06 -39.04 86.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.153 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -62.03 -17.72 58.25 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.823 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.486 ' CE1' HG12 ' A' ' 12' ' ' VAL . 22.6 m-85 -69.6 158.87 34.47 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.478 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -88.86 -9.86 50.11 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.91 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -132.88 56.12 1.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 119.532 -0.271 . . . . 0.0 110.302 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.425 ' O ' HG23 ' A' ' 22' ' ' VAL . 15.5 ptt180 -61.11 -32.43 72.11 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -177.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.33 -50.86 64.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.92 -41.96 73.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.099 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.2 m -61.51 -47.08 87.26 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 121.161 -0.216 . . . . 0.0 111.238 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.866 HG13 HD23 ' A' ' 8' ' ' LEU . 37.4 t -61.04 -46.51 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -60.32 -45.1 94.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.805 0.812 . . . . 0.0 110.586 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -68.23 -34.43 76.22 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.506 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.599 ' O ' HG23 ' A' ' 29' ' ' ILE . 5.6 p -67.81 -33.66 75.23 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.408 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.57 -44.96 94.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 C-N-CA 118.951 -1.1 . . . . 0.0 108.167 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -60.87 -37.32 81.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.011 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.2 t -68.83 -45.63 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.88 -17.25 8.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.702 -178.385 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -76.8 -49.87 14.83 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.183 0.516 . . . . 0.0 109.709 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.819 HD23 HD21 ' A' ' 125' ' ' LEU . 38.9 tp -76.61 -39.91 51.03 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.643 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -113.85 67.77 0.68 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -53.75 -20.34 5.45 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.522 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -65.69 -21.33 66.53 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.57 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.1 tp -89.64 117.59 28.63 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -115.05 126.52 27.75 Favored Pre-proline 0 C--N 1.356 0.879 0 CA-C-N 119.618 1.099 . . . . 0.0 111.916 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.51 135.1 14.41 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 CA-C-N 120.379 1.171 . . . . 0.0 112.232 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.17 136.64 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.728 HD13 ' SD ' ' A' ' 11' ' ' MET . 16.9 tp -85.15 116.32 23.45 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.529 ' HB2' HD22 ' A' ' 54' ' ' ASN . 99.9 m-20 -119.48 133.69 55.57 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.107 0.479 . . . . 0.0 111.76 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.2 m -68.24 138.74 55.8 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -122.0 135.72 54.86 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.532 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.5 t -114.26 127.77 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.724 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -105.17 165.71 10.91 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.338 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.0 p-10 -65.64 -15.45 62.78 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -80.07 -10.38 59.76 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.798 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.42 -8.85 78.96 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.8 m -80.92 157.97 25.41 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.8 p -119.38 151.53 38.34 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.524 0.678 . . . . 0.0 111.448 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 -152.97 131.69 12.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.089 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.58 118.7 19.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.029 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.577 HD21 ' O ' ' A' ' 76' ' ' LEU . 19.6 tp -116.99 121.03 40.21 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.2 ttp -84.62 142.91 29.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.025 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.529 HD22 ' HB2' ' A' ' 40' ' ' ASP . 4.8 m-20 -133.51 162.15 32.67 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.384 -178.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 55' ' ' LEU . 3.4 mm? -108.5 123.39 48.82 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.9 m -140.6 139.07 34.85 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.0 -148.59 14.93 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.187 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.6 p -132.67 161.02 35.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.822 -0.689 . . . . 0.0 112.334 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.416 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.4 pt -131.05 116.03 16.69 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.995 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.17 126.23 9.73 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 CA-C-N 119.689 0.925 . . . . 0.0 109.945 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.0 129.84 21.94 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.795 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.94 150.03 48.23 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.388 2.059 . . . . 0.0 110.876 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -163.97 112.04 1.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.971 0.415 . . . . 0.0 111.955 -178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? 49.88 44.52 25.24 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.448 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.81 18.38 68.36 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -137.6 127.11 25.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.5 m -111.44 130.78 55.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.455 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -112.67 150.81 30.95 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.734 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -94.61 105.04 16.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.495 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -90.67 116.57 66.71 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.47 124.62 3.68 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.196 1.93 . . . . 0.0 110.849 177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.495 HG23 HG22 ' A' ' 70' ' ' ILE . 26.7 pt -132.32 148.0 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.958 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.0 t -125.76 120.19 29.94 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.37 116.94 33.37 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.56 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.552 ' HE3' HD23 ' A' ' 52' ' ' LEU . 46.9 m95 -105.48 118.36 36.38 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.577 ' O ' HD21 ' A' ' 52' ' ' LEU . 59.0 mt -88.11 135.9 33.22 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.611 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -85.2 150.42 24.82 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.744 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -59.64 -15.32 18.24 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.315 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 p -100.75 7.77 43.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.541 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -66.46 144.05 98.49 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -92.08 3.88 63.09 Favored 'Cis proline' 0 N--CA 1.518 2.962 0 N-CA-C 116.13 1.55 . . . . 0.0 116.13 1.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -73.77 -17.12 61.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.467 1.031 . . . . 0.0 109.922 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -107.52 131.16 21.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.51 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -59.54 131.02 38.13 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 CA-C-N 121.319 1.507 . . . . 0.0 112.28 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.15 145.23 12.17 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.371 2.047 . . . . 0.0 111.545 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.9 129.89 48.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.0 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . 0.461 ' SG ' HD12 ' A' ' 109' ' ' ILE . 42.7 t -110.82 144.08 40.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.627 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -126.53 127.4 45.25 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.438 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.53 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 71.7 t -82.44 137.36 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -93.87 96.12 1.55 Allowed Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.135 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 97.7 Cg_endo -78.9 160.98 27.25 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 C-N-CA 121.711 1.607 . . . . 0.0 112.794 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.407 HG22 ' HB2' ' A' ' 95' ' ' MET . 5.5 t -148.37 167.22 25.81 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.661 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.9 p -58.46 -27.59 64.52 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 62.6 m -94.06 6.54 48.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.974 0.806 . . . . 0.0 110.972 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.407 ' HB2' HG22 ' A' ' 92' ' ' THR . 82.8 mmm -130.99 144.1 51.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.3 m -121.44 145.04 48.33 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.568 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 97' ' ' ILE . 12.2 tt -113.25 122.22 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.32 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.65 98.22 6.91 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.1 p -55.23 140.72 37.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.695 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.11 -142.2 3.33 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.431 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -65.46 -25.49 67.53 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -119.03 -30.29 5.04 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 119.322 0.965 . . . . 0.0 113.207 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.4 t -96.4 134.21 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.313 0.961 . . . . 0.0 110.925 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -98.68 160.47 14.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.287 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.12 85.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.053 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.31 -7.14 34.47 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.119 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.85 8.01 58.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.747 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.61 151.53 34.32 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.153 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.461 HD12 ' SG ' ' A' ' 87' ' ' CYS . 76.2 mt -109.18 122.03 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.481 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.44 ' HH ' ' CE1' ' A' ' 115' ' ' HIS . 0.9 OUTLIER -99.64 130.96 45.91 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.449 HD22 HG11 ' A' ' 134' ' ' VAL . 16.1 mt -134.33 108.37 11.27 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.89 -177.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -48.52 -34.26 25.73 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.971 1.781 . . . . 0.0 114.475 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -62.29 -29.24 70.29 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.337 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.58 -41.09 80.16 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.422 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.44 ' CE1' ' HH ' ' A' ' 110' ' ' TYR . 2.0 m-70 -65.81 -31.67 72.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.459 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -96.65 -8.4 31.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.336 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -54.1 124.83 16.82 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.898 0.856 . . . . 0.0 109.967 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -107.69 106.26 16.51 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.739 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 34.1 t-80 -58.23 123.55 66.09 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.721 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 20.3 Cg_endo -109.63 91.74 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.549 0 CA-C-N 120.707 1.288 . . . . 0.0 112.496 -3.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -113.88 -62.66 1.56 Allowed 'General case' 0 C--O 1.232 0.149 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.4 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.8 m -67.8 -41.04 83.75 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.136 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 60.62 163.5 0.06 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.527 0.679 . . . . 0.0 111.53 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.8 tt -60.24 -45.91 91.6 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.246 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.819 HD21 HD23 ' A' ' 31' ' ' LEU . 13.6 tp -54.68 -33.65 61.16 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -64.41 -40.54 97.86 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 tp -58.01 -40.0 79.71 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -75.73 -47.16 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.745 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.427 ' OE1' HG21 ' A' ' 132' ' ' ILE . 7.6 tp-100 -66.73 -35.74 80.82 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 126' ' ' GLY . 54.5 t -67.19 -38.38 80.95 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.1 tpp -58.66 -44.06 90.02 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.427 HG21 ' OE1' ' A' ' 129' ' ' GLN . 0.9 OUTLIER -62.8 -35.05 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.744 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -86.3 -47.27 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.774 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.449 HG11 HD22 ' A' ' 111' ' ' LEU . 3.8 p -69.58 -13.68 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.221 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.404 ' HD1' HG13 ' A' ' 134' ' ' VAL . 4.2 m-30 -103.58 -16.34 15.55 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.646 177.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -84.58 -23.76 49.17 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -66.44 -29.22 69.3 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.349 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -161.55 84.25 1.76 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.704 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -45.38 108.16 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.324 1.349 . . . . 0.0 110.925 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.11 -17.87 35.73 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.652 1.568 . . . . 0.0 110.982 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.28 138.41 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.458 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -160.35 160.59 32.56 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.577 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.6 m -93.11 129.5 39.06 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.961 0.41 . . . . 0.0 110.436 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 45.9 ttm-85 -112.97 103.46 55.67 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.06 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 N--CA 1.489 1.226 0 C-N-CA 121.875 1.717 . . . . 0.0 111.924 179.623 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.1 t -105.29 128.57 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.203 0.525 . . . . 0.0 110.617 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 t -98.28 153.98 18.13 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.55 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 37.2 mp0 -60.13 -42.6 95.16 Favored 'General case' 0 C--O 1.214 -0.795 0 C-N-CA 118.43 -1.308 . . . . 0.0 110.947 -178.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.8 m -53.38 -45.94 69.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.825 0.822 . . . . 0.0 109.651 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -63.5 -38.06 89.67 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.601 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.912 HD23 HG13 ' A' ' 22' ' ' VAL . 15.4 tp -55.08 -42.07 72.34 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.55 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -59.67 -40.1 86.68 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.94 -32.43 70.7 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.05 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.831 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -73.55 -31.72 63.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.456 -178.566 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -115.36 20.76 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.687 0.28 . . . . 0.0 111.333 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -61.31 -37.94 85.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.365 0.602 . . . . 0.0 110.298 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -60.22 -21.15 61.46 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.612 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.417 ' OH ' HD22 ' A' ' 52' ' ' LEU . 37.0 m-85 -74.49 151.87 39.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.915 0.388 . . . . 0.0 111.889 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -70.93 -37.15 72.88 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.985 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.401 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 39.1 m-85 -109.14 60.84 0.6 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 121.25 -0.18 . . . . 0.0 111.448 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.0 ptp180 -67.37 -24.74 65.73 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -75.12 -50.0 17.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.93 -40.14 83.38 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.647 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.5 m -61.2 -46.73 89.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.247 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.912 HG13 HD23 ' A' ' 8' ' ' LEU . 41.5 t -61.85 -44.4 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-O 120.821 0.343 . . . . 0.0 110.155 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -62.93 -41.6 99.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.209 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -66.42 -37.73 85.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.676 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.646 ' O ' HG23 ' A' ' 29' ' ' ILE . 38.7 p -66.19 -37.13 84.86 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.299 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.18 -45.08 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 C-N-CA 118.849 -1.14 . . . . 0.0 108.506 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 58.5 m-20 -61.28 -37.83 84.57 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.251 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.57 HG21 HD22 ' A' ' 124' ' ' LEU . 79.9 t -71.27 -43.41 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.05 -23.1 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.386 -178.035 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.1 m -72.19 -44.5 62.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.046 0.451 . . . . 0.0 110.264 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.738 HD23 HD11 ' A' ' 125' ' ' LEU . 23.9 tp -88.73 -40.68 13.06 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.417 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.55 67.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -56.83 -17.19 8.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.029 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -66.08 -14.6 62.02 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.59 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 tp -102.42 113.03 26.02 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -110.07 137.12 20.45 Favored Pre-proline 0 C--N 1.36 1.024 0 CA-C-N 119.921 1.237 . . . . 0.0 112.182 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.13 139.92 10.89 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.004 1.803 . . . . 0.0 112.423 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.53 139.22 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.072 0.463 . . . . 0.0 109.794 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.831 HD13 ' SD ' ' A' ' 11' ' ' MET . 14.2 tp -83.74 122.41 28.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.175 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -129.7 140.61 51.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.981 0.42 . . . . 0.0 112.073 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.7 t -94.05 115.29 27.6 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.476 ' CD2' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -128.13 156.8 42.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.71 -178.202 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.7 t -100.37 124.44 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -72.67 166.72 22.25 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.778 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -60.89 -36.07 78.27 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.652 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.09 -18.22 63.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.224 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.97 -17.9 44.06 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.8 t -72.36 148.28 45.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 96.9 p -114.44 152.18 32.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.315 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -158.16 137.91 12.1 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.294 0.569 . . . . 0.0 111.389 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -67.62 118.51 10.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.395 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.476 HD12 ' CD2' ' A' ' 42' ' ' TYR . 14.9 mt -125.53 142.53 51.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.955 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 49.8 ttp -90.93 144.57 25.54 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.11 152.76 51.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.551 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.8 mt -104.41 117.89 35.29 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -132.32 136.79 47.13 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.26 -143.95 8.34 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.424 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 p -136.34 159.31 42.16 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.449 HD13 HG21 ' A' ' 59' ' ' ILE . 1.3 pt -131.27 116.03 16.43 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.031 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -72.32 125.85 11.13 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 120.867 1.044 . . . . 0.0 110.793 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.5 t -128.77 115.91 19.3 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.578 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.31 150.63 15.4 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 122.718 2.279 . . . . 0.0 112.224 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.02 115.05 1.32 Allowed 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.258 0.551 . . . . 0.0 111.229 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.95 39.44 22.84 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.862 -0.523 . . . . 0.0 112.119 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 0.79 90.05 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.139 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -119.89 128.78 53.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 109.896 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.2 m -119.26 132.04 55.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.502 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -115.75 150.88 36.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.916 0.388 . . . . 0.0 110.574 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -95.6 100.94 12.61 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.489 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -87.37 116.98 67.92 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.464 -177.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -82.29 126.27 4.82 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 122.718 2.279 . . . . 0.0 110.687 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.489 HG23 HG22 ' A' ' 70' ' ' ILE . 26.4 pt -133.35 147.96 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 118.943 -1.103 . . . . 0.0 112.502 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.6 m -121.89 123.42 41.69 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.365 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.07 109.92 21.89 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.42 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -96.08 128.98 43.46 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 mp -99.42 140.08 34.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.13 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tp -95.14 140.56 29.9 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.71 -17.1 0.09 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.17 12.43 37.01 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -69.08 143.41 94.21 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -91.68 4.51 64.91 Favored 'Cis proline' 0 N--CA 1.516 2.806 0 CA-C-N 120.928 1.367 . . . . 0.0 114.501 0.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.4 m-85 -67.73 -18.93 65.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.378 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.08 120.98 40.6 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.201 178.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -49.55 136.41 33.37 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 CA-C-N 121.235 1.477 . . . . 0.0 111.859 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.62 144.7 14.2 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.337 2.025 . . . . 0.0 111.277 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 mp -97.76 132.77 41.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-O 121.591 0.71 . . . . 0.0 109.789 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 33.8 t -106.41 154.86 20.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.529 -177.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.1 128.76 30.75 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.053 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.63 ' CG2' HD11 ' A' ' 109' ' ' ILE . 58.9 t -98.05 124.13 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -75.28 108.12 5.12 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.187 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -85.64 159.24 10.68 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.267 1.311 . . . . 0.0 112.454 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -129.24 164.86 22.55 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 m -58.6 -39.84 81.56 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.2 m -84.74 -0.68 54.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.85 0.75 . . . . 0.0 111.581 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 32.8 ttm -120.92 145.92 47.18 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -131.39 163.07 28.7 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.588 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.444 ' N ' HG23 ' A' ' 96' ' ' THR . 72.4 mt -95.8 103.59 14.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -87.32 113.52 23.12 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.149 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.5 p -68.52 147.74 51.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.256 0.55 . . . . 0.0 110.479 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.87 -145.16 4.28 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -79.47 -7.53 58.5 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -133.11 -30.46 1.34 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.14 0.882 . . . . 0.0 112.297 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.2 t -97.03 139.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.48 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -94.83 -174.61 3.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.661 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.32 -35.03 21.72 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -83.86 5.46 25.14 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.957 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.13 13.12 50.32 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.346 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -75.52 136.26 40.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.779 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.63 HD11 ' CG2' ' A' ' 89' ' ' VAL . 91.7 mt -110.8 114.98 48.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 140.86 49.2 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.624 HD23 HG11 ' A' ' 134' ' ' VAL . 1.6 mp -134.43 128.63 19.29 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.01 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -49.02 -35.16 31.49 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 121.388 1.392 . . . . 0.0 113.384 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -32.42 71.92 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.23 -41.93 76.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.273 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -63.68 -31.06 72.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.016 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -108.42 9.95 27.53 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.769 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -65.57 127.25 31.13 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.688 0.756 . . . . 0.0 110.439 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.39 122.17 43.75 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.453 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 12.8 t-80 -75.82 125.93 87.71 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.626 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 7.4 Cg_endo -109.85 91.27 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.718 0 CA-C-N 120.597 1.249 . . . . 0.0 112.626 -2.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -113.19 -59.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.538 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.403 ' O ' ' HA3' ' A' ' 126' ' ' GLY . 27.2 p -68.85 -34.74 75.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.138 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 p30 49.21 178.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.603 0.716 . . . . 0.0 111.613 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.57 HD22 HG21 ' A' ' 28' ' ' VAL . 1.5 tt -66.0 -40.59 91.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.379 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.738 HD11 HD23 ' A' ' 31' ' ' LEU . 2.9 tt -56.77 -40.36 75.73 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -60.86 -39.87 97.48 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.0 tp -58.69 -40.77 84.59 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 122.265 -0.55 . . . . 0.0 111.556 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -76.61 -48.89 25.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.096 -0.642 . . . . 0.0 112.314 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -66.71 -34.0 76.87 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.618 ' O ' HG12 ' A' ' 134' ' ' VAL . 58.5 t -68.6 -38.33 78.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 48.7 tpp -58.9 -44.1 91.14 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -61.64 -40.84 88.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.888 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -82.46 -47.86 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 120.002 -0.679 . . . . 0.0 112.543 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.624 HG11 HD23 ' A' ' 111' ' ' LEU . 4.2 p -66.75 -14.06 17.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.072 -178.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.472 ' CD1' HG13 ' A' ' 134' ' ' VAL . 11.8 m-30 -109.22 -18.43 13.61 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.91 88.52 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -63.66 -34.91 78.9 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-N 115.294 -0.453 . . . . 0.0 110.489 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -156.63 84.08 3.16 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.327 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -43.96 107.42 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.679 1.586 . . . . 0.0 111.018 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.03 -24.23 47.77 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.105 1.87 . . . . 0.0 111.578 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.6 m -128.33 147.33 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.565 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -160.47 158.63 29.67 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.542 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.08 107.94 5.7 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -111.04 109.99 56.9 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.885 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo . . . . . 0 N--CA 1.496 1.629 0 C-N-CA 122.08 1.853 . . . . 0.0 112.317 -179.859 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -103.26 129.5 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.15 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.82 153.56 18.79 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.541 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 95.3 mt-10 -61.72 -42.17 98.59 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.099 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.0 t -56.78 -46.49 81.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.19 0.995 . . . . 0.0 108.649 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -61.18 -39.07 88.8 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.144 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.784 HD23 HG13 ' A' ' 22' ' ' VAL . 27.6 tp -56.12 -42.19 76.47 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.6 mptp? -60.14 -40.65 90.57 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -28.19 67.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.69 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.653 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -80.39 -30.51 37.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.99 -178.296 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -118.61 19.71 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.577 0.227 . . . . 0.0 111.387 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -61.05 -38.1 84.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.53 0.681 . . . . 0.0 110.306 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -60.2 -26.06 66.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.122 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.686 ' OH ' HD22 ' A' ' 52' ' ' LEU . 40.3 m-85 -67.36 159.4 29.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.716 0.293 . . . . 0.0 110.941 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -80.33 -29.92 38.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.811 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -116.89 58.04 0.78 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -63.59 -28.51 69.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.3 -47.41 61.26 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.1 tp -70.27 -40.25 74.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.501 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 25' ' ' THR . 98.8 m -62.94 -46.14 89.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.784 HG13 HD23 ' A' ' 8' ' ' LEU . 14.4 t -63.28 -45.6 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 120.695 0.283 . . . . 0.0 110.991 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -63.14 -43.52 98.11 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.154 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -66.68 -37.43 84.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.995 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.667 ' O ' HG23 ' A' ' 29' ' ' ILE . 28.1 p -64.76 -36.94 85.94 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.976 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -57.32 -45.03 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -60.98 -40.41 93.34 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.998 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -68.0 -43.6 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.38 -23.77 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.217 -178.05 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.5 m -74.48 -44.54 51.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.009 0.433 . . . . 0.0 110.595 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.663 ' O ' HD13 ' A' ' 31' ' ' LEU . 2.8 tm? -85.32 -36.61 20.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.666 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.86 68.38 0.72 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -57.01 -19.39 18.12 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.539 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.81 -21.55 66.8 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.067 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.457 HD23 HD13 ' A' ' 55' ' ' LEU . 2.9 tp -90.24 113.32 25.11 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -108.98 125.12 32.3 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 119.439 1.018 . . . . 0.0 111.77 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.09 137.58 17.38 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.32 1.347 . . . . 0.0 112.102 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.18 143.99 37.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 120.968 0.414 . . . . 0.0 110.264 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.653 HD13 ' SD ' ' A' ' 11' ' ' MET . 17.5 tp -91.63 122.01 33.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.533 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -131.47 139.5 49.36 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.088 0.47 . . . . 0.0 111.965 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 t -68.82 136.22 52.37 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -121.06 138.16 54.31 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.163 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.8 t -111.12 126.1 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.221 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -95.38 161.48 14.06 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.625 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -68.24 -13.24 62.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -88.42 -4.39 58.65 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.22 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.32 -13.01 68.26 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.2 t -72.39 142.68 48.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.0 t -116.73 141.31 48.37 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.214 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -148.19 137.73 22.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.641 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -79.83 120.1 23.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.558 0.694 . . . . 0.0 110.623 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.686 HD22 ' OH ' ' A' ' 15' ' ' TYR . 39.8 mt -116.18 142.51 46.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.907 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -101.37 137.12 40.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.097 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -129.34 151.08 50.38 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.744 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.457 HD13 HD23 ' A' ' 35' ' ' LEU . 6.8 mt -95.16 122.34 37.73 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.2 m -133.65 136.02 44.52 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.81 -144.54 9.16 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.859 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -135.18 160.47 38.26 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.414 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.2 pt -129.32 116.14 18.62 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.924 177.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -73.55 124.24 9.2 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 120.661 0.907 . . . . 0.0 109.887 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.4 t -123.76 117.72 27.36 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.03 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.5 146.77 50.58 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.334 2.022 . . . . 0.0 110.753 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.404 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -162.88 108.97 1.17 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.514 -178.74 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.01 35.12 21.3 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 122.022 -0.424 . . . . 0.0 111.411 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.65 -2.74 77.69 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -113.57 135.1 54.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.6 m -120.28 132.27 55.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.034 0.445 . . . . 0.0 111.993 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -111.02 147.53 34.56 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.807 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -95.26 100.53 12.31 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.521 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -86.92 115.42 62.46 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.034 -177.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.38 123.37 3.87 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.874 2.383 . . . . 0.0 111.058 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.521 HG23 HG22 ' A' ' 70' ' ' ILE . 35.2 pt -136.49 149.12 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.935 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 53.7 m -123.92 122.42 37.91 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.568 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.4 HD22 HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -97.64 121.6 39.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.025 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -111.23 119.43 38.89 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.12 139.97 32.09 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.034 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' O ' ' HE2' ' A' ' 15' ' ' TYR . 2.8 mt -89.28 149.38 23.09 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -56.69 -16.58 6.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.619 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.0 5.41 43.1 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.156 0.503 . . . . 0.0 111.788 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -63.77 144.08 97.99 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -90.19 5.32 68.53 Favored 'Cis proline' 0 N--CA 1.514 2.693 0 CA-C-N 121.004 1.394 . . . . 0.0 115.227 1.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -70.07 -25.02 63.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.865 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.3 138.2 19.47 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.37 141.67 75.66 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 CA-C-N 121.767 1.667 . . . . 0.0 111.304 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -82.52 142.87 11.91 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.016 1.81 . . . . 0.0 111.878 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.55 135.34 28.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 42.2 t -112.09 139.93 47.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.839 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.1 124.98 44.31 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.943 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -84.41 144.48 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -98.29 98.21 5.48 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 119.221 -0.418 . . . . 0.0 110.318 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -80.79 160.18 21.5 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.256 1.304 . . . . 0.0 111.921 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 t -137.34 161.68 35.62 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.2 t -54.64 -39.37 67.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.177 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.6 t -76.64 -2.25 31.74 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.536 0.607 . . . . 0.0 111.956 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.3 mtp -130.13 145.47 51.7 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.443 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -126.73 163.35 23.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.596 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.443 ' N ' HG23 ' A' ' 96' ' ' THR . 3.3 mm -90.77 110.04 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.567 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -95.09 104.75 16.63 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 34.3 p -67.73 138.17 56.04 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.684 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.76 -133.64 1.93 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -86.09 -7.26 58.72 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -134.84 -23.09 1.59 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 140' ' ' PRO . 2.3 t -91.62 134.59 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 119.6 1.091 . . . . 0.0 110.635 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.428 ' O ' HG12 ' A' ' 103' ' ' VAL . 15.3 t0 -84.72 -168.29 2.14 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.59 -34.54 19.85 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.683 -0.636 . . . . 0.0 112.399 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -88.81 1.26 55.57 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.736 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.01 -8.43 38.89 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.465 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 131.67 23.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.243 0.522 . . . . 0.0 110.172 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.408 HG22 ' HG ' ' A' ' 111' ' ' LEU . 76.5 mt -97.67 121.5 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.928 0.395 . . . . 0.0 110.535 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.87 119.43 38.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.424 ' CD2' HG11 ' A' ' 134' ' ' VAL . 7.1 mt -126.57 113.42 22.91 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.59 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -48.42 -38.27 34.54 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 121.962 1.775 . . . . 0.0 114.25 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -63.82 -31.51 72.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.22 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.29 -42.23 79.78 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.793 0.33 . . . . 0.0 110.927 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -67.1 -29.26 68.96 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.687 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -104.36 7.15 35.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.229 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -71.6 127.25 31.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 122.033 0.92 . . . . 0.0 110.651 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -97.41 124.72 41.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.824 -1.534 . . . . 0.0 108.217 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -80.25 126.64 78.7 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 119.133 -0.46 . . . . 0.0 110.539 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -108.8 93.36 0.03 OUTLIER 'Cis proline' 0 N--CA 1.498 1.755 0 CA-C-N 120.631 1.261 . . . . 0.0 112.778 -2.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -113.69 -60.7 1.85 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.722 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.2 p -69.99 -31.8 69.67 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.0 p30 48.46 179.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.73 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 tt -66.88 -43.31 83.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.983 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.553 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -52.9 -40.69 63.73 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.341 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.1 -39.67 97.93 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.0 -41.38 87.53 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -75.41 -46.88 36.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 119.796 -0.761 . . . . 0.0 111.766 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -36.59 75.73 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.219 -0.992 . . . . 0.0 108.626 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 126' ' ' GLY . 55.6 t -65.49 -42.24 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.197 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 56.6 ttm -57.16 -43.47 82.57 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.414 HD11 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -59.79 -26.51 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.702 178.285 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.5 t -94.99 -54.61 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 130' ' ' VAL . 11.2 p -63.8 -13.71 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.394 -0.191 . . . . 0.0 111.317 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -100.59 -16.92 17.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.433 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.8 -25.36 60.48 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -65.29 -34.5 78.49 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -158.37 83.67 2.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -44.25 111.44 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.716 1.611 . . . . 0.0 110.984 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HB2' HG21 ' A' ' 103' ' ' VAL . 56.9 Cg_endo -72.49 -14.98 27.84 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 121.741 1.627 . . . . 0.0 111.519 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.8 m -127.49 139.53 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.643 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -159.41 160.61 35.06 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.953 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.1 m -99.56 121.86 41.79 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.099 0.476 . . . . 0.0 111.287 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -111.85 116.45 49.8 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.147 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 N--CA 1.495 1.588 0 C-N-CA 121.801 1.668 . . . . 0.0 111.957 179.748 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.3 t -105.28 129.93 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.439 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.48 153.54 19.04 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.527 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 28.5 mp0 -62.64 -41.44 99.03 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.849 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.1 m -58.18 -46.02 86.49 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.083 0.944 . . . . 0.0 108.834 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.19 -34.58 77.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.548 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.677 HD23 HG13 ' A' ' 22' ' ' VAL . 11.0 tp -57.66 -36.94 72.56 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.527 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.4 mptp? -61.71 -44.61 96.6 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.464 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -64.39 -36.36 83.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.34 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.655 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -69.55 -33.67 73.11 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.79 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.4 m -114.0 20.98 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 122.021 -0.425 . . . . 0.0 110.906 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -60.55 -37.67 82.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.194 0.521 . . . . 0.0 111.13 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -62.96 -13.45 34.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.896 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -76.42 155.01 34.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.942 0.401 . . . . 0.0 111.365 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -72.28 -36.9 69.11 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.88 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -113.06 65.16 0.64 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.289 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -63.66 -25.52 68.25 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.93 -54.03 8.81 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 tp -64.29 -38.63 91.73 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.535 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 25' ' ' THR . 95.9 m -61.66 -48.2 81.9 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.752 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.677 HG13 HD23 ' A' ' 8' ' ' LEU . 27.3 t -62.62 -47.96 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 120.751 0.31 . . . . 0.0 111.161 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -62.7 -42.03 99.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.106 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.6 -39.1 93.51 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.305 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.648 ' O ' HG23 ' A' ' 29' ' ' ILE . 40.1 p -68.05 -37.7 81.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.736 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -55.23 -43.05 69.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -60.57 -39.6 88.58 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.47 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.62 ' HA ' HD13 ' A' ' 125' ' ' LEU . 68.7 t -72.55 -40.67 63.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -88.17 -23.71 6.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.261 -178.13 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.2 m -73.85 -48.7 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.097 0.475 . . . . 0.0 109.833 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.929 HD23 HD21 ' A' ' 125' ' ' LEU . 16.4 tp -84.39 -38.85 19.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.989 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.733 ' HD1' HD11 ' A' ' 125' ' ' LEU . 2.3 m-85 -112.9 65.72 0.64 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.208 0.528 . . . . 0.0 109.986 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -58.62 -14.6 8.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -64.2 -20.92 66.35 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.534 HD23 HD13 ' A' ' 55' ' ' LEU . 2.9 tp -94.54 113.8 25.69 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -107.87 129.31 24.32 Favored Pre-proline 0 C--N 1.357 0.916 0 CA-C-N 120.094 1.315 . . . . 0.0 111.716 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -84.39 137.04 6.81 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 121.804 1.669 . . . . 0.0 112.991 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.35 154.39 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.655 HD13 ' SD ' ' A' ' 11' ' ' MET . 15.2 tp -94.99 126.11 40.11 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.407 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.9 161.62 26.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.48 0.657 . . . . 0.0 112.091 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -97.64 124.59 42.0 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.358 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.63 131.55 54.78 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 118.306 0.503 . . . . 0.0 109.892 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.8 t -117.31 123.18 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.59 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -104.09 156.16 18.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -58.89 -27.97 65.71 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.717 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.84 -16.38 61.19 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.665 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.1 -8.73 67.61 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.5 m -74.76 150.61 39.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.2 p -130.72 154.63 47.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.123 0.487 . . . . 0.0 110.777 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 -161.5 136.01 7.09 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.223 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.82 121.33 23.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.91 0.862 . . . . 0.0 109.976 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.508 HD21 ' O ' ' A' ' 76' ' ' LEU . 11.8 tp -120.31 131.91 55.08 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.316 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.2 ttp -91.03 137.77 32.11 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.884 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -131.23 152.04 50.89 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.534 HD13 HD23 ' A' ' 35' ' ' LEU . 9.2 mt -100.96 130.47 46.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.1 m -145.55 137.88 25.69 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.071 0.463 . . . . 0.0 111.857 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.71 -145.21 9.34 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.279 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.4 p -131.26 158.15 41.39 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.659 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.4 pt -132.48 116.33 15.1 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.608 177.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -69.03 124.16 11.09 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 CA-C-N 119.98 1.029 . . . . 0.0 110.849 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.8 t -127.6 112.59 20.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.259 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.18 151.6 20.78 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.879 2.386 . . . . 0.0 112.62 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -163.5 115.03 1.43 Allowed 'General case' 0 CA--C 1.56 1.343 0 CA-C-O 121.546 0.689 . . . . 0.0 111.23 179.046 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 49.97 38.93 17.57 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.86 -4.49 85.67 Favored Glycine 0 N--CA 1.473 1.151 0 O-C-N 121.727 -0.608 . . . . 0.0 113.025 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -119.6 130.29 55.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.97 0.414 . . . . 0.0 109.98 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.8 m -118.25 131.41 56.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.685 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -113.28 149.29 34.08 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.949 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -97.13 102.64 14.46 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.453 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -89.39 119.15 69.62 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.39 128.58 4.16 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.784 2.323 . . . . 0.0 110.624 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.453 HG23 HG22 ' A' ' 70' ' ' ILE . 23.1 pt -134.5 147.5 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.971 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 69.3 m -120.62 122.48 40.6 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 121.534 0.683 . . . . 0.0 110.021 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.19 114.4 28.51 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.326 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -105.23 122.99 47.08 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.508 ' O ' HD21 ' A' ' 52' ' ' LEU . 63.4 mt -93.86 131.12 39.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.738 -177.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mt -74.82 149.43 39.65 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -56.9 -14.18 3.28 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.577 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.6 0.29 36.07 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -51.79 144.71 18.42 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HG2' ' CD2' ' A' ' 119' ' ' HIS . 29.0 Cg_endo -93.62 10.1 53.6 Favored 'Cis proline' 0 N--CA 1.516 2.81 0 CA-C-N 120.842 1.336 . . . . 0.0 115.369 0.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -75.45 -12.0 60.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.235 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.17 121.81 35.74 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.88 137.65 35.21 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 CA-C-N 121.182 1.458 . . . . 0.0 111.995 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.12 142.11 12.06 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.19 1.927 . . . . 0.0 111.488 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.31 133.43 40.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.699 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.3 t -114.69 143.45 45.02 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.017 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -127.86 131.14 49.5 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.681 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.7 t -103.92 126.31 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.14 101.78 5.32 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.957 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -83.82 129.24 4.73 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.622 1.548 . . . . 0.0 113.254 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.4 p -80.91 165.54 21.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.7 p -59.27 -25.07 63.77 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -99.51 23.76 9.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.971 0.805 . . . . 0.0 109.888 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.7 ttm -129.64 139.41 51.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.888 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.6 m -115.64 133.06 56.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.019 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 97' ' ' ILE . 1.4 tp -84.26 106.94 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.971 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -87.22 99.27 11.83 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.352 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.6 p -67.67 143.11 56.14 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.74 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.76 -152.45 6.9 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -74.59 -15.63 60.83 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -114.15 -27.35 7.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.578 HG21 ' HB2' ' A' ' 140' ' ' PRO . 2.0 t -106.65 136.09 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -100.07 175.78 5.63 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.15 93.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -79.34 -17.84 53.71 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.02 33.78 2.71 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.215 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -82.21 148.48 28.4 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.61 116.01 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.604 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.36 116.61 32.45 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 mt -126.05 113.71 24.13 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 118.249 0.477 . . . . 0.0 110.942 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -48.21 -37.55 31.57 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.733 1.622 . . . . 0.0 114.661 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.43 ' OH ' HD13 ' A' ' 127' ' ' LEU . 1.7 p90 -61.47 -32.24 72.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.652 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.409 ' N ' ' CG ' ' A' ' 113' ' ' TYR . 0.8 OUTLIER -68.55 -41.5 79.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.717 -178.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -62.99 -33.86 76.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.628 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -101.03 2.88 40.95 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.163 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -52.5 123.08 10.12 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.992 0.901 . . . . 0.0 110.221 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -101.58 100.22 10.6 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.797 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 81' ' ' PRO . 23.5 t-80 -57.03 122.29 52.24 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.897 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -111.66 91.24 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.576 0 CA-C-N 120.687 1.281 . . . . 0.0 112.235 -3.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -114.96 -51.63 2.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.984 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.3 m -71.24 -41.33 70.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.983 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t70 66.53 165.04 0.2 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.585 0.707 . . . . 0.0 111.807 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.459 HD23 HG21 ' A' ' 28' ' ' VAL . 21.9 tp -67.05 -41.13 87.01 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.694 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.929 HD21 HD23 ' A' ' 31' ' ' LEU . 30.3 tp -59.69 -37.28 78.39 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -60.87 -39.6 97.12 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.43 HD13 ' OH ' ' A' ' 113' ' ' TYR . 31.2 tp -57.37 -39.51 76.17 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.416 HD12 HD13 ' A' ' 35' ' ' LEU . 1.2 mm -72.08 -49.3 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.619 -177.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -66.92 -35.68 80.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 118.661 -1.216 . . . . 0.0 108.683 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 126' ' ' GLY . 54.6 t -64.25 -38.63 83.0 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 C-N-CA 119.432 -0.907 . . . . 0.0 108.864 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.7 tpp -60.49 -43.12 97.36 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.659 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.1 mp -67.92 -36.64 76.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.683 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.5 t -81.59 -41.5 18.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.47 HG13 ' CD2' ' A' ' 135' ' ' PHE . 2.1 p -77.71 -15.62 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.784 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.47 ' CD2' HG13 ' A' ' 134' ' ' VAL . 13.8 m-30 -107.3 -18.08 13.97 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.393 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.88 -27.1 69.64 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -66.47 -27.56 67.89 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.635 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -168.18 89.72 0.66 Allowed Pre-proline 0 C--O 1.232 0.15 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -44.76 119.35 2.28 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.67 1.58 . . . . 0.0 110.588 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.578 ' HB2' HG21 ' A' ' 103' ' ' VAL . 55.3 Cg_endo -70.97 -16.3 32.46 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.561 1.507 . . . . 0.0 111.448 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.17 140.37 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.337 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -159.52 160.7 34.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.2 m -106.77 130.23 54.51 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.708 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -112.25 113.69 51.33 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.177 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.495 1.578 0 C-N-CA 122.063 1.842 . . . . 0.0 112.187 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.515 HG11 ' HG2' ' A' ' 37' ' ' PRO . 3.9 p -63.64 143.38 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-O 121.586 0.707 . . . . 0.0 110.957 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -104.96 153.81 20.93 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.0 mt-10 -59.47 -42.48 92.16 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.109 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.2 m -58.23 -47.89 82.09 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.952 0.882 . . . . 0.0 109.355 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -62.57 -34.42 76.94 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.95 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.819 HD23 HG13 ' A' ' 22' ' ' VAL . 13.2 tp -56.09 -39.27 71.89 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 11.0 mptt -61.05 -43.95 98.13 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.557 0.694 . . . . 0.0 109.613 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.03 -36.32 83.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.617 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.78 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.4 mmm -66.92 -37.04 83.6 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.619 -178.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -115.73 23.46 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.526 0.203 . . . . 0.0 111.245 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.3 p -66.62 -18.13 65.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.705 0.288 . . . . 0.0 111.029 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -77.41 -20.78 54.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.121 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -72.47 149.88 43.79 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -66.23 -40.04 89.99 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.789 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -110.56 64.21 0.61 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.783 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -65.24 -27.74 68.87 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.37 -49.48 33.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.37 -41.7 93.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.634 -0.827 . . . . 0.0 109.389 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 25' ' ' THR . 53.1 m -60.22 -48.49 81.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.156 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.819 HG13 HD23 ' A' ' 8' ' ' LEU . 20.8 t -63.55 -46.02 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 120.536 0.208 . . . . 0.0 111.445 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.74 -42.74 99.36 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.619 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -34.19 72.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.541 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 29' ' ' ILE . 24.9 p -66.21 -38.49 88.09 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.4 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 30' ' ' THR . 53.2 t -57.64 -45.42 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -61.24 -38.77 87.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.327 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.516 HG21 HD22 ' A' ' 124' ' ' LEU . 55.2 t -67.12 -46.05 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -81.81 -13.5 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.33 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.0 p -76.33 -52.09 10.64 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.0 tp -85.03 -38.15 19.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.416 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -108.89 64.26 0.61 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.135 0.493 . . . . 0.0 109.89 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -55.31 -18.82 7.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.534 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -65.5 -22.55 66.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.364 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.55 HD23 HD13 ' A' ' 55' ' ' LEU . 2.0 tp -91.18 113.86 26.23 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -110.69 132.24 21.69 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.576 1.08 . . . . 0.0 111.805 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.515 ' HG2' HG11 ' A' ' 3' ' ' VAL . 43.5 Cg_endo -81.43 135.01 9.15 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 122.242 1.961 . . . . 0.0 112.94 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -131.56 137.01 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.78 HD13 ' SD ' ' A' ' 11' ' ' MET . 15.4 tp -82.41 121.77 27.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.27 160.04 24.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.731 0.3 . . . . 0.0 110.925 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m -99.8 131.68 45.63 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -116.44 136.11 53.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.141 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.8 t -109.56 121.21 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.767 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -94.61 159.65 14.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -66.15 -12.87 58.62 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.331 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -82.8 -9.14 59.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.398 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.35 -8.11 79.53 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.5 m -83.12 145.04 29.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.037 0.446 . . . . 0.0 109.925 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.9 t -113.25 142.23 46.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.15 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -144.4 134.7 24.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.265 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.16 122.97 28.03 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.672 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 52' ' ' LEU . 51.4 mt -122.29 144.17 49.16 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.936 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.491 ' SD ' HD11 ' A' ' 8' ' ' LEU . 57.9 ttp -97.43 139.09 33.88 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.84 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -132.35 150.55 52.13 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 121.161 0.505 . . . . 0.0 111.254 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.55 HD13 HD23 ' A' ' 35' ' ' LEU . 7.0 mt -98.38 124.19 42.92 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 m -134.97 138.62 44.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.68 -145.33 9.65 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.58 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.6 p -133.27 159.39 40.37 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.42 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.1 pt -133.73 116.56 13.77 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.38 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -70.95 127.56 13.8 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 CA-C-N 120.058 1.057 . . . . 0.0 110.014 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 89.8 t -127.31 118.1 21.7 Favored Pre-proline 0 C--N 1.347 0.485 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.284 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.29 142.23 37.04 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.885 1.723 . . . . 0.0 110.066 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.402 ' HD2' ' OD1' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -159.77 113.46 2.24 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.888 -178.826 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 60.84 25.37 15.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.755 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.86 -13.23 67.36 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.563 ' C ' ' OD1' ' A' ' 66' ' ' ASN . 3.1 p-10 -99.85 169.96 8.86 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.1 m -139.88 133.98 31.01 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.515 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -121.08 148.62 43.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.304 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -96.34 106.66 18.92 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.544 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -91.7 115.41 64.48 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.215 -177.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.56 126.3 4.66 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.304 2.003 . . . . 0.0 110.376 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.544 HG23 HG22 ' A' ' 70' ' ' ILE . 27.0 pt -133.97 150.44 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 119.156 -1.018 . . . . 0.0 112.091 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.6 m -121.61 120.68 35.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.81 115.68 31.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.929 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -109.24 128.05 54.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.8 mt -97.3 142.02 29.69 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.043 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -87.45 151.41 23.07 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -58.92 -15.16 11.48 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.87 5.48 33.02 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.204 0.526 . . . . 0.0 112.233 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -60.93 145.59 88.76 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -92.42 10.26 57.56 Favored 'Cis proline' 0 N--CA 1.516 2.798 0 CA-C-N 120.856 1.341 . . . . 0.0 114.753 0.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.59 -12.17 60.67 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.84 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.48 127.78 26.49 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.66 -0.686 . . . . 0.0 109.408 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -49.39 134.28 31.72 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 CA-C-N 121.192 1.461 . . . . 0.0 112.217 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.416 ' HD2' HD11 ' A' ' 114' ' ' LEU . 86.3 Cg_endo -79.9 142.12 15.51 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.366 2.044 . . . . 0.0 111.274 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.6 mt -98.75 135.67 32.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.088 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.3 t -121.66 145.98 47.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.023 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -125.71 134.48 51.78 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.159 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.403 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.8 p -95.65 127.92 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -69.3 107.42 2.15 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 44.5 Cg_endo -84.8 155.91 11.73 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.268 1.312 . . . . 0.0 113.147 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.3 p -129.01 169.85 14.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.062 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.7 m -59.18 -39.59 83.03 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -89.92 -3.61 57.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.617 0.644 . . . . 0.0 111.53 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.7 ttm -116.23 137.15 52.39 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -129.22 165.83 20.59 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.109 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.469 ' N ' HG23 ' A' ' 96' ' ' THR . 70.2 mt -111.27 108.78 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.716 178.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -97.52 126.91 43.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.9 p -72.01 143.6 49.11 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.92 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.54 -142.18 3.5 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.752 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -66.0 -26.6 67.62 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.484 ' NE2' HG23 ' A' ' 103' ' ' VAL . 20.5 p-80 -133.68 -26.67 1.57 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.484 HG23 ' NE2' ' A' ' 102' ' ' HIS . 0.9 OUTLIER -92.72 132.08 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 119.477 1.035 . . . . 0.0 110.536 -179.177 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -98.97 175.41 5.94 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.45 77.42 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -74.94 -9.83 58.91 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.415 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.69 5.29 55.45 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.156 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 147.26 53.73 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.468 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.527 HD13 ' CZ ' ' A' ' 135' ' ' PHE . 96.8 mt -120.74 125.13 73.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -99.7 137.82 37.65 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.679 HD22 HG11 ' A' ' 134' ' ' VAL . 29.2 mt -136.61 116.57 10.87 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.441 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -47.56 -37.36 26.37 Favored 'Trans proline' 0 N--CA 1.504 2.091 0 C-N-CA 122.075 1.85 . . . . 0.0 114.505 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -61.09 -29.37 69.71 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.679 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.416 HD11 ' HD2' ' A' ' 85' ' ' PRO . 1.2 tt -69.8 -43.16 72.64 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.489 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -68.05 -27.61 66.67 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.378 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -103.86 3.91 34.31 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.932 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TRP . . . . . 0.479 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.6 t90 -70.16 120.05 15.26 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.806 0.812 . . . . 0.0 109.742 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -88.05 129.51 35.26 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.161 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 46.4 t-80 -78.81 124.06 85.11 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.463 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 14.0 Cg_endo -111.04 93.1 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.664 0 CA-C-N 120.953 1.376 . . . . 0.0 111.63 -3.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -113.6 -56.17 2.43 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.115 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.5 t -74.3 -34.61 63.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.773 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 47.02 -176.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.707 0.765 . . . . 0.0 111.621 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -69.52 -40.59 76.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.306 -179.369 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.1 tt -55.68 -39.51 71.07 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.58 -39.86 98.4 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.4 tp -57.6 -40.28 78.74 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.444 HD12 HD13 ' A' ' 35' ' ' LEU . 1.1 mm -73.19 -49.96 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.816 -176.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.56 ' NE2' HG21 ' A' ' 132' ' ' ILE . 69.0 tp60 -64.78 -35.92 82.63 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 126' ' ' GLY . 73.5 t -68.25 -37.27 77.77 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.4 tpp -58.32 -43.04 88.0 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.56 HG21 ' NE2' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -62.65 -39.63 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.13 178.675 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.9 t -81.48 -47.32 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.679 HG11 HD22 ' A' ' 111' ' ' LEU . 4.7 p -67.71 -15.47 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.34 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.527 ' CZ ' HD13 ' A' ' 109' ' ' ILE . 10.8 m-30 -106.57 -19.34 13.7 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.138 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.21 -37.29 93.85 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -64.88 -36.87 85.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.762 -0.719 . . . . 0.0 110.687 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -158.1 81.99 2.9 Favored Pre-proline 0 CA--C 1.52 -0.195 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -51.04 128.88 26.34 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 120.709 0.939 . . . . 0.0 109.731 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.43 -15.25 34.56 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.469 1.446 . . . . 0.0 112.142 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.1 m -132.64 153.72 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.974 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.35 166.08 34.05 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 28.3 m -85.78 121.94 29.16 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.122 0.487 . . . . 0.0 111.414 -178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -111.73 110.66 54.73 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.99 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 N--CA 1.495 1.592 0 C-N-CA 121.919 1.746 . . . . 0.0 112.079 -179.912 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.485 HG13 ' HE3' ' A' ' 11' ' ' MET . 76.6 t -89.21 129.87 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.767 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -95.68 158.36 15.48 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.502 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 94.9 mt-10 -63.34 -41.73 98.89 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.267 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -60.33 -48.29 82.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.225 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -63.51 -27.73 69.47 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.152 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.938 HD23 HG13 ' A' ' 22' ' ' VAL . 38.7 tp -61.23 -41.69 97.31 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.658 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 3.4 mptp? -59.27 -38.95 81.38 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.208 0.528 . . . . 0.0 109.824 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.61 -34.69 76.08 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.128 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.792 ' CB ' HD13 ' A' ' 39' ' ' LEU . 11.8 ptp -84.31 -14.58 49.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.808 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -126.34 17.97 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.413 179.34 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.9 t -61.92 -37.75 85.85 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.817 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -64.6 -19.82 65.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.875 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.449 ' CE1' HG12 ' A' ' 12' ' ' VAL . 35.9 m-85 -72.11 152.64 42.2 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -75.44 -26.14 58.05 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.675 0.274 . . . . 0.0 110.683 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -120.67 60.36 0.9 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.403 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 22' ' ' VAL . 19.8 ptt180 -64.77 -25.42 67.91 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -71.7 -55.82 6.97 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mt -64.39 -39.72 94.4 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.088 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.4 m -62.47 -47.85 82.2 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.876 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.938 HG13 HD23 ' A' ' 8' ' ' LEU . 25.8 t -62.56 -47.24 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 120.837 0.351 . . . . 0.0 110.673 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -40.44 95.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.044 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -63.42 -39.55 94.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.583 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 29' ' ' ILE . 57.5 p -70.48 -35.56 73.33 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.252 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 22' ' ' VAL . 59.7 t -56.89 -44.37 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -62.0 -39.78 93.4 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.485 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.57 HG21 HD22 ' A' ' 124' ' ' LEU . 76.6 t -70.76 -43.43 77.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.01 -17.94 8.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.517 -177.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.9 m -82.7 -47.2 12.27 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.092 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.589 HD23 HD11 ' A' ' 125' ' ' LEU . 32.7 tp -87.9 -37.8 16.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.937 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -109.12 65.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -59.0 -16.95 20.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.973 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -64.95 -21.1 66.78 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.116 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.584 HD13 HD12 ' A' ' 128' ' ' ILE . 2.1 tp -98.16 124.01 42.5 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -118.07 129.28 25.47 Favored Pre-proline 0 C--N 1.36 1.061 0 CA-C-N 120.221 1.373 . . . . 0.0 111.946 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -80.89 136.53 10.58 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 121.593 1.529 . . . . 0.0 112.81 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.39 135.59 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.792 HD13 ' CB ' ' A' ' 11' ' ' MET . 40.9 tp -83.1 122.14 27.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.02 151.24 48.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.219 0.533 . . . . 0.0 112.041 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m -98.68 119.33 37.23 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -103.94 139.09 39.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.992 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.2 t -115.16 124.23 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.862 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -95.33 166.12 12.04 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.318 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.42 -39.72 84.4 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.653 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -65.66 -9.41 27.09 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.819 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.43 -11.98 69.51 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.8 m -61.45 136.08 57.9 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.6 m -122.35 140.08 53.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.116 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.44 129.58 11.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.055 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -76.33 116.1 16.69 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.323 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.4 mt -122.86 138.31 54.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.454 ' SD ' HD11 ' A' ' 8' ' ' LEU . 64.2 ttp -84.29 139.55 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.137 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -125.88 156.4 39.71 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.198 0.523 . . . . 0.0 110.897 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.5 mm? -108.99 117.69 34.85 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.0 m -134.13 137.99 44.92 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.088 0.471 . . . . 0.0 112.159 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.27 -149.65 15.31 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.896 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.9 p -132.01 158.94 40.21 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.433 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.2 pt -132.58 115.97 14.86 Favored Pre-proline 0 C--O 1.237 0.433 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.416 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.74 125.46 10.01 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.8 1.0 . . . . 0.0 110.197 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.73 119.34 25.77 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.875 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.63 147.42 57.27 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.187 1.925 . . . . 0.0 109.675 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.41 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -163.74 108.79 1.04 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.339 -177.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 49.65 44.23 24.47 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.79 13.89 75.36 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.36 -0.924 . . . . 0.0 110.839 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -134.77 131.15 37.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -117.4 132.47 56.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.847 0.356 . . . . 0.0 111.797 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -112.68 148.88 33.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.99 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.95 102.46 14.26 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.447 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -91.22 116.28 66.12 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.262 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.9 127.55 4.2 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.654 2.236 . . . . 0.0 110.308 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.447 HG23 HG22 ' A' ' 70' ' ' ILE . 26.4 pt -134.57 146.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.541 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 84.8 m -120.57 121.63 38.8 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.83 120.09 39.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.664 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -104.39 117.94 35.4 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.3 mt -84.56 137.69 33.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mt -88.36 154.91 20.01 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.8 p30 -63.4 -13.83 43.92 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.501 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 p -99.24 -4.35 32.17 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -55.83 145.11 54.1 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.447 ' HG2' ' CE1' ' A' ' 119' ' ' HIS . 31.7 Cg_endo -91.18 6.29 66.54 Favored 'Cis proline' 0 N--CA 1.514 2.732 0 CA-C-N 121.121 1.436 . . . . 0.0 115.697 1.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -71.27 -19.2 62.38 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.974 -1.09 . . . . 0.0 110.349 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.21 139.5 21.95 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.056 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.0 142.76 63.22 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 CA-C-N 121.665 1.63 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 142.84 17.31 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.955 1.77 . . . . 0.0 111.906 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -92.41 134.59 29.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 39.0 t -107.78 144.35 35.06 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.765 -177.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.56 126.06 43.04 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.272 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.42 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 57.3 t -98.39 130.31 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 99.36 3.53 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 123.44 0.463 . . . . 0.0 109.873 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 44.2 Cg_endo -86.85 148.09 8.25 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.387 1.391 . . . . 0.0 113.23 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.3 p -95.95 165.27 12.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.553 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t -55.16 -19.11 6.93 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.2 t -105.52 15.65 26.73 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.002 0.819 . . . . 0.0 111.572 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.4 mtp -132.77 141.83 48.71 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -125.43 163.64 22.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.063 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.458 ' N ' HG23 ' A' ' 96' ' ' THR . 4.3 mm -93.02 101.98 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -84.89 104.71 15.08 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.802 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.7 p -72.61 150.07 43.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.349 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.5 -137.49 2.3 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.769 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -67.73 -21.08 65.31 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.531 ' CE1' HG23 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -132.57 -29.54 1.53 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.884 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.683 HG21 ' HB2' ' A' ' 140' ' ' PRO . 6.2 t -88.97 140.3 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.739 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -103.16 176.45 5.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.441 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.33 94.2 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -88.39 0.3 56.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.292 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.48 11.74 46.95 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.259 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -64.46 141.47 58.76 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.466 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.49 115.57 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.072 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.42 ' C ' ' HG ' ' A' ' 111' ' ' LEU . 27.5 m-85 -104.57 136.23 44.5 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.42 ' HG ' ' C ' ' A' ' 110' ' ' TYR . 2.1 mt -135.17 124.84 16.62 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.3 -32.7 52.34 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.365 1.376 . . . . 0.0 113.519 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -67.51 -31.8 72.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.75 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.02 -41.67 74.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.162 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -71.16 -26.54 63.03 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.29 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -100.71 -0.75 36.72 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.22 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -53.97 126.01 20.91 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 122.055 0.931 . . . . 0.0 110.733 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -97.98 94.5 6.9 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.239 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.447 ' CE1' ' HG2' ' A' ' 81' ' ' PRO . 15.7 t-80 -59.68 124.51 76.38 Favored Pre-proline 0 C--N 1.323 -0.556 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.067 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 9.6 Cg_endo -108.88 91.71 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.708 0 CA-C-N 120.454 1.198 . . . . 0.0 112.948 -2.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -113.07 -58.16 2.19 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.463 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.6 t -67.37 -40.6 85.78 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.314 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 64.37 166.21 0.15 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.741 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.57 HD22 HG21 ' A' ' 28' ' ' VAL . 7.8 tt -61.03 -41.84 97.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.589 HD11 HD23 ' A' ' 31' ' ' LEU . 5.4 tt -57.17 -36.16 70.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -60.28 -39.8 96.54 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.74 -40.79 93.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.584 HD12 HD13 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -75.17 -47.59 35.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.683 -176.649 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -68.81 -36.48 78.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.021 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 134' ' ' VAL . 79.4 t -66.85 -39.75 84.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.081 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.1 ttm -58.73 -44.5 90.49 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.433 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -60.26 -34.97 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.815 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.8 t -90.36 -46.22 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.543 HG13 ' CD2' ' A' ' 135' ' ' PHE . 4.9 p -68.91 -13.31 17.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.723 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.543 ' CD2' HG13 ' A' ' 134' ' ' VAL . 12.6 m-30 -103.76 -15.17 15.81 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.024 178.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.88 -24.92 75.94 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -70.45 -34.53 72.55 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.595 0.236 . . . . 0.0 111.012 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -162.38 83.13 1.64 Allowed Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -49.17 124.18 11.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.222 1.281 . . . . 0.0 110.752 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.683 ' HB2' HG21 ' A' ' 103' ' ' VAL . 57.1 Cg_endo -72.9 -18.56 24.38 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.741 1.627 . . . . 0.0 112.019 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.11 146.03 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.151 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -159.47 162.29 35.58 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.3 m -85.46 118.29 24.89 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.101 0.477 . . . . 0.0 111.599 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.0 131.21 23.27 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.1 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo . . . . . 0 N--CA 1.491 1.364 0 C-N-CA 121.601 1.534 . . . . 0.0 112.195 -179.741 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.4 t . . . . . 0 N--CA 1.449 -0.476 0 CA-C-O 120.892 0.377 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -94.58 158.43 15.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.468 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 95.4 mt-10 -64.14 -41.15 97.3 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.196 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.3 m -58.58 -47.43 84.33 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.165 0.984 . . . . 0.0 108.985 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -63.32 -33.64 75.96 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.874 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.741 HD23 HG13 ' A' ' 22' ' ' VAL . 12.7 tp -56.3 -38.49 71.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.6 mptp? -60.73 -42.8 98.04 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.367 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.1 -37.73 88.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.617 0.722 . . . . 0.0 110.884 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.767 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.3 mmm -67.54 -36.68 81.46 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.114 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -111.87 19.69 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.651 0.263 . . . . 0.0 111.116 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.7 p -64.56 -21.78 66.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.806 0.336 . . . . 0.0 110.532 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -72.06 -23.01 61.29 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.984 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.49 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 30.2 m-85 -77.44 160.18 28.89 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.849 0.357 . . . . 0.0 110.365 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.6 -21.19 24.15 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.305 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.16 47.53 1.12 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 122.324 -0.235 . . . . 0.0 110.766 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -58.27 -24.65 60.12 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -73.61 -53.79 9.65 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.6 tp -65.13 -39.7 93.43 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.722 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 25' ' ' THR . 77.1 m -63.08 -48.68 77.55 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.338 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.741 HG13 HD23 ' A' ' 8' ' ' LEU . 25.3 t -61.5 -46.42 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 120.635 0.255 . . . . 0.0 110.47 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -62.63 -44.91 95.08 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.647 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -64.21 -36.88 85.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.948 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.63 ' O ' HG23 ' A' ' 29' ' ' ILE . 35.3 p -64.81 -34.3 78.04 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.736 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.69 -44.91 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -61.37 -38.02 85.49 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.408 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.517 HG21 HD22 ' A' ' 124' ' ' LEU . 73.3 t -70.72 -44.73 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.95 -21.57 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.354 -178.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.5 m -73.47 -45.88 51.52 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.535 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.776 HD23 HD21 ' A' ' 125' ' ' LEU . 30.0 tp -88.47 -39.27 14.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.032 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -111.07 66.97 0.63 Allowed 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -56.99 -17.64 10.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.288 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -66.85 -14.87 63.18 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.87 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.45 HD23 HD13 ' A' ' 55' ' ' LEU . 1.8 tp -99.98 114.27 27.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.1 ttpp -108.89 131.86 21.53 Favored Pre-proline 0 C--N 1.356 0.874 0 CA-C-N 119.521 1.055 . . . . 0.0 112.007 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.1 133.42 11.0 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.49 1.46 . . . . 0.0 112.535 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.4 t -133.96 139.36 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 110.71 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.767 HD13 ' SD ' ' A' ' 11' ' ' MET . 11.1 tp -81.93 136.27 35.32 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -140.6 154.48 46.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.144 0.497 . . . . 0.0 111.27 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.6 m -91.56 131.46 36.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.9 t80 . . . . . 0 C--O 1.236 0.381 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.818 179.821 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 . . . . . 0 CA--C 1.515 -0.367 0 CA-C-O 121.121 0.486 . . . . 0.0 110.07 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -82.12 119.3 23.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.848 0.832 . . . . 0.0 109.733 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.49 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 61.3 mt -121.44 146.71 46.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.791 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.457 ' SD ' HD11 ' A' ' 8' ' ' LEU . 53.5 ttp -97.54 142.79 28.94 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.682 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -135.81 152.85 51.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.452 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.45 HD13 HD23 ' A' ' 35' ' ' LEU . 8.5 mt -95.45 123.58 39.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -135.89 136.61 40.67 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.16 -146.69 11.47 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.522 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.1 p -132.84 159.4 39.93 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.439 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.3 pt -129.77 116.48 18.18 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.895 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -70.56 124.81 11.1 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 CA-C-N 120.017 1.042 . . . . 0.0 109.942 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.1 t -125.56 118.43 24.62 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 119.671 -0.812 . . . . 0.0 113.015 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.7 142.22 52.19 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.944 1.763 . . . . 0.0 109.813 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -163.08 117.54 1.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.48 26.39 10.83 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.299 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.93 -5.62 78.44 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -112.97 142.78 45.27 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -121.65 132.26 54.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.775 0.321 . . . . 0.0 111.818 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -115.9 151.74 34.76 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.523 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -95.69 106.29 18.38 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.532 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -90.83 118.56 68.71 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.79 122.1 2.24 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.601 2.201 . . . . 0.0 110.534 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.532 HG23 HG22 ' A' ' 70' ' ' ILE . 31.9 pt -134.44 149.51 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.796 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.1 m -123.5 127.9 49.01 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.947 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.71 115.49 30.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.868 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -103.69 125.81 50.42 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.6 mt -90.84 138.64 31.43 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.0 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.51 146.44 36.38 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -56.79 -14.99 3.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.476 0.58 . . . . 0.0 111.679 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.4 p -106.03 13.11 29.65 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.259 0.552 . . . . 0.0 111.536 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -61.4 144.39 92.07 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -92.23 8.09 61.35 Favored 'Cis proline' 0 N--CA 1.514 2.721 0 CA-C-N 121.216 1.47 . . . . 0.0 115.623 1.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -71.51 -15.28 62.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.853 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.82 137.76 19.85 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.24 143.82 66.07 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 121.579 1.6 . . . . 0.0 110.751 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.82 138.9 13.57 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.444 1.43 . . . . 0.0 111.893 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 mt -95.2 131.73 41.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 40.3 t -110.06 150.75 28.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.066 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -133.28 127.05 32.81 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.535 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.3 t -96.1 121.56 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -68.95 109.69 4.74 Favored Pre-proline 0 N--CA 1.476 0.846 0 CA-C-O 119.167 -0.444 . . . . 0.0 111.15 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.21 164.71 11.26 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.577 1.518 . . . . 0.0 112.238 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.7 p -139.31 172.85 12.22 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.7 m -57.95 -41.19 82.33 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.86 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.9 m -90.29 -11.89 39.44 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.897 0.771 . . . . 0.0 111.733 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.0 tpp -108.91 124.45 50.69 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.459 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -119.15 165.33 14.32 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.353 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.459 ' N ' HG23 ' A' ' 96' ' ' THR . 87.2 mt -96.16 110.59 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -90.98 102.14 14.9 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.4 p -59.83 142.71 52.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.314 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -158.33 -144.15 3.86 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.705 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -65.95 -27.48 68.19 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.528 ' NE2' HG23 ' A' ' 103' ' ' VAL . 16.9 p-80 -128.96 -7.79 4.93 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 119.047 -1.061 . . . . 0.0 113.407 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.681 HG21 ' HB2' ' A' ' 140' ' ' PRO . 40.3 t -108.21 126.56 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.167 0.894 . . . . 0.0 111.736 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 103' ' ' VAL . 32.6 p-10 -88.65 -161.41 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.76 -20.83 25.62 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.863 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -90.23 -1.79 57.97 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.728 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.9 11.73 56.26 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.855 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -63.01 140.56 58.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.527 0.664 . . . . 0.0 109.667 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 98.7 mt -116.6 117.99 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.107 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -102.38 137.29 40.83 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.961 HD22 HG11 ' A' ' 134' ' ' VAL . 26.8 mt -136.64 116.61 10.85 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.317 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.14 -38.25 24.66 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 121.844 1.696 . . . . 0.0 114.519 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.402 ' CD2' ' N ' ' A' ' 114' ' ' LEU . 1.3 p90 -61.53 -29.73 70.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.512 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 1.7 tt -69.56 -42.53 74.44 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.717 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -65.03 -29.29 70.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.309 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -107.44 13.56 26.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.071 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.424 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 6.5 t90 -76.43 121.96 23.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.75 0.786 . . . . 0.0 110.36 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -92.42 128.08 38.14 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.277 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 85.4 t60 -84.34 125.47 71.91 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.424 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 15.7 Cg_endo -108.8 91.93 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.705 0 CA-C-N 120.866 1.345 . . . . 0.0 112.628 -2.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -113.77 -58.83 2.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.778 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.1 p -67.19 -39.02 86.3 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.52 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 58.95 161.69 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.474 0.654 . . . . 0.0 111.829 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.517 HD22 HG21 ' A' ' 28' ' ' VAL . 4.7 tt -58.39 -41.17 84.24 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.194 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.776 HD21 HD23 ' A' ' 31' ' ' LEU . 7.9 tp -56.75 -38.13 72.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.68 -39.69 98.24 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 tp -59.07 -38.98 80.73 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.413 HD12 HD13 ' A' ' 35' ' ' LEU . 1.1 mm -73.02 -47.53 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.579 -177.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -66.08 -36.83 84.26 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 126' ' ' GLY . 78.6 t -66.89 -37.82 80.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.9 tpp -59.0 -43.03 91.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.439 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -62.82 -26.07 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.621 178.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.2 t -94.63 -52.05 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.961 HG11 HD22 ' A' ' 111' ' ' LEU . 5.5 p -64.77 -13.72 15.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 122.547 0.339 . . . . 0.0 111.402 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.453 ' CD1' HG13 ' A' ' 134' ' ' VAL . 6.6 m-30 -101.98 -17.64 16.01 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.255 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.55 -28.07 60.14 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -64.81 -35.48 81.23 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.332 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -163.49 84.6 1.35 Allowed Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -44.06 112.6 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.497 1.465 . . . . 0.0 110.665 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.681 ' HB2' HG21 ' A' ' 103' ' ' VAL . 28.8 Cg_endo -65.35 -20.44 61.71 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.358 1.372 . . . . 0.0 110.427 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.9 m -127.72 150.11 33.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 16.7 p90 . . . . . 0 N--CA 1.471 0.608 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.03 -179.513 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.406 HG22 ' HE1' ' A' ' 11' ' ' MET . 87.4 t . . . . . 0 CA--C 1.515 -0.398 0 CA-C-O 121.298 0.571 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.48 154.57 18.13 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.513 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 39.9 mt-10 -62.18 -40.61 96.62 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.954 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.8 t -58.83 -47.7 83.9 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 122.148 0.975 . . . . 0.0 109.269 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -64.51 -30.4 71.43 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.855 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.858 HD23 HG13 ' A' ' 22' ' ' VAL . 10.2 tp -60.0 -37.05 78.56 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -62.8 -43.27 99.24 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.432 178.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.31 -37.44 83.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.94 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.503 ' SD ' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -64.01 -37.51 87.71 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.017 -178.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -119.39 24.82 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.883 0.373 . . . . 0.0 111.856 -178.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.5 t -64.59 -37.17 86.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.07 0.462 . . . . 0.0 111.147 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.22 -12.38 60.87 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.89 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.488 ' CE1' HG12 ' A' ' 12' ' ' VAL . 10.4 m-85 -77.99 159.55 28.72 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -81.86 -26.87 33.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.651 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -116.19 55.24 0.81 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 119.67 -0.205 . . . . 0.0 110.809 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 ptt-85 -63.76 -24.7 67.87 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -53.88 8.56 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.038 -0.414 . . . . 0.0 111.709 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -42.88 96.6 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.117 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.0 m -60.61 -48.07 83.4 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.419 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.858 HG13 HD23 ' A' ' 8' ' ' LEU . 32.6 t -61.05 -44.74 98.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -41.4 98.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.566 -0.853 . . . . 0.0 109.784 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -39.2 89.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.071 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 29' ' ' ILE . 41.4 p -65.72 -37.86 87.58 Favored 'General case' 0 CA--C 1.507 -0.673 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.461 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.85 -43.99 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.486 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -61.86 -37.91 86.29 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.025 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.1 t -71.23 -43.11 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.82 -20.27 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.114 -178.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -78.31 -47.54 17.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.647 ' O ' HD13 ' A' ' 31' ' ' LEU . 2.8 tm? -84.23 -39.74 18.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.794 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -110.56 66.98 0.63 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -58.08 -16.58 13.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.82 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -65.34 -22.0 66.77 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.826 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 tp -91.84 114.29 26.78 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -108.26 123.21 38.17 Favored Pre-proline 0 C--N 1.357 0.926 0 CA-C-N 119.551 1.069 . . . . 0.0 111.663 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.89 134.09 9.37 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.383 1.388 . . . . 0.0 112.976 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.9 155.3 41.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 110.711 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.503 HD12 ' SD ' ' A' ' 11' ' ' MET . 0.9 OUTLIER -86.97 122.43 30.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.992 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -125.07 133.06 53.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.584 0.23 . . . . 0.0 111.21 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.3 p -69.48 146.09 52.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.237 0.443 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.425 -179.107 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 . . . . . 0 N--CA 1.468 0.435 0 CA-C-O 120.966 0.412 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.7 121.59 17.48 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -128.92 126.43 39.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.962 0.411 . . . . 0.0 109.914 -178.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.407 ' HB2' ' HB3' ' A' ' 11' ' ' MET . 61.9 ttp -84.55 150.48 25.19 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.922 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -138.73 157.28 46.38 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.318 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mt -108.36 125.05 51.28 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.4 m -140.33 139.2 35.36 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.977 0.418 . . . . 0.0 112.12 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.19 -149.51 15.05 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.628 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.504 HG21 ' OD1' ' A' ' 69' ' ' ASN . 23.0 p -131.75 159.21 39.12 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.499 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.2 pt -130.25 116.53 17.68 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.9 177.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -70.79 125.97 12.15 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 CA-C-N 119.892 0.997 . . . . 0.0 109.878 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.0 t -130.02 127.32 22.68 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.573 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.09 149.64 52.71 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.092 1.861 . . . . 0.0 110.452 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -161.63 106.42 1.28 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.338 0.589 . . . . 0.0 111.889 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 51.15 39.58 23.84 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.914 -0.491 . . . . 0.0 111.951 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.22 -0.55 83.73 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -121.13 132.16 54.69 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -110.09 131.04 55.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.659 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -113.89 151.43 32.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.621 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.504 ' OD1' HG21 ' A' ' 58' ' ' THR . 3.7 t-20 -97.96 104.07 16.07 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.508 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -88.98 117.09 67.92 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.11 124.88 3.91 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.525 2.15 . . . . 0.0 110.919 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 70' ' ' ILE . 26.4 pt -132.67 147.96 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.613 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.5 m -123.01 126.13 46.55 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-O 121.385 0.612 . . . . 0.0 110.0 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.09 109.97 22.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.506 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.523 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 91.0 m95 -98.38 121.62 40.55 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.657 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.464 ' O ' HD21 ' A' ' 52' ' ' LEU . 72.8 mt -89.7 144.28 26.12 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.874 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mt -88.76 154.48 20.25 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -60.13 -17.68 42.07 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.524 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -100.47 1.32 41.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.732 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -53.81 145.77 30.13 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -92.37 12.07 53.97 Favored 'Cis proline' 0 N--CA 1.519 2.994 0 N-CA-C 116.061 1.524 . . . . 0.0 116.061 1.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -80.78 -2.38 46.86 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.296 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.82 122.83 26.32 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 118.555 -0.736 . . . . 0.0 109.08 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.76 132.66 21.58 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 CA-C-N 121.313 1.505 . . . . 0.0 112.505 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.32 144.27 14.41 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 122.382 2.054 . . . . 0.0 111.474 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.55 132.9 42.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.881 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 41.8 t -110.33 151.21 27.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.642 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -131.69 127.39 36.79 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.325 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.652 ' CG2' HD11 ' A' ' 109' ' ' ILE . 56.7 t -90.76 123.77 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -71.12 110.21 6.84 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 119.338 -0.363 . . . . 0.0 111.334 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -85.73 157.87 10.46 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.901 1.734 . . . . 0.0 113.218 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.2 p -135.78 165.59 25.25 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.93 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.2 p -60.32 -24.57 65.11 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -104.19 13.53 32.13 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.93 0.786 . . . . 0.0 110.728 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.24 148.15 50.8 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.476 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -133.59 165.98 23.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 120.156 -0.617 . . . . 0.0 110.438 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.476 ' N ' HG23 ' A' ' 96' ' ' THR . 90.3 mt -103.27 105.76 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -94.77 108.64 20.65 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.238 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 82.3 p -65.98 151.21 47.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.928 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.78 -134.74 1.8 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.356 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 101' ' ' LYS . 6.7 pttp -86.03 -3.8 59.02 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -136.42 -24.09 1.23 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.22 145.99 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.683 0.674 . . . . 0.0 110.171 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -101.37 -179.55 4.06 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.699 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.31 73.13 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -79.88 2.53 22.93 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.796 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.01 27.78 15.41 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.087 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -82.56 132.42 35.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 117.588 0.694 . . . . 0.0 110.149 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.652 HD11 ' CG2' ' A' ' 89' ' ' VAL . 96.3 mt -110.44 109.94 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.606 0.241 . . . . 0.0 110.782 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -114.07 138.86 49.84 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.548 ' CD2' HG11 ' A' ' 134' ' ' VAL . 1.1 mt -131.65 130.57 22.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 118.563 0.62 . . . . 0.0 111.883 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -46.93 -39.8 25.03 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.433 1.422 . . . . 0.0 113.957 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.05 -29.69 70.47 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.669 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 tt -70.79 -41.07 72.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.804 0.335 . . . . 0.0 111.008 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -67.36 -27.07 66.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.381 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -105.57 -3.64 22.11 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.878 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.424 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.8 t90 -62.82 124.07 20.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.671 0.748 . . . . 0.0 110.16 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -91.65 126.05 36.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.561 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -79.92 125.45 81.96 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 119.032 -0.508 . . . . 0.0 110.119 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -109.12 92.68 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 120.823 1.33 . . . . 0.0 112.454 -2.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -114.11 -61.26 1.77 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.401 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.426 ' O ' ' CG ' ' A' ' 123' ' ' ASP . 15.7 t -69.99 -30.76 68.17 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.689 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 122' ' ' SER . 4.6 p-10 48.89 -175.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.622 0.725 . . . . 0.0 111.947 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 tt -71.84 -43.5 65.42 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.711 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 125' ' ' LEU . 0.6 OUTLIER -51.53 -37.76 50.94 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -64.09 -41.42 98.49 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.8 tp -59.14 -40.87 86.83 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -73.16 -45.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.577 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.78 -33.22 68.41 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.097 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.573 ' O ' HG12 ' A' ' 134' ' ' VAL . 67.4 t -68.61 -37.75 78.08 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 53.2 tpp -59.79 -42.45 93.41 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.1 mp -66.3 -44.5 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.603 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.4 t -74.2 -40.83 51.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.6 HG13 ' CD1' ' A' ' 135' ' ' PHE . 2.5 p -78.66 -13.62 13.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.678 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.6 ' CD1' HG13 ' A' ' 134' ' ' VAL . 10.3 m-30 -108.49 -17.59 13.94 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.436 178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.66 -27.53 70.01 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 107.435 -2.266 . . . . 0.0 107.435 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -65.29 -35.83 82.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.019 -0.59 . . . . 0.0 110.618 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -166.88 84.89 0.86 Allowed Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -47.78 114.65 1.15 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.327 1.351 . . . . 0.0 109.852 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.33 -21.05 27.71 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.797 1.665 . . . . 0.0 111.235 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.67 147.08 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.094 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 20.2 p90 . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.723 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.446 -0.657 0 CA-C-O 121.39 0.614 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.18 151.79 19.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.514 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 93.0 mt-10 -62.6 -41.89 99.25 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.358 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.4 m -59.05 -45.03 91.78 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.017 0.913 . . . . 0.0 109.58 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -64.91 -36.5 84.56 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.207 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.946 HD23 HG13 ' A' ' 22' ' ' VAL . 38.2 tp -56.58 -40.02 74.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.768 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 3.3 mptp? -62.46 -42.78 99.72 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.844 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -66.32 -33.4 75.64 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.894 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.583 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -69.49 -36.02 76.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.036 -178.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 8' ' ' LEU . 1.6 m -120.02 30.96 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 111.162 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.1 p -69.27 -12.9 62.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.727 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -85.6 -12.92 50.31 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 121.016 -0.273 . . . . 0.0 111.386 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.456 ' CE1' HD23 ' A' ' 52' ' ' LEU . 5.8 m-85 -71.94 151.13 43.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.005 0.431 . . . . 0.0 111.109 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -70.94 -38.07 72.87 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -111.28 64.22 0.61 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.478 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.5 ptp85 -66.81 -30.35 70.52 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.44 -42.97 78.08 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.09 -38.33 61.26 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.784 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 25' ' ' THR . 99.2 m -62.58 -41.79 99.16 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.057 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.946 HG13 HD23 ' A' ' 8' ' ' LEU . 45.4 t -71.29 -46.14 66.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.439 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -63.98 -44.06 93.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.333 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.554 ' OE2' HD12 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -68.27 -29.35 68.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.385 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 21' ' ' THR . 28.2 p -70.14 -37.83 75.37 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.717 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.77 -43.32 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -60.63 -40.25 91.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.29 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.465 HG21 ' HB3' ' A' ' 124' ' ' LEU . 68.4 t -70.1 -42.55 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.99 -16.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.22 -178.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.7 m -80.86 -49.41 11.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.6 tp -83.19 -37.15 24.02 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.269 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.36 68.45 0.7 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.467 0.651 . . . . 0.0 109.381 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -58.39 -18.9 31.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.944 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.18 -21.08 66.72 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.458 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.525 HD23 HD13 ' A' ' 55' ' ' LEU . 2.4 tp -93.78 113.51 25.57 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -109.87 125.25 31.57 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 119.451 1.023 . . . . 0.0 112.352 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -80.31 138.68 12.65 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.655 1.57 . . . . 0.0 113.149 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.37 156.56 39.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.583 HD13 ' SD ' ' A' ' 11' ' ' MET . 22.8 tp -97.1 107.56 20.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -110.04 130.19 55.57 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.071 0.462 . . . . 0.0 111.609 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.8 p -79.89 131.87 35.95 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.4 t80 . . . . . 0 C--O 1.238 0.47 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.115 -178.897 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 121.107 0.479 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.21 105.64 13.46 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.057 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.456 HD23 ' CE1' ' A' ' 15' ' ' TYR . 15.2 mt -119.29 125.19 48.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.105 0.479 . . . . 0.0 110.01 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -92.83 138.42 31.5 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.606 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -127.44 152.22 47.82 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.18 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.525 HD13 HD23 ' A' ' 35' ' ' LEU . 7.4 mt -97.37 130.11 44.55 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.3 m -141.2 137.63 32.77 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.15 -144.08 8.76 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.405 HG21 ' OD1' ' A' ' 69' ' ' ASN . 22.9 p -136.81 159.71 41.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.5 pt -132.19 115.22 15.1 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.074 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -70.54 125.41 11.71 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.164 1.243 . . . . 0.0 110.293 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.1 t -126.37 121.85 23.78 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.057 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.72 148.7 41.96 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.414 2.076 . . . . 0.0 110.936 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.449 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -163.42 109.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.442 0.639 . . . . 0.0 111.522 -178.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 52.86 37.91 25.4 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.712 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.54 82.01 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -119.34 130.71 55.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -115.29 132.29 56.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.957 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -112.51 148.94 33.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.883 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.405 ' OD1' HG21 ' A' ' 58' ' ' THR . 5.4 t-20 -94.42 106.42 18.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.472 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -91.09 116.25 66.03 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -85.17 124.94 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.808 2.339 . . . . 0.0 110.25 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.472 HG23 HG22 ' A' ' 70' ' ' ILE . 24.6 pt -134.98 148.7 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.572 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.1 m -121.77 123.14 41.12 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.475 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.95 112.81 25.94 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.232 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -105.7 125.29 50.82 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 75.5 mt -92.38 139.33 30.71 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.24 157.95 27.69 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -69.37 -7.66 39.46 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.268 -0.27 . . . . 0.0 111.509 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.57 2.29 23.91 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.916 0.389 . . . . 0.0 110.979 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.421 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 46.1 t80 -57.89 147.79 61.97 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 1.7 Cg_endo -91.22 13.71 52.29 Favored 'Cis proline' 0 N--CA 1.515 2.743 0 CA-C-N 120.975 1.384 . . . . 0.0 114.653 0.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -80.04 -2.61 44.98 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.052 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.83 140.33 33.03 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -66.27 143.11 69.39 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 CA-C-N 121.56 1.593 . . . . 0.0 111.014 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.67 141.38 9.76 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.153 1.902 . . . . 0.0 112.26 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -93.07 129.7 43.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.465 ' SG ' HD12 ' A' ' 109' ' ' ILE . 52.6 t -120.65 141.8 50.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.763 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -127.67 132.16 49.72 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.581 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.475 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 42.8 t -90.41 131.8 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.01 100.02 2.62 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.128 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 64.7 Cg_endo -82.36 166.35 16.08 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 122.222 1.948 . . . . 0.0 112.837 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -145.71 171.3 14.95 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.8 p -57.32 -25.46 59.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 119.866 -0.734 . . . . 0.0 112.036 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 96.7 p -95.14 3.42 54.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.702 0.683 . . . . 0.0 110.794 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 39.3 ttm -141.93 122.02 13.78 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.048 0.452 . . . . 0.0 109.84 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 95.2 m -107.0 140.95 38.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.443 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 97' ' ' ILE . 3.9 tp -75.43 120.74 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -110.64 101.12 9.79 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.7 p -58.31 151.69 19.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.591 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.47 -132.13 1.49 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 119.774 -1.203 . . . . 0.0 112.644 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -86.81 -3.5 59.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -138.92 -25.94 0.86 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 119.402 1.001 . . . . 0.0 113.616 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 t -111.95 135.46 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 119.218 0.917 . . . . 0.0 110.198 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -90.54 -159.97 0.66 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.547 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.39 -8.24 55.34 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.8 -6.14 16.92 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.78 11.47 37.6 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.974 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -72.77 135.98 45.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.399 0.599 . . . . 0.0 110.063 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.465 HD12 ' SG ' ' A' ' 87' ' ' CYS . 69.9 mt -114.8 115.49 49.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 O-C-N 123.311 0.382 . . . . 0.0 110.718 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -115.21 138.77 50.56 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 134' ' ' VAL . 1.3 mp -130.88 130.96 22.96 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.475 -176.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.71 -32.45 55.24 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.125 1.217 . . . . 0.0 113.184 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -67.41 -30.12 69.79 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.26 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.77 -41.22 83.63 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.208 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -64.3 -34.31 77.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.2 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -100.81 2.71 41.41 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.539 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -68.72 124.21 23.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.921 0.867 . . . . 0.0 110.17 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -94.37 124.85 38.64 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.522 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 56.2 t60 -80.83 125.3 80.48 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.643 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 9.5 Cg_endo -108.98 92.19 0.03 OUTLIER 'Cis proline' 0 N--CA 1.5 1.867 0 CA-C-N 120.791 1.318 . . . . 0.0 112.799 -2.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.88 -59.99 1.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.613 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -65.13 -40.93 95.12 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.412 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 58.54 164.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.25 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.554 HD12 ' OE2' ' A' ' 24' ' ' GLU . 1.4 mt -50.89 -48.57 60.39 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.311 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.72 -36.72 26.4 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -63.74 -40.65 98.72 Favored Glycine 0 N--CA 1.477 1.42 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 tp -62.53 -41.73 99.06 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -74.69 -45.87 43.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.619 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -68.85 -36.74 78.52 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.665 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 134' ' ' VAL . 56.1 t -66.99 -40.3 85.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.873 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.8 ttm -58.23 -43.24 87.63 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.434 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -60.3 -35.2 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.74 178.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.4 t -89.64 -50.1 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.677 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.534 HG13 ' CD1' ' A' ' 135' ' ' PHE . 4.7 p -65.21 -13.85 15.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.832 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.534 ' CD1' HG13 ' A' ' 134' ' ' VAL . 13.5 m-30 -106.78 -17.23 14.27 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.586 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.89 -27.89 73.51 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.82 -34.72 79.03 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.785 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -165.91 85.43 0.97 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -45.7 113.32 0.54 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.37 1.38 . . . . 0.0 110.533 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.6 0.44 8.68 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.511 1.474 . . . . 0.0 111.548 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.24 123.56 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.72 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.285 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.419 HG13 ' HE3' ' A' ' 11' ' ' MET . 85.6 t . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 120.908 0.385 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -95.21 157.65 15.8 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 86.6 mt-10 -63.13 -41.92 99.4 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.118 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.1 t -59.71 -49.87 76.06 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.044 0.926 . . . . 0.0 109.383 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -62.69 -28.2 69.77 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.744 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.814 HD23 HG13 ' A' ' 22' ' ' VAL . 59.3 tp -59.77 -42.67 93.8 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.766 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.9 mptp? -58.82 -39.89 82.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.148 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.11 -31.0 72.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.781 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.596 ' CB ' HD13 ' A' ' 39' ' ' LEU . 14.6 ptp -86.39 -14.78 42.39 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.622 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.679 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -125.94 16.5 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.83 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.3 t -59.78 -21.98 61.53 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.496 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -84.04 -15.96 45.64 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -70.09 152.18 44.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.003 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -70.02 -37.64 75.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.838 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 40.8 m-85 -110.65 60.66 0.61 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.564 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.4 ptp180 -66.44 -20.73 66.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.125 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -77.04 -52.06 9.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.8 tp -67.93 -41.0 83.24 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.151 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.677 ' O ' HG23 ' A' ' 25' ' ' THR . 66.2 m -61.13 -47.03 88.13 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.778 0.323 . . . . 0.0 110.789 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.814 HG13 HD23 ' A' ' 8' ' ' LEU . 40.3 t -63.25 -42.83 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.654 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -55.31 23.43 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 118.834 -1.147 . . . . 0.0 110.526 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -61.37 -31.83 71.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.367 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 21' ' ' THR . 23.5 p -66.86 -35.26 79.62 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.31 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 22' ' ' VAL . 53.0 t -57.77 -44.03 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.19 -39.88 88.11 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.307 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 124' ' ' LEU . 79.1 t -69.84 -43.36 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -88.25 -17.4 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.567 -178.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.2 m -82.35 -49.05 10.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.192 0.52 . . . . 0.0 109.617 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.531 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.3 tm? -81.89 -38.99 24.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.525 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -110.2 67.44 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -56.14 -18.92 11.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.953 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.31 -21.54 66.72 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.038 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.562 HD13 HD12 ' A' ' 128' ' ' ILE . 1.6 tp -94.15 113.18 25.08 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.19 119.02 43.2 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 119.181 0.9 . . . . 0.0 112.091 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 92.5 Cg_endo -78.29 137.53 15.14 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 CA-C-N 120.653 1.269 . . . . 0.0 112.282 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.539 HG23 ' OD1' ' A' ' 40' ' ' ASP . 27.0 m -126.19 150.9 32.07 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.596 HD13 ' CB ' ' A' ' 11' ' ' MET . 44.1 tp -97.78 119.3 36.13 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.113 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.539 ' OD1' HG23 ' A' ' 38' ' ' VAL . 10.5 m-20 -135.43 135.44 40.58 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.016 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.0 t -64.22 139.97 58.82 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.37 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.014 -178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 121.435 0.636 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -77.07 121.74 23.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.264 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -124.04 144.51 49.8 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.054 0.454 . . . . 0.0 110.31 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -100.2 141.22 33.33 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.646 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.413 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 6.2 p-10 -133.08 154.28 50.71 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.388 0.613 . . . . 0.0 111.863 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.481 ' HG ' HD23 ' A' ' 35' ' ' LEU . 4.6 mm? -93.49 124.94 37.82 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.575 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.4 m -139.29 136.98 35.46 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.44 -145.6 10.13 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.836 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 p -134.61 159.74 40.27 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 59' ' ' ILE . 1.3 pt -131.83 116.21 15.82 Favored Pre-proline 0 N--CA 1.471 0.594 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.178 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -71.97 124.4 10.08 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 N-CA-C 109.538 -0.986 . . . . 0.0 109.538 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.42 121.35 24.89 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.891 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.39 149.03 55.92 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.197 1.931 . . . . 0.0 110.429 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.7 109.7 1.09 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.521 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.96 40.59 25.62 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.439 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.72 13.84 80.22 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -134.71 127.86 31.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.5 m -112.02 133.1 54.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.84 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -113.89 150.63 33.37 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -95.16 108.72 20.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.492 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -97.21 116.16 65.9 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.34 124.77 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.658 2.238 . . . . 0.0 110.75 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.492 HG23 HG22 ' A' ' 70' ' ' ILE . 26.9 pt -132.79 147.99 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 119.421 -0.911 . . . . 0.0 111.994 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 63.8 m -123.88 121.58 35.73 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.071 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.81 114.41 28.61 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.489 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.413 ' CE3' ' HB3' ' A' ' 54' ' ' ASN . 48.3 m95 -102.1 115.29 30.23 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.1 mt -85.9 135.15 33.8 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -80.28 155.34 27.33 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -60.68 -17.18 46.18 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.746 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.61 -3.02 50.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.523 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -57.09 144.42 69.23 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.41 ' HG2' ' CD2' ' A' ' 119' ' ' HIS . 25.0 Cg_endo -92.04 9.13 60.74 Favored 'Cis proline' 0 N--CA 1.521 3.101 0 N-CA-C 115.936 1.475 . . . . 0.0 115.936 0.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.409 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 42.7 m-85 -76.94 -11.97 59.88 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.636 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.86 127.17 27.11 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.511 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -49.39 132.49 29.47 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 CA-C-N 121.21 1.468 . . . . 0.0 112.467 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HD2' HD11 ' A' ' 114' ' ' LEU . 96.6 Cg_endo -86.04 143.83 8.14 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 122.574 2.183 . . . . 0.0 111.878 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 86' ' ' ILE . 1.4 mp -97.43 132.97 40.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.39 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 46.1 t -116.47 143.57 45.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.176 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -127.89 129.95 47.74 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.954 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.28 121.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.82 107.53 1.35 Allowed Pre-proline 0 N--CA 1.474 0.744 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.019 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.03 156.64 13.27 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 CA-C-N 120.675 1.277 . . . . 0.0 112.772 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -136.14 171.69 14.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.43 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.8 t -58.55 -40.67 83.69 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.5 m -96.79 20.73 10.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.037 0.835 . . . . 0.0 111.126 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.0 ttm -137.96 141.16 40.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -137.29 162.76 32.65 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.174 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.433 ' N ' HG23 ' A' ' 96' ' ' THR . 67.9 mt -97.95 103.43 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -90.59 109.96 21.11 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.8 p -59.85 147.4 38.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.282 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.88 -145.3 4.15 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.518 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -64.14 -27.5 69.12 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.515 ' NE2' HG23 ' A' ' 103' ' ' VAL . 13.1 p-80 -132.63 -15.63 2.72 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 119.167 -1.013 . . . . 0.0 113.214 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.517 HG21 ' CB ' ' A' ' 140' ' ' PRO . 23.8 t -91.93 129.27 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.438 1.017 . . . . 0.0 111.375 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.429 ' O ' HG12 ' A' ' 103' ' ' VAL . 36.9 p-10 -89.72 -168.79 2.24 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.71 -22.79 25.83 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.683 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -82.24 -8.0 59.63 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.623 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.21 -0.7 62.18 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.098 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.404 ' N ' ' OD1' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -63.71 143.58 57.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -110.87 122.46 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -99.86 139.91 34.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.606 HD22 HG11 ' A' ' 134' ' ' VAL . 28.4 mt -139.55 117.92 8.78 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.83 -29.47 63.17 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.553 1.502 . . . . 0.0 114.056 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -69.23 -30.76 68.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.875 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.434 HD11 ' HD2' ' A' ' 85' ' ' PRO . 1.1 tt -71.75 -41.05 68.92 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.043 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -72.3 -25.5 61.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.309 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -102.23 -4.69 25.33 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.483 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 7.2 t90 -53.07 121.32 7.2 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.94 0.876 . . . . 0.0 110.503 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -96.42 106.61 18.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.491 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 44.9 t-80 -61.95 125.26 84.72 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.133 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 21.8 Cg_endo -111.05 90.78 0.03 OUTLIER 'Cis proline' 0 N--CA 1.488 1.201 0 CA-C-N 120.676 1.277 . . . . 0.0 112.831 -3.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -114.59 -55.2 2.51 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.428 -0.509 . . . . 0.0 112.142 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 p -70.54 -39.42 74.03 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.387 0.613 . . . . 0.0 110.767 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 t70 59.28 165.59 0.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.408 0.623 . . . . 0.0 111.091 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.9 tt -62.2 -43.68 98.29 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.566 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -52.12 -36.32 50.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.27 -39.52 97.82 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.2 tp -59.48 -40.99 88.78 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.562 HD12 HD13 ' A' ' 35' ' ' LEU . 1.2 mm -75.32 -49.91 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.206 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -63.74 -37.7 88.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.161 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 134' ' ' VAL . 54.4 t -66.29 -38.59 82.19 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 C-N-CA 119.465 -0.894 . . . . 0.0 108.712 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.4 tpp -58.48 -43.3 88.92 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.11 -43.54 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.453 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.3 t -77.78 -42.02 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.606 HG11 HD22 ' A' ' 111' ' ' LEU . 3.7 p -75.91 -13.22 14.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.014 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.526 ' CD1' HG13 ' A' ' 134' ' ' VAL . 6.2 m-30 -104.81 -18.37 14.26 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.602 177.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.31 -20.83 79.44 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -68.72 -36.16 78.08 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.653 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -164.47 90.91 1.03 Allowed Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -44.9 109.96 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.304 1.336 . . . . 0.0 110.382 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.517 ' CB ' HG21 ' A' ' 103' ' ' VAL . 34.9 Cg_exo -58.02 -26.14 73.81 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.77 1.647 . . . . 0.0 109.942 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.58 146.91 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.957 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 9.0 p90 . . . . . 0 N--CA 1.476 0.829 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.997 -179.86 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.443 -0.779 0 CA-C-O 121.401 0.62 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 p -100.46 158.12 16.14 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.492 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.4 mt-10 -62.76 -42.04 99.5 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.525 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 t -59.81 -48.7 80.63 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.839 0.828 . . . . 0.0 109.593 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -62.42 -31.98 72.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.307 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.846 HD23 HG13 ' A' ' 22' ' ' VAL . 25.1 tp -57.86 -40.61 80.56 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.538 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.7 mptp? -60.83 -41.79 96.46 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.441 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.06 -37.84 86.53 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.465 0.65 . . . . 0.0 109.902 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.797 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -69.83 -38.57 76.58 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.477 -177.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.3 m -112.65 16.1 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -65.13 -25.51 67.79 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.368 0.604 . . . . 0.0 109.987 178.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.05 -13.57 62.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.037 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.476 ' CE1' HG12 ' A' ' 12' ' ' VAL . 14.2 m-85 -82.22 159.93 23.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -81.9 -27.67 33.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.781 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CZ ' ' CE1' ' A' ' 82' ' ' TYR . 62.5 m-85 -113.77 58.57 0.67 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -65.59 -24.93 67.19 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -79.46 -50.45 10.76 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 121.419 -0.801 . . . . 0.0 112.168 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 20' ' ' LEU . 13.0 tp -65.27 -40.62 94.15 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.548 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -61.56 -46.48 89.72 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.301 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.846 HG13 HD23 ' A' ' 8' ' ' LEU . 7.6 t -61.36 -45.03 99.45 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 CA-C-O 121.089 0.471 . . . . 0.0 110.166 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -40.15 91.4 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.705 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -38.13 80.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.328 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 29' ' ' ILE . 17.7 p -67.58 -33.73 75.6 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.738 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.07 -44.81 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.519 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -60.77 -37.49 82.05 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.098 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.438 HG21 HD13 ' A' ' 124' ' ' LEU . 78.9 t -70.77 -44.18 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.93 -22.11 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.004 -1.079 . . . . 0.0 111.615 -178.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.2 m -72.62 -43.64 63.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.939 0.4 . . . . 0.0 110.645 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -88.0 -38.64 15.33 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.749 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.7 66.74 0.65 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -55.99 -17.85 7.83 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.093 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.38 -21.38 66.61 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.966 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.471 HD23 HD13 ' A' ' 55' ' ' LEU . 3.9 tp -89.69 113.62 25.14 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -109.11 125.39 31.63 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-N 119.686 1.13 . . . . 0.0 111.829 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.68 136.31 13.53 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.323 1.348 . . . . 0.0 112.66 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.3 133.65 68.28 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.797 HD13 ' SD ' ' A' ' 11' ' ' MET . 21.8 tp -83.11 118.7 23.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.94 132.89 50.75 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.3 m -62.44 140.42 58.58 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.625 -177.713 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.0 ttm105 . . . . . 0 CA--C 1.517 -0.316 0 CA-C-O 121.05 0.452 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -72.97 117.33 14.57 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.419 HD21 ' O ' ' A' ' 76' ' ' LEU . 13.3 tp -115.91 121.85 43.56 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -83.81 137.04 33.9 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -132.71 154.73 49.89 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.29 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.471 HD13 HD23 ' A' ' 35' ' ' LEU . 7.6 mt -102.2 122.26 43.85 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.8 m -135.1 137.52 42.91 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.19 -147.05 10.7 Favored Glycine 0 N--CA 1.47 0.955 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.909 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 p -132.75 158.45 42.37 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.447 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.3 pt -131.6 116.99 16.3 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.168 177.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -71.28 128.02 14.13 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.832 1.021 . . . . 0.0 109.801 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 74.4 t -127.1 119.52 22.22 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.696 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -64.48 146.1 88.85 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.064 1.842 . . . . 0.0 109.534 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -161.83 106.96 1.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.867 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.4 36.53 13.36 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.83 -6.98 79.25 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.438 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -117.5 146.08 43.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.0 m -123.31 134.36 54.06 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.951 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -116.62 149.92 38.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.27 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.71 105.26 17.38 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.452 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -93.9 120.58 65.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.55 123.59 3.39 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.818 2.345 . . . . 0.0 110.88 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.452 HG23 HG22 ' A' ' 70' ' ' ILE . 32.5 pt -128.96 146.04 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 119.131 -1.027 . . . . 0.0 112.168 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.4 m -120.54 122.47 40.68 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-O 121.67 0.747 . . . . 0.0 109.634 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.19 112.51 25.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.165 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -107.67 123.41 48.47 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.419 ' O ' HD21 ' A' ' 52' ' ' LEU . 62.1 mt -90.88 130.98 36.78 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.659 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mt -72.72 153.31 41.21 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.376 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -60.33 -12.79 10.08 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p -103.28 -1.22 29.16 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -48.23 146.24 4.68 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -95.6 19.46 33.06 Favored 'Cis proline' 0 N--CA 1.517 2.885 0 N-CA-C 116.616 1.737 . . . . 0.0 116.616 2.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.424 ' CE1' ' CZ ' ' A' ' 17' ' ' TYR . 46.3 m-85 -80.52 -1.03 40.14 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.192 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.31 126.13 24.65 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.601 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -50.87 137.49 43.19 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 121.66 1.629 . . . . 0.0 109.67 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.81 144.13 19.05 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 121.824 1.682 . . . . 0.0 111.852 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mt -88.46 130.6 37.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.596 0.713 . . . . 0.0 109.276 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.8 t -119.53 136.97 54.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.496 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -123.67 129.86 51.76 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.376 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.0 t -93.11 120.97 43.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -63.56 107.27 1.19 Allowed Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.689 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -84.13 158.71 13.32 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.549 1.5 . . . . 0.0 112.262 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.7 p -139.15 174.48 10.47 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.928 0.394 . . . . 0.0 110.66 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -59.35 -39.92 84.76 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -101.12 12.08 38.28 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.985 0.811 . . . . 0.0 111.174 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 8.7 mmm -130.54 119.98 23.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -118.68 162.71 17.97 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.181 -178.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.448 ' N ' HG23 ' A' ' 96' ' ' THR . 80.0 mt -97.79 108.02 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -91.19 106.62 18.64 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.7 p -62.55 142.35 58.02 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.49 -139.29 2.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.157 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -66.46 -25.71 66.85 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.544 ' NE2' HG23 ' A' ' 103' ' ' VAL . 5.9 p-80 -133.32 -20.85 2.08 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.627 HG21 ' HB2' ' A' ' 140' ' ' PRO . 22.2 t -91.93 133.56 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.241 0.928 . . . . 0.0 111.332 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -98.13 -168.72 1.7 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.001 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.82 -29.66 29.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -84.19 3.13 36.53 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.821 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.45 6.18 58.72 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.432 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -59.13 137.47 57.94 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.991 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -114.95 112.98 42.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.633 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -99.9 140.73 33.69 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.962 HD22 HG11 ' A' ' 134' ' ' VAL . 32.2 mt -137.77 121.68 11.77 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.832 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.06 -39.02 25.26 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.666 1.577 . . . . 0.0 113.611 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -61.55 -31.27 71.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.666 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.89 -42.78 84.93 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.472 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -62.46 -36.48 82.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.604 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -95.74 -0.22 51.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.654 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -62.76 125.27 23.39 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.796 0.807 . . . . 0.0 110.228 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -109.03 106.84 16.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.858 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 63.4 t60 -60.64 124.05 77.16 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.451 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 7.8 Cg_endo -108.57 91.67 0.03 OUTLIER 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 120.354 1.162 . . . . 0.0 112.646 -2.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -113.49 -62.77 1.54 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.392 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.0 t -67.13 -41.17 86.61 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.23 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.8 t70 68.04 166.27 0.24 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.751 0.786 . . . . 0.0 112.008 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.2 tt -64.11 -44.58 91.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.319 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 125' ' ' LEU . 0.6 OUTLIER -52.42 -38.45 59.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.521 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.07 -40.48 98.57 Favored Glycine 0 N--CA 1.478 1.499 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.7 tp -59.75 -41.17 90.41 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.54 -46.98 46.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.854 -0.738 . . . . 0.0 111.886 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -68.16 -35.72 78.5 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 134' ' ' VAL . 53.4 t -66.08 -37.5 79.91 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.1 tpp -58.9 -44.34 91.19 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.447 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -63.41 -32.52 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.734 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.54 -46.04 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.343 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.962 HG11 HD22 ' A' ' 111' ' ' LEU . 4.5 p -70.1 -13.79 17.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.988 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.482 ' CD1' HG13 ' A' ' 134' ' ' VAL . 6.0 m-30 -103.25 -17.26 15.4 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.258 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.13 -31.05 54.01 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.73 -37.9 89.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.745 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -155.85 82.26 3.7 Favored Pre-proline 0 N--CA 1.447 -0.603 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -44.49 112.36 0.35 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.818 1.679 . . . . 0.0 111.144 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.627 ' HB2' HG21 ' A' ' 103' ' ' VAL . 32.2 Cg_endo -67.21 -22.32 46.92 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.656 1.57 . . . . 0.0 111.698 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.8 m -128.48 140.49 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.853 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.2 p90 . . . . . 0 N--CA 1.473 0.703 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.107 -179.642 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 CA--C 1.514 -0.428 0 CA-C-O 121.077 0.465 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -93.54 161.13 14.49 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.486 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 3.2 mm-40 -65.82 -43.04 89.79 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.837 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -59.57 -48.52 81.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 122.034 0.921 . . . . 0.0 109.126 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -62.9 -29.09 70.5 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.9 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.848 HD23 HG13 ' A' ' 22' ' ' VAL . 65.9 tp -60.32 -42.24 95.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.728 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.635 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.6 mptp? -59.69 -39.39 84.39 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.898 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -61.76 -33.88 74.86 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.408 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.691 ' CB ' HD13 ' A' ' 39' ' ' LEU . 17.5 ptp -85.48 -13.3 49.54 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.4 m -128.16 16.98 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.882 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -61.06 -38.25 85.52 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.111 0.481 . . . . 0.0 111.222 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -62.58 -18.72 62.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.825 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -72.26 153.15 41.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.92 0.391 . . . . 0.0 111.52 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -78.68 -29.21 45.44 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.016 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.412 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 45.0 m-85 -112.2 55.32 0.68 Allowed 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.987 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 22' ' ' VAL . 17.4 ptt180 -63.65 -27.55 69.3 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.73 -52.18 22.59 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -40.09 83.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.324 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.3 m -61.73 -46.81 88.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.093 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.848 HG13 HD23 ' A' ' 8' ' ' LEU . 51.7 t -64.34 -46.95 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.034 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 tmt_? -63.22 -41.75 99.18 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.426 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -66.7 -37.99 85.85 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.258 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.644 ' O ' HG23 ' A' ' 29' ' ' ILE . 16.5 p -64.17 -33.86 76.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.07 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.58 -44.75 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.097 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -60.58 -37.82 82.57 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.902 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.615 HG21 HD23 ' A' ' 124' ' ' LEU . 73.6 t -69.97 -44.08 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.89 -18.76 8.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 118.807 -1.157 . . . . 0.0 111.447 -178.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.3 m -74.27 -44.81 51.3 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.068 0.461 . . . . 0.0 110.07 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.783 HD23 HD21 ' A' ' 125' ' ' LEU . 24.7 tp -87.02 -37.86 17.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.407 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -114.56 67.58 0.69 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.864 0.364 . . . . 0.0 110.252 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -56.3 -17.33 7.38 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.084 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -65.65 -21.0 66.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.896 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.433 ' CD2' HD13 ' A' ' 55' ' ' LEU . 2.0 tp -95.99 113.65 25.28 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -114.44 136.74 22.38 Favored Pre-proline 0 C--N 1.357 0.923 0 CA-C-N 119.596 1.089 . . . . 0.0 111.614 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -79.75 136.75 12.26 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.003 1.802 . . . . 0.0 113.033 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.7 t -129.21 138.07 55.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.691 HD13 ' CB ' ' A' ' 11' ' ' MET . 22.7 tp -89.51 113.69 25.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.115 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -119.84 139.64 52.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.407 0.622 . . . . 0.0 112.417 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.1 m -71.71 140.79 49.74 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.463 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.7 t80 . . . . . 0 N--CA 1.476 0.859 0 CA-C-N 118.388 0.54 . . . . 0.0 110.077 179.85 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.3 ttm-85 . . . . . 0 N--CA 1.472 0.641 0 CA-C-O 120.949 0.404 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -79.14 122.6 26.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.523 0.678 . . . . 0.0 109.883 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.549 HD23 ' HE3' ' A' ' 75' ' ' TRP . 12.0 tp -120.99 124.38 44.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.693 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -85.28 140.76 30.58 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.014 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -136.73 147.0 46.47 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.012 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 35' ' ' LEU . 6.7 mt -92.96 127.45 38.47 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.4 m -138.81 138.68 37.78 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.26 -143.09 8.19 Favored Glycine 0 N--CA 1.466 0.661 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.459 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.1 p -134.36 160.14 38.87 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -132.37 116.11 15.16 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.036 -0.983 . . . . 0.0 108.927 177.022 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -69.58 123.28 10.0 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 120.822 1.015 . . . . 0.0 110.691 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.0 t -124.0 106.76 31.11 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.113 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.75 147.02 13.48 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 123.307 2.671 . . . . 0.0 113.21 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -163.93 118.84 1.55 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.953 0.882 . . . . 0.0 111.282 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.67 41.0 25.37 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 -1.44 87.05 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.419 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -119.28 129.29 54.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.239 0.52 . . . . 0.0 109.841 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.5 m -120.82 129.62 53.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.499 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -108.59 145.28 35.11 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.963 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.35 100.72 12.46 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.515 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -88.68 118.09 68.99 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.04 124.12 2.08 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.779 2.319 . . . . 0.0 110.417 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.515 HG23 HG22 ' A' ' 70' ' ' ILE . 29.3 pt -134.23 148.63 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.182 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.0 m -118.48 122.03 41.72 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 109.533 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.48 106.12 17.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.996 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.549 ' HE3' HD23 ' A' ' 52' ' ' LEU . 53.8 m95 -94.18 129.82 40.64 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.536 ' O ' HD21 ' A' ' 52' ' ' LEU . 1.3 mp -98.26 141.81 30.71 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.228 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.14 145.61 30.03 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -57.68 -9.87 1.37 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.4 p -114.89 17.31 17.02 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.9 0.381 . . . . 0.0 111.876 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -57.74 143.08 77.16 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -93.41 7.56 57.2 Favored 'Cis proline' 0 N--CA 1.515 2.792 0 CA-C-N 120.99 1.389 . . . . 0.0 115.303 0.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.412 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 36.9 m-85 -73.86 -7.65 53.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.046 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.58 115.12 37.65 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -49.98 134.66 36.08 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 CA-C-N 121.062 1.415 . . . . 0.0 112.373 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.23 143.95 14.34 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.216 1.944 . . . . 0.0 111.684 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.482 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -98.57 152.1 4.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.247 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.7 t -138.52 135.7 35.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.026 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -118.4 128.7 54.88 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.816 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.445 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 61.2 t -89.69 129.66 40.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.97 99.94 2.54 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 123.267 0.355 . . . . 0.0 110.945 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 43.8 Cg_endo -84.89 150.88 11.14 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.652 1.568 . . . . 0.0 113.058 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.2 p -116.25 168.08 10.44 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.719 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.4 m -56.03 -34.05 65.51 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.3 m -87.3 20.89 2.61 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.781 0.718 . . . . 0.0 110.591 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 30.9 ttm -144.76 146.58 32.22 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.0 m -124.56 140.7 52.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 97' ' ' ILE . 1.7 tp -85.84 103.97 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.243 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -87.82 102.14 14.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.258 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 74.2 p -72.21 148.68 45.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.612 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -172.86 -138.97 2.72 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -87.89 -3.84 58.89 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -122.21 -30.28 4.04 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.294 0.952 . . . . 0.0 112.242 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 t -112.04 134.65 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.882 0.765 . . . . 0.0 109.268 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -93.01 162.04 14.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.031 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.95 -32.44 73.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.467 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -76.93 -6.23 51.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.7 5.62 59.93 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.844 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.15 147.48 40.44 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.5 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 86.0 mt -106.36 121.44 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.125 0.488 . . . . 0.0 111.236 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -102.35 120.27 40.22 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mt -126.75 122.34 23.47 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.258 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.04 -30.08 85.4 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 121.474 1.449 . . . . 0.0 114.363 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -66.67 -31.0 71.39 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.815 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 tt -69.59 -41.36 75.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.967 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -66.98 -28.3 68.15 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.375 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -104.29 1.59 30.56 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.521 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -68.95 125.94 28.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.872 0.844 . . . . 0.0 110.221 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -98.07 130.16 44.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.03 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 29.2 t60 -79.06 124.27 84.71 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.537 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 12.1 Cg_endo -112.06 92.1 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.563 0 CA-C-N 120.929 1.367 . . . . 0.0 112.786 -2.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -113.77 -52.8 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.088 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.9 p -74.62 -40.07 61.76 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.368 0.604 . . . . 0.0 110.694 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 59.47 164.65 0.05 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.956 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.615 HD23 HG21 ' A' ' 28' ' ' VAL . 6.2 tp -58.29 -44.94 88.72 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.104 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.783 HD21 HD23 ' A' ' 31' ' ' LEU . 9.0 tp -52.72 -35.43 55.77 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -64.7 -38.97 96.31 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.9 tp -58.91 -40.3 84.1 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.487 -0.419 . . . . 0.0 111.877 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -76.53 -45.71 32.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.343 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -69.2 -34.34 74.73 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 126' ' ' GLY . 55.7 t -66.67 -38.58 81.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 48.1 tpp -60.67 -44.0 97.0 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.434 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.1 mp -63.73 -38.27 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.385 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.7 t -82.25 -48.25 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 130' ' ' VAL . 2.5 p -69.17 -16.17 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.717 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.5 ' HZ ' HG23 ' A' ' 109' ' ' ILE . 12.6 m-30 -107.27 -19.68 13.52 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.001 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.93 -34.61 90.4 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -62.91 -37.89 88.77 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.997 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -154.87 90.38 3.06 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -45.87 116.59 1.48 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.419 1.412 . . . . 0.0 110.609 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.92 -14.5 35.65 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.627 1.552 . . . . 0.0 111.54 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.24 133.2 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.332 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.6 p90 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.807 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 120.999 0.428 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -95.66 158.41 15.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -65.28 -39.21 92.29 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.65 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.8 m -60.08 -41.98 93.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.352 1.072 . . . . 0.0 109.139 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -68.5 -39.64 81.19 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.052 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.034 HD23 HG13 ' A' ' 22' ' ' VAL . 12.1 tp -53.74 -33.53 56.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.442 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 4.7 mmtt -68.11 -47.7 67.48 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.031 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.98 -34.87 73.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.633 0.73 . . . . 0.0 110.216 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.829 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.9 mmm -64.51 -37.06 86.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.042 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -122.17 23.91 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.565 0.221 . . . . 0.0 110.941 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 9' ' ' LYS . 99.9 p -66.24 -23.72 66.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.543 0.211 . . . . 0.0 111.345 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -77.53 -18.74 56.72 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.326 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.525 ' OH ' HD22 ' A' ' 52' ' ' LEU . 39.1 m-85 -69.93 143.34 52.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.469 0.652 . . . . 0.0 111.603 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -21.74 64.05 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.339 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 96.7 m-85 -121.89 55.43 1.11 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.591 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.7 ptp180 -65.34 -26.18 67.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 119.871 -0.732 . . . . 0.0 112.808 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -67.02 -56.13 11.43 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 20' ' ' LEU . 13.0 mt -65.68 -40.3 92.2 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.47 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 25' ' ' THR . 75.3 m -61.95 -49.68 75.18 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.708 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.034 HG13 HD23 ' A' ' 8' ' ' LEU . 53.3 t -64.26 -47.56 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 120.513 0.197 . . . . 0.0 110.74 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -65.1 -40.9 95.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.37 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -63.99 -38.75 92.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.694 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.664 ' O ' HG23 ' A' ' 29' ' ' ILE . 26.2 p -66.91 -38.69 86.71 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.74 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 30' ' ' THR . 55.7 t -56.58 -44.39 80.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.489 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -62.86 -39.52 94.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.702 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 124' ' ' LEU . 51.6 t -66.78 -44.09 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -81.95 -13.12 12.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.3 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.8 p -80.98 -48.68 11.93 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.788 0.328 . . . . 0.0 110.589 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 125' ' ' LEU . 32.5 tp -88.09 -36.59 16.84 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.399 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -109.78 66.19 0.63 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -57.17 -19.16 18.79 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.134 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -66.46 -18.18 65.21 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.384 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.599 HD13 HD12 ' A' ' 128' ' ' ILE . 2.6 tp -98.26 113.51 25.47 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -110.63 135.87 20.69 Favored Pre-proline 0 C--N 1.354 0.801 0 CA-C-N 119.354 0.979 . . . . 0.0 111.391 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.87 139.41 22.07 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.462 1.441 . . . . 0.0 111.794 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 p -133.79 147.06 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.829 HD13 ' SD ' ' A' ' 11' ' ' MET . 22.3 tp -99.1 119.67 38.22 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.585 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -121.69 135.77 54.95 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.039 0.447 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.5 p -70.92 139.79 50.8 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.0 t80 . . . . . 0 C--O 1.236 0.374 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.725 -179.569 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.235 0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 110.097 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.611 ' CG ' HD11 ' A' ' 39' ' ' LEU . 7.0 tp10 -85.1 106.32 16.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.525 HD22 ' OH ' ' A' ' 15' ' ' TYR . 36.6 mt -110.13 142.9 40.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.454 0.645 . . . . 0.0 111.349 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.474 ' SD ' HD12 ' A' ' 8' ' ' LEU . 55.3 ttp -105.61 142.42 35.38 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.804 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -136.35 154.47 50.83 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.561 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.453 HD13 HD23 ' A' ' 35' ' ' LEU . 7.3 mt -95.41 120.18 35.2 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.3 m -132.9 135.19 45.43 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.22 -149.21 11.94 Favored Glycine 0 N--CA 1.464 0.51 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.481 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.0 p -133.11 158.36 42.99 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.433 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.5 pt -129.12 116.03 18.82 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.27 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -72.48 125.6 10.82 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 N-CA-C 109.495 -1.002 . . . . 0.0 109.495 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.17 126.77 21.65 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 119.688 -0.805 . . . . 0.0 112.001 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.83 148.66 46.49 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.271 1.981 . . . . 0.0 110.498 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.93 112.61 1.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.609 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.96 32.01 11.93 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.88 -0.513 . . . . 0.0 111.857 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.51 -10.21 67.91 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -110.32 137.78 47.58 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.9 m -115.27 131.72 56.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.671 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -114.6 152.38 31.92 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.296 0.569 . . . . 0.0 110.906 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -98.92 103.81 15.8 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.447 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -91.13 118.67 68.68 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -85.55 126.45 3.06 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.786 2.324 . . . . 0.0 110.944 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.447 HG23 HG22 ' A' ' 70' ' ' ILE . 30.5 pt -133.74 149.86 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.819 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 m -124.05 122.55 38.18 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.762 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.2 112.22 25.14 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.315 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -103.01 125.41 49.75 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.2 mt -88.12 140.04 29.89 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.898 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 tp -93.91 143.69 26.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -48.27 -18.29 0.2 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.68 16.94 25.19 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -69.84 144.58 93.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -92.87 4.27 60.21 Favored 'Cis proline' 0 N--CA 1.514 2.694 0 CA-C-N 121.426 1.545 . . . . 0.0 115.422 1.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 36.0 m-85 -73.34 -15.62 61.38 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.637 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.23 120.26 44.81 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.71 134.4 33.95 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.253 1.483 . . . . 0.0 111.701 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.08 145.11 21.72 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.956 1.77 . . . . 0.0 110.76 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.33 131.52 41.89 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 119.179 -1.009 . . . . 0.0 109.545 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.7 m -111.86 137.83 49.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.672 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -126.5 128.26 46.64 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.225 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.53 127.52 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.48 109.04 12.51 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.72 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.25 161.56 13.25 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 122.149 1.899 . . . . 0.0 112.882 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.9 p -133.43 173.24 11.69 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.7 m -57.94 -39.27 77.63 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 120.136 -0.626 . . . . 0.0 112.252 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.7 p -92.24 0.52 57.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.64 0.654 . . . . 0.0 111.866 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -130.66 125.59 34.39 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.474 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -113.97 167.44 10.66 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.348 -179.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.474 ' N ' HG23 ' A' ' 96' ' ' THR . 5.8 mm -92.73 105.3 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.546 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -86.71 108.66 18.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.498 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.6 p -67.42 140.16 57.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.418 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.63 -146.78 4.41 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -71.55 -22.2 61.79 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.554 ' NE2' HG23 ' A' ' 103' ' ' VAL . 3.2 p-80 -123.8 -25.0 4.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.329 -0.949 . . . . 0.0 112.914 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.554 HG23 ' NE2' ' A' ' 102' ' ' HIS . 14.2 t -91.25 131.39 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.423 1.01 . . . . 0.0 110.671 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -95.31 -163.4 1.04 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.605 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.08 -13.53 47.04 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.39 -1.55 23.14 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.371 -0.206 . . . . 0.0 110.735 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.76 0.08 42.36 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.767 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.66 128.99 24.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.707 0.754 . . . . 0.0 109.898 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.36 114.5 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 O-C-N 123.264 0.353 . . . . 0.0 110.411 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -96.87 134.3 40.37 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.756 HD22 HG11 ' A' ' 134' ' ' VAL . 33.1 mt -137.71 118.86 10.61 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.859 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -47.51 -38.91 28.61 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 121.793 1.662 . . . . 0.0 114.037 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.83 -29.55 69.56 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.174 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.62 -43.76 75.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.743 0.306 . . . . 0.0 111.645 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -69.35 -28.23 66.03 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.689 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -103.97 4.3 34.43 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.989 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.417 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.0 t90 -68.62 121.65 16.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.717 0.77 . . . . 0.0 109.683 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -90.49 122.9 33.73 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.245 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -79.56 126.78 80.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.738 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -107.7 92.67 0.04 OUTLIER 'Cis proline' 0 N--CA 1.499 1.801 0 CA-C-N 120.802 1.322 . . . . 0.0 112.649 -2.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -115.12 -61.31 1.77 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.586 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.3 t -68.97 -33.82 74.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.762 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 p30 47.82 -177.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.82 0.819 . . . . 0.0 111.962 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 28' ' ' VAL . 2.7 tt -68.28 -39.56 82.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.137 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.414 HD11 HD23 ' A' ' 31' ' ' LEU . 8.2 tt -57.79 -38.74 76.03 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -63.55 -39.28 97.46 Favored Glycine 0 N--CA 1.479 1.561 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.0 tp -58.22 -40.57 82.01 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.427 -0.455 . . . . 0.0 111.768 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.599 HD12 HD13 ' A' ' 35' ' ' LEU . 1.1 mm -72.71 -49.43 40.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.848 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -65.54 -35.96 82.39 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 126' ' ' GLY . 53.4 t -66.86 -37.39 79.34 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 60.9 tpp -58.54 -43.64 89.33 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.433 HD11 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -63.07 -42.77 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.564 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.8 t -77.19 -44.07 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.756 HG11 HD22 ' A' ' 111' ' ' LEU . 2.6 p -73.62 -13.64 16.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.015 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.547 ' CD1' HG13 ' A' ' 134' ' ' VAL . 6.6 m-30 -105.85 -17.59 14.32 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.209 -0.996 . . . . 0.0 109.703 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.69 -34.44 89.64 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.03 -35.5 81.38 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.604 -0.298 . . . . 0.0 110.711 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -155.95 116.52 2.23 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.47 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -75.12 120.48 6.05 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 N-CA-C 108.648 -1.328 . . . . 0.0 108.648 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.524 ' CB ' HG21 ' A' ' 103' ' ' VAL . 36.3 Cg_endo -67.94 -19.05 46.57 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.066 1.177 . . . . 0.0 111.217 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.92 147.95 29.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.56 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.4 p90 . . . . . 0 N--CA 1.47 0.554 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.66 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.9 t . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 121.21 0.528 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.1 156.01 16.8 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.504 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 57.7 mp0 -63.0 -41.51 99.6 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.97 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.8 p -57.38 -47.99 80.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.165 0.984 . . . . 0.0 109.379 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -62.79 -34.52 77.43 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.778 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.939 HD23 HG13 ' A' ' 22' ' ' VAL . 21.1 tp -55.97 -38.39 70.33 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.625 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 3.1 mptp? -63.64 -42.8 98.09 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.331 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.47 -36.36 83.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.142 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.807 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.61 -36.76 84.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.947 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -119.8 23.18 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.795 0.331 . . . . 0.0 111.45 -179.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 t -58.8 -25.42 63.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.575 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -64.84 -21.45 66.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.709 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.422 ' HE1' HD23 ' A' ' 52' ' ' LEU . 2.6 m-85 -67.89 150.57 48.39 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.95 -29.6 70.75 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.058 0.456 . . . . 0.0 112.175 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' HD2' ' H ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -138.0 69.03 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.097 0.959 . . . . 0.0 111.73 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -57.69 -25.31 60.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.89 -41.67 97.65 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.027 -0.42 . . . . 0.0 111.497 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 tp -71.68 -43.32 66.2 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.447 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 m -62.69 -46.77 86.61 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.33 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.939 HG13 HD23 ' A' ' 8' ' ' LEU . 40.8 t -62.43 -44.1 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 120.6 0.238 . . . . 0.0 110.428 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.17 -41.99 89.71 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.682 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.83 -39.57 93.79 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.248 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.606 ' O ' HG23 ' A' ' 29' ' ' ILE . 40.9 p -67.89 -38.33 82.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.46 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.15 -44.12 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.496 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -60.72 -38.75 86.15 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.138 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.37 -45.3 70.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -84.78 -22.43 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.989 -178.142 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.8 m -72.18 -45.68 59.38 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.81 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.3 tp -84.47 -37.74 21.0 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.11 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -114.43 66.93 0.68 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -57.76 -17.58 16.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.323 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -65.65 -16.34 63.64 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.26 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 tp -96.36 125.58 40.96 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -118.27 129.27 25.47 Favored Pre-proline 0 C--N 1.359 0.995 0 CA-C-N 119.814 1.188 . . . . 0.0 111.955 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.09 140.23 15.63 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 121.855 1.703 . . . . 0.0 112.592 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.2 p -136.84 141.2 41.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.221 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.807 HD13 ' SD ' ' A' ' 11' ' ' MET . 14.2 tp -82.66 119.22 24.02 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -119.75 137.81 53.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.212 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.5 m -76.39 141.23 41.52 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.8 t80 . . . . . 0 C--O 1.239 0.51 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.994 -179.284 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.5 ttm-85 . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 121.216 0.532 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -87.74 111.23 21.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.226 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.422 HD23 ' HE1' ' A' ' 15' ' ' TYR . 25.8 mt -111.53 140.03 46.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.413 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -92.75 138.33 31.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -130.05 153.15 48.74 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.023 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.88 119.16 34.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.6 m -130.23 136.81 49.6 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.928 0.394 . . . . 0.0 112.021 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.46 -147.96 13.61 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.606 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.564 HG21 ' OD1' ' A' ' 69' ' ' ASN . 22.0 p -133.29 161.09 35.42 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.46 116.6 18.53 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.494 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -72.39 126.08 11.3 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 CA-C-N 120.037 1.049 . . . . 0.0 110.193 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.0 t -128.13 125.87 23.54 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.583 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.67 150.0 55.88 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.184 1.923 . . . . 0.0 110.294 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -162.84 106.5 1.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.31 0.576 . . . . 0.0 111.746 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 52.68 39.29 28.16 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.939 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.88 -2.37 74.82 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -119.64 134.16 55.35 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -114.59 131.92 56.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.063 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -113.34 150.05 33.14 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.668 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.564 ' OD1' HG21 ' A' ' 58' ' ' THR . 4.6 t-20 -94.12 107.05 19.01 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.516 HG22 HG23 ' A' ' 72' ' ' ILE . 1.5 mp -90.22 116.23 65.89 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.356 -177.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.31 124.69 4.88 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 122.553 2.168 . . . . 0.0 111.381 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.516 HG23 HG22 ' A' ' 70' ' ' ILE . 31.4 pt -135.89 148.68 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.918 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 63.0 m -125.24 125.04 42.96 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.4 0.619 . . . . 0.0 109.884 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.62 115.75 30.69 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.304 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -103.8 126.33 50.85 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.2 mt -94.5 139.82 30.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.217 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mt -79.65 160.12 26.46 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -59.94 -13.96 13.53 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 p -120.77 18.01 11.89 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -59.5 148.14 74.81 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.403 ' HD2' ' OH ' ' A' ' 17' ' ' TYR . 20.0 Cg_endo -92.89 10.26 56.32 Favored 'Cis proline' 0 N--CA 1.509 2.417 0 CA-C-N 121.333 1.512 . . . . 0.0 115.415 -0.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.63 -16.97 64.44 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 118.665 -1.214 . . . . 0.0 110.695 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.14 128.06 26.28 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.362 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -46.81 129.62 14.68 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 CA-C-N 121.269 1.489 . . . . 0.0 113.179 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -82.78 148.67 13.93 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.634 2.223 . . . . 0.0 111.401 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -96.45 153.8 3.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.601 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.11 136.24 24.88 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.624 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -120.42 137.79 54.12 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.703 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.46 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -88.04 125.18 41.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -64.22 104.61 0.55 Allowed Pre-proline 0 N--CA 1.475 0.805 0 CA-C-O 119.162 -0.446 . . . . 0.0 110.631 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 48.3 Cg_endo -88.93 157.99 5.95 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.56 1.507 . . . . 0.0 112.783 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.9 t -157.44 161.67 38.94 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.289 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.6 m -56.36 -23.02 34.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -98.45 6.66 47.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.653 0.66 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.8 mmm -131.37 140.14 49.63 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.1 m -128.77 147.37 50.78 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.744 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 93.2 mt -101.09 117.12 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.083 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -101.41 106.89 18.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.3 p -57.47 148.44 23.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.754 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -161.26 -140.36 2.86 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.116 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -88.45 -3.42 58.83 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -135.46 -29.14 1.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.619 1.099 . . . . 0.0 113.617 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.29 144.31 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 119.036 0.835 . . . . 0.0 110.247 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -98.09 159.6 14.83 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.04 79.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.418 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -73.92 -5.51 41.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.169 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.62 6.23 58.49 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.418 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 143.1 34.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.939 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 98.3 mt -106.55 119.88 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.177 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.23 139.67 50.95 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.03 126.25 18.55 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 118.49 0.586 . . . . 0.0 112.183 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.68 -38.87 37.62 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 121.735 1.623 . . . . 0.0 114.07 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -62.43 -31.83 72.59 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.861 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 tt -69.66 -41.59 75.35 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.371 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -66.3 -29.09 69.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.606 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -101.54 -3.29 28.75 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.694 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.404 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.1 t90 -67.56 127.5 32.96 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.924 0.868 . . . . 0.0 110.475 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.37 130.24 43.53 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.776 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 78.7 t60 -80.21 126.13 79.9 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.33 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 13.2 Cg_endo -108.33 93.59 0.04 OUTLIER 'Cis proline' 0 N--CA 1.498 1.787 0 CA-C-N 120.794 1.319 . . . . 0.0 112.539 -2.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -113.99 -62.39 1.6 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.308 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.1 p -70.3 -40.11 74.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.159 0.504 . . . . 0.0 110.297 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.2 t70 65.76 167.67 0.2 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.418 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.3 tt -62.47 -43.86 97.79 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.452 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -53.11 -36.4 60.71 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.65 -40.19 98.42 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.3 tp -60.46 -40.76 92.34 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -75.98 -47.14 33.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.597 -176.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -67.97 -35.57 78.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 126' ' ' GLY . 61.1 t -68.65 -39.39 80.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.7 ttm -59.01 -45.26 91.13 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.68 -43.28 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.351 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 73.6 t -75.25 -39.68 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.4 p -72.32 -17.45 18.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.54 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -110.13 -17.77 13.48 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.575 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.19 -35.55 91.71 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 107.146 -2.382 . . . . 0.0 107.146 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.99 -34.2 77.86 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.556 -0.822 . . . . 0.0 110.608 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -157.95 90.75 2.26 Favored Pre-proline 0 C--N 1.333 -0.125 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.526 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -50.23 114.15 1.31 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.776 0.984 . . . . 0.0 110.128 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.26 -13.29 28.19 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.471 1.447 . . . . 0.0 111.154 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.1 m -131.64 138.88 51.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.343 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.4 p90 . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.672 179.716 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.415 HG13 ' HE2' ' A' ' 11' ' ' MET . 98.2 t . . . . . 0 N--CA 1.45 -0.475 0 CA-C-O 121.264 0.554 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -96.58 156.0 16.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.499 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 93.9 mt-10 -62.79 -40.53 97.62 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.145 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -58.76 -47.0 86.17 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 122.219 1.009 . . . . 0.0 109.052 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -61.57 -36.49 80.81 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.002 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.883 HD23 HG13 ' A' ' 22' ' ' VAL . 25.0 tp -55.3 -39.54 70.04 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.608 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 3.2 mptp? -60.65 -43.31 97.75 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.867 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -67.94 -26.32 65.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.735 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.743 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -79.03 -34.61 43.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.52 -178.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -113.17 17.64 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.711 0.291 . . . . 0.0 110.789 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.67 -11.51 60.24 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.656 0.265 . . . . 0.0 111.302 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -85.22 -12.85 51.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.453 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.71 ' OH ' HD22 ' A' ' 52' ' ' LEU . 40.2 m-85 -77.75 152.47 33.59 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.408 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -64.93 -39.13 93.03 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.076 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 25.0 m-85 -114.58 70.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 122.404 -0.185 . . . . 0.0 111.077 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -69.04 -27.31 65.54 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -72.74 -46.56 52.86 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.79 -39.6 73.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.969 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.7 m -61.19 -45.71 93.46 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.872 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.883 HG13 HD23 ' A' ' 8' ' ' LEU . 30.1 t -61.86 -45.9 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 120.839 0.352 . . . . 0.0 110.483 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -43.05 99.65 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.873 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -65.16 -37.12 86.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.943 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 29' ' ' ILE . 39.5 p -67.38 -37.36 83.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.922 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.49 -43.62 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -60.4 -39.04 85.91 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.411 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -70.58 -42.75 78.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.27 -21.92 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.191 -177.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.0 m -72.46 -42.9 64.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.046 0.451 . . . . 0.0 110.311 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.844 HD23 HD21 ' A' ' 125' ' ' LEU . 33.8 tp -88.75 -34.52 17.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.092 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -118.24 68.85 0.78 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -57.32 -20.59 29.59 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.159 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -65.84 -15.05 62.55 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.755 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.458 ' CD2' HD13 ' A' ' 55' ' ' LEU . 2.7 tp -96.95 112.43 24.19 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.12 129.52 23.84 Favored Pre-proline 0 C--N 1.358 0.937 0 CA-C-N 119.572 1.078 . . . . 0.0 112.334 -177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -82.92 135.64 7.74 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.603 1.535 . . . . 0.0 112.834 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.84 155.58 41.54 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.743 HD13 ' SD ' ' A' ' 11' ' ' MET . 15.7 tp -95.21 117.6 30.53 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -121.42 134.74 55.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.907 0.384 . . . . 0.0 111.9 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.5 t -71.99 136.72 46.85 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.445 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.864 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 . . . . . 0 N--CA 1.468 0.439 0 CA-C-O 121.192 0.52 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 51' ' ' GLU . 17.4 pm0 -83.97 116.99 23.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.213 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.71 HD22 ' OH ' ' A' ' 15' ' ' TYR . 69.9 mt -117.23 145.09 44.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.086 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -98.93 138.23 36.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.849 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -130.08 151.12 50.96 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.479 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.458 HD13 ' CD2' ' A' ' 35' ' ' LEU . 6.2 mt -97.59 129.57 44.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.1 m -145.3 138.5 26.43 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.85 -141.9 7.31 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.485 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.5 p -133.41 158.92 41.83 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.458 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -129.59 116.18 18.32 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.848 177.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -70.98 123.85 10.07 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 CA-C-N 119.886 0.995 . . . . 0.0 110.001 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.1 t -130.67 125.71 21.59 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.909 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.09 147.39 42.83 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.281 1.987 . . . . 0.0 110.634 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -163.48 116.08 1.49 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 55.93 28.29 12.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.448 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.68 -5.74 77.03 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -112.93 142.51 45.52 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.9 m -120.29 131.93 55.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.884 0.374 . . . . 0.0 111.74 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -115.11 152.02 33.29 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.98 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -96.52 104.93 16.95 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.517 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -88.7 117.13 68.0 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.94 124.31 3.84 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.711 2.274 . . . . 0.0 111.12 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.517 HG23 HG22 ' A' ' 70' ' ' ILE . 29.5 pt -135.72 148.69 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.973 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.3 m -121.43 123.55 42.35 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-O 121.839 0.828 . . . . 0.0 110.12 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.97 117.0 32.9 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.349 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -107.72 126.23 52.35 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.5 mt -92.87 139.36 30.62 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.838 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mt -85.42 152.58 23.12 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.492 ' OD1' HD21 ' A' ' 52' ' ' LEU . 95.9 m-20 -58.66 -16.05 14.5 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.906 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.2 10.75 31.79 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -65.3 144.54 99.02 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.427 ' HG2' ' CD2' ' A' ' 119' ' ' HIS . 28.7 Cg_endo -91.05 3.84 67.11 Favored 'Cis proline' 0 N--CA 1.515 2.786 0 CA-C-N 121.219 1.471 . . . . 0.0 115.726 1.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.428 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 18.8 m-85 -71.54 -20.67 62.0 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.945 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.06 126.64 30.1 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.826 -0.607 . . . . 0.0 109.695 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -49.08 131.48 26.06 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 CA-C-N 121.235 1.477 . . . . 0.0 112.403 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.16 145.53 11.01 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.463 2.109 . . . . 0.0 111.784 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.479 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -91.79 147.44 5.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.241 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' A' ' 109' ' ' ILE . 53.8 t -139.57 132.58 29.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.56 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -121.88 130.86 53.69 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.66 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.491 HG13 HD11 ' A' ' 109' ' ' ILE . 11.4 m -82.83 145.93 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -93.56 99.1 3.03 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.871 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 87.3 Cg_endo -77.03 157.25 34.3 Favored 'Trans proline' 0 N--CA 1.504 2.118 0 C-N-CA 121.482 1.455 . . . . 0.0 112.738 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 p -139.24 176.17 8.93 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.1 t -59.79 -43.86 94.2 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 m -88.18 11.84 15.3 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.795 0.725 . . . . 0.0 111.493 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.2 mmm -129.13 138.46 51.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.66 146.03 48.52 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.813 -178.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.411 HG23 HG11 ' A' ' 103' ' ' VAL . 6.6 mm -88.2 103.43 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.077 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -95.58 110.9 22.93 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.9 p -69.65 155.97 39.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.687 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.89 -135.01 2.24 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.826 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -86.38 -1.24 57.37 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -134.97 -27.31 1.26 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.665 1.12 . . . . 0.0 113.729 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.411 HG11 HG23 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -110.55 134.81 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 118.931 0.787 . . . . 0.0 110.215 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -87.2 -172.57 4.01 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.418 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.13 0.34 56.14 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.978 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -109.04 -5.67 15.94 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.745 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.89 -3.44 57.26 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.534 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 145.22 47.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.408 0.604 . . . . 0.0 110.446 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.491 HD11 HG13 ' A' ' 89' ' ' VAL . 97.5 mt -108.92 122.12 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.434 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.61 130.65 56.86 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.553 ' CD2' HG11 ' A' ' 134' ' ' VAL . 1.1 mt -123.99 124.23 26.02 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.251 -176.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -49.15 -36.9 37.59 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 121.739 1.626 . . . . 0.0 113.865 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.465 ' OH ' HD13 ' A' ' 127' ' ' LEU . 1.2 p90 -60.07 -33.0 71.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.079 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.423 ' N ' ' CG ' ' A' ' 113' ' ' TYR . 1.5 tt -70.89 -41.23 71.59 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.918 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -64.17 -26.37 68.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.633 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -113.78 11.52 18.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.495 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -72.19 125.99 28.67 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.924 0.868 . . . . 0.0 109.996 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -96.57 127.89 42.99 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.784 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.427 ' CD2' ' HG2' ' A' ' 81' ' ' PRO . 39.4 t-80 -81.6 126.49 75.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 119.069 -0.491 . . . . 0.0 110.112 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -108.94 92.35 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.707 0 CA-C-N 120.756 1.306 . . . . 0.0 112.43 -2.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.26 -61.96 1.66 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.504 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.5 t -67.94 -42.11 81.5 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.087 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 t70 66.98 165.84 0.22 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.487 0.66 . . . . 0.0 111.7 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.7 tt -65.79 -43.71 87.94 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.663 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.844 HD21 HD23 ' A' ' 31' ' ' LEU . 21.3 tp -56.81 -38.54 72.72 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.24 -39.12 96.75 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.465 HD13 ' OH ' ' A' ' 113' ' ' TYR . 33.4 tp -56.95 -40.28 76.15 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.889 -0.183 . . . . 0.0 111.431 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -73.98 -47.82 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.941 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -66.42 -35.0 79.22 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.58 ' O ' HG12 ' A' ' 134' ' ' VAL . 62.9 t -67.41 -39.02 81.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.0 tpp -58.24 -42.13 85.7 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.458 HD11 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -63.62 -39.55 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.597 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -79.09 -46.82 23.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 130' ' ' VAL . 9.9 p -71.6 -14.21 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.138 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.466 ' CD1' HG13 ' A' ' 134' ' ' VAL . 5.6 m-30 -104.75 -19.09 14.04 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.18 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.43 -32.05 60.3 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -63.89 -38.87 92.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.817 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -157.67 81.66 3.08 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -49.1 109.31 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.266 1.311 . . . . 0.0 110.76 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.64 -23.47 40.6 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.456 1.437 . . . . 0.0 110.462 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 m -120.09 140.41 44.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.29 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.7 p90 . . . . . 0 CA--C 1.538 0.507 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.297 -179.008 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.445 -0.685 0 CA-C-O 121.391 0.615 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -103.74 157.84 16.8 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 97.7 mt-10 -65.04 -40.45 94.81 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.266 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -63.26 -41.51 99.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.355 1.074 . . . . 0.0 109.214 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -69.97 -29.93 67.16 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.657 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.036 HD23 HG13 ' A' ' 22' ' ' VAL . 51.6 tp -61.9 -39.65 92.71 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.698 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -58.85 -43.22 90.73 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.074 -0.967 . . . . 0.0 108.657 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -60.43 -35.52 76.02 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.298 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.734 ' CB ' HD13 ' A' ' 39' ' ' LEU . 13.5 ptp -83.33 -10.58 58.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.172 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.878 HG22 ' O ' ' A' ' 8' ' ' LEU . 16.2 m -130.9 19.21 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.01 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.7 p -66.44 -18.22 65.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.558 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.82 -13.15 40.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.98 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -72.9 148.64 44.17 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.527 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -66.57 -37.82 85.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.799 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 19.8 m-85 -108.18 61.92 0.61 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.428 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.4 ptp85 -64.76 -27.31 68.81 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -76.68 -53.03 8.55 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.11 -38.77 82.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.084 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -60.77 -47.45 86.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.698 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.036 HG13 HD23 ' A' ' 8' ' ' LEU . 38.9 t -61.08 -44.62 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -40.53 97.87 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.115 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.13 -38.44 91.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.059 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.647 ' O ' HG23 ' A' ' 29' ' ' ILE . 48.8 p -68.27 -34.33 75.99 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.923 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.68 -45.64 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.742 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -61.31 -39.07 89.13 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.471 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.64 -43.09 71.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.57 -20.13 7.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.698 -178.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.5 m -78.07 -46.97 19.4 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.992 0.425 . . . . 0.0 110.848 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.599 HD23 HD21 ' A' ' 125' ' ' LEU . 22.8 tp -88.65 -36.0 16.49 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.842 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -111.97 68.14 0.66 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -59.38 -18.15 36.22 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.671 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -65.22 -21.88 66.81 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.855 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.641 HD13 HD12 ' A' ' 128' ' ' ILE . 1.3 tp -95.51 115.26 27.18 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.72 132.76 22.11 Favored Pre-proline 0 C--N 1.356 0.881 0 CA-C-N 119.828 1.194 . . . . 0.0 112.104 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.39 135.3 11.82 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.424 1.416 . . . . 0.0 112.46 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.1 t -127.87 136.27 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.734 HD13 ' CB ' ' A' ' 11' ' ' MET . 38.1 tp -84.55 119.24 24.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -129.91 137.25 50.28 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.9 t -68.6 137.98 54.69 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.206 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 . . . . . 0 C--O 1.235 0.294 0 CA-C-O 121.359 0.6 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -80.39 120.5 24.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.741 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 52' ' ' LEU . 77.7 mt -122.22 140.01 53.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.553 0.692 . . . . 0.0 110.817 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.455 ' SD ' HD11 ' A' ' 8' ' ' LEU . 62.0 ttp -84.51 148.66 26.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.424 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -134.2 151.53 51.36 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.296 0.57 . . . . 0.0 111.689 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.498 ' HG ' HD23 ' A' ' 35' ' ' LEU . 3.2 mm? -102.66 116.02 31.74 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.5 m -134.47 137.13 43.7 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.27 -143.24 7.99 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.593 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.493 HG21 ' OD1' ' A' ' 69' ' ' ASN . 19.8 p -135.27 161.25 35.92 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.43 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.2 pt -132.31 116.07 15.22 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.206 177.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -72.35 125.87 11.14 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 120.935 1.09 . . . . 0.0 110.092 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.6 t -129.48 124.43 21.96 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 119.744 -0.783 . . . . 0.0 112.329 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.56 145.85 48.11 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.137 1.891 . . . . 0.0 110.162 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -163.57 114.78 1.4 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.932 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.23 32.09 12.78 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.82 -6.86 72.36 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -113.79 148.51 36.42 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -125.2 132.58 52.99 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.609 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -115.47 152.09 33.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.138 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.493 ' OD1' HG21 ' A' ' 58' ' ' THR . 3.8 t-20 -97.09 103.88 15.85 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.494 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -88.33 116.98 67.83 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -82.18 127.26 5.22 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 122.516 2.144 . . . . 0.0 111.062 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.494 HG23 HG22 ' A' ' 70' ' ' ILE . 29.6 pt -137.1 149.13 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 118.939 -1.105 . . . . 0.0 112.577 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.46 123.05 40.4 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-O 121.513 0.673 . . . . 0.0 110.057 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.32 103.68 13.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.646 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -90.69 124.05 34.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 119.046 -1.062 . . . . 0.0 108.3 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -91.98 138.64 31.38 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mt -88.9 155.46 19.51 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.28 -16.26 32.54 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.629 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.04 0.43 51.57 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.669 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -65.03 143.03 98.82 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HG2' ' CE1' ' A' ' 119' ' ' HIS . 41.5 Cg_endo -89.34 4.15 69.62 Favored 'Cis proline' 0 N--CA 1.517 2.892 0 CA-C-N 120.975 1.384 . . . . 0.0 115.299 1.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 12.0 m-85 -68.85 -23.13 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.242 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.86 126.3 30.15 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.959 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.19 137.48 37.88 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 CA-C-N 121.263 1.487 . . . . 0.0 111.555 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.03 144.1 11.8 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.387 2.058 . . . . 0.0 111.771 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.49 131.55 40.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.65 0.738 . . . . 0.0 109.406 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 38.7 t -118.28 142.0 47.94 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.326 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -127.93 127.64 43.68 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.103 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.585 ' CG2' HD11 ' A' ' 109' ' ' ILE . 57.9 t -85.79 131.92 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -87.35 101.76 2.61 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.979 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 79.4 Cg_endo -82.03 159.36 18.18 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.39 1.393 . . . . 0.0 112.206 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 p -123.39 168.13 12.93 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.06 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.2 m -56.75 -36.09 69.37 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.433 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.0 m -88.36 2.59 52.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.854 0.752 . . . . 0.0 112.295 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -129.54 140.15 51.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.68 156.81 26.46 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.631 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 97' ' ' ILE . 2.7 tp -85.25 109.98 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-O 121.262 0.553 . . . . 0.0 109.96 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -97.53 101.39 12.9 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.033 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.7 p -65.54 151.18 47.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.883 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -166.23 -143.75 3.85 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.663 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.403 ' O ' ' CZ ' ' A' ' 110' ' ' TYR . 24.8 pttm -65.96 -18.96 65.69 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.62 ' HD2' HG23 ' A' ' 103' ' ' VAL . 6.6 p-80 -131.86 -26.67 1.95 Allowed 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.62 HG23 ' HD2' ' A' ' 102' ' ' HIS . 13.4 t -93.78 137.66 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.667 1.121 . . . . 0.0 111.36 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -100.97 177.51 4.93 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.417 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.58 -38.55 87.28 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -86.41 -0.37 55.83 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.843 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.69 21.56 18.66 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.722 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -75.79 136.84 40.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.687 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.585 HD11 ' CG2' ' A' ' 89' ' ' VAL . 88.7 mt -117.26 125.2 73.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.95 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CZ ' ' O ' ' A' ' 101' ' ' LYS . 30.2 p90 -136.44 148.87 47.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.73 HD23 HG11 ' A' ' 134' ' ' VAL . 3.3 mp -143.45 140.03 17.12 Favored Pre-proline 0 CA--C 1.555 1.152 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.257 -175.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.476 ' HA ' ' ND1' ' A' ' 115' ' ' HIS . 50.4 Cg_exo -46.43 -38.64 21.24 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 C-N-CA 121.954 1.769 . . . . 0.0 113.792 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.46 ' OH ' HD13 ' A' ' 127' ' ' LEU . 0.4 OUTLIER -63.69 -31.94 73.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.073 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.24 -43.08 64.91 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.476 ' ND1' ' HA ' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -68.96 -27.01 65.35 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.78 -177.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -97.65 1.12 48.32 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.293 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -60.13 126.51 27.79 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.766 0.793 . . . . 0.0 110.657 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -104.46 96.29 6.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.619 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 65.0 t60 -55.64 122.84 47.97 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.309 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 8.5 Cg_endo -108.0 91.97 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 120.304 1.144 . . . . 0.0 113.019 -2.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -110.43 -58.83 2.03 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.483 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.1 p -71.02 -39.72 72.19 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.355 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 t70 69.32 164.09 0.24 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.355 0.598 . . . . 0.0 112.095 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.4 tt -66.15 -44.28 84.57 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.326 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.599 HD21 HD23 ' A' ' 31' ' ' LEU . 2.6 tp -56.12 -37.95 70.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.67 -39.42 97.39 Favored Glycine 0 N--CA 1.477 1.391 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.46 HD13 ' OH ' ' A' ' 113' ' ' TYR . 32.4 tp -58.68 -41.17 85.59 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.605 -0.35 . . . . 0.0 111.902 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.641 HD12 HD13 ' A' ' 35' ' ' LEU . 1.1 mm -72.71 -47.74 48.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.954 -176.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.405 ' OE1' HG21 ' A' ' 132' ' ' ILE . 6.9 tp-100 -67.71 -34.73 77.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.668 ' O ' HG12 ' A' ' 134' ' ' VAL . 64.5 t -67.91 -39.2 81.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.055 177.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.404 ' SD ' ' CE1' ' A' ' 135' ' ' PHE . 44.5 tpp -58.14 -41.47 83.77 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.43 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.1 mp -63.67 -44.14 98.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.562 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.74 -44.21 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.73 HG11 HD23 ' A' ' 111' ' ' LEU . 8.7 p -73.52 -14.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.177 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.464 ' CD2' HG13 ' A' ' 134' ' ' VAL . 11.6 m-30 -105.38 -17.78 14.33 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.547 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.95 -22.97 72.59 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -76.43 -27.31 56.18 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.578 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -161.73 83.77 1.75 Allowed Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -46.99 119.25 3.26 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.341 1.361 . . . . 0.0 110.407 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.602 ' HB2' HG21 ' A' ' 103' ' ' VAL . 37.7 Cg_endo -68.47 -18.61 43.57 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 120.875 1.05 . . . . 0.0 110.856 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.76 147.86 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 4.8 p90 . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.526 -179.589 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.432 HG11 ' HG2' ' A' ' 37' ' ' PRO . 7.4 p . . . . . 0 N--CA 1.442 -0.859 0 CA-C-O 121.679 0.752 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.05 149.65 24.99 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.441 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 56.0 mp0 -61.23 -42.3 98.37 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.768 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.6 m -57.73 -46.92 83.79 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.364 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -63.07 -34.08 76.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.87 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.697 HD23 HG13 ' A' ' 22' ' ' VAL . 11.7 tp -55.83 -38.66 70.32 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.605 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.3 mptp? -61.22 -42.52 98.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.757 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.57 -37.21 86.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.362 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.784 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -66.01 -37.01 84.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.149 -177.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.6 m -119.43 28.91 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.658 0.266 . . . . 0.0 111.213 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.2 p -64.95 -22.66 67.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -74.71 -15.5 60.78 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.921 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -71.09 152.25 43.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.016 0.436 . . . . 0.0 111.437 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -75.47 -29.22 59.53 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.12 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.407 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 35.7 m-85 -117.94 61.77 0.76 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.148 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 ptt-85 -64.65 -29.62 70.63 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.98 -44.03 70.25 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tp -74.74 -41.28 60.42 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.392 -0.923 . . . . 0.0 109.813 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 25' ' ' THR . 96.0 m -61.19 -47.99 83.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.616 0.246 . . . . 0.0 111.154 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.697 HG13 HD23 ' A' ' 8' ' ' LEU . 14.2 t -61.32 -45.49 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.397 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -63.4 -43.0 98.81 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.653 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.59 -36.28 83.3 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.682 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.657 ' O ' HG23 ' A' ' 29' ' ' ILE . 40.7 p -67.31 -38.58 85.21 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.543 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -57.44 -43.43 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -60.05 -41.3 92.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.101 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 124' ' ' LEU . 77.5 t -68.85 -43.07 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -87.56 -15.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.452 -178.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.3 m -85.04 -46.95 10.69 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.128 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.9 tp -83.14 -35.88 25.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.259 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -115.47 68.4 0.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.039 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -57.03 -20.84 26.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.091 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -65.15 -22.02 66.86 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.685 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.543 HD13 HD12 ' A' ' 128' ' ' ILE . 1.4 tp -93.17 115.2 27.84 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -111.11 133.59 21.28 Favored Pre-proline 0 C--N 1.357 0.904 0 CA-C-N 119.713 1.142 . . . . 0.0 111.937 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 97.5 Cg_endo -79.69 133.01 10.13 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.194 1.263 . . . . 0.0 112.028 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -126.93 134.27 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.784 HD13 ' SD ' ' A' ' 11' ' ' MET . 24.4 tp -81.82 113.89 20.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -123.64 137.36 54.74 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 83.1 p -71.63 148.02 46.97 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 N--CA 1.465 0.286 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.599 179.784 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 C--O 1.234 0.241 0 CA-C-O 121.196 0.522 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.492 ' HG3' HD11 ' A' ' 39' ' ' LEU . 8.0 tp10 -83.37 106.43 15.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.213 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 52' ' ' LEU . 70.2 mt -114.26 140.64 48.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.401 0.62 . . . . 0.0 110.927 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.499 ' SD ' HD11 ' A' ' 8' ' ' LEU . 57.7 ttp -84.41 148.83 26.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.321 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 4.5 t30 -124.74 161.34 26.61 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.991 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.525 ' HA ' HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -119.15 112.78 19.94 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -138.58 139.94 38.82 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.45 -143.66 8.26 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.761 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.8 p -134.9 159.19 42.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.438 HD13 HG21 ' A' ' 59' ' ' ILE . 1.2 pt -130.8 115.74 16.89 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.283 177.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.14 125.06 10.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 N-CA-C 109.405 -1.037 . . . . 0.0 109.405 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.0 t -126.97 121.86 23.05 Favored Pre-proline 0 C--O 1.24 0.605 0 C-N-CA 119.834 -0.746 . . . . 0.0 112.285 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.27 146.49 51.16 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.074 1.85 . . . . 0.0 110.287 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -162.74 107.9 1.15 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.102 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.77 37.92 25.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.551 -0.46 . . . . 0.0 112.205 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.17 -0.77 82.95 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -118.5 138.26 52.63 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.2 m -121.35 132.56 54.84 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.483 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -115.96 149.58 38.55 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.121 0.486 . . . . 0.0 111.261 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -94.88 100.47 12.34 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.442 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -87.67 115.35 62.66 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.237 -177.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.64 127.87 4.45 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.753 2.302 . . . . 0.0 111.158 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.442 HG23 HG22 ' A' ' 70' ' ' ILE . 25.1 pt -135.27 148.7 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.411 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.1 m -116.62 124.23 49.27 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.354 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.53 112.25 24.04 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.204 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.517 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 70.1 m95 -96.03 130.25 43.08 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.224 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.25 134.64 41.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tp -94.16 143.82 26.04 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.87 -16.86 0.47 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.37 9.97 40.91 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.421 -0.512 . . . . 0.0 112.316 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -65.7 143.49 98.59 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.425 ' HG2' ' CE1' ' A' ' 119' ' ' HIS . 25.2 Cg_endo -92.0 3.36 63.15 Favored 'Cis proline' 0 N--CA 1.517 2.865 0 CA-C-N 121.033 1.405 . . . . 0.0 115.256 1.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.407 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 17.2 m-85 -69.78 -21.02 63.45 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.465 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.37 118.92 53.48 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.52 135.99 33.25 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 CA-C-N 121.182 1.458 . . . . 0.0 111.423 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.51 140.86 17.29 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.817 1.678 . . . . 0.0 111.199 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -79.78 152.89 4.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.155 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 13.1 t -140.93 140.37 34.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.093 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -131.32 129.72 41.8 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.771 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.59 134.77 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -100.17 101.2 13.68 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.647 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -90.15 127.57 1.47 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.874 1.716 . . . . 0.0 113.197 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.3 p -77.19 172.54 13.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.8 p -55.86 -28.64 57.46 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.9 m -95.64 -2.2 48.64 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.945 0.793 . . . . 0.0 111.579 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 52.9 tpp -93.25 134.35 35.53 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 85.1 m -108.16 133.22 52.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.79 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.555 HG23 ' O ' ' A' ' 97' ' ' ILE . 2.5 tp -93.95 109.07 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.08 0.467 . . . . 0.0 109.816 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -92.85 100.13 12.66 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.673 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 74.0 p -66.91 148.44 51.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.985 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -172.96 -150.6 7.49 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.26 -20.44 64.79 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 47.3 m170 -115.35 -30.38 6.28 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 119.028 0.831 . . . . 0.0 113.008 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.581 HG21 ' HB2' ' A' ' 140' ' ' PRO . 4.1 t -100.78 138.36 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 CA-C-N 119.24 0.927 . . . . 0.0 110.58 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.407 ' O ' HG12 ' A' ' 103' ' ' VAL . 18.2 t0 -93.85 -169.72 2.16 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.421 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.59 -30.94 22.91 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -92.08 0.34 57.46 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.993 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.84 6.02 37.97 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.104 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -64.04 148.46 49.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.693 0.747 . . . . 0.0 110.181 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.432 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 84.1 mt -116.44 122.82 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 110.718 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.62 121.22 44.22 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.408 ' CD2' HG11 ' A' ' 134' ' ' VAL . 1.2 mt -126.98 116.52 22.04 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.945 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -48.98 -36.88 35.93 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.581 1.521 . . . . 0.0 113.69 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -31.51 71.56 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.477 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 tt -69.46 -41.71 75.86 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.89 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -65.57 -28.47 69.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.017 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -109.84 3.77 21.02 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.679 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.403 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.1 t90 -64.84 125.03 23.54 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.038 0.923 . . . . 0.0 110.076 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -95.81 127.1 41.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.816 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.425 ' CE1' ' HG2' ' A' ' 81' ' ' PRO . 79.2 t60 -81.28 126.65 76.18 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 119.026 -0.512 . . . . 0.0 110.514 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -109.4 91.39 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.674 0 CA-C-N 120.677 1.277 . . . . 0.0 112.453 -2.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.3 -62.75 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 t -67.74 -37.26 81.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.699 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 51.4 175.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.061 0.934 . . . . 0.0 112.143 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.1 tt -62.94 -44.33 96.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.821 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -53.6 -38.71 64.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.64 -39.63 98.14 Favored Glycine 0 N--CA 1.482 1.704 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.4 tp -58.25 -40.65 82.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.435 -0.45 . . . . 0.0 111.829 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.543 HD12 HD13 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -74.34 -48.16 37.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.948 -176.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.43 ' OE1' HG21 ' A' ' 132' ' ' ILE . 9.3 tp-100 -68.77 -35.15 76.7 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 126' ' ' GLY . 63.4 t -67.92 -40.07 82.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 178.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.5 ttm -58.39 -42.8 87.92 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.438 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -61.17 -41.12 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.475 178.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.26 -47.73 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.476 HG13 ' CD2' ' A' ' 135' ' ' PHE . 4.6 p -66.7 -14.45 17.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.501 -178.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.476 ' CD2' HG13 ' A' ' 134' ' ' VAL . 15.4 m-30 -106.91 -20.12 13.42 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.358 177.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.7 -35.2 91.64 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.16 -37.31 86.99 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.957 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -154.56 83.96 3.95 Favored Pre-proline 0 N--CA 1.451 -0.393 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.139 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -45.35 117.59 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.689 1.593 . . . . 0.0 110.939 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.581 ' HB2' HG21 ' A' ' 103' ' ' VAL . 59.7 Cg_endo -74.71 -4.97 16.23 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.504 1.469 . . . . 0.0 111.4 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.7 m -120.46 157.38 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.708 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.8 t80 . . . . . 0 N--CA 1.478 0.934 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.247 -179.686 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 N--CA 1.448 -0.547 0 CA-C-O 121.158 0.504 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -94.54 156.54 16.4 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.8 mt-10 -63.3 -40.91 98.66 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.111 -1.035 . . . . 0.0 111.329 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -60.18 -47.21 86.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.237 1.018 . . . . 0.0 108.633 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -63.11 -30.64 71.75 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.38 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.901 HD23 HG13 ' A' ' 22' ' ' VAL . 38.7 tp -58.86 -41.05 86.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 10.8 mptt -60.5 -41.84 95.13 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.657 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.35 -37.09 82.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.354 0.597 . . . . 0.0 110.621 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.761 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -68.9 -36.28 77.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.566 -178.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.0 m -113.61 20.91 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.61 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.7 t -68.85 -4.48 16.46 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.353 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -103.98 -11.19 17.56 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.705 ' CE1' HG12 ' A' ' 12' ' ' VAL . 17.9 m-85 -67.65 160.12 28.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.883 0.373 . . . . 0.0 110.675 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -70.88 -39.43 72.84 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.705 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.16 74.15 1.02 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.813 -0.176 . . . . 0.0 110.965 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -72.12 -21.61 61.45 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -79.19 -47.63 15.66 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.754 -0.592 . . . . 0.0 111.864 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 tp -70.15 -40.6 74.68 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.478 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 83.2 m -60.93 -48.09 83.42 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.55 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.901 HG13 HD23 ' A' ' 8' ' ' LEU . 30.8 t -62.83 -45.49 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 120.666 0.269 . . . . 0.0 110.899 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -41.63 97.26 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.135 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -37.76 84.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.742 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.632 ' O ' HG23 ' A' ' 29' ' ' ILE . 13.6 p -66.28 -33.73 76.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.437 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.2 t -59.65 -45.45 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.286 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -61.66 -38.76 88.94 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.913 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.71 -46.43 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.66 -21.21 7.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.475 -178.493 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 79.8 m -70.91 -40.87 71.9 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.069 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -88.09 -36.56 16.85 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.448 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -117.75 69.63 0.78 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -57.8 -19.68 30.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.703 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -65.47 -19.17 65.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.412 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 tp -90.15 116.6 28.28 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -112.32 132.72 21.99 Favored Pre-proline 0 C--N 1.358 0.97 0 CA-C-N 120.1 1.318 . . . . 0.0 111.775 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.04 135.63 11.2 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.588 1.525 . . . . 0.0 112.973 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.6 t -129.66 136.56 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.761 HD13 ' SD ' ' A' ' 11' ' ' MET . 16.0 tp -82.74 125.19 30.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.95 158.89 24.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.033 0.444 . . . . 0.0 111.149 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m -97.01 125.17 41.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.2 t80 . . . . . 0 N--CA 1.472 0.65 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.592 -179.176 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 . . . . . 0 C--O 1.234 0.262 0 CA-C-O 121.061 0.458 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.27 113.79 10.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.706 0.765 . . . . 0.0 110.347 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.485 HD21 ' O ' ' A' ' 76' ' ' LEU . 20.0 tp -111.5 123.05 49.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -83.34 143.46 30.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.899 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.412 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -132.87 160.33 37.28 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.041 0.448 . . . . 0.0 111.738 -178.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.0 mt -111.44 117.66 33.66 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -132.8 137.49 46.8 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.97 -146.19 10.79 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.375 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.9 p -134.41 159.16 41.93 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.88 116.6 18.09 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.229 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -67.11 123.32 10.77 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 N-CA-C 109.527 -0.99 . . . . 0.0 109.527 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.03 118.04 22.07 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.991 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.93 149.58 77.71 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.991 1.794 . . . . 0.0 111.315 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -162.8 111.98 1.36 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.935 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 45.85 45.03 11.51 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.3 -4.55 76.61 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.683 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -118.93 162.26 18.81 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.6 m -129.35 130.03 45.54 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.787 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -106.0 144.73 32.3 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.579 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.03 103.29 14.81 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.534 HG22 HG23 ' A' ' 72' ' ' ILE . 1.5 mp -91.18 117.35 67.81 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -85.1 124.46 2.9 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 123.023 2.482 . . . . 0.0 110.214 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.534 HG23 HG22 ' A' ' 70' ' ' ILE . 27.9 pt -135.82 150.11 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 118.955 -1.098 . . . . 0.0 112.56 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.1 m -121.55 124.77 45.2 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.215 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 mp -103.13 107.58 18.44 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.436 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.459 ' HE3' HD23 ' A' ' 52' ' ' LEU . 86.1 m95 -96.06 125.63 40.73 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.485 ' O ' HD21 ' A' ' 52' ' ' LEU . 67.8 mt -95.21 129.89 42.15 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.804 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 mt -73.72 149.99 41.49 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.47 -14.05 11.1 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.433 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.89 -8.74 36.33 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.404 ' OH ' HD12 ' A' ' 124' ' ' LEU . 25.8 t80 -53.92 145.83 30.91 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -91.4 12.11 55.99 Favored 'Cis proline' 0 N--CA 1.513 2.668 0 CA-C-N 120.682 1.279 . . . . 0.0 115.187 0.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -73.23 -12.97 61.05 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.724 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -121.23 129.53 25.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.068 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -49.38 138.18 30.6 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 CA-C-N 121.591 1.604 . . . . 0.0 111.844 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.48 144.05 15.7 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.056 1.837 . . . . 0.0 111.473 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mt -96.47 135.98 28.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 121.308 0.575 . . . . 0.0 110.118 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.428 ' SG ' HD12 ' A' ' 109' ' ' ILE . 48.9 t -111.99 149.29 32.2 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.611 -178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.85 126.53 30.69 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.623 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -84.95 123.5 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.81 108.48 2.71 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-O 119.05 -0.5 . . . . 0.0 109.901 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.77 155.89 7.47 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.619 1.546 . . . . 0.0 113.455 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 p -137.59 163.88 30.13 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.2 p -59.63 -26.77 65.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.863 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.7 p -90.74 -3.19 57.64 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.961 0.8 . . . . 0.0 111.244 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 41.4 ttm -124.11 142.05 51.53 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.23 159.16 35.17 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.836 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 85.8 mt -96.04 101.88 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -96.15 111.88 23.79 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.1 p -61.51 141.67 57.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.315 0.579 . . . . 0.0 111.392 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.37 -135.42 2.57 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.342 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -88.27 -3.33 58.87 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -138.4 -33.52 0.67 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.218 0.917 . . . . 0.0 112.446 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.62 138.59 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.375 0.989 . . . . 0.0 110.429 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -96.17 -161.51 0.87 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.375 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.91 -35.82 23.79 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.681 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -83.16 -1.79 53.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.546 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.07 8.51 47.53 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.504 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -62.51 137.49 58.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.365 0.583 . . . . 0.0 111.033 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.428 HD12 ' SG ' ' A' ' 87' ' ' CYS . 60.2 mt -114.63 113.22 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.442 ' CZ ' ' HA ' ' A' ' 102' ' ' HIS . 53.3 p90 -113.46 139.82 48.61 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 177.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.427 HD11 HG22 ' A' ' 109' ' ' ILE . 1.3 mp -133.15 130.55 21.35 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.462 -176.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -46.35 -39.91 22.0 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 121.664 1.576 . . . . 0.0 114.277 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -62.97 -31.3 72.39 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.863 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.08 -42.48 76.14 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.632 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.08 -28.49 66.56 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.026 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -95.46 -6.15 41.39 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.446 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -57.85 126.99 29.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.912 0.863 . . . . 0.0 110.656 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -104.63 102.96 12.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.98 -1.464 . . . . 0.0 108.435 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 60.5 t60 -60.88 123.91 77.26 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.038 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 5.8 Cg_endo -108.27 91.9 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 120.704 1.287 . . . . 0.0 113.211 -2.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -112.98 -60.59 1.86 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.423 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.0 t -67.48 -41.83 83.93 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.53 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 69.67 159.22 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.04 0.448 . . . . 0.0 111.634 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 124' ' ' LEU . 5.0 tt -59.99 -44.68 94.36 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 63.0 tp -53.8 -33.04 54.83 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.45 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -63.6 -40.67 98.9 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.2 tp -60.69 -39.68 89.37 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.93 -44.08 24.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.903 -177.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -68.68 -37.0 79.26 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 126' ' ' GLY . 64.9 t -68.11 -42.93 85.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 C-N-CA 118.992 -1.083 . . . . 0.0 108.518 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.5 ttm -55.97 -44.89 78.96 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.409 HG22 HG23 ' A' ' 133' ' ' VAL . 1.0 OUTLIER -54.81 -32.26 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.043 178.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.409 HG23 HG22 ' A' ' 132' ' ' ILE . 63.0 t -94.46 -48.98 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 119.556 -0.857 . . . . 0.0 113.118 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.4 p -80.33 -11.11 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -93.52 -13.22 28.06 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.427 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -95.23 -5.2 60.76 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -65.99 -36.05 82.25 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.214 0.507 . . . . 0.0 110.428 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -157.26 82.79 3.07 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -44.82 106.58 0.09 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.563 1.508 . . . . 0.0 111.365 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.03 -12.0 31.54 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.835 1.69 . . . . 0.0 111.282 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.15 146.94 32.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.869 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.5 p90 . . . . . 0 N--CA 1.47 0.548 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.521 -179.736 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 121.303 0.573 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -101.77 156.61 17.4 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.509 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 94.5 mt-10 -62.71 -41.38 99.12 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.235 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 t -60.17 -46.17 90.6 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.941 0.876 . . . . 0.0 109.327 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -65.78 -28.4 68.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.059 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.985 HD23 HG13 ' A' ' 22' ' ' VAL . 59.3 tp -61.83 -39.61 92.42 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -65.42 -40.72 93.68 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.987 178.276 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.96 -37.15 81.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.47 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.567 ' SD ' HD12 ' A' ' 8' ' ' LEU . 19.8 ptp -76.14 -11.47 59.94 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.547 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 8' ' ' LEU . 10.2 m -142.35 31.71 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.459 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.5 p -72.01 -24.7 61.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.225 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.96 -13.51 55.86 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.792 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.0 151.49 26.21 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.972 0.415 . . . . 0.0 110.744 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -70.51 -37.49 74.15 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 21.3 m-85 -114.66 65.68 0.68 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.3 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.522 ' O ' HG23 ' A' ' 22' ' ' VAL . 15.9 ptt180 -64.91 -34.11 77.61 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.57 -42.08 83.15 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.85 -38.79 61.89 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.825 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 25' ' ' THR . 66.1 m -61.68 -43.27 99.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.408 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.985 HG13 HD23 ' A' ' 8' ' ' LEU . 79.5 t -72.7 -46.14 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.176 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -42.09 97.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.345 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.7 pp20? -69.1 -30.99 69.41 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.706 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.66 ' O ' HG23 ' A' ' 29' ' ' ILE . 24.0 p -70.39 -39.36 74.56 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.969 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 30' ' ' THR . 55.4 t -56.29 -45.57 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -39.5 91.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 24' ' ' GLU . 63.9 t -66.17 -43.59 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -83.8 -13.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.412 -178.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 26' ' ' VAL . 7.9 p -82.99 -51.04 7.93 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.419 0.628 . . . . 0.0 109.786 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.2 tp -81.38 -37.67 27.82 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.466 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.92 68.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -58.63 -19.85 42.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.825 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.11 -21.12 66.76 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.244 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.481 ' CD2' HD13 ' A' ' 55' ' ' LEU . 2.8 tp -93.16 113.96 26.34 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -109.94 126.97 27.91 Favored Pre-proline 0 C--N 1.356 0.866 0 CA-C-N 119.385 0.993 . . . . 0.0 112.157 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.94 134.68 10.77 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.553 1.502 . . . . 0.0 112.88 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.4 t -124.07 135.33 63.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.504 HD13 ' CB ' ' A' ' 11' ' ' MET . 21.6 tp -82.84 118.32 23.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.6 136.23 53.04 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.787 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.1 p -84.35 119.11 24.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.3 t80 . . . . . 0 N--CA 1.469 0.475 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.283 -178.621 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.425 0 CA-C-O 121.537 0.684 . . . . 0.0 110.529 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -79.56 106.52 11.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.027 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tp -116.54 121.45 41.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -91.77 136.38 33.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.643 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -127.32 150.82 49.42 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.887 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.481 HD13 ' CD2' ' A' ' 35' ' ' LEU . 8.0 mt -99.73 123.05 43.6 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.5 m -133.7 137.14 45.13 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.76 -149.37 13.73 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.738 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.413 HG21 ' OD1' ' A' ' 69' ' ' ASN . 19.6 p -133.98 159.77 39.74 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.443 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.3 pt -134.22 116.3 13.16 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.998 177.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.5 126.93 10.63 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 120.908 1.072 . . . . 0.0 110.394 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.63 118.56 15.75 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.369 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.62 149.7 90.23 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.282 1.988 . . . . 0.0 110.257 177.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -162.7 107.51 1.14 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.201 0.524 . . . . 0.0 111.686 -178.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 52.3 38.82 25.9 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.105 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.61 81.78 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -122.14 131.63 54.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.9 m -113.02 130.97 55.95 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.847 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -112.97 150.49 31.8 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.871 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.413 ' OD1' HG21 ' A' ' 58' ' ' THR . 5.3 t-20 -95.15 104.4 16.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.426 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -88.55 115.3 62.97 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -86.46 125.74 2.55 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.965 2.443 . . . . 0.0 110.958 177.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.426 HG23 HG22 ' A' ' 70' ' ' ILE . 31.9 pt -133.81 148.6 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.758 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 54.0 m -121.7 122.05 38.69 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.999 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.89 115.9 31.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.147 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -107.52 127.1 53.32 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.5 mt -94.56 135.69 35.72 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.207 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mt -79.76 151.23 30.49 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -61.49 -13.01 17.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.122 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.61 0.46 39.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.138 0.494 . . . . 0.0 111.397 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -55.93 146.24 49.52 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -93.51 7.83 56.48 Favored 'Cis proline' 0 N--CA 1.509 2.388 0 CA-C-N 120.765 1.309 . . . . 0.0 114.042 1.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.445 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 7.2 m-85 -70.3 -18.77 63.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.75 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.93 137.77 19.89 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.31 140.95 66.4 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 CA-C-N 121.531 1.583 . . . . 0.0 111.196 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.21 142.86 12.32 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.236 1.958 . . . . 0.0 112.242 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.18 130.66 41.91 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.014 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.4 t -113.52 137.73 51.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.285 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -123.08 127.13 48.31 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.531 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.58 121.96 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -63.11 108.43 1.73 Allowed Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 119.161 -0.447 . . . . 0.0 110.021 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -84.23 160.7 13.27 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 121.627 1.551 . . . . 0.0 113.04 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.8 p -142.54 165.1 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.789 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.6 p -58.21 -35.22 71.33 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.153 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 t -88.3 -22.28 23.97 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.748 -0.595 . . . . 0.0 110.814 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 41.1 tpp -89.12 135.87 33.33 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.968 0.413 . . . . 0.0 110.192 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 84.0 m -125.61 141.22 52.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.594 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.6 mt -90.05 105.82 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -89.6 102.78 15.46 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 104' ' ' ASP . 69.1 p -64.44 152.46 41.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.28 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.44 -137.43 2.28 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.154 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -65.3 -23.98 67.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.519 ' NE2' HG23 ' A' ' 103' ' ' VAL . 10.5 p-80 -136.22 -16.85 1.61 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.719 HG21 ' HB2' ' A' ' 140' ' ' PRO . 6.8 t -100.32 132.09 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.508 1.049 . . . . 0.0 111.15 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.435 ' O ' HG22 ' A' ' 99' ' ' THR . 15.9 p-10 -93.21 -160.99 0.8 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.56 -21.26 25.51 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -89.72 -9.49 49.22 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.924 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.96 12.23 30.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.683 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -66.4 139.09 57.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.387 0.593 . . . . 0.0 109.952 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.5 mt -113.57 118.61 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.48 0.488 . . . . 0.0 111.752 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -102.49 140.13 37.18 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.667 HD22 HG11 ' A' ' 134' ' ' VAL . 27.8 mt -138.35 120.22 10.53 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.779 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.33 -38.95 27.28 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.357 1.371 . . . . 0.0 113.465 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -30.63 71.63 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.491 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.33 -41.17 73.57 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -69.44 -22.77 63.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.167 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -112.63 9.75 19.38 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.97 178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.0 t90 -76.93 123.45 26.31 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.944 0.878 . . . . 0.0 109.729 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -93.72 124.91 38.03 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.821 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 82.0 t60 -79.37 125.82 82.37 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.651 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 12.2 Cg_endo -108.32 92.84 0.04 OUTLIER 'Cis proline' 0 N--CA 1.497 1.717 0 CA-C-N 120.774 1.312 . . . . 0.0 112.529 -2.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -114.32 -61.75 1.7 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.361 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.3 t -68.51 -31.96 71.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.905 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 48.49 -178.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.811 0.815 . . . . 0.0 111.806 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.432 HD22 HG21 ' A' ' 28' ' ' VAL . 4.8 tt -68.36 -40.28 81.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.747 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.465 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -54.28 -40.99 68.37 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.39 -39.46 97.79 Favored Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.6 tp -58.69 -41.38 86.11 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.437 HD12 HD13 ' A' ' 35' ' ' LEU . 1.2 mm -72.85 -48.88 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 119.884 -0.727 . . . . 0.0 112.063 -176.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -66.41 -35.59 80.68 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 126' ' ' GLY . 53.4 t -68.47 -38.19 78.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.735 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 60.8 tpp -58.8 -42.49 89.22 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.443 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -61.71 -34.81 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.912 179.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.8 t -90.83 -45.12 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.667 HG11 HD22 ' A' ' 111' ' ' LEU . 6.2 p -66.05 -15.63 19.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.88 -177.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.414 ' CD2' HG13 ' A' ' 134' ' ' VAL . 12.0 m-30 -104.41 -19.23 14.12 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.196 177.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.72 -36.99 93.03 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.5 -40.54 95.85 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.133 -0.533 . . . . 0.0 110.9 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -153.45 84.62 4.27 Favored Pre-proline 0 CA--C 1.52 -0.199 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -48.3 120.35 4.94 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.983 1.122 . . . . 0.0 110.138 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.719 ' HB2' HG21 ' A' ' 103' ' ' VAL . 47.6 Cg_endo -70.93 -21.29 28.24 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.493 1.462 . . . . 0.0 111.887 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.33 140.88 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.154 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 6.4 p90 . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.395 -179.359 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 121.027 0.442 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.78 155.07 17.9 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.49 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 92.2 mt-10 -61.38 -43.19 99.29 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.254 -0.979 . . . . 0.0 112.017 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 t -58.47 -46.16 87.18 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.935 0.874 . . . . 0.0 108.984 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -62.9 -36.54 83.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.357 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.924 HD23 HG13 ' A' ' 22' ' ' VAL . 41.8 tp -55.73 -43.45 76.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.533 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.0 mptp? -61.3 -42.88 99.39 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.309 0.576 . . . . 0.0 109.528 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -61.1 -36.52 79.92 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.332 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.789 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -70.88 -37.72 73.03 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.723 -178.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 8' ' ' LEU . 3.3 m -112.12 24.37 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.736 0.303 . . . . 0.0 110.879 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.2 t -62.39 -37.87 87.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.022 0.439 . . . . 0.0 110.963 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -60.12 -21.91 62.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.601 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -63.88 157.57 24.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.112 0.482 . . . . 0.0 111.662 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.88 -37.9 54.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.621 177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 14.8 m-85 -113.94 64.61 0.66 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.356 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -61.79 -25.64 67.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -76.59 -51.97 10.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.04 -39.94 90.57 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.307 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.9 m -60.55 -47.56 85.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.166 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.924 HG13 HD23 ' A' ' 8' ' ' LEU . 12.6 t -66.24 -45.1 90.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.54 -41.92 98.06 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.485 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -67.51 -35.3 78.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 29' ' ' ILE . 22.2 p -67.65 -37.6 82.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.63 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 30' ' ' THR . 53.9 t -57.29 -45.61 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -37.63 80.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.5 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.692 HG21 HD22 ' A' ' 124' ' ' LEU . 54.7 t -68.89 -46.55 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -81.11 -13.76 12.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.169 -178.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.6 p -76.36 -50.96 12.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.045 0.45 . . . . 0.0 109.864 177.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.485 HD23 HD11 ' A' ' 125' ' ' LEU . 48.9 tp -82.37 -37.57 25.43 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.34 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -112.08 66.67 0.64 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm -55.59 -17.21 5.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.465 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -69.07 -15.19 63.39 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.176 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.477 ' CD2' HD13 ' A' ' 55' ' ' LEU . 2.6 tp -94.4 113.22 25.06 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -110.11 124.29 33.83 Favored Pre-proline 0 C--N 1.356 0.89 0 CA-C-N 119.474 1.034 . . . . 0.0 111.978 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.53 136.37 9.73 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 121.697 1.598 . . . . 0.0 113.202 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.04 156.34 42.68 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 110.397 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.789 HD13 ' SD ' ' A' ' 11' ' ' MET . 13.7 tp -92.28 118.69 31.14 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -124.43 132.81 53.51 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.321 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.8 p -76.86 137.38 39.14 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 N--CA 1.473 0.717 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.962 179.683 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 . . . . . 0 N--CA 1.467 0.395 0 CA-C-O 121.088 0.47 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.83 118.81 19.03 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.303 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 mt -121.48 140.7 51.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.557 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -96.92 137.71 35.59 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.322 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -130.49 151.2 51.23 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.457 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.477 HD13 ' CD2' ' A' ' 35' ' ' LEU . 5.4 mt -95.09 126.7 40.6 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.9 m -137.69 136.38 37.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.74 -147.11 11.55 Favored Glycine 0 N--CA 1.466 0.65 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.655 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.1 p -132.49 158.09 42.96 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -129.9 117.03 18.14 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.092 177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -72.23 123.49 9.24 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 119.947 1.017 . . . . 0.0 110.099 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.0 t -123.67 113.12 28.91 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.631 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.84 147.53 89.53 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.228 1.952 . . . . 0.0 109.695 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -163.57 107.4 1.01 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.63 -178.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.51 43.35 27.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.068 0.461 . . . . 0.0 111.557 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.01 14.76 76.2 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -134.69 125.6 27.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.2 m -113.26 131.18 56.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.997 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -112.59 149.23 33.06 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.466 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.79 100.08 11.83 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.523 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -87.6 117.69 68.85 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.314 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.81 123.81 2.9 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.453 2.102 . . . . 0.0 110.415 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.523 HG23 HG22 ' A' ' 70' ' ' ILE . 21.3 pt -131.6 147.12 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.349 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 67.4 m -121.08 123.12 41.57 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.205 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.33 109.62 21.31 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.144 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -99.49 125.35 45.22 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.01 140.85 29.04 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.257 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -84.18 155.11 22.7 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -62.53 -17.19 59.27 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.908 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.25 3.51 40.95 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.986 0.422 . . . . 0.0 111.718 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -59.16 145.37 81.03 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HG2' ' CE1' ' A' ' 119' ' ' HIS . 22.5 Cg_endo -91.59 8.64 62.81 Favored 'Cis proline' 0 N--CA 1.519 2.99 0 CA-C-N 121.019 1.4 . . . . 0.0 115.246 1.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.414 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 22.6 m-85 -74.46 -13.02 60.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.436 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.2 129.56 24.45 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.564 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -49.67 134.34 33.65 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 CA-C-N 121.205 1.466 . . . . 0.0 112.169 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.15 146.16 17.73 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.037 1.825 . . . . 0.0 111.886 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.446 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -95.49 151.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.79 -179.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.451 ' SG ' HD12 ' A' ' 109' ' ' ILE . 50.1 t -134.78 142.07 46.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.665 -178.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -127.09 131.21 50.91 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.086 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.408 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 57.6 t -97.44 123.62 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -76.37 106.26 3.09 Favored Pre-proline 0 N--CA 1.476 0.87 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.56 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 48.5 Cg_endo -90.61 128.66 1.42 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 CA-C-N 121.146 1.445 . . . . 0.0 113.548 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.5 p -81.15 168.95 17.99 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 88.1 p -59.27 -22.53 61.31 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 t -106.55 22.17 16.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.871 0.76 . . . . 0.0 110.946 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 42.5 ttm -133.52 144.73 49.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.43 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -131.22 163.71 27.16 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.864 179.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.43 ' N ' HG23 ' A' ' 96' ' ' THR . 5.7 mm -89.35 103.37 13.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.484 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -89.0 110.09 20.83 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.5 p -68.19 138.28 55.49 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.341 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.36 -141.82 3.54 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.249 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -70.84 -23.93 62.43 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.418 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 38.4 p-80 -130.4 -16.79 3.43 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.434 HG21 ' HB2' ' A' ' 140' ' ' PRO . 2.2 t -91.72 137.27 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.855 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -93.71 175.78 6.61 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.56 -39.07 93.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -91.15 4.78 51.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.11 10.27 49.28 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.99 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -67.82 140.96 56.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.451 HD12 ' SG ' ' A' ' 87' ' ' CYS . 62.7 mt -118.35 116.44 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.872 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.408 ' CE2' ' HA ' ' A' ' 102' ' ' HIS . 0.5 OUTLIER -116.88 142.94 46.28 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.637 HD23 HG11 ' A' ' 134' ' ' VAL . 1.8 mp -133.7 131.41 21.18 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.79 -177.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.1 -32.62 40.2 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 121.154 1.236 . . . . 0.0 113.693 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -65.76 -30.44 71.09 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.509 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.92 -41.45 74.63 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.229 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -67.94 -28.03 67.12 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.227 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -102.35 0.56 34.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.338 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.412 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.7 t90 -69.37 124.16 23.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.959 0.885 . . . . 0.0 109.985 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -95.34 125.0 39.67 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.158 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.422 ' CE1' ' HG2' ' A' ' 81' ' ' PRO . 60.0 t60 -76.7 125.64 86.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.409 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -108.85 92.03 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.65 0 CA-C-N 120.937 1.37 . . . . 0.0 112.36 -2.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -114.12 -61.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.936 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.1 t -66.64 -40.75 88.84 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.794 0.331 . . . . 0.0 111.277 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 59.07 168.15 0.06 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.787 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.692 HD22 HG21 ' A' ' 28' ' ' VAL . 6.7 tt -60.04 -42.1 93.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.69 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 125' ' ' LEU . 5.0 tt -52.63 -37.64 58.76 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.488 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.36 -39.31 97.08 Favored Glycine 0 N--CA 1.477 1.37 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.7 tp -60.51 -40.25 90.73 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -75.57 -48.85 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.644 -176.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.401 ' OE1' HG21 ' A' ' 132' ' ' ILE . 9.3 tp-100 -67.01 -35.48 80.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.616 ' O ' HG12 ' A' ' 134' ' ' VAL . 60.0 t -69.12 -39.7 79.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.414 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 51.7 ttm -57.85 -44.73 86.75 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.401 HG21 ' OE1' ' A' ' 129' ' ' GLN . 1.1 mp -61.0 -36.42 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.792 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -88.77 -47.27 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.637 HG11 HD23 ' A' ' 111' ' ' LEU . 5.4 p -66.75 -13.79 16.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.197 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.622 ' CD2' HG13 ' A' ' 134' ' ' VAL . 9.8 m-30 -101.83 -17.08 16.37 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.441 177.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.22 -26.74 71.74 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.96 -31.76 72.85 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.199 -0.501 . . . . 0.0 110.547 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -166.58 84.43 0.91 Allowed Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.257 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -46.6 121.83 5.2 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.225 1.283 . . . . 0.0 109.844 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.434 ' HB2' HG21 ' A' ' 103' ' ' VAL . 47.6 Cg_endo -70.13 -14.93 35.51 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.458 1.439 . . . . 0.0 112.427 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 m -131.42 151.2 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.245 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.7 p90 . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.374 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 121.005 0.431 . . . . 0.0 110.581 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.34 155.13 17.03 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 92.3 mt-10 -62.16 -41.08 97.95 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -57.1 -48.45 78.58 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.054 0.93 . . . . 0.0 109.398 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -64.05 -30.8 71.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.518 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.866 HD23 HG13 ' A' ' 22' ' ' VAL . 13.3 tp -59.14 -39.07 81.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.764 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 12.0 mptt -59.56 -42.79 93.25 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.669 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.71 -25.48 64.79 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.996 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.728 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -80.92 -28.92 35.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.893 -178.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -116.6 23.83 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 120.903 0.382 . . . . 0.0 110.489 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 t -67.06 -39.04 86.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.153 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -62.03 -17.72 58.25 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.823 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.486 ' CE1' HG12 ' A' ' 12' ' ' VAL . 22.6 m-85 -69.6 158.87 34.47 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.478 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -88.86 -9.86 50.11 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.91 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -132.88 56.12 1.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 119.532 -0.271 . . . . 0.0 110.302 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.425 ' O ' HG23 ' A' ' 22' ' ' VAL . 15.5 ptt180 -61.11 -32.43 72.11 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -177.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.33 -50.86 64.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.92 -41.96 73.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.099 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.2 m -61.51 -47.08 87.26 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 121.161 -0.216 . . . . 0.0 111.238 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.866 HG13 HD23 ' A' ' 8' ' ' LEU . 37.4 t -61.04 -46.51 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -60.32 -45.1 94.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.805 0.812 . . . . 0.0 110.586 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -68.23 -34.43 76.22 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.506 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.599 ' O ' HG23 ' A' ' 29' ' ' ILE . 5.6 p -67.81 -33.66 75.23 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.408 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.57 -44.96 94.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 C-N-CA 118.951 -1.1 . . . . 0.0 108.167 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -60.87 -37.32 81.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.011 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.2 t -68.83 -45.63 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.88 -17.25 8.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.702 -178.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -76.8 -49.87 14.83 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.183 0.516 . . . . 0.0 109.709 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.819 HD23 HD21 ' A' ' 125' ' ' LEU . 38.9 tp -76.61 -39.91 51.03 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.643 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -113.85 67.77 0.68 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -53.75 -20.34 5.45 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.522 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -65.69 -21.33 66.53 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.57 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.1 tp -89.64 117.59 28.63 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -115.05 126.52 27.75 Favored Pre-proline 0 C--N 1.356 0.879 0 CA-C-N 119.618 1.099 . . . . 0.0 111.916 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.51 135.1 14.41 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 CA-C-N 120.379 1.171 . . . . 0.0 112.232 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.17 136.64 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.728 HD13 ' SD ' ' A' ' 11' ' ' MET . 16.9 tp -85.15 116.32 23.45 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -119.48 133.69 55.57 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.107 0.479 . . . . 0.0 111.76 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.2 m -68.24 138.74 55.8 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.9 t80 . . . . . 0 N--CA 1.467 0.389 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.532 -179.873 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 121.272 0.558 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.58 118.7 19.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.029 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.577 HD21 ' O ' ' A' ' 76' ' ' LEU . 19.6 tp -116.99 121.03 40.21 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.2 ttp -84.62 142.91 29.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.025 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -133.51 162.15 32.67 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.384 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 55' ' ' LEU . 3.4 mm? -108.5 123.39 48.82 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.9 m -140.6 139.07 34.85 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.0 -148.59 14.93 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.187 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.6 p -132.67 161.02 35.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.822 -0.689 . . . . 0.0 112.334 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.416 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.4 pt -131.05 116.03 16.69 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.995 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.17 126.23 9.73 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 CA-C-N 119.689 0.925 . . . . 0.0 109.945 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.0 129.84 21.94 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.795 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.94 150.03 48.23 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.388 2.059 . . . . 0.0 110.876 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -163.97 112.04 1.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.971 0.415 . . . . 0.0 111.955 -178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? 49.88 44.52 25.24 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.448 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.81 18.38 68.36 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -137.6 127.11 25.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.5 m -111.44 130.78 55.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.455 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -112.67 150.81 30.95 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.734 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -94.61 105.04 16.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.495 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -90.67 116.57 66.71 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.47 124.62 3.68 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.196 1.93 . . . . 0.0 110.849 177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.495 HG23 HG22 ' A' ' 70' ' ' ILE . 26.7 pt -132.32 148.0 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.958 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.0 t -125.76 120.19 29.94 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.37 116.94 33.37 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.56 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.552 ' HE3' HD23 ' A' ' 52' ' ' LEU . 46.9 m95 -105.48 118.36 36.38 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.577 ' O ' HD21 ' A' ' 52' ' ' LEU . 59.0 mt -88.11 135.9 33.22 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.611 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -85.2 150.42 24.82 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -59.64 -15.32 18.24 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.315 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 p -100.75 7.77 43.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.541 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -66.46 144.05 98.49 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -92.08 3.88 63.09 Favored 'Cis proline' 0 N--CA 1.518 2.962 0 N-CA-C 116.13 1.55 . . . . 0.0 116.13 1.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -73.77 -17.12 61.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.467 1.031 . . . . 0.0 109.922 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.52 131.16 21.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.51 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -59.54 131.02 38.13 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 CA-C-N 121.319 1.507 . . . . 0.0 112.28 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.15 145.23 12.17 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.371 2.047 . . . . 0.0 111.545 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.9 129.89 48.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.0 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . 0.461 ' SG ' HD12 ' A' ' 109' ' ' ILE . 42.7 t -110.82 144.08 40.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.627 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -126.53 127.4 45.25 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.438 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.53 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 71.7 t -82.44 137.36 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -93.87 96.12 1.55 Allowed Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.135 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 97.7 Cg_endo -78.9 160.98 27.25 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 C-N-CA 121.711 1.607 . . . . 0.0 112.794 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.407 HG22 ' HB2' ' A' ' 95' ' ' MET . 5.5 t -148.37 167.22 25.81 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.661 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.9 p -58.46 -27.59 64.52 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 62.6 m -94.06 6.54 48.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.974 0.806 . . . . 0.0 110.972 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.407 ' HB2' HG22 ' A' ' 92' ' ' THR . 82.8 mmm -130.99 144.1 51.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.3 m -121.44 145.04 48.33 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.568 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 97' ' ' ILE . 12.2 tt -113.25 122.22 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.32 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.65 98.22 6.91 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.1 p -55.23 140.72 37.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.695 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.11 -142.2 3.33 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.431 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -65.46 -25.49 67.53 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -119.03 -30.29 5.04 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 119.322 0.965 . . . . 0.0 113.207 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.4 t -96.4 134.21 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.313 0.961 . . . . 0.0 110.925 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -98.68 160.47 14.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.287 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.12 85.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.053 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.31 -7.14 34.47 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.119 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.85 8.01 58.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.747 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.61 151.53 34.32 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.153 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.461 HD12 ' SG ' ' A' ' 87' ' ' CYS . 76.2 mt -109.18 122.03 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.481 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.44 ' HH ' ' CE1' ' A' ' 115' ' ' HIS . 0.9 OUTLIER -99.64 130.96 45.91 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.449 HD22 HG11 ' A' ' 134' ' ' VAL . 16.1 mt -134.33 108.37 11.27 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.89 -177.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -48.52 -34.26 25.73 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.971 1.781 . . . . 0.0 114.475 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -62.29 -29.24 70.29 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.337 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.58 -41.09 80.16 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.422 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.44 ' CE1' ' HH ' ' A' ' 110' ' ' TYR . 2.0 m-70 -65.81 -31.67 72.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.459 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -96.65 -8.4 31.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.336 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -54.1 124.83 16.82 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.898 0.856 . . . . 0.0 109.967 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -107.69 106.26 16.51 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.739 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 34.1 t-80 -58.23 123.55 66.09 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.721 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 20.3 Cg_endo -109.63 91.74 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.549 0 CA-C-N 120.707 1.288 . . . . 0.0 112.496 -3.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.88 -62.66 1.56 Allowed 'General case' 0 C--O 1.232 0.149 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.4 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.8 m -67.8 -41.04 83.75 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.136 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 60.62 163.5 0.06 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.527 0.679 . . . . 0.0 111.53 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.8 tt -60.24 -45.91 91.6 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.246 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.819 HD21 HD23 ' A' ' 31' ' ' LEU . 13.6 tp -54.68 -33.65 61.16 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -64.41 -40.54 97.86 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 tp -58.01 -40.0 79.71 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -75.73 -47.16 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.745 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.427 ' OE1' HG21 ' A' ' 132' ' ' ILE . 7.6 tp-100 -66.73 -35.74 80.82 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 126' ' ' GLY . 54.5 t -67.19 -38.38 80.95 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.1 tpp -58.66 -44.06 90.02 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.427 HG21 ' OE1' ' A' ' 129' ' ' GLN . 0.9 OUTLIER -62.8 -35.05 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.744 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -86.3 -47.27 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.774 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.449 HG11 HD22 ' A' ' 111' ' ' LEU . 3.8 p -69.58 -13.68 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.221 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.404 ' HD1' HG13 ' A' ' 134' ' ' VAL . 4.2 m-30 -103.58 -16.34 15.55 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.646 177.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -84.58 -23.76 49.17 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -66.44 -29.22 69.3 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.349 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -161.55 84.25 1.76 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.704 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -45.38 108.16 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.324 1.349 . . . . 0.0 110.925 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.11 -17.87 35.73 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.652 1.568 . . . . 0.0 110.982 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.28 138.41 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.458 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.5 p90 . . . . . 0 N--CA 1.471 0.624 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.577 -179.568 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.1 t . . . . . 0 N--CA 1.447 -0.616 0 CA-C-O 121.203 0.525 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 t -98.28 153.98 18.13 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.55 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 37.2 mp0 -60.13 -42.6 95.16 Favored 'General case' 0 C--O 1.214 -0.795 0 C-N-CA 118.43 -1.308 . . . . 0.0 110.947 -178.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.8 m -53.38 -45.94 69.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.825 0.822 . . . . 0.0 109.651 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -63.5 -38.06 89.67 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.601 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.912 HD23 HG13 ' A' ' 22' ' ' VAL . 15.4 tp -55.08 -42.07 72.34 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.55 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -59.67 -40.1 86.68 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.94 -32.43 70.7 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.05 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.831 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -73.55 -31.72 63.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.456 -178.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -115.36 20.76 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.687 0.28 . . . . 0.0 111.333 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -61.31 -37.94 85.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.365 0.602 . . . . 0.0 110.298 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -60.22 -21.15 61.46 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.612 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.417 ' OH ' HD22 ' A' ' 52' ' ' LEU . 37.0 m-85 -74.49 151.87 39.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.915 0.388 . . . . 0.0 111.889 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -70.93 -37.15 72.88 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.985 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.401 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 39.1 m-85 -109.14 60.84 0.6 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 121.25 -0.18 . . . . 0.0 111.448 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.0 ptp180 -67.37 -24.74 65.73 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -75.12 -50.0 17.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.93 -40.14 83.38 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.647 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.5 m -61.2 -46.73 89.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.247 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.912 HG13 HD23 ' A' ' 8' ' ' LEU . 41.5 t -61.85 -44.4 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-O 120.821 0.343 . . . . 0.0 110.155 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -62.93 -41.6 99.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.209 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -66.42 -37.73 85.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.676 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.646 ' O ' HG23 ' A' ' 29' ' ' ILE . 38.7 p -66.19 -37.13 84.86 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.299 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.18 -45.08 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 C-N-CA 118.849 -1.14 . . . . 0.0 108.506 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -61.28 -37.83 84.57 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.251 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.57 HG21 HD22 ' A' ' 124' ' ' LEU . 79.9 t -71.27 -43.41 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.05 -23.1 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.386 -178.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.1 m -72.19 -44.5 62.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.046 0.451 . . . . 0.0 110.264 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.738 HD23 HD11 ' A' ' 125' ' ' LEU . 23.9 tp -88.73 -40.68 13.06 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.417 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.55 67.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -56.83 -17.19 8.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.029 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -66.08 -14.6 62.02 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.59 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 tp -102.42 113.03 26.02 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -110.07 137.12 20.45 Favored Pre-proline 0 C--N 1.36 1.024 0 CA-C-N 119.921 1.237 . . . . 0.0 112.182 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.13 139.92 10.89 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.004 1.803 . . . . 0.0 112.423 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.53 139.22 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.072 0.463 . . . . 0.0 109.794 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.831 HD13 ' SD ' ' A' ' 11' ' ' MET . 14.2 tp -83.74 122.41 28.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.175 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -129.7 140.61 51.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.981 0.42 . . . . 0.0 112.073 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.7 t -94.05 115.29 27.6 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.476 ' CD2' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.71 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 . . . . . 0 C--O 1.238 0.481 0 CA-C-O 121.294 0.569 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -67.62 118.51 10.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.395 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.476 HD12 ' CD2' ' A' ' 42' ' ' TYR . 14.9 mt -125.53 142.53 51.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.955 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 49.8 ttp -90.93 144.57 25.54 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.11 152.76 51.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.551 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.8 mt -104.41 117.89 35.29 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -132.32 136.79 47.13 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.26 -143.95 8.34 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.424 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 p -136.34 159.31 42.16 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.449 HD13 HG21 ' A' ' 59' ' ' ILE . 1.3 pt -131.27 116.03 16.43 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.031 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -72.32 125.85 11.13 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 120.867 1.044 . . . . 0.0 110.793 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.5 t -128.77 115.91 19.3 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.578 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.31 150.63 15.4 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 122.718 2.279 . . . . 0.0 112.224 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.02 115.05 1.32 Allowed 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.258 0.551 . . . . 0.0 111.229 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.95 39.44 22.84 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.862 -0.523 . . . . 0.0 112.119 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 0.79 90.05 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.139 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.412 ' ND2' ' CZ ' ' A' ' 68' ' ' TYR . 1.7 t30 -119.89 128.78 53.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 109.896 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.2 m -119.26 132.04 55.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.502 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.412 ' CZ ' ' ND2' ' A' ' 66' ' ' ASN . 67.5 m-85 -115.75 150.88 36.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.916 0.388 . . . . 0.0 110.574 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.6 100.94 12.61 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.489 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -87.37 116.98 67.92 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.464 -177.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -82.29 126.27 4.82 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 122.718 2.279 . . . . 0.0 110.687 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.489 HG23 HG22 ' A' ' 70' ' ' ILE . 26.4 pt -133.35 147.96 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 118.943 -1.103 . . . . 0.0 112.502 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.6 m -121.89 123.42 41.69 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.365 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.07 109.92 21.89 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.42 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -96.08 128.98 43.46 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 mp -99.42 140.08 34.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.13 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tp -95.14 140.56 29.9 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.71 -17.1 0.09 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.17 12.43 37.01 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -69.08 143.41 94.21 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -91.68 4.51 64.91 Favored 'Cis proline' 0 N--CA 1.516 2.806 0 CA-C-N 120.928 1.367 . . . . 0.0 114.501 0.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.401 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.4 m-85 -67.73 -18.93 65.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.378 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.08 120.98 40.6 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.201 178.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -49.55 136.41 33.37 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 CA-C-N 121.235 1.477 . . . . 0.0 111.859 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.62 144.7 14.2 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.337 2.025 . . . . 0.0 111.277 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 mp -97.76 132.77 41.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-O 121.591 0.71 . . . . 0.0 109.789 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 33.8 t -106.41 154.86 20.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.529 -177.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.1 128.76 30.75 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.053 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.63 ' CG2' HD11 ' A' ' 109' ' ' ILE . 58.9 t -98.05 124.13 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -75.28 108.12 5.12 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.187 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -85.64 159.24 10.68 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.267 1.311 . . . . 0.0 112.454 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -129.24 164.86 22.55 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 m -58.6 -39.84 81.56 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.2 m -84.74 -0.68 54.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.85 0.75 . . . . 0.0 111.581 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 32.8 ttm -120.92 145.92 47.18 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -131.39 163.07 28.7 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.588 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.444 ' N ' HG23 ' A' ' 96' ' ' THR . 72.4 mt -95.8 103.59 14.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -87.32 113.52 23.12 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.149 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.5 p -68.52 147.74 51.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.256 0.55 . . . . 0.0 110.479 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.87 -145.16 4.28 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -79.47 -7.53 58.5 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -133.11 -30.46 1.34 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.14 0.882 . . . . 0.0 112.297 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.2 t -97.03 139.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.48 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -94.83 -174.61 3.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.661 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.32 -35.03 21.72 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -83.86 5.46 25.14 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.957 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.13 13.12 50.32 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.346 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -75.52 136.26 40.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.779 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.63 HD11 ' CG2' ' A' ' 89' ' ' VAL . 91.7 mt -110.8 114.98 48.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 140.86 49.2 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.624 HD23 HG11 ' A' ' 134' ' ' VAL . 1.6 mp -134.43 128.63 19.29 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.01 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -49.02 -35.16 31.49 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 121.388 1.392 . . . . 0.0 113.384 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -32.42 71.92 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.23 -41.93 76.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.273 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -63.68 -31.06 72.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.016 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -108.42 9.95 27.53 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.769 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -65.57 127.25 31.13 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.688 0.756 . . . . 0.0 110.439 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.39 122.17 43.75 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.453 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 43.8 t60 -75.82 125.93 87.71 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.626 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 7.4 Cg_endo -109.85 91.27 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.718 0 CA-C-N 120.597 1.249 . . . . 0.0 112.626 -2.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -113.19 -59.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.538 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.403 ' O ' ' HA3' ' A' ' 126' ' ' GLY . 27.2 p -68.85 -34.74 75.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.138 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 p30 49.21 178.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.603 0.716 . . . . 0.0 111.613 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.57 HD22 HG21 ' A' ' 28' ' ' VAL . 1.5 tt -66.0 -40.59 91.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.379 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.738 HD11 HD23 ' A' ' 31' ' ' LEU . 2.9 tt -56.77 -40.36 75.73 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -60.86 -39.87 97.48 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.0 tp -58.69 -40.77 84.59 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 122.265 -0.55 . . . . 0.0 111.556 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -76.61 -48.89 25.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.096 -0.642 . . . . 0.0 112.314 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -66.71 -34.0 76.87 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.618 ' O ' HG12 ' A' ' 134' ' ' VAL . 58.5 t -68.6 -38.33 78.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 48.7 tpp -58.9 -44.1 91.14 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -61.64 -40.84 88.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.888 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -82.46 -47.86 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 120.002 -0.679 . . . . 0.0 112.543 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.624 HG11 HD23 ' A' ' 111' ' ' LEU . 4.2 p -66.75 -14.06 17.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.072 -178.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.472 ' CD1' HG13 ' A' ' 134' ' ' VAL . 11.8 m-30 -109.22 -18.43 13.61 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.91 88.52 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -63.66 -34.91 78.9 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-N 115.294 -0.453 . . . . 0.0 110.489 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -156.63 84.08 3.16 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.327 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -43.96 107.42 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.679 1.586 . . . . 0.0 111.018 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.03 -24.23 47.77 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.105 1.87 . . . . 0.0 111.578 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.6 m -128.33 147.33 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.565 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.0 p90 . . . . . 0 N--CA 1.474 0.727 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.542 179.865 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 N--CA 1.449 -0.515 0 CA-C-O 121.052 0.453 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.82 153.56 18.79 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.541 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 95.3 mt-10 -61.72 -42.17 98.59 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.099 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.0 t -56.78 -46.49 81.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.19 0.995 . . . . 0.0 108.649 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -61.18 -39.07 88.8 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.144 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.784 HD23 HG13 ' A' ' 22' ' ' VAL . 27.6 tp -56.12 -42.19 76.47 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.6 mptp? -60.14 -40.65 90.57 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -28.19 67.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.69 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.653 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -80.39 -30.51 37.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.99 -178.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -118.61 19.71 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.577 0.227 . . . . 0.0 111.387 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -61.05 -38.1 84.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.53 0.681 . . . . 0.0 110.306 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -60.2 -26.06 66.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.122 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.686 ' OH ' HD22 ' A' ' 52' ' ' LEU . 40.3 m-85 -67.36 159.4 29.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.716 0.293 . . . . 0.0 110.941 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -80.33 -29.92 38.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.811 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -116.89 58.04 0.78 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -63.59 -28.51 69.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.3 -47.41 61.26 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.1 tp -70.27 -40.25 74.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.501 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 25' ' ' THR . 98.8 m -62.94 -46.14 89.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.784 HG13 HD23 ' A' ' 8' ' ' LEU . 14.4 t -63.28 -45.6 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 120.695 0.283 . . . . 0.0 110.991 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -63.14 -43.52 98.11 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.154 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -66.68 -37.43 84.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.995 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.667 ' O ' HG23 ' A' ' 29' ' ' ILE . 28.1 p -64.76 -36.94 85.94 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.976 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -57.32 -45.03 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -60.98 -40.41 93.34 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.998 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -68.0 -43.6 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.38 -23.77 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.217 -178.05 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.5 m -74.48 -44.54 51.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.009 0.433 . . . . 0.0 110.595 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.663 ' O ' HD13 ' A' ' 31' ' ' LEU . 2.8 tm? -85.32 -36.61 20.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.666 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.86 68.38 0.72 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -57.01 -19.39 18.12 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.539 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.81 -21.55 66.8 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.067 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.457 HD23 HD13 ' A' ' 55' ' ' LEU . 2.9 tp -90.24 113.32 25.11 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -108.98 125.12 32.3 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 119.439 1.018 . . . . 0.0 111.77 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.09 137.58 17.38 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.32 1.347 . . . . 0.0 112.102 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.18 143.99 37.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 120.968 0.414 . . . . 0.0 110.264 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.653 HD13 ' SD ' ' A' ' 11' ' ' MET . 17.5 tp -91.63 122.01 33.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.533 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -131.47 139.5 49.36 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.088 0.47 . . . . 0.0 111.965 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 t -68.82 136.22 52.37 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.2 t80 . . . . . 0 N--CA 1.465 0.321 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.163 -179.978 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 . . . . . 0 N--CA 1.468 0.448 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -79.83 120.1 23.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.558 0.694 . . . . 0.0 110.623 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.686 HD22 ' OH ' ' A' ' 15' ' ' TYR . 39.8 mt -116.18 142.51 46.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.907 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -101.37 137.12 40.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.097 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -129.34 151.08 50.38 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.744 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.457 HD13 HD23 ' A' ' 35' ' ' LEU . 6.8 mt -95.16 122.34 37.73 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.2 m -133.65 136.02 44.52 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.81 -144.54 9.16 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.859 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -135.18 160.47 38.26 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.414 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.2 pt -129.32 116.14 18.62 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.924 177.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -73.55 124.24 9.2 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 120.661 0.907 . . . . 0.0 109.887 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.4 t -123.76 117.72 27.36 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.03 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.5 146.77 50.58 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.334 2.022 . . . . 0.0 110.753 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.404 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -162.88 108.97 1.17 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.514 -178.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.01 35.12 21.3 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 122.022 -0.424 . . . . 0.0 111.411 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.65 -2.74 77.69 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -113.57 135.1 54.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.6 m -120.28 132.27 55.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.034 0.445 . . . . 0.0 111.993 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -111.02 147.53 34.56 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.807 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -95.26 100.53 12.31 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.521 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -86.92 115.42 62.46 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.034 -177.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.38 123.37 3.87 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.874 2.383 . . . . 0.0 111.058 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.521 HG23 HG22 ' A' ' 70' ' ' ILE . 35.2 pt -136.49 149.12 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.935 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 53.7 m -123.92 122.42 37.91 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.568 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.4 HD22 HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -97.64 121.6 39.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.025 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -111.23 119.43 38.89 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.12 139.97 32.09 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.034 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' O ' ' HE2' ' A' ' 15' ' ' TYR . 2.8 mt -89.28 149.38 23.09 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -56.69 -16.58 6.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.619 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.0 5.41 43.1 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.156 0.503 . . . . 0.0 111.788 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -63.77 144.08 97.99 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -90.19 5.32 68.53 Favored 'Cis proline' 0 N--CA 1.514 2.693 0 CA-C-N 121.004 1.394 . . . . 0.0 115.227 1.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -70.07 -25.02 63.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.865 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.3 138.2 19.47 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.37 141.67 75.66 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 CA-C-N 121.767 1.667 . . . . 0.0 111.304 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -82.52 142.87 11.91 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.016 1.81 . . . . 0.0 111.878 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.55 135.34 28.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 42.2 t -112.09 139.93 47.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.839 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.1 124.98 44.31 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.943 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -84.41 144.48 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -98.29 98.21 5.48 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 119.221 -0.418 . . . . 0.0 110.318 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -80.79 160.18 21.5 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.256 1.304 . . . . 0.0 111.921 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 t -137.34 161.68 35.62 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.2 t -54.64 -39.37 67.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.177 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.6 t -76.64 -2.25 31.74 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.536 0.607 . . . . 0.0 111.956 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.3 mtp -130.13 145.47 51.7 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.443 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -126.73 163.35 23.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.596 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.443 ' N ' HG23 ' A' ' 96' ' ' THR . 3.3 mm -90.77 110.04 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.567 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -95.09 104.75 16.63 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 34.3 p -67.73 138.17 56.04 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.684 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.76 -133.64 1.93 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -86.09 -7.26 58.72 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -134.84 -23.09 1.59 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 140' ' ' PRO . 2.3 t -91.62 134.59 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 119.6 1.091 . . . . 0.0 110.635 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.428 ' O ' HG12 ' A' ' 103' ' ' VAL . 15.3 t0 -84.72 -168.29 2.14 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.59 -34.54 19.85 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.683 -0.636 . . . . 0.0 112.399 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -88.81 1.26 55.57 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.736 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.01 -8.43 38.89 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.465 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 131.67 23.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.243 0.522 . . . . 0.0 110.172 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.408 HG22 ' HG ' ' A' ' 111' ' ' LEU . 76.5 mt -97.67 121.5 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.928 0.395 . . . . 0.0 110.535 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.87 119.43 38.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.424 ' CD2' HG11 ' A' ' 134' ' ' VAL . 7.1 mt -126.57 113.42 22.91 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.59 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -48.42 -38.27 34.54 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 121.962 1.775 . . . . 0.0 114.25 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -63.82 -31.51 72.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.22 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.29 -42.23 79.78 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.793 0.33 . . . . 0.0 110.927 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -67.1 -29.26 68.96 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.687 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -104.36 7.15 35.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.229 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -71.6 127.25 31.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 122.033 0.92 . . . . 0.0 110.651 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -97.41 124.72 41.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.824 -1.534 . . . . 0.0 108.217 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -80.25 126.64 78.7 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 119.133 -0.46 . . . . 0.0 110.539 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -108.8 93.36 0.03 OUTLIER 'Cis proline' 0 N--CA 1.498 1.755 0 CA-C-N 120.631 1.261 . . . . 0.0 112.778 -2.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -113.69 -60.7 1.85 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.722 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.2 p -69.99 -31.8 69.67 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.0 p30 48.46 179.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.73 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 tt -66.88 -43.31 83.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.983 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.553 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -52.9 -40.69 63.73 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.341 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.1 -39.67 97.93 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.0 -41.38 87.53 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -75.41 -46.88 36.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 119.796 -0.761 . . . . 0.0 111.766 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -36.59 75.73 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.219 -0.992 . . . . 0.0 108.626 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 126' ' ' GLY . 55.6 t -65.49 -42.24 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.197 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 56.6 ttm -57.16 -43.47 82.57 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.414 HD11 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -59.79 -26.51 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.702 178.285 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.5 t -94.99 -54.61 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 130' ' ' VAL . 11.2 p -63.8 -13.71 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.394 -0.191 . . . . 0.0 111.317 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -100.59 -16.92 17.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.433 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.8 -25.36 60.48 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -65.29 -34.5 78.49 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -158.37 83.67 2.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -44.25 111.44 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.716 1.611 . . . . 0.0 110.984 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HB2' HG21 ' A' ' 103' ' ' VAL . 56.9 Cg_endo -72.49 -14.98 27.84 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 121.741 1.627 . . . . 0.0 111.519 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.8 m -127.49 139.53 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.643 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 39.2 p90 . . . . . 0 N--CA 1.472 0.673 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.953 -179.004 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.3 t . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 120.884 0.373 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.48 153.54 19.04 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.527 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 28.5 mp0 -62.64 -41.44 99.03 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.849 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.1 m -58.18 -46.02 86.49 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.083 0.944 . . . . 0.0 108.834 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.19 -34.58 77.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.548 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.677 HD23 HG13 ' A' ' 22' ' ' VAL . 11.0 tp -57.66 -36.94 72.56 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.527 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.4 mptp? -61.71 -44.61 96.6 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.464 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -64.39 -36.36 83.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.34 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.655 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -69.55 -33.67 73.11 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.4 m -114.0 20.98 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 122.021 -0.425 . . . . 0.0 110.906 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -60.55 -37.67 82.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.194 0.521 . . . . 0.0 111.13 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -62.96 -13.45 34.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.896 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -76.42 155.01 34.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.942 0.401 . . . . 0.0 111.365 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -72.28 -36.9 69.11 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.88 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -113.06 65.16 0.64 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.289 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -63.66 -25.52 68.25 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.93 -54.03 8.81 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 tp -64.29 -38.63 91.73 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.535 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 25' ' ' THR . 95.9 m -61.66 -48.2 81.9 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.752 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.677 HG13 HD23 ' A' ' 8' ' ' LEU . 27.3 t -62.62 -47.96 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 120.751 0.31 . . . . 0.0 111.161 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -62.7 -42.03 99.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.106 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.6 -39.1 93.51 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.305 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.648 ' O ' HG23 ' A' ' 29' ' ' ILE . 40.1 p -68.05 -37.7 81.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.736 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -55.23 -43.05 69.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -60.57 -39.6 88.58 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.47 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.62 ' HA ' HD13 ' A' ' 125' ' ' LEU . 68.7 t -72.55 -40.67 63.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -88.17 -23.71 6.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.261 -178.13 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.2 m -73.85 -48.7 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.097 0.475 . . . . 0.0 109.833 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.929 HD23 HD21 ' A' ' 125' ' ' LEU . 16.4 tp -84.39 -38.85 19.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.989 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.733 ' HD1' HD11 ' A' ' 125' ' ' LEU . 2.3 m-85 -112.9 65.72 0.64 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.208 0.528 . . . . 0.0 109.986 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -58.62 -14.6 8.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -64.2 -20.92 66.35 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.534 HD23 HD13 ' A' ' 55' ' ' LEU . 2.9 tp -94.54 113.8 25.69 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -107.87 129.31 24.32 Favored Pre-proline 0 C--N 1.357 0.916 0 CA-C-N 120.094 1.315 . . . . 0.0 111.716 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -84.39 137.04 6.81 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 121.804 1.669 . . . . 0.0 112.991 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.35 154.39 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.655 HD13 ' SD ' ' A' ' 11' ' ' MET . 15.2 tp -94.99 126.11 40.11 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.407 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.9 161.62 26.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.48 0.657 . . . . 0.0 112.091 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -97.64 124.59 42.0 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.358 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.481 1.125 0 CA-C-N 118.306 0.503 . . . . 0.0 109.892 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.029 0.443 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.82 121.33 23.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.91 0.862 . . . . 0.0 109.976 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.508 HD21 ' O ' ' A' ' 76' ' ' LEU . 11.8 tp -120.31 131.91 55.08 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.316 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.2 ttp -91.03 137.77 32.11 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.884 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -131.23 152.04 50.89 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.534 HD13 HD23 ' A' ' 35' ' ' LEU . 9.2 mt -100.96 130.47 46.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.1 m -145.55 137.88 25.69 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.071 0.463 . . . . 0.0 111.857 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.71 -145.21 9.34 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.279 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.4 p -131.26 158.15 41.39 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.659 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.4 pt -132.48 116.33 15.1 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.608 177.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -69.03 124.16 11.09 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 CA-C-N 119.98 1.029 . . . . 0.0 110.849 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.8 t -127.6 112.59 20.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.259 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.18 151.6 20.78 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.879 2.386 . . . . 0.0 112.62 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -163.5 115.03 1.43 Allowed 'General case' 0 CA--C 1.56 1.343 0 CA-C-O 121.546 0.689 . . . . 0.0 111.23 179.046 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 49.97 38.93 17.57 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.86 -4.49 85.67 Favored Glycine 0 N--CA 1.473 1.151 0 O-C-N 121.727 -0.608 . . . . 0.0 113.025 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -119.6 130.29 55.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.97 0.414 . . . . 0.0 109.98 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.8 m -118.25 131.41 56.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.685 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -113.28 149.29 34.08 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.949 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -97.13 102.64 14.46 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.453 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -89.39 119.15 69.62 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.39 128.58 4.16 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.784 2.323 . . . . 0.0 110.624 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.453 HG23 HG22 ' A' ' 70' ' ' ILE . 23.1 pt -134.5 147.5 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.971 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 69.3 m -120.62 122.48 40.6 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 121.534 0.683 . . . . 0.0 110.021 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.19 114.4 28.51 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.326 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -105.23 122.99 47.08 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.508 ' O ' HD21 ' A' ' 52' ' ' LEU . 63.4 mt -93.86 131.12 39.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.738 -177.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mt -74.82 149.43 39.65 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -56.9 -14.18 3.28 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.577 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.6 0.29 36.07 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -51.79 144.71 18.42 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HG2' ' CD2' ' A' ' 119' ' ' HIS . 29.0 Cg_endo -93.62 10.1 53.6 Favored 'Cis proline' 0 N--CA 1.516 2.81 0 CA-C-N 120.842 1.336 . . . . 0.0 115.369 0.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -75.45 -12.0 60.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.235 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.17 121.81 35.74 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.88 137.65 35.21 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 CA-C-N 121.182 1.458 . . . . 0.0 111.995 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.12 142.11 12.06 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.19 1.927 . . . . 0.0 111.488 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.31 133.43 40.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.699 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.3 t -114.69 143.45 45.02 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.017 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -127.86 131.14 49.5 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.681 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.7 t -103.92 126.31 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.14 101.78 5.32 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.957 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -83.82 129.24 4.73 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.622 1.548 . . . . 0.0 113.254 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.4 p -80.91 165.54 21.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.7 p -59.27 -25.07 63.77 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -99.51 23.76 9.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.971 0.805 . . . . 0.0 109.888 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.7 ttm -129.64 139.41 51.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.888 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.6 m -115.64 133.06 56.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.019 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 97' ' ' ILE . 1.4 tp -84.26 106.94 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.971 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -87.22 99.27 11.83 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.352 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.6 p -67.67 143.11 56.14 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.74 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.76 -152.45 6.9 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -74.59 -15.63 60.83 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -114.15 -27.35 7.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.578 HG21 ' HB2' ' A' ' 140' ' ' PRO . 2.0 t -106.65 136.09 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -100.07 175.78 5.63 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.15 93.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -79.34 -17.84 53.71 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.02 33.78 2.71 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.215 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -82.21 148.48 28.4 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.61 116.01 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.604 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.36 116.61 32.45 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 mt -126.05 113.71 24.13 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 118.249 0.477 . . . . 0.0 110.942 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -48.21 -37.55 31.57 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.733 1.622 . . . . 0.0 114.661 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.43 ' OH ' HD13 ' A' ' 127' ' ' LEU . 1.7 p90 -61.47 -32.24 72.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.652 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.409 ' N ' ' CG ' ' A' ' 113' ' ' TYR . 0.8 OUTLIER -68.55 -41.5 79.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.717 -178.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -62.99 -33.86 76.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.628 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -101.03 2.88 40.95 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.163 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -52.5 123.08 10.12 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.992 0.901 . . . . 0.0 110.221 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -101.58 100.22 10.6 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.797 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 81' ' ' PRO . 23.5 t-80 -57.03 122.29 52.24 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.897 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -111.66 91.24 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.576 0 CA-C-N 120.687 1.281 . . . . 0.0 112.235 -3.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -114.96 -51.63 2.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.984 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.3 m -71.24 -41.33 70.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.983 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t70 66.53 165.04 0.2 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.585 0.707 . . . . 0.0 111.807 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.459 HD23 HG21 ' A' ' 28' ' ' VAL . 21.9 tp -67.05 -41.13 87.01 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.694 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.929 HD21 HD23 ' A' ' 31' ' ' LEU . 30.3 tp -59.69 -37.28 78.39 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -60.87 -39.6 97.12 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.43 HD13 ' OH ' ' A' ' 113' ' ' TYR . 31.2 tp -57.37 -39.51 76.17 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.416 HD12 HD13 ' A' ' 35' ' ' LEU . 1.2 mm -72.08 -49.3 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.619 -177.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -66.92 -35.68 80.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 118.661 -1.216 . . . . 0.0 108.683 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 126' ' ' GLY . 54.6 t -64.25 -38.63 83.0 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 C-N-CA 119.432 -0.907 . . . . 0.0 108.864 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.7 tpp -60.49 -43.12 97.36 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.659 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.1 mp -67.92 -36.64 76.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.683 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.5 t -81.59 -41.5 18.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.47 HG13 ' CD2' ' A' ' 135' ' ' PHE . 2.1 p -77.71 -15.62 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.784 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.47 ' CD2' HG13 ' A' ' 134' ' ' VAL . 13.8 m-30 -107.3 -18.08 13.97 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.393 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.88 -27.1 69.64 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -66.47 -27.56 67.89 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.635 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -168.18 89.72 0.66 Allowed Pre-proline 0 C--O 1.232 0.15 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -44.76 119.35 2.28 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.67 1.58 . . . . 0.0 110.588 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.578 ' HB2' HG21 ' A' ' 103' ' ' VAL . 55.3 Cg_endo -70.97 -16.3 32.46 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.561 1.507 . . . . 0.0 111.448 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.17 140.37 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.337 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 26.6 p90 . . . . . 0 N--CA 1.472 0.661 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.817 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.515 HG11 ' HG2' ' A' ' 37' ' ' PRO . 3.9 p . . . . . 0 N--CA 1.444 -0.747 0 CA-C-O 121.586 0.707 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -104.96 153.81 20.93 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.0 mt-10 -59.47 -42.48 92.16 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.109 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.2 m -58.23 -47.89 82.09 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.952 0.882 . . . . 0.0 109.355 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -62.57 -34.42 76.94 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.95 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.819 HD23 HG13 ' A' ' 22' ' ' VAL . 13.2 tp -56.09 -39.27 71.89 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 11.0 mptt -61.05 -43.95 98.13 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.557 0.694 . . . . 0.0 109.613 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.03 -36.32 83.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.617 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.78 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.4 mmm -66.92 -37.04 83.6 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.619 -178.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -115.73 23.46 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.526 0.203 . . . . 0.0 111.245 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.3 p -66.62 -18.13 65.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.705 0.288 . . . . 0.0 111.029 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -77.41 -20.78 54.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.121 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -72.47 149.88 43.79 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -66.23 -40.04 89.99 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.789 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -110.56 64.21 0.61 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.783 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -65.24 -27.74 68.87 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.37 -49.48 33.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.37 -41.7 93.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.634 -0.827 . . . . 0.0 109.389 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 25' ' ' THR . 53.1 m -60.22 -48.49 81.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.156 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.819 HG13 HD23 ' A' ' 8' ' ' LEU . 20.8 t -63.55 -46.02 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 120.536 0.208 . . . . 0.0 111.445 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.74 -42.74 99.36 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.619 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -34.19 72.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.541 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 29' ' ' ILE . 24.9 p -66.21 -38.49 88.09 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.4 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 30' ' ' THR . 53.2 t -57.64 -45.42 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -61.24 -38.77 87.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.327 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.516 HG21 HD22 ' A' ' 124' ' ' LEU . 55.2 t -67.12 -46.05 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -81.81 -13.5 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.33 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.0 p -76.33 -52.09 10.64 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.0 tp -85.03 -38.15 19.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.416 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -108.89 64.26 0.61 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.135 0.493 . . . . 0.0 109.89 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -55.31 -18.82 7.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.534 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -65.5 -22.55 66.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.364 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.55 HD23 HD13 ' A' ' 55' ' ' LEU . 2.0 tp -91.18 113.86 26.23 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -110.69 132.24 21.69 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.576 1.08 . . . . 0.0 111.805 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.515 ' HG2' HG11 ' A' ' 3' ' ' VAL . 43.5 Cg_endo -81.43 135.01 9.15 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 122.242 1.961 . . . . 0.0 112.94 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -131.56 137.01 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.78 HD13 ' SD ' ' A' ' 11' ' ' MET . 15.4 tp -82.41 121.77 27.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.27 160.04 24.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.731 0.3 . . . . 0.0 110.925 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m -99.8 131.68 45.63 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.0 t80 . . . . . 0 N--CA 1.47 0.538 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.141 -179.5 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 . . . . . 0 CA--C 1.514 -0.409 0 CA-C-O 121.433 0.635 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.16 122.97 28.03 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.672 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 52' ' ' LEU . 51.4 mt -122.29 144.17 49.16 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.936 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.491 ' SD ' HD11 ' A' ' 8' ' ' LEU . 57.9 ttp -97.43 139.09 33.88 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.84 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -132.35 150.55 52.13 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 121.161 0.505 . . . . 0.0 111.254 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.55 HD13 HD23 ' A' ' 35' ' ' LEU . 7.0 mt -98.38 124.19 42.92 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 m -134.97 138.62 44.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.68 -145.33 9.65 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.58 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.6 p -133.27 159.39 40.37 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.42 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.1 pt -133.73 116.56 13.77 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.38 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -70.95 127.56 13.8 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 CA-C-N 120.058 1.057 . . . . 0.0 110.014 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 89.8 t -127.31 118.1 21.7 Favored Pre-proline 0 C--N 1.347 0.485 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.284 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.29 142.23 37.04 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.885 1.723 . . . . 0.0 110.066 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.402 ' HD2' ' OD1' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -159.77 113.46 2.24 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.888 -178.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 60.84 25.37 15.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.755 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.86 -13.23 67.36 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.563 ' C ' ' OD1' ' A' ' 66' ' ' ASN . 3.1 p-10 -99.85 169.96 8.86 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.1 m -139.88 133.98 31.01 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.515 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -121.08 148.62 43.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.304 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.34 106.66 18.92 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.544 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -91.7 115.41 64.48 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.215 -177.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.56 126.3 4.66 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.304 2.003 . . . . 0.0 110.376 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.544 HG23 HG22 ' A' ' 70' ' ' ILE . 27.0 pt -133.97 150.44 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 119.156 -1.018 . . . . 0.0 112.091 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.6 m -121.61 120.68 35.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.81 115.68 31.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.929 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -109.24 128.05 54.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.8 mt -97.3 142.02 29.69 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.043 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -87.45 151.41 23.07 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -58.92 -15.16 11.48 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.87 5.48 33.02 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.204 0.526 . . . . 0.0 112.233 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -60.93 145.59 88.76 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -92.42 10.26 57.56 Favored 'Cis proline' 0 N--CA 1.516 2.798 0 CA-C-N 120.856 1.341 . . . . 0.0 114.753 0.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.59 -12.17 60.67 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.84 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.48 127.78 26.49 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.66 -0.686 . . . . 0.0 109.408 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -49.39 134.28 31.72 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 CA-C-N 121.192 1.461 . . . . 0.0 112.217 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.416 ' HD2' HD11 ' A' ' 114' ' ' LEU . 86.3 Cg_endo -79.9 142.12 15.51 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.366 2.044 . . . . 0.0 111.274 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.6 mt -98.75 135.67 32.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.088 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.3 t -121.66 145.98 47.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.023 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -125.71 134.48 51.78 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.159 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.403 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.8 p -95.65 127.92 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -69.3 107.42 2.15 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 44.5 Cg_endo -84.8 155.91 11.73 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.268 1.312 . . . . 0.0 113.147 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.3 p -129.01 169.85 14.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.062 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.7 m -59.18 -39.59 83.03 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -89.92 -3.61 57.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.617 0.644 . . . . 0.0 111.53 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.7 ttm -116.23 137.15 52.39 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -129.22 165.83 20.59 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.109 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.469 ' N ' HG23 ' A' ' 96' ' ' THR . 70.2 mt -111.27 108.78 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.716 178.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -97.52 126.91 43.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.9 p -72.01 143.6 49.11 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.92 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.54 -142.18 3.5 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.752 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -66.0 -26.6 67.62 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.484 ' NE2' HG23 ' A' ' 103' ' ' VAL . 20.5 p-80 -133.68 -26.67 1.57 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.484 HG23 ' NE2' ' A' ' 102' ' ' HIS . 0.9 OUTLIER -92.72 132.08 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 119.477 1.035 . . . . 0.0 110.536 -179.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -98.97 175.41 5.94 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.45 77.42 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -74.94 -9.83 58.91 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.415 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.69 5.29 55.45 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.156 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 147.26 53.73 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.468 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.527 HD13 ' CZ ' ' A' ' 135' ' ' PHE . 96.8 mt -120.74 125.13 73.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -99.7 137.82 37.65 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.679 HD22 HG11 ' A' ' 134' ' ' VAL . 29.2 mt -136.61 116.57 10.87 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.441 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -47.56 -37.36 26.37 Favored 'Trans proline' 0 N--CA 1.504 2.091 0 C-N-CA 122.075 1.85 . . . . 0.0 114.505 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -61.09 -29.37 69.71 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.679 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.416 HD11 ' HD2' ' A' ' 85' ' ' PRO . 1.2 tt -69.8 -43.16 72.64 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.489 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -68.05 -27.61 66.67 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.378 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -103.86 3.91 34.31 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.932 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . 0.479 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.6 t90 -70.16 120.05 15.26 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.806 0.812 . . . . 0.0 109.742 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -88.05 129.51 35.26 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.161 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 46.4 t-80 -78.81 124.06 85.11 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.463 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 14.0 Cg_endo -111.04 93.1 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.664 0 CA-C-N 120.953 1.376 . . . . 0.0 111.63 -3.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -113.6 -56.17 2.43 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.115 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.5 t -74.3 -34.61 63.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.773 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 47.02 -176.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.707 0.765 . . . . 0.0 111.621 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -69.52 -40.59 76.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.306 -179.369 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.1 tt -55.68 -39.51 71.07 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.58 -39.86 98.4 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.4 tp -57.6 -40.28 78.74 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.444 HD12 HD13 ' A' ' 35' ' ' LEU . 1.1 mm -73.19 -49.96 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.816 -176.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.41 ' OE1' HG21 ' A' ' 132' ' ' ILE . 10.6 tp-100 -64.78 -35.92 82.63 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 126' ' ' GLY . 73.5 t -68.25 -37.27 77.77 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.4 tpp -58.32 -43.04 88.0 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.42 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -62.65 -39.63 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.13 178.675 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.9 t -81.48 -47.32 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.679 HG11 HD22 ' A' ' 111' ' ' LEU . 4.7 p -67.71 -15.47 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.34 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.527 ' CZ ' HD13 ' A' ' 109' ' ' ILE . 10.8 m-30 -106.57 -19.34 13.7 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.138 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.21 -37.29 93.85 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -64.88 -36.87 85.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.762 -0.719 . . . . 0.0 110.687 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -158.1 81.99 2.9 Favored Pre-proline 0 CA--C 1.52 -0.195 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -51.04 128.88 26.34 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 120.709 0.939 . . . . 0.0 109.731 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.43 -15.25 34.56 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.469 1.446 . . . . 0.0 112.142 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.1 m -132.64 153.72 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.974 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.485 HG13 ' HE3' ' A' ' 11' ' ' MET . 76.6 t . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 121.084 0.469 . . . . 0.0 110.767 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -95.68 158.36 15.48 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.502 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 94.9 mt-10 -63.34 -41.73 98.89 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.267 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -60.33 -48.29 82.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.225 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -63.51 -27.73 69.47 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.152 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.938 HD23 HG13 ' A' ' 22' ' ' VAL . 38.7 tp -61.23 -41.69 97.31 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.658 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 3.4 mptp? -59.27 -38.95 81.38 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.208 0.528 . . . . 0.0 109.824 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.61 -34.69 76.08 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.128 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.792 ' CB ' HD13 ' A' ' 39' ' ' LEU . 11.8 ptp -84.31 -14.58 49.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.808 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -126.34 17.97 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.413 179.34 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.9 t -61.92 -37.75 85.85 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.817 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -64.6 -19.82 65.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.875 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.449 ' CE1' HG12 ' A' ' 12' ' ' VAL . 35.9 m-85 -72.11 152.64 42.2 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -75.44 -26.14 58.05 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.675 0.274 . . . . 0.0 110.683 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -120.67 60.36 0.9 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.403 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 22' ' ' VAL . 19.8 ptt180 -64.77 -25.42 67.91 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -71.7 -55.82 6.97 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mt -64.39 -39.72 94.4 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.088 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.4 m -62.47 -47.85 82.2 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.876 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.938 HG13 HD23 ' A' ' 8' ' ' LEU . 25.8 t -62.56 -47.24 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 120.837 0.351 . . . . 0.0 110.673 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -40.44 95.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.044 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -63.42 -39.55 94.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.583 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 29' ' ' ILE . 57.5 p -70.48 -35.56 73.33 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.252 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 22' ' ' VAL . 59.7 t -56.89 -44.37 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -62.0 -39.78 93.4 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.485 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.57 HG21 HD22 ' A' ' 124' ' ' LEU . 76.6 t -70.76 -43.43 77.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.01 -17.94 8.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.517 -177.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.9 m -82.7 -47.2 12.27 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.092 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.589 HD23 HD11 ' A' ' 125' ' ' LEU . 32.7 tp -87.9 -37.8 16.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.937 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -109.12 65.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -59.0 -16.95 20.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.973 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -64.95 -21.1 66.78 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.116 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.584 HD13 HD12 ' A' ' 128' ' ' ILE . 2.1 tp -98.16 124.01 42.5 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -118.07 129.28 25.47 Favored Pre-proline 0 C--N 1.36 1.061 0 CA-C-N 120.221 1.373 . . . . 0.0 111.946 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -80.89 136.53 10.58 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 121.593 1.529 . . . . 0.0 112.81 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.39 135.59 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.792 HD13 ' CB ' ' A' ' 11' ' ' MET . 40.9 tp -83.1 122.14 27.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.02 151.24 48.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.219 0.533 . . . . 0.0 112.041 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m -98.68 119.33 37.23 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.1 t80 . . . . . 0 N--CA 1.47 0.55 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.992 -178.604 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.516 -0.346 0 CA-C-O 121.462 0.648 . . . . 0.0 110.055 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -76.33 116.1 16.69 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.323 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.4 mt -122.86 138.31 54.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.454 ' SD ' HD11 ' A' ' 8' ' ' LEU . 64.2 ttp -84.29 139.55 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.137 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -125.88 156.4 39.71 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.198 0.523 . . . . 0.0 110.897 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.5 mm? -108.99 117.69 34.85 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.0 m -134.13 137.99 44.92 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.088 0.471 . . . . 0.0 112.159 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.27 -149.65 15.31 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.896 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.9 p -132.01 158.94 40.21 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.433 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.2 pt -132.58 115.97 14.86 Favored Pre-proline 0 C--O 1.237 0.433 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.416 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.74 125.46 10.01 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.8 1.0 . . . . 0.0 110.197 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.73 119.34 25.77 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.875 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.63 147.42 57.27 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.187 1.925 . . . . 0.0 109.675 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.41 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -163.74 108.79 1.04 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.339 -177.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 49.65 44.23 24.47 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.79 13.89 75.36 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.36 -0.924 . . . . 0.0 110.839 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -134.77 131.15 37.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -117.4 132.47 56.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.847 0.356 . . . . 0.0 111.797 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -112.68 148.88 33.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.99 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.95 102.46 14.26 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.447 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -91.22 116.28 66.12 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.262 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.9 127.55 4.2 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.654 2.236 . . . . 0.0 110.308 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.447 HG23 HG22 ' A' ' 70' ' ' ILE . 26.4 pt -134.57 146.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.541 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 84.8 m -120.57 121.63 38.8 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.83 120.09 39.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.664 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -104.39 117.94 35.4 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.3 mt -84.56 137.69 33.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mt -88.36 154.91 20.01 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.8 p30 -63.4 -13.83 43.92 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.501 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 p -99.24 -4.35 32.17 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -55.83 145.11 54.1 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -91.18 6.29 66.54 Favored 'Cis proline' 0 N--CA 1.514 2.732 0 CA-C-N 121.121 1.436 . . . . 0.0 115.697 1.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -71.27 -19.2 62.38 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.974 -1.09 . . . . 0.0 110.349 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.21 139.5 21.95 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.056 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.0 142.76 63.22 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 CA-C-N 121.665 1.63 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 142.84 17.31 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.955 1.77 . . . . 0.0 111.906 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -92.41 134.59 29.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 39.0 t -107.78 144.35 35.06 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.765 -177.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.56 126.06 43.04 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.272 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.42 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 57.3 t -98.39 130.31 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 99.36 3.53 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 123.44 0.463 . . . . 0.0 109.873 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 44.2 Cg_endo -86.85 148.09 8.25 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.387 1.391 . . . . 0.0 113.23 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.3 p -95.95 165.27 12.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.553 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t -55.16 -19.11 6.93 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.2 t -105.52 15.65 26.73 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.002 0.819 . . . . 0.0 111.572 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.4 mtp -132.77 141.83 48.71 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -125.43 163.64 22.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.063 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.458 ' N ' HG23 ' A' ' 96' ' ' THR . 4.3 mm -93.02 101.98 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -84.89 104.71 15.08 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.802 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.7 p -72.61 150.07 43.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.349 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.5 -137.49 2.3 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.769 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -67.73 -21.08 65.31 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.531 ' CE1' HG23 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -132.57 -29.54 1.53 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.884 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.683 HG21 ' HB2' ' A' ' 140' ' ' PRO . 6.2 t -88.97 140.3 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.739 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -103.16 176.45 5.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.441 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.33 94.2 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -88.39 0.3 56.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.292 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.48 11.74 46.95 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.259 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -64.46 141.47 58.76 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.466 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.49 115.57 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.072 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.42 ' C ' ' HG ' ' A' ' 111' ' ' LEU . 27.5 m-85 -104.57 136.23 44.5 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.42 ' HG ' ' C ' ' A' ' 110' ' ' TYR . 2.1 mt -135.17 124.84 16.62 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.3 -32.7 52.34 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.365 1.376 . . . . 0.0 113.519 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -67.51 -31.8 72.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.75 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.02 -41.67 74.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.162 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -71.16 -26.54 63.03 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.29 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -100.71 -0.75 36.72 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.22 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -53.97 126.01 20.91 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 122.055 0.931 . . . . 0.0 110.733 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -97.98 94.5 6.9 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.239 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 57.8 t60 -59.68 124.51 76.38 Favored Pre-proline 0 C--N 1.323 -0.556 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.067 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 9.6 Cg_endo -108.88 91.71 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.708 0 CA-C-N 120.454 1.198 . . . . 0.0 112.948 -2.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -113.07 -58.16 2.19 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.463 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.6 t -67.37 -40.6 85.78 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.314 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 64.37 166.21 0.15 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.741 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.57 HD22 HG21 ' A' ' 28' ' ' VAL . 7.8 tt -61.03 -41.84 97.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.589 HD11 HD23 ' A' ' 31' ' ' LEU . 5.4 tt -57.17 -36.16 70.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -60.28 -39.8 96.54 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.74 -40.79 93.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.584 HD12 HD13 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -75.17 -47.59 35.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.683 -176.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -68.81 -36.48 78.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.021 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 134' ' ' VAL . 79.4 t -66.85 -39.75 84.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.081 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.1 ttm -58.73 -44.5 90.49 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.433 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -60.26 -34.97 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.815 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.8 t -90.36 -46.22 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.543 HG13 ' CD2' ' A' ' 135' ' ' PHE . 4.9 p -68.91 -13.31 17.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.723 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.543 ' CD2' HG13 ' A' ' 134' ' ' VAL . 12.6 m-30 -103.76 -15.17 15.81 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.024 178.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.88 -24.92 75.94 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -70.45 -34.53 72.55 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.595 0.236 . . . . 0.0 111.012 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -162.38 83.13 1.64 Allowed Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -49.17 124.18 11.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.222 1.281 . . . . 0.0 110.752 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.683 ' HB2' HG21 ' A' ' 103' ' ' VAL . 57.1 Cg_endo -72.9 -18.56 24.38 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.741 1.627 . . . . 0.0 112.019 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.11 146.03 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.151 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 22.3 p90 . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.861 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.4 t -105.02 124.96 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.467 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -94.58 158.43 15.54 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.468 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 95.4 mt-10 -64.14 -41.15 97.3 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.196 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.3 m -58.58 -47.43 84.33 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.165 0.984 . . . . 0.0 108.985 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -63.32 -33.64 75.96 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.874 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.741 HD23 HG13 ' A' ' 22' ' ' VAL . 12.7 tp -56.3 -38.49 71.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.6 mptp? -60.73 -42.8 98.04 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.367 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.1 -37.73 88.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.617 0.722 . . . . 0.0 110.884 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.767 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.3 mmm -67.54 -36.68 81.46 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.114 -177.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -111.87 19.69 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 120.651 0.263 . . . . 0.0 111.116 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.7 p -64.56 -21.78 66.79 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.806 0.336 . . . . 0.0 110.532 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -72.06 -23.01 61.29 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.984 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.49 ' CZ ' HD22 ' A' ' 52' ' ' LEU . 30.2 m-85 -77.44 160.18 28.89 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.849 0.357 . . . . 0.0 110.365 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -88.6 -21.19 24.15 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.305 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -113.16 47.53 1.12 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 122.324 -0.235 . . . . 0.0 110.766 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 49.2 ptt85 -58.27 -24.65 60.12 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 -177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -73.61 -53.79 9.65 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.6 tp -65.13 -39.7 93.43 Favored 'General case' 0 N--CA 1.436 -1.16 0 C-N-CA 120.163 -0.615 . . . . 0.0 109.722 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.489 ' O ' HG23 ' A' ' 25' ' ' THR . 77.1 m -63.08 -48.68 77.55 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.338 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.741 HG13 HD23 ' A' ' 8' ' ' LEU . 25.3 t -61.5 -46.42 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.535 0 CA-C-O 120.635 0.255 . . . . 0.0 110.47 178.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.9 ttp180 -62.63 -44.91 95.08 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.647 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -64.21 -36.88 85.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.948 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.63 ' O ' HG23 ' A' ' 29' ' ' ILE . 35.3 p -64.81 -34.3 78.04 Favored 'General case' 0 CA--C 1.504 -0.806 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.736 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.8 t -57.69 -44.91 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.839 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -61.37 -38.02 85.49 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.408 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.517 HG21 HD22 ' A' ' 124' ' ' LEU . 73.3 t -70.72 -44.73 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.63 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.95 -21.57 7.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.354 -178.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 95.5 m -73.47 -45.88 51.52 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.535 178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.776 HD23 HD21 ' A' ' 125' ' ' LEU . 30.0 tp -88.47 -39.27 14.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.032 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -111.07 66.97 0.63 Allowed 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -56.99 -17.64 10.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.288 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -66.85 -14.87 63.18 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.87 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.45 HD23 HD13 ' A' ' 55' ' ' LEU . 1.8 tp -99.98 114.27 27.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.1 ttpp -108.89 131.86 21.53 Favored Pre-proline 0 C--N 1.356 0.874 0 CA-C-N 119.521 1.055 . . . . 0.0 112.007 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.1 133.42 11.0 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.49 1.46 . . . . 0.0 112.535 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 89.4 t -133.96 139.36 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 110.71 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.767 HD13 ' SD ' ' A' ' 11' ' ' MET . 11.1 tp -81.93 136.27 35.32 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -140.6 154.48 46.48 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.144 0.497 . . . . 0.0 111.27 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.6 m -91.56 131.46 36.97 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -118.85 133.99 55.46 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.818 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 83.0 t -110.37 122.55 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.75 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -92.51 161.57 14.56 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.0 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -61.83 -30.29 70.74 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.987 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -64.27 -16.47 62.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.75 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.3 -11.54 65.35 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.9 m -76.24 142.35 41.44 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 63.2 m -116.22 143.98 44.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.211 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -142.78 136.69 29.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.07 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -82.12 119.3 23.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.848 0.832 . . . . 0.0 109.733 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.49 HD22 ' CZ ' ' A' ' 15' ' ' TYR . 61.3 mt -121.44 146.71 46.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.791 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.457 ' SD ' HD11 ' A' ' 8' ' ' LEU . 53.5 ttp -97.54 142.79 28.94 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.682 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -135.81 152.85 51.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.452 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.45 HD13 HD23 ' A' ' 35' ' ' LEU . 8.5 mt -95.45 123.58 39.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -135.89 136.61 40.67 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.16 -146.69 11.47 Favored Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.522 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.1 p -132.84 159.4 39.93 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.439 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.3 pt -129.77 116.48 18.18 Favored Pre-proline 0 N--CA 1.472 0.632 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.895 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -70.56 124.81 11.1 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 CA-C-N 120.017 1.042 . . . . 0.0 109.942 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.1 t -125.56 118.43 24.62 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 119.671 -0.812 . . . . 0.0 113.015 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.7 142.22 52.19 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.944 1.763 . . . . 0.0 109.813 177.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -163.08 117.54 1.68 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.48 26.39 10.83 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.299 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.93 -5.62 78.44 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -112.97 142.78 45.27 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -121.65 132.26 54.56 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.775 0.321 . . . . 0.0 111.818 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -115.9 151.74 34.76 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.523 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -95.69 106.29 18.38 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.532 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -90.83 118.56 68.71 Favored Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.79 122.1 2.24 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.601 2.201 . . . . 0.0 110.534 177.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.532 HG23 HG22 ' A' ' 70' ' ' ILE . 31.9 pt -134.44 149.51 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.796 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.1 m -123.5 127.9 49.01 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.947 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.71 115.49 30.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.868 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -103.69 125.81 50.42 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.6 mt -90.84 138.64 31.43 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.0 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.51 146.44 36.38 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -56.79 -14.99 3.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.476 0.58 . . . . 0.0 111.679 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.4 p -106.03 13.11 29.65 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.259 0.552 . . . . 0.0 111.536 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -61.4 144.39 92.07 Favored Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -92.23 8.09 61.35 Favored 'Cis proline' 0 N--CA 1.514 2.721 0 CA-C-N 121.216 1.47 . . . . 0.0 115.623 1.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -71.51 -15.28 62.3 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.853 178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.82 137.76 19.85 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -67.24 143.82 66.07 Favored 'Trans proline' 0 N--CA 1.497 1.678 0 CA-C-N 121.579 1.6 . . . . 0.0 110.751 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -79.82 138.9 13.57 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 121.444 1.43 . . . . 0.0 111.893 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 mt -95.2 131.73 41.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 40.3 t -110.06 150.75 28.1 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.066 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -133.28 127.05 32.81 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.535 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 37.3 t -96.1 121.56 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -68.95 109.69 4.74 Favored Pre-proline 0 N--CA 1.476 0.846 0 CA-C-O 119.167 -0.444 . . . . 0.0 111.15 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -85.21 164.71 11.26 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.577 1.518 . . . . 0.0 112.238 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.7 p -139.31 172.85 12.22 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.7 m -57.95 -41.19 82.33 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.86 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.9 m -90.29 -11.89 39.44 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.897 0.771 . . . . 0.0 111.733 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 6.0 tpp -108.91 124.45 50.69 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.459 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -119.15 165.33 14.32 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.353 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.459 ' N ' HG23 ' A' ' 96' ' ' THR . 87.2 mt -96.16 110.59 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.9 tttp -90.98 102.14 14.9 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 71.4 p -59.83 142.71 52.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.314 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -158.33 -144.15 3.86 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.705 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -65.95 -27.48 68.19 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.528 ' NE2' HG23 ' A' ' 103' ' ' VAL . 16.9 p-80 -128.96 -7.79 4.93 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 119.047 -1.061 . . . . 0.0 113.407 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.681 HG21 ' HB2' ' A' ' 140' ' ' PRO . 40.3 t -108.21 126.56 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 119.167 0.894 . . . . 0.0 111.736 178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.46 ' O ' HG12 ' A' ' 103' ' ' VAL . 32.6 p-10 -88.65 -161.41 0.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.76 -20.83 25.62 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.863 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -90.23 -1.79 57.97 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.728 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.9 11.73 56.26 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.855 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -63.01 140.56 58.89 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.527 0.664 . . . . 0.0 109.667 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 98.7 mt -116.6 117.99 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.107 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -102.38 137.29 40.83 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.961 HD22 HG11 ' A' ' 134' ' ' VAL . 26.8 mt -136.64 116.61 10.85 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 119.995 -0.682 . . . . 0.0 110.317 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -47.14 -38.25 24.66 Favored 'Trans proline' 0 N--CA 1.503 2.047 0 C-N-CA 121.844 1.696 . . . . 0.0 114.519 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.402 ' CD2' ' N ' ' A' ' 114' ' ' LEU . 1.3 p90 -61.53 -29.73 70.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.512 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 1.7 tt -69.56 -42.53 74.44 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.717 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -65.03 -29.29 70.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.309 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -107.44 13.56 26.79 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.071 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.424 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 6.5 t90 -76.43 121.96 23.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.75 0.786 . . . . 0.0 110.36 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -92.42 128.08 38.14 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.277 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 85.4 t60 -84.34 125.47 71.91 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.424 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 15.7 Cg_endo -108.8 91.93 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.705 0 CA-C-N 120.866 1.345 . . . . 0.0 112.628 -2.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -113.77 -58.83 2.1 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.706 -0.397 . . . . 0.0 111.778 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 28.1 p -67.19 -39.02 86.3 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.52 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 58.95 161.69 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 CA-C-O 121.474 0.654 . . . . 0.0 111.829 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.517 HD22 HG21 ' A' ' 28' ' ' VAL . 4.7 tt -58.39 -41.17 84.24 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.194 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.776 HD21 HD23 ' A' ' 31' ' ' LEU . 7.9 tp -56.75 -38.13 72.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.68 -39.69 98.24 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 tp -59.07 -38.98 80.73 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.413 HD12 HD13 ' A' ' 35' ' ' LEU . 1.1 mm -73.02 -47.53 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.579 -177.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -66.08 -36.83 84.26 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 126' ' ' GLY . 78.6 t -66.89 -37.82 80.19 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.823 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.9 tpp -59.0 -43.03 91.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.439 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -62.82 -26.07 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.621 178.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 38.2 t -94.63 -52.05 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.961 HG11 HD22 ' A' ' 111' ' ' LEU . 5.5 p -64.77 -13.72 15.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 122.547 0.339 . . . . 0.0 111.402 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.453 ' CD1' HG13 ' A' ' 134' ' ' VAL . 6.6 m-30 -101.98 -17.64 16.01 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.255 177.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.55 -28.07 60.14 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -64.81 -35.48 81.23 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.332 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 33.9 tp10 -163.49 84.6 1.35 Allowed Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -44.06 112.6 0.34 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.497 1.465 . . . . 0.0 110.665 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.681 ' HB2' HG21 ' A' ' 103' ' ' VAL . 28.8 Cg_endo -65.35 -20.44 61.71 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.358 1.372 . . . . 0.0 110.427 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.9 m -127.72 150.11 33.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -157.84 163.54 37.87 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.03 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.4 m -91.85 121.36 33.39 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.307 0.575 . . . . 0.0 111.333 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 57.2 ttm-85 -111.58 114.33 52.61 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.594 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo . . . . . 0 N--CA 1.497 1.681 0 C-N-CA 122.195 1.93 . . . . 0.0 112.55 -179.898 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.406 HG22 ' HE1' ' A' ' 11' ' ' MET . 87.4 t -89.07 133.85 30.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.076 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.48 154.57 18.13 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.513 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 39.9 mt-10 -62.18 -40.61 96.62 Favored 'General case' 0 C--O 1.214 -0.805 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.954 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.8 t -58.83 -47.7 83.9 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 122.148 0.975 . . . . 0.0 109.269 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -64.51 -30.4 71.43 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.521 -1.218 . . . . 0.0 109.855 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.858 HD23 HG13 ' A' ' 22' ' ' VAL . 10.2 tp -60.0 -37.05 78.56 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.1 OUTLIER -62.8 -43.27 99.24 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.432 178.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.31 -37.44 83.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.94 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.503 ' SD ' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -64.01 -37.51 87.71 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.544 -1.207 . . . . 0.0 112.017 -178.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -119.39 24.82 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.883 0.373 . . . . 0.0 111.856 -178.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 46.5 t -64.59 -37.17 86.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.07 0.462 . . . . 0.0 111.147 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -68.22 -12.38 60.87 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.89 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.488 ' CE1' HG12 ' A' ' 12' ' ' VAL . 10.4 m-85 -77.99 159.55 28.72 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -81.86 -26.87 33.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.651 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -116.19 55.24 0.81 Allowed 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 119.67 -0.205 . . . . 0.0 110.809 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 ptt-85 -63.76 -24.7 67.87 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -53.88 8.56 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 122.038 -0.414 . . . . 0.0 111.709 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.15 -42.88 96.6 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.117 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.0 m -60.61 -48.07 83.4 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.77 -0.372 . . . . 0.0 111.419 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.858 HG13 HD23 ' A' ' 8' ' ' LEU . 32.6 t -61.05 -44.74 98.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -41.4 98.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 119.566 -0.853 . . . . 0.0 109.784 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.1 -39.2 89.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.071 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 29' ' ' ILE . 41.4 p -65.72 -37.86 87.58 Favored 'General case' 0 CA--C 1.507 -0.673 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.461 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.9 t -56.85 -43.99 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.841 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.486 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -61.86 -37.91 86.29 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.025 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.1 t -71.23 -43.11 74.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.633 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.82 -20.27 7.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.114 -178.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -78.31 -47.54 17.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.647 ' O ' HD13 ' A' ' 31' ' ' LEU . 2.8 tm? -84.23 -39.74 18.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.794 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -110.56 66.98 0.63 Allowed 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.7 pttm -58.08 -16.58 13.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.82 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -65.34 -22.0 66.77 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.826 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 tp -91.84 114.29 26.78 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -108.26 123.21 38.17 Favored Pre-proline 0 C--N 1.357 0.926 0 CA-C-N 119.551 1.069 . . . . 0.0 111.663 -178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.89 134.09 9.37 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.383 1.388 . . . . 0.0 112.976 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.9 155.3 41.49 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 CA-C-O 121.096 0.474 . . . . 0.0 110.711 178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.503 HD12 ' SD ' ' A' ' 11' ' ' MET . 0.9 OUTLIER -86.97 122.43 30.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.992 179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -125.07 133.06 53.05 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.584 0.23 . . . . 0.0 111.21 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 96.3 p -69.48 146.09 52.21 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -135.22 134.49 40.11 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 119.075 -1.05 . . . . 0.0 112.425 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.2 t -121.1 125.66 74.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 114.982 -1.008 . . . . 0.0 109.254 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -96.28 166.42 11.73 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.733 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.26 -38.06 82.35 Favored 'General case' 0 C--N 1.334 -0.092 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.762 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -62.84 -13.93 39.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.261 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.4 -3.94 64.05 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.9 m -71.78 144.9 49.02 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.148 0.499 . . . . 0.0 110.326 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.4 m -125.04 144.15 50.55 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.449 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -161.17 143.67 12.38 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.999 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.7 121.59 17.48 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -128.92 126.43 39.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.962 0.411 . . . . 0.0 109.914 -178.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.407 ' HB2' ' HB3' ' A' ' 11' ' ' MET . 61.9 ttp -84.55 150.48 25.19 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.922 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -138.73 157.28 46.38 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.318 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mt -108.36 125.05 51.28 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.4 m -140.33 139.2 35.36 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.977 0.418 . . . . 0.0 112.12 -177.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.19 -149.51 15.05 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.628 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.504 HG21 ' OD1' ' A' ' 69' ' ' ASN . 23.0 p -131.75 159.21 39.12 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.499 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.2 pt -130.25 116.53 17.68 Favored Pre-proline 0 N--CA 1.47 0.541 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.9 177.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -70.79 125.97 12.15 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 CA-C-N 119.892 0.997 . . . . 0.0 109.878 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.0 t -130.02 127.32 22.68 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.573 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.09 149.64 52.71 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.092 1.861 . . . . 0.0 110.452 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -161.63 106.42 1.28 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.338 0.589 . . . . 0.0 111.889 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 51.15 39.58 23.84 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 121.914 -0.491 . . . . 0.0 111.951 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.22 -0.55 83.73 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -121.13 132.16 54.69 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.6 m -110.09 131.04 55.41 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.659 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -113.89 151.43 32.21 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.621 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.504 ' OD1' HG21 ' A' ' 58' ' ' THR . 3.7 t-20 -97.96 104.07 16.07 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.508 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -88.98 117.09 67.92 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.11 124.88 3.91 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.525 2.15 . . . . 0.0 110.919 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 70' ' ' ILE . 26.4 pt -132.67 147.96 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.613 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.5 m -123.01 126.13 46.55 Favored 'General case' 0 C--N 1.345 0.405 0 CA-C-O 121.385 0.612 . . . . 0.0 110.0 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.09 109.97 22.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.506 -178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.523 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 91.0 m95 -98.38 121.62 40.55 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.657 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.464 ' O ' HD21 ' A' ' 52' ' ' LEU . 72.8 mt -89.7 144.28 26.12 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.874 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mt -88.76 154.48 20.25 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 49.1 p-10 -60.13 -17.68 42.07 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.524 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 p -100.47 1.32 41.03 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.732 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.0 t80 -53.81 145.77 30.13 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -92.37 12.07 53.97 Favored 'Cis proline' 0 N--CA 1.519 2.994 0 N-CA-C 116.061 1.524 . . . . 0.0 116.061 1.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -80.78 -2.38 46.86 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.296 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.82 122.83 26.32 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 118.555 -0.736 . . . . 0.0 109.08 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -47.76 132.66 21.58 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 CA-C-N 121.313 1.505 . . . . 0.0 112.505 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.32 144.27 14.41 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 122.382 2.054 . . . . 0.0 111.474 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.55 132.9 42.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.881 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 41.8 t -110.33 151.21 27.7 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.642 -178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -131.69 127.39 36.79 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.325 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.652 ' CG2' HD11 ' A' ' 109' ' ' ILE . 56.7 t -90.76 123.77 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -71.12 110.21 6.84 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-O 119.338 -0.363 . . . . 0.0 111.334 -178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -85.73 157.87 10.46 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 121.901 1.734 . . . . 0.0 113.218 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.2 p -135.78 165.59 25.25 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.93 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.2 p -60.32 -24.57 65.11 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -104.19 13.53 32.13 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 118.93 0.786 . . . . 0.0 110.728 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 37.4 ttm -134.24 148.15 50.8 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.476 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -133.59 165.98 23.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 120.156 -0.617 . . . . 0.0 110.438 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.476 ' N ' HG23 ' A' ' 96' ' ' THR . 90.3 mt -103.27 105.76 18.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.3 ttmt -94.77 108.64 20.65 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.238 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 82.3 p -65.98 151.21 47.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.928 -178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.78 -134.74 1.8 Allowed Glycine 0 CA--C 1.527 0.823 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.356 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 101' ' ' LYS . 6.7 pttp -86.03 -3.8 59.02 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -136.42 -24.09 1.23 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -114.22 145.99 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-N 118.683 0.674 . . . . 0.0 110.171 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -101.37 -179.55 4.06 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.699 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.31 73.13 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -79.88 2.53 22.93 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.796 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.01 27.78 15.41 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.087 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -82.56 132.42 35.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 117.588 0.694 . . . . 0.0 110.149 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.652 HD11 ' CG2' ' A' ' 89' ' ' VAL . 96.3 mt -110.44 109.94 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.606 0.241 . . . . 0.0 110.782 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -114.07 138.86 49.84 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.548 ' CD2' HG11 ' A' ' 134' ' ' VAL . 1.1 mt -131.65 130.57 22.41 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 118.563 0.62 . . . . 0.0 111.883 -177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -46.93 -39.8 25.03 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.433 1.422 . . . . 0.0 113.957 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.05 -29.69 70.47 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.669 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.0 tt -70.79 -41.07 72.13 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.804 0.335 . . . . 0.0 111.008 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -67.36 -27.07 66.82 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.381 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -105.57 -3.64 22.11 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.878 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.424 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.8 t90 -62.82 124.07 20.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.671 0.748 . . . . 0.0 110.16 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -91.65 126.05 36.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.561 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -79.92 125.45 81.96 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 119.032 -0.508 . . . . 0.0 110.119 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -109.12 92.68 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.684 0 CA-C-N 120.823 1.33 . . . . 0.0 112.454 -2.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 61.4 mm-40 -114.11 -61.26 1.77 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.401 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.426 ' O ' ' CG ' ' A' ' 123' ' ' ASP . 15.7 t -69.99 -30.76 68.17 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.689 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 122' ' ' SER . 4.6 p-10 48.89 -175.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.622 0.725 . . . . 0.0 111.947 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 tt -71.84 -43.5 65.42 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.711 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 125' ' ' LEU . 0.6 OUTLIER -51.53 -37.76 50.94 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.048 -1.094 . . . . 0.0 108.048 179.103 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -64.09 -41.42 98.49 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.8 tp -59.14 -40.87 86.83 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -73.16 -45.0 55.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.577 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -71.78 -33.22 68.41 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.097 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.573 ' O ' HG12 ' A' ' 134' ' ' VAL . 67.4 t -68.61 -37.75 78.08 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 176.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 53.2 tpp -59.79 -42.45 93.41 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.499 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.1 mp -66.3 -44.5 91.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.603 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.4 t -74.2 -40.83 51.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.6 HG13 ' CD1' ' A' ' 135' ' ' PHE . 2.5 p -78.66 -13.62 13.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.678 -177.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.6 ' CD1' HG13 ' A' ' 134' ' ' VAL . 10.3 m-30 -108.49 -17.59 13.94 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.436 178.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.66 -27.53 70.01 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 107.435 -2.266 . . . . 0.0 107.435 176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -65.29 -35.83 82.22 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.019 -0.59 . . . . 0.0 110.618 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -166.88 84.89 0.86 Allowed Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -47.78 114.65 1.15 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.327 1.351 . . . . 0.0 109.852 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.33 -21.05 27.71 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 121.797 1.665 . . . . 0.0 111.235 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 28.6 m -126.67 147.08 31.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.094 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -155.72 161.93 40.63 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 74.9 m -87.51 121.48 30.01 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.223 0.535 . . . . 0.0 111.046 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.2 ttm-85 -112.71 105.08 56.08 Favored Pre-proline 0 C--N 1.319 -0.744 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.61 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo . . . . . 0 N--CA 1.494 1.539 0 C-N-CA 121.81 1.674 . . . . 0.0 112.098 179.817 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -62.46 142.68 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.555 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.18 151.79 19.46 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.514 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 93.0 mt-10 -62.6 -41.89 99.25 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.358 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.4 m -59.05 -45.03 91.78 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 122.017 0.913 . . . . 0.0 109.58 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -64.91 -36.5 84.56 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.207 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.946 HD23 HG13 ' A' ' 22' ' ' VAL . 38.2 tp -56.58 -40.02 74.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.768 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 3.3 mptp? -62.46 -42.78 99.72 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.844 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -66.32 -33.4 75.64 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.894 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.583 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.5 OUTLIER -69.49 -36.02 76.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.411 -0.358 . . . . 0.0 111.036 -178.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 8' ' ' LEU . 1.6 m -120.02 30.96 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.789 0.328 . . . . 0.0 111.162 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 93.1 p -69.27 -12.9 62.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.727 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -85.6 -12.92 50.31 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 121.016 -0.273 . . . . 0.0 111.386 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.456 ' CE1' HD23 ' A' ' 52' ' ' LEU . 5.8 m-85 -71.94 151.13 43.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.005 0.431 . . . . 0.0 111.109 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -70.94 -38.07 72.87 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -111.28 64.22 0.61 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.478 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.5 ptp85 -66.81 -30.35 70.52 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -68.44 -42.97 78.08 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.09 -38.33 61.26 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.784 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 25' ' ' THR . 99.2 m -62.58 -41.79 99.16 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.057 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.946 HG13 HD23 ' A' ' 8' ' ' LEU . 45.4 t -71.29 -46.14 66.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.439 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -63.98 -44.06 93.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.333 -178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.554 ' OE2' HD12 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -68.27 -29.35 68.12 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.385 -179.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 21' ' ' THR . 28.2 p -70.14 -37.83 75.37 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.717 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -56.77 -43.32 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -60.63 -40.25 91.21 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.29 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.465 HG21 ' HB3' ' A' ' 124' ' ' LEU . 68.4 t -70.1 -42.55 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.99 -16.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 119.069 -1.053 . . . . 0.0 111.22 -178.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 52.7 m -80.86 -49.41 11.09 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 57.6 tp -83.19 -37.15 24.02 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.269 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.36 68.45 0.7 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.467 0.651 . . . . 0.0 109.381 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -58.39 -18.9 31.54 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.944 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.18 -21.08 66.72 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.458 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.525 HD23 HD13 ' A' ' 55' ' ' LEU . 2.4 tp -93.78 113.51 25.57 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -109.87 125.25 31.57 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-N 119.451 1.023 . . . . 0.0 112.352 -178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -80.31 138.68 12.65 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 121.655 1.57 . . . . 0.0 113.149 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.37 156.56 39.05 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.583 HD13 ' SD ' ' A' ' 11' ' ' MET . 22.8 tp -97.1 107.56 20.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -110.04 130.19 55.57 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.071 0.462 . . . . 0.0 111.609 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.8 p -79.89 131.87 35.95 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -115.6 138.73 50.77 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.115 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.0 t -109.26 124.22 65.77 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.078 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.816 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -96.01 172.64 7.87 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.63 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -60.54 -39.06 86.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.135 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -67.41 -15.34 63.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.834 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.94 -9.86 63.87 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.9 m -65.91 149.18 50.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.042 0.448 . . . . 0.0 110.083 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.5 t -121.1 142.62 49.68 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.84 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -143.26 150.36 39.17 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.697 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.21 105.64 13.46 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.057 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.456 HD23 ' CE1' ' A' ' 15' ' ' TYR . 15.2 mt -119.29 125.19 48.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.105 0.479 . . . . 0.0 110.01 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -92.83 138.42 31.5 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.606 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -127.44 152.22 47.82 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 120.26 -0.576 . . . . 0.0 111.18 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.525 HD13 HD23 ' A' ' 35' ' ' LEU . 7.4 mt -97.37 130.11 44.55 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.3 m -141.2 137.63 32.77 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.15 -144.08 8.76 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.405 HG21 ' OD1' ' A' ' 69' ' ' ASN . 22.9 p -136.81 159.71 41.02 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.5 pt -132.19 115.22 15.1 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.074 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -70.54 125.41 11.71 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.164 1.243 . . . . 0.0 110.293 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.1 t -126.37 121.85 23.78 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.167 -0.613 . . . . 0.0 112.057 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.72 148.7 41.96 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.414 2.076 . . . . 0.0 110.936 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.449 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -163.42 109.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.442 0.639 . . . . 0.0 111.522 -178.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.9 tpp180 52.86 37.91 25.4 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.712 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.54 82.01 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -119.34 130.71 55.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -115.29 132.29 56.66 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.957 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -112.51 148.94 33.4 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.883 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.405 ' OD1' HG21 ' A' ' 58' ' ' THR . 5.4 t-20 -94.42 106.42 18.4 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.472 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -91.09 116.25 66.03 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 112.837 0.681 . . . . 0.0 112.837 -176.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -85.17 124.94 2.96 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.808 2.339 . . . . 0.0 110.25 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.472 HG23 HG22 ' A' ' 70' ' ' ILE . 24.6 pt -134.98 148.7 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 119.161 -1.016 . . . . 0.0 112.572 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.1 m -121.77 123.14 41.12 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.475 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.95 112.81 25.94 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.232 -179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 21.4 m95 -105.7 125.29 50.82 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 75.5 mt -92.38 139.33 30.71 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.984 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.24 157.95 27.69 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -69.37 -7.66 39.46 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.268 -0.27 . . . . 0.0 111.509 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.57 2.29 23.91 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.916 0.389 . . . . 0.0 110.979 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.421 ' CG ' ' HA ' ' A' ' 81' ' ' PRO . 46.1 t80 -57.89 147.79 61.97 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HA ' ' CG ' ' A' ' 80' ' ' TYR . 1.7 Cg_endo -91.22 13.71 52.29 Favored 'Cis proline' 0 N--CA 1.515 2.743 0 CA-C-N 120.975 1.384 . . . . 0.0 114.653 0.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -80.04 -2.61 44.98 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.052 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.83 140.33 33.03 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -66.27 143.11 69.39 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 CA-C-N 121.56 1.593 . . . . 0.0 111.014 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.67 141.38 9.76 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.153 1.902 . . . . 0.0 112.26 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -93.07 129.7 43.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.465 ' SG ' HD12 ' A' ' 109' ' ' ILE . 52.6 t -120.65 141.8 50.04 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.763 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -127.67 132.16 49.72 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.581 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.475 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 42.8 t -90.41 131.8 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.01 100.02 2.62 Favored Pre-proline 0 CA--C 1.554 1.106 0 CA-C-O 119.292 -0.385 . . . . 0.0 111.128 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 64.7 Cg_endo -82.36 166.35 16.08 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 122.222 1.948 . . . . 0.0 112.837 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.3 t -145.71 171.3 14.95 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.8 p -57.32 -25.46 59.37 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 119.866 -0.734 . . . . 0.0 112.036 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 96.7 p -95.14 3.42 54.74 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.702 0.683 . . . . 0.0 110.794 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 39.3 ttm -141.93 122.02 13.78 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.048 0.452 . . . . 0.0 109.84 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 95.2 m -107.0 140.95 38.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.443 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 97' ' ' ILE . 3.9 tp -75.43 120.74 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -110.64 101.12 9.79 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 51.7 p -58.31 151.69 19.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.591 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -173.47 -132.13 1.49 Allowed Glycine 0 CA--C 1.527 0.811 0 C-N-CA 119.774 -1.203 . . . . 0.0 112.644 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -86.81 -3.5 59.07 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -138.92 -25.94 0.86 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 119.402 1.001 . . . . 0.0 113.616 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 t -111.95 135.46 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 119.218 0.917 . . . . 0.0 110.198 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.9 p-10 -90.54 -159.97 0.66 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.547 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.39 -8.24 55.34 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.8 -6.14 16.92 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.491 0.182 . . . . 0.0 111.491 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.78 11.47 37.6 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.974 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -72.77 135.98 45.38 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.399 0.599 . . . . 0.0 110.063 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.465 HD12 ' SG ' ' A' ' 87' ' ' CYS . 69.9 mt -114.8 115.49 49.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 O-C-N 123.311 0.382 . . . . 0.0 110.718 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -115.21 138.77 50.56 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 134' ' ' VAL . 1.3 mp -130.88 130.96 22.96 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.475 -176.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.71 -32.45 55.24 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 121.125 1.217 . . . . 0.0 113.184 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -67.41 -30.12 69.79 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 119.609 -0.836 . . . . 0.0 109.26 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.77 -41.22 83.63 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.208 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -64.3 -34.31 77.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.2 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -100.81 2.71 41.41 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.539 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 5.1 t90 -68.72 124.21 23.02 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.921 0.867 . . . . 0.0 110.17 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.0 mtmm -94.37 124.85 38.64 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.522 178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 56.2 t60 -80.83 125.3 80.48 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 119.012 -0.518 . . . . 0.0 110.643 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 9.5 Cg_endo -108.98 92.19 0.03 OUTLIER 'Cis proline' 0 N--CA 1.5 1.867 0 CA-C-N 120.791 1.318 . . . . 0.0 112.799 -2.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.88 -59.99 1.94 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.613 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.6 t -65.13 -40.93 95.12 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.412 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 58.54 164.92 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.25 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.554 HD12 ' OE2' ' A' ' 24' ' ' GLU . 1.4 mt -50.89 -48.57 60.39 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.311 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.72 -36.72 26.4 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.472 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -63.74 -40.65 98.72 Favored Glycine 0 N--CA 1.477 1.42 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 tp -62.53 -41.73 99.06 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -74.69 -45.87 43.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.619 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -68.85 -36.74 78.52 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.665 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 134' ' ' VAL . 56.1 t -66.99 -40.3 85.28 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 C-N-CA 119.019 -1.072 . . . . 0.0 108.873 177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.8 ttm -58.23 -43.24 87.63 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.434 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -60.3 -35.2 60.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.74 178.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 55.4 t -89.64 -50.1 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 120.027 -0.669 . . . . 0.0 112.677 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.534 HG13 ' CD1' ' A' ' 135' ' ' PHE . 4.7 p -65.21 -13.85 15.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.832 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.534 ' CD1' HG13 ' A' ' 134' ' ' VAL . 13.5 m-30 -106.78 -17.23 14.27 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.586 177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.89 -27.89 73.51 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.82 -34.72 79.03 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.468 -0.366 . . . . 0.0 110.785 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -165.91 85.43 0.97 Allowed Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -45.7 113.32 0.54 Allowed 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.37 1.38 . . . . 0.0 110.533 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -74.6 0.44 8.68 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.511 1.474 . . . . 0.0 111.548 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.24 123.56 43.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -160.17 165.51 31.45 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.285 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.2 125.18 40.54 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.003 0.43 . . . . 0.0 110.94 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -111.49 114.1 53.02 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.55 179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.499 1.849 0 C-N-CA 121.76 1.64 . . . . 0.0 111.974 -179.926 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.419 HG13 ' HE3' ' A' ' 11' ' ' MET . 85.6 t -105.39 130.11 57.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.821 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -95.21 157.65 15.8 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 86.6 mt-10 -63.13 -41.92 99.4 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.118 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 36.1 t -59.71 -49.87 76.06 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 122.044 0.926 . . . . 0.0 109.383 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -62.69 -28.2 69.77 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.744 178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.814 HD23 HG13 ' A' ' 22' ' ' VAL . 59.3 tp -59.77 -42.67 93.8 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.766 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.9 mptp? -58.82 -39.89 82.53 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.148 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.11 -31.0 72.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.781 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.596 ' CB ' HD13 ' A' ' 39' ' ' LEU . 14.6 ptp -86.39 -14.78 42.39 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.622 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.679 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -125.94 16.5 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.83 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 43.3 t -59.78 -21.98 61.53 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.496 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -84.04 -15.96 45.64 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -70.09 152.18 44.64 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.003 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -70.02 -37.64 75.68 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.838 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.409 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 40.8 m-85 -110.65 60.66 0.61 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.564 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.443 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.4 ptp180 -66.44 -20.73 66.13 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.501 -0.48 . . . . 0.0 112.125 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -77.04 -52.06 9.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.8 tp -67.93 -41.0 83.24 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.151 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.677 ' O ' HG23 ' A' ' 25' ' ' THR . 66.2 m -61.13 -47.03 88.13 Favored 'General case' 0 C--O 1.225 -0.231 0 CA-C-O 120.778 0.323 . . . . 0.0 110.789 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.814 HG13 HD23 ' A' ' 8' ' ' LEU . 40.3 t -63.25 -42.83 97.88 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.654 179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.96 -55.31 23.43 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 118.834 -1.147 . . . . 0.0 110.526 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -61.37 -31.83 71.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.367 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.677 HG23 ' O ' ' A' ' 21' ' ' THR . 23.5 p -66.86 -35.26 79.62 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.31 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 22' ' ' VAL . 53.0 t -57.77 -44.03 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.915 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -60.19 -39.88 88.11 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 119.841 -0.744 . . . . 0.0 110.307 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 124' ' ' LEU . 79.1 t -69.84 -43.36 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 -178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.617 HG23 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -88.25 -17.4 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.567 -178.827 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.2 m -82.35 -49.05 10.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.192 0.52 . . . . 0.0 109.617 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.531 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.3 tm? -81.89 -38.99 24.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.525 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -110.2 67.44 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -56.14 -18.92 11.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.953 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.31 -21.54 66.72 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.038 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.562 HD13 HD12 ' A' ' 128' ' ' ILE . 1.6 tp -94.15 113.18 25.08 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.19 119.02 43.2 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-N 119.181 0.9 . . . . 0.0 112.091 -177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 92.5 Cg_endo -78.29 137.53 15.14 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 CA-C-N 120.653 1.269 . . . . 0.0 112.282 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.539 HG23 ' OD1' ' A' ' 40' ' ' ASP . 27.0 m -126.19 150.9 32.07 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.596 HD13 ' CB ' ' A' ' 11' ' ' MET . 44.1 tp -97.78 119.3 36.13 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.113 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.539 ' OD1' HG23 ' A' ' 38' ' ' VAL . 10.5 m-20 -135.43 135.44 40.58 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.016 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 43.0 t -64.22 139.97 58.82 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 177.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -127.06 143.35 51.3 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.014 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.1 t -120.6 126.63 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.296 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -104.3 155.53 18.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.259 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.1 p-10 -60.84 -19.06 59.17 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.584 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -68.68 -13.03 62.1 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.196 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.14 -17.91 58.43 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.2 t -74.45 146.56 42.73 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.166 0.508 . . . . 0.0 110.2 179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.2 m -119.19 141.23 49.06 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.942 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -159.21 136.84 10.08 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.908 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -77.07 121.74 23.98 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.264 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -124.04 144.51 49.8 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.054 0.454 . . . . 0.0 110.31 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -100.2 141.22 33.33 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.646 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.413 ' HB3' ' CE3' ' A' ' 75' ' ' TRP . 6.2 p-10 -133.08 154.28 50.71 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.388 0.613 . . . . 0.0 111.863 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.481 ' HG ' HD23 ' A' ' 35' ' ' LEU . 4.6 mm? -93.49 124.94 37.82 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.306 -1.316 . . . . 0.0 108.575 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.4 m -139.29 136.98 35.46 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.44 -145.6 10.13 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.836 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.7 p -134.61 159.74 40.27 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.416 HG21 HD13 ' A' ' 59' ' ' ILE . 1.3 pt -131.83 116.21 15.82 Favored Pre-proline 0 N--CA 1.471 0.594 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.178 177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -71.97 124.4 10.08 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 N-CA-C 109.538 -0.986 . . . . 0.0 109.538 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.42 121.35 24.89 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.891 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.39 149.03 55.92 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.197 1.931 . . . . 0.0 110.429 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.7 109.7 1.09 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 120.108 -0.637 . . . . 0.0 112.521 -178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.96 40.59 25.62 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 120.306 -0.558 . . . . 0.0 111.439 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.72 13.84 80.22 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -134.71 127.86 31.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.5 m -112.02 133.1 54.4 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.84 -177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -113.89 150.63 33.37 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -95.16 108.72 20.85 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.492 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -97.21 116.16 65.9 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -85.34 124.77 2.86 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.658 2.238 . . . . 0.0 110.75 177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.492 HG23 HG22 ' A' ' 70' ' ' ILE . 26.9 pt -132.79 147.99 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 119.421 -0.911 . . . . 0.0 111.994 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 63.8 m -123.88 121.58 35.73 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.071 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.81 114.41 28.61 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.489 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.413 ' CE3' ' HB3' ' A' ' 54' ' ' ASN . 48.3 m95 -102.1 115.29 30.23 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.1 mt -85.9 135.15 33.8 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -80.28 155.34 27.33 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -60.68 -17.18 46.18 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.746 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.61 -3.02 50.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.523 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -57.09 144.42 69.23 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.41 ' HG2' ' CD2' ' A' ' 119' ' ' HIS . 25.0 Cg_endo -92.04 9.13 60.74 Favored 'Cis proline' 0 N--CA 1.521 3.101 0 N-CA-C 115.936 1.475 . . . . 0.0 115.936 0.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.409 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 42.7 m-85 -76.94 -11.97 59.88 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.636 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.86 127.17 27.11 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.747 -0.644 . . . . 0.0 109.511 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -49.39 132.49 29.47 Favored 'Trans proline' 0 N--CA 1.504 2.134 0 CA-C-N 121.21 1.468 . . . . 0.0 112.467 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.434 ' HD2' HD11 ' A' ' 114' ' ' LEU . 96.6 Cg_endo -86.04 143.83 8.14 Favored 'Trans proline' 0 N--CA 1.501 1.931 0 C-N-CA 122.574 2.183 . . . . 0.0 111.878 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 86' ' ' ILE . 1.4 mp -97.43 132.97 40.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.39 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 46.1 t -116.47 143.57 45.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.176 -178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -127.89 129.95 47.74 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.954 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.28 121.95 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.82 107.53 1.35 Allowed Pre-proline 0 N--CA 1.474 0.744 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.019 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.03 156.64 13.27 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 CA-C-N 120.675 1.277 . . . . 0.0 112.772 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -136.14 171.69 14.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.43 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.8 t -58.55 -40.67 83.69 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.5 m -96.79 20.73 10.52 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.037 0.835 . . . . 0.0 111.126 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.0 ttm -137.96 141.16 40.52 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -137.29 162.76 32.65 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 119.784 -0.767 . . . . 0.0 110.174 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.433 ' N ' HG23 ' A' ' 96' ' ' THR . 67.9 mt -97.95 103.43 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.2 tttm -90.59 109.96 21.11 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.8 p -59.85 147.4 38.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.282 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.88 -145.3 4.15 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.707 -0.758 . . . . 0.0 111.518 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -64.14 -27.5 69.12 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.515 ' NE2' HG23 ' A' ' 103' ' ' VAL . 13.1 p-80 -132.63 -15.63 2.72 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 119.167 -1.013 . . . . 0.0 113.214 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.517 HG21 ' CB ' ' A' ' 140' ' ' PRO . 23.8 t -91.93 129.27 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.438 1.017 . . . . 0.0 111.375 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.429 ' O ' HG12 ' A' ' 103' ' ' VAL . 36.9 p-10 -89.72 -168.79 2.24 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.71 -22.79 25.83 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.683 179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -82.24 -8.0 59.63 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.623 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.21 -0.7 62.18 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.098 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.404 ' N ' ' OD1' ' A' ' 104' ' ' ASP . 0.0 OUTLIER -63.71 143.58 57.72 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -110.87 122.46 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -99.86 139.91 34.84 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.606 HD22 HG11 ' A' ' 134' ' ' VAL . 28.4 mt -139.55 117.92 8.78 Favored Pre-proline 0 N--CA 1.448 -0.563 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -54.83 -29.47 63.17 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 121.553 1.502 . . . . 0.0 114.056 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -69.23 -30.76 68.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.875 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.434 HD11 ' HD2' ' A' ' 85' ' ' PRO . 1.1 tt -71.75 -41.05 68.92 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.043 -178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -72.3 -25.5 61.6 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.309 -177.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -102.23 -4.69 25.33 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.483 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 7.2 t90 -53.07 121.32 7.2 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.94 0.876 . . . . 0.0 110.503 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -96.42 106.61 18.87 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.491 177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 44.9 t-80 -61.95 125.26 84.72 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.133 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 21.8 Cg_endo -111.05 90.78 0.03 OUTLIER 'Cis proline' 0 N--CA 1.488 1.201 0 CA-C-N 120.676 1.277 . . . . 0.0 112.831 -3.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -114.59 -55.2 2.51 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.428 -0.509 . . . . 0.0 112.142 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 p -70.54 -39.42 74.03 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.387 0.613 . . . . 0.0 110.767 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 t70 59.28 165.59 0.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.408 0.623 . . . . 0.0 111.091 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 124' ' ' LEU . 3.9 tt -62.2 -43.68 98.29 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.566 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -52.12 -36.32 50.83 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.471 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.27 -39.52 97.82 Favored Glycine 0 N--CA 1.48 1.57 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.2 tp -59.48 -40.99 88.78 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.562 HD12 HD13 ' A' ' 35' ' ' LEU . 1.2 mm -75.32 -49.91 26.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.206 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -63.74 -37.7 88.34 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.161 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 134' ' ' VAL . 54.4 t -66.29 -38.59 82.19 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.757 0 C-N-CA 119.465 -0.894 . . . . 0.0 108.712 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.4 tpp -58.48 -43.3 88.92 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.11 -43.54 98.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.453 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.3 t -77.78 -42.02 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.606 HG11 HD22 ' A' ' 111' ' ' LEU . 3.7 p -75.91 -13.22 14.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.298 -0.41 . . . . 0.0 112.014 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.526 ' CD1' HG13 ' A' ' 134' ' ' VAL . 6.2 m-30 -104.81 -18.37 14.26 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.602 177.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.31 -20.83 79.44 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -68.72 -36.16 78.08 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 121.121 -0.232 . . . . 0.0 110.653 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -164.47 90.91 1.03 Allowed Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -44.9 109.96 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.304 1.336 . . . . 0.0 110.382 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.517 ' CB ' HG21 ' A' ' 103' ' ' VAL . 34.9 Cg_exo -58.02 -26.14 73.81 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.77 1.647 . . . . 0.0 109.942 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.58 146.91 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 114.667 -1.151 . . . . 0.0 108.957 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -152.64 160.23 43.19 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.997 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 41.0 m -79.83 111.74 16.44 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 120.952 0.406 . . . . 0.0 111.027 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 26.7 ttp-105 -113.44 105.6 54.98 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.173 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo . . . . . 0 N--CA 1.498 1.753 0 C-N-CA 121.85 1.7 . . . . 0.0 112.339 -179.766 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -58.5 141.09 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 121.401 0.62 . . . . 0.0 110.938 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 p -100.46 158.12 16.14 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.492 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.4 mt-10 -62.76 -42.04 99.5 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.525 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 t -59.81 -48.7 80.63 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.839 0.828 . . . . 0.0 109.593 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -62.42 -31.98 72.75 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.307 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.846 HD23 HG13 ' A' ' 22' ' ' VAL . 25.1 tp -57.86 -40.61 80.56 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.538 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.7 mptp? -60.83 -41.79 96.46 Favored 'General case' 0 C--O 1.212 -0.885 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.441 178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.06 -37.84 86.53 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.465 0.65 . . . . 0.0 109.902 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.797 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -69.83 -38.57 76.58 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.477 -177.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.3 m -112.65 16.1 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -65.13 -25.51 67.79 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.368 0.604 . . . . 0.0 109.987 178.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -71.05 -13.57 62.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.037 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.476 ' CE1' HG12 ' A' ' 12' ' ' VAL . 14.2 m-85 -82.22 159.93 23.12 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -81.9 -27.67 33.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.781 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CZ ' ' CE1' ' A' ' 82' ' ' TYR . 62.5 m-85 -113.77 58.57 0.67 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -65.59 -24.93 67.19 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -79.46 -50.45 10.76 Favored 'General case' 0 CA--C 1.507 -0.688 0 O-C-N 121.419 -0.801 . . . . 0.0 112.168 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 20' ' ' LEU . 13.0 tp -65.27 -40.62 94.15 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.548 -178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -61.56 -46.48 89.72 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.301 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.846 HG13 HD23 ' A' ' 8' ' ' LEU . 7.6 t -61.36 -45.03 99.45 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 CA-C-O 121.089 0.471 . . . . 0.0 110.166 178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.75 -40.15 91.4 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.705 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.43 -38.13 80.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.328 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 29' ' ' ILE . 17.7 p -67.58 -33.73 75.6 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.738 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.07 -44.81 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 C-N-CA 118.825 -1.15 . . . . 0.0 108.519 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -60.77 -37.49 82.05 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.011 -0.676 . . . . 0.0 110.098 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.438 HG21 HD13 ' A' ' 124' ' ' LEU . 78.9 t -70.77 -44.18 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.653 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.93 -22.11 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 119.004 -1.079 . . . . 0.0 111.615 -178.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.2 m -72.62 -43.64 63.01 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.939 0.4 . . . . 0.0 110.645 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -88.0 -38.64 15.33 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.749 -179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -112.7 66.74 0.65 Allowed 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -55.99 -17.85 7.83 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.093 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.38 -21.38 66.61 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.966 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.471 HD23 HD13 ' A' ' 55' ' ' LEU . 3.9 tp -89.69 113.62 25.14 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -109.11 125.39 31.63 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-N 119.686 1.13 . . . . 0.0 111.829 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.68 136.31 13.53 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.323 1.348 . . . . 0.0 112.66 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.3 t -126.3 133.65 68.28 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.797 HD13 ' SD ' ' A' ' 11' ' ' MET . 21.8 tp -83.11 118.7 23.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -126.94 132.89 50.75 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.3 m -62.44 140.42 58.58 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -133.91 141.4 47.33 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.625 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 77.9 t -112.9 124.47 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.683 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -88.91 161.18 16.81 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -61.19 -23.8 65.85 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.745 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -75.35 -11.55 60.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.003 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.15 -14.78 63.35 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.1 m -67.62 141.1 56.86 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.7 m -113.68 138.66 49.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.824 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 35.0 ttm105 -150.68 139.85 21.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.89 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -72.97 117.33 14.57 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.419 HD21 ' O ' ' A' ' 76' ' ' LEU . 13.3 tp -115.91 121.85 43.56 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -83.81 137.04 33.9 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -132.71 154.73 49.89 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.29 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.471 HD13 HD23 ' A' ' 35' ' ' LEU . 7.6 mt -102.2 122.26 43.85 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 54.8 m -135.1 137.52 42.91 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.19 -147.05 10.7 Favored Glycine 0 N--CA 1.47 0.955 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.909 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.9 p -132.75 158.45 42.37 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.447 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.3 pt -131.6 116.99 16.3 Favored Pre-proline 0 C--O 1.241 0.626 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.168 177.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -71.28 128.02 14.13 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 120.832 1.021 . . . . 0.0 109.801 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 74.4 t -127.1 119.52 22.22 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.696 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -64.48 146.1 88.85 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.064 1.842 . . . . 0.0 109.534 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -161.83 106.96 1.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.601 -0.84 . . . . 0.0 112.867 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.4 36.53 13.36 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.83 -6.98 79.25 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.438 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -117.5 146.08 43.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 85.0 m -123.31 134.36 54.06 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.951 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -116.62 149.92 38.93 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.27 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.71 105.26 17.38 Favored 'General case' 0 N--CA 1.462 0.143 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.452 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -93.9 120.58 65.71 Favored Pre-proline 0 CA--C 1.546 0.814 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -83.55 123.59 3.39 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.818 2.345 . . . . 0.0 110.88 177.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.452 HG23 HG22 ' A' ' 70' ' ' ILE . 32.5 pt -128.96 146.04 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 119.131 -1.027 . . . . 0.0 112.168 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 68.4 m -120.54 122.47 40.68 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-O 121.67 0.747 . . . . 0.0 109.634 177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.19 112.51 25.05 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.165 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.0 m95 -107.67 123.41 48.47 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.419 ' O ' HD21 ' A' ' 52' ' ' LEU . 62.1 mt -90.88 130.98 36.78 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.659 -177.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mt -72.72 153.31 41.21 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 119.247 -0.981 . . . . 0.0 108.376 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -60.33 -12.79 10.08 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.6 p -103.28 -1.22 29.16 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -48.23 146.24 4.68 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -95.6 19.46 33.06 Favored 'Cis proline' 0 N--CA 1.517 2.885 0 N-CA-C 116.616 1.737 . . . . 0.0 116.616 2.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.424 ' CE1' ' CZ ' ' A' ' 17' ' ' TYR . 46.3 m-85 -80.52 -1.03 40.14 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.192 179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.31 126.13 24.65 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.601 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -50.87 137.49 43.19 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 CA-C-N 121.66 1.629 . . . . 0.0 109.67 177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.81 144.13 19.05 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 121.824 1.682 . . . . 0.0 111.852 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.2 mt -88.46 130.6 37.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 121.596 0.713 . . . . 0.0 109.276 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 49.8 t -119.53 136.97 54.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.496 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -123.67 129.86 51.76 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.376 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.0 t -93.11 120.97 43.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -63.56 107.27 1.19 Allowed Pre-proline 0 CA--C 1.545 0.76 0 CA-C-O 119.189 -0.434 . . . . 0.0 110.689 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -84.13 158.71 13.32 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.549 1.5 . . . . 0.0 112.262 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.7 p -139.15 174.48 10.47 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.928 0.394 . . . . 0.0 110.66 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.7 m -59.35 -39.92 84.76 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -101.12 12.08 38.28 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 118.985 0.811 . . . . 0.0 111.174 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 8.7 mmm -130.54 119.98 23.38 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.448 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -118.68 162.71 17.97 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.181 -178.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.448 ' N ' HG23 ' A' ' 96' ' ' THR . 80.0 mt -97.79 108.02 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -91.19 106.62 18.64 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.7 p -62.55 142.35 58.02 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.49 -139.29 2.78 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.157 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -66.46 -25.71 66.85 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.544 ' NE2' HG23 ' A' ' 103' ' ' VAL . 5.9 p-80 -133.32 -20.85 2.08 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.627 HG21 ' HB2' ' A' ' 140' ' ' PRO . 22.2 t -91.93 133.56 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.241 0.928 . . . . 0.0 111.332 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -98.13 -168.72 1.7 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.001 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -82.82 -29.66 29.35 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -84.19 3.13 36.53 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.821 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.45 6.18 58.72 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.407 -0.902 . . . . 0.0 112.432 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -59.13 137.47 57.94 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.991 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -114.95 112.98 42.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.633 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -99.9 140.73 33.69 Favored 'General case' 0 C--O 1.225 -0.195 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.962 HD22 HG11 ' A' ' 134' ' ' VAL . 32.2 mt -137.77 121.68 11.77 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.832 -178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.06 -39.02 25.26 Favored 'Trans proline' 0 N--CA 1.501 1.951 0 C-N-CA 121.666 1.577 . . . . 0.0 113.611 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -61.55 -31.27 71.29 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.666 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.89 -42.78 84.93 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.472 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -62.46 -36.48 82.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.604 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -95.74 -0.22 51.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.654 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 12.2 t90 -62.76 125.27 23.39 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.796 0.807 . . . . 0.0 110.228 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -109.03 106.84 16.95 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.858 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 63.4 t60 -60.64 124.05 77.16 Favored Pre-proline 0 C--N 1.319 -0.718 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.451 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 7.8 Cg_endo -108.57 91.67 0.03 OUTLIER 'Cis proline' 0 N--CA 1.5 1.866 0 CA-C-N 120.354 1.162 . . . . 0.0 112.646 -2.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -113.49 -62.77 1.54 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.392 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.0 t -67.13 -41.17 86.61 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.23 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.8 t70 68.04 166.27 0.24 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.751 0.786 . . . . 0.0 112.008 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.2 tt -64.11 -44.58 91.81 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.319 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 125' ' ' LEU . 0.6 OUTLIER -52.42 -38.45 59.14 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.521 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.07 -40.48 98.57 Favored Glycine 0 N--CA 1.478 1.499 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.7 tp -59.75 -41.17 90.41 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -73.54 -46.98 46.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 119.854 -0.738 . . . . 0.0 111.886 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -68.16 -35.72 78.5 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.549 ' O ' HG12 ' A' ' 134' ' ' VAL . 53.4 t -66.08 -37.5 79.91 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.129 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.1 tpp -58.9 -44.34 91.19 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.447 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -63.41 -32.52 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.734 179.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 94.6 t -90.54 -46.04 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 120.347 -0.541 . . . . 0.0 112.343 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.962 HG11 HD22 ' A' ' 111' ' ' LEU . 4.5 p -70.1 -13.79 17.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.988 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.482 ' CD1' HG13 ' A' ' 134' ' ' VAL . 6.0 m-30 -103.25 -17.26 15.4 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.258 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.13 -31.05 54.01 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.73 -37.9 89.16 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.961 -0.296 . . . . 0.0 110.745 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -155.85 82.26 3.7 Favored Pre-proline 0 N--CA 1.447 -0.603 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -44.49 112.36 0.35 Allowed 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 121.818 1.679 . . . . 0.0 111.144 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.627 ' HB2' HG21 ' A' ' 103' ' ' VAL . 32.2 Cg_endo -67.21 -22.32 46.92 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.656 1.57 . . . . 0.0 111.698 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.8 m -128.48 140.49 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.853 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -155.24 161.52 41.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.107 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.94 122.18 35.04 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 120.719 0.295 . . . . 0.0 110.336 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.8 ttm-85 -111.62 126.96 27.59 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.859 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 N--CA 1.498 1.737 0 C-N-CA 121.965 1.777 . . . . 0.0 112.265 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.7 t -103.22 131.67 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.638 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -93.54 161.13 14.49 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.486 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 3.2 mm-40 -65.82 -43.04 89.79 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.837 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.5 m -59.57 -48.52 81.32 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 122.034 0.921 . . . . 0.0 109.126 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -62.9 -29.09 70.5 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.9 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.848 HD23 HG13 ' A' ' 22' ' ' VAL . 65.9 tp -60.32 -42.24 95.2 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.728 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.635 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.6 mptp? -59.69 -39.39 84.39 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.898 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -61.76 -33.88 74.86 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.408 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.691 ' CB ' HD13 ' A' ' 39' ' ' LEU . 17.5 ptp -85.48 -13.3 49.54 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.4 m -128.16 16.98 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.882 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.7 t -61.06 -38.25 85.52 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.111 0.481 . . . . 0.0 111.222 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -62.58 -18.72 62.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.825 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -72.26 153.15 41.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.92 0.391 . . . . 0.0 111.52 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -78.68 -29.21 45.44 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.016 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.412 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 45.0 m-85 -112.2 55.32 0.68 Allowed 'General case' 0 N--CA 1.483 1.175 0 CA-C-O 119.674 -0.203 . . . . 0.0 110.987 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 22' ' ' VAL . 17.4 ptt180 -63.65 -27.55 69.3 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.73 -52.18 22.59 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 -40.09 83.09 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.324 -178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.3 m -61.73 -46.81 88.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.093 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.848 HG13 HD23 ' A' ' 8' ' ' LEU . 51.7 t -64.34 -46.95 91.65 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 C-N-CA 121.076 -0.25 . . . . 0.0 111.034 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.9 tmt_? -63.22 -41.75 99.18 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.426 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -66.7 -37.99 85.85 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.258 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.644 ' O ' HG23 ' A' ' 29' ' ' ILE . 16.5 p -64.17 -33.86 76.75 Favored 'General case' 0 CA--C 1.509 -0.602 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.07 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.58 -44.75 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.779 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.097 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -60.58 -37.82 82.57 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.902 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.615 HG21 HD23 ' A' ' 124' ' ' LEU . 73.6 t -69.97 -44.08 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.644 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.89 -18.76 8.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 118.807 -1.157 . . . . 0.0 111.447 -178.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 89.3 m -74.27 -44.81 51.3 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.068 0.461 . . . . 0.0 110.07 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.783 HD23 HD21 ' A' ' 125' ' ' LEU . 24.7 tp -87.02 -37.86 17.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.407 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -114.56 67.58 0.69 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.864 0.364 . . . . 0.0 110.252 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -56.3 -17.33 7.38 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.084 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -65.65 -21.0 66.52 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.896 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.433 ' CD2' HD13 ' A' ' 55' ' ' LEU . 2.0 tp -95.99 113.65 25.28 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 ttpp -114.44 136.74 22.38 Favored Pre-proline 0 C--N 1.357 0.923 0 CA-C-N 119.596 1.089 . . . . 0.0 111.614 -178.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -79.75 136.75 12.26 Favored 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.003 1.802 . . . . 0.0 113.033 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 65.7 t -129.21 138.07 55.39 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.691 HD13 ' CB ' ' A' ' 11' ' ' MET . 22.7 tp -89.51 113.69 25.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.115 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -119.84 139.64 52.05 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.407 0.622 . . . . 0.0 112.417 -178.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.1 m -71.71 140.79 49.74 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.463 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -122.81 136.52 54.9 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.388 0.54 . . . . 0.0 110.077 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 56.8 t -117.43 124.98 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.712 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -98.35 156.9 16.51 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -63.55 -28.16 69.75 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.741 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -62.77 -18.51 62.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.711 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.0 -9.31 56.48 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 85.4 p -76.85 166.85 22.79 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 99.9 p -139.86 155.21 47.34 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.754 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.3 ttm-85 -162.58 139.94 8.1 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.769 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -79.14 122.6 26.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.523 0.678 . . . . 0.0 109.883 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.549 HD23 ' HE3' ' A' ' 75' ' ' TRP . 12.0 tp -120.99 124.38 44.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.693 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 10.2 tmm? -85.28 140.76 30.58 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.014 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -136.73 147.0 46.47 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.012 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.433 HD13 ' CD2' ' A' ' 35' ' ' LEU . 6.7 mt -92.96 127.45 38.47 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.4 m -138.81 138.68 37.78 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.26 -143.09 8.19 Favored Glycine 0 N--CA 1.466 0.661 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.459 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.1 p -134.36 160.14 38.87 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -132.37 116.11 15.16 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.036 -0.983 . . . . 0.0 108.927 177.022 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -69.58 123.28 10.0 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 120.822 1.015 . . . . 0.0 110.691 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.0 t -124.0 106.76 31.11 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.113 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -82.75 147.02 13.48 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 123.307 2.671 . . . . 0.0 113.21 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.41 ' CD2' ' O ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -163.93 118.84 1.55 Allowed 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.953 0.882 . . . . 0.0 111.282 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.67 41.0 25.37 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 -1.44 87.05 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.419 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -119.28 129.29 54.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.239 0.52 . . . . 0.0 109.841 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.5 m -120.82 129.62 53.63 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.499 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -108.59 145.28 35.11 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.963 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.35 100.72 12.46 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.515 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -88.68 118.09 68.99 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -176.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -87.04 124.12 2.08 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.779 2.319 . . . . 0.0 110.417 177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.515 HG23 HG22 ' A' ' 70' ' ' ILE . 29.3 pt -134.23 148.63 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.182 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.0 m -118.48 122.03 41.72 Favored 'General case' 0 C--N 1.347 0.48 0 CA-C-O 121.629 0.728 . . . . 0.0 109.533 177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.48 106.12 17.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.996 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.549 ' HE3' HD23 ' A' ' 52' ' ' LEU . 53.8 m95 -94.18 129.82 40.64 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.536 ' O ' HD21 ' A' ' 52' ' ' LEU . 1.3 mp -98.26 141.81 30.71 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.228 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.14 145.61 30.03 Favored 'General case' 0 C--N 1.338 0.107 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -57.68 -9.87 1.37 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.4 p -114.89 17.31 17.02 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.9 0.381 . . . . 0.0 111.876 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -57.74 143.08 77.16 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -93.41 7.56 57.2 Favored 'Cis proline' 0 N--CA 1.515 2.792 0 CA-C-N 120.99 1.389 . . . . 0.0 115.303 0.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.412 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 36.9 m-85 -73.86 -7.65 53.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.046 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -117.58 115.12 37.65 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -49.98 134.66 36.08 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 CA-C-N 121.062 1.415 . . . . 0.0 112.373 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -81.23 143.95 14.34 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.216 1.944 . . . . 0.0 111.684 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.482 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -98.57 152.1 4.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.247 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 52.7 t -138.52 135.7 35.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.026 -178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -118.4 128.7 54.88 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.816 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.445 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 61.2 t -89.69 129.66 40.27 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.33 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.97 99.94 2.54 Favored Pre-proline 0 CA--C 1.548 0.901 0 O-C-N 123.267 0.355 . . . . 0.0 110.945 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 43.8 Cg_endo -84.89 150.88 11.14 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.652 1.568 . . . . 0.0 113.058 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 50.2 p -116.25 168.08 10.44 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.719 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.4 m -56.03 -34.05 65.51 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.3 m -87.3 20.89 2.61 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.781 0.718 . . . . 0.0 110.591 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 30.9 ttm -144.76 146.58 32.22 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.0 m -124.56 140.7 52.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.584 HG23 ' O ' ' A' ' 97' ' ' ILE . 1.7 tp -85.84 103.97 13.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.243 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -87.82 102.14 14.39 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.258 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 74.2 p -72.21 148.68 45.33 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.612 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -172.86 -138.97 2.72 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -87.89 -3.84 58.89 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 49.2 m170 -122.21 -30.28 4.04 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 119.294 0.952 . . . . 0.0 112.242 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 1.3 t -112.04 134.65 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.882 0.765 . . . . 0.0 109.268 177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -93.01 162.04 14.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.031 0.443 . . . . 0.0 110.031 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.95 -32.44 73.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.467 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -76.93 -6.23 51.7 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.7 5.62 59.93 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.844 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.15 147.48 40.44 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.5 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 86.0 mt -106.36 121.44 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 121.125 0.488 . . . . 0.0 111.236 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -102.35 120.27 40.22 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.0 mt -126.75 122.34 23.47 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 120.321 -0.551 . . . . 0.0 111.258 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -57.04 -30.08 85.4 Favored 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 121.474 1.449 . . . . 0.0 114.363 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -66.67 -31.0 71.39 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.815 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.2 tt -69.59 -41.36 75.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.967 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -66.98 -28.3 68.15 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.432 -0.507 . . . . 0.0 110.375 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -104.29 1.59 30.56 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.521 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -68.95 125.94 28.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.872 0.844 . . . . 0.0 110.221 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -98.07 130.16 44.88 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.116 -1.402 . . . . 0.0 109.03 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 29.2 t60 -79.06 124.27 84.71 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.537 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 12.1 Cg_endo -112.06 92.1 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.563 0 CA-C-N 120.929 1.367 . . . . 0.0 112.786 -2.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -113.77 -52.8 2.73 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.088 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.9 p -74.62 -40.07 61.76 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.368 0.604 . . . . 0.0 110.694 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 59.47 164.65 0.05 Allowed 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.956 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.615 HD23 HG21 ' A' ' 28' ' ' VAL . 6.2 tp -58.29 -44.94 88.72 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.104 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.783 HD21 HD23 ' A' ' 31' ' ' LEU . 9.0 tp -52.72 -35.43 55.77 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -64.7 -38.97 96.31 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.9 tp -58.91 -40.3 84.1 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 122.487 -0.419 . . . . 0.0 111.877 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -76.53 -45.71 32.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 119.622 -0.831 . . . . 0.0 112.343 -176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -69.2 -34.34 74.73 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 126' ' ' GLY . 55.7 t -66.67 -38.58 81.88 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 48.1 tpp -60.67 -44.0 97.0 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.434 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.1 mp -63.73 -38.27 81.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.385 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.7 t -82.25 -48.25 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 130' ' ' VAL . 2.5 p -69.17 -16.17 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.717 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.5 ' HZ ' HG23 ' A' ' 109' ' ' ILE . 12.6 m-30 -107.27 -19.68 13.52 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.001 176.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -63.93 -34.61 90.4 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -62.91 -37.89 88.77 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.002 -0.599 . . . . 0.0 110.997 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -154.87 90.38 3.06 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -45.87 116.59 1.48 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.419 1.412 . . . . 0.0 110.609 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.92 -14.5 35.65 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.627 1.552 . . . . 0.0 111.54 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.2 m -126.24 133.2 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.332 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -161.07 163.5 31.46 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.44 127.67 50.77 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.371 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -110.99 121.55 40.44 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.365 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo . . . . . 0 N--CA 1.493 1.49 0 C-N-CA 122.109 1.873 . . . . 0.0 112.247 179.285 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.2 t -106.15 130.35 57.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.02 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -95.66 158.41 15.46 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 177.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -65.28 -39.21 92.29 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.65 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 72.8 m -60.08 -41.98 93.62 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.352 1.072 . . . . 0.0 109.139 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -68.5 -39.64 81.19 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.052 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.034 HD23 HG13 ' A' ' 22' ' ' VAL . 12.1 tp -53.74 -33.53 56.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.442 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 4.7 mmtt -68.11 -47.7 67.48 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.031 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -59.98 -34.87 73.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.633 0.73 . . . . 0.0 110.216 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.829 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.9 mmm -64.51 -37.06 86.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.506 -1.225 . . . . 0.0 111.042 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -122.17 23.91 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-O 120.565 0.221 . . . . 0.0 110.941 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 9' ' ' LYS . 99.9 p -66.24 -23.72 66.47 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.543 0.211 . . . . 0.0 111.345 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -77.53 -18.74 56.72 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.326 -178.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.525 ' OH ' HD22 ' A' ' 52' ' ' LEU . 39.1 m-85 -69.93 143.34 52.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.469 0.652 . . . . 0.0 111.603 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.08 -21.74 64.05 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.339 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 96.7 m-85 -121.89 55.43 1.11 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.591 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' O ' HG23 ' A' ' 22' ' ' VAL . 4.7 ptp180 -65.34 -26.18 67.92 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 119.871 -0.732 . . . . 0.0 112.808 -178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -67.02 -56.13 11.43 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 20' ' ' LEU . 13.0 mt -65.68 -40.3 92.2 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.47 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 25' ' ' THR . 75.3 m -61.95 -49.68 75.18 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.437 -0.505 . . . . 0.0 111.708 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.034 HG13 HD23 ' A' ' 8' ' ' LEU . 53.3 t -64.26 -47.56 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.534 0 CA-C-O 120.513 0.197 . . . . 0.0 110.74 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -65.1 -40.9 95.24 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.364 -0.934 . . . . 0.0 110.37 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -63.99 -38.75 92.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.694 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.664 ' O ' HG23 ' A' ' 29' ' ' ILE . 26.2 p -66.91 -38.69 86.71 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.74 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 30' ' ' THR . 55.7 t -56.58 -44.39 80.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 119.273 -0.971 . . . . 0.0 108.489 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -62.86 -39.52 94.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.702 178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 124' ' ' LEU . 51.6 t -66.78 -44.09 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.664 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -81.95 -13.12 12.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.3 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.8 p -80.98 -48.68 11.93 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.788 0.328 . . . . 0.0 110.589 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 125' ' ' LEU . 32.5 tp -88.09 -36.59 16.84 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.399 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -109.78 66.19 0.63 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -57.17 -19.16 18.79 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.134 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 48.1 p-10 -66.46 -18.18 65.21 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.384 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.599 HD13 HD12 ' A' ' 128' ' ' ILE . 2.6 tp -98.26 113.51 25.47 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -110.63 135.87 20.69 Favored Pre-proline 0 C--N 1.354 0.801 0 CA-C-N 119.354 0.979 . . . . 0.0 111.391 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -75.87 139.41 22.07 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.462 1.441 . . . . 0.0 111.794 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 p -133.79 147.06 30.81 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.829 HD13 ' SD ' ' A' ' 11' ' ' MET . 22.3 tp -99.1 119.67 38.22 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.585 -178.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -121.69 135.77 54.95 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.039 0.447 . . . . 0.0 111.416 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 90.5 p -70.92 139.79 50.8 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -123.78 134.03 53.72 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.725 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.1 t -112.25 127.42 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.308 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -97.69 161.22 13.87 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.811 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -61.07 -38.12 85.1 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.588 0.232 . . . . 0.0 111.457 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -63.11 -16.57 60.43 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.59 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.78 -5.12 56.52 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.9 p -71.67 166.15 22.5 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 t -128.99 146.13 51.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.341 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.04 134.12 19.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.097 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.611 ' CG ' HD11 ' A' ' 39' ' ' LEU . 7.0 tp10 -85.1 106.32 16.48 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.525 HD22 ' OH ' ' A' ' 15' ' ' TYR . 36.6 mt -110.13 142.9 40.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.454 0.645 . . . . 0.0 111.349 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.474 ' SD ' HD12 ' A' ' 8' ' ' LEU . 55.3 ttp -105.61 142.42 35.38 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.804 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -136.35 154.47 50.83 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.561 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.453 HD13 HD23 ' A' ' 35' ' ' LEU . 7.3 mt -95.41 120.18 35.2 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 72.3 m -132.9 135.19 45.43 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.22 -149.21 11.94 Favored Glycine 0 N--CA 1.464 0.51 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.481 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.0 p -133.11 158.36 42.99 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.433 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.5 pt -129.12 116.03 18.82 Favored Pre-proline 0 C--O 1.238 0.462 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.27 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -72.48 125.6 10.82 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 N-CA-C 109.495 -1.002 . . . . 0.0 109.495 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.17 126.77 21.65 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 119.688 -0.805 . . . . 0.0 112.001 -178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -72.83 148.66 46.49 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.271 1.981 . . . . 0.0 110.498 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.93 112.61 1.37 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.609 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 52.96 32.01 11.93 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 121.88 -0.513 . . . . 0.0 111.857 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.51 -10.21 67.91 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.729 -0.948 . . . . 0.0 110.729 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -110.32 137.78 47.58 Favored 'General case' 0 C--O 1.224 -0.266 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.9 m -115.27 131.72 56.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.671 -178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -114.6 152.38 31.92 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.296 0.569 . . . . 0.0 110.906 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -98.92 103.81 15.8 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.447 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -91.13 118.67 68.68 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -85.55 126.45 3.06 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.786 2.324 . . . . 0.0 110.944 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.447 HG23 HG22 ' A' ' 70' ' ' ILE . 30.5 pt -133.74 149.86 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.819 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 m -124.05 122.55 38.18 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.762 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.2 112.22 25.14 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.315 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -103.01 125.41 49.75 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 85.2 mt -88.12 140.04 29.89 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.898 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 tp -93.91 143.69 26.12 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -48.27 -18.29 0.2 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -103.68 16.94 25.19 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -69.84 144.58 93.55 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -92.87 4.27 60.21 Favored 'Cis proline' 0 N--CA 1.514 2.694 0 CA-C-N 121.426 1.545 . . . . 0.0 115.422 1.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.462 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 36.0 m-85 -73.34 -15.62 61.38 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.637 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.23 120.26 44.81 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -49.71 134.4 33.95 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.253 1.483 . . . . 0.0 111.701 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.08 145.11 21.72 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.956 1.77 . . . . 0.0 110.76 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mp -95.33 131.52 41.89 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 C-N-CA 119.179 -1.009 . . . . 0.0 109.545 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 79.7 m -111.86 137.83 49.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.672 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -126.5 128.26 46.64 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.225 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 t -88.53 127.52 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.48 109.04 12.51 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.72 -178.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -84.25 161.56 13.25 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 122.149 1.899 . . . . 0.0 112.882 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 23.9 p -133.43 173.24 11.69 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.7 m -57.94 -39.27 77.63 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 120.136 -0.626 . . . . 0.0 112.252 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.7 p -92.24 0.52 57.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.64 0.654 . . . . 0.0 111.866 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -130.66 125.59 34.39 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.474 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -113.97 167.44 10.66 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 120.036 -0.666 . . . . 0.0 111.348 -179.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.474 ' N ' HG23 ' A' ' 96' ' ' THR . 5.8 mm -92.73 105.3 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.546 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.0 ttmm -86.71 108.66 18.77 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.498 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.6 p -67.42 140.16 57.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.418 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -151.63 -146.78 4.41 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -71.55 -22.2 61.79 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.554 ' NE2' HG23 ' A' ' 103' ' ' VAL . 3.2 p-80 -123.8 -25.0 4.35 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.329 -0.949 . . . . 0.0 112.914 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.554 HG23 ' NE2' ' A' ' 102' ' ' HIS . 14.2 t -91.25 131.39 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.423 1.01 . . . . 0.0 110.671 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -95.31 -163.4 1.04 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.605 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.08 -13.53 47.04 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -106.39 -1.55 23.14 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.371 -0.206 . . . . 0.0 110.735 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 104.76 0.08 42.36 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.767 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.66 128.99 24.95 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 117.707 0.754 . . . . 0.0 109.898 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.36 114.5 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 O-C-N 123.264 0.353 . . . . 0.0 110.411 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -96.87 134.3 40.37 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.756 HD22 HG11 ' A' ' 134' ' ' VAL . 33.1 mt -137.71 118.86 10.61 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.859 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -47.51 -38.91 28.61 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 121.793 1.662 . . . . 0.0 114.037 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.83 -29.55 69.56 Favored 'General case' 0 C--O 1.222 -0.373 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.174 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.62 -43.76 75.69 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.743 0.306 . . . . 0.0 111.645 -178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -69.35 -28.23 66.03 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.689 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -103.97 4.3 34.43 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.989 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.417 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.0 t90 -68.62 121.65 16.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.717 0.77 . . . . 0.0 109.683 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -90.49 122.9 33.73 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.245 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -79.56 126.78 80.11 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.738 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -107.7 92.67 0.04 OUTLIER 'Cis proline' 0 N--CA 1.499 1.801 0 CA-C-N 120.802 1.322 . . . . 0.0 112.649 -2.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -115.12 -61.31 1.77 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.586 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.3 t -68.97 -33.82 74.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.762 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 p30 47.82 -177.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.82 0.819 . . . . 0.0 111.962 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 28' ' ' VAL . 2.7 tt -68.28 -39.56 82.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.137 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.414 HD11 HD23 ' A' ' 31' ' ' LEU . 8.2 tt -57.79 -38.74 76.03 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.5 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -63.55 -39.28 97.46 Favored Glycine 0 N--CA 1.479 1.561 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.0 tp -58.22 -40.57 82.01 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.427 -0.455 . . . . 0.0 111.768 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.599 HD12 HD13 ' A' ' 35' ' ' LEU . 1.1 mm -72.71 -49.43 40.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.771 -0.771 . . . . 0.0 111.848 -177.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -65.54 -35.96 82.39 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 126' ' ' GLY . 53.4 t -66.86 -37.39 79.34 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.697 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 60.9 tpp -58.54 -43.64 89.33 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.433 HD11 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -63.07 -42.77 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.564 179.065 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 77.8 t -77.19 -44.07 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.756 HG11 HD22 ' A' ' 111' ' ' LEU . 2.6 p -73.62 -13.64 16.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.015 -177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.547 ' CD1' HG13 ' A' ' 134' ' ' VAL . 6.6 m-30 -105.85 -17.59 14.32 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.209 -0.996 . . . . 0.0 109.703 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.69 -34.44 89.64 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -65.03 -35.5 81.38 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.604 -0.298 . . . . 0.0 110.711 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -155.95 116.52 2.23 Favored Pre-proline 0 CA--C 1.536 0.412 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.47 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -75.12 120.48 6.05 Favored 'Trans proline' 0 C--N 1.319 -0.998 0 N-CA-C 108.648 -1.328 . . . . 0.0 108.648 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.524 ' CB ' HG21 ' A' ' 103' ' ' VAL . 36.3 Cg_endo -67.94 -19.05 46.57 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.066 1.177 . . . . 0.0 111.217 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.92 147.95 29.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.56 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -155.38 165.68 35.87 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 3.4 p -77.59 121.0 23.33 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-O 121.375 0.607 . . . . 0.0 111.414 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -113.15 123.07 34.21 Favored Pre-proline 0 N--CA 1.438 -1.036 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.743 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo . . . . . 0 N--CA 1.499 1.846 0 C-N-CA 121.775 1.65 . . . . 0.0 112.014 -179.738 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.9 t -96.3 130.03 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.791 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.1 156.01 16.8 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.504 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 57.7 mp0 -63.0 -41.51 99.6 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.97 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 87.8 p -57.38 -47.99 80.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.165 0.984 . . . . 0.0 109.379 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -62.79 -34.52 77.43 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.272 -1.331 . . . . 0.0 109.778 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.939 HD23 HG13 ' A' ' 22' ' ' VAL . 21.1 tp -55.97 -38.39 70.33 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.625 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 3.1 mptp? -63.64 -42.8 98.09 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.331 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -63.47 -36.36 83.48 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.142 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.807 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -65.61 -36.76 84.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.642 -1.163 . . . . 0.0 111.947 -178.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -119.8 23.18 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 120.795 0.331 . . . . 0.0 111.45 -179.109 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 t -58.8 -25.42 63.12 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.575 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -64.84 -21.45 66.8 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.709 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.422 ' HE1' HD23 ' A' ' 52' ' ' LEU . 2.6 m-85 -67.89 150.57 48.39 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.95 -29.6 70.75 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.058 0.456 . . . . 0.0 112.175 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' HD2' ' H ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -138.0 69.03 1.39 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 124.097 0.959 . . . . 0.0 111.73 -179.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.3 ptt180 -57.69 -25.31 60.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.89 -41.67 97.65 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.027 -0.42 . . . . 0.0 111.497 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 tp -71.68 -43.32 66.2 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.447 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.8 m -62.69 -46.77 86.61 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.625 -0.43 . . . . 0.0 111.33 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.939 HG13 HD23 ' A' ' 8' ' ' LEU . 40.8 t -62.43 -44.1 98.91 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.513 0 CA-C-O 120.6 0.238 . . . . 0.0 110.428 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.17 -41.99 89.71 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.682 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.83 -39.57 93.79 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.248 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.606 ' O ' HG23 ' A' ' 29' ' ' ILE . 40.9 p -67.89 -38.33 82.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.46 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.15 -44.12 82.78 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 C-N-CA 119.206 -0.998 . . . . 0.0 108.496 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -60.72 -38.75 86.15 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.138 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -71.37 -45.3 70.09 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.445 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -84.78 -22.43 7.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.989 -178.142 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.8 m -72.18 -45.68 59.38 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.259 -0.576 . . . . 0.0 109.81 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.3 tp -84.47 -37.74 21.0 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.11 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -114.43 66.93 0.68 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 8.7 ptpt -57.76 -17.58 16.47 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.323 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -65.65 -16.34 63.64 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.364 -0.535 . . . . 0.0 110.26 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.1 tp -96.36 125.58 40.96 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.2 ttpt -118.27 129.27 25.47 Favored Pre-proline 0 C--N 1.359 0.995 0 CA-C-N 119.814 1.188 . . . . 0.0 111.955 -177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.09 140.23 15.63 Favored 'Trans proline' 0 N--CA 1.503 2.075 0 C-N-CA 121.855 1.703 . . . . 0.0 112.592 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.2 p -136.84 141.2 41.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 CA-C-O 120.929 0.395 . . . . 0.0 110.221 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.807 HD13 ' SD ' ' A' ' 11' ' ' MET . 14.2 tp -82.66 119.22 24.02 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -119.75 137.81 53.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.212 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.5 m -76.39 141.23 41.52 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -126.38 134.91 50.92 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.994 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.8 t -110.4 125.6 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.391 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -99.09 164.95 11.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.575 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -60.38 -41.95 94.83 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 120.714 0.292 . . . . 0.0 110.951 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -66.0 -14.72 62.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.512 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.18 -7.76 58.71 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 111.209 -0.757 . . . . 0.0 111.209 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.2 t -62.52 143.18 57.48 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.148 0.499 . . . . 0.0 110.027 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -115.7 140.03 49.58 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.051 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 58.5 ttm-85 -153.75 139.02 17.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.652 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -87.74 111.23 21.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.226 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.422 HD23 ' HE1' ' A' ' 15' ' ' TYR . 25.8 mt -111.53 140.03 46.47 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.413 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -92.75 138.33 31.59 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -130.05 153.15 48.74 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.023 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.88 119.16 34.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.6 m -130.23 136.81 49.6 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.928 0.394 . . . . 0.0 112.021 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.46 -147.96 13.61 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.606 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.564 HG21 ' OD1' ' A' ' 69' ' ' ASN . 22.0 p -133.29 161.09 35.42 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -129.46 116.6 18.53 Favored Pre-proline 0 N--CA 1.47 0.557 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.494 177.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -72.39 126.08 11.3 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 CA-C-N 120.037 1.049 . . . . 0.0 110.193 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.0 t -128.13 125.87 23.54 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 119.708 -0.797 . . . . 0.0 111.583 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.67 150.0 55.88 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.184 1.923 . . . . 0.0 110.294 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -162.84 106.5 1.08 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.31 0.576 . . . . 0.0 111.746 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 23.9 ttp180 52.68 39.29 28.16 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.939 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.88 -2.37 74.82 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -119.64 134.16 55.35 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.8 m -114.59 131.92 56.52 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.256 -0.429 . . . . 0.0 112.063 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -113.34 150.05 33.14 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.668 178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.564 ' OD1' HG21 ' A' ' 58' ' ' THR . 4.6 t-20 -94.12 107.05 19.01 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.516 HG22 HG23 ' A' ' 72' ' ' ILE . 1.5 mp -90.22 116.23 65.89 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.356 -177.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.31 124.69 4.88 Favored 'Trans proline' 0 N--CA 1.501 1.95 0 C-N-CA 122.553 2.168 . . . . 0.0 111.381 177.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.516 HG23 HG22 ' A' ' 70' ' ' ILE . 31.4 pt -135.89 148.68 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.918 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 63.0 m -125.24 125.04 42.96 Favored 'General case' 0 C--N 1.347 0.475 0 CA-C-O 121.4 0.619 . . . . 0.0 109.884 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.62 115.75 30.69 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.836 -1.074 . . . . 0.0 111.304 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 61.1 m95 -103.8 126.33 50.85 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 78.2 mt -94.5 139.82 30.64 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.217 -178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.7 mt -79.65 160.12 26.46 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 177.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -59.94 -13.96 13.53 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 p -120.77 18.01 11.89 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -59.5 148.14 74.81 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.403 ' HD2' ' OH ' ' A' ' 17' ' ' TYR . 20.0 Cg_endo -92.89 10.26 56.32 Favored 'Cis proline' 0 N--CA 1.509 2.417 0 CA-C-N 121.333 1.512 . . . . 0.0 115.415 -0.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.63 -16.97 64.44 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 118.665 -1.214 . . . . 0.0 110.695 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.14 128.06 26.28 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.362 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -46.81 129.62 14.68 Favored 'Trans proline' 0 N--CA 1.505 2.157 0 CA-C-N 121.269 1.489 . . . . 0.0 113.179 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -82.78 148.67 13.93 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.634 2.223 . . . . 0.0 111.401 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -96.45 153.8 3.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.601 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.11 136.24 24.88 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.624 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -120.42 137.79 54.12 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.703 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.46 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -88.04 125.18 41.5 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.362 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.401 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.7 tttt -64.22 104.61 0.55 Allowed Pre-proline 0 N--CA 1.475 0.805 0 CA-C-O 119.162 -0.446 . . . . 0.0 110.631 -178.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 48.3 Cg_endo -88.93 157.99 5.95 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 121.56 1.507 . . . . 0.0 112.783 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.9 t -157.44 161.67 38.94 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.289 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.6 m -56.36 -23.02 34.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.0 m -98.45 6.66 47.03 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.653 0.66 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.8 mmm -131.37 140.14 49.63 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.1 m -128.77 147.37 50.78 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.744 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 93.2 mt -101.09 117.12 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.083 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.7 tttp -101.41 106.89 18.08 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.3 p -57.47 148.44 23.57 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.754 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -161.26 -140.36 2.86 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 115.124 -0.943 . . . . 0.0 111.116 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -88.45 -3.42 58.83 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -135.46 -29.14 1.09 Allowed 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 119.619 1.099 . . . . 0.0 113.617 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.29 144.31 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 119.036 0.835 . . . . 0.0 110.247 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 35.4 t0 -98.09 159.6 14.83 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.43 -35.04 79.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.418 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -73.92 -5.51 41.63 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.169 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.62 6.23 58.49 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.418 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 143.1 34.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.864 -0.735 . . . . 0.0 109.939 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 98.3 mt -106.55 119.88 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.177 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.23 139.67 50.95 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.03 126.25 18.55 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 118.49 0.586 . . . . 0.0 112.183 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.68 -38.87 37.62 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 121.735 1.623 . . . . 0.0 114.07 177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -62.43 -31.83 72.59 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.861 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.6 tt -69.66 -41.59 75.35 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.371 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -66.3 -29.09 69.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.606 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -101.54 -3.29 28.75 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.694 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.404 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.1 t90 -67.56 127.5 32.96 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.924 0.868 . . . . 0.0 110.475 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.37 130.24 43.53 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 113.835 -1.529 . . . . 0.0 108.776 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 78.7 t60 -80.21 126.13 79.9 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.33 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 13.2 Cg_endo -108.33 93.59 0.04 OUTLIER 'Cis proline' 0 N--CA 1.498 1.787 0 CA-C-N 120.794 1.319 . . . . 0.0 112.539 -2.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -113.99 -62.39 1.6 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.308 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.1 p -70.3 -40.11 74.43 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.159 0.504 . . . . 0.0 110.297 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.2 t70 65.76 167.67 0.2 Allowed 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.418 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 124' ' ' LEU . 2.3 tt -62.47 -43.86 97.79 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.452 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -53.11 -36.4 60.71 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.65 -40.19 98.42 Favored Glycine 0 N--CA 1.479 1.526 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.3 tp -60.46 -40.76 92.34 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -75.98 -47.14 33.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.597 -176.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -67.97 -35.57 78.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 126' ' ' GLY . 61.1 t -68.65 -39.39 80.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.427 0 N-CA-C 108.326 -0.991 . . . . 0.0 108.326 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.7 ttm -59.01 -45.26 91.13 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -60.68 -43.28 94.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.351 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 73.6 t -75.25 -39.68 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.4 p -72.32 -17.45 18.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.54 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -110.13 -17.77 13.48 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.575 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.19 -35.55 91.71 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 107.146 -2.382 . . . . 0.0 107.146 176.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.99 -34.2 77.86 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.556 -0.822 . . . . 0.0 110.608 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -157.95 90.75 2.26 Favored Pre-proline 0 C--N 1.333 -0.125 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.526 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -50.23 114.15 1.31 Allowed 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.776 0.984 . . . . 0.0 110.128 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -72.26 -13.29 28.19 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.471 1.447 . . . . 0.0 111.154 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.1 m -131.64 138.88 51.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.343 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -160.19 164.16 33.05 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.672 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 66.4 m -93.1 126.37 38.16 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.246 0.546 . . . . 0.0 111.02 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -112.92 103.19 55.58 Favored Pre-proline 0 N--CA 1.444 -0.736 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.795 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo . . . . . 0 N--CA 1.497 1.685 0 C-N-CA 121.877 1.718 . . . . 0.0 112.143 179.6 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.415 HG13 ' HE2' ' A' ' 11' ' ' MET . 98.2 t -100.75 129.75 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.722 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -96.58 156.0 16.53 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.499 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 93.9 mt-10 -62.79 -40.53 97.62 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.045 -1.062 . . . . 0.0 111.145 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -58.76 -47.0 86.17 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 122.219 1.009 . . . . 0.0 109.052 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -61.57 -36.49 80.81 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.002 178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.883 HD23 HG13 ' A' ' 22' ' ' VAL . 25.0 tp -55.3 -39.54 70.04 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.608 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 3.2 mptp? -60.65 -43.31 97.75 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.867 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.6 mttp -67.94 -26.32 65.89 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.735 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.743 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -79.03 -34.61 43.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.52 -178.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -113.17 17.64 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.711 0.291 . . . . 0.0 110.789 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -68.67 -11.51 60.24 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.656 0.265 . . . . 0.0 111.302 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -85.22 -12.85 51.64 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.453 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.71 ' OH ' HD22 ' A' ' 52' ' ' LEU . 40.2 m-85 -77.75 152.47 33.59 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.408 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.8 ttmm -64.93 -39.13 93.03 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.076 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.428 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 25.0 m-85 -114.58 70.16 0.73 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 122.404 -0.185 . . . . 0.0 111.077 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ptp85 -69.04 -27.31 65.54 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -72.74 -46.56 52.86 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.79 -39.6 73.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.969 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.7 m -61.19 -45.71 93.46 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.872 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.883 HG13 HD23 ' A' ' 8' ' ' LEU . 30.1 t -61.86 -45.9 97.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 CA-C-O 120.839 0.352 . . . . 0.0 110.483 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -43.05 99.65 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 119.474 -0.89 . . . . 0.0 109.873 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -65.16 -37.12 86.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.943 -178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.639 ' O ' HG23 ' A' ' 29' ' ' ILE . 39.5 p -67.38 -37.36 83.03 Favored 'General case' 0 CA--C 1.509 -0.616 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.922 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.49 -43.62 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -60.4 -39.04 85.91 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.411 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -70.58 -42.75 78.08 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.412 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.639 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.27 -21.92 7.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.191 -177.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.0 m -72.46 -42.9 64.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.046 0.451 . . . . 0.0 110.311 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.844 HD23 HD21 ' A' ' 125' ' ' LEU . 33.8 tp -88.75 -34.52 17.1 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.092 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -118.24 68.85 0.78 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -57.32 -20.59 29.59 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.159 -179.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -65.84 -15.05 62.55 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.755 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.458 ' CD2' HD13 ' A' ' 55' ' ' LEU . 2.7 tp -96.95 112.43 24.19 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -110.12 129.52 23.84 Favored Pre-proline 0 C--N 1.358 0.937 0 CA-C-N 119.572 1.078 . . . . 0.0 112.334 -177.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -82.92 135.64 7.74 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 121.603 1.535 . . . . 0.0 112.834 179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.84 155.58 41.54 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.743 HD13 ' SD ' ' A' ' 11' ' ' MET . 15.7 tp -95.21 117.6 30.53 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -121.42 134.74 55.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.907 0.384 . . . . 0.0 111.9 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.5 t -71.99 136.72 46.85 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -118.27 124.31 47.54 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.864 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.1 t -110.2 124.85 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.926 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -104.18 166.7 10.24 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.893 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -60.49 -38.0 82.88 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.488 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.54 -15.87 59.17 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.843 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.72 -8.88 66.16 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.8 t -67.35 145.04 55.49 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -125.08 139.18 54.02 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.414 -179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -150.02 136.95 19.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.109 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 51' ' ' GLU . 17.4 pm0 -83.97 116.99 23.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.213 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.71 HD22 ' OH ' ' A' ' 15' ' ' TYR . 69.9 mt -117.23 145.09 44.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.086 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -98.93 138.23 36.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.849 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -130.08 151.12 50.96 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.479 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.458 HD13 ' CD2' ' A' ' 35' ' ' LEU . 6.2 mt -97.59 129.57 44.7 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.1 m -145.3 138.5 26.43 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.85 -141.9 7.31 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.485 179.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 63.5 p -133.41 158.92 41.83 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.458 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.0 OUTLIER -129.59 116.18 18.32 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.848 177.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -70.98 123.85 10.07 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 CA-C-N 119.886 0.995 . . . . 0.0 110.001 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.1 t -130.67 125.71 21.59 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.909 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.09 147.39 42.83 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.281 1.987 . . . . 0.0 110.634 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -163.48 116.08 1.49 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 55.93 28.29 12.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.448 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.68 -5.74 77.03 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -112.93 142.51 45.52 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.9 m -120.29 131.93 55.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.884 0.374 . . . . 0.0 111.74 -178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -115.11 152.02 33.29 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.98 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -96.52 104.93 16.95 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.517 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -88.7 117.13 68.0 Favored Pre-proline 0 CA--C 1.545 0.77 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -82.94 124.31 3.84 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.711 2.274 . . . . 0.0 111.12 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.517 HG23 HG22 ' A' ' 70' ' ' ILE . 29.5 pt -135.72 148.69 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 119.115 -1.034 . . . . 0.0 111.973 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 64.3 m -121.43 123.55 42.35 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-O 121.839 0.828 . . . . 0.0 110.12 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.97 117.0 32.9 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.151 -1.386 . . . . 0.0 110.349 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -107.72 126.23 52.35 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 72.5 mt -92.87 139.36 30.62 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.838 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mt -85.42 152.58 23.12 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.492 ' OD1' HD21 ' A' ' 52' ' ' LEU . 95.9 m-20 -58.66 -16.05 14.5 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.906 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.2 10.75 31.79 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -65.3 144.54 99.02 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.427 ' HG2' ' CD2' ' A' ' 119' ' ' HIS . 28.7 Cg_endo -91.05 3.84 67.11 Favored 'Cis proline' 0 N--CA 1.515 2.786 0 CA-C-N 121.219 1.471 . . . . 0.0 115.726 1.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.428 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 18.8 m-85 -71.54 -20.67 62.0 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 119.307 -0.957 . . . . 0.0 109.945 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -106.06 126.64 30.1 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 118.826 -0.607 . . . . 0.0 109.695 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -49.08 131.48 26.06 Favored 'Trans proline' 0 N--CA 1.504 2.102 0 CA-C-N 121.235 1.477 . . . . 0.0 112.403 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -84.16 145.53 11.01 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.463 2.109 . . . . 0.0 111.784 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.479 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -91.79 147.44 5.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.241 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' A' ' 109' ' ' ILE . 53.8 t -139.57 132.58 29.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.56 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -121.88 130.86 53.69 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.66 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.491 HG13 HD11 ' A' ' 109' ' ' ILE . 11.4 m -82.83 145.93 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.9 tttt -93.56 99.1 3.03 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 119.153 -0.451 . . . . 0.0 110.871 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 87.3 Cg_endo -77.03 157.25 34.3 Favored 'Trans proline' 0 N--CA 1.504 2.118 0 C-N-CA 121.482 1.455 . . . . 0.0 112.738 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 p -139.24 176.17 8.93 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.093 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.1 t -59.79 -43.86 94.2 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.8 m -88.18 11.84 15.3 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 118.795 0.725 . . . . 0.0 111.493 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.2 mmm -129.13 138.46 51.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.66 146.03 48.52 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 120.119 -0.632 . . . . 0.0 111.813 -178.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.411 HG23 HG11 ' A' ' 103' ' ' VAL . 6.6 mm -88.2 103.43 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.077 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -95.58 110.9 22.93 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 80.9 p -69.65 155.97 39.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.687 -178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -178.89 -135.01 2.24 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.826 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -86.38 -1.24 57.37 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -134.97 -27.31 1.26 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 119.665 1.12 . . . . 0.0 113.729 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.411 HG11 HG23 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -110.55 134.81 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 118.931 0.787 . . . . 0.0 110.215 178.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -87.2 -172.57 4.01 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.418 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.13 0.34 56.14 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.978 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -109.04 -5.67 15.94 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.745 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.89 -3.44 57.26 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.534 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.74 145.22 47.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.408 0.604 . . . . 0.0 110.446 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.491 HD11 HG13 ' A' ' 89' ' ' VAL . 97.5 mt -108.92 122.12 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.434 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.61 130.65 56.86 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.553 ' CD2' HG11 ' A' ' 134' ' ' VAL . 1.1 mt -123.99 124.23 26.02 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.251 -176.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -49.15 -36.9 37.59 Favored 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 121.739 1.626 . . . . 0.0 113.865 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.465 ' OH ' HD13 ' A' ' 127' ' ' LEU . 1.2 p90 -60.07 -33.0 71.47 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.079 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.423 ' N ' ' CG ' ' A' ' 113' ' ' TYR . 1.5 tt -70.89 -41.23 71.59 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.918 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -64.17 -26.37 68.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.633 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -113.78 11.52 18.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.495 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 4.0 t90 -72.19 125.99 28.67 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.924 0.868 . . . . 0.0 109.996 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -96.57 127.89 42.99 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.058 -1.428 . . . . 0.0 108.784 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.427 ' CD2' ' HG2' ' A' ' 81' ' ' PRO . 39.4 t-80 -81.6 126.49 75.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 119.069 -0.491 . . . . 0.0 110.112 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -108.94 92.35 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.707 0 CA-C-N 120.756 1.306 . . . . 0.0 112.43 -2.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.26 -61.96 1.66 Allowed 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.504 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.5 t -67.94 -42.11 81.5 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.46 -0.496 . . . . 0.0 111.087 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 t70 66.98 165.84 0.22 Allowed 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.487 0.66 . . . . 0.0 111.7 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.576 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.7 tt -65.79 -43.71 87.94 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.663 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.844 HD21 HD23 ' A' ' 31' ' ' LEU . 21.3 tp -56.81 -38.54 72.72 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.24 -39.12 96.75 Favored Glycine 0 N--CA 1.48 1.591 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 178.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.465 HD13 ' OH ' ' A' ' 113' ' ' TYR . 33.4 tp -56.95 -40.28 76.15 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.889 -0.183 . . . . 0.0 111.431 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mm -73.98 -47.82 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 119.711 -0.796 . . . . 0.0 111.941 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 49.0 tp60 -66.42 -35.0 79.22 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.58 ' O ' HG12 ' A' ' 134' ' ' VAL . 62.9 t -67.41 -39.02 81.82 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.555 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.0 tpp -58.24 -42.13 85.7 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.458 HD11 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -63.62 -39.55 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.597 179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -79.09 -46.82 23.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 130' ' ' VAL . 9.9 p -71.6 -14.21 17.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.138 -177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.466 ' CD1' HG13 ' A' ' 134' ' ' VAL . 5.6 m-30 -104.75 -19.09 14.04 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.18 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -73.43 -32.05 60.3 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -63.89 -38.87 92.7 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.817 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -157.67 81.66 3.08 Favored Pre-proline 0 C--N 1.332 -0.181 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -49.1 109.31 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 121.266 1.311 . . . . 0.0 110.76 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.64 -23.47 40.6 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.456 1.437 . . . . 0.0 110.462 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 m -120.09 140.41 44.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.29 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -159.57 164.19 34.46 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 120.236 -0.585 . . . . 0.0 110.297 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.4 m -105.81 130.17 53.85 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.853 0.358 . . . . 0.0 110.72 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.13 132.2 22.16 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.445 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo . . . . . 0 N--CA 1.494 1.538 0 C-N-CA 121.791 1.661 . . . . 0.0 111.982 179.434 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.8 p -71.23 139.3 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 121.391 0.615 . . . . 0.0 110.805 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -103.74 157.84 16.8 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.404 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 97.7 mt-10 -65.04 -40.45 94.81 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.266 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -63.26 -41.51 99.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.355 1.074 . . . . 0.0 109.214 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -69.97 -29.93 67.16 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.657 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.036 HD23 HG13 ' A' ' 22' ' ' VAL . 51.6 tp -61.9 -39.65 92.71 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.698 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 0.7 OUTLIER -58.85 -43.22 90.73 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.074 -0.967 . . . . 0.0 108.657 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -60.43 -35.52 76.02 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.298 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.734 ' CB ' HD13 ' A' ' 39' ' ' LEU . 13.5 ptp -83.33 -10.58 58.4 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.172 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.878 HG22 ' O ' ' A' ' 8' ' ' LEU . 16.2 m -130.9 19.21 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.01 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 98.7 p -66.44 -18.22 65.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.558 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.82 -13.15 40.03 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.98 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -72.9 148.64 44.17 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.527 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -66.57 -37.82 85.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.799 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 19.8 m-85 -108.18 61.92 0.61 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 121.144 -0.222 . . . . 0.0 110.428 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.48 ' O ' HG23 ' A' ' 22' ' ' VAL . 2.4 ptp85 -64.76 -27.31 68.81 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -76.68 -53.03 8.55 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.11 -38.77 82.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.084 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.1 m -60.77 -47.45 86.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.698 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.036 HG13 HD23 ' A' ' 8' ' ' LEU . 38.9 t -61.08 -44.62 98.64 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.13 -40.53 97.87 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.115 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -63.13 -38.44 91.18 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.059 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.647 ' O ' HG23 ' A' ' 29' ' ' ILE . 48.8 p -68.27 -34.33 75.99 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.923 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.8 t -55.68 -45.64 79.2 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.742 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -61.31 -39.07 89.13 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.471 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.3 t -71.64 -43.09 71.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.57 -20.13 7.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.698 -178.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.5 m -78.07 -46.97 19.4 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.992 0.425 . . . . 0.0 110.848 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.599 HD23 HD21 ' A' ' 125' ' ' LEU . 22.8 tp -88.65 -36.0 16.49 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.842 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -111.97 68.14 0.66 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -59.38 -18.15 36.22 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.671 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -65.22 -21.88 66.81 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.855 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.641 HD13 HD12 ' A' ' 128' ' ' ILE . 1.3 tp -95.51 115.26 27.18 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.72 132.76 22.11 Favored Pre-proline 0 C--N 1.356 0.881 0 CA-C-N 119.828 1.194 . . . . 0.0 112.104 -178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.39 135.3 11.82 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.424 1.416 . . . . 0.0 112.46 178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.1 t -127.87 136.27 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.734 HD13 ' CB ' ' A' ' 11' ' ' MET . 38.1 tp -84.55 119.24 24.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -129.91 137.25 50.28 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.9 t -68.6 137.98 54.69 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.56 133.45 53.98 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.206 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.2 t -120.78 126.63 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.992 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -100.79 159.51 15.13 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.178 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -58.59 -35.44 72.42 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 122.369 -0.207 . . . . 0.0 110.934 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -61.38 -15.36 35.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.876 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.71 -13.45 60.94 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.0 t -65.75 141.81 58.2 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.2 p -121.9 138.74 54.28 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.546 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -161.23 138.69 9.05 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.359 0.6 . . . . 0.0 110.79 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -80.39 120.5 24.5 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.741 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 52' ' ' LEU . 77.7 mt -122.22 140.01 53.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.553 0.692 . . . . 0.0 110.817 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.455 ' SD ' HD11 ' A' ' 8' ' ' LEU . 62.0 ttp -84.51 148.66 26.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.424 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -134.2 151.53 51.36 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 121.296 0.57 . . . . 0.0 111.689 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.498 ' HG ' HD23 ' A' ' 35' ' ' LEU . 3.2 mm? -102.66 116.02 31.74 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.5 m -134.47 137.13 43.7 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.27 -143.24 7.99 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.593 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.493 HG21 ' OD1' ' A' ' 69' ' ' ASN . 19.8 p -135.27 161.25 35.92 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.43 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.2 pt -132.31 116.07 15.22 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.206 177.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -72.35 125.87 11.14 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 120.935 1.09 . . . . 0.0 110.092 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.6 t -129.48 124.43 21.96 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 119.744 -0.783 . . . . 0.0 112.329 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.56 145.85 48.11 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.137 1.891 . . . . 0.0 110.162 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -163.57 114.78 1.4 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.481 -0.487 . . . . 0.0 111.932 -177.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 53.23 32.09 12.78 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.82 -6.86 72.36 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -113.79 148.51 36.42 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.2 m -125.2 132.58 52.99 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.609 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -115.47 152.09 33.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.138 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.493 ' OD1' HG21 ' A' ' 58' ' ' THR . 3.8 t-20 -97.09 103.88 15.85 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.494 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -88.33 116.98 67.83 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -177.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -82.18 127.26 5.22 Favored 'Trans proline' 0 N--CA 1.503 2.082 0 C-N-CA 122.516 2.144 . . . . 0.0 111.062 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.494 HG23 HG22 ' A' ' 70' ' ' ILE . 29.6 pt -137.1 149.13 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 118.939 -1.105 . . . . 0.0 112.577 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.46 123.05 40.4 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-O 121.513 0.673 . . . . 0.0 110.057 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.32 103.68 13.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.646 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -90.69 124.05 34.77 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 119.046 -1.062 . . . . 0.0 108.3 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -91.98 138.64 31.38 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mt -88.9 155.46 19.51 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.28 -16.26 32.54 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.629 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.04 0.43 51.57 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.669 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -65.03 143.03 98.82 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HG2' ' CE1' ' A' ' 119' ' ' HIS . 41.5 Cg_endo -89.34 4.15 69.62 Favored 'Cis proline' 0 N--CA 1.517 2.892 0 CA-C-N 120.975 1.384 . . . . 0.0 115.299 1.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 12.0 m-85 -68.85 -23.13 64.2 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.242 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.86 126.3 30.15 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.959 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -50.19 137.48 37.88 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 CA-C-N 121.263 1.487 . . . . 0.0 111.555 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -83.03 144.1 11.8 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 122.387 2.058 . . . . 0.0 111.771 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.49 131.55 40.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 CA-C-O 121.65 0.738 . . . . 0.0 109.406 179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 38.7 t -118.28 142.0 47.94 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.702 -1.135 . . . . 0.0 112.326 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -127.93 127.64 43.68 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.103 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.585 ' CG2' HD11 ' A' ' 109' ' ' ILE . 57.9 t -85.79 131.92 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -87.35 101.76 2.61 Favored Pre-proline 0 CA--C 1.547 0.833 0 CA-C-O 118.944 -0.55 . . . . 0.0 110.979 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 79.4 Cg_endo -82.03 159.36 18.18 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 121.39 1.393 . . . . 0.0 112.206 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 p -123.39 168.13 12.93 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.06 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.2 m -56.75 -36.09 69.37 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.433 -179.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.0 m -88.36 2.59 52.26 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.854 0.752 . . . . 0.0 112.295 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -129.54 140.15 51.32 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -116.68 156.81 26.46 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.631 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 97' ' ' ILE . 2.7 tp -85.25 109.98 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-O 121.262 0.553 . . . . 0.0 109.96 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.8 tttp -97.53 101.39 12.9 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.033 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.7 p -65.54 151.18 47.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.883 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -166.23 -143.75 3.85 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.663 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.403 ' O ' ' CZ ' ' A' ' 110' ' ' TYR . 24.8 pttm -65.96 -18.96 65.69 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.62 ' HD2' HG23 ' A' ' 103' ' ' VAL . 6.6 p-80 -131.86 -26.67 1.95 Allowed 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.62 HG23 ' HD2' ' A' ' 102' ' ' HIS . 13.4 t -93.78 137.66 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.667 1.121 . . . . 0.0 111.36 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -100.97 177.51 4.93 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.417 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.58 -38.55 87.28 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -86.41 -0.37 55.83 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.843 -179.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.69 21.56 18.66 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 119.988 -1.101 . . . . 0.0 112.722 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -75.79 136.84 40.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.687 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.585 HD11 ' CG2' ' A' ' 89' ' ' VAL . 88.7 mt -117.26 125.2 73.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.95 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CZ ' ' O ' ' A' ' 101' ' ' LYS . 30.2 p90 -136.44 148.87 47.96 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.73 HD23 HG11 ' A' ' 134' ' ' VAL . 3.3 mp -143.45 140.03 17.12 Favored Pre-proline 0 CA--C 1.555 1.152 0 CA-C-O 119.138 -0.458 . . . . 0.0 111.257 -175.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.476 ' HA ' ' ND1' ' A' ' 115' ' ' HIS . 50.4 Cg_exo -46.43 -38.64 21.24 Favored 'Trans proline' 0 N--CA 1.513 2.619 0 C-N-CA 121.954 1.769 . . . . 0.0 113.792 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.46 ' OH ' HD13 ' A' ' 127' ' ' LEU . 0.4 OUTLIER -63.69 -31.94 73.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.073 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.24 -43.08 64.91 Favored 'General case' 0 CA--C 1.521 -0.159 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.476 ' ND1' ' HA ' ' A' ' 112' ' ' PRO . 0.2 OUTLIER -68.96 -27.01 65.35 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.78 -177.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -97.65 1.12 48.32 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.293 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -60.13 126.51 27.79 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 121.766 0.793 . . . . 0.0 110.657 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -104.46 96.29 6.51 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.205 -1.361 . . . . 0.0 108.619 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 65.0 t60 -55.64 122.84 47.97 Favored Pre-proline 0 C--N 1.317 -0.838 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.309 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 8.5 Cg_endo -108.0 91.97 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.81 0 CA-C-N 120.304 1.144 . . . . 0.0 113.019 -2.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -110.43 -58.83 2.03 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 120.396 -0.522 . . . . 0.0 111.483 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.1 p -71.02 -39.72 72.19 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.355 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.5 t70 69.32 164.09 0.24 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.355 0.598 . . . . 0.0 112.095 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.589 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.4 tt -66.15 -44.28 84.57 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.326 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.599 HD21 HD23 ' A' ' 31' ' ' LEU . 2.6 tp -56.12 -37.95 70.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.512 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.67 -39.42 97.39 Favored Glycine 0 N--CA 1.477 1.391 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.46 HD13 ' OH ' ' A' ' 113' ' ' TYR . 32.4 tp -58.68 -41.17 85.59 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.605 -0.35 . . . . 0.0 111.902 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.641 HD12 HD13 ' A' ' 35' ' ' LEU . 1.1 mm -72.71 -47.74 48.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.954 -176.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.405 ' OE1' HG21 ' A' ' 132' ' ' ILE . 6.9 tp-100 -67.71 -34.73 77.44 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.668 ' O ' HG12 ' A' ' 134' ' ' VAL . 64.5 t -67.91 -39.2 81.32 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.689 0 C-N-CA 119.663 -0.815 . . . . 0.0 109.055 177.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.404 ' SD ' ' CE1' ' A' ' 135' ' ' PHE . 44.5 tpp -58.14 -41.47 83.77 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.43 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.1 mp -63.67 -44.14 98.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 114.672 -1.149 . . . . 0.0 111.562 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.74 -44.21 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.73 HG11 HD23 ' A' ' 111' ' ' LEU . 8.7 p -73.52 -14.09 16.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.177 -177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.464 ' CD2' HG13 ' A' ' 134' ' ' VAL . 11.6 m-30 -105.38 -17.78 14.33 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.547 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.95 -22.97 72.59 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -76.43 -27.31 56.18 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.403 -0.399 . . . . 0.0 111.578 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -161.73 83.77 1.75 Allowed Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -46.99 119.25 3.26 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 121.341 1.361 . . . . 0.0 110.407 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.602 ' HB2' HG21 ' A' ' 103' ' ' VAL . 37.7 Cg_endo -68.47 -18.61 43.57 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 120.875 1.05 . . . . 0.0 110.856 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.76 147.86 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -158.75 164.86 35.47 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 119.991 -0.683 . . . . 0.0 109.526 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 67.1 m -86.87 120.76 28.5 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.164 0.507 . . . . 0.0 111.15 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.2 ttm-85 -112.03 111.88 53.14 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.044 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo . . . . . 0 N--CA 1.494 1.543 0 C-N-CA 122.126 1.884 . . . . 0.0 112.292 -179.614 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.432 HG11 ' HG2' ' A' ' 37' ' ' PRO . 7.4 p -88.55 146.44 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 CA-C-O 121.679 0.752 . . . . 0.0 111.079 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.05 149.65 24.99 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 177.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.441 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 56.0 mp0 -61.23 -42.3 98.37 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.768 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.6 m -57.73 -46.92 83.79 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.364 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -63.07 -34.08 76.83 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.87 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.697 HD23 HG13 ' A' ' 22' ' ' VAL . 11.7 tp -55.83 -38.66 70.32 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.605 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.3 mptp? -61.22 -42.52 98.75 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.757 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.57 -37.21 86.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.362 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.784 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -66.01 -37.01 84.82 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.149 -177.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.6 m -119.43 28.91 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.658 0.266 . . . . 0.0 111.213 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 96.2 p -64.95 -22.66 67.03 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -74.71 -15.5 60.78 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.921 -178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -71.09 152.25 43.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.016 0.436 . . . . 0.0 111.437 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -75.47 -29.22 59.53 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.12 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.407 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 35.7 m-85 -117.94 61.77 0.76 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.148 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.0 ptt-85 -64.65 -29.62 70.63 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.98 -44.03 70.25 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tp -74.74 -41.28 60.42 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 119.392 -0.923 . . . . 0.0 109.813 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 25' ' ' THR . 96.0 m -61.19 -47.99 83.62 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.616 0.246 . . . . 0.0 111.154 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.697 HG13 HD23 ' A' ' 8' ' ' LEU . 14.2 t -61.32 -45.49 98.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.596 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.397 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -63.4 -43.0 98.81 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.653 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.59 -36.28 83.3 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.682 -179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.657 ' O ' HG23 ' A' ' 29' ' ' ILE . 40.7 p -67.31 -38.58 85.21 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.543 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -57.44 -43.43 82.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -60.05 -41.3 92.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.101 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 124' ' ' LEU . 77.5 t -68.85 -43.07 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.657 HG23 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -87.56 -15.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.452 -178.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 98.3 m -85.04 -46.95 10.69 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.128 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.9 tp -83.14 -35.88 25.21 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.259 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -115.47 68.4 0.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.039 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -57.03 -20.84 26.67 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.091 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -65.15 -22.02 66.86 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.685 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.543 HD13 HD12 ' A' ' 128' ' ' ILE . 1.4 tp -93.17 115.2 27.84 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm -111.11 133.59 21.28 Favored Pre-proline 0 C--N 1.357 0.904 0 CA-C-N 119.713 1.142 . . . . 0.0 111.937 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 97.5 Cg_endo -79.69 133.01 10.13 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 121.194 1.263 . . . . 0.0 112.028 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -126.93 134.27 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.784 HD13 ' SD ' ' A' ' 11' ' ' MET . 24.4 tp -81.82 113.89 20.07 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -123.64 137.36 54.74 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 83.1 p -71.63 148.02 46.97 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -133.09 134.59 44.48 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.599 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 78.5 t -119.43 126.42 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.2 179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -96.71 164.22 12.67 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.863 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 -64.73 -19.4 65.76 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -85.83 3.55 41.08 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.186 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.53 -5.96 81.79 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.509 -0.637 . . . . 0.0 111.509 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.4 t -71.18 142.21 50.67 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.168 0.509 . . . . 0.0 109.951 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.0 m -124.96 145.94 49.62 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.643 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -158.98 140.37 13.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.145 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.492 ' HG3' HD11 ' A' ' 39' ' ' LEU . 8.0 tp10 -83.37 106.43 15.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.213 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 52' ' ' LEU . 70.2 mt -114.26 140.64 48.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.401 0.62 . . . . 0.0 110.927 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.499 ' SD ' HD11 ' A' ' 8' ' ' LEU . 57.7 ttp -84.41 148.83 26.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.321 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.517 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 4.5 t30 -124.74 161.34 26.61 Favored 'General case' 0 C--O 1.218 -0.555 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.991 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.525 ' HA ' HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -119.15 112.78 19.94 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.9 m -138.58 139.94 38.82 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.45 -143.66 8.26 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.761 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.8 p -134.9 159.19 42.2 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.438 HD13 HG21 ' A' ' 59' ' ' ILE . 1.2 pt -130.8 115.74 16.89 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.283 177.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -73.14 125.06 10.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 N-CA-C 109.405 -1.037 . . . . 0.0 109.405 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 94.0 t -126.97 121.86 23.05 Favored Pre-proline 0 C--O 1.24 0.605 0 C-N-CA 119.834 -0.746 . . . . 0.0 112.285 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.27 146.49 51.16 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 122.074 1.85 . . . . 0.0 110.287 178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -162.74 107.9 1.15 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.201 -0.6 . . . . 0.0 112.102 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.77 37.92 25.11 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 120.551 -0.46 . . . . 0.0 112.205 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.17 -0.77 82.95 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -118.5 138.26 52.63 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.2 m -121.35 132.56 54.84 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.483 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -115.96 149.58 38.55 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.121 0.486 . . . . 0.0 111.261 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -94.88 100.47 12.34 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.442 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -87.67 115.35 62.66 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 120.183 -0.607 . . . . 0.0 112.237 -177.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.64 127.87 4.45 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.753 2.302 . . . . 0.0 111.158 177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.442 HG23 HG22 ' A' ' 70' ' ' ILE . 25.1 pt -135.27 148.7 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.411 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 93.1 m -116.62 124.23 49.27 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.354 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.53 112.25 24.04 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.204 -178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.517 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 70.1 m95 -96.03 130.25 43.08 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.224 177.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.25 134.64 41.82 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 tp -94.16 143.82 26.04 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.87 -16.86 0.47 Allowed 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.37 9.97 40.91 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 120.421 -0.512 . . . . 0.0 112.316 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -65.7 143.49 98.59 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 178.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.425 ' HG2' ' CE1' ' A' ' 119' ' ' HIS . 25.2 Cg_endo -92.0 3.36 63.15 Favored 'Cis proline' 0 N--CA 1.517 2.865 0 CA-C-N 121.033 1.405 . . . . 0.0 115.256 1.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.407 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 17.2 m-85 -69.78 -21.02 63.45 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.465 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -106.37 118.92 53.48 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -49.52 135.99 33.25 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 CA-C-N 121.182 1.458 . . . . 0.0 111.423 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.51 140.86 17.29 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.817 1.678 . . . . 0.0 111.199 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -79.78 152.89 4.63 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.155 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 13.1 t -140.93 140.37 34.46 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.093 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -131.32 129.72 41.8 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.771 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -84.59 134.77 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -100.17 101.2 13.68 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 119.424 -0.322 . . . . 0.0 110.647 -178.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -90.15 127.57 1.47 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.874 1.716 . . . . 0.0 113.197 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.3 p -77.19 172.54 13.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.8 p -55.86 -28.64 57.46 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.9 m -95.64 -2.2 48.64 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.945 0.793 . . . . 0.0 111.579 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 52.9 tpp -93.25 134.35 35.53 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 85.1 m -108.16 133.22 52.73 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.79 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.555 HG23 ' O ' ' A' ' 97' ' ' ILE . 2.5 tp -93.95 109.07 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.08 0.467 . . . . 0.0 109.816 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.8 tttm -92.85 100.13 12.66 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.673 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 74.0 p -66.91 148.44 51.94 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.985 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -172.96 -150.6 7.49 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -68.26 -20.44 64.79 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 47.3 m170 -115.35 -30.38 6.28 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 119.028 0.831 . . . . 0.0 113.008 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.581 HG21 ' HB2' ' A' ' 140' ' ' PRO . 4.1 t -100.78 138.36 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 CA-C-N 119.24 0.927 . . . . 0.0 110.58 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.407 ' O ' HG12 ' A' ' 103' ' ' VAL . 18.2 t0 -93.85 -169.72 2.16 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.421 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.59 -30.94 22.91 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -92.08 0.34 57.46 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.993 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 105.84 6.02 37.97 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.104 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.2 mtpm? -64.04 148.46 49.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.693 0.747 . . . . 0.0 110.181 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.432 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 84.1 mt -116.44 122.82 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.872 0.368 . . . . 0.0 110.718 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.62 121.22 44.22 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.408 ' CD2' HG11 ' A' ' 134' ' ' VAL . 1.2 mt -126.98 116.52 22.04 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.945 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -48.98 -36.88 35.93 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 121.581 1.521 . . . . 0.0 113.69 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.58 -31.51 71.56 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 119.868 -0.733 . . . . 0.0 109.477 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.6 tt -69.46 -41.71 75.86 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 110.89 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -65.57 -28.47 69.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.017 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -109.84 3.77 21.02 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 120.359 -0.537 . . . . 0.0 111.679 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.403 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.1 t90 -64.84 125.03 23.54 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.038 0.923 . . . . 0.0 110.076 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -95.81 127.1 41.54 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.83 -1.532 . . . . 0.0 108.816 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.425 ' CE1' ' HG2' ' A' ' 81' ' ' PRO . 79.2 t60 -81.28 126.65 76.18 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 119.026 -0.512 . . . . 0.0 110.514 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -109.4 91.39 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.674 0 CA-C-N 120.677 1.277 . . . . 0.0 112.453 -2.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.3 -62.75 1.54 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 t -67.74 -37.26 81.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.699 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 51.4 175.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.061 0.934 . . . . 0.0 112.143 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.1 tt -62.94 -44.33 96.35 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.66 -1.155 . . . . 0.0 109.821 -179.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.503 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -53.6 -38.71 64.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.483 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.64 -39.63 98.14 Favored Glycine 0 N--CA 1.482 1.704 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 178.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.4 tp -58.25 -40.65 82.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 122.435 -0.45 . . . . 0.0 111.829 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.543 HD12 HD13 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -74.34 -48.16 37.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.948 -176.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.43 ' OE1' HG21 ' A' ' 132' ' ' ILE . 9.3 tp-100 -68.77 -35.15 76.7 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 126' ' ' GLY . 63.4 t -67.92 -40.07 82.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 178.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.5 ttm -58.39 -42.8 87.92 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.438 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -61.17 -41.12 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.475 178.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 54.6 t -81.26 -47.73 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.476 HG13 ' CD2' ' A' ' 135' ' ' PHE . 4.6 p -66.7 -14.45 17.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.501 -178.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.476 ' CD2' HG13 ' A' ' 134' ' ' VAL . 15.4 m-30 -106.91 -20.12 13.42 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.358 177.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.7 -35.2 91.64 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 108.187 -1.965 . . . . 0.0 108.187 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -64.16 -37.31 86.99 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.162 -0.519 . . . . 0.0 111.957 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -154.56 83.96 3.95 Favored Pre-proline 0 N--CA 1.451 -0.393 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.139 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -45.35 117.59 1.74 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.689 1.593 . . . . 0.0 110.939 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.581 ' HB2' HG21 ' A' ' 103' ' ' VAL . 59.7 Cg_endo -74.71 -4.97 16.23 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.504 1.469 . . . . 0.0 111.4 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 26.7 m -120.46 157.38 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.708 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -150.96 140.67 21.74 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.247 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.5 m -84.05 112.35 20.13 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.833 0.349 . . . . 0.0 110.677 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -111.42 109.38 56.26 Favored Pre-proline 0 N--CA 1.446 -0.657 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.228 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 N--CA 1.494 1.556 0 C-N-CA 121.916 1.744 . . . . 0.0 112.376 -179.732 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.6 t -79.16 130.93 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.659 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -94.54 156.54 16.4 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.8 mt-10 -63.3 -40.91 98.66 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.111 -1.035 . . . . 0.0 111.329 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -60.18 -47.21 86.92 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 122.237 1.018 . . . . 0.0 108.633 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -63.11 -30.64 71.75 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.38 178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.901 HD23 HG13 ' A' ' 22' ' ' VAL . 38.7 tp -58.86 -41.05 86.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 10.8 mptt -60.5 -41.84 95.13 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 120.286 -0.566 . . . . 0.0 110.657 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.35 -37.09 82.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.354 0.597 . . . . 0.0 110.621 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.761 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -68.9 -36.28 77.86 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.566 -178.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.71 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.0 m -113.61 20.91 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.61 -178.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.7 t -68.85 -4.48 16.46 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.706 -0.224 . . . . 0.0 111.353 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HD3' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -103.98 -11.19 17.56 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.705 ' CE1' HG12 ' A' ' 12' ' ' VAL . 17.9 m-85 -67.65 160.12 28.59 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.883 0.373 . . . . 0.0 110.675 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -70.88 -39.43 72.84 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.705 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.16 74.15 1.02 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 116.813 -0.176 . . . . 0.0 110.965 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -72.12 -21.61 61.45 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -79.19 -47.63 15.66 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.754 -0.592 . . . . 0.0 111.864 -177.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 tp -70.15 -40.6 74.68 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.478 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 83.2 m -60.93 -48.09 83.42 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.55 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.901 HG13 HD23 ' A' ' 8' ' ' LEU . 30.8 t -62.83 -45.49 98.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-O 120.666 0.269 . . . . 0.0 110.899 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.27 -41.63 97.26 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 119.409 -0.917 . . . . 0.0 110.135 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -37.76 84.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.742 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.632 ' O ' HG23 ' A' ' 29' ' ' ILE . 13.6 p -66.28 -33.73 76.4 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.437 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.2 t -59.65 -45.45 94.28 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.875 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.286 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -61.66 -38.76 88.94 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.913 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.71 -46.43 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -86.66 -21.21 7.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 C-N-CA 119.075 -1.05 . . . . 0.0 111.475 -178.493 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 79.8 m -70.91 -40.87 71.9 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.069 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -88.09 -36.56 16.85 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.448 179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -117.75 69.63 0.78 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -57.8 -19.68 30.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.703 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -65.47 -19.17 65.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.412 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.7 tp -90.15 116.6 28.28 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 178.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -112.32 132.72 21.99 Favored Pre-proline 0 C--N 1.358 0.97 0 CA-C-N 120.1 1.318 . . . . 0.0 111.775 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.04 135.63 11.2 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.588 1.525 . . . . 0.0 112.973 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 92.6 t -129.66 136.56 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.119 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.761 HD13 ' SD ' ' A' ' 11' ' ' MET . 16.0 tp -82.74 125.19 30.98 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.95 158.89 24.85 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.033 0.444 . . . . 0.0 111.149 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.7 m -97.01 125.17 41.25 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -110.42 133.29 53.42 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.592 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 79.8 t -119.6 125.36 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.292 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -97.05 171.1 8.69 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.622 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -60.56 -39.03 86.46 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.021 -0.272 . . . . 0.0 110.805 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -67.47 -8.94 37.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.862 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.03 -10.21 74.91 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.1 t -62.43 141.55 58.31 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 93.6 p -116.19 150.54 37.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.989 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -160.41 134.02 6.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.115 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.27 113.79 10.74 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.706 0.765 . . . . 0.0 110.347 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.485 HD21 ' O ' ' A' ' 76' ' ' LEU . 20.0 tp -111.5 123.05 49.43 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -83.34 143.46 30.33 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.899 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.412 ' OD1' ' HA ' ' A' ' 75' ' ' TRP . 0.7 OUTLIER -132.87 160.33 37.28 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.041 0.448 . . . . 0.0 111.738 -178.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.0 mt -111.44 117.66 33.66 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -132.8 137.49 46.8 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.97 -146.19 10.79 Favored Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.375 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.9 p -134.41 159.16 41.93 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.88 116.6 18.09 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.229 177.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -67.11 123.32 10.77 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 N-CA-C 109.527 -0.99 . . . . 0.0 109.527 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.03 118.04 22.07 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.991 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.93 149.58 77.71 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.991 1.794 . . . . 0.0 111.315 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -162.8 111.98 1.36 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.935 -178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 45.85 45.03 11.51 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.3 -4.55 76.61 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.683 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -118.93 162.26 18.81 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.6 m -129.35 130.03 45.54 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.787 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -106.0 144.73 32.3 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.579 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.03 103.29 14.81 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.534 HG22 HG23 ' A' ' 72' ' ' ILE . 1.5 mp -91.18 117.35 67.81 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -177.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -85.1 124.46 2.9 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 123.023 2.482 . . . . 0.0 110.214 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.534 HG23 HG22 ' A' ' 70' ' ' ILE . 27.9 pt -135.82 150.11 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 118.955 -1.098 . . . . 0.0 112.56 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.1 m -121.55 124.77 45.2 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.215 177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 mp -103.13 107.58 18.44 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.436 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.459 ' HE3' HD23 ' A' ' 52' ' ' LEU . 86.1 m95 -96.06 125.63 40.73 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.485 ' O ' HD21 ' A' ' 52' ' ' LEU . 67.8 mt -95.21 129.89 42.15 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.804 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 mt -73.72 149.99 41.49 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -59.47 -14.05 11.1 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.433 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.89 -8.74 36.33 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.404 ' OH ' HD12 ' A' ' 124' ' ' LEU . 25.8 t80 -53.92 145.83 30.91 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -91.4 12.11 55.99 Favored 'Cis proline' 0 N--CA 1.513 2.668 0 CA-C-N 120.682 1.279 . . . . 0.0 115.187 0.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -73.23 -12.97 61.05 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.539 -0.864 . . . . 0.0 109.724 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -121.23 129.53 25.22 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.068 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_exo -49.38 138.18 30.6 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 CA-C-N 121.591 1.604 . . . . 0.0 111.844 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -80.48 144.05 15.7 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 122.056 1.837 . . . . 0.0 111.473 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.2 mt -96.47 135.98 28.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-O 121.308 0.575 . . . . 0.0 110.118 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.428 ' SG ' HD12 ' A' ' 109' ' ' ILE . 48.9 t -111.99 149.29 32.2 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.611 -178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -133.85 126.53 30.69 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.623 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.1 t -84.95 123.5 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.81 108.48 2.71 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-O 119.05 -0.5 . . . . 0.0 109.901 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -87.77 155.89 7.47 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.619 1.546 . . . . 0.0 113.455 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.7 p -137.59 163.88 30.13 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.2 p -59.63 -26.77 65.77 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 119.96 -0.696 . . . . 0.0 112.863 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.7 p -90.74 -3.19 57.64 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 118.961 0.8 . . . . 0.0 111.244 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 41.4 ttm -124.11 142.05 51.53 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.23 159.16 35.17 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.836 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 85.8 mt -96.04 101.88 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -96.15 111.88 23.79 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.1 p -61.51 141.67 57.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.315 0.579 . . . . 0.0 111.392 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.37 -135.42 2.57 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.342 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -88.27 -3.33 58.87 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.442 ' HA ' ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -138.4 -33.52 0.67 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 119.218 0.917 . . . . 0.0 112.446 179.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.62 138.59 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.375 0.989 . . . . 0.0 110.429 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -96.17 -161.51 0.87 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.375 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.91 -35.82 23.79 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 120.024 -0.671 . . . . 0.0 112.681 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -83.16 -1.79 53.84 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.546 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 101.07 8.51 47.53 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.504 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.4 mttm -62.51 137.49 58.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.365 0.583 . . . . 0.0 111.033 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.428 HD12 ' SG ' ' A' ' 87' ' ' CYS . 60.2 mt -114.63 113.22 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.442 ' CZ ' ' HA ' ' A' ' 102' ' ' HIS . 53.3 p90 -113.46 139.82 48.61 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.302 -1.369 . . . . 0.0 107.302 177.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.427 HD11 HG22 ' A' ' 109' ' ' ILE . 1.3 mp -133.15 130.55 21.35 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.462 -176.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -46.35 -39.91 22.0 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 121.664 1.576 . . . . 0.0 114.277 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -62.97 -31.3 72.39 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.863 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.08 -42.48 76.14 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.632 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -69.08 -28.49 66.56 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.026 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -95.46 -6.15 41.39 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.446 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -57.85 126.99 29.81 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 121.912 0.863 . . . . 0.0 110.656 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.2 mtpt -104.63 102.96 12.54 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 113.98 -1.464 . . . . 0.0 108.435 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 60.5 t60 -60.88 123.91 77.26 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 119.089 -0.481 . . . . 0.0 110.038 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 5.8 Cg_endo -108.27 91.9 0.03 OUTLIER 'Cis proline' 0 N--CA 1.499 1.836 0 CA-C-N 120.704 1.287 . . . . 0.0 113.211 -2.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -112.98 -60.59 1.86 Allowed 'General case' 0 C--O 1.234 0.278 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.423 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.0 t -67.48 -41.83 83.93 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.53 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 69.67 159.22 0.18 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.04 0.448 . . . . 0.0 111.634 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 124' ' ' LEU . 5.0 tt -59.99 -44.68 94.36 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 63.0 tp -53.8 -33.04 54.83 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.45 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -63.6 -40.67 98.9 Favored Glycine 0 CA--C 1.538 1.49 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.2 tp -60.69 -39.68 89.37 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.93 -44.08 24.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.903 -177.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -68.68 -37.0 79.26 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 126' ' ' GLY . 64.9 t -68.11 -42.93 85.4 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 C-N-CA 118.992 -1.083 . . . . 0.0 108.518 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.5 ttm -55.97 -44.89 78.96 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.409 HG22 HG23 ' A' ' 133' ' ' VAL . 1.0 OUTLIER -54.81 -32.26 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.043 178.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.409 HG23 HG22 ' A' ' 132' ' ' ILE . 63.0 t -94.46 -48.98 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 119.556 -0.857 . . . . 0.0 113.118 -178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.4 p -80.33 -11.11 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -93.52 -13.22 28.06 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.427 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -95.23 -5.2 60.76 Favored Glycine 0 CA--C 1.533 1.173 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -65.99 -36.05 82.25 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 117.214 0.507 . . . . 0.0 110.428 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -157.26 82.79 3.07 Favored Pre-proline 0 N--CA 1.452 -0.336 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -44.82 106.58 0.09 OUTLIER 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.563 1.508 . . . . 0.0 111.365 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.03 -12.0 31.54 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.835 1.69 . . . . 0.0 111.282 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.6 m -127.15 146.94 32.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.869 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -160.05 160.41 33.15 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.521 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.2 m -89.5 121.52 31.79 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 120.897 0.379 . . . . 0.0 110.454 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -112.08 121.74 38.65 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.781 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo . . . . . 0 N--CA 1.497 1.684 0 C-N-CA 121.703 1.602 . . . . 0.0 112.158 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.4 p -60.42 140.33 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.561 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 p -101.77 156.61 17.4 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.509 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 94.5 mt-10 -62.71 -41.38 99.12 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 118.683 -1.207 . . . . 0.0 111.235 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.4 t -60.17 -46.17 90.6 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.941 0.876 . . . . 0.0 109.327 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -65.78 -28.4 68.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.059 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.985 HD23 HG13 ' A' ' 22' ' ' VAL . 59.3 tp -61.83 -39.61 92.42 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.509 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -65.42 -40.72 93.68 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.987 178.276 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -60.96 -37.15 81.38 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.47 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.567 ' SD ' HD12 ' A' ' 8' ' ' LEU . 19.8 ptp -76.14 -11.47 59.94 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.047 -0.661 . . . . 0.0 112.547 -178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 8' ' ' LEU . 10.2 m -142.35 31.71 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.459 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 85.5 p -72.01 -24.7 61.6 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.225 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.96 -13.51 55.86 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.792 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -60.0 151.49 26.21 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.972 0.415 . . . . 0.0 110.744 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -70.51 -37.49 74.15 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.445 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 21.3 m-85 -114.66 65.68 0.68 Allowed 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.3 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.522 ' O ' HG23 ' A' ' 22' ' ' VAL . 15.9 ptt180 -64.91 -34.11 77.61 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.57 -42.08 83.15 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.85 -38.79 61.89 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 119.049 -1.06 . . . . 0.0 109.825 -179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.596 ' O ' HG23 ' A' ' 25' ' ' THR . 66.1 m -61.68 -43.27 99.18 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.408 178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.985 HG13 HD23 ' A' ' 8' ' ' LEU . 79.5 t -72.7 -46.14 54.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.176 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.94 -42.09 97.43 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 119.728 -0.789 . . . . 0.0 111.345 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' HG23 ' A' ' 28' ' ' VAL . 1.7 pp20? -69.1 -30.99 69.41 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.706 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.66 ' O ' HG23 ' A' ' 29' ' ' ILE . 24.0 p -70.39 -39.36 74.56 Favored 'General case' 0 CA--C 1.503 -0.843 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.969 178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 30' ' ' THR . 55.4 t -56.29 -45.57 81.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.879 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.77 -39.5 91.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.645 178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 24' ' ' GLU . 63.9 t -66.17 -43.59 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -83.8 -13.67 11.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.412 -178.594 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 26' ' ' VAL . 7.9 p -82.99 -51.04 7.93 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.419 0.628 . . . . 0.0 109.786 177.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.2 tp -81.38 -37.67 27.82 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.466 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -113.92 68.62 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mtmt -58.63 -19.85 42.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.825 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -65.11 -21.12 66.76 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.244 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.481 ' CD2' HD13 ' A' ' 55' ' ' LEU . 2.8 tp -93.16 113.96 26.34 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -109.94 126.97 27.91 Favored Pre-proline 0 C--N 1.356 0.866 0 CA-C-N 119.385 0.993 . . . . 0.0 112.157 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.94 134.68 10.77 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 121.553 1.502 . . . . 0.0 112.88 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.4 t -124.07 135.33 63.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.504 HD13 ' CB ' ' A' ' 11' ' ' MET . 21.6 tp -82.84 118.32 23.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.6 136.23 53.04 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.918 0.389 . . . . 0.0 110.787 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 66.1 p -84.35 119.11 24.71 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -99.83 136.37 39.84 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.283 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.8 t -111.48 123.61 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.512 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -101.56 165.19 11.37 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.424 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -60.2 -36.88 78.65 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.631 0.253 . . . . 0.0 111.317 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.83 -18.47 62.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.482 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.96 -8.96 61.46 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 48.5 t -73.86 146.88 43.77 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.122 0.486 . . . . 0.0 110.31 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 98.1 p -104.85 155.99 18.42 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.539 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.06 135.96 13.71 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.537 0.684 . . . . 0.0 110.529 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -79.56 106.52 11.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.849 -1.069 . . . . 0.0 111.027 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.4 tp -116.54 121.45 41.8 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 12.8 tmm? -91.77 136.38 33.19 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.643 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -127.32 150.82 49.42 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 120.311 -0.555 . . . . 0.0 110.887 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.481 HD13 ' CD2' ' A' ' 35' ' ' LEU . 8.0 mt -99.73 123.05 43.6 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.5 m -133.7 137.14 45.13 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -177.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.76 -149.37 13.73 Favored Glycine 0 C--N 1.338 0.66 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.738 179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.413 HG21 ' OD1' ' A' ' 69' ' ' ASN . 19.6 p -133.98 159.77 39.74 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.443 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.3 pt -134.22 116.3 13.16 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.998 177.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -74.5 126.93 10.63 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 120.908 1.072 . . . . 0.0 110.394 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.63 118.56 15.75 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 119.376 -0.93 . . . . 0.0 112.369 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -62.62 149.7 90.23 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 C-N-CA 122.282 1.988 . . . . 0.0 110.257 177.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.421 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.5 OUTLIER -162.7 107.51 1.14 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.201 0.524 . . . . 0.0 111.686 -178.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.6 ttm-85 52.3 38.82 25.9 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 120.338 -0.545 . . . . 0.0 112.105 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.81 -0.61 81.78 Favored Glycine 0 CA--C 1.533 1.189 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -122.14 131.63 54.06 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.9 m -113.02 130.97 55.95 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.847 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -112.97 150.49 31.8 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.871 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.413 ' OD1' HG21 ' A' ' 58' ' ' THR . 5.3 t-20 -95.15 104.4 16.28 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.426 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -88.55 115.3 62.97 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -176.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -86.46 125.74 2.55 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.965 2.443 . . . . 0.0 110.958 177.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.426 HG23 HG22 ' A' ' 70' ' ' ILE . 31.9 pt -133.81 148.6 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.758 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 54.0 m -121.7 122.05 38.69 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-N 115.53 -0.759 . . . . 0.0 108.999 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.89 115.9 31.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.147 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -107.52 127.1 53.32 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.5 mt -94.56 135.69 35.72 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.207 -176.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mt -79.76 151.23 30.49 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -61.49 -13.01 17.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.122 -178.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.61 0.46 39.31 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.138 0.494 . . . . 0.0 111.397 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -55.93 146.24 49.52 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -93.51 7.83 56.48 Favored 'Cis proline' 0 N--CA 1.509 2.388 0 CA-C-N 120.765 1.309 . . . . 0.0 114.042 1.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.445 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 7.2 m-85 -70.3 -18.77 63.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.334 -0.946 . . . . 0.0 109.75 179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.93 137.77 19.89 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.31 140.95 66.4 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 CA-C-N 121.531 1.583 . . . . 0.0 111.196 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.21 142.86 12.32 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.236 1.958 . . . . 0.0 112.242 -179.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.5 mp -93.18 130.66 41.91 Favored 'Isoleucine or valine' 0 C--N 1.352 0.68 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.014 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.4 t -113.52 137.73 51.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.285 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -123.08 127.13 48.31 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.531 179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.58 121.96 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -63.11 108.43 1.73 Allowed Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 119.161 -0.447 . . . . 0.0 110.021 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -84.23 160.7 13.27 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 121.627 1.551 . . . . 0.0 113.04 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.8 p -142.54 165.1 28.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.789 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.6 p -58.21 -35.22 71.33 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 120.32 -0.552 . . . . 0.0 112.153 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 t -88.3 -22.28 23.97 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.748 -0.595 . . . . 0.0 110.814 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 41.1 tpp -89.12 135.87 33.33 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.968 0.413 . . . . 0.0 110.192 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 84.0 m -125.61 141.22 52.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.594 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.6 mt -90.05 105.82 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -89.6 102.78 15.46 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 104' ' ' ASP . 69.1 p -64.44 152.46 41.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.28 -179.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.44 -137.43 2.28 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.154 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -65.3 -23.98 67.16 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -177.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.519 ' NE2' HG23 ' A' ' 103' ' ' VAL . 10.5 p-80 -136.22 -16.85 1.61 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.719 HG21 ' HB2' ' A' ' 140' ' ' PRO . 6.8 t -100.32 132.09 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 119.508 1.049 . . . . 0.0 111.15 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.435 ' O ' HG22 ' A' ' 99' ' ' THR . 15.9 p-10 -93.21 -160.99 0.8 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.56 -21.26 25.51 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -89.72 -9.49 49.22 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.924 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 103.96 12.23 30.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.683 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -66.4 139.09 57.98 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.387 0.593 . . . . 0.0 109.952 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.5 mt -113.57 118.61 58.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 123.48 0.488 . . . . 0.0 111.752 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -102.49 140.13 37.18 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.667 HD22 HG11 ' A' ' 134' ' ' VAL . 27.8 mt -138.35 120.22 10.53 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.779 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.33 -38.95 27.28 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.357 1.371 . . . . 0.0 113.465 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.81 -30.63 71.63 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.491 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.33 -41.17 73.57 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.284 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -69.44 -22.77 63.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.167 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -112.63 9.75 19.38 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.97 178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.0 t90 -76.93 123.45 26.31 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.944 0.878 . . . . 0.0 109.729 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -93.72 124.91 38.03 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.843 -1.526 . . . . 0.0 108.821 178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 82.0 t60 -79.37 125.82 82.37 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.651 -179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 12.2 Cg_endo -108.32 92.84 0.04 OUTLIER 'Cis proline' 0 N--CA 1.497 1.717 0 CA-C-N 120.774 1.312 . . . . 0.0 112.529 -2.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -114.32 -61.75 1.7 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.361 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.3 t -68.51 -31.96 71.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.905 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 48.49 -178.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.811 0.815 . . . . 0.0 111.806 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.432 HD22 HG21 ' A' ' 28' ' ' VAL . 4.8 tt -68.36 -40.28 81.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.747 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.465 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.1 OUTLIER -54.28 -40.99 68.37 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.475 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.39 -39.46 97.79 Favored Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 178.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 41.6 tp -58.69 -41.38 86.11 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.437 HD12 HD13 ' A' ' 35' ' ' LEU . 1.2 mm -72.85 -48.88 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 119.884 -0.727 . . . . 0.0 112.063 -176.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -66.41 -35.59 80.68 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 126' ' ' GLY . 53.4 t -68.47 -38.19 78.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.735 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 60.8 tpp -58.8 -42.49 89.22 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.443 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -61.71 -34.81 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.912 179.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 70.8 t -90.83 -45.12 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.667 HG11 HD22 ' A' ' 111' ' ' LEU . 6.2 p -66.05 -15.63 19.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.88 -177.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.414 ' CD2' HG13 ' A' ' 134' ' ' VAL . 12.0 m-30 -104.41 -19.23 14.12 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.196 177.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.72 -36.99 93.03 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -64.5 -40.54 95.85 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.133 -0.533 . . . . 0.0 110.9 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -153.45 84.62 4.27 Favored Pre-proline 0 CA--C 1.52 -0.199 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -48.3 120.35 4.94 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 120.983 1.122 . . . . 0.0 110.138 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.719 ' HB2' HG21 ' A' ' 103' ' ' VAL . 47.6 Cg_endo -70.93 -21.29 28.24 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 121.493 1.462 . . . . 0.0 111.887 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 1.7 m -126.33 140.88 47.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.154 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -158.89 165.49 34.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.395 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.13 112.09 12.22 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 120.831 0.348 . . . . 0.0 110.821 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 50.5 ttm-85 -111.96 115.3 50.8 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.639 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo . . . . . 0 N--CA 1.497 1.708 0 C-N-CA 121.679 1.586 . . . . 0.0 112.072 179.745 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t -105.29 130.04 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.481 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.78 155.07 17.9 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.49 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 92.2 mt-10 -61.38 -43.19 99.29 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.254 -0.979 . . . . 0.0 112.017 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 t -58.47 -46.16 87.18 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.935 0.874 . . . . 0.0 108.984 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -62.9 -36.54 83.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.357 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.924 HD23 HG13 ' A' ' 22' ' ' VAL . 41.8 tp -55.73 -43.45 76.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.533 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 2.0 mptp? -61.3 -42.88 99.39 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.309 0.576 . . . . 0.0 109.528 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -61.1 -36.52 79.92 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.332 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.789 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -70.88 -37.72 73.03 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.723 -178.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.724 HG22 ' O ' ' A' ' 8' ' ' LEU . 3.3 m -112.12 24.37 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.736 0.303 . . . . 0.0 110.879 -179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.2 t -62.39 -37.87 87.42 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.022 0.439 . . . . 0.0 110.963 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -60.12 -21.91 62.16 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.601 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -63.88 157.57 24.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.112 0.482 . . . . 0.0 111.662 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.88 -37.9 54.63 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.621 177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CE1' ' CD1' ' A' ' 82' ' ' TYR . 14.8 m-85 -113.94 64.61 0.66 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.356 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -61.79 -25.64 67.6 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -76.59 -51.97 10.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp -66.04 -39.94 90.57 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 119.614 -0.834 . . . . 0.0 109.307 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.9 m -60.55 -47.56 85.65 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.166 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.924 HG13 HD23 ' A' ' 8' ' ' LEU . 12.6 t -66.24 -45.1 90.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.54 -41.92 98.06 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.485 -179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -67.51 -35.3 78.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.818 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 29' ' ' ILE . 22.2 p -67.65 -37.6 82.63 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.63 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.526 ' O ' HG23 ' A' ' 30' ' ' THR . 53.9 t -57.29 -45.61 85.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -37.63 80.08 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.5 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.692 HG21 HD22 ' A' ' 124' ' ' LEU . 54.7 t -68.89 -46.55 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -81.11 -13.76 12.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 119.166 -1.013 . . . . 0.0 111.169 -178.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.6 p -76.36 -50.96 12.87 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.045 0.45 . . . . 0.0 109.864 177.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.485 HD23 HD11 ' A' ' 125' ' ' LEU . 48.9 tp -82.37 -37.57 25.43 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.34 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -112.08 66.67 0.64 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 mtmm -55.59 -17.21 5.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.465 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -69.07 -15.19 63.39 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.176 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.477 ' CD2' HD13 ' A' ' 55' ' ' LEU . 2.6 tp -94.4 113.22 25.06 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -110.11 124.29 33.83 Favored Pre-proline 0 C--N 1.356 0.89 0 CA-C-N 119.474 1.034 . . . . 0.0 111.978 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -81.53 136.37 9.73 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 121.697 1.598 . . . . 0.0 113.202 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.04 156.34 42.68 Favored 'Isoleucine or valine' 0 C--N 1.345 0.412 0 CA-C-O 120.881 0.372 . . . . 0.0 110.397 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.789 HD13 ' SD ' ' A' ' 11' ' ' MET . 13.7 tp -92.28 118.69 31.14 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -124.43 132.81 53.51 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.321 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.8 p -76.86 137.38 39.14 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -118.81 136.34 54.05 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 120.565 -0.454 . . . . 0.0 109.962 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.6 t -114.85 127.01 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.048 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -105.99 168.44 9.13 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.852 0.358 . . . . 0.0 111.264 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -60.47 -37.29 80.55 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.937 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -63.34 -11.88 25.79 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.753 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.93 -13.06 67.87 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.6 t -74.45 145.87 43.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.5 p -128.52 153.65 46.96 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.904 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -152.58 137.95 17.57 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.542 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.83 118.81 19.03 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.303 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.8 mt -121.48 140.7 51.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.557 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -96.92 137.71 35.59 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.322 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -130.49 151.2 51.23 Favored 'General case' 0 C--N 1.345 0.382 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.457 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.477 HD13 ' CD2' ' A' ' 35' ' ' LEU . 5.4 mt -95.09 126.7 40.6 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.9 m -137.69 136.38 37.35 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.74 -147.11 11.55 Favored Glycine 0 N--CA 1.466 0.65 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.655 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.1 p -132.49 158.09 42.96 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.2 pt -129.9 117.03 18.14 Favored Pre-proline 0 N--CA 1.472 0.647 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.092 177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -72.23 123.49 9.24 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 119.947 1.017 . . . . 0.0 110.099 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.0 t -123.67 113.12 28.91 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 120.049 -0.66 . . . . 0.0 112.631 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -64.84 147.53 89.53 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 C-N-CA 122.228 1.952 . . . . 0.0 109.695 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -163.57 107.4 1.01 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 120.237 -0.585 . . . . 0.0 111.63 -178.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.51 43.35 27.25 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.068 0.461 . . . . 0.0 111.557 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 72.01 14.76 76.2 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -134.69 125.6 27.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 92.2 m -113.26 131.18 56.01 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.997 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -112.59 149.23 33.06 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.466 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.79 100.08 11.83 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.523 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -87.6 117.69 68.85 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.314 -177.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.81 123.81 2.9 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.453 2.102 . . . . 0.0 110.415 177.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.523 HG23 HG22 ' A' ' 70' ' ' ILE . 21.3 pt -131.6 147.12 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 119.057 -1.057 . . . . 0.0 112.349 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 67.4 m -121.08 123.12 41.57 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.205 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.33 109.62 21.31 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.144 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 40.6 m95 -99.49 125.35 45.22 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.1 mt -93.01 140.85 29.04 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.257 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -84.18 155.11 22.7 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -62.53 -17.19 59.27 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 121.132 -0.227 . . . . 0.0 110.908 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.25 3.51 40.95 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.986 0.422 . . . . 0.0 111.718 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -59.16 145.37 81.03 Favored Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HG2' ' CE1' ' A' ' 119' ' ' HIS . 22.5 Cg_endo -91.59 8.64 62.81 Favored 'Cis proline' 0 N--CA 1.519 2.99 0 CA-C-N 121.019 1.4 . . . . 0.0 115.246 1.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.414 ' CD1' ' CE1' ' A' ' 17' ' ' TYR . 22.6 m-85 -74.46 -13.02 60.64 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.436 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.2 129.56 24.45 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.564 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -49.67 134.34 33.65 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 CA-C-N 121.205 1.466 . . . . 0.0 112.169 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -80.15 146.16 17.73 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.037 1.825 . . . . 0.0 111.886 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.446 ' N ' HD13 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -95.49 151.42 3.92 Favored 'Isoleucine or valine' 0 C--N 1.35 0.624 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.79 -179.596 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.451 ' SG ' HD12 ' A' ' 109' ' ' ILE . 50.1 t -134.78 142.07 46.61 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.665 -178.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -127.09 131.21 50.91 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.086 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.408 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 57.6 t -97.44 123.62 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -76.37 106.26 3.09 Favored Pre-proline 0 N--CA 1.476 0.87 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.56 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 48.5 Cg_endo -90.61 128.66 1.42 Allowed 'Trans proline' 0 N--CA 1.488 1.165 0 CA-C-N 121.146 1.445 . . . . 0.0 113.548 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.5 p -81.15 168.95 17.99 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 88.1 p -59.27 -22.53 61.31 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 t -106.55 22.17 16.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.871 0.76 . . . . 0.0 110.946 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 42.5 ttm -133.52 144.73 49.57 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.43 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -131.22 163.71 27.16 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.864 179.526 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.43 ' N ' HG23 ' A' ' 96' ' ' THR . 5.7 mm -89.35 103.37 13.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.484 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -89.0 110.09 20.83 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.5 p -68.19 138.28 55.49 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.341 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.36 -141.82 3.54 Favored Glycine 0 CA--C 1.527 0.798 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.249 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -70.84 -23.93 62.43 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.418 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 38.4 p-80 -130.4 -16.79 3.43 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 -177.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.434 HG21 ' HB2' ' A' ' 140' ' ' PRO . 2.2 t -91.72 137.27 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.855 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -93.71 175.78 6.61 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.56 -39.07 93.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -91.15 4.78 51.33 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.11 10.27 49.28 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.99 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.4 mttp -67.82 140.96 56.62 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.451 HD12 ' SG ' ' A' ' 87' ' ' CYS . 62.7 mt -118.35 116.44 51.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 120.384 -0.526 . . . . 0.0 110.872 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.408 ' CE2' ' HA ' ' A' ' 102' ' ' HIS . 0.5 OUTLIER -116.88 142.94 46.28 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.637 HD23 HG11 ' A' ' 134' ' ' VAL . 1.8 mp -133.7 131.41 21.18 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.79 -177.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.1 -32.62 40.2 Favored 'Trans proline' 0 N--CA 1.5 1.886 0 C-N-CA 121.154 1.236 . . . . 0.0 113.693 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -65.76 -30.44 71.09 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.509 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.1 tt -69.92 -41.45 74.63 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.229 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -67.94 -28.03 67.12 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.227 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -102.35 0.56 34.29 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.338 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.412 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 2.7 t90 -69.37 124.16 23.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.959 0.885 . . . . 0.0 109.985 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -95.34 125.0 39.67 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.158 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.422 ' CE1' ' HG2' ' A' ' 81' ' ' PRO . 60.0 t60 -76.7 125.64 86.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.409 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -108.85 92.03 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.65 0 CA-C-N 120.937 1.37 . . . . 0.0 112.36 -2.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -114.12 -61.98 1.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.936 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 36.1 t -66.64 -40.75 88.84 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.794 0.331 . . . . 0.0 111.277 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 59.07 168.15 0.06 Allowed 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.787 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.692 HD22 HG21 ' A' ' 28' ' ' VAL . 6.7 tt -60.04 -42.1 93.7 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.69 -178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.556 HD23 ' O ' ' A' ' 125' ' ' LEU . 5.0 tt -52.63 -37.64 58.76 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.488 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -61.36 -39.31 97.08 Favored Glycine 0 N--CA 1.477 1.37 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.7 tp -60.51 -40.25 90.73 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -75.57 -48.85 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.644 -176.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.401 ' OE1' HG21 ' A' ' 132' ' ' ILE . 9.3 tp-100 -67.01 -35.48 80.03 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.616 ' O ' HG12 ' A' ' 134' ' ' VAL . 60.0 t -69.12 -39.7 79.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.414 ' HG3' ' CE1' ' A' ' 135' ' ' PHE . 51.7 ttm -57.85 -44.73 86.75 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.401 HG21 ' OE1' ' A' ' 129' ' ' GLN . 1.1 mp -61.0 -36.42 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.792 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -88.77 -47.27 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.637 HG11 HD23 ' A' ' 111' ' ' LEU . 5.4 p -66.75 -13.79 16.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.197 -178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.622 ' CD2' HG13 ' A' ' 134' ' ' VAL . 9.8 m-30 -101.83 -17.08 16.37 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 118.915 -1.114 . . . . 0.0 109.441 177.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.22 -26.74 71.74 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 108.312 -1.915 . . . . 0.0 108.312 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.96 -31.76 72.85 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.199 -0.501 . . . . 0.0 110.547 178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.8 tp10 -166.58 84.43 0.91 Allowed Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.257 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -46.6 121.83 5.2 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.225 1.283 . . . . 0.0 109.844 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.434 ' HB2' HG21 ' A' ' 103' ' ' VAL . 47.6 Cg_endo -70.13 -14.93 35.51 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.458 1.439 . . . . 0.0 112.427 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 m -131.42 151.2 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.245 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -154.36 160.56 41.76 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.1 112.42 19.14 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 120.911 0.386 . . . . 0.0 111.184 -178.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -112.35 108.69 54.49 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.863 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo . . . . . 0 N--CA 1.498 1.77 0 C-N-CA 122.036 1.824 . . . . 0.0 112.647 -179.854 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.4 t -105.22 129.9 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.581 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.34 155.13 17.03 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 92.3 mt-10 -62.16 -41.08 97.95 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.2 p -57.1 -48.45 78.58 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-O 122.054 0.93 . . . . 0.0 109.398 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -64.05 -30.8 71.84 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.518 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.866 HD23 HG13 ' A' ' 22' ' ' VAL . 13.3 tp -59.14 -39.07 81.24 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.764 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 12.0 mptt -59.56 -42.79 93.25 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 119.969 -0.692 . . . . 0.0 109.669 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.71 -25.48 64.79 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.996 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.728 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -80.92 -28.92 35.65 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.893 -178.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -116.6 23.83 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 120.903 0.382 . . . . 0.0 110.489 -179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.8 t -67.06 -39.04 86.8 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.153 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -62.03 -17.72 58.25 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.823 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.486 ' CE1' HG12 ' A' ' 12' ' ' VAL . 22.6 m-85 -69.6 158.87 34.47 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.671 -0.24 . . . . 0.0 110.478 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -88.86 -9.86 50.11 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.91 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -132.88 56.12 1.86 Allowed 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 119.532 -0.271 . . . . 0.0 110.302 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.425 ' O ' HG23 ' A' ' 22' ' ' VAL . 15.5 ptt180 -61.11 -32.43 72.11 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.539 0.941 . . . . 0.0 113.539 -177.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.33 -50.86 64.01 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.92 -41.96 73.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.099 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.2 m -61.51 -47.08 87.26 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 121.161 -0.216 . . . . 0.0 111.238 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.866 HG13 HD23 ' A' ' 8' ' ' LEU . 37.4 t -61.04 -46.51 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.634 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -60.32 -45.1 94.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.805 0.812 . . . . 0.0 110.586 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -68.23 -34.43 76.22 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.506 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.599 ' O ' HG23 ' A' ' 29' ' ' ILE . 5.6 p -67.81 -33.66 75.23 Favored 'General case' 0 CA--C 1.51 -0.573 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.408 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.57 -44.96 94.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 C-N-CA 118.951 -1.1 . . . . 0.0 108.167 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -60.87 -37.32 81.76 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.011 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.2 t -68.83 -45.63 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.599 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.88 -17.25 8.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.702 -178.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -76.8 -49.87 14.83 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.183 0.516 . . . . 0.0 109.709 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.819 HD23 HD21 ' A' ' 125' ' ' LEU . 38.9 tp -76.61 -39.91 51.03 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.643 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -113.85 67.77 0.68 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 ptmm? -53.75 -20.34 5.45 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.522 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -65.69 -21.33 66.53 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.57 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.1 tp -89.64 117.59 28.63 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -115.05 126.52 27.75 Favored Pre-proline 0 C--N 1.356 0.879 0 CA-C-N 119.618 1.099 . . . . 0.0 111.916 -177.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.51 135.1 14.41 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 CA-C-N 120.379 1.171 . . . . 0.0 112.232 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.4 t -125.17 136.64 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.728 HD13 ' SD ' ' A' ' 11' ' ' MET . 16.9 tp -85.15 116.32 23.45 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -119.48 133.69 55.57 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.107 0.479 . . . . 0.0 111.76 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.2 m -68.24 138.74 55.8 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -122.0 135.72 54.86 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.167 -0.613 . . . . 0.0 110.532 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 76.5 t -114.26 127.77 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.724 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -105.17 165.71 10.91 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.338 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.0 p-10 -65.64 -15.45 62.78 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -80.07 -10.38 59.76 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.057 -0.257 . . . . 0.0 110.798 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.42 -8.85 78.96 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.8 m -80.92 157.97 25.41 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 90.8 p -119.38 151.53 38.34 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.524 0.678 . . . . 0.0 111.448 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 -152.97 131.69 12.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.089 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -76.58 118.7 19.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.029 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.577 HD21 ' O ' ' A' ' 76' ' ' LEU . 19.6 tp -116.99 121.03 40.21 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.2 ttp -84.62 142.91 29.6 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.025 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -133.51 162.15 32.67 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.384 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.428 HD13 ' HA ' ' A' ' 55' ' ' LEU . 3.4 mm? -108.5 123.39 48.82 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 31.9 m -140.6 139.07 34.85 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.0 -148.59 14.93 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.187 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.6 p -132.67 161.02 35.04 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.822 -0.689 . . . . 0.0 112.334 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.416 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.4 pt -131.05 116.03 16.69 Favored Pre-proline 0 N--CA 1.471 0.623 0 CA-C-N 115.388 -0.824 . . . . 0.0 108.995 177.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.17 126.23 9.73 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 CA-C-N 119.689 0.925 . . . . 0.0 109.945 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.6 t -132.0 129.84 21.94 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 119.582 -0.847 . . . . 0.0 111.795 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.94 150.03 48.23 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.388 2.059 . . . . 0.0 110.876 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -163.97 112.04 1.16 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.971 0.415 . . . . 0.0 111.955 -178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 6.9 tpm_? 49.88 44.52 25.24 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.448 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.81 18.38 68.36 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -137.6 127.11 25.02 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.5 m -111.44 130.78 55.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.455 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -112.67 150.81 30.95 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.734 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -94.61 105.04 16.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.495 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -90.67 116.57 66.71 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -176.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -83.47 124.62 3.68 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.196 1.93 . . . . 0.0 110.849 177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.495 HG23 HG22 ' A' ' 70' ' ' ILE . 26.7 pt -132.32 148.0 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.958 179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 6.0 t -125.76 120.19 29.94 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.37 116.94 33.37 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.56 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.552 ' HE3' HD23 ' A' ' 52' ' ' LEU . 46.9 m95 -105.48 118.36 36.38 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 176.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.577 ' O ' HD21 ' A' ' 52' ' ' LEU . 59.0 mt -88.11 135.9 33.22 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.611 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -85.2 150.42 24.82 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -59.64 -15.32 18.24 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.315 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 p -100.75 7.77 43.63 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.541 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -66.46 144.05 98.49 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -92.08 3.88 63.09 Favored 'Cis proline' 0 N--CA 1.518 2.962 0 N-CA-C 116.13 1.55 . . . . 0.0 116.13 1.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -73.77 -17.12 61.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 119.467 1.031 . . . . 0.0 109.922 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.52 131.16 21.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 118.53 -0.748 . . . . 0.0 109.51 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -59.54 131.02 38.13 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 CA-C-N 121.319 1.507 . . . . 0.0 112.28 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.15 145.23 12.17 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.371 2.047 . . . . 0.0 111.545 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 mp -98.9 129.89 48.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.0 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . 0.461 ' SG ' HD12 ' A' ' 109' ' ' ILE . 42.7 t -110.82 144.08 40.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.627 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -126.53 127.4 45.25 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.438 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.53 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 71.7 t -82.44 137.36 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 tttp -93.87 96.12 1.55 Allowed Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.135 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 97.7 Cg_endo -78.9 160.98 27.25 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 C-N-CA 121.711 1.607 . . . . 0.0 112.794 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.407 HG22 ' HB2' ' A' ' 95' ' ' MET . 5.5 t -148.37 167.22 25.81 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.661 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 80.9 p -58.46 -27.59 64.52 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 62.6 m -94.06 6.54 48.2 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.974 0.806 . . . . 0.0 110.972 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.407 ' HB2' HG22 ' A' ' 92' ' ' THR . 82.8 mmm -130.99 144.1 51.22 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 76.3 m -121.44 145.04 48.33 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.568 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 97' ' ' ILE . 12.2 tt -113.25 122.22 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.32 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.65 98.22 6.91 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 60.1 p -55.23 140.72 37.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.695 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.11 -142.2 3.33 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.431 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -65.46 -25.49 67.53 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 37.9 m170 -119.03 -30.29 5.04 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 119.322 0.965 . . . . 0.0 113.207 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.4 t -96.4 134.21 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 119.313 0.961 . . . . 0.0 110.925 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -98.68 160.47 14.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.287 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.21 -37.12 85.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.053 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.31 -7.14 34.47 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.119 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.85 8.01 58.39 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.747 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.61 151.53 34.32 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.153 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.461 HD12 ' SG ' ' A' ' 87' ' ' CYS . 76.2 mt -109.18 122.03 63.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.481 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.44 ' HH ' ' CE1' ' A' ' 115' ' ' HIS . 0.9 OUTLIER -99.64 130.96 45.91 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.449 HD22 HG11 ' A' ' 134' ' ' VAL . 16.1 mt -134.33 108.37 11.27 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.89 -177.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -48.52 -34.26 25.73 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.971 1.781 . . . . 0.0 114.475 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -62.29 -29.24 70.29 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.337 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.58 -41.09 80.16 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.422 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.44 ' CE1' ' HH ' ' A' ' 110' ' ' TYR . 2.0 m-70 -65.81 -31.67 72.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.459 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -96.65 -8.4 31.69 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.336 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 11.2 t90 -54.1 124.83 16.82 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.898 0.856 . . . . 0.0 109.967 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -107.69 106.26 16.51 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.739 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 34.1 t-80 -58.23 123.55 66.09 Favored Pre-proline 0 C--N 1.318 -0.784 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.721 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 20.3 Cg_endo -109.63 91.74 0.03 OUTLIER 'Cis proline' 0 N--CA 1.494 1.549 0 CA-C-N 120.707 1.288 . . . . 0.0 112.496 -3.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.88 -62.66 1.56 Allowed 'General case' 0 C--O 1.232 0.149 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.4 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 66.8 m -67.8 -41.04 83.75 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.136 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 60.62 163.5 0.06 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.527 0.679 . . . . 0.0 111.53 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.55 HD23 ' O ' ' A' ' 124' ' ' LEU . 1.8 tt -60.24 -45.91 91.6 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.246 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.819 HD21 HD23 ' A' ' 31' ' ' LEU . 13.6 tp -54.68 -33.65 61.16 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -64.41 -40.54 97.86 Favored Glycine 0 N--CA 1.475 1.255 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 36.3 tp -58.01 -40.0 79.71 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -75.73 -47.16 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.745 -176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.427 ' OE1' HG21 ' A' ' 132' ' ' ILE . 7.6 tp-100 -66.73 -35.74 80.82 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 126' ' ' GLY . 54.5 t -67.19 -38.38 80.95 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 59.1 tpp -58.66 -44.06 90.02 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.427 HG21 ' OE1' ' A' ' 129' ' ' GLN . 0.9 OUTLIER -62.8 -35.05 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.744 179.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 62.3 t -86.3 -47.27 16.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 119.914 -0.714 . . . . 0.0 112.774 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.449 HG11 HD22 ' A' ' 111' ' ' LEU . 3.8 p -69.58 -13.68 17.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.221 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.404 ' HD1' HG13 ' A' ' 134' ' ' VAL . 4.2 m-30 -103.58 -16.34 15.55 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.646 177.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -84.58 -23.76 49.17 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -66.44 -29.22 69.3 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.349 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -161.55 84.25 1.76 Allowed Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.704 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -45.38 108.16 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 121.324 1.349 . . . . 0.0 110.925 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.11 -17.87 35.73 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 121.652 1.568 . . . . 0.0 110.982 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.28 138.41 54.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.458 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -160.35 160.59 32.56 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.577 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.6 m -93.11 129.5 39.06 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 120.961 0.41 . . . . 0.0 110.436 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 45.9 ttm-85 -112.97 103.46 55.67 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.06 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo . . . . . 0 N--CA 1.489 1.226 0 C-N-CA 121.875 1.717 . . . . 0.0 111.924 179.623 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.1 t -105.29 128.57 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.203 0.525 . . . . 0.0 110.617 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.3 t -98.28 153.98 18.13 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.55 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 37.2 mp0 -60.13 -42.6 95.16 Favored 'General case' 0 C--O 1.214 -0.795 0 C-N-CA 118.43 -1.308 . . . . 0.0 110.947 -178.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.8 m -53.38 -45.94 69.44 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.825 0.822 . . . . 0.0 109.651 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -63.5 -38.06 89.67 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.601 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.912 HD23 HG13 ' A' ' 22' ' ' VAL . 15.4 tp -55.08 -42.07 72.34 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.55 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 0.0 OUTLIER -59.67 -40.1 86.68 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -69.94 -32.43 70.7 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.05 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.831 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -73.55 -31.72 63.79 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.456 -178.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -115.36 20.76 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.687 0.28 . . . . 0.0 111.333 179.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -61.31 -37.94 85.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.365 0.602 . . . . 0.0 110.298 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -60.22 -21.15 61.46 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.612 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.417 ' OH ' HD22 ' A' ' 52' ' ' LEU . 37.0 m-85 -74.49 151.87 39.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.915 0.388 . . . . 0.0 111.889 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -70.93 -37.15 72.88 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.985 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.401 ' CZ ' ' CD1' ' A' ' 82' ' ' TYR . 39.1 m-85 -109.14 60.84 0.6 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 121.25 -0.18 . . . . 0.0 111.448 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.498 ' O ' HG23 ' A' ' 22' ' ' VAL . 9.0 ptp180 -67.37 -24.74 65.73 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -75.12 -50.0 17.76 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.93 -40.14 83.38 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.647 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.5 m -61.2 -46.73 89.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.247 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.912 HG13 HD23 ' A' ' 8' ' ' LEU . 41.5 t -61.85 -44.4 98.78 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 CA-C-O 120.821 0.343 . . . . 0.0 110.155 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -62.93 -41.6 99.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.209 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -66.42 -37.73 85.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.676 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.646 ' O ' HG23 ' A' ' 29' ' ' ILE . 38.7 p -66.19 -37.13 84.86 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.299 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.18 -45.08 84.51 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 C-N-CA 118.849 -1.14 . . . . 0.0 108.506 -179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -61.28 -37.83 84.57 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.251 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.57 HG21 HD22 ' A' ' 124' ' ' LEU . 79.9 t -71.27 -43.41 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 -178.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.05 -23.1 6.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.386 -178.035 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 99.1 m -72.19 -44.5 62.89 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.046 0.451 . . . . 0.0 110.264 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.738 HD23 HD11 ' A' ' 125' ' ' LEU . 23.9 tp -88.73 -40.68 13.06 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.417 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.55 67.3 0.65 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -56.83 -17.19 8.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.029 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -66.08 -14.6 62.02 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.59 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 tp -102.42 113.03 26.02 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.9 mtmm -110.07 137.12 20.45 Favored Pre-proline 0 C--N 1.36 1.024 0 CA-C-N 119.921 1.237 . . . . 0.0 112.182 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.13 139.92 10.89 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.004 1.803 . . . . 0.0 112.423 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.53 139.22 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.072 0.463 . . . . 0.0 109.794 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.831 HD13 ' SD ' ' A' ' 11' ' ' MET . 14.2 tp -83.74 122.41 28.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.175 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -129.7 140.61 51.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.981 0.42 . . . . 0.0 112.073 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.7 t -94.05 115.29 27.6 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.476 ' CD2' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -128.13 156.8 42.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 119.641 -0.824 . . . . 0.0 110.71 -178.202 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.7 t -100.37 124.44 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -72.67 166.72 22.25 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.778 177.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -60.89 -36.07 78.27 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.652 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.09 -18.22 63.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.224 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.97 -17.9 44.06 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.8 t -72.36 148.28 45.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 96.9 p -114.44 152.18 32.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.315 -179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -158.16 137.91 12.1 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.294 0.569 . . . . 0.0 111.389 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -67.62 118.51 10.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.395 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.476 HD12 ' CD2' ' A' ' 42' ' ' TYR . 14.9 mt -125.53 142.53 51.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.955 -178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 49.8 ttp -90.93 144.57 25.54 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.11 152.76 51.94 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.551 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.8 mt -104.41 117.89 35.29 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 88.5 m -132.32 136.79 47.13 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 169.26 -143.95 8.34 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.424 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.9 p -136.34 159.31 42.16 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.449 HD13 HG21 ' A' ' 59' ' ' ILE . 1.3 pt -131.27 116.03 16.43 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.031 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -72.32 125.85 11.13 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 120.867 1.044 . . . . 0.0 110.793 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 84.5 t -128.77 115.91 19.3 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.578 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -82.31 150.63 15.4 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 122.718 2.279 . . . . 0.0 112.224 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -164.02 115.05 1.32 Allowed 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.258 0.551 . . . . 0.0 111.229 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 50.95 39.44 22.84 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.862 -0.523 . . . . 0.0 112.119 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 0.79 90.05 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.139 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.412 ' ND2' ' CZ ' ' A' ' 68' ' ' TYR . 1.7 t30 -119.89 128.78 53.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.961 0.41 . . . . 0.0 109.896 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.2 m -119.26 132.04 55.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.502 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.412 ' CZ ' ' ND2' ' A' ' 66' ' ' ASN . 67.5 m-85 -115.75 150.88 36.17 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.916 0.388 . . . . 0.0 110.574 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.6 100.94 12.61 Favored 'General case' 0 C--O 1.231 0.091 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.489 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -87.37 116.98 67.92 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 120.168 -0.613 . . . . 0.0 112.464 -177.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -82.29 126.27 4.82 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 122.718 2.279 . . . . 0.0 110.687 177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.489 HG23 HG22 ' A' ' 70' ' ' ILE . 26.4 pt -133.35 147.96 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 118.943 -1.103 . . . . 0.0 112.502 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.6 m -121.89 123.42 41.69 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.365 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.07 109.92 21.89 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.42 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -96.08 128.98 43.46 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.8 mp -99.42 140.08 34.13 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.13 -177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.3 tp -95.14 140.56 29.9 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.71 -17.1 0.09 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -100.17 12.43 37.01 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -69.08 143.41 94.21 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -91.68 4.51 64.91 Favored 'Cis proline' 0 N--CA 1.516 2.806 0 CA-C-N 120.928 1.367 . . . . 0.0 114.501 0.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' CD1' ' CZ ' ' A' ' 17' ' ' TYR . 13.4 m-85 -67.73 -18.93 65.06 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.378 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.08 120.98 40.6 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.201 178.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -49.55 136.41 33.37 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 CA-C-N 121.235 1.477 . . . . 0.0 111.859 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -81.62 144.7 14.2 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.337 2.025 . . . . 0.0 111.277 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 mp -97.76 132.77 41.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 CA-C-O 121.591 0.71 . . . . 0.0 109.789 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 33.8 t -106.41 154.86 20.21 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 114.853 -1.067 . . . . 0.0 112.529 -177.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.1 128.76 30.75 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.053 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.63 ' CG2' HD11 ' A' ' 109' ' ' ILE . 58.9 t -98.05 124.13 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.0 mtmt -75.28 108.12 5.12 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.187 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -85.64 159.24 10.68 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.267 1.311 . . . . 0.0 112.454 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -129.24 164.86 22.55 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.0 m -58.6 -39.84 81.56 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.2 m -84.74 -0.68 54.54 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 118.85 0.75 . . . . 0.0 111.581 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 32.8 ttm -120.92 145.92 47.18 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.5 OUTLIER -131.39 163.07 28.7 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.588 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.444 ' N ' HG23 ' A' ' 96' ' ' THR . 72.4 mt -95.8 103.59 14.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -87.32 113.52 23.12 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.149 178.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.5 p -68.52 147.74 51.56 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.256 0.55 . . . . 0.0 110.479 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.87 -145.16 4.28 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -79.47 -7.53 58.5 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -133.11 -30.46 1.34 Allowed 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.14 0.882 . . . . 0.0 112.297 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 2.2 t -97.03 139.13 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.48 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -94.83 -174.61 3.32 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.661 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.32 -35.03 21.72 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -83.86 5.46 25.14 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.957 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 96.13 13.12 50.32 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.346 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -75.52 136.26 40.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.779 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.63 HD11 ' CG2' ' A' ' 89' ' ' VAL . 91.7 mt -110.8 114.98 48.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.39 140.86 49.2 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.624 HD23 HG11 ' A' ' 134' ' ' VAL . 1.6 mp -134.43 128.63 19.29 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.01 -176.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -49.02 -35.16 31.49 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 121.388 1.392 . . . . 0.0 113.384 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -32.42 71.92 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.23 -41.93 76.37 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.273 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -63.68 -31.06 72.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.016 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -108.42 9.95 27.53 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.769 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 7.7 t90 -65.57 127.25 31.13 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.688 0.756 . . . . 0.0 110.439 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -102.39 122.17 43.75 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.182 -1.372 . . . . 0.0 108.453 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 43.8 t60 -75.82 125.93 87.71 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.626 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 7.4 Cg_endo -109.85 91.27 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.718 0 CA-C-N 120.597 1.249 . . . . 0.0 112.626 -2.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -113.19 -59.65 1.99 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.538 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.403 ' O ' ' HA3' ' A' ' 126' ' ' GLY . 27.2 p -68.85 -34.74 75.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.616 -0.433 . . . . 0.0 111.138 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.6 p30 49.21 178.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.603 0.716 . . . . 0.0 111.613 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.57 HD22 HG21 ' A' ' 28' ' ' VAL . 1.5 tt -66.0 -40.59 91.28 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.379 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.738 HD11 HD23 ' A' ' 31' ' ' LEU . 2.9 tt -56.77 -40.36 75.73 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -60.86 -39.87 97.48 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 42.0 tp -58.69 -40.77 84.59 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 122.265 -0.55 . . . . 0.0 111.556 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -76.61 -48.89 25.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 120.096 -0.642 . . . . 0.0 112.314 -177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.4 tp60 -66.71 -34.0 76.87 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.618 ' O ' HG12 ' A' ' 134' ' ' VAL . 58.5 t -68.6 -38.33 78.9 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.768 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 48.7 tpp -58.9 -44.1 91.14 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 1.1 mp -61.64 -40.84 88.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.888 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 59.9 t -82.46 -47.86 18.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 120.002 -0.679 . . . . 0.0 112.543 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.624 HG11 HD23 ' A' ' 111' ' ' LEU . 4.2 p -66.75 -14.06 17.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.072 -178.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.472 ' CD1' HG13 ' A' ' 134' ' ' VAL . 11.8 m-30 -109.22 -18.43 13.61 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -64.29 -33.91 88.52 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -63.66 -34.91 78.9 Favored 'General case' 0 N--CA 1.46 0.07 0 CA-C-N 115.294 -0.453 . . . . 0.0 110.489 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -156.63 84.08 3.16 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.327 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -43.96 107.42 0.1 OUTLIER 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 121.679 1.586 . . . . 0.0 111.018 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.03 -24.23 47.77 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.105 1.87 . . . . 0.0 111.578 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 10.6 m -128.33 147.33 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.565 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -160.47 158.63 29.67 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.542 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.08 107.94 5.7 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -111.04 109.99 56.9 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.885 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo . . . . . 0 N--CA 1.496 1.629 0 C-N-CA 122.08 1.853 . . . . 0.0 112.317 -179.859 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -103.26 129.5 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.15 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.82 153.56 18.79 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.541 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 95.3 mt-10 -61.72 -42.17 98.59 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 118.681 -1.208 . . . . 0.0 111.099 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.0 t -56.78 -46.49 81.48 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 122.19 0.995 . . . . 0.0 108.649 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -61.18 -39.07 88.8 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.341 -1.3 . . . . 0.0 110.144 178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.784 HD23 HG13 ' A' ' 22' ' ' VAL . 27.6 tp -56.12 -42.19 76.47 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.6 mptp? -60.14 -40.65 90.57 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 178.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.37 -28.19 67.74 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.69 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.653 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -80.39 -30.51 37.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.99 -178.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -118.61 19.71 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 120.577 0.227 . . . . 0.0 111.387 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.5 t -61.05 -38.1 84.96 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.53 0.681 . . . . 0.0 110.306 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -60.2 -26.06 66.07 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.122 -177.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.686 ' OH ' HD22 ' A' ' 52' ' ' LEU . 40.3 m-85 -67.36 159.4 29.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.716 0.293 . . . . 0.0 110.941 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -80.33 -29.92 38.08 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.811 179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -116.89 58.04 0.78 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -63.59 -28.51 69.98 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.3 -47.41 61.26 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.1 tp -70.27 -40.25 74.45 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.501 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 25' ' ' THR . 98.8 m -62.94 -46.14 89.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.877 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.784 HG13 HD23 ' A' ' 8' ' ' LEU . 14.4 t -63.28 -45.6 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-O 120.695 0.283 . . . . 0.0 110.991 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -63.14 -43.52 98.11 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.154 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.2 tm-20 -66.68 -37.43 84.73 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.995 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.667 ' O ' HG23 ' A' ' 29' ' ' ILE . 28.1 p -64.76 -36.94 85.94 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.976 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.4 t -57.32 -45.03 85.12 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -60.98 -40.41 93.34 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 119.848 -0.741 . . . . 0.0 109.998 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -68.0 -43.6 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.38 -23.77 6.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.217 -178.05 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.5 m -74.48 -44.54 51.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.009 0.433 . . . . 0.0 110.595 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.663 ' O ' HD13 ' A' ' 31' ' ' LEU . 2.8 tm? -85.32 -36.61 20.7 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.666 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.86 68.38 0.72 Allowed 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -57.01 -19.39 18.12 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.539 -178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.81 -21.55 66.8 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.067 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.457 HD23 HD13 ' A' ' 55' ' ' LEU . 2.9 tp -90.24 113.32 25.11 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -108.98 125.12 32.3 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 119.439 1.018 . . . . 0.0 111.77 -178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.09 137.58 17.38 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.32 1.347 . . . . 0.0 112.102 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.18 143.99 37.66 Favored 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 120.968 0.414 . . . . 0.0 110.264 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.653 HD13 ' SD ' ' A' ' 11' ' ' MET . 17.5 tp -91.63 122.01 33.82 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.533 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -131.47 139.5 49.36 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.088 0.47 . . . . 0.0 111.965 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.4 t -68.82 136.22 52.37 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -121.06 138.16 54.31 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.163 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.8 t -111.12 126.1 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.221 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -95.38 161.48 14.06 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.625 179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 51.3 p30 -68.24 -13.24 62.1 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -88.42 -4.39 58.65 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 121.146 -0.222 . . . . 0.0 111.22 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.32 -13.01 68.26 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.2 t -72.39 142.68 48.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.0 t -116.73 141.31 48.37 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.214 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.3 ttp180 -148.19 137.73 22.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.641 179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -79.83 120.1 23.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.558 0.694 . . . . 0.0 110.623 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.686 HD22 ' OH ' ' A' ' 15' ' ' TYR . 39.8 mt -116.18 142.51 46.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.907 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -101.37 137.12 40.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.097 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -129.34 151.08 50.38 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.744 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.457 HD13 HD23 ' A' ' 35' ' ' LEU . 6.8 mt -95.16 122.34 37.73 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.2 m -133.65 136.02 44.52 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 166.81 -144.54 9.16 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.859 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.2 p -135.18 160.47 38.26 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.414 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.2 pt -129.32 116.14 18.62 Favored Pre-proline 0 N--CA 1.47 0.545 0 CA-C-N 115.436 -0.802 . . . . 0.0 108.924 177.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -73.55 124.24 9.2 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 120.661 0.907 . . . . 0.0 109.887 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 82.4 t -123.76 117.72 27.36 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 119.94 -0.704 . . . . 0.0 112.03 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.5 146.77 50.58 Favored 'Trans proline' 0 N--CA 1.494 1.514 0 C-N-CA 122.334 2.022 . . . . 0.0 110.753 178.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.404 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.2 OUTLIER -162.88 108.97 1.17 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.514 -178.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.01 35.12 21.3 Favored 'General case' 0 N--CA 1.479 0.983 0 O-C-N 122.022 -0.424 . . . . 0.0 111.411 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.65 -2.74 77.69 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -113.57 135.1 54.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.6 m -120.28 132.27 55.26 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.034 0.445 . . . . 0.0 111.993 -177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -111.02 147.53 34.56 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.807 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -95.26 100.53 12.31 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.521 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -86.92 115.42 62.46 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 120.116 -0.634 . . . . 0.0 112.034 -177.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.38 123.37 3.87 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.874 2.383 . . . . 0.0 111.058 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.521 HG23 HG22 ' A' ' 70' ' ' ILE . 35.2 pt -136.49 149.12 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 118.887 -1.125 . . . . 0.0 112.935 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 53.7 m -123.92 122.42 37.91 Favored 'General case' 0 C--N 1.35 0.604 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.568 177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.4 HD22 HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -97.64 121.6 39.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.025 179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -111.23 119.43 38.89 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 79.5 mt -84.12 139.97 32.09 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.034 -177.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' O ' ' HE2' ' A' ' 15' ' ' TYR . 2.8 mt -89.28 149.38 23.09 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -56.69 -16.58 6.61 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.619 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.0 5.41 43.1 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.156 0.503 . . . . 0.0 111.788 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -63.77 144.08 97.99 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -90.19 5.32 68.53 Favored 'Cis proline' 0 N--CA 1.514 2.693 0 CA-C-N 121.004 1.394 . . . . 0.0 115.227 1.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -70.07 -25.02 63.34 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 118.727 -1.189 . . . . 0.0 109.865 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -103.3 138.2 19.47 Favored Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.37 141.67 75.66 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 CA-C-N 121.767 1.667 . . . . 0.0 111.304 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -82.52 142.87 11.91 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.016 1.81 . . . . 0.0 111.878 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mt -93.55 135.34 28.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 42.2 t -112.09 139.93 47.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.839 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -123.1 124.98 44.31 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.943 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.6 m -84.41 144.48 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -98.29 98.21 5.48 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 119.221 -0.418 . . . . 0.0 110.318 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -80.79 160.18 21.5 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 121.256 1.304 . . . . 0.0 111.921 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.5 t -137.34 161.68 35.62 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 47.2 t -54.64 -39.37 67.91 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 119.839 -0.744 . . . . 0.0 112.177 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.6 t -76.64 -2.25 31.74 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.536 0.607 . . . . 0.0 111.956 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.3 mtp -130.13 145.47 51.7 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.443 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -126.73 163.35 23.72 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.596 179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.443 ' N ' HG23 ' A' ' 96' ' ' THR . 3.3 mm -90.77 110.04 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.567 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -95.09 104.75 16.63 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 34.3 p -67.73 138.17 56.04 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.684 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.76 -133.64 1.93 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.321 -0.712 . . . . 0.0 111.321 -178.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -86.09 -7.26 58.72 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -134.84 -23.09 1.59 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.456 HG21 ' HB2' ' A' ' 140' ' ' PRO . 2.3 t -91.62 134.59 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 119.6 1.091 . . . . 0.0 110.635 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.428 ' O ' HG12 ' A' ' 103' ' ' VAL . 15.3 t0 -84.72 -168.29 2.14 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -86.59 -34.54 19.85 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 121.683 -0.636 . . . . 0.0 112.399 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -88.81 1.26 55.57 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.215 -0.194 . . . . 0.0 110.736 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.01 -8.43 38.89 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.465 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.17 131.67 23.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 117.243 0.522 . . . . 0.0 110.172 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.408 HG22 ' HG ' ' A' ' 111' ' ' LEU . 76.5 mt -97.67 121.5 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.928 0.395 . . . . 0.0 110.535 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -101.87 119.43 38.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.424 ' CD2' HG11 ' A' ' 134' ' ' VAL . 7.1 mt -126.57 113.42 22.91 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.59 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_exo -48.42 -38.27 34.54 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 121.962 1.775 . . . . 0.0 114.25 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -63.82 -31.51 72.71 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.22 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 tt -68.29 -42.23 79.78 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.793 0.33 . . . . 0.0 110.927 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -67.1 -29.26 68.96 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.687 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -104.36 7.15 35.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.229 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -71.6 127.25 31.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 122.033 0.92 . . . . 0.0 110.651 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 23.5 mmmt -97.41 124.72 41.69 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.824 -1.534 . . . . 0.0 108.217 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -80.25 126.64 78.7 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 119.133 -0.46 . . . . 0.0 110.539 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -108.8 93.36 0.03 OUTLIER 'Cis proline' 0 N--CA 1.498 1.755 0 CA-C-N 120.631 1.261 . . . . 0.0 112.778 -2.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -113.69 -60.7 1.85 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.722 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.2 p -69.99 -31.8 69.67 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.791 -178.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.0 p30 48.46 179.91 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.73 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.0 tt -66.88 -43.31 83.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.983 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.553 ' O ' HD13 ' A' ' 125' ' ' LEU . 0.2 OUTLIER -52.9 -40.69 63.73 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.341 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.476 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.1 -39.67 97.93 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.0 tp -59.0 -41.38 87.53 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mm -75.41 -46.88 36.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 119.796 -0.761 . . . . 0.0 111.766 -176.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -36.59 75.73 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.219 -0.992 . . . . 0.0 108.626 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 126' ' ' GLY . 55.6 t -65.49 -42.24 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.197 177.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 56.6 ttm -57.16 -43.47 82.57 Favored 'General case' 0 C--N 1.34 0.173 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.414 HD11 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -59.79 -26.51 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.702 178.285 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.5 t -94.99 -54.61 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 130' ' ' VAL . 11.2 p -63.8 -13.71 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 122.394 -0.191 . . . . 0.0 111.317 -178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 -100.59 -16.92 17.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.433 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.8 -25.36 60.48 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -65.29 -34.5 78.49 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -158.37 83.67 2.65 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -44.25 111.44 0.27 Allowed 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 121.716 1.611 . . . . 0.0 110.984 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.456 ' HB2' HG21 ' A' ' 103' ' ' VAL . 56.9 Cg_endo -72.49 -14.98 27.84 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 121.741 1.627 . . . . 0.0 111.519 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 30.8 m -127.49 139.53 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.643 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -159.41 160.61 35.06 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.319 -0.4 . . . . 0.0 109.953 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.1 m -99.56 121.86 41.79 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.099 0.476 . . . . 0.0 111.287 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 54.2 ttm-85 -111.85 116.45 49.8 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.147 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo . . . . . 0 N--CA 1.495 1.588 0 C-N-CA 121.801 1.668 . . . . 0.0 111.957 179.748 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.3 t -105.28 129.93 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.439 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.48 153.54 19.04 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.527 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 28.5 mp0 -62.64 -41.44 99.03 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.849 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.1 m -58.18 -46.02 86.49 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 122.083 0.944 . . . . 0.0 108.834 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.19 -34.58 77.95 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.548 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.677 HD23 HG13 ' A' ' 22' ' ' VAL . 11.0 tp -57.66 -36.94 72.56 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.527 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 2.4 mptp? -61.71 -44.61 96.6 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.464 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -64.39 -36.36 83.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.34 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.655 ' SD ' HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -69.55 -33.67 73.11 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -177.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 8' ' ' LEU . 2.4 m -114.0 20.98 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 122.021 -0.425 . . . . 0.0 110.906 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.9 t -60.55 -37.67 82.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.194 0.521 . . . . 0.0 111.13 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -62.96 -13.45 34.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.896 -177.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -76.42 155.01 34.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.942 0.401 . . . . 0.0 111.365 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -72.28 -36.9 69.11 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.88 177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -113.06 65.16 0.64 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 116.728 -0.214 . . . . 0.0 111.289 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -63.66 -25.52 68.25 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -73.93 -54.03 8.81 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 113.099 0.778 . . . . 0.0 113.099 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.3 tp -64.29 -38.63 91.73 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.535 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 25' ' ' THR . 95.9 m -61.66 -48.2 81.9 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.752 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.677 HG13 HD23 ' A' ' 8' ' ' LEU . 27.3 t -62.62 -47.96 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 120.751 0.31 . . . . 0.0 111.161 179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -62.7 -42.03 99.44 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.106 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.6 -39.1 93.51 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.305 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.648 ' O ' HG23 ' A' ' 29' ' ' ILE . 40.1 p -68.05 -37.7 81.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.736 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -55.23 -43.05 69.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -60.57 -39.6 88.58 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.47 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.62 ' HA ' HD13 ' A' ' 125' ' ' LEU . 68.7 t -72.55 -40.67 63.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.648 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -88.17 -23.71 6.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.261 -178.13 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.2 m -73.85 -48.7 29.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.097 0.475 . . . . 0.0 109.833 177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.929 HD23 HD21 ' A' ' 125' ' ' LEU . 16.4 tp -84.39 -38.85 19.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.989 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.733 ' HD1' HD11 ' A' ' 125' ' ' LEU . 2.3 m-85 -112.9 65.72 0.64 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.208 0.528 . . . . 0.0 109.986 178.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -58.62 -14.6 8.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.971 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -64.2 -20.92 66.35 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.534 HD23 HD13 ' A' ' 55' ' ' LEU . 2.9 tp -94.54 113.8 25.69 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.8 mtmm -107.87 129.31 24.32 Favored Pre-proline 0 C--N 1.357 0.916 0 CA-C-N 120.094 1.315 . . . . 0.0 111.716 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -84.39 137.04 6.81 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 121.804 1.669 . . . . 0.0 112.991 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.8 m -131.35 154.39 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.655 HD13 ' SD ' ' A' ' 11' ' ' MET . 15.2 tp -94.99 126.11 40.11 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.407 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.9 161.62 26.19 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.48 0.657 . . . . 0.0 112.091 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -97.64 124.59 42.0 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.358 178.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.63 131.55 54.78 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 118.306 0.503 . . . . 0.0 109.892 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.8 t -117.31 123.18 71.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.59 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -104.09 156.16 18.1 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -58.89 -27.97 65.71 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.717 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.84 -16.38 61.19 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.665 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.1 -8.73 67.61 Favored Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.5 m -74.76 150.61 39.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 92.2 p -130.72 154.63 47.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.123 0.487 . . . . 0.0 110.777 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 -161.5 136.01 7.09 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.223 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.82 121.33 23.22 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.91 0.862 . . . . 0.0 109.976 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.508 HD21 ' O ' ' A' ' 76' ' ' LEU . 11.8 tp -120.31 131.91 55.08 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.316 -177.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 61.2 ttp -91.03 137.77 32.11 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.884 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -131.23 152.04 50.89 Favored 'General case' 0 CA--C 1.516 -0.361 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.931 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.534 HD13 HD23 ' A' ' 35' ' ' LEU . 9.2 mt -100.96 130.47 46.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 51.1 m -145.55 137.88 25.69 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.071 0.463 . . . . 0.0 111.857 -177.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.71 -145.21 9.34 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.279 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.4 p -131.26 158.15 41.39 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.659 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.4 pt -132.48 116.33 15.1 Favored Pre-proline 0 N--CA 1.473 0.71 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.608 177.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -69.03 124.16 11.09 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 CA-C-N 119.98 1.029 . . . . 0.0 110.849 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 98.8 t -127.6 112.59 20.87 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.259 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -80.18 151.6 20.78 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.879 2.386 . . . . 0.0 112.62 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.403 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.0 OUTLIER -163.5 115.03 1.43 Allowed 'General case' 0 CA--C 1.56 1.343 0 CA-C-O 121.546 0.689 . . . . 0.0 111.23 179.046 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 49.97 38.93 17.57 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.86 -4.49 85.67 Favored Glycine 0 N--CA 1.473 1.151 0 O-C-N 121.727 -0.608 . . . . 0.0 113.025 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -119.6 130.29 55.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.97 0.414 . . . . 0.0 109.98 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.8 m -118.25 131.41 56.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.685 -178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -113.28 149.29 34.08 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.949 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -97.13 102.64 14.46 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.453 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -89.39 119.15 69.62 Favored Pre-proline 0 N--CA 1.476 0.836 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -177.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -84.39 128.58 4.16 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.784 2.323 . . . . 0.0 110.624 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.453 HG23 HG22 ' A' ' 70' ' ' ILE . 23.1 pt -134.5 147.5 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 119.276 -0.969 . . . . 0.0 111.971 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 69.3 m -120.62 122.48 40.6 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 121.534 0.683 . . . . 0.0 110.021 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.19 114.4 28.51 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.326 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -105.23 122.99 47.08 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.508 ' O ' HD21 ' A' ' 52' ' ' LEU . 63.4 mt -93.86 131.12 39.58 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.738 -177.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mt -74.82 149.43 39.65 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -56.9 -14.18 3.28 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 120.63 -0.428 . . . . 0.0 111.577 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.6 0.29 36.07 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -51.79 144.71 18.42 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.419 ' HG2' ' CD2' ' A' ' 119' ' ' HIS . 29.0 Cg_endo -93.62 10.1 53.6 Favored 'Cis proline' 0 N--CA 1.516 2.81 0 CA-C-N 120.842 1.336 . . . . 0.0 115.369 0.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -75.45 -12.0 60.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.235 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.17 121.81 35.74 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.88 137.65 35.21 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 CA-C-N 121.182 1.458 . . . . 0.0 111.995 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -82.12 142.11 12.06 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.19 1.927 . . . . 0.0 111.488 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.31 133.43 40.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.699 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 53.3 t -114.69 143.45 45.02 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.017 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -127.86 131.14 49.5 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.681 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.7 t -103.92 126.31 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.14 101.78 5.32 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.957 -178.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -83.82 129.24 4.73 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.622 1.548 . . . . 0.0 113.254 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 63.4 p -80.91 165.54 21.7 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.7 p -59.27 -25.07 63.77 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.8 t -99.51 23.76 9.03 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.971 0.805 . . . . 0.0 109.888 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 38.7 ttm -129.64 139.41 51.42 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.888 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 72.6 m -115.64 133.06 56.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.019 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 97' ' ' ILE . 1.4 tp -84.26 106.94 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.971 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -87.22 99.27 11.83 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.352 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.6 p -67.67 143.11 56.14 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.74 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.76 -152.45 6.9 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -74.59 -15.63 60.83 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -114.15 -27.35 7.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.578 HG21 ' HB2' ' A' ' 140' ' ' PRO . 2.0 t -106.65 136.09 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -100.07 175.78 5.63 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.15 93.55 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -79.34 -17.84 53.71 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.02 33.78 2.71 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.215 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -82.21 148.48 28.4 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.1 mt -113.61 116.01 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.604 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.36 116.61 32.45 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.6 mt -126.05 113.71 24.13 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 118.249 0.477 . . . . 0.0 110.942 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -48.21 -37.55 31.57 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.733 1.622 . . . . 0.0 114.661 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.43 ' OH ' HD13 ' A' ' 127' ' ' LEU . 1.7 p90 -61.47 -32.24 72.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.652 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.409 ' N ' ' CG ' ' A' ' 113' ' ' TYR . 0.8 OUTLIER -68.55 -41.5 79.72 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.717 -178.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -62.99 -33.86 76.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.628 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -101.03 2.88 40.95 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.163 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -52.5 123.08 10.12 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.992 0.901 . . . . 0.0 110.221 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -101.58 100.22 10.6 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.809 -1.541 . . . . 0.0 108.797 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.419 ' CD2' ' HG2' ' A' ' 81' ' ' PRO . 23.5 t-80 -57.03 122.29 52.24 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.897 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -111.66 91.24 0.03 OUTLIER 'Cis proline' 0 N--CA 1.495 1.576 0 CA-C-N 120.687 1.281 . . . . 0.0 112.235 -3.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -114.96 -51.63 2.72 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.984 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.3 m -71.24 -41.33 70.28 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.983 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t70 66.53 165.04 0.2 Allowed 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.585 0.707 . . . . 0.0 111.807 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.459 HD23 HG21 ' A' ' 28' ' ' VAL . 21.9 tp -67.05 -41.13 87.01 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.694 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.929 HD21 HD23 ' A' ' 31' ' ' LEU . 30.3 tp -59.69 -37.28 78.39 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -60.87 -39.6 97.12 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 177.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.43 HD13 ' OH ' ' A' ' 113' ' ' TYR . 31.2 tp -57.37 -39.51 76.17 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.416 HD12 HD13 ' A' ' 35' ' ' LEU . 1.2 mm -72.08 -49.3 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.619 -177.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -66.92 -35.68 80.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 118.661 -1.216 . . . . 0.0 108.683 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 126' ' ' GLY . 54.6 t -64.25 -38.63 83.0 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.727 0 C-N-CA 119.432 -0.907 . . . . 0.0 108.864 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.7 tpp -60.49 -43.12 97.36 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.659 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.1 mp -67.92 -36.64 76.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.683 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 89.5 t -81.59 -41.5 18.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.47 HG13 ' CD2' ' A' ' 135' ' ' PHE . 2.1 p -77.71 -15.62 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.784 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.47 ' CD2' HG13 ' A' ' 134' ' ' VAL . 13.8 m-30 -107.3 -18.08 13.97 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.393 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.88 -27.1 69.64 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -66.47 -27.56 67.89 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.635 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -168.18 89.72 0.66 Allowed Pre-proline 0 C--O 1.232 0.15 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -44.76 119.35 2.28 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.67 1.58 . . . . 0.0 110.588 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.578 ' HB2' HG21 ' A' ' 103' ' ' VAL . 55.3 Cg_endo -70.97 -16.3 32.46 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 121.561 1.507 . . . . 0.0 111.448 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 25.2 m -129.17 140.37 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.337 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -159.52 160.7 34.87 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 68.2 m -106.77 130.23 54.51 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 120.86 0.362 . . . . 0.0 110.708 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.4 ttm-85 -112.25 113.69 51.33 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.177 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.495 1.578 0 C-N-CA 122.063 1.842 . . . . 0.0 112.187 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.515 HG11 ' HG2' ' A' ' 37' ' ' PRO . 3.9 p -63.64 143.38 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-O 121.586 0.707 . . . . 0.0 110.957 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -104.96 153.81 20.93 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 91.0 mt-10 -59.47 -42.48 92.16 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.109 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.2 m -58.23 -47.89 82.09 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.952 0.882 . . . . 0.0 109.355 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -62.57 -34.42 76.94 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.95 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.819 HD23 HG13 ' A' ' 22' ' ' VAL . 13.2 tp -56.09 -39.27 71.89 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HD3' ' O ' ' A' ' 5' ' ' GLU . 11.0 mptt -61.05 -43.95 98.13 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.557 0.694 . . . . 0.0 109.613 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.03 -36.32 83.18 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.617 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.78 ' SD ' HD13 ' A' ' 39' ' ' LEU . 1.4 mmm -66.92 -37.04 83.6 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.619 -178.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -115.73 23.46 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.526 0.203 . . . . 0.0 111.245 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 90.3 p -66.62 -18.13 65.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.705 0.288 . . . . 0.0 111.029 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -77.41 -20.78 54.12 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.121 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -72.47 149.88 43.79 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -66.23 -40.04 89.99 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.789 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -110.56 64.21 0.61 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.783 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -65.24 -27.74 68.87 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -72.37 -49.48 33.71 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 tt -65.37 -41.7 93.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 119.634 -0.827 . . . . 0.0 109.389 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 25' ' ' THR . 53.1 m -60.22 -48.49 81.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.156 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.819 HG13 HD23 ' A' ' 8' ' ' LEU . 20.8 t -63.55 -46.02 96.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 120.536 0.208 . . . . 0.0 111.445 179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.74 -42.74 99.36 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.619 -178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.48 -34.19 72.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.541 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.614 ' O ' HG23 ' A' ' 29' ' ' ILE . 24.9 p -66.21 -38.49 88.09 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.4 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 30' ' ' THR . 53.2 t -57.64 -45.42 86.48 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -61.24 -38.77 87.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.327 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.516 HG21 HD22 ' A' ' 124' ' ' LEU . 55.2 t -67.12 -46.05 85.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -81.81 -13.5 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.33 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 26' ' ' VAL . 3.0 p -76.33 -52.09 10.64 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 178.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.0 tp -85.03 -38.15 19.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.416 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -108.89 64.26 0.61 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.135 0.493 . . . . 0.0 109.89 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -55.31 -18.82 7.09 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.534 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -65.5 -22.55 66.74 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.364 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.55 HD23 HD13 ' A' ' 55' ' ' LEU . 2.0 tp -91.18 113.86 26.23 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.0 ttpt -110.69 132.24 21.69 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.576 1.08 . . . . 0.0 111.805 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.515 ' HG2' HG11 ' A' ' 3' ' ' VAL . 43.5 Cg_endo -81.43 135.01 9.15 Favored 'Trans proline' 0 N--CA 1.504 2.126 0 C-N-CA 122.242 1.961 . . . . 0.0 112.94 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -131.56 137.01 56.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.78 HD13 ' SD ' ' A' ' 11' ' ' MET . 15.4 tp -82.41 121.77 27.15 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.27 160.04 24.73 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.731 0.3 . . . . 0.0 110.925 -178.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m -99.8 131.68 45.63 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -116.44 136.11 53.27 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 120.764 -0.374 . . . . 0.0 110.141 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 70.8 t -109.56 121.21 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.767 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -94.61 159.65 14.98 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.993 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -66.15 -12.87 58.62 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.331 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -82.8 -9.14 59.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.398 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.35 -8.11 79.53 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.5 m -83.12 145.04 29.45 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.037 0.446 . . . . 0.0 109.925 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.9 t -113.25 142.23 46.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.15 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -144.4 134.7 24.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.265 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -81.16 122.97 28.03 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.672 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 52' ' ' LEU . 51.4 mt -122.29 144.17 49.16 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.936 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.491 ' SD ' HD11 ' A' ' 8' ' ' LEU . 57.9 ttp -97.43 139.09 33.88 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 120.906 -0.318 . . . . 0.0 110.84 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -132.35 150.55 52.13 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 121.161 0.505 . . . . 0.0 111.254 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.55 HD13 HD23 ' A' ' 35' ' ' LEU . 7.0 mt -98.38 124.19 42.92 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.2 m -134.97 138.62 44.2 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.68 -145.33 9.65 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.58 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.6 p -133.27 159.39 40.37 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.42 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.1 pt -133.73 116.56 13.77 Favored Pre-proline 0 N--CA 1.472 0.641 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.38 177.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -70.95 127.56 13.8 Favored 'Trans proline' 0 N--CA 1.501 1.92 0 CA-C-N 120.058 1.057 . . . . 0.0 110.014 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 89.8 t -127.31 118.1 21.7 Favored Pre-proline 0 C--N 1.347 0.485 0 C-N-CA 119.778 -0.769 . . . . 0.0 112.284 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.29 142.23 37.04 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.885 1.723 . . . . 0.0 110.066 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.402 ' HD2' ' OD1' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -159.77 113.46 2.24 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.888 -178.826 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.3 ttt180 60.84 25.37 15.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 120.164 -0.615 . . . . 0.0 111.755 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.86 -13.23 67.36 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.563 ' C ' ' OD1' ' A' ' 66' ' ' ASN . 3.1 p-10 -99.85 169.96 8.86 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.1 m -139.88 133.98 31.01 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.515 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -121.08 148.62 43.91 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.304 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.34 106.66 18.92 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.544 HG22 HG23 ' A' ' 72' ' ' ILE . 1.6 mp -91.7 115.41 64.48 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.215 -177.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.56 126.3 4.66 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.304 2.003 . . . . 0.0 110.376 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.544 HG23 HG22 ' A' ' 70' ' ' ILE . 27.0 pt -133.97 150.44 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 119.156 -1.018 . . . . 0.0 112.091 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 58.6 m -121.61 120.68 35.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.81 115.68 31.07 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.929 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -109.24 128.05 54.74 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 74.8 mt -97.3 142.02 29.69 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.043 -176.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mt -87.45 151.41 23.07 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 178.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -58.92 -15.16 11.48 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.87 5.48 33.02 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.204 0.526 . . . . 0.0 112.233 179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -60.93 145.59 88.76 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -92.42 10.26 57.56 Favored 'Cis proline' 0 N--CA 1.516 2.798 0 CA-C-N 120.856 1.341 . . . . 0.0 114.753 0.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -73.59 -12.17 60.67 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.84 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.48 127.78 26.49 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.66 -0.686 . . . . 0.0 109.408 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -49.39 134.28 31.72 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 CA-C-N 121.192 1.461 . . . . 0.0 112.217 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.416 ' HD2' HD11 ' A' ' 114' ' ' LEU . 86.3 Cg_endo -79.9 142.12 15.51 Favored 'Trans proline' 0 N--CA 1.501 1.914 0 C-N-CA 122.366 2.044 . . . . 0.0 111.274 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.6 mt -98.75 135.67 32.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.088 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 34.3 t -121.66 145.98 47.46 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.023 -178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -125.71 134.48 51.78 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.159 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.403 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 4.8 p -95.65 127.92 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -69.3 107.42 2.15 Favored Pre-proline 0 N--CA 1.474 0.765 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 44.5 Cg_endo -84.8 155.91 11.73 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.268 1.312 . . . . 0.0 113.147 -178.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 29.3 p -129.01 169.85 14.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.062 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.7 m -59.18 -39.59 83.03 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.9 m -89.92 -3.61 57.96 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.617 0.644 . . . . 0.0 111.53 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 40.7 ttm -116.23 137.15 52.39 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.469 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -129.22 165.83 20.59 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.109 179.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.469 ' N ' HG23 ' A' ' 96' ' ' THR . 70.2 mt -111.27 108.78 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 120.37 -0.532 . . . . 0.0 109.716 178.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -97.52 126.91 43.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 81.9 p -72.01 143.6 49.11 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.92 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.54 -142.18 3.5 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.752 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -66.0 -26.6 67.62 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -178.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.484 ' NE2' HG23 ' A' ' 103' ' ' VAL . 20.5 p-80 -133.68 -26.67 1.57 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.484 HG23 ' NE2' ' A' ' 102' ' ' HIS . 0.9 OUTLIER -92.72 132.08 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 119.477 1.035 . . . . 0.0 110.536 -179.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -98.97 175.41 5.94 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.45 77.42 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -74.94 -9.83 58.91 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.415 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 99.69 5.29 55.45 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.156 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.42 147.26 53.73 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.468 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.527 HD13 ' CZ ' ' A' ' 135' ' ' PHE . 96.8 mt -120.74 125.13 73.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -99.7 137.82 37.65 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.679 HD22 HG11 ' A' ' 134' ' ' VAL . 29.2 mt -136.61 116.57 10.87 Favored Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.441 -178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -47.56 -37.36 26.37 Favored 'Trans proline' 0 N--CA 1.504 2.091 0 C-N-CA 122.075 1.85 . . . . 0.0 114.505 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -61.09 -29.37 69.71 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.679 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.416 HD11 ' HD2' ' A' ' 85' ' ' PRO . 1.2 tt -69.8 -43.16 72.64 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.489 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -68.05 -27.61 66.67 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.378 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -103.86 3.91 34.31 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.932 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . 0.479 ' CD1' ' C ' ' A' ' 117' ' ' TRP . 1.6 t90 -70.16 120.05 15.26 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.806 0.812 . . . . 0.0 109.742 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -88.05 129.51 35.26 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.161 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 46.4 t-80 -78.81 124.06 85.11 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.463 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 14.0 Cg_endo -111.04 93.1 0.03 OUTLIER 'Cis proline' 0 N--CA 1.496 1.664 0 CA-C-N 120.953 1.376 . . . . 0.0 111.63 -3.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -113.6 -56.17 2.43 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.232 -0.587 . . . . 0.0 112.115 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.5 t -74.3 -34.61 63.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.773 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 47.02 -176.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.707 0.765 . . . . 0.0 111.621 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 28' ' ' VAL . 1.0 OUTLIER -69.52 -40.59 76.84 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.306 -179.369 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.1 tt -55.68 -39.51 71.07 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -62.58 -39.86 98.4 Favored Glycine 0 N--CA 1.479 1.532 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.4 tp -57.6 -40.28 78.74 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.444 HD12 HD13 ' A' ' 35' ' ' LEU . 1.1 mm -73.19 -49.96 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.816 -176.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.41 ' OE1' HG21 ' A' ' 132' ' ' ILE . 10.6 tp-100 -64.78 -35.92 82.63 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 126' ' ' GLY . 73.5 t -68.25 -37.27 77.77 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.795 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.4 tpp -58.32 -43.04 88.0 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.42 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -62.65 -39.63 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.13 178.675 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.9 t -81.48 -47.32 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.679 HG11 HD22 ' A' ' 111' ' ' LEU . 4.7 p -67.71 -15.47 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.34 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.527 ' CZ ' HD13 ' A' ' 109' ' ' ILE . 10.8 m-30 -106.57 -19.34 13.7 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.138 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.21 -37.29 93.85 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 107.846 -2.102 . . . . 0.0 107.846 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -64.88 -36.87 85.76 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 114.762 -0.719 . . . . 0.0 110.687 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -158.1 81.99 2.9 Favored Pre-proline 0 CA--C 1.52 -0.195 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -51.04 128.88 26.34 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 120.709 0.939 . . . . 0.0 109.731 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.43 -15.25 34.56 Favored 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.469 1.446 . . . . 0.0 112.142 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 23.1 m -132.64 153.72 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.974 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.35 166.08 34.05 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 28.3 m -85.78 121.94 29.16 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.122 0.487 . . . . 0.0 111.414 -178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -111.73 110.66 54.73 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.99 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 N--CA 1.495 1.592 0 C-N-CA 121.919 1.746 . . . . 0.0 112.079 -179.912 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.485 HG13 ' HE3' ' A' ' 11' ' ' MET . 76.6 t -89.21 129.87 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.767 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -95.68 158.36 15.48 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.502 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 94.9 mt-10 -63.34 -41.73 98.89 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.267 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -60.33 -48.29 82.39 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.225 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -63.51 -27.73 69.47 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.152 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.938 HD23 HG13 ' A' ' 22' ' ' VAL . 38.7 tp -61.23 -41.69 97.31 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.658 ' NZ ' HG11 ' A' ' 22' ' ' VAL . 3.4 mptp? -59.27 -38.95 81.38 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.208 0.528 . . . . 0.0 109.824 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -61.61 -34.69 76.08 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.128 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.792 ' CB ' HD13 ' A' ' 39' ' ' LEU . 11.8 ptp -84.31 -14.58 49.31 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 119.927 -0.709 . . . . 0.0 112.808 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -126.34 17.97 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.413 179.34 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 45.9 t -61.92 -37.75 85.85 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.817 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -64.6 -19.82 65.89 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.875 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.449 ' CE1' HG12 ' A' ' 12' ' ' VAL . 35.9 m-85 -72.11 152.64 42.2 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 -179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -75.44 -26.14 58.05 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.675 0.274 . . . . 0.0 110.683 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -120.67 60.36 0.9 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.403 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.431 ' O ' HG23 ' A' ' 22' ' ' VAL . 19.8 ptt180 -64.77 -25.42 67.91 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -71.7 -55.82 6.97 Favored 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 mt -64.39 -39.72 94.4 Favored 'General case' 0 CA--C 1.516 -0.339 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.088 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.4 m -62.47 -47.85 82.2 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.876 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.938 HG13 HD23 ' A' ' 8' ' ' LEU . 25.8 t -62.56 -47.24 93.9 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 CA-C-O 120.837 0.351 . . . . 0.0 110.673 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -40.44 95.16 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.044 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -63.42 -39.55 94.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.583 178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 29' ' ' ILE . 57.5 p -70.48 -35.56 73.33 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.252 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 22' ' ' VAL . 59.7 t -56.89 -44.37 82.12 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -62.0 -39.78 93.4 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.485 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.57 HG21 HD22 ' A' ' 124' ' ' LEU . 76.6 t -70.76 -43.43 77.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.669 HG23 ' O ' ' A' ' 25' ' ' THR . 0.1 OUTLIER -87.01 -17.94 8.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.517 -177.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 94.9 m -82.7 -47.2 12.27 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.092 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.589 HD23 HD11 ' A' ' 125' ' ' LEU . 32.7 tp -87.9 -37.8 16.15 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.937 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -109.12 65.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -59.0 -16.95 20.65 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.973 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -64.95 -21.1 66.78 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.116 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.584 HD13 HD12 ' A' ' 128' ' ' ILE . 2.1 tp -98.16 124.01 42.5 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -118.07 129.28 25.47 Favored Pre-proline 0 C--N 1.36 1.061 0 CA-C-N 120.221 1.373 . . . . 0.0 111.946 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -80.89 136.53 10.58 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 121.593 1.529 . . . . 0.0 112.81 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.3 t -128.39 135.59 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 178.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.792 HD13 ' CB ' ' A' ' 11' ' ' MET . 40.9 tp -83.1 122.14 27.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.02 151.24 48.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.219 0.533 . . . . 0.0 112.041 -178.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 72.8 m -98.68 119.33 37.23 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -103.94 139.09 39.58 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.992 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 69.2 t -115.16 124.23 71.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.862 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -95.33 166.12 12.04 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.318 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.42 -39.72 84.4 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.653 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 52.4 p-10 -65.66 -9.41 27.09 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.819 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.43 -11.98 69.51 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 75.8 m -61.45 136.08 57.9 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.6 m -122.35 140.08 53.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.116 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.44 129.58 11.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.055 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -76.33 116.1 16.69 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.323 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 74.4 mt -122.86 138.31 54.69 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.454 ' SD ' HD11 ' A' ' 8' ' ' LEU . 64.2 ttp -84.29 139.55 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.137 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -125.88 156.4 39.71 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.198 0.523 . . . . 0.0 110.897 -178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 55' ' ' LEU . 2.5 mm? -108.99 117.69 34.85 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.0 m -134.13 137.99 44.92 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.088 0.471 . . . . 0.0 112.159 -177.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 167.27 -149.65 15.31 Favored Glycine 0 C--N 1.337 0.635 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.896 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.9 p -132.01 158.94 40.21 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.433 ' HB ' HD11 ' A' ' 132' ' ' ILE . 1.2 pt -132.58 115.97 14.86 Favored Pre-proline 0 C--O 1.237 0.433 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.416 177.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -73.74 125.46 10.01 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.8 1.0 . . . . 0.0 110.197 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 97.3 t -124.73 119.34 25.77 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 120.082 -0.647 . . . . 0.0 111.875 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.63 147.42 57.27 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.187 1.925 . . . . 0.0 109.675 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.41 ' O ' ' CG ' ' A' ' 63' ' ' TYR . 0.6 OUTLIER -163.74 108.79 1.04 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 120.06 -0.656 . . . . 0.0 112.339 -177.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.1 ttp180 49.65 44.23 24.47 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 71.79 13.89 75.36 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 120.36 -0.924 . . . . 0.0 110.839 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -134.77 131.15 37.21 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.1 m -117.4 132.47 56.57 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.847 0.356 . . . . 0.0 111.797 -177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -112.68 148.88 33.75 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.99 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -95.95 102.46 14.26 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.447 HG22 HG23 ' A' ' 72' ' ' ILE . 1.7 mp -91.22 116.28 66.12 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 120.141 -0.624 . . . . 0.0 112.262 -177.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.9 127.55 4.2 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.654 2.236 . . . . 0.0 110.308 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.447 HG23 HG22 ' A' ' 70' ' ' ILE . 26.4 pt -134.57 146.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.541 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 84.8 m -120.57 121.63 38.8 Favored 'General case' 0 C--N 1.345 0.375 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.83 120.09 39.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.664 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -104.39 117.94 35.4 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 53.3 mt -84.56 137.69 33.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mt -88.36 154.91 20.01 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.8 p30 -63.4 -13.83 43.92 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.799 -0.36 . . . . 0.0 111.501 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 p -99.24 -4.35 32.17 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -55.83 145.11 54.1 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -91.18 6.29 66.54 Favored 'Cis proline' 0 N--CA 1.514 2.732 0 CA-C-N 121.121 1.436 . . . . 0.0 115.697 1.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -71.27 -19.2 62.38 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 118.974 -1.09 . . . . 0.0 110.349 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -111.21 139.5 21.95 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.056 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.0 142.76 63.22 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 CA-C-N 121.665 1.63 . . . . 0.0 110.867 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.16 142.84 17.31 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.955 1.77 . . . . 0.0 111.906 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.6 mt -92.41 134.59 29.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 39.0 t -107.78 144.35 35.06 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.765 -177.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.56 126.06 43.04 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.272 178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.42 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 57.3 t -98.39 130.31 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 99.36 3.53 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 123.44 0.463 . . . . 0.0 109.873 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 89' ' ' VAL . 44.2 Cg_endo -86.85 148.09 8.25 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 121.387 1.391 . . . . 0.0 113.23 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.3 p -95.95 165.27 12.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.553 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.7 t -55.16 -19.11 6.93 Favored 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.2 t -105.52 15.65 26.73 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.002 0.819 . . . . 0.0 111.572 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 62.4 mtp -132.77 141.83 48.71 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.458 HG23 ' N ' ' A' ' 97' ' ' ILE . 0.4 OUTLIER -125.43 163.64 22.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.063 179.673 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.458 ' N ' HG23 ' A' ' 96' ' ' THR . 4.3 mm -93.02 101.98 13.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -84.89 104.71 15.08 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 119.439 -0.905 . . . . 0.0 108.802 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.7 p -72.61 150.07 43.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.349 -179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -170.5 -137.49 2.3 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.562 -0.827 . . . . 0.0 111.769 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -67.73 -21.08 65.31 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -177.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.531 ' CE1' HG23 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -132.57 -29.54 1.53 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 119.013 -1.075 . . . . 0.0 112.884 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.683 HG21 ' HB2' ' A' ' 140' ' ' PRO . 6.2 t -88.97 140.3 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.739 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -103.16 176.45 5.14 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.441 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.33 94.2 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -88.39 0.3 56.37 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.292 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 98.48 11.74 46.95 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.259 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -64.46 141.47 58.76 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.466 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.9 mt -109.49 115.57 49.93 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.072 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.42 ' C ' ' HG ' ' A' ' 111' ' ' LEU . 27.5 m-85 -104.57 136.23 44.5 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.42 ' HG ' ' C ' ' A' ' 110' ' ' TYR . 2.1 mt -135.17 124.84 16.62 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.3 -32.7 52.34 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 121.365 1.376 . . . . 0.0 113.519 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -67.51 -31.8 72.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.75 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.02 -41.67 74.0 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.162 -179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.8 m170 -71.16 -26.54 63.03 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.29 -178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -100.71 -0.75 36.72 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.22 177.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -53.97 126.01 20.91 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 122.055 0.931 . . . . 0.0 110.733 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -97.98 94.5 6.9 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.633 -1.621 . . . . 0.0 108.239 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 120' ' ' PRO . 57.8 t60 -59.68 124.51 76.38 Favored Pre-proline 0 C--N 1.323 -0.556 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.067 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 119' ' ' HIS . 9.6 Cg_endo -108.88 91.71 0.03 OUTLIER 'Cis proline' 0 N--CA 1.497 1.708 0 CA-C-N 120.454 1.198 . . . . 0.0 112.948 -2.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -113.07 -58.16 2.19 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.463 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 35.6 t -67.37 -40.6 85.78 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.314 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 64.37 166.21 0.15 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.741 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.57 HD22 HG21 ' A' ' 28' ' ' VAL . 7.8 tt -61.03 -41.84 97.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.589 HD11 HD23 ' A' ' 31' ' ' LEU . 5.4 tt -57.17 -36.16 70.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 130' ' ' VAL . . . -60.28 -39.8 96.54 Favored Glycine 0 N--CA 1.476 1.336 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 tp -60.74 -40.79 93.71 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.584 HD12 HD13 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -75.17 -47.59 35.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.683 -176.649 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -68.81 -36.48 78.29 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.021 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.542 ' O ' HG12 ' A' ' 134' ' ' VAL . 79.4 t -66.85 -39.75 84.29 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.081 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.1 ttm -58.73 -44.5 90.49 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.433 HD11 ' HB ' ' A' ' 59' ' ' ILE . 1.0 OUTLIER -60.26 -34.97 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.815 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 72.8 t -90.36 -46.22 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.543 HG13 ' CD2' ' A' ' 135' ' ' PHE . 4.9 p -68.91 -13.31 17.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.723 -178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.543 ' CD2' HG13 ' A' ' 134' ' ' VAL . 12.6 m-30 -103.76 -15.17 15.81 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.024 178.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -71.88 -24.92 75.94 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -70.45 -34.53 72.55 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.595 0.236 . . . . 0.0 111.012 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -162.38 83.13 1.64 Allowed Pre-proline 0 N--CA 1.455 -0.205 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -49.17 124.18 11.24 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 121.222 1.281 . . . . 0.0 110.752 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.683 ' HB2' HG21 ' A' ' 103' ' ' VAL . 57.1 Cg_endo -72.9 -18.56 24.38 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 121.741 1.627 . . . . 0.0 112.019 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.11 146.03 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.151 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -159.47 162.29 35.58 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.3 m -85.46 118.29 24.89 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.101 0.477 . . . . 0.0 111.599 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.0 131.21 23.27 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.1 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo . . . . . 0 N--CA 1.491 1.364 0 C-N-CA 121.601 1.534 . . . . 0.0 112.195 -179.741 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' 4N1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_